PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Akum, BF; Chen, M; Gunderson, SI; Riefler, GM; Scerri-Hansen, MM; Firestein, BL				Akum, BF; Chen, M; Gunderson, SI; Riefler, GM; Scerri-Hansen, MM; Firestein, BL			Cypin regulates dendrite patterning in hippocampal neurons by promoting microtubule assembly	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; PRE-MESSENGER-RNA; GUANINE DEAMINASE; MAMMALIAN-CELLS; BRAIN TUBULIN; IN-VIVO; RHO; PROTEIN; GROWTH; MOUSE	Dendrite branching has an important role in normal brain function. Here we report that overexpression of cypin, a protein that has guanine deaminase activity and is expressed in developing processes in rat hippocampal neurons, results in increased dendrite branching in primary culture. Mutant cypin proteins that lack guanine deaminase activity act in a dominant-negative manner when expressed in primary neurons. Furthermore, we knocked down cypin protein levels using a new strategy: expressing a 5' end-mutated U1 small nuclear RNA (snRNA) to inhibit maturation of cypin mRNA. Neurons that express this mutant snRNA show little or no detectable cypin protein and fewer dendrites than normal. In addition, we found that cypin binds directly to tubulin heterodimers and promotes microtubule polymerization. Thus, our results demonstrate a new pathway by which dendrite patterning is regulated, and we also introduce a new method for decreasing endogenous protein expression in neurons.	Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; Rutgers State Univ, Mol Biosci Grad Program, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057286] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57286] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CLAIBORNE BJ, 1992, METHODS NEUROSCIENCE, V10, P315; El-Hussein AE, 2000, SCIENCE, V290, P1364; Ellezam B, 2002, PROG BRAIN RES, V137, P371; FELIPO V, 1990, NEUROCHEM RES, V15, P945, DOI 10.1007/BF00965917; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hernandez-Deviez DJ, 2002, NAT NEUROSCI, V5, P623, DOI 10.1038/nn865; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LI W, 1992, GENETICS, V132, P675; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MINANA MD, 1989, NEUROCHEM RES, V14, P235, DOI 10.1007/BF00971316; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Paletzki RF, 2002, NEUROSCIENCE, V109, P15, DOI 10.1016/S0306-4522(01)00352-9; Petrausch B, 2000, J NEUROSCI, V20, P8031; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; SCHMIDT CJ, 1994, J NEUROSCI RES, V38, P182, DOI 10.1002/jnr.490380208; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; VOLONTE C, 1989, J CELL BIOL, V109, P2395, DOI 10.1083/jcb.109.5.2395; Wang LH, 1997, J NEUROCHEM, V69, P2261; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Wong WT, 2000, J NEUROSCI, V20, P5024; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuan G, 1999, J BIOL CHEM, V274, P8175, DOI 10.1074/jbc.274.12.8175; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	33	108	111	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					145	152		10.1038/nn1179	http://dx.doi.org/10.1038/nn1179			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730308				2022-12-28	WOS:000188468500012
J	Engblom, D; Saha, S; Engstrom, L; Westman, M; Audoly, LP; Jakobsson, PJ; Blomqvist, A				Engblom, D; Saha, S; Engstrom, L; Westman, M; Audoly, LP; Jakobsson, PJ; Blomqvist, A			Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis	NATURE NEUROSCIENCE			English	Article							MICE LACKING; IDENTIFICATION; INDUCTION; CELLS	We studied the febrile response in mice deficient in microsomal prostaglandin E synthase-1 (mPGES-1), an inducible terminal isomerase expressed in cytokine-sensitive brain endothelial cells. These animals showed no fever and no central prostaglandin (PG) E-2 synthesis after peripheral injection of bacterial-wall lipopolysaccharide, but their pyretic capacity in response to centrally administered PGE(2) was intact. Our findings identify mPGES-1 as the central switch during immune-induced pyresis and as a target for the treatment of fever and other PGE(2)-dependent acute phase reactions elicited by the brain.	Linkoping Univ, Fac Hlth Sci, Div Cell Biol, S-58185 Linkoping, Sweden; Karolinska Inst, Ctr Struct Biochem, S-14157 Huddinge, Sweden; Karolinska Inst, Dept Biochem & Biophys, S-17177 Stockholm, Sweden; Pfizer Inc, Global Res & Dev, Groton Labs, Inflammat Unit, Groton, CT 06340 USA	Linkoping University; Karolinska Institutet; Karolinska Institutet; Pfizer	Blomqvist, A (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Cell Biol, S-58185 Linkoping, Sweden.	andbl@ibk.liu.se	Blomqvist, Anders/K-3990-2019; Jakobsson, Per-Johan/ABC-5594-2021	Blomqvist, Anders/0000-0002-6928-4473; Engstrom Ruud, Linda/0000-0002-3924-5844				Dinarello CA, 1999, CURR BIOL, V9, pR147, DOI 10.1016/S0960-9822(99)80085-2; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Engblom D, 2002, J COMP NEUROL, V452, P205, DOI 10.1002/cne.10380; Engblom D, 2002, J MOL MED, V80, P5, DOI 10.1007/s00109-001-0289-z; Inoue W, 2002, NEUROSCI RES, V44, P51, DOI 10.1016/S0168-0102(02)00083-4; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Wang JP, 1997, NEUROIMMUNOMODULAT, V4, P230, DOI 10.1159/000097341; Yamagata K, 2001, J NEUROSCI, V21, P2669, DOI 10.1523/JNEUROSCI.21-08-02669.2001	14	240	259	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1137	1138		10.1038/nn1137	http://dx.doi.org/10.1038/nn1137			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14566340				2022-12-28	WOS:000186229200009
J	Blanchi, B; Kelly, LM; Viemari, JC; Lafon, I; Burnet, H; Bevengut, M; Tillmanns, S; Daniel, L; Graf, T; Hilaire, G; Sieweke, MH				Blanchi, B; Kelly, LM; Viemari, JC; Lafon, I; Burnet, H; Bevengut, M; Tillmanns, S; Daniel, L; Graf, T; Hilaire, G; Sieweke, MH			MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; INFANT-DEATH-SYNDROME; IN-VIVO; PREBOTZINGER COMPLEX; EXPRESSION PATTERN; SEGMENTATION GENE; PACEMAKER NEURONS; RHYTHM GENERATION; REVEALS; MATURATION	The genetic basis for the development of brainstem neurons that generate respiratory rhythm is unknown. Here we show that mice deficient for the transcription factor MafB die from central apnea at birth and are defective for respiratory rhythmogenesis in vitro. MafB is expressed in a subpopulation of neurons in the preBotzinger complex (preBotC), a putative principal site of rhythmogenesis. Brainstems from Mafb(-/-) mice are insensitive to preBotC electrolytic lesion or stimulation and modulation of rhythmogenesis by hypoxia or peptidergic input. Furthermore, in Mafb(-/-) mice the preBotC, but not major neuromodulatory groups, presents severe anatomical defects with loss of cellularity. Our results show an essential role of MafB in central respiratory control, possibly involving the specification of rhythmogenic preBotC neurons.	Univ Mediterrane, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; CNRS, Grp Etud Reseaux Moteurs, F-13009 Marseille, France; Fac Med Timone, IBDM, Lab Pathol Nerveuse & Musculaire, F-13005 Marseille, France; Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Yeshiva University; Albert Einstein College of Medicine	Sieweke, MH (corresponding author), Univ Mediterrane, INSERM, CNRS, Ctr Immunol Marseille Luminy, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Graf, Thomas/B-4252-2015; Sieweke, Michael/AAR-7515-2020; daniel, laurent/R-2826-2016	Graf, Thomas/0000-0003-2774-4117; Sieweke, Michael/0000-0002-3228-9537; daniel, laurent/0000-0002-7539-0109; Viemari, Jean-Charles/0000-0001-6614-1461; blanchi, bruno/0000-0002-0814-5525				Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Champagnat J, 1997, TRENDS NEUROSCI, V20, P119, DOI 10.1016/S0166-2236(96)10078-3; Chatonnet F, 2002, EUR J NEUROSCI, V15, P684, DOI 10.1046/j.1460-9568.2002.01909.x; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; DIPASQUALE E, 1992, EXP BRAIN RES, V89, P459; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; ERRCHIDI S, 1990, J PHYSIOL-LONDON, V429, P497, DOI 10.1113/jphysiol.1990.sp018269; FELDMAN JL, 2003, ANN REV NEUROSCI; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Fortin G, 2000, RESP PHYSIOL, V122, P247, DOI 10.1016/S0034-5687(00)00163-8; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2002, J NEUROSCI, V22, P3806; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984; Hilaire G, 1997, NEUROSCI LETT, V224, P13, DOI 10.1016/S0304-3940(97)13458-9; Hilaire G, 1999, PHYSIOL REV, V79, P325, DOI 10.1152/physrev.1999.79.2.325; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Koshiya N, 1996, J PHYSIOL-LONDON, V491, P859, DOI 10.1113/jphysiol.1996.sp021263; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; McCrimmon DR, 2000, BIOESSAYS, V22, P6, DOI 10.1002/(SICI)1521-1878(200001)22:1<6::AID-BIES3>3.0.CO;2-Q; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; MONTEAU R, 1991, PROG NEUROBIOL, V37, P83, DOI 10.1016/0301-0082(91)90024-U; ONIMARU H, 1995, EXP BRAIN RES, V106, P57; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Poon CS, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-09-j0003.2000; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P895, DOI 10.1111/j.1469-7793.1998.895bs.x; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Ren J, 2003, J NEUROSCI, V23, P1569; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Solomon IC, 1999, J NEUROPHYSIOL, V81, P1150, DOI 10.1152/jn.1999.81.3.1150; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; WANG WG, 1993, J APPL PHYSIOL, V74, P2801, DOI 10.1152/jappl.1993.74.6.2801	50	134	141	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1091	1099		10.1038/nn1129	http://dx.doi.org/10.1038/nn1129			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14513037				2022-12-28	WOS:000185633600022
J	Weimer, RM; Richmond, JE; Davis, WS; Hadwiger, G; Nonet, ML; Jorgensen, EM				Weimer, RM; Richmond, JE; Davis, WS; Hadwiger, G; Nonet, ML; Jorgensen, EM			Defects in synaptic vesicle docking in unc-18 mutants	NATURE NEUROSCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN MUTANTS; LOCUS ENCODES; SYNTAXIN 1A; PROTEIN; FUSION; ROP; SYNAPTOBREVIN; EXOCYTOSIS; INTERACTS	Sec1-related proteins function in most, if not all, membrane trafficking pathways in eukaryotic cells. The Sec1-related protein required in neurons for synaptic vesicle exocytosis is UNC-18. Several models for UNC-18 function during vesicle exocytosis are under consideration. We have tested these models by characterizing unc-18 mutants of the nematode Caenorhabditis elegans. In the absence of UNC-18, the size of the readily releasable pool is severely reduced. Our results show that the near absence of fusion-competent vesicles is not caused by a reduction in syntaxin levels, by a mislocalization of syntaxin, by a defect in fusion or by a failure to open syntaxin during priming. Rather, we found a reduction of docked vesicles at the active zone in unc-18 mutants, suggesting that UNC-18 functions, directly or indirectly, as a facilitator of vesicle docking.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041477-01A1, R01 NS041477] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber BA, 1999, J NEUROSCI, V19, P5348; BEKKERS JM, 1969, PRACTICAL ELECT METH, P150; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Lonart G, 2000, J BIOL CHEM, V275, P27703; Marsal J, 1997, P NATL ACAD SCI USA, V94, P14871, DOI 10.1073/pnas.94.26.14871; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Reist NE, 1998, J NEUROSCI, V18, P7662; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; Rowe J, 2001, J CELL SCI, V114, P3323; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Wu MN, 2001, EUR J CELL BIOL, V80, P196, DOI 10.1078/0171-9335-00143; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	49	191	203	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1023	1030		10.1038/nn1118	http://dx.doi.org/10.1038/nn1118			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973353	Green Accepted			2022-12-28	WOS:000185633600013
J	Ditterich, J; Mazurek, ME; Shadlen, MN				Ditterich, J; Mazurek, ME; Shadlen, MN			Microstimulation of visual cortex affects the speed of perceptual decisions	NATURE NEUROSCIENCE			English	Article							TRANSPARENT MOTION PERCEPTION; SACCADIC EYE-MOVEMENTS; AREA MT; MACAQUE MT; DIRECTION; PSYCHOPHYSICS; SIGNALS; PROBABILITY; RESPONSES; NEURONS	Direction-selective neurons in the middle temporal visual area (MT) are crucially involved in motion perception, although it is not known exactly how the activity of these neurons is interpreted by the rest of the brain. Here we report that in a two-alternative task, the activity of MT neurons is interpreted as evidence for one direction and against the other. We measured the speed and accuracy of decisions as rhesus monkeys performed a direction- discrimination task. On half of the trials, we stimulated direction- selective neurons in area MT, thereby causing the monkeys to choose the neurons' preferred direction more often. Microstimulation quickened decisions in favor of the preferred direction and slowed decisions in favor of the opposite direction. Even on trials in which microstimulation did not induce a preferred direction choice, it still affected response times. Our findings suggest that during the formation of a decision, sensory evidence for competing propositions is compared and accumulates to a decision-making threshold.	Univ Washington, Natl Primate Res Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Natl Primate Res Ctr, Howard Hughes Med Inst, 1959 NE Pacific St, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Albright T D, 1993, Rev Oculomot Res, V5, P177; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; Churchland MM, 2001, J NEUROSCI, V21, P9387, DOI 10.1523/JNEUROSCI.21-23-09387.2001; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Escobar, 1999, STAT METHODS RELIABI; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; GOOD IJ, 1979, BIOMETRIKA, V66, P393, DOI 10.1093/biomet/66.2.393; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; LAMING DRJ, 1969, J MATH PSYCHOL, V6, P81, DOI 10.1016/0022-2496(69)90030-3; LEVINSON E, 1975, J PHYSIOL-LONDON, V250, P347, DOI 10.1113/jphysiol.1975.sp011058; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; PANTLE A, 1974, VISION RES, V14, P1229, DOI 10.1016/0042-6989(74)90221-1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Press W.H, 1992, NUMERICAL RECIPES C, P666; QIAN N, 1994, J NEUROSCI, V14, P7367; QIAN N, 1994, J NEUROSCI, V14, P7357; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; Wald A., 1947, SEQUENTIAL ANAL	30	156	192	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					891	898		10.1038/nn1094	http://dx.doi.org/10.1038/nn1094			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	705UP	12858179				2022-12-28	WOS:000184413700020
J	Jin, RS; Banke, TG; Mayer, ML; Traynelis, SF; Gouaux, E				Jin, RS; Banke, TG; Mayer, ML; Traynelis, SF; Gouaux, E			Structural basis for partial agonist action at ionotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							POTASSIUM CHANNELS I; LIGAND-BINDING CORE; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURES; ION-CHANNEL; ACTIVATION; GLUR2; DESENSITIZATION; KAINATE	An unresolved problem in understanding neurotransmitter receptor function concerns the mechanism(s) by which full and partial agonists elicit different amplitude responses at equal receptor occupancy. The widely held view of 'partial agonism' posits that resting and active states of the receptor are in equilibrium, and partial agonists simply do not shift the equilibrium toward the active state as efficaciously as full agonists. Here we report findings from crystallographic and electrophysiological studies of the mechanism of activation of an AMPA-subtype glutamate receptor ion channel. In these experiments, we used 5-substituted willardiines, a series of partial agonists that differ by only a single atom. Our results show that the GluR2 ligand-binding core can adopt a range of ligand-dependent conformational states, which in turn control the open probability of discrete subconductance states of the intact ion channel. Our findings thus provide a structure-based model of partial agonism.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr, Atlanta, GA 30322 USA; Natl Inst Child Hlth & Dev, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Emory University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168 St, New York, NY 10032 USA.		Mayer, Mark/AAE-7356-2019; Gouaux, Eric/Y-4370-2019; Jin, Rongsheng/M-7797-2013; Mayer, Mark L/H-5500-2013	Mayer, Mark/0000-0003-4378-8451; Gouaux, Eric/0000-0002-8549-2360; Jin, Rongsheng/0000-0003-0348-7363; Banke, Tue/0000-0001-8417-4400	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Colquhoun David, 1995, P483; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dingledine R, 1999, PHARMACOL REV, V51, P7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; EVANS RH, 1980, J PHYSIOL-LONDON, V308, pP71; GMELIN R, 1961, ACTA CHEM SCAND, V15, P1188, DOI 10.3891/acta.chem.scand.15-1188; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kizelsztein P, 2000, BIOCHEMISTRY-US, V39, P12819, DOI 10.1021/bi000962i; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Smith TC, 2000, J NEUROSCI, V20, P2073; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; WONG LA, 1994, J NEUROSCI, V14, P3881; WYMAN J, 1951, J POLYM SCI, V7, P499, DOI 10.1002/pol.1951.120070506; ZORUMSKI CF, 1988, J NEUROSCI, V8, P4277	43	321	329	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					803	810		10.1038/nn1091	http://dx.doi.org/10.1038/nn1091			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872125				2022-12-28	WOS:000184413700008
J	Puelles, E; Acampora, D; Lacroix, E; Signore, M; Annino, A; Tuorto, F; Filosa, S; Corte, G; Wurst, W; Ang, SL; Simeone, A				Puelles, E; Acampora, D; Lacroix, E; Signore, M; Annino, A; Tuorto, F; Filosa, S; Corte, G; Wurst, W; Ang, SL; Simeone, A			Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; SONIC-HEDGEHOG; NEURAL PLATE; ISTHMIC ORGANIZER; BRAIN MORPHOGENESIS; MICE LACKING; EXPRESSION; REGIONALIZATION; SPECIFICATION; GENE	Organizing centers emit signaling molecules that specify different neuronal cell types at precise positions along the anterior-posterior (A-P) and dorsal-ventral (D-V) axes of neural tube during development. Here we report that reduction in Otx proteins near the alar-basal plate boundary (ABB) of murine midbrain resulted in a dorsal shift of Shh expression, and reduction in Otx proteins at the midbrain-hindbrain boundary (MHB) resulted in an anterior expansion of the Fgf8 domain. Our data thus indicate that an Otx dose-dependent repressive effect coordinates proper positioning of Shh and Fgf8 expression. Furthermore, this control is effective for conferring proper cell identity in the floor-plate region of midbrain and does not require an Otx2-specific property. We propose that this mechanism may provide both A-P and D-V positional information to neuronal precursors located within the midbrain.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; CNR, Inst Genet & Biophys, I-80125 Naples, Italy; CU Strasbourg, IGBMC, F-67404 Illkirch Graffenstaden, France; Univ Genoa, IST Natl Inst Canc Res, I-16132 Genoa, Italy; Univ Genoa, Dipartimento Oncol Clin & Sperimentale, I-16132 Genoa, Italy; GSF Munich, Res Ctr, Inst Dev Genet, D-85764 Munich, Germany; Max Planck Inst Psychiat, D-80804 Munich, Germany	University of London; King's College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Genoa; IRCCS AOU San Martino IST; University of Genoa; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society	Simeone, A (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, New Hunts House,4th Floor,Guys Campus,London Brid, London SE1 1UL, England.	sang@nimr.mrc.ac.uk; antonio.simeone@kcl.ac.uk	Puelles, Eduardo/G-1819-2015; Simeone, Antonio/ABG-5269-2020; Tuorto, Francesca/AAJ-2760-2021; Acampora, Dario/C-2156-2013; Puelles, Eduardo/ABF-9767-2020; Filosa, Stefania/A-4609-2014	Puelles, Eduardo/0000-0002-0560-9240; Simeone, Antonio/0000-0003-2693-9836; Tuorto, Francesca/0000-0003-1625-1181; Puelles, Eduardo/0000-0002-0560-9240; Wurst, Wolfgang/0000-0003-4422-7410; Filosa, Stefania/0000-0003-2896-3362	Medical Research Council [MC_U117570533] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Acampora D, 1999, DEVELOPMENT, V126, P1417; Acampora D, 1998, DEVELOPMENT, V125, P5091; Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Acampora D, 1997, DEVELOPMENT, V124, P3639; Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Agarwala S, 2002, DEVELOPMENT, V129, P5779, DOI 10.1242/dev.00179; Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; ALTABA ARI, 1995, MOL CELL NEUROSCI, V6, P106, DOI 10.1006/mcne.1995.1011; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein DJ, 1999, DEVELOPMENT, V126, P281; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Houart C, 1998, NATURE, V391, P788, DOI 10.1038/35853; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Li JYH, 2001, DEVELOPMENT, V128, P4979; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; Millett S, 1999, NATURE, V401, P161, DOI 10.1038/43664; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; SASAKI H, 1993, DEVELOPMENT, V118, P47; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Simeone A., 1999, IN SITU HYBRIDIZATIO, P69; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Sugiyama S, 2000, DEV BIOL, V221, P168, DOI 10.1006/dbio.2000.9643; Watanabe Y, 2000, DEVELOPMENT, V127, P1131; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Ying LT, 2000, DEV DYNAM, V219, P143, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1050>3.3.CO;2-H; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	45	116	117	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					453	460		10.1038/nn1037	http://dx.doi.org/10.1038/nn1037			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12652306				2022-12-28	WOS:000182553200011
J	Sowell, ER; Peterson, BS; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW				Sowell, ER; Peterson, BS; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW			Mapping cortical change across the human life span	NATURE NEUROSCIENCE			English	Article							AGE-RELATED-CHANGES; IN-VIVO; HUMAN BRAIN; REGIONAL BRAIN; ADOLESCENCE; MATURATION; CHILDHOOD; VOLUMES; MRI; MYELINATION	We used magnetic resonance imaging and cortical matching algorithms to map gray matter density (GMD) in 176 normal individuals ranging in age from 7 to 87 years. We found a significant, nonlinear decline in GMD with age, which was most rapid between 7 and about 60 years, over dorsal frontal and parietal association cortices on both the lateral and interhemispheric surfaces. Age effects were inverted in the left posterior temporal region, where GMD gain continued up to age 30 and then rapidly declined. The trajectory of maturational and aging effects varied considerably over the cortex. Visual, auditory and limbic cortices, which are known to myelinate early, showed a more linear pattern of aging than the frontal and parietal neocortices, which continue myelination into adulthood. Our findings also indicate that the posterior temporal cortices, primarily in the left hemisphere, which typically support language functions, have a more protracted course of maturation than any other cortical region.	Univ Calif Los Angeles, Lab Neuro Imaging, Dept Neurol, Los Angeles, CA 90095 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute	Sowell, ER (corresponding author), Univ Calif Los Angeles, Lab Neuro Imaging, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	NCRR NIH HHS [P41 RR13642] Funding Source: Medline; NIMH NIH HHS [5T32 MH16381, MH01232, MH01733, MH59139, P20 MH/DA52176] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016381, R01MH059139, P20MH052176, K08MH001232] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Ono M, 1990, ATLAS CEREBRAL SULCI; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Ravid D, 2002, J CHILD LANG, V29, P417, DOI 10.1017/S0305000902005111; SALM, 2002, NEUROIMAGE, V17, P1027; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 2002, CEREB CORTEX, V12, P856, DOI 10.1093/cercor/12.8.856; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; THOMPSON PM, 2002, COMPUTING VISUALIZAT, V5, P1; THOMPSON PM, INPRESS J NEUROSCI; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	35	1611	1630	3	152	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					309	315		10.1038/nn1008	http://dx.doi.org/10.1038/nn1008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12548289				2022-12-28	WOS:000181178300020
J	Husain, M; Parton, A; Hodgson, TL; Mort, D; Rees, G				Husain, M; Parton, A; Hodgson, TL; Mort, D; Rees, G			Self-control during response conflict by human supplementary eye field	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; SACCADES; LESIONS		Charing Cross Hosp, Imperial Coll, Div Neurosci & Psychol Med, London W6 8RF, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Univ Exeter, Washington Singer Labs, Sch Psychol, Exeter EX4 4QG, Devon, England	Imperial College London; University of London; University College London; University of Exeter	Husain, M (corresponding author), Charing Cross Hosp, Imperial Coll, Div Neurosci & Psychol Med, London W6 8RF, England.	m.husain@ic.ac.uk	Rees, Geraint/C-1493-2008; Husain, Masud/C-2074-2008; Parton, Andrew/J-8174-2012	Rees, Geraint/0000-0002-9623-7007; Husain, Masud/0000-0002-6850-9255; Parton, Andrew/0000-0003-0633-7846; Hodgson, Timothy/0000-0002-0860-8892	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; HENIK A, 1994, J COGNITIVE NEUROSCI, V6, P400, DOI 10.1162/jocn.1994.6.4.400; Hodgson TL, 2002, NEUROPSYCHOLOGIA, V40, P1891, DOI 10.1016/S0028-3932(02)00064-7; Humberstone M, 1997, ANN NEUROL, V42, P632, DOI 10.1002/ana.410420414; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Scheffers MK, 1996, PSYCHOPHYSIOLOGY, V33, P42, DOI 10.1111/j.1469-8986.1996.tb02107.x; Schiller PH, 1998, NAT NEUROSCI, V1, P248, DOI 10.1038/693; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Walker R, 2000, EXP BRAIN RES, V130, P540, DOI 10.1007/s002219900285	15	72	72	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					117	118		10.1038/nn1005	http://dx.doi.org/10.1038/nn1005			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536212				2022-12-28	WOS:000180669100010
J	Murai, KK; Nguyen, LN; Irie, F; Yamaguchi, Y; Pasquale, EB				Murai, KK; Nguyen, LN; Irie, F; Yamaguchi, Y; Pasquale, EB			Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling	NATURE NEUROSCIENCE			English	Article							EPH RECEPTORS; GLIA; INTERMEDIATE; EXPRESSION; VARIANTS; SYNAPSES; MOTILITY; NEURONS; MICE	Communication between glial cells and neurons is emerging as a critical parameter of synaptic function. However, the molecular mechanisms underlying the ability of glial cells to modify synaptic structure and physiology are poorly understood. Here we describe a repulsive interaction that regulates postsynaptic morphology through the EphA4 receptor tyrosine kinase and its ligand ephrin-A3. EphA4 is enriched on dendritic spines of pyramidal neurons in the adult mouse hippocampus, and ephrin-A3 is localized on astrocytic processes that envelop spines. Activation of EphA4 by ephrin-A3 was found to induce spine retraction, whereas inhibiting ephrin/EphA4 interactions distorted spine shape and organization in hippocampal slices. Furthermore, spine irregularities in pyramidal neurons from EphA4 knockout mice and in slices transfected with kinase-inactive EphA4 indicated that ephrin/EphA4 signaling is critical for spine morphology. Thus, our data support a model in which transient interactions between the ephrin-A3 ligand and the EphA4 receptor regulate the structure of excitatory synaptic connections through neuroglial cross-talk.	Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA; Univ Calif San Diego, Mol Pathol Program, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst, Neurobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	elenap@burnham.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043029] Funding Source: NIH RePORTER; NEI NIH HHS [EY10576] Funding Source: Medline; NICHD NIH HHS [HD25938] Funding Source: Medline; NINDS NIH HHS [NS43029] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davenport RW, 1998, J NEUROSCI, V18, P975; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gerlai R, 2000, BEHAV BRAIN RES, V108, P133, DOI 10.1016/S0166-4328(99)00139-4; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Korkotian E, 2000, HIPPOCAMPUS, V10, P587, DOI 10.1002/1098-1063(2000)10:5<587::AID-HIPO9>3.0.CO;2-C; Lai KO, 1999, FEBS LETT, V458, P265, DOI 10.1016/S0014-5793(99)01159-X; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pasini A, 2002, BIOESSAYS, V24, P427, DOI 10.1002/bies.10085; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stein C A, 1993, Antisense Res Dev, V3, P19; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang JH, 1996, J NEUROSCI, V16, P7182	41	370	404	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					153	160		10.1038/nn994	http://dx.doi.org/10.1038/nn994			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12496762				2022-12-28	WOS:000180669100015
J	Ringach, DL				Ringach, DL			Look at the big picture (details will follow)	NATURE NEUROSCIENCE			English	Editorial Material							HUMAN STEREO VISION; BINOCULAR FUSION; SPATIAL SCALES; COARSE	Psychophysics suggests that binocular information at multiple spatial scales Is used in depth perception. A new study provides physiological evidence for this idea in primary visual cortex.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ringach, DL (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.							ADELSON EH, 1982, J OPT SOC AM, V72, P1803; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; GRIMSON WEL, 1984, 762 AI MIT; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KOENDERINK JJ, 1984, BIOL CYBERN, V50, P363, DOI 10.1007/BF00336961; Mallot HA, 1996, BIOL CYBERN, V74, P95, DOI 10.1007/BF00204198; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; MARROQUIN JL, 1984, 792 AI MIT; Menz MD, 2003, NAT NEUROSCI, V6, P59, DOI 10.1038/nn986; ROHALY AM, 1994, VISION RES, V34, P1315, DOI 10.1016/0042-6989(94)90205-4; ROHALY AM, 1993, J OPT SOC AM A, V10, P2433, DOI 10.1364/JOSAA.10.002433; SMALLMAN HS, 1995, VISION RES, V35, P1047, DOI 10.1016/0042-6989(94)00197-T; WILSON HR, 1991, J OPT SOC AM A, V8, P229, DOI 10.1364/JOSAA.8.000229; Witkin A.P., 1983, P 8 INT JOINT C ART, P1019, DOI DOI 10.1007/978-3-8348-9190-729	15	12	13	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					7	8		10.1038/nn0103-7	http://dx.doi.org/10.1038/nn0103-7			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12494241				2022-12-28	WOS:000180089300005
J	Davis, KD; Pope, GE; Crawley, AP; Mikulis, DJ				Davis, KD; Pope, GE; Crawley, AP; Mikulis, DJ			Neural correlates of prickle sensation: a percept-related fMRI study	NATURE NEUROSCIENCE			English	Article							PAIN; CORTEX; HUMANS		Univ Toronto, Dept Surg, Toronto, ON, Canada; Toronto Western Hosp, Univ Hlth Network MP14 306, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Davis, KD (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.		Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892				BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Chen CC, 1996, PAIN, V68, P33, DOI 10.1016/S0304-3959(96)03180-6; Davis KD, 2002, PAIN, V98, P179, DOI 10.1016/S0304-3959(02)00043-X; Davis KD, 1998, NEUROREPORT, V9, P3019, DOI 10.1097/00001756-199809140-00018; Davis KD, 1998, PAIN, V75, P47, DOI 10.1016/S0304-3959(97)00203-0; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; GARNSWORTHY RK, 1988, J NEUROPHYSIOL, V59, P1083, DOI 10.1152/jn.1988.59.4.1083; GARNSWORTHY RK, 1988, J NEUROPHYSIOL, V59, P1116, DOI 10.1152/jn.1988.59.4.1116; HSIEH JC, 1994, J NEUROPHYSIOL, V72, P3004, DOI 10.1152/jn.1994.72.6.3004; MELZACK R, 1968, P423; Penfield W, 1954, EPILEPSY FUNCTIONAL; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Porro CA, 1998, J NEUROPHYSIOL, V80, P3312, DOI 10.1152/jn.1998.80.6.3312; TOLAIRACH J, 1988, COPLANAR STEREOTAXIC; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5	15	84	85	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1121	1122		10.1038/nn955	http://dx.doi.org/10.1038/nn955			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368810				2022-12-28	WOS:000178884600013
J	Schoppa, NE; Westbrook, GL				Schoppa, NE; Westbrook, GL			AMPA autoreceptors drive correlated spiking in olfactory bulb glomeruli	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; MITRAL CELLS; GAP-JUNCTIONS; TEMPORAL INFORMATION; RAT-BRAIN; NEURONS; EXPRESSION; SYNCHRONY; SYNAPSES; EXCITATION	Information processing in the brain may rely on temporal correlations in spike activity between neurons. Within the olfactory bulb, correlated spiking in output mitral cells could affect the odor code by either binding or amplifying signals from individual odorant receptors. We examined the timing of spike trains in mitral cells of rat olfactory bulb slices. Depolarization of mitral cell pairs elicited spikes that were correlated on a rapid timescale (less than or equal to10 ms) for cells whose primary dendrites projected to the same glomerulus. Correlated spiking was driven by a novel mechanism that depended on electrical coupling at mitral cell primary dendrites; the specific synchronizing signal was a coupled depolarization (similar to20 ms) that was mediated by dendritic AMPA autoreceptors. We suggest that glomerulus-specific correlated spiking in mitral cells helps to preserve the fidelity of odor signals that are delivered to the olfactory cortex.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Schoppa, NE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	schoppan@hotmail.com			NINDS NIH HHS [NS26494] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026494, R01NS026494] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Bozza TC, 2001, CURR BIOL, V11, pR687, DOI 10.1016/S0960-9822(01)00409-2; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Carlson GC, 2000, J NEUROSCI, V20, P2011; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; DildyMayfield JE, 1996, J PHARMACOL EXP THER, V276, P1058; FREEMAN WJ, 1972, J NEUROPHYSIOL, V35, P762, DOI 10.1152/jn.1972.35.6.762; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kirson ED, 1998, BRIT J PHARMACOL, V124, P1607, DOI 10.1038/sj.bjp.0701996; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Miragall F, 1996, NEUROSCI LETT, V216, P199, DOI 10.1016/0304-3940(96)13042-1; Montague AA, 1999, J COMP NEUROL, V405, P233, DOI 10.1002/(SICI)1096-9861(19990308)405:2<233::AID-CNE7>3.0.CO;2-A; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; PATERNOSTRO MA, 1995, DEV BRAIN RES, V84, P1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Shadlen M.N., 1999, NEURON, V24.1, P111, DOI DOI 10.1016/S0896-627380822-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shen GYY, 1999, J NEUROPHYSIOL, V82, P3006, DOI 10.1152/jn.1999.82.6.3006; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Srinivas M, 1999, J NEUROSCI, V19, P9848; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhang CB, 2002, BRAIN RES, V929, P37, DOI 10.1016/S0006-8993(01)03372-8; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	51	121	123	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1194	1202		10.1038/nn953	http://dx.doi.org/10.1038/nn953			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379859				2022-12-28	WOS:000178884600023
J	Henze, DA; Wittner, L; Buzsaki, G				Henze, DA; Wittner, L; Buzsaki, G			Single granule cells reliably discharge targets in the hippocampal CA3 network in vivo	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSE; DENTATE GYRUS; SPIKE TRANSMISSION; UNIT-ACTIVITY; RAT; PLASTICITY; NEURONS; MEMORY; INTERNEURONS; INFORMATION	Processing of neuronal information depends on interactions between the anatomical connectivity and cellular properties of single cells. We examined how these computational building blocks work together in the intact rat hippocampus. Single spikes in dentate granule cells, controlled intracellularly, generally failed to discharge either interneurons or CA3 pyramidal cells. In contrast, trains of spikes effectively discharged both CA3 cell types. Increasing the discharge rate of the granule cell increased the discharge probability of its target neuron and decreased the delay between the onset of a granule cell train and evoked firing in postsynaptic targets. Thus, we conclude that the granule cell to CA3 synapses are 'conditional detonators,' dependent on granule cell firing pattern. In addition, we suggest that information in single granule cells is converted into a temporal delay code in target CA3 pyramidal cells and interneurons. These data demonstrate how a neural circuit of the CNS may process information.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Wittner, Lucia/C-9386-2013	Wittner, Lucia/0000-0001-6800-0953; Buzsaki, Gyorgy/0000-0002-3100-4800	NCRR NIH HHS [5P41RR009754] Funding Source: Medline; NIMH NIH HHS [MH54671, MH12403] Funding Source: Medline; NINDS NIH HHS [NS34994, NS43157] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043157, R01NS034994] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; COLLIER TJ, 1982, BEHAV NEURAL BIOL, V34, P227, DOI 10.1016/S0163-1047(82)91623-5; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Doherty J, 2001, J NEUROSCI, V21, P2048, DOI 10.1523/JNEUROSCI.21-06-02048.2001; FROTSCHER M, 1994, SYNAPSE, V16, P148, DOI 10.1002/syn.890160208; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HARRIS KD, IN PRESS NATURE; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lorincz A, 2000, ANN NY ACAD SCI, V911, P83; LOTHMAN EW, 1992, DENTATE GYRUS ITS RO, P301; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; ROLLS E, 1989, COMP NEUR S, P125; Rolls E.T., 1989, NEURAL MODELS PLASTI, P240; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; TANK DW, 1987, P NATL ACAD SCI USA, V84, P1896, DOI 10.1073/pnas.84.7.1896; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; YLINEN A, 1995, J NEUROSCI, V15, P30	43	322	327	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					790	795		10.1038/nn887	http://dx.doi.org/10.1038/nn887			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118256				2022-12-28	WOS:000177088900023
J	Shen, Y; Hansel, C; Linden, DJ				Shen, Y; Hansel, C; Linden, DJ			Glutamate release during LTD at cerebellar climbing fiber-Purkinje cell synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; PLASTICITY; EXPRESSION; KINETICS		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Erasmus Univ, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands	Johns Hopkins University; Erasmus University Rotterdam	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051106, R37MH051106, R01MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bear MF, 2001, SYNAPSES, P455; Dittman JS, 1998, J NEUROSCI, V18, P6147; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Malenka RC, 2001, SYNAPSES, P393; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	14	31	31	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					725	726		10.1038/nn895	http://dx.doi.org/10.1038/nn895			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134155				2022-12-28	WOS:000177088900012
J	Hinkle, DA; Connor, CE				Hinkle, DA; Connor, CE			Three-dimensional orientation tuning in macaque area V4	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; 3-DIMENSIONAL SHAPES; BINOCULAR DISPARITY; OBJECT RECOGNITION; VISUAL PROPERTIES; SLANT PERCEPTION; NEURONS; MONKEY; SENSITIVITY; DEPTH	Tuning for the orientation of elongated, linear image elements (edges, bars, gratings), first discovered by Hubel and Wiesel, is considered a key feature of visual processing in the brain. It has been studied extensively in two dimensions (2D) using frontoparallel stimuli, but in real life most lines, edges and contours are slanted with respect to the viewer. Here we report that neurons in macaque area V4, an intermediate stage in the ventral (object-related) pathway of visual cortex, were tuned for 3D orientation-that is, for specific slants as well as for 2D orientation. The tuning for 3D orientation was consistent across depth position (binocular disparity) and position within the 2D classical receptive field. The existence of 3D orientation signals in the ventral pathway suggests that the brain may use such information to interpret 3D shape.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 338 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA.							Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V226, P725, DOI 10.1113/jphysiol.1972.sp010006; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Bradley DC, 1998, J NEUROSCI, V18, P7552; Bridge H, 2001, J NEUROSCI, V21, P7293, DOI 10.1523/JNEUROSCI.21-18-07293.2001; CAGENELLO R, 1993, VISION RES, V33, P2189, DOI 10.1016/0042-6989(93)90099-I; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DICKINSON SJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P130, DOI 10.1016/1049-9660(92)90013-S; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; GATTASS R, 1988, J NEUROSCI, V8, P1831; GILLAM B, 1992, PERCEPTION, V21, P427, DOI 10.1068/p210427; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hanazawa A, 2001, J NEUROSCI, V21, P4490, DOI 10.1523/JNEUROSCI.21-12-04490.2001; Hinkle DA, 2001, NEUROREPORT, V12, P365, DOI 10.1097/00001756-200102120-00036; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; MANLY BFJ, 1991, RANDOMIZATION MONTE, P114; MANTEL N, 1967, CANCER RES, V27, P209; MARDIA KV, 2000, DIRECTIONAL STAT, P248; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MITCHISON GJ, 1990, VISION RES, V30, P1781, DOI 10.1016/0042-6989(90)90159-I; NELSON JI, 1977, J NEUROPHYSIOL, V40, P260, DOI 10.1152/jn.1977.40.2.260; NINIO J, 1985, PERCEPTION, V14, P305, DOI 10.1068/p140305; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROY JP, 1992, J NEUROSCI, V12, P2478; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; Vetter T., 1995, CEREB CORTEX, V3, P261; VONDERHEYDT R, 1982, INVEST OPHTHALMOL  S, V22, P12; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000; WIENIAWANARKIEWICZ E, 1992, OPHTHAL PHYSL OPT, V12, P269, DOI 10.1111/j.1475-1313.1992.tb00304.x	49	97	100	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					665	670		10.1038/nn875	http://dx.doi.org/10.1038/nn875			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068303				2022-12-28	WOS:000176414300016
J	Ullman, S; Vidal-Naquet, M; Sali, E				Ullman, S; Vidal-Naquet, M; Sali, E			Visual features of intermediate complexity and their use in classification	NATURE NEUROSCIENCE			English	Article							OBJECT RECOGNITION; FACE RECOGNITION; NATURAL SCENES; CORTEX; SELECTIVITY; EIGENFACES; IMAGES; SHAPE	The human visual system analyzes shapes and objects in a series of stages in which stimulus features of increasing complexity are extracted and analyzed. The first stages use simple local features, and the image is subsequently represented in terms of larger and more complex features. These include features of intermediate complexity and partial object views. The nature and use of these higher-order representations remains an open question in the study of visual processing by the primate cortex. Here we show that intermediate complexity (IC) features are optimal for the basic visual task of classification. Moderately complex features are more informative for classification than very simple or very complex ones, and so they emerge naturally by the simple coding principle of information maximization with respect to a class of images. Our findings suggest a specific role for IC features in visual processing and a principle for their extraction.	Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ullman, S (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, POB 26, IL-76100 Rehovot, Israel.	shimon.ullman@weizmann.ac.il						ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Ballard DH, 1982, COMPUTER VISION; BARLOW H, 1989, COMP NEUR S, P54; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bhat DN, 1998, IEEE T PATTERN ANAL, V20, P415, DOI 10.1109/34.677275; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROLLS ET, 1991, CURR OPIN NEUROBIOL, V1, P275; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Ullman S, 1999, NEURAL NETWORKS, V12, P1021, DOI 10.1016/S0893-6080(99)00048-9; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogels R, 1999, NEUROREPORT, V10, P1811, DOI 10.1097/00001756-199906230-00002; Wiskott L, 1997, IEEE T PATTERN ANAL, V19, P775, DOI 10.1109/34.598235; Yang MH, 2002, IEEE T PATTERN ANAL, V24, P34, DOI 10.1109/34.982883	28	391	396	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					682	687		10.1038/nn870	http://dx.doi.org/10.1038/nn870			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055634				2022-12-28	WOS:000176414300019
J	Wong, PC; Cai, HB; Borchelt, DR; Price, DL				Wong, PC; Cai, HB; Borchelt, DR; Price, DL			Genetically engineered mouse models of neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID PRECURSOR PROTEIN; SPINAL MUSCULAR-ATROPHY; FAMILIAL ALZHEIMERS-DISEASE; MOTOR-NEURON DEGENERATION; BETA-SECRETASE; TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; KNOCKOUT MICE; ANIMAL-MODEL	Recent research has significantly advanced our understanding of the molecular mechanisms of neurodegenerative diseases, including Alzheimer's disease (AD) and motor neuron disease. Here we emphasize the use of genetically engineered mouse models that are instrumental for understanding why AD is a neuronal disease, and for validating attractive therapeutic targets. In motor neuron diseases, Cu/Zn superoxide dismutase and survival motor neuron mouse models are useful in testing disease mechanisms and therapeutic strategies for amyotrophic lateral sclerosis (ALS) and spinal motor atrophy, respectively, but the mechanisms that account for selective motor neuron loss remain uncertain. We anticipate that, in the future, therapies based on understanding disease mechanisms will be identified and tested in mouse model systems.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 558 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	NIA NIH HHS [AG05146, AG10480, AG07914, AG10491, AG14248] Funding Source: Medline; NINDS NIH HHS [NS07435, NS38065, NS40014, NS37145, NS37771, NS38377, NS10580, NS20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038065, P50NS020471, R01NS040014, R01NS037145, R01NS037771, P50NS038377, P01NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010491, P01AG014248, P01AG010480, R35AG007914] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albert MS, 2000, NEUROLOGY, V55, P166, DOI 10.1212/WNL.55.2.166; ANDERSEN PM, 2000, AMYOTROPHIC LATERAL, P223; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beach TG, 2000, J NEUROPATH EXP NEUR, V59, P308, DOI 10.1093/jnen/59.4.308; Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; Bodendorf U, 2001, J BIOL CHEM, V276, P12019, DOI 10.1074/jbc.M008861200; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Eisler WP.WolfeM, 2001, SCIENCE, V293, P1449; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Eyer J, 1998, NATURE, V391, P584, DOI 10.1038/35378; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Heber S, 2000, J NEUROSCI, V20, P7951; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ince P, 2000, AMYOTROPHIC LATERAL, P83; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; JACKSON M, 2000, AMYOTROPHIC LATERAL, P263; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Kong JM, 2000, NEUROSCI LETT, V281, P72, DOI 10.1016/S0304-3940(00)00808-9; Kopan R, 2002, NEURON, V33, P321, DOI 10.1016/S0896-6273(02)00585-8; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lee VMY, 1999, NEURON, V24, P507, DOI 10.1016/S0896-6273(00)81106-X; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Serpell LC, 2000, BIOCHEMISTRY-US, V39, P13269, DOI 10.1021/bi000637v; SHAW PJ, 2000, AMYOTROPHIC LATERAL, P113; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wong PC, 2001, SCIENCE, V293, P1434; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	98	175	183	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					633	639		10.1038/nn0702-633	http://dx.doi.org/10.1038/nn0702-633			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12085093				2022-12-28	WOS:000176414300012
J	Couve, A; Thomas, P; Calver, AR; Hirst, WD; Pangalos, MN; Walsh, FS; Smart, TG; Moss, SJ				Couve, A; Thomas, P; Calver, AR; Hirst, WD; Pangalos, MN; Walsh, FS; Smart, TG; Moss, SJ			Cyclic AMP-dependent protein kinase phosphorylation facilitates GABA(B) receptor-effector coupling	NATURE NEUROSCIENCE			English	Article							K+ CHANNELS; ACTIVATION; SUBUNITS; ASSOCIATION; DOMAINS; NEURONS; BINDING; SITES	GABA (gamma-aminobutyric acid)(B) receptors are heterodimeric G protein-coupled receptors that mediate slow synaptic inhibition in the central nervous system. Here we show that the functional coupling of GABA(B)R1/GABA(B)R2 receptors to inwardly rectifying K(+) channels rapidly desensitizes. This effect is alleviated after direct phosphorylation of a single serine residue (Ser892) in the cytoplasmic tail of GABA(B)R2 by cyclic AMP (cAMP)-dependent protein kinase (PKA). Basal phosphorylation of this residue is evident in rat brain membranes and in cultured neurons. Phosphorylation of Ser892 is modulated positively by pathways that elevate cAMP concentration, such as those involving forskolin and beta-adrenergic receptors. GABA(B) receptor agonists reduce receptor phosphorylation, which is consistent with PKA functioning in the control of GABA(B)-activated currents. Mechanistically, phosphorylation of Ser892 specifically enhances the membrane stability of GABA(B) receptors. We conclude that signaling pathways that activate PKA may have profound effects on GABA(B) receptor-mediated synaptic inhibition. These results also challenge the accepted view that phosphorylation is a universal negative modulator of G protein-coupled receptors.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Pharmacol, London WC1E 6BT, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; GlaxoSmithKline Inc, Neurol Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London School of Pharmacy; GlaxoSmithKline	Moss, SJ (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	steve.moss@ucl.ac.uk	couve, andres/I-2249-2013	couve, andres/0000-0003-4216-8672; Hirst, Warren/0000-0003-0389-8891				Brandon NJ, 1999, J NEUROSCI, V19, P9228; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Cai ZH, 2001, J NEUROCHEM, V78, P756, DOI 10.1046/j.1471-4159.2001.00468.x; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Calver AR, 2001, J NEUROSCI, V21, P1203; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; HIRST WD, 2000, BRIT J PHARMACOL, V129, P80; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; KAMATCHI GL, 1990, MOL PHARMACOL, V38, P342; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kelly MJ, 1999, TRENDS ENDOCRIN MET, V10, P369, DOI 10.1016/S1043-2760(99)00190-3; KENELLY PJ, 1991, J BIOL CHEM, V76, P2626; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Macek TA, 1998, J NEUROSCI, V18, P6138; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; Mullner C, 2000, J GEN PHYSIOL, V115, P547, DOI 10.1085/jgp.115.5.547; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ruppert H, 1987, BAYERISCHES GEOLOGIS, V2, P1; Saitow F, 2000, J NEUROPHYSIOL, V84, P2016, DOI 10.1152/jn.2000.84.4.2016; Schaffhauser H, 2000, J NEUROSCI, V20, P5663, DOI 10.1523/JNEUROSCI.20-15-05663.2000; SESSLER FM, 1995, BRAIN RES, V675, P171, DOI 10.1016/0006-8993(95)00060-4; TANIYAMA K, 1992, J NEUROCHEM, V58, P1239, DOI 10.1111/j.1471-4159.1992.tb11334.x; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; YOSHIMURA M, 1995, LIFE SCI, V57, P2397, DOI 10.1016/0024-3205(95)02235-1; Zhang J, 1997, J GEN PHYSIOL, V110, P45, DOI 10.1085/jgp.110.1.45	33	100	105	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					415	424		10.1038/nn833	http://dx.doi.org/10.1038/nn833			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976702				2022-12-28	WOS:000175272000011
J	Song, HJ; Stevens, CF; Gage, FH				Song, HJ; Stevens, CF; Gage, FH			Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; IN-VITRO; RAT HIPPOCAMPUS; MESSENGER-RNAS; BONE-MARROW; GLIA; DIFFERENTIATION; NEUROGENESIS; EXPRESSION	Neural stem cells are present both in the developing nervous system and in the adult nervous system of all mammals, including humans. Little is known, however, about the extent to which stem cells in adults can give rise to new neurons. We used immunocytochemistry, electron microscopy, fluorescence microscopy (FM imaging) and electrophysiology to demonstrate that progeny of adult rat neural stem cells, when co-cultured with primary neurons and astrocytes from neonatal hippocampus, develop into electrically active neurons and integrate into neuronal networks with functional synaptic transmission. We also found that functional neurogenesis from adult stem cells is possible in co-culture with astrocytes from neonatal and adult hippocampus. These studies show that neural stem cells derived from adult tissues, like those derived from embryonic tissues, retain the potential to differentiate into functional neurons with essential properties of mature CNS neurons.	Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cfs@salk.edu; gage@salk.edu						ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Auerbach JM, 2000, EUR J NEUROSCI, V12, P1696, DOI 10.1046/j.1460-9568.2000.00067.x; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blondel O, 2000, J NEUROSCI, V20, P8012; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; Finley MFA, 1996, J NEUROSCI, V16, P1056; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goslin K., 1998, CULTURING NERVE CELL, P339; HALES TG, 1994, J NEUROSCI, V14, P5429; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kandel E., 2000, PRINCIPLES NEURAL SC; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NICHOLLS JG, 1992, NEURON BRAIN, P149; NOBEL M, 1998, CULTURING NERVE CELL, P499; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1989, BLOOD, V73, P438; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; SONG HJ, IN PRESS NATURE; SUCHER NJ, 1993, J BIOL CHEM, V268, P22299; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toda H, 2000, EXP NEUROL, V165, P66, DOI 10.1006/exnr.2000.7473; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Ye GL, 2000, DEV BRAIN RES, V124, P33, DOI 10.1016/S0165-3806(00)00103-6; ZAHEER A, 1995, CELL MOL NEUROBIOL, V15, P221, DOI 10.1007/BF02073330	50	511	556	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					438	445		10.1038/nn844	http://dx.doi.org/10.1038/nn844			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953752				2022-12-28	WOS:000175272000014
J	Winston, JS; Strange, BA; O'Doherty, J; Dolan, RJ				Winston, JS; Strange, BA; O'Doherty, J; Dolan, RJ			Automatic and intentional brain responses during evaluation of trustworthiness of faces	NATURE NEUROSCIENCE			English	Article							FACIAL EXPRESSIONS; HUMAN AMYGDALA; NEURAL RESPONSES; PERCEPTION; RECOGNITION; EMOTION; FEAR; MIND; ACTIVATION; MECHANISMS	Successful social interaction partly depends on appraisal of others from their facial appearance. A critical aspect of this appraisal relates to whether we consider others to be trustworthy. We determined the neural basis for such trustworthiness judgments using event-related functional magnetic resonance imaging. Subjects viewed faces and assessed either trustworthiness or age. In a parametric factorial design, trustworthiness ratings were correlated with BOLD signal change to reveal task-independent increased activity in bilateral amygdala and right insula in response to faces judged untrustworthy. Right superior temporal sulcus (STS) showed enhanced signal change during explicit trustworthiness judgments alone. The findings extend a proposed model of social cognition by highlighting a functional dissociation between automatic engagement of amygdala versus intentional engagement of STS in social judgment.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Inst Cognit Neurosci, London WC1N 3AR, England; UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School	Winston, JS (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	j.winston@fil.ion.ucl.ac.uk	O'Doherty, John P/F-1204-2013; Winston, Joel/F-6180-2010; Strange, Bryan A/L-9466-2014; Strange, Bryan/AAF-3805-2019	Winston, Joel/0000-0002-3957-0612; Strange, Bryan A/0000-0001-6476-4091; Strange, Bryan/0000-0001-6476-4091; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bonda E, 1996, J NEUROSCI, V16, P3737; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Cohen DonaldJ., 2000, UNDERSTANDING OTHER, P334; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Duvernoy HM, 1999, HUMAN BRAIN; Ekman P., 1975, PICTURES FACIAL AFFE; Elliott R, 1998, J NEUROSCI, V18, P4697; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Humphrey N, 1983, CONSCIOUSNESS REGAIN; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Talairach J., 1988, COPLANAR STEREOTAXIC; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, J NEUROSCI, V18, P411; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	50	745	753	6	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					277	283		10.1038/nn816	http://dx.doi.org/10.1038/nn816			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850635	Green Published			2022-12-28	WOS:000174146000020
J	Dahanukar, A; Foster, K; van Naters, WMVDG; Carlson, JR				Dahanukar, A; Foster, K; van Naters, WMVDG; Carlson, JR			A Gr receptor is required for response to the sugar trehalose in taste neurons of Drosophila	NATURE NEUROSCIENCE			English	Article							SWEET TASTE; GENE; FAMILY; MELANOGASTER; SENSITIVITY; IDENTIFICATION; PROJECTIONS; MOUTHPARTS; EXPRESSION	We recently identified from the Drosophila genome database a large family of G protein-coupled receptor genes, the Gr genes, and predicted that they encode taste receptors on the basis of their structure and specificity of expression. The expression of Gr genes in gustatory neurons has subsequently been confirmed and 56 family members have been reported. Here we provide functional evidence that one Gr gene, Gr5a, encodes a taste receptor required for response to the sugar trehalose. In two different mutants that carry deletions in Gr5a, electrophysiological and behavioral responses to trehalose were diminished but the response to sucrose was unaffected. Transgenic rescue experiments showed that Gr5a confers response to trehalose. The results correlate a particular taste ligand with a Gr receptor and indicate a role for G protein-mediated signaling in the transduction of sweet taste in Drosophila.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	Dahanukar, Anupama/0000-0003-0534-7700				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; AMAKAWA T, 1990, J INSECT PHYSIOL, V36, P281, DOI 10.1016/0022-1910(90)90112-S; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; GLENDINNING JI, 2000, NEUROBIOLOGY TASTE S, V2, P315; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; RODRIGUES V, 1981, MOL GEN GENET, V181, P406, DOI 10.1007/BF00425621; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; TANIMURA T, 1988, GENETICS, V119, P399; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; TANIMURA T, 1981, J COMP PHYSIOL, V141, P265, DOI 10.1007/BF01342672; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754	31	199	201	4	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1182	1186		10.1038/nn765	http://dx.doi.org/10.1038/nn765			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704765				2022-12-28	WOS:000172525000013
J	Laviolette, SR; Gallegos, RA; Henriksen, SJ; van der Kooy, D				Laviolette, SR; Gallegos, RA; Henriksen, SJ; van der Kooy, D			Opiate state controls bi-directional reward signaling via GABA(A) receptors in the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							A10 DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; SINGLE EXPOSURE; RAT; MORPHINE; RELEASE; RETROGRADE; SENSITIZATION; LOCALIZATION; INVOLVEMENT	The neural mechanisms that mediate the transition from a drug-naive state to a state of drug dependence and addiction are not yet known. Here we show that a discrete population of GABA(A) receptors in the mammalian ventral tegmental area (VTA) serves as a potential addiction switching mechanism by gating reward transmission through one of two neural motivational systems: either a dopamine-independent (opiate-naive) or a dopaminergic (opiate-dependent or opiate-withdrawn) system. Bi-directional transmission of reward signals through this GABA(A) receptor substrate is dynamically controlled by the opiate state of the organism and involves a molecular alteration of the GABA(A) receptor. After opiate exposure and subsequent withdrawal, the functional conductance properties of the rat VTA GABA(A) receptor switch from an inhibitory to an excitatory signaling mode.	Univ Toronto, Dept Anat & Cell Biol, Neurobiol Res Grp, Toronto, ON M5S 1A8, Canada; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Scripps Research Institute; University of Toronto	Laviolette, SR (corresponding author), Univ Toronto, Dept Anat & Cell Biol, Neurobiol Res Grp, Toronto, ON M5S 1A8, Canada.	laviolette@bns.pitt.edu						Auger AP, 2001, P NATL ACAD SCI USA, V98, P8059, DOI 10.1073/pnas.131016298; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bonci A, 1997, J NEUROSCI, V17, P796; Borsook D, 1999, J MOL NEUROSCI, V12, P35, DOI 10.1385/JMN:12:1:35; Brebner K, 2000, PHARMACOL BIOCHEM BE, V66, P857, DOI 10.1016/S0091-3057(00)00286-0; CHURCHILL L, 1992, NEUROCHEM RES, V17, P101, DOI 10.1007/BF00966870; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Garzon M, 2001, SYNAPSE, V41, P311, DOI 10.1002/syn.1088; GERRITS MAFM, 1994, PSYCHOPHARMACOLOGY, V114, P486, DOI 10.1007/BF02249340; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; JOHNSON SW, 1992, J NEUROSCI, V12, P483; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Laviolette SR, 2003, MOL PSYCHIATR, V8, P50, DOI 10.1038/sj.mp.4001197; Laviolette SR, 2002, BEHAV BRAIN RES, V129, P17, DOI 10.1016/S0166-4328(01)00327-8; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; MACKEY WB, 1985, PHARMACOL BIOCHEM BE, V22, P101, DOI 10.1016/0091-3057(85)90492-7; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Mark TL, 2001, DRUG ALCOHOL DEPEN, V61, P195, DOI 10.1016/S0376-8716(00)00162-9; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Olmstead MC, 1998, J NEUROSCI, V18, P5035; OLPE HR, 1977, BRAIN RES, V134, P577, DOI 10.1016/0006-8993(77)90834-4; Robinson TE, 2000, ADDICTION, V95, pS91; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schulteis G, 1997, PSYCHOPHARMACOLOGY, V129, P56, DOI 10.1007/s002130050162; SEMBA K, 1992, J COMP NEUROL, V323, P387, DOI 10.1002/cne.903230307; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Steffensen SC, 2001, BRAIN RES, V906, P190, DOI 10.1016/S0006-8993(01)02581-1; STEININGER TL, 1992, J COMP NEUROL, V321, P515, DOI 10.1002/cne.903210403; STINUS L, 1982, PSYCHOPHARMACOLOGY, V77, P186, DOI 10.1007/BF00431946; Svingos AL, 2001, SYNAPSE, V41, P221, DOI 10.1002/syn.1079; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Vanderschuren LJMJ, 2001, EUR J NEUROSCI, V14, P1533, DOI 10.1046/j.0953-816x.2001.01775.x; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Westerink BHC, 1996, J NEUROSCI, V16, P2605; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5	47	145	149	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					160	169		10.1038/nn1182	http://dx.doi.org/10.1038/nn1182			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730310				2022-12-28	WOS:000188468500014
J	Grunwald, IC; Korte, M; Adelmann, G; Plueck, A; Kullander, K; Adams, RH; Frotscher, M; Bonhoeffer, T; Klein, R				Grunwald, IC; Korte, M; Adelmann, G; Plueck, A; Kullander, K; Adams, RH; Frotscher, M; Bonhoeffer, T; Klein, R			Hippocampal plasticity requires postsynaptic ephrinBs	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASE; LONG-TERM DEPRESSION; EPHB RECEPTORS; CORTICOSPINAL TRACT; SYNAPSE FORMATION; DENSITY FRACTION; NERVOUS-SYSTEM; AMPA RECEPTORS; MULTIPLE ROLES; AREA CA1	Chemical synapses contain specialized pre- and postsynaptic structures that regulate synaptic transmission and plasticity. EphB receptor tyrosine kinases are important molecular components in this process. Previously, EphB receptors were shown to act postsynaptically, whereas their transmembrane ligands, the ephrinBs, were presumed to act presynaptically. Here we show that in mouse hippocampal CA1 neurons, the Eph/ephrin system is used in an inverted manner: ephrinBs are predominantly localized postsynaptically and are required for synaptic plasticity. We further demonstrate that EphA4, a candidate receptor, is also critically involved in long-term plasticity independent of its cytoplasmic domain, suggesting that ephrinBs are the active signaling partner. This work raises the intriguing possibility that depending on the type of synapse, Eph/ephrins can be involved in activity-dependent plasticity in converse ways, with ephrinBs on the pre- or the postsynaptic side.	Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany; Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Munich, Germany; Univ Freiburg, Inst Anat & Cell Biol, D-79001 Freiburg, Germany; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden; Canc Res UK, London Res Inst, London WC2A 3PX, England	Max Planck Society; Max Planck Society; University of Freiburg; University of Cologne; University of Gothenburg; Cancer Research UK	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany.		Adams, Ralf H/AAE-9274-2019; Bonhoeffer, Tobias/B-9481-2009; Grunwald, Iris/AAY-2521-2021; Klein, Ruediger/C-6147-2008	Bonhoeffer, Tobias/0000-0001-7897-6634; Grunwald, Iris/0000-0002-3404-7590; Klein, Ruediger/0000-0002-3109-0163; Grunwald Kadow, Ilona/0000-0002-9085-4274; Kullander, Klas/0000-0001-6418-5460				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HENKEMEYER M, IN PRESS J CELL BIOL; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	38	206	212	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					33	40		10.1038/nn1164	http://dx.doi.org/10.1038/nn1164			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699416				2022-12-28	WOS:000187636000010
J	Hirsch, JA; Martinez, LM; Pillai, C; Alonso, JM; Wang, QB; Sommer, FT				Hirsch, JA; Martinez, LM; Pillai, C; Alonso, JM; Wang, QB; Sommer, FT			Functionally distinct inhibitory neurons at the first stage of visual cortical processing	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; RAT SOMATOSENSORY CORTEX; ORIENTATION SELECTIVITY; RECEPTIVE-FIELDS; SIMPLE CELLS; IN-VIVO; SYNAPTIC INTEGRATION; MACAQUE MONKEY; BASKET CELLS; CONTRAST	Here we explore inhibitory circuits at the thalamocortical stage of processing in layer 4 of the cat's visual cortex, focusing on the anatomy and physiology of the interneurons themselves. Our immediate aim was to explore the inhibitory mechanisms that contribute to orientation selectivity, perhaps the most dramatic response property to emerge across the thalamocortical synapse. The broader goal was to understand how inhibitory circuits operate. Using whole-cell recording in cats in vivo, we found that layer 4 contains two populations of inhibitory cells defined by receptive field class-simple and complex. The simple cells were selective for stimulus orientation, whereas the complex cells were not. Our observations help to explain how neurons become sensitive to stimulus orientation and maintain that selectivity as stimulus contrast changes. Overall, the work suggests that different sources of inhibition, either selective for specific features or broadly tuned, interact to provide appropriate representations of elements within the environment.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ A Coruna, Dept Med, La Coruna 15006, Spain; SUNY Optometry, Dept Biol Sci, New York, NY 10036 USA; Redwood Neurosci Inst, Menlo Pk, CA 94025 USA	University of Southern California; Universidade da Coruna; State University of New York (SUNY) System	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, 3641 Watt Way, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013	Pillai, Cinthi/0000-0002-7662-443X	NEI NIH HHS [EY09593] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009593, R29EY009593] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2002, J NEUROSCI, V22, P10966; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1251, DOI 10.1152/jn.1979.42.5.1251; BURR D, 1981, EXP BRAIN RES, V43, P455; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carandini M, 2002, J NEUROSCI, V22, P10053; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; HENRY GH, 1977, BRAIN RES, V133, P1, DOI 10.1016/0006-8993(77)90045-2; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kayser AS, 2002, NEURON, V33, P131, DOI 10.1016/S0896-6273(01)00570-0; LAURITZEN TZ, IN PRESS J NEUROSCI; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MARTIN KAC, 1983, EXP BRAIN RES, V50, P193; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2003, J NEUROPHYSIOL, V90, P342, DOI 10.1152/jn.01018.2002; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SILLITO AM, 1992, PROG BRAIN RES, V90, P349; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; Thomson AM, 2003, CEREB CORTEX, V13, P136, DOI 10.1093/cercor/13.2.136; Troyer TW, 2002, J NEUROPHYSIOL, V87, P2741, DOI 10.1152/jn.2002.87.6.2741; Troyer TW, 1998, J NEUROSCI, V18, P5908; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; VOLGUSHEV M, 1993, VISUAL NEUROSCI, V10, P1151, DOI 10.1017/S0952523800010257; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001	50	144	144	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1300	1308		10.1038/nn1152	http://dx.doi.org/10.1038/nn1152			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625553				2022-12-28	WOS:000186725600015
J	Sippy, T; Cruz-Martin, A; Jeromin, A; Schweizer, FE				Sippy, T; Cruz-Martin, A; Jeromin, A; Schweizer, FE			Acute changes in short-term plasticity at synapses with elevated levels of neuronal calcium sensor-1	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; CULTURED HIPPOCAMPAL-NEURONS; PAIRED-PULSE FACILITATION; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; BINDING-PROTEINS; NERVE-TERMINALS; PYRAMIDAL CELLS; CA2+ CHANNELS	Short-term synaptic plasticity is a defining feature of neuronal activity, but the underlying molecular mechanisms are poorly understood. Depression of synaptic activity might be due to limited vesicle availability, whereas facilitation is thought to result from elevated calcium levels. However, it is unclear whether the strength and direction (facilitation versus depression) of plasticity at a given synapse result from preexisting synaptic strength or whether they are regulated by separate mechanisms. Here we show, in rat hippocampal cell cultures, that increases in the calcium binding protein neuronal calcium sensor-1 (NCS-1) can switch paired-pulse depression to facilitation without altering basal synaptic transmission or initial neurotransmitter release probability. Facilitation persisted during high-frequency trains of stimulation, indicating that NCS-1 can recruit 'dormant' vesicles. Our results suggest that NCS-1 acts as a calcium sensor for short-term plasticity by facilitating neurotransmitter output independent of initial release. We conclude that separate mechanisms are responsible for determining basal synaptic strength and short-term plasticity.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdept Ph D Program Neurosci, Los Angeles, CA 90095 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Baylor College of Medicine	Schweizer, FE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA.		Cruz-Martín, Alberto/AAO-5320-2020	Cruz-Martin, Alberto/0000-0002-3271-7220	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041317] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041317, NS41317, R01 NS041317-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atluri PP, 1996, J NEUROSCI, V16, P5661; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Burgoyne RD, 2001, BIOCHEM J, V353, P1; COX JA, 1994, J BIOL CHEM, V269, P32807; Cummings DD, 1996, J NEUROSCI, V16, P5312; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Marder E, 1998, ANNU REV NEUROSCI, V21, P25, DOI 10.1146/annurev.neuro.21.1.25; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Rajebhosale M, 2003, J BIOL CHEM, V278, P6075, DOI 10.1074/jbc.M204702200; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Vyshedskiy A, 2000, J NEUROSCI, V20, P6326, DOI 10.1523/JNEUROSCI.20-17-06326.2000; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Weiss JL, 2001, J BIOL CHEM, V276, P44804, DOI 10.1074/jbc.M103262200; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 2001, J PHYSIOL-LONDON, V531, P583, DOI 10.1111/j.1469-7793.2001.0583h.x; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	42	140	146	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1031	1038		10.1038/nn1117	http://dx.doi.org/10.1038/nn1117			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947410	Green Accepted			2022-12-28	WOS:000185633600014
J	Hirai, H; Launey, T; Mikawa, S; Torashima, T; Yanagihara, D; Kasaura, T; Miyamoto, A; Yuzaki, M				Hirai, H; Launey, T; Mikawa, S; Torashima, T; Yanagihara, D; Kasaura, T; Miyamoto, A; Yuzaki, M			New role of delta 2-glutamate receptors in AMPA receptor trafficking and cerebellar function	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; ORNITHINE-BINDING PROTEIN; CULTURED PURKINJE-CELLS; DELTA 2 SUBUNIT; GLUTAMATE-RECEPTOR; LIGAND-BINDING; CRYSTAL-STRUCTURE; MUTANT MICE; SYNAPTIC PLASTICITY; NMDA RECEPTOR	Previous gene knockout studies have shown that the orphan glutamate receptor delta2 (GluRdelta2) is critically involved in synaptogenesis between parallel fibers and Purkinje cells during development. However, the precise function of GluRdelta2 and whether it is functional in the mature cerebellum remain unclear. To address these issues, we developed an antibody specific for the putative ligand-binding region of GluRdelta2, and application of this antibody to cultured Purkinje cells induced AMPA receptor endocytosis, attenuated synaptic transmission and abrogated long-term depression. Moreover, injection of this antibody into the subarachnoidal supracerebellar space of adult mice caused transient cerebellar dysfunction, such as ataxic gait and poor performance in the rotorod test. These results indicate that GluRdelta2 is involved in AMPA receptor trafficking and cerebellar function in adult mice.	RIKEN, Brain Sci Inst, Lab Memory & Learning, Saitama 3510198, Japan; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Toyohashi Univ Technol, Neurophysiol Lab, Toyohashi, Aichi 4418580, Japan; Japan Sci & Technol Corp, CREST, Saitama 3320012, Japan; Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan	RIKEN; St Jude Children's Research Hospital; Toyohashi University of Technology; Japan Science & Technology Agency (JST); Keio University	Hirai, H (corresponding author), Kobe Univ, Grad Sch Med, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hirai@med.kobe-u.ac.jp	Hirai, Hirokazu/ABP-1143-2022; Yuzaki, Michisuke/K-5328-2013; Launey, Thomas/A-2605-2010	Yuzaki, Michisuke/0000-0002-5750-3544; Launey, Thomas/0000-0001-9153-9260; Hirai, Hirokazu/0000-0002-0721-4293	NCI NIH HHS [CA 21765] Funding Source: Medline; NINDS NIH HHS [NS36925] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036925] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Atluri PP, 1996, J NEUROSCI, V16, P5661; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Furuya S, 1998, BRAIN RES PROTOC, V3, P192, DOI 10.1016/S1385-299X(98)00040-3; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Hirai H, 2001, EUR J NEUROSCI, V14, P73, DOI 10.1046/j.0953-816x.2001.01630.x; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1984, CEREBELLUM NEURAL CO; Jeromin A, 1996, J NEUROPHYSIOL, V76, P3578, DOI 10.1152/jn.1996.76.5.3578; KANG CH, 1991, J BIOL CHEM, V266, P23893; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kawamoto Susumu, 1997, Molecular Brain Research, V47, P339, DOI 10.1016/S0169-328X(97)00103-4; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kurihara H, 1997, J NEUROSCI, V17, P9613; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Larkum ME, 1998, J NEUROPHYSIOL, V80, P924, DOI 10.1152/jn.1998.80.2.924; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Matsumoto M, 2000, INORG REACT MECH, V2, P19; MAYAT E, 1995, J NEUROSCI, V15, P2533, DOI 10.1523/JNEUROSCI.15-03-02533.1995; Murashima M, 1999, J NEUROSCI, V19, P7326, DOI 10.1523/JNEUROSCI.19-17-07326.1999; OH BH, 1993, J BIOL CHEM, V268, P11348; Paas Y, 2000, TRENDS PHARMACOL SCI, V21, P87, DOI 10.1016/S0165-6147(99)01443-1; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	39	102	106	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					869	876		10.1038/nn1086	http://dx.doi.org/10.1038/nn1086			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12833050				2022-12-28	WOS:000184413700017
J	Melcher, D; Morrone, MC				Melcher, D; Morrone, MC			Spatiotopic temporal integration of visual motion across saccadic eye movements	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; SUCCESSIVE FIXATIONS; RECEPTIVE-FIELDS; OPTIC FLOW; NEURONS; SPACE; INFORMATION; REPRESENTATION; PERCEPTION; FAILURE	Saccadic eye movements pose many challenges for stable and continuous vision, such as how information from successive fixations is amalgamated into a single precept. Here we show in humans that motion signals are temporally integrated across separate fixations, but only when the motion stimulus falls either on the same retinal region (retinotopic integration) or on different retinal positions that correspond to the same external spatial coordinates (spatiotopic integration). We used individual motion signals that were below detection threshold, implicating spatiotopic trans-saccadic integration in relatively early stages of visual processing such as the middle temporal area (MT) or V5 of visual cortex. The trans-saccadic buildup of important congruent visual information while irrelevant non-congruent information fades could provide a simple and robust strategy to stabilize perception during eye movements.	Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy; CNR, Inst Neurosci, Pisa, Italy	Vita-Salute San Raffaele University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Morrone, MC (corresponding author), Univ Vita Salute San Raffaele, Fac Psychol, Via Olgettina 58, Milan, Italy.		Melcher, David/D-1775-2010; Morrone, Maria Concetta/C-6756-2014	Melcher, David/0000-0003-0926-585X; Morrone, Maria Concetta/0000-0002-1025-0316				BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; BRIDGEMAN B, 1983, B PSYCHONOMIC SOC, V21, P285; Brockmole JR, 2002, J EXP PSYCHOL HUMAN, V28, P315, DOI 10.1037//0096-1523.28.2.315; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; JONIDES J, 1983, SCIENCE, V222, P188, DOI 10.1126/science.6623072; Land MF., 2001, ANIMAL EYES; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SALZMAN CD, 1990, NATURE, V346, P106; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	29	147	151	1	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					877	881		10.1038/nn1098	http://dx.doi.org/10.1038/nn1098			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872128				2022-12-28	WOS:000184413700018
J	Bergeron, A; Matsuo, S; Guitton, D				Bergeron, A; Matsuo, S; Guitton, D			Superior colliculus encodes distance to target, not saccade amplitude, in multi-step gaze shifts	NATURE NEUROSCIENCE			English	Article							HEAD-FREE CAT; CAUDAL FASTIGIAL NUCLEUS; STEM OMNIPAUSE NEURONS; EYE-MOVEMENTS; TECTORETICULOSPINAL SYSTEM; REVERSIBLE INACTIVATION; VESTIBULOOCULAR REFLEX; MUSCIMOL INACTIVATION; FIXATION NEURONS; MOTOR MAP	The superior colliculus (SC) is important for generating coordinated eye-head gaze saccades. Its deeper layers contain a retinotopically organized motor map in which each site is thought to encode a specific gaze saccade vector. Here we show that this fundamental assumption in current models of collicular function does not hold true during horizontal multi-step gaze shifts in darkness that are directed to a goal and composed of a sequence of gaze saccades separated by periods of steady fixation. At the start of a muiti-step gaze shift in cats, neural activity on the SC's map was located caudally to encode the overall amplitude of the gaze displacement, not the first saccade in the sequence. As the gaze shift progressed, the locus of activity moved to encode the error between the goal and the current gaze position. Contrary to common belief, the locus of activity never encoded gaze saccade amplitude, except for the last saccade in the sequence.	McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Guitton, D (corresponding author), McGill Univ, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	daniel.guitton@mcgill.ca						Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Bergeron A, 2001, PROG BRAIN RES, V134, P97; Bergeron A, 2000, NAT NEUROSCI, V3, P932, DOI 10.1038/78847; CHUN KS, 1978, BIOL CYBERN, V28, P209, DOI 10.1007/BF00344268; Edelman JA, 2001, J NEUROPHYSIOL, V86, P676, DOI 10.1152/jn.2001.86.2.676; FAKHRI S, 1994, PERG S NEUR, P53; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; GALIANA HL, 1991, IEEE T BIO-MED ENG, V38, P532, DOI 10.1109/10.81578; Gandhi NJ, 1999, J NEUROPHYSIOL, V82, P3236, DOI 10.1152/jn.1999.82.6.3236; Goffart L, 1998, J NEUROPHYSIOL, V79, P1959, DOI 10.1152/jn.1998.79.4.1959; Goffart L, 1998, J NEUROPHYSIOL, V79, P1942, DOI 10.1152/jn.1998.79.4.1942; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; GUITTON D, 1991, J NEUROPHYSIOL, V66, P1605, DOI 10.1152/jn.1991.66.5.1605; GUITTON D, 1984, J NEUROPHYSIOL, V52, P1030, DOI 10.1152/jn.1984.52.6.1030; Keller EL, 1996, J NEUROPHYSIOL, V76, P3573, DOI 10.1152/jn.1996.76.5.3573; KELLER EL, 1994, J NEUROPHYSIOL, V72, P2754, DOI 10.1152/jn.1994.72.6.2754; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; MACPHERSON JM, 1979, BRAIN RES, V175, P183, DOI 10.1016/0006-8993(79)90530-4; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1991, SCIENCE, V251, P1358, DOI 10.1126/science.2003221; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Munoz DP, 1996, J NEUROPHYSIOL, V75, P2562, DOI 10.1152/jn.1996.75.6.2562; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1624, DOI 10.1152/jn.1991.66.5.1624; MUNOZ DP, 1989, REV NEUROL-FRANCE, V145, P567; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1642, DOI 10.1152/jn.1991.66.5.1642; Pare M, 1998, J NEUROPHYSIOL, V79, P3060, DOI 10.1152/jn.1998.79.6.3060; PARE M, 1994, EXP BRAIN RES, V101, P123; PECK CK, 1989, J PHYSIOL-LONDON, V414, P301, DOI 10.1113/jphysiol.1989.sp017689; Peck CK, 1997, EXP BRAIN RES, V113, P291, DOI 10.1007/BF02450327; Pelisson D, 1998, J NEUROPHYSIOL, V80, P1180, DOI 10.1152/jn.1998.80.3.1180; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; Quaia C, 1998, J NEUROPHYSIOL, V79, P2097, DOI 10.1152/jn.1998.79.4.2097; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; ROUCOUX A, 1980, EXP BRAIN RES, V39, P75; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; STANFORD TR, 1994, VISION RES, V34, P93, DOI 10.1016/0042-6989(94)90260-7	43	54	55	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					404	413		10.1038/nn1027	http://dx.doi.org/10.1038/nn1027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627166				2022-12-28	WOS:000181833100019
J	d'Avella, A; Saltiel, P; Bizzi, E				d'Avella, A; Saltiel, P; Bizzi, E			Combinations of muscle synergies in the construction of a natural motor behavior	NATURE NEUROSCIENCE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; SPINAL-CORD; ELECTROMYOGRAPHIC ACTIVITY; DIFFERENT DIRECTIONS; BLIND SEPARATION; MOVEMENTS; FROG; GENERATION; PATTERNS; ARM	A central issue in motor control is how the central nervous system generates the muscle activity patterns necessary to achieve a variety of behavioral goals. The many degrees of freedom of the musculoskeletal apparatus provide great flexibility but make the control problem extremely complex. Muscle synergies-coherent activations, in space or time, of a group of muscles-have been proposed as building blocks that could simplify the construction of motor behaviors. To evaluate this hypothesis, we developed a new method to extract invariant spatiotemporal components from the simultaneous recordings of the activity of many muscles. We used this technique to analyze the muscle patterns of intact and unrestrained frogs during kicking, a natural defensive behavior. Here we show that combinations of three time-varying muscle synergies underlie the variety of muscle patterns required to kick in different directions, that the recruitment of these synergies is related to movement kinematics, and that there are similarities among the synergies extracted from different behaviors.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; IRCCS, Fdn Santa Lucia, Human Physiol Sect, I-00179 Rome, Italy	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); IRCCS Santa Lucia	Bizzi, E (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St, Cambridge, MA 02139 USA.	ebizzi@mit.edu	d'Avella, Andrea/K-6856-2018	d'Avella, Andrea/0000-0002-3393-4956; /0000-0002-7644-4498	NINDS NIH HHS [NS09343] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009343] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bernstein N, 1967, COORDINATION REGULAT; Bishop CM., 1995, NEURAL NETWORKS PATT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; BUCHANAN TS, 1986, J NEUROPHYSIOL, V56, P1225, DOI 10.1152/jn.1986.56.5.1225; Cheng JG, 1998, J NEUROSCI, V18, P4295; d'Avella A, 2002, ADV NEUR IN, V14, P141; ECKER A, 1989, ANATOMY FROG; FLANDERS M, 1994, J NEUROPHYSIOL, V71, P811, DOI 10.1152/jn.1994.71.2.811; GISZTER SF, 1993, J NEUROSCI, V13, P467; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HOGAN N, 1988, CAN J PHYSIOL PHARM, V66, P508, DOI 10.1139/y88-080; Kargo WJ, 2002, J EXP BIOL, V205, P1987; Kargo WJ, 2000, J NEUROSCI, V20, P409, DOI 10.1523/JNEUROSCI.20-01-00409.2000; KARST GM, 1991, J NEUROPHYSIOL, V66, P1594, DOI 10.1152/jn.1991.66.5.1594; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; LEE WA, 1984, J MOTOR BEHAV, V16, P135; Lombard WP, 1907, AM J PHYSIOL, V20, P1, DOI 10.1152/ajplegacy.1907.20.1.1; MACPHERSON JM, 1991, LIFE SCI R, V50, P33; MACPHERSON JM, 1988, J NEUROPHYSIOL, V60, P218, DOI 10.1152/jn.1988.60.1.218; MAIER MA, 1995, EXP BRAIN RES, V103, P123, DOI 10.1007/BF00241970; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Rossignol Serge, 1994, Current Opinion in Neurobiology, V4, P894, DOI 10.1016/0959-4388(94)90139-2; Saltiel P, 2001, J NEUROPHYSIOL, V85, P605, DOI 10.1152/jn.2001.85.2.605; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; Sherrington C, 1948, INTEGRATIVE ACTION N; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SOECHTING JF, 1989, EXP BRAIN RES, V74, P535; Stein PSG, 1998, ANN NY ACAD SCI, V860, P142, DOI 10.1111/j.1749-6632.1998.tb09045.x; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; WADMAN W J, 1980, Journal of Human Movement Studies, V6, P19	39	813	818	5	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					300	308		10.1038/nn1010	http://dx.doi.org/10.1038/nn1010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563264				2022-12-28	WOS:000181178300019
J	Murphy, TH				Murphy, TH			Activity-dependent synapse development: changing the rules	NATURE NEUROSCIENCE			English	Editorial Material							RELEASE; PLASTICITY; NETWORKS	In a recent Nature paper, reduction of postsynaptic activity within single neurons of an active network reveals a new role for Hebbian competition during early development.	Univ British Columbia, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Physiol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Murphy, TH (corresponding author), Univ British Columbia, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada.		Murphy, Timothy H/I-4982-2014; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490				Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Johns DC, 1999, J NEUROSCI, V19, P1691; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Prange O, 1999, J NEUROSCI, V19, P6427; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	15	18	18	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					9	11		10.1038/nn0103-9	http://dx.doi.org/10.1038/nn0103-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12494242				2022-12-28	WOS:000180089300006
J	Middlebrooks, JC				Middlebrooks, JC			Auditory space processing: here, there or everywhere?	NATURE NEUROSCIENCE			English	Editorial Material							STREAMS		Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Middlebrooks, JC (corresponding author), Univ Michigan, Kresge Hearing Res Inst, 1301 E Ann St, Ann Arbor, MI 48109 USA.	jmidd@umich.edu						ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; Middlebrooks JC, 2002, SPR HDB AUD, V15, P319; Middlebrooks JC, 1998, J NEUROPHYSIOL, V80, P863, DOI 10.1152/jn.1998.80.2.863; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tian B, 1998, J NEUROPHYSIOL, V79, P2629, DOI 10.1152/jn.1998.79.5.2629; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Zatorre RJ, 2001, J NEUROSCI, V21, P6321, DOI 10.1523/JNEUROSCI.21-16-06321.2001; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904	12	45	46	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					824	826		10.1038/nn0902-824	http://dx.doi.org/10.1038/nn0902-824			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12196806				2022-12-28	WOS:000177656300005
J	O'Connor, V; Lee, AG				O'Connor, V; Lee, AG			Synaptic vesicle fusion and synaptotagmin: 2B or not 2B?	NATURE NEUROSCIENCE			English	Editorial Material							C2B DOMAIN; RELEASE		Univ Southampton, Sch Biol Sci, Div Cell Sci, Southampton SO16 7PX, Hants, England; Univ Southampton, Sch Biol Sci, Div Biochem & Mol Biol, Southampton SO16 7PX, Hants, England	University of Southampton; University of Southampton	O'Connor, V (corresponding author), Univ Southampton, Sch Biol Sci, Div Cell Sci, Southampton SO16 7PX, Hants, England.							Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c	14	8	9	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					823	824		10.1038/nn0902-823	http://dx.doi.org/10.1038/nn0902-823			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12196805				2022-12-28	WOS:000177656300004
J	Ross, J; Ma-Wyatt, A				Ross, J; Ma-Wyatt, A			Saccades actively maintain perceptual continuity	NATURE NEUROSCIENCE			English	Article							VISUAL SPACE; TERM-MEMORY; EYE; MONKEY; MAINTENANCE; COMPRESSION; INFORMATION; ATTENTION; MOTION	People make saccades-rapid eye movements to a new fixation-approximately three times per second. This would seemingly disrupt perceptual continuity, yet our brains construct a coherent, stable view of the world from these successive fixations. There is conflicting evidence regarding the effects of saccades on perceptual continuity: some studies report that they are disruptive, with little information carryover between saccades; others report that carryover is substantial. Here we show that saccades actively contribute to perceptual continuity in humans in two different ways. When bistable stimuli are presented intermittently, saccades executed during the blank interval shorten the duration of states of ambiguous figures, indicating that saccades can erase immediately past perceptual states. On the other hand, they prolong the McCollough effect, indicating that saccades strengthen learned contingencies. Our results indicate that saccades help, rather than hinder, perceptual continuity.	Univ Western Australia, Sch Psychol, Crawley, WA 6009, Australia; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	University of Western Australia; The Smith-Kettlewell Eye Research Institute	Ma-Wyatt, A (corresponding author), Univ Western Australia, Sch Psychol, 35 Stirling Highway, Crawley, WA 6009, Australia.	anna@ski.org						Balan PF, 2003, J NEUROSCI, V23, P5446; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Burr DC, 2001, CURR BIOL, V11, P798, DOI 10.1016/S0960-9822(01)00183-X; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUTOUR EF, 1760, ACAD SCI MEMOIRES MA, V3, P514; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; JONIDES J, 1982, SCIENCE, V215, P192, DOI 10.1126/science.7053571; JUTTNER M, 1993, PERCEPT PSYCHOPHYS, V53, P210, DOI 10.3758/BF03211731; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Ma-Wyatt A, 2003, INVEST OPHTH VIS SCI, V44, pU443; MACKAY D M, 1974, Journal of Physiology (Cambridge), V237, P38; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MAWYATT A, 2002, J VIS, V2, P569; MCCOLLOUGH C, 1965, SCIENCE, V176, P541; McPeek RM, 1999, VISION RES, V39, P1555, DOI 10.1016/S0042-6989(98)00228-4; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Morrone MC, 1997, J NEUROSCI, V17, P7941; Necker LA., 1832, LONDON EDINBURGH, V1, P329, DOI [10.1080/14786443208647909, DOI 10.1080/14786443208647909]; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; SCHLAG J, 1995, VISION RES, V35, P2347, DOI 10.1016/0042-6989(95)00021-Q; SHUTE CCD, 1979, MCCOLLOUGHD EFFECT; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; WOLF W, 1980, VISION RES, V20, P117, DOI 10.1016/0042-6989(80)90153-4	39	39	40	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					65	69		10.1038/nn1163	http://dx.doi.org/10.1038/nn1163			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14661023				2022-12-28	WOS:000187636000014
J	Thilo, KV; Santoro, L; Walsh, V; Blakemore, C				Thilo, KV; Santoro, L; Walsh, V; Blakemore, C			The site of saccadic suppression	NATURE NEUROSCIENCE			English	Article							EYE-MOVEMENTS; VISION	During rapid eye movements, or saccades, stable vision is maintained by active reduction of visual sensitivity. The site of this saccadic suppression remains uncertain. Here we show that phosphenes-small illusory visual perceptions-induced by transcranial magnetic stimulation (TMS) to the human occipital cortex are immune to saccadic suppression, whereas phosphenes induced by retinal stimulation are not, thus providing direct physiological evidence that saccadic suppression occurs between the retina and the occipital visual cortex.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England	University of Oxford; University of London; University College London; University of London; University College London	Thilo, KV (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.	kai.thilo@physiol.ox.ac.uk		Blakemore, Colin/0000-0003-2659-7899				ADRIAN DJ, 1977, RADIO SCI, V12, P243, DOI 10.1029/RS012i06Sp00243; Bodis-Wollner I, 1999, NEUROLOGY, V53, P1800, DOI 10.1212/WNL.53.8.1800; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castet E, 2000, NAT NEUROSCI, V3, P177, DOI 10.1038/72124; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; Lee D, 1998, J NEUROPHYSIOL, V79, P922, DOI 10.1152/jn.1998.79.2.922; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; RICHARDS W, 1968, J OPT SOC AM, V58, P1159, DOI 10.1364/JOSA.58.001159; RIGGS LA, 1974, VISION RES, V14, P997, DOI 10.1016/0042-6989(74)90169-2; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; TYRRELL RA, 1988, BEHAV RES METH INSTR, V20, P137, DOI 10.3758/BF03203817; VOLKMANN FC, 1962, J OPT SOC AM, V52, P571, DOI 10.1364/JOSA.52.000571	14	82	82	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					13	U3		10.1038/nn1171	http://dx.doi.org/10.1038/nn1171			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699413				2022-12-28	WOS:000187636000006
J	Colwell, CS; Michel, S				Colwell, CS; Michel, S			Sleep and circadian rhythms: do sleep centers talk back to the clock?	NATURE NEUROSCIENCE			English	Editorial Material							HOMEOSTASIS; PHYSIOLOGY; AROUSAL; NUCLEUS		Univ Calif Los Angeles, Sch Med, Dept Psychiat, Lab Circadian Neurobiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Colwell, CS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Psychiat, Lab Circadian Neurobiol, 760 Westwood Plaza, Los Angeles, CA 90024 USA.		Colwell, Chris/AAM-6111-2020	Colwell, Christopher/0000-0002-1059-184X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043169] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064582-04, R01 HL064582] Funding Source: Medline; NINDS NIH HHS [R01 NS043169-05, R01 NS043169] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antle MC, 2000, J NEUROSCI, V20, P9326; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Naylor E, 2000, J NEUROSCI, V20, P8138; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Wurts SW, 2000, J NEUROSCI, V20, P4300	14	9	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1005	1006		10.1038/nn1003-1005	http://dx.doi.org/10.1038/nn1003-1005			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14513032	Green Accepted			2022-12-28	WOS:000185633600005
J	Lu, HC; She, WC; Plas, DT; Neumann, PE; Janz, R; Crair, MC				Lu, HC; She, WC; Plas, DT; Neumann, PE; Janz, R; Crair, MC			Adenylyl cyclase I regulates AMPA receptor trafficking during mouse cortical 'barrel' map development	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DEPENDENT PROTEIN-KINASE; SILENT SYNAPSES; CRITICAL PERIOD; GLUR1 SUBUNIT; PLASTICITY; CORTEX; CAMP; LTP; PHOSPHORYLATION	Cortical map formation requires the accurate targeting, synaptogenesis, elaboration and refinement of thalamocortical afferents. Here we demonstrate the role of Ca2+/calmodulin-activated type-I adenylyl cyclase (AC1) in regulating the strength of thalamocortical synapses through modulation of AMPA receptor (AMPAR) trafficking using barrelless mice, a mutant without AC1 activity or cortical 'barrel' maps. Barrelless synapses are stuck in an immature state that contains few functional AMPARs that are rarely silent (NMDAR-only). Long-term potentiation (LTP) and long-term depression (LTD) at thalamocortical synapses require postsynaptic protein kinase A (PKA) activity and are difficult to induce in barrelless mice, probably due to an inability to properly regulate synaptic AMPAR trafficking. Consistent with this, both the extent of PKA phosphorylation on AMPAR subunit GluR1 and the expression of surface GluR1 are reduced in barrelless neurons. These results suggest that activity-dependent mechanisms operate through an AC1/PKA signaling pathway to target some synapses for consolidation and others for elimination during barrel map formation.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Dalhousie Univ, Fac Med, Dept Anat & Neurobiol, Halifax, NS B3H 1X5, Canada; Univ Texas, Houston Med Sch, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Dalhousie University; University of Texas System; University of Texas Health Science Center Houston	Lu, HC (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza S-603, Houston, TX 77030 USA.	hlu@cns.bcm.tmc.edu; mcrair@bcm.tmc.edu		Neumann, Paul/0000-0002-8480-4799; Janz, Roger/0000-0002-9872-0596	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011034] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NIMH NIH HHS [MH62639] Funding Source: Medline; NINDS NIH HHS [F32 NS011034, NS11034] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Glazewski S, 1999, CEREB CORTEX, V9, P249, DOI 10.1093/cercor/9.3.249; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Goslin K., 1998, CULTURING NERVE CELL, P339; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kind PC, 2001, TRENDS NEUROSCI, V24, P553, DOI 10.1016/S0166-2236(00)01921-4; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; VANDERLOOS H, 1986, J HERED, V77, P66, DOI 10.1093/oxfordjournals.jhered.a110201; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850	50	90	93	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					939	947		10.1038/nn1106	http://dx.doi.org/10.1038/nn1106			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897788				2022-12-28	WOS:000184970400012
J	Mednick, S; Nakayama, K; Stickgold, R				Mednick, S; Nakayama, K; Stickgold, R			Sleep-dependent learning: a nap is as good as a night	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION; IMPROVEMENT	The learning of perceptual skills has been shown in some cases to depend on the plasticity of the visual cortex(1) and to require post-training nocturnal sleep(2). We now report that sleep-dependent learning of a texture discrimination task can be accomplished in humans by brief (60-90 min) naps containing both slow-wave sleep (SWS) and rapid eye movement (REM) sleep. This nap-dependent learning closely resembled that previously reported for an 8-h night of sleep in terms of magnitude, sleep-stage dependency and retinotopic specificity, and it was additive to subsequent sleep-dependent improvement, such that performance over 24 h showed as much learning as is normally seen after twice that length of time. Thus, from the perspective of behavioral improvement, a nap is as good as a night of sleep for learning on this perceptual task.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Mednick, S (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	smednick@post.harvard.edu		mednick, sara/0000-0002-0906-3097	NIDA NIH HHS [DA 11744] Funding Source: Medline; NIMH NIH HHS [MH 48832] Funding Source: Medline; NINDS NIH HHS [NS 26985] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS026985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011744] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Dinges D., 1989, SLEEP ALERTNESS CHRO; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Takahashi M, 2000, SLEEP, V23, P813; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	13	384	395	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					697	698		10.1038/nn1078	http://dx.doi.org/10.1038/nn1078			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12819785				2022-12-28	WOS:000183780400015
J	Patel, AD				Patel, AD			Language, music, syntax and the brain	NATURE NEUROSCIENCE			English	Review							HUMAN AUDITORY-CORTEX; SENTENCE COMPREHENSION; WORKING-MEMORY; COMPLEXITY; CONTEXT; CHORDS; BROCAS; SPEECH; EXPECTANCY; ACTIVATION	The comparative study of music and language is drawing an increasing amount of research interest. Like language, music is a human universal involving perceptually discrete elements organized into hierarchically structured sequences. Music and language can thus serve as foils for each other in the study of brain mechanisms underlying complex sound processing, and comparative research can provide novel insights into the functional and neural architecture of both domains. This review focuses on syntax, using recent neuroimaging data and cognitive theory to propose a specific point of convergence between syntactic processing in language and music. This leads to testable predictions, including the prediction that that syntactic comprehension problems in Broca's aphasia are not selective to language but influence music perception as well.	Inst Neurosci, San Diego, CA 92121 USA		Patel, AD (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.							[Anonymous], [No title captured]; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Babyonyshev M, 1999, LANGUAGE, V75, P423, DOI 10.2307/417056; Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BHARUCHA JJ, 1987, PERCEPT PSYCHOPHYS, V41, P519, DOI 10.3758/BF03210486; Bigand E, 1999, PSYCHOL RES-PSYCH FO, V62, P237, DOI 10.1007/s004260050053; Bigand E, 1997, PERCEPT PSYCHOPHYS, V59, P1098, DOI 10.3758/BF03205524; Bigand E, 1999, J EXP PSYCHOL HUMAN, V25, P184, DOI 10.1037/0096-1523.25.1.184; Bigand E, 2003, MUSIC SCI, V7, P121, DOI 10.1177/102986490300700107; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; BLUMSTEIN SE, 1991, BRAIN LANG, V40, P393, DOI 10.1016/0093-934X(91)90138-Q; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Deutsch D., 1999, PSYCHOL MUSIC; Elman JL, 1996, RETHINKING INNATENES; Fodor J. A, 1983, MODULARITY MIND; FRANCES R, 1973, REV INT PSYCHOL APPL, V22, P117; Frisch S, 2003, CLIN NEUROPHYSIOL, V114, P336, DOI 10.1016/S1388-2457(02)00366-8; Gandour J, 2000, J COGNITIVE NEUROSCI, V12, P207, DOI 10.1162/089892900561841; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Gibson E, 1998, TRENDS COGN SCI, V2, P262, DOI 10.1016/S1364-6613(98)01187-5; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; HAARMANN HJ, 1991, COGNITIVE SCI, V15, P49, DOI 10.1207/s15516709cog1501_2; HAARMANN HJ, 1991, APHASIOLOGY, V5, P247, DOI 10.1080/02687039108248527; Hagoort Peter, 1999, NEUROCOGNITION LANGU; Hebert S, 2001, BRAIN COGNITION, V46, P169, DOI 10.1016/S0278-2626(01)80058-0; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; HSIAO F, IN PRESS COGNITION; Jackendoff Ray, 2002, FDN LANGUAGE; Jakobson LS, 2003, MUSIC PERCEPT, V20, P307, DOI 10.1525/mp.2003.20.3.307; Justus TC, 2001, J EXP PSYCHOL HUMAN, V27, P1000, DOI 10.1037/0096-1523.27.4.1000; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Koelsch S, 2001, NEUROREPORT, V12, P1385, DOI 10.1097/00001756-200105250-00019; KOLK HHJ, 1985, CORTEX, V21, P47, DOI 10.1016/S0010-9452(85)80015-0; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; KRUMHANSL CL, 1979, COGNITIVE PSYCHOL, V11, P346, DOI 10.1016/0010-0285(79)90016-1; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; KRUMHANSL CL, 1982, J EXP PSYCHOL HUMAN, V8, P24, DOI 10.1037/0096-1523.8.1.24; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; LERDAHL F, 1983, GENERATIVE THEORY TO; LERDAHL F, IN PRESS ULTIMOS DIE; Lerdahl F., 2001, TONAL PITCH SPACE; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Marin O.S.M., 1999, PSYCHOL MUSIC, P653; McNellis MG, 2001, J COGNITIVE NEUROSCI, V13, P151, DOI 10.1162/089892901564216; Menning H, 2002, LEARN MEMORY, V9, P253, DOI 10.1101/lm.49402; Nettl B, 2000, ORIGINS OF MUSIC, P463; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; PERETZ I, 1993, COGNITIVE NEUROPSYCH, V10, P21, DOI 10.1080/02643299308253455; Peretz Isabelle, 2003, COGNITIVE NEUROSCIEN; Phillips Colin, 1996, THESIS MIT; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; SCHON D, IN PRESS PSYCHOPHYSI; Sloboda J., 1985, THE MUSICAL MIND, V1999; SMITH N, IN PRESS MUSICAE SCI; Swaab TY, 1998, NEUROPSYCHOLOGIA, V36, P737, DOI 10.1016/S0028-3932(97)00174-7; Swain J., 1997, MUSICAL LANGUAGES; Tekman HG, 1998, J EXP PSYCHOL HUMAN, V24, P252, DOI 10.1037/0096-1523.24.1.252; Tervaniemi M, 1999, NEUROIMAGE, V9, P330, DOI 10.1006/nimg.1999.0405; Tillmann B, 1998, MUSIC PERCEPT, V16, P99; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Tillmann B, 2001, J EXP PSYCHOL HUMAN, V27, P1185, DOI 10.1037//0096-1523.27.5.1185; TREHUB SE, 1993, ADV CHILD DEV BEHAV, V24, P1, DOI 10.1016/S0065-2407(08)60298-0; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vega D, 2003, MUSIC SCI, V7, P35, DOI 10.1177/102986490300700103; WALLACE WT, 1994, J EXP PSYCHOL LEARN, V20, P1471, DOI 10.1037/0278-7393.20.6.1471; Warren T, 2002, COGNITION, V85, P79, DOI 10.1016/S0010-0277(02)00087-2; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	89	698	718	15	287	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					674	681		10.1038/nn1082	http://dx.doi.org/10.1038/nn1082			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830158				2022-12-28	WOS:000183780400011
J	Gray, JR; Chabris, CF; Braver, TS				Gray, JR; Chabris, CF; Braver, TS			Neural mechanisms of general fluid intelligence	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PROGRESSIVE MATRICES TEST; WORKING-MEMORY CAPACITY; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; BRAIN ACTIVATION; COGNITIVE CONTROL; TASK-PERFORMANCE; FMRI; INTERFERENCE	We used an individual-differences approach to test whether general fluid intelligence (gF) is mediated by brain regions that support attentional (executive) control, including subregions of the prefrontal cortex. Forty-eight participants first completed a standard measure of gF (Raven's Advanced Progressive Matrices). They then performed verbal and nonverbal versions of a challenging working-memory task (three-back) while their brain activity was measured using functional magnetic resonance imaging (fMRI). Trials within the three-back task varied greatly in the demand for attentional control because of differences in trial-to-trial interference. On high-interference trials specifically, participants with higher gF were more accurate and had greater event-related neural activity in several brain regions. Multiple regression analyses indicated that lateral prefrontal and parietal regions may mediate the relation between ability (gF) and performance (accuracy despite interference), providing constraints on the neural mechanisms that support gF.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Washington University (WUSTL); Harvard University	Braver, TS (corresponding author), Washington Univ, Dept Psychol, Campus Box 1125, St Louis, MO 63130 USA.		Gray, Jeremy/A-2635-2013; Kennedy, Kristen M/B-4699-2008; Gray, Jeremy/A-9719-2008	Kennedy, Kristen M/0000-0001-5373-9026; Braver, Todd/0000-0002-2631-3393				BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bischoff-Grethe A, 2002, J NEUROSCI, V22, P546, DOI 10.1523/JNEUROSCI.22-02-00546.2002; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cattell R. B., 1971, ABILITIES THEIR STRU; CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Ceci SJ, 1997, AM PSYCHOL, V52, P1051, DOI 10.1037/0003-066X.52.10.1051; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen J., 1983, APPL MULTIPLE REGRES; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; CRONBACH LJ, 1957, AM PSYCHOL, V12, P671, DOI 10.1037/h0043943; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; DEARY IJ, 2000, LOOKING DOWN HUMAN I; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; Gray JR, 2002, COGN AFFECT BEHAV NE, V2, P64, DOI 10.3758/CABN.2.1.64; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Gruber O, 2001, CEREB CORTEX, V11, P1047, DOI 10.1093/cercor/11.11.1047; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; KANE MJ, IN PRESS PSYCHONOM B; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Markowitsch HJ, 2000, EXP BRAIN RES, V133, P94, DOI 10.1007/s002210000404; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Raven J.C., 1998, ADV PROGR MATRICES; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Sternberg RJ, 2000, SCIENCE, V289, P399, DOI 10.1126/science.289.5478.399; STERNBERG RJ, 1985, BEYOND IQ TRIARCHIC; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Williams W. M., 1998, RISING CURVE LONG TE, P125	48	750	769	2	113	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					316	322		10.1038/nn1014	http://dx.doi.org/10.1038/nn1014			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592404				2022-12-28	WOS:000181178300021
J	Hallam, SJ; Goncharov, A; McEwen, J; Baran, R; Jin, YS				Hallam, SJ; Goncharov, A; McEwen, J; Baran, R; Jin, YS			SYD-1, a presynaptic protein with PDZ, C2 and rhoGAP-like domains, specifies axon identity in C-elegans	NATURE NEUROSCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CULTURED HIPPOCAMPAL-NEURONS; GLUTAMIC-ACID DECARBOXYLASE; BINDING PROTEIN; NERVOUS-SYSTEM; CELL-LINEAGE; ACTIVE ZONE; MORPHOGENESIS; LOCALIZATION; POLARITY	Axons are defined by the presence of presynaptic specializations at specific locations. We show here that loss-of-function mutations in the C. elegans gene syd-1 cause presynaptic specializations to form in the dendritic processes of GABA-expressing motor neurons during initial differentiation. At a later developmental stage, however, syd-1 is not required for the polarity respecification of a subset of these neurons. The SYD-1 protein contains PDZ, C2 and rho-GTPase activating protein (GAP)-like domains, and is localized to presynaptic terminals in mature neurons. A truncated SYD-1 that lacks the rhoGAP domain interferes with neurite outgrowth and guidance. Our data indicate that syd-1 may be involved in specifying axon identity during initial polarity acquisition.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Jin, YS (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.			Jin, Yishi/0000-0002-9371-9860				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BRENNER S, 1974, GENETICS, V77, P71; CLARK SG, 1994, GENETICS, V137, P987; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Eastman C, 1999, J NEUROSCI, V19, P6225; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; HORVITZ HR, 1980, GENETICS, V96, P435; Hung TJ, 1999, DEVELOPMENT, V126, P127; Jin YS, 1999, J NEUROSCI, V19, P539; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; McFarlane S, 2000, MOL NEUROBIOL, V22, P1, DOI 10.1385/MN:22:1-3:001; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Rittinger K, 1998, NATURE, V392, P448, DOI 10.1038/33043; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; ZOLLER MJ, 1987, METHOD ENZYMOL, V154, P329	45	78	94	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1137	1146		10.1038/nn959	http://dx.doi.org/10.1038/nn959			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379863				2022-12-28	WOS:000178884600016
J	Hardingham, GE; Fukunaga, Y; Bading, H				Hardingham, GE; Fukunaga, Y; Bading, H			Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways	NATURE NEUROSCIENCE			English	Article							FAMILY TRANSCRIPTION FACTOR; D-ASPARTATE RECEPTOR; GENE-EXPRESSION; MITOCHONDRIAL DEPOLARIZATION; DEPENDENT SURVIVAL; CALCIUM; GLUTAMATE; PHOSPHORYLATION; NUCLEAR; DEPHOSPHORYLATION	Here we report that synaptic and extrasynaptic NMDA (N-methyl-D-aspartate) receptors have opposite effects on CREB (cAMP response element binding protein) function, gene regulation and neuron survival. Calcium entry through synaptic NMDA receptors induced CREB activity and brain-derived neurotrophic factor (BDNF) gene expression as strongly as did stimulation of L-type calcium channels. In contrast, calcium entry through extrasynaptic NMDA receptors, triggered by bath glutamate exposure or hypoxic/ischemic conditions, activated a general and dominant CREB shut-off pathway that blocked induction of BDNF expression. Synaptic NMDA receptors have anti-apoptotic activity, whereas stimulation of extrasynaptic NMDA receptors caused loss of mitochondrial membrane potential (an early marker for glutamate-induced neuronal damage) and cell death. Specific blockade of extrasynaptic NMDA receptors may effectively prevent neuron loss following stroke and other neuropathological conditions associated with glutamate toxicity.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de		Hardingham, Giles/0000-0002-7629-5314				Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittigau P, 1997, J CHILD NEUROL, V12, P471, DOI 10.1177/088307389701200802; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Chawla S, 2001, J NEUROCHEM, V79, P849, DOI 10.1046/j.1471-4159.2001.00645.x; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fields RD, 1997, J NEUROSCI, V17, P7252; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Keelan J, 1999, J PHYSIOL-LONDON, V520, P797, DOI 10.1111/j.1469-7793.1999.00797.x; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Olney J W, 1986, Adv Neurol, V44, P857; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sattler R, 1998, J NEUROCHEM, V71, P2349; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tovar KR, 1999, J NEUROSCI, V19, P4180; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; WHITFIELD W, 1988, J ROYAL SOC HLTH, V1, P1; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	50	1255	1301	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					405	414		10.1038/nn835	http://dx.doi.org/10.1038/nn835			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953750				2022-12-28	WOS:000175272000010
J	Swadlow, HA; Gusev, AG				Swadlow, HA; Gusev, AG			Receptive-field construction in cortical inhibitory interneurons	NATURE NEUROSCIENCE			English	Article							AWAKE RABBIT; CORTEX; NEURONS		Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; Russian Acad Med Sci, Moscow Brain Res Inst, Moscow 103064, Russia	University of Connecticut; Russian Academy of Medical Sciences	Swadlow, HA (corresponding author), Univ Connecticut, Dept Psychol, 406 Babbidge Rd, Storrs, CT 06269 USA.	swadlow@psych.psy.uconn.edu			NIMH NIH HHS [MH64024] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; HARRIS RM, 1983, J COMP NEUROL, V220, P63, DOI 10.1002/cne.902200107; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Troyer TW, 1998, J NEUROSCI, V18, P5908; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	15	119	122	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					403	404		10.1038/nn847	http://dx.doi.org/10.1038/nn847			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967546				2022-12-28	WOS:000175272000009
J	Heins, N; Malatesta, P; Cecconi, F; Nakafuku, M; Tucker, KL; Hack, MA; Chapouton, P; Barde, YA; Gotz, M				Heins, N; Malatesta, P; Cecconi, F; Nakafuku, M; Tucker, KL; Hack, MA; Chapouton, P; Barde, YA; Gotz, M			Glial cells generate neurons: the role of the transcription factor Pax6	NATURE NEUROSCIENCE			English	Article							SUBVENTRICULAR ZONE; MOUSE; EXPRESSION; DIFFERENTIATION; ASTROCYTES; IDENTITY; GENES; IDENTIFICATION; RETROVIRUSES; NEUROGENIN2	Radial glial cells, ubiquitous throughout the developing CNS, guide radially migrating neurons and are the precursors of astrocytes. Recent evidence indicates that radial glial cells also generate neurons in the developing cerebral cortex. Here we investigated the role of the transcription factor Pax6 expressed in cortical radial glia. We showed that radial glial cells isolated from the cortex of Pax6 mutant mice have a reduced neurogenic potential, whereas the neurogenic potential of non-radial glial precursors is not affected. Consistent with defects in only one neurogenic lineage, the number of neurons in the Pax6 mutant cortex in vivo is reduced by half. Conversely, retrovirally mediated Pax6 expression instructs neurogenesis even in astrocytes from postnatal cortex in vitro. These results demonstrated an important role of Pax6 as intrinsic fate determinant of the neurogenic potential of glial cells.	Max Planck Inst Neurobiol, D-82152 Munich, Germany; Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Max Planck Society; University of Rome Tor Vergata; University of Tokyo; Friedrich Miescher Institute for Biomedical Research	Gotz, M (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Munich, Germany.	mgoetz@neuro.mpg.de	Barde, Yves/F-6019-2011; Malatesta, Paolo/J-3570-2012; Cecconi, Francesco/K-3969-2016; Nakafuku, Masato/J-3068-2013	Malatesta, Paolo/0000-0003-3045-3361; Cecconi, Francesco/0000-0002-5614-4359; Barde, Yves/0000-0002-7627-461X; Nakafuku, Masato/0000-0001-7783-9005	Telethon [TCP99038] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goetz M, 1998, TRENDS NEUROSCI, V21, P135, DOI 10.1016/S0166-2236(98)01228-4; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GROVE EA, 1993, DEVELOPMENT, V117, P553; HAJIHOSSEINI M, 1993, EMBO J, V12, P4969, DOI 10.1002/j.1460-2075.1993.tb06190.x; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Hildebrand B, 1997, NEUROSCIENCE, V78, P957, DOI 10.1016/S0306-4522(96)00676-8; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lillien L, 1997, CURR BIOL, V7, pR168, DOI 10.1016/S0960-9822(97)70080-0; Lo LC, 1998, DEVELOPMENT, V125, P609; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	48	581	603	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					308	315		10.1038/nn828	http://dx.doi.org/10.1038/nn828			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896398				2022-12-28	WOS:000174606900010
J	Kida, S; Josselyn, SA; de Ortiz, SP; Kogan, JH; Chevere, I; Masushige, S; Silva, AJ				Kida, S; Josselyn, SA; de Ortiz, SP; Kogan, JH; Chevere, I; Masushige, S; Silva, AJ			CREB required for the stability of new and reactivated fear memories	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; SITE-SPECIFIC RECOMBINATION; CAMP-RESPONSIVE ELEMENT; CONTEXTUAL FEAR; MICE; HIPPOCAMPUS; RECONSOLIDATION; CONSOLIDATION; RETRIEVAL	The cAMP-responsive element binding protein (CREB) family of transcription factors is thought to be critical in memory formation. To define the role of CREB in distinct memory processes, we derived transgenic mice with an inducible and reversible CREB repressor by fusing CREBS133A to a tamoxifen (TAM)-dependent mutant of an estrogen receptor ligand-binding domain (LBD). We found that CREB is crucial for the consolidation of long-term conditioned fear memories, but not for encoding, storage or retrieval of these memories. Our studies also showed that CREB is required for the stability of reactivated or retrieved conditioned fear memories. Although the transcriptional processes necessary for the stability of initial and reactivated memories differ, CREB is required for both. The findings presented here delineate the memory processes that require CREB and demonstrate the power of LBD-inducible transgenic systems in the study of complex cognitive processes.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Tokyo Univ Agr, Fac Appl Biosci, Dept Biosci, SetagayaKu, Tokyo 1568502, Japan; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA	University of California System; University of California Los Angeles; Tokyo University of Agriculture; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Young Dr S,Gonda Bldg, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Chevere Torres, Itzamarie/0000-0001-9001-8172				Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAWSON RG, 1969, SCIENCE, V166, P525, DOI 10.1126/science.166.3904.525; de Ortiz SP, 2000, NEUROBIOL LEARN MEM, V74, P161, DOI 10.1006/nlme.1999.3952; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GERSON R, 1978, ANIM LEARN BEHAV, V6, P346, DOI 10.3758/BF03209625; GOLD PE, 1972, PHYSIOL BEHAV, V8, P797, DOI 10.1016/0031-9384(72)90286-7; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORDON WC, 1977, PHYSIOL BEHAV, V18, P95, DOI 10.1016/0031-9384(77)90099-3; GORDON WC, 1977, AM J PSYCHOL, V90, P231, DOI 10.2307/1422045; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hall J, 2001, EUR J NEUROSCI, V13, P1453, DOI 10.1046/j.0953-816x.2001.01531.x; JAMIESON JL, 1970, PSYCHON SCI, V18, P14, DOI 10.3758/BF03332303; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Lamprecht R, 1997, J NEUROSCI, V17, P8443; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LOGIE C, 1995, P NATL ACAD SCI USA, V92, P5940, DOI 10.1073/pnas.92.13.5940; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; MACTUTUS CF, 1982, PHYSIOL BEHAV, V28, P939, DOI 10.1016/0031-9384(82)90218-9; MACTUTUS CF, 1980, BEHAV NEURAL BIOL, V30, P260, DOI 10.1016/S0163-1047(80)91150-4; MATTHIES H, 1989, PROG NEUROBIOL, V32, P277, DOI 10.1016/0301-0082(89)90024-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Muratake T, 1996, GENOMICS, V36, P63, DOI 10.1006/geno.1996.0426; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Rodriguez WA, 1999, PROG NEURO-PSYCHOPH, V23, P1285, DOI 10.1016/S0278-5846(99)00063-9; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHNEIDER AM, 1968, SCIENCE, V159, P219, DOI 10.1126/science.159.3811.219; Sengupta S, 2000, ONCOGENE, V19, P337, DOI 10.1038/sj.onc.1203256; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SQUIRE LR, 1976, BEHAV BIOL, V18, P335, DOI 10.1016/S0091-6773(76)92295-1; Summers MJ, 1997, COGNITIVE BRAIN RES, V5, P311, DOI 10.1016/S0926-6410(97)00007-4; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	462	475	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					348	355		10.1038/nn819	http://dx.doi.org/10.1038/nn819			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889468				2022-12-28	WOS:000174606900015
J	Ling, DSF; Benardo, LS; Serrano, PA; Blace, N; Kelly, MT; Crary, JF; Sacktor, TC				Ling, DSF; Benardo, LS; Serrano, PA; Blace, N; Kelly, MT; Crary, JF; Sacktor, TC			Protein kinase M zeta is necessary and sufficient for LTP maintenance	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACTIVATION; MECHANISMS; INDUCTION; CELLS		SUNY Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Sacktor, TC (corresponding author), SUNY Downstate Med Ctr, Dept Physiol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.			Blace, Nancy/0000-0002-6174-6004				Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; DENNY JB, 1990, BRAIN RES, V534, P201, DOI 10.1016/0006-8993(90)90130-4; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MCGLYNN E, 1992, J CELL BIOCHEM, V49, P239, DOI 10.1002/jcb.240490306; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Otmakhov N, 1997, J NEUROSCI, V17, P5357; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; SCHWARTZ JH, 1987, ANNU REV NEUROSCI, V10, P459; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045	15	327	345	0	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					295	296		10.1038/nn829	http://dx.doi.org/10.1038/nn829			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914719				2022-12-28	WOS:000174606900006
J	Shanley, LJ; Irving, AJ; Rae, MG; Ashford, MLJ; Harvey, J				Shanley, LJ; Irving, AJ; Rae, MG; Ashford, MLJ; Harvey, J			Leptin inhibits rat hippocampal neurons via activation of large conductance calcium-activated K+ channels	NATURE NEUROSCIENCE			English	Article							SENSITIVE POTASSIUM CHANNELS; CELL-LINE; CLONING; CRI-G1		Univ Dundee, Ninewells Hosp & Med Sch, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland	University of Dundee	Harvey, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland.		rae, mark/M-1277-2019	Ashford, Michael/0000-0002-0861-7676; Harvey, Jenni/0000-0002-9858-001X; Rae, Mark/0000-0002-9836-2688				Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; FRANCIOLINI F, 1988, BIOCHIM BIOPHYS ACTA, V943, P419, DOI 10.1016/0005-2736(88)90373-2; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Latorre R, 1989, Acta Physiol Scand Suppl, V582, P13; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; WANN KT, 1994, EUR J NEUROSCI, V6, P607, DOI 10.1111/j.1460-9568.1994.tb00305.x	13	66	73	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					299	300		10.1038/nn824	http://dx.doi.org/10.1038/nn824			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889470				2022-12-28	WOS:000174606900008
J	Constantinidis, C; Williams, GV; Goldman-Rakic, PS				Constantinidis, C; Williams, GV; Goldman-Rakic, PS			A role for inhibition in shaping the temporal flow of information in prefrontal cortex	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; VISUAL-CORTEX; ORIENTATION SELECTIVITY; NEURONAL-ACTIVITY; NETWORK MODEL; DYNAMICS; MONKEY; SYNCHRONIZATION; CONNECTIVITY; ASSOCIATION	The prefrontal cortex is important in guiding or inhibiting future responses, which requires the temporal integration of events and which provides continuity to the thought process. No cellular mechanism has been proposed to explain how the mental representation of a response or idea is linked to the next. Using simultaneous recordings in monkeys, we revealed inhibitory interactions between neurons active at different time points relative to the cue presentation, delay interval and response period of a working memory task. These findings suggest an important role of inhibition in the cerebral cortex-controlling the timing of neuronal activities during cognitive operations and thereby shaping the temporal flow of information.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, POB 208001,333 Cedar St,SHM B404, New Haven, CT 06520 USA.	patricia.goldman-rakic@yale.edu	Constantinidis, Christos/ABB-5760-2021	Constantinidis, Christos/0000-0001-7441-022X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038546, R01MH038546] Funding Source: NIH RePORTER; NIMH NIH HHS [MH38546] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Changeux JP, 2000, INT J PSYCHOPHYSIOL, V35, P179, DOI 10.1016/S0167-8760(99)00052-5; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; ELHANANY E, 1990, J COMP NEUROL, V291, P43, DOI 10.1002/cne.902910105; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FETZ E, 1991, CEREB CORTEX, V9, P1; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; GUIGON E, 1995, CEREB CORTEX, V5, P135, DOI 10.1093/cercor/5.2.135; Krimer LS, 2001, J NEUROSCI, V21, P3788, DOI 10.1523/JNEUROSCI.21-11-03788.2001; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Melchitzky DS, 1998, J COMP NEUROL, V390, P211, DOI 10.1002/(SICI)1096-9861(19980112)390:2<211::AID-CNE4>3.0.CO;2-4; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Oram MW, 2001, J NEUROPHYSIOL, V86, P1700, DOI 10.1152/jn.2001.86.4.1700; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Troyer TW, 1998, J NEUROSCI, V18, P5908; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	42	264	271	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					175	180		10.1038/nn799	http://dx.doi.org/10.1038/nn799			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802172				2022-12-28	WOS:000173558400021
J	Coffey, PJ; Girman, S; Wang, SM; Hetherington, L; Keegan, DJ; Adamson, P; Greenwood, J; Lund, RD				Coffey, PJ; Girman, S; Wang, SM; Hetherington, L; Keegan, DJ; Adamson, P; Greenwood, J; Lund, RD			Long-term preservation of cortically dependent visual function in RCS rats by transplantation	NATURE NEUROSCIENCE			English	Article							PUPILLARY LIGHT REFLEX; DISCRIMINATION	Cell transplantation is one way of limiting the progress of retinal degeneration in animal models of blinding diseases such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Here we transplanted a human retinal pigment epithelia] (RPE) cell line into the subretinal space of one such model, the Royal College of Surgeons (RCS) rat, and showed, using head tracking to moving stripes and pattern discrimination in conjunction with single-unit cortical physiology, that cortically mediated vision can be preserved with this treatment.	Univ Utah, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Univ Coll, Inst Ophthalmol, London EC1V 9EL, England	Utah System of Higher Education; University of Utah; University of Sheffield; University of London; University College London	Lund, RD (corresponding author), Univ Utah, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.			Coffey, Peter/0000-0002-5427-2939; Greenwood, John/0000-0003-4496-2984				BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; COWEY A, 1979, EXP BRAIN RES, V35, P443; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DELCERRO M, 1991, NEUROREPORT, V2, P529, DOI 10.1097/00001756-199109000-00008; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; KANUGA N, IN PRESS INVEST OPHT; LAVAIL MM, 1974, VISION RES, V14, P693, DOI 10.1016/0042-6989(74)90066-2; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; Sauve Y, 2001, NEUROSCIENCE, V103, P51, DOI 10.1016/S0306-4522(00)00557-1; TREJO LJ, 1982, VISION RES, V22, P1163, DOI 10.1016/0042-6989(82)90081-5; Whiteley SJO, 1996, EXP NEUROL, V140, P100, DOI 10.1006/exnr.1996.0120	13	168	179	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					53	56		10.1038/nn782	http://dx.doi.org/10.1038/nn782			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753416				2022-12-28	WOS:000173031800015
J	Ohno, M; Frankland, PW; Chen, AP; Costa, RM; Silva, AJ				Ohno, M; Frankland, PW; Chen, AP; Costa, RM; Silva, AJ			Inducible, pharmacogenetic approaches to the study of learning and memory	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; MAP KINASE; CONTEXTUAL FEAR; MOUSE GENOME; RAS; HIPPOCAMPUS; ACTIVATION; CASCADE; PHOSPHORYLATION	Here we introduce a strategy in which pharmacology is used to induce the effects of recessive mutations. For example, mice heterozygous for a null mutation of the K-ras gene (K-ras(+/-)) show normal hippocampal mitogen-activated protein kinase (MAPK) activation, long-term potentiation (LTP) and contextual conditioning. However, a dose of a mitogen-activated/extracellular-signal-regulated kinase (MEK) inhibitor, ineffective in wild-type controls, blocks MAPK activation, LTP and contextual learning in K-ras(+/-) mutants. These indicate that K-Ras/MEK/MAPK signaling is critical in synaptic and behavioral plasticity. A subthreshold dose of NMDA receptor antagonists triggered a contextual learning deficit in mice heterozygous for a point mutation (T286A) in the alpha CaMKII gene, but not in K-ras(+/-) mutants, demonstrating the specificity of the synergistic interaction between the MEK inhibitor and the K-ras(+/-) mutation. This pharmacogenetic approach combines the high temporal specificity that pharmacological manipulations offer, with the molecular specificity of genetic disruptions.	Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Costa, Rui M./0000-0003-0495-8374; Silva, Alcino/0000-0001-5525-0494	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622, U01AG013622, R37AG013622] Funding Source: NIH RePORTER; NIA NIH HHS [AG13622] Funding Source: Medline; NICHD NIH HHS [P01HD33098] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRANDON EP, 1995, CURR BIOL, V5, P625, DOI 10.1016/S0960-9822(95)00127-8; BRANDON EP, 1995, CURR BIOL, V5, P758, DOI 10.1016/S0960-9822(95)00152-7; Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.t01-1-00254.x; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Derkinderen P, 1999, NEUROREPORT, V10, pR24; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Giese KP, 2001, NEUROPHARMACOLOGY, V41, P791, DOI 10.1016/S0028-3908(01)00096-X; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Johnson L, 1997, GENE DEV, V11, P3277; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Manabe T, 2000, J NEUROSCI, V20, P2504; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Ouyang Y, 1997, J NEUROSCI, V17, P5416; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Ray P, 1997, J CLIN INVEST, V100, P2501, DOI 10.1172/JCI119792; Roberson ED, 1999, J NEUROSCI, V19, P4337; Schafe GE, 1999, LEARN MEMORY, V6, P97; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Silva AJ, 1997, ANNU REV GENET, V31, P527, DOI 10.1146/annurev.genet.31.1.527; SILVA AJ, 1998, NEUROBIOLOGY LEARNIN, P89; Steimer W, 2001, CLIN CHIM ACTA, V308, P33, DOI 10.1016/S0009-8981(01)00423-5; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tan SE, 1996, BRAIN RES, V711, P234, DOI 10.1016/0006-8993(95)01411-X; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995	47	83	83	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1238	1243		10.1038/nn771	http://dx.doi.org/10.1038/nn771			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713472				2022-12-28	WOS:000172525000021
J	Noctor, SC; Martinez-Cerdeno, V; Ivic, L; Kriegstein, AR				Noctor, SC; Martinez-Cerdeno, V; Ivic, L; Kriegstein, AR			Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; BASAL FOREBRAIN; MAMMALIAN BRAIN; VISUAL-CORTEX; NEOCORTEX; NEUROGENESIS; ASTROCYTES; MOUSE	Precise patterns of cell division and migration are crucial to transform the neuroepithelium of the embryonic forebrain into the adult cerebral cortex. Using time-lapse imaging of clonal cells in rat cortex over several generations, we show here that neurons are generated in two proliferative zones by distinct patterns of division. Neurons arise directly from radial glial cells in the ventricular zone (VZ) and indirectly from intermediate progenitor cells in the subventricular zone (SVZ). Furthermore, newborn neurons do not migrate directly to the cortex; instead, most exhibit four distinct phases of migration, including a phase of retrograde movement toward the ventricle before migration to the cortical plate. These findings provide a comprehensive and new view of the dynamics of cortical neurogenesis and migration.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Noctor, SC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.	scn8@columbia.edu			NINDS NIH HHS [NS21223, NS35710, NS38658] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038658, R01NS035710, R01NS021223] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bayer S.A., 1991, NEOCORTICAL DEV; BERRY M, 1965, J ANAT, V99, P691; BOULDER C, 1970, ANAT REC, V166, P257; Cai L, 2002, J NEUROSCI RES, V69, P731, DOI 10.1002/jnr.10398; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; MIONE MC, 1994, J NEUROSCI, V14, P107; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; PARNAVELAS JG, 1979, ANAT EMBRYOL, V157, P311, DOI 10.1007/BF00304996; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Reid CB, 1997, DEVELOPMENT, V124, P2441; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHWARTZ ML, 1991, P NATL ACAD SCI USA, V88, P1354, DOI 10.1073/pnas.88.4.1354; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shen Q, 2002, DEVELOPMENT, V129, P4843; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Tabata H, 2003, J NEUROSCI, V23, P9996; Takahashi T, 1996, J NEUROSCI, V16, P6183; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	50	1545	1579	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					136	144		10.1038/nn1172	http://dx.doi.org/10.1038/nn1172			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14703572				2022-12-28	WOS:000188468500011
J	Fritz, J; Shamma, S; Elhilali, M; Klein, D				Fritz, J; Shamma, S; Elhilali, M; Klein, D			Rapid task-related plasticity of spectrotemporal receptive fields in primary auditory cortex	NATURE NEUROSCIENCE			English	Article							PHYSIOLOGICAL PLASTICITY; DEPENDENT PLASTICITY; REORGANIZATION; SYSTEM; REPRESENTATION; EXPERIENCE; MICROSTIMULATION; STIMULATION; NEURONS; CAT	We investigated the hypothesis that task performance can rapidly and adaptively reshape cortical receptive field properties in accord with specific task demands and salient sensory cues. We recorded neuronal responses in the primary auditory cortex of behaving ferrets that were trained to detect a target tone of any frequency. Cortical plasticity was quantified by measuring focal changes in each cell's spectrotemporal response field (STRF) in a series of passive and active behavioral conditions. STRF measurements were made simultaneously with task performance, providing multiple snapshots of the dynamic STRF during ongoing behavior. Attending to a specific target frequency during the detection task consistently induced localized facilitative changes in STRF shape, which were swift in onset. Such modulatory changes may enhance overall cortical responsiveness to the target tone and increase the likelihood of 'capturing' the attended target during the detection task. Some receptive field changes persisted for hours after the task was over and hence may contribute to long-term sensory memory.	Univ Maryland, Inst Syst Res Elect & Comp Engn, Ctr Auditory & Acoust Res, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Fritz, J (corresponding author), Univ Maryland, Inst Syst Res Elect & Comp Engn, Ctr Auditory & Acoust Res, College Pk, MD 20742 USA.	ripple@isr.umd.edu	Shamma, Shihab A/F-9852-2012; Elhilali, Mounya/A-3396-2010; Fritz, Jonathan/AAK-4863-2020	Elhilali, Mounya/0000-0003-2597-738X; Fritz, Jonathan/0000-0002-0625-172X				Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Dorris MC, 2000, J NEUROSCI, V20; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P539, DOI 10.1037/0735-7044.107.4.539; Efron B, 1998, INTRO BOOTSTRAP; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fu KMG, 2003, J NEUROSCI, V23, P7510; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Heffner H.E., 1995, METHODS COMP PSYCHOA, P79; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; Kilgard MP, 2002, BIOL CYBERN, V87, P333, DOI 10.1007/s00422-002-0352-z; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kilgard MP, 2001, J NEUROPHYSIOL, V86, P326, DOI 10.1152/jn.2001.86.1.326; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; Maldonado PE, 1996, EXP BRAIN RES, V112, P420; METHERATE R, 1998, FRONT BIOSCI, V6, P494; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; PADOASCHIOPPA C, 2003, J NEUROPHYSIOL  0910; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Schulze H, 2002, ACTA ACUST UNITED AC, V88, P399; SHAMMA SA, 1993, J NEUROPHYSIOL, V69, P367, DOI 10.1152/jn.1993.69.2.367; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Thiel CM, 2002, NEURON, V35, P567, DOI 10.1016/S0896-6273(02)00801-2; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Weinberger NM, 2001, MODEL SYSTEMS AND THE NEUROBIOLOGY OF ASSOCIATIVE LEARNING: A FESTSCHRIFT IN HONOR OF RICHARD F. THOMPSON, P187; WEINBERGER NM, 1984, BEHAV NEUROSCI, V98, P171, DOI 10.1037/0735-7044.98.2.171; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Xiao ZJ, 2002, P NATL ACAD SCI USA, V99, P15743, DOI 10.1073/pnas.242606699	50	567	571	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1216	1223		10.1038/nn1141	http://dx.doi.org/10.1038/nn1141			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14583754				2022-12-28	WOS:000186229200022
J	Gan, WB; Kwon, E; Feng, GP; Sanes, JR; Lichtman, JW				Gan, WB; Kwon, E; Feng, GP; Sanes, JR; Lichtman, JW			Synaptic dynamism measured over minutes to months: age-dependent decline in an autonomic ganglion	NATURE NEUROSCIENCE			English	Article							LIVING MICE; NEUROMUSCULAR-JUNCTIONS; CRITICAL PERIODS; STRIATE CORTEX; VISUAL-CORTEX; ADULT CORTEX; PLASTICITY; NEURONS; EXPERIENCE; SYNAPSES	Naturally occurring rearrangements of synaptic terminals are common in the nervous systems of young mammals, but little is known about their incidence in adults. Using transgenic mice that express yellow fluorescent protein (YFP) in axons, we repeatedly imaged nerve terminals in the parasympathetic submandibular ganglion. We found that the pattern of synaptic branches underwent significant rearrangements over several weeks in young adult mice. In older mice, rearrangements were less common, and synaptic patterns on individual neurons were recognizable for many months to years. Axonal branches frequently retracted or extended on a time scale of minutes in young adult mice, but seldom in mature animals. These results provide direct evidence for a decrease in plasticity of interneuronal connections as animals make the transition from young adulthood to middle age. The long-term stability of synaptic patterns could provide a structural basis for the persistence of memory in the adult nervous system.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid,Box 8108, St Louis, MO 63110 USA.		Feng, Guoping/Y-2827-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041846] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS41846-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BertoniFreddari C, 1996, GERONTOLOGY, V42, P170; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; DAWAKI L, 2003, ANN NEUROL, V53, P521; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1986, J NEUROSCI, V6, P1051; PURVES D, 1987, J NEUROSCI, V7, P1492; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SNIDER WD, 1987, J NEUROSCI, V7, P1760; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	34	55	56	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					956	960		10.1038/nn1115	http://dx.doi.org/10.1038/nn1115			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12925856				2022-12-28	WOS:000184970400014
J	Greka, A; Navarro, B; Oancea, E; Duggan, A; Clapham, DE				Greka, A; Navarro, B; Oancea, E; Duggan, A; Clapham, DE			TRPC5 is a regulator of hippocampal neurite length and growth cone morphology	NATURE NEUROSCIENCE			English	Article							CALCIUM TRANSIENTS; CATION CHANNEL; FUNCTIONAL-CHARACTERIZATION; NEURONAL DIFFERENTIATION; SYNAPTIC VESICLE; STATHMIN FAMILY; NERVOUS-SYSTEM; PROTEIN; CORTACTIN; RECEPTOR	Growth cone motility is regulated by both fast voltage-dependent Ca2+ channels and by unknown receptor-operated Ca2+ entry mechanisms. Transient receptor potential (TRP) homomeric TRPC5 ion channels are receptor-operated, Ca2+-permeable channels predominantly expressed in the brain. Here we show that TRPC5 is expressed in growth cones of young rat hippocampal neurons. Our results indicate that TRPC5 channel subunits interact with the growth cone-enriched protein stathmin 2, are packaged into vesicles and are carried to newly forming growth cones and synapses. Once in the growth cone, TRPC5 channels regulate neurite extension and growth-cone morphology. Dominant-negative TRPC5 expression allowed significantly longer neurites and filopodia to form. We conclude that TRPC5 channels are important components of the mechanism controlling neurite extension and growth cone morphology.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonsson B, 1997, PROTEIN EXPRES PURIF, V9, P363, DOI 10.1006/prep.1996.0710; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Gavet O, 1998, J CELL SCI, V111, P3333; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Martin TFJ, 2002, NEURON, V34, P9, DOI 10.1016/S0896-6273(02)00651-7; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spitzer NC, 2000, BIOESSAYS, V22, P811; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 1998, J CELL SCI, V111, P2433	42	293	308	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					837	845		10.1038/nn1092	http://dx.doi.org/10.1038/nn1092			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12858178				2022-12-28	WOS:000184413700013
J	Kinouchi, R; Takeda, M; Yang, L; Wilhelmsson, U; Lundkvist, A; Pekny, M; Chen, DF				Kinouchi, R; Takeda, M; Yang, L; Wilhelmsson, U; Lundkvist, A; Pekny, M; Chen, DF			Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin	NATURE NEUROSCIENCE			English	Article							FIBRILLARY ACIDIC PROTEIN; STEM-CELLS; PROGENITOR CELLS; INTERMEDIATE-FILAMENTS; NEURONAL SURVIVAL; NEURITE OUTGROWTH; SPINAL-CORD; ASTROCYTES; DIFFERENTIATION; DEVELOP	With recent progress in neuroscience and stem-cell research, neural transplantation has emerged as a promising therapy for treating CNS diseases. The success of transplantation has been limited, however, by the restricted ability of neural implants to survive and establish neuronal connections with the host. Little is known about the mechanisms responsible for this failure. Neural implantation triggers reactive gliosis, a process accompanied by upregulation of intermediate filaments in astrocytes and formation of astroglial scar tissue. Here we show that the retinas of adult mice deficient in glial fibrillary acidic protein and vimentin, and consequently lacking intermediate filaments in reactive astrocytes and Muller cells, provide a permissive environment for grafted neurons to migrate and extend neurites. The transplanted cells integrated robustly into the host retina with distinct neuronal identity and appropriate neuronal projections. Our results indicate an essential role for reactive astroglial cells in preventing neural graft integration after transplantation.	Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Program Neurosci, Boston, MA 02114 USA; Univ Gothenburg, Dept Med Biochem, SE-41390 Gothenburg, Sweden; Asahikawa Med Coll, Dept Ophthalmol, Asahikawa, Hokkaido 0788510, Japan	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Gothenburg; Asahikawa Medical College	Pekny, M (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	Milos.Pekny@medkem.gu.se; dfchen@vision.eri.harvard.edu	Kinouchi, Reiko/R-6833-2019; Chen, Dong/AAJ-2444-2020	Chen, Dong/0000-0001-6283-8843; Wilhelmsson, Ulrika/0000-0003-3227-2687; kinouchi, reiko/0000-0003-1344-1641	NATIONAL EYE INSTITUTE [R01EY012983] Funding Source: NIH RePORTER; NEI NIH HHS [EY012983] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Berson EL, 1999, OPHTHALMOLOGY, V106, P445, DOI 10.1016/S0161-6420(99)90134-3; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dunnett SB, 1999, NEUROPATH APPL NEURO, V25, P351; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Ghosh F, 2002, GLIA, V40, P78, DOI 10.1002/glia.10121; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GOURAS P, 1994, INVEST OPHTH VIS SCI, V35, P3145; Kurimoto Y, 2001, NEUROSCI LETT, V306, P57, DOI 10.1016/S0304-3940(01)01857-2; Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Menet V, 2001, J NEUROSCI, V21, P6147; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 1998, EXP CELL RES, V239, P332, DOI 10.1006/excr.1997.3922; Pekny M, 2001, Prog Brain Res, V132, P23; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; SEILER M, 1988, DEV BRAIN RES, V43, P111, DOI 10.1016/0165-3806(88)90156-3; SMITHTHOMAS LC, 1994, J CELL SCI, V107, P1687; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Svendsen CN, 2001, NAT REV NEUROSCI, V2, P831, DOI 10.1038/35097581; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Van Hoffelen SJ, 2003, INVEST OPHTH VIS SCI, V44, P426, DOI 10.1167/iovs.02-0269; Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702; Xu KX, 1999, GLIA, V25, P390, DOI 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang YQ, 2003, INVEST OPHTH VIS SCI, V44, P324, DOI 10.1167/iovs.02-0132	39	186	189	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					863	868		10.1038/nn1088	http://dx.doi.org/10.1038/nn1088			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12845328				2022-12-28	WOS:000184413700016
J	Picconi, B; Centonze, D; Hakansson, K; Bernardi, G; Greengard, P; Fisone, G; Cenci, MA; Calabresi, P				Picconi, B; Centonze, D; Hakansson, K; Bernardi, G; Greengard, P; Fisone, G; Cenci, MA; Calabresi, P			Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CAMP-REGULATED PHOSPHOPROTEIN; LOW-FREQUENCY STIMULATION; PARKINSONS-DISEASE; RAT NEOSTRIATUM; IN-VIVO; RECEPTOR; DEPOTENTIATION; MODEL; PATHOPHYSIOLOGY	Long-term treatment with the dopamine precursor levodopa (L-DOPA) induces dyskinesia in Parkinson's disease (PD) patients. We divided hemiparkinsonian rats treated chronically with L-DOPA into two groups: one showed motor improvement without dyskinesia, and the other developed debilitating dyskinesias in response to the treatment. We then compared the plasticity of corticostriatal synapses between the two groups. High-frequency stimulation of cortical afferents induced long-term potentiation (LTP) of corticostriatal synapses in both groups of animals. Control and non-dyskinetic rats showed synaptic depotentiation in response to subsequent low-frequency synaptic stimulation, but dyskinetic rats did not. The depotentiation seen in both L-DOPA-treated non-dyskinetic rats and intact controls was prevented by activation of the D1 subclass of dopamine receptors or inhibition of protein phosphatases. The striata of dyskinetic rats contained abnormally high levels of phospho[Thr34]-DARPP-32, an inhibitor of protein phosphatase 1. These results indicate that abnormal information storage in corticostriatal synapses is linked with the development of L-DOPA-induced dyskinesia.	Univ Roma Tor Vergata, Clin Neurol, Dipartimento Neurosci, I-00133 Rome, Italy; IRCCS, Lab Neurofisiol, Fdn Santa Lucia, I-00179 Rome, Italy; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Lund Univ, Wallenberg Neurosci Ctr, Div Neurobiol, S-22362 Lund, Sweden	University of Rome Tor Vergata; IRCCS Santa Lucia; Karolinska Institutet; Rockefeller University; Lund University	Calabresi, P (corresponding author), Univ Roma Tor Vergata, Clin Neurol, Dipartimento Neurosci, Via Montpellier 1, I-00133 Rome, Italy.	calabre@uniroma2.it	Centonze, Diego/J-7767-2016; Calabresi, Paolo/G-8496-2011; Picconi, Barbara/G-8299-2011	Centonze, Diego/0000-0002-8390-8545; Calabresi, Paolo/0000-0003-0326-5509; Picconi, Barbara/0000-0001-6020-1021; Cenci Nilsson, M. Angela/0000-0003-2216-2900; Fisone, Gilberto/0000-0002-0719-8000	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline; Telethon [GGP02035] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon)		Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Bedard PJ, 1999, MOVEMENT DISORD, V14, P4; Bezard E, 2001, NAT REV NEUROSCI, V2, P577, DOI 10.1038/35086062; Calabresi P, 2000, ANN NEUROL, V47, pS60; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Calabresi P, 2000, TRENDS NEUROSCI, V23, pS57, DOI 10.1016/S1471-1931(00)00017-3; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hagell P, 1999, MOVEMENT DISORD, V14, P448, DOI 10.1002/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; Huang CC, 2001, J BIOL CHEM, V276, P48108, DOI 10.1074/jbc.M106388200; Huang CC, 2001, REV NEUROSCIENCE, V12, P51; Ingham CA, 1998, J NEUROSCI, V18, P4732; Jankovic J, 2002, NEUROLOGY, V58, pS19, DOI 10.1212/WNL.58.suppl_1.S19; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; MARSDEN CD, 1982, LANCET, V2, P1141; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Dell T J, 1994, Learn Mem, V1, P129; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHMIDT RH, 1982, J NEUROCHEM, V38, P737, DOI 10.1111/j.1471-4159.1982.tb08693.x; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856	37	657	667	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					501	506		10.1038/nn1040	http://dx.doi.org/10.1038/nn1040			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665799				2022-12-28	WOS:000182553200017
J	Popescu, G; Auerbach, A				Popescu, G; Auerbach, A			Modal gating of NMDA receptors and the shape of their synaptic response	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTORS; BURST-KINETICS; TIME COURSE; XENOPUS-OOCYTES; ION CHANNELS; K+ CHANNEL; GLUTAMATE; ACETYLCHOLINE; CURRENTS; NEURONS	N-methyl-D-aspartate receptor (NMDAR) channels mediate the slow component of excitatory potentials at glutamatergic synapses. They have complex kinetic behavior, and much remains to be understood about NMDAR gating mechanisms and the molecular events that shape the synaptic current. Here we show that an individual NMDAR produces at least three stable patterns of activity. For all modes, channels gate by the same mechanism and can occupy either of two open states. The relative stability of the open states differs across modes because of a common perturbation to the NMDAR structure that may be subject to cellular control. Simulations indicate that native NMDAR-mediated synaptic responses arise mainly from the most common mode, and that the slow rise and decay of the current can be attributed to multiple transitions between fully liganded open and closed states rather than to agonist dissociation.	SUNY Buffalo, Ctr Single Mol Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, G (corresponding author), SUNY Buffalo, Ctr Single Mol Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.		popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015164] Funding Source: NIH RePORTER; NIDA NIH HHS [F32 DA015164, DA015164] Funding Source: Medline; NINDS NIH HHS [NS036554] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; AUERBACH A, 1986, J PHYSIOL-LONDON, V378, P119, DOI 10.1113/jphysiol.1986.sp016211; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; Catacuzzeno L, 1999, J MEMBRANE BIOL, V170, P165, DOI 10.1007/s002329900546; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dreyer I, 2001, FEBS LETT, V505, P233, DOI 10.1016/S0014-5793(01)02832-0; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; GIBB AJ, 1991, P ROY SOC B-BIOL SCI, V243, P39, DOI 10.1098/rspb.1991.0007; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; HOWE JR, 1992, J PHYSIOL-LONDON, V455, P529, DOI 10.1113/jphysiol.1992.sp019315; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KLECKNER NW, 1995, J PHYSIOL-LONDON, V486, P411, DOI 10.1113/jphysiol.1995.sp020822; Leffler JE., 1989, RATES EQUILIBRIA ORG; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NARANJO D, 1993, SCIENCE, V260, P1811, DOI 10.1126/science.8511590; Premkumar LS, 1996, NEURON, V16, P869, DOI 10.1016/S0896-6273(00)80107-5; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; Zhu YL, 2001, J GEN PHYSIOL, V117, P275, DOI 10.1085/jgp.117.3.275	44	137	139	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					476	483		10.1038/nn1044	http://dx.doi.org/10.1038/nn1044			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12679783				2022-12-28	WOS:000182553200014
J	Furrer, MP; Kim, S; Wolf, B; Chiba, A				Furrer, MP; Kim, S; Wolf, B; Chiba, A			Robo and Frazzled/DCC mediate dendritic guidance at the CNS midline	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; NEURONS IN-VIVO; AXON GUIDANCE; DROSOPHILA CNS; RECEPTORS SPECIFY; COMMISSURAL AXONS; LATERAL POSITION; RHO-GTPASES; SLIT; GENES	Neuronal connectivity is established by the axo-dendritic polarity, correct guidance and targeting of neurons. Unlike for axons, the mechanisms responsible for directed outgrowth of dendrites are not well understood. Using single-cell labeling, we describe specific guidance defects in dendrites of identified neurons in frazzled, robo, netrin and commissureless mutant embryos of Drosophila melanogaster. We found that the cell-surface molecules Frazzled and Robo work as guidance molecules not only for axons but also for dendrites as they navigate within the CNS. Furthermore, we report that each neuron showed a cell-autonomous and independent use of guidance molecules.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chiba, A (corresponding author), Univ Illinois, Dept Cell & Struct Biol, 601 S Goodwin Ave, Urbana, IL 61801 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040420] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40420, NS350049] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 1999, DEVELOPMENT, V126, P2475; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chiba A, 1999, INT REV NEUROBIOL, V43, P1, DOI 10.1016/S0074-7742(08)60538-3; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Merz DC, 2001, GENETICS, V158, P1071; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wolf B, 1998, DEVELOPMENT, V125, P3853; Wolf BD, 2000, DEVELOPMENT, V127, P2001; Wu GY, 1999, J NEUROSCI, V19, P4472; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	39	85	86	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					223	230		10.1038/nn1017	http://dx.doi.org/10.1038/nn1017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592406				2022-12-28	WOS:000181178300010
J	Donoghue, JP				Donoghue, JP			Connecting cortex to machines: recent advances in brain interfaces	NATURE NEUROSCIENCE			English	Review							MOVEMENT; PERFORMANCE; NEURONS; VISION; BLIND	Recent technological and scientific advances have generated wide interest in the possibility of creating a brain-machine interface (BMI), particularly as a means to aid paralyzed humans in communication. Advances have been made in detecting neural signals and translating them into command signals that can control devices. We now have systems that use externally derived neural signals as a command source, and faster and potentially more flexible systems that directly use intracortical recording are being tested. Studies in behaving monkeys show that neural output from the motor cortex can be used to control computer cursors almost as effectively as a natural hand would carry out the task. Additional research findings explore the possibility of using computers to return behaviorally useful feedback information to the cortex. Although significant scientific and technological challenges remain, progress in creating useful human BMIs is accelerating.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Donoghue, JP (corresponding author), Brown Univ, Dept Neurosci, Box 1953, Providence, RI 02912 USA.	John_Donoghue@Brown.edu						Bai Q, 2001, IEEE T BIO-MED ENG, V48, P911, DOI 10.1109/10.936367; Bauby J.D., 1997, DIVING BELL BUTTERFL, V4th ed.; Benabid AL, 2001, ADV NEUROL, V86, P405; COOPER IS, 1981, NEUROSURGERY, V9, P190, DOI 10.1227/00006123-198108000-00017; DELGADO JMR, 1969, PHYSICAL CONTROL MIN; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; GAO Y, 2002, P ADV NEUR INF PROC, V14; GEORGOPOULOS AP, 1994, INT REV NEUROBIOL, V37, P103; HAMBRECHT FT, 1995, BAILLIERE CLIN NEUR, V4, P147; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; MARG E, 1967, ELECTROEN CLIN NEURO, V23, P277, DOI 10.1016/0013-4694(67)90126-5; MAURITZ K H, 1987, International Journal of Rehabilitation Research, V10, P57, DOI 10.1097/00004356-198700105-00010; Maynard EM, 2001, ANNU REV BIOMED ENG, V3, P145, DOI 10.1146/annurev.bioeng.3.1.145; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Maynard EM, 1999, J NEUROSCI, V19, P8083; Moxon KA, 2001, METH NE FRO NEUROSCI, P179; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; PALMER C, 1978, BRAIN RES BULL, V3, P285, DOI 10.1016/0361-9230(78)90129-6; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wickersham I, 1998, CURR BIOL, V8, pR412, DOI 10.1016/S0960-9822(98)70265-9; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	33	457	513	2	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1085	1088		10.1038/nn947	http://dx.doi.org/10.1038/nn947			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403992				2022-12-28	WOS:000179041300020
J	Li, B; Chen, NS; Luo, T; Otsu, Y; Murphy, TH; Raymond, LA				Li, B; Chen, NS; Luo, T; Otsu, Y; Murphy, TH; Raymond, LA			Differential regulation of synaptic and extrasynaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							CHANNEL ACTIVITY; INTERNALIZATION; PHOSPHATASE; NEURONS; SUBUNIT		Univ British Columbia, Dept Psychiat, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Raymond, LA (corresponding author), Univ British Columbia, Dept Psychiat, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada.		Raymond, Lynn A/A-6664-2010; Raymond, Lynn A./R-6707-2016; Chen, Nansheng/E-6450-2012; Murphy, Timothy/AAW-1975-2021; Murphy, Timothy H/I-4982-2014; Otsu, Yo/P-6353-2017	Raymond, Lynn A/0000-0002-8610-1042; Raymond, Lynn A./0000-0002-8610-1042; Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490; Otsu, Yo/0000-0003-2828-5063; Li, Bo/0000-0002-0154-3088				Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Dingledine R, 1999, PHARMACOL REV, V51, P7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721	14	125	132	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					833	834		10.1038/nn912	http://dx.doi.org/10.1038/nn912			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195433				2022-12-28	WOS:000177656300008
J	Baseler, HA; Brewer, AA; Sharpe, LT; Morland, AB; Jagle, H; Wandell, BA				Baseler, HA; Brewer, AA; Sharpe, LT; Morland, AB; Jagle, H; Wandell, BA			Reorganization of human cortical maps caused by inherited photoreceptor abnormalities	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; CLINICAL VISION CHARACTERISTICS; LATERAL GENICULATE-NUCLEUS; CONE PHOTORECEPTOR; CONGENITAL ACHROMATOPSIAS; FUNCTIONAL MRI; VISUALIZATION; TOPOGRAPHY; PLASTICITY; MUTATIONS	We describe a compelling demonstration of large-scale developmental reorganization in the human visual pathways. The developmental reorganization was observed in rod monochromats, a rare group of congenitally colorblind individuals who virtually lack cone photoreceptor function. Normal controls had a cortical region, spanning several square centimeters, that responded to signals initiated in the all-cone foveola but was inactive under rod viewing conditions; in rod monochromats this cortical region responded powerfully to rod-initiated signals. The measurements trace a causal pathway that begins with a genetic anomaly that directly influences sensory cells and ultimately results in a substantial central reorganization.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Tubingen, Tubingen, Germany	Stanford University; Stanford University; Eberhard Karls University of Tubingen	Wandell, BA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.		Baseler, Heidi/AAI-7387-2020; Jägle, Herbert/GPP-2945-2022	Baseler, Heidi/0000-0003-0995-8453; Morland, Antony/0000-0002-6754-5545	NEI NIH HHS [EY30164] Funding Source: Medline; NIMH NIH HHS [T32 MH020016] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GLICKSTEIN M, 1975, VISION RES, V15, P633, DOI 10.1016/0042-6989(75)90276-X; Hadjikhani N, 2000, HUM BRAIN MAPP, V9, P55, DOI 10.1002/(SICI)1097-0193(2000)9:1<55::AID-HBM6>3.3.CO;2-L; HaegerstromPortnoy G, 1996, OPTOMETRY VISION SCI, V73, P446, DOI 10.1097/00006324-199607000-00001; HaegerstromPortnoy G, 1996, OPTOMETRY VISION SCI, V73, P457, DOI 10.1097/00006324-199607000-00002; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1994, J NEUROSCI, V14, P451; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; MEYER CH, 1992, MAGNET RESON MED, V28, P202, DOI 10.1002/mrm.1910280204; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Osterberg G., 1935, ACTA OPHTHALMOL    S, V6, P1; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; Polyak S. L., 1941, RETINA-J RET VIT DIS; RODIECK RW, 1979, ANNU REV NEUROSCI, V2, P193, DOI 10.1146/annurev.ne.02.030179.001205; Sharpe L.T., 1999, COLOR VISION GENES P, P3; SHARPE LT, 1986, CLIN VISION SCI, V1, P39; Sharpe LT, 1990, NIGHT VISION BASIC C, P335; Sharpe LT, 1990, NIGHT VISION BASIC C, P253; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Wandell B., 1995, FDN VISION; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568	35	114	115	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					364	370		10.1038/nn817	http://dx.doi.org/10.1038/nn817			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914722				2022-12-28	WOS:000174606900017
J	Levenson, J; Weeber, E; Selcher, JC; Kategaya, LS; Sweatt, JD; Eskin, A				Levenson, J; Weeber, E; Selcher, JC; Kategaya, LS; Sweatt, JD; Eskin, A			Long-term potentiation and contextual fear conditioning increase neuronal glutamate uptake	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPUS; SYNAPTIC LOCALIZATION; TRANSPORTER CURRENTS; PROTEIN-SYNTHESIS; PYRAMIDAL CELLS; D-ASPARTATE; C6 GLIOMA; SYNAPSES; RELEASE; ACTIVATION	Induction and expression of long-term potentiation (LTP) in area CA1 of the hippocampus require the coordinated regulation of several cellular processes. We found that LTP in area CA1 was associated with an N-methyl-D-aspartate (NMDA) receptor-dependent increase in glutamate uptake. The increase in glutamate uptake was inhibited by either removal of Na+ or addition of D, L-threo-beta-hydroxyaspartate. Dihydrokainate (DHK), a specific inhibitor of the glial glutamate transporter GLT-1, did not block the increase in glutamate uptake. LTP was also associated with a translocation of the EAAC1 glutamate transporter from the cytosol to the plasma membrane. Contextual fear conditioning increased the maximum rate (V-max) of glutamate uptake and membrane expression of EAAC1 in area CA1. These results indicate that regulation of glutamate uptake may be important for maintaining the level of synaptic strength during long-term changes in synaptic efficacy.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	University of Houston System; University of Houston; Baylor College of Medicine	Eskin, A (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.		Weeber, Edwin J/A-5396-2012	Sweatt, J. David/0000-0003-3567-485X	NIMH NIH HHS [MH48147] Funding Source: Medline; NINDS NIH HHS [NS42156, NS28462] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042156, R01NS028462] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AbdulGhani AS, 1997, BRAIN RES, V755, P202, DOI 10.1016/S0006-8993(97)00098-X; Aggleton JP, 2000, HIPPOCAMPUS, V10, P466, DOI 10.1002/1098-1063(2000)10:4<466::AID-HIPO13>3.3.CO;2-P; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bergles DE, 1998, J NEUROSCI, V18, P7709; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; CASADO M, 1993, J BIOL CHEM, V268, P27313; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Dube GR, 2000, J NEUROPHYSIOL, V83, P1141, DOI 10.1152/jn.2000.83.3.1141; FERKANY J, 1986, J NEUROSCI RES, V16, P491, DOI 10.1002/jnr.490160305; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; GUNDERSEN V, 1993, NEUROSCIENCE, V57, P97, DOI 10.1016/0306-4522(93)90114-U; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; He Y, 2000, J COMP NEUROL, V418, P255; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Levenson J, 2000, P NATL ACAD SCI USA, V97, P12858, DOI 10.1073/pnas.220256497; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Ng KT, 1997, NEUROSCI BIOBEHAV R, V21, P45, DOI 10.1016/0149-7634(95)00079-8; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SORRA KE, 1993, J NEUROSCI, V13, P3736; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Torp R, 1997, ANAT EMBRYOL, V195, P317, DOI 10.1007/s004290050051; Turecek R, 2000, J NEUROSCI, V20, P2054	48	117	122	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					155	161		10.1038/nn791	http://dx.doi.org/10.1038/nn791			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788834				2022-12-28	WOS:000173558400018
J	Murray, SO; Wojciulik, E				Murray, SO; Wojciulik, E			Attention increases neural selectivity in the human lateral occipital complex	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; INFERIOR TEMPORAL CORTEX; SURFACE-BASED ANALYSIS; MACAQUE VISUAL-CORTEX; EXTRASTRIATE CORTEX; SPATIAL-RESOLUTION; OBJECT RECOGNITION; AREA V4; SHAPE; PERFORMANCE	It is well established that attention increases the efficiency of information processing, but the neural mechanisms underlying this improvement are not fully understood. Evidence indicates that neural firing rates increase for attended stimuli, but another possibility is that attention could increase the selectivity of the neural population representing an attended stimulus. We tested this latter hypothesis by using functional magnetic resonance imaging (fMRI) to measure population selectivity for object views under different attention conditions in the human lateral occipital complex (LOC). Our data not only show increased neural activity (or 'gain') with attention, consistent with existing models, but also increased population selectivity that cannot be accounted for by gain mechanisms alone. Our results suggest that attention increases the specificity of the neural population representing an attended object.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Murray, SO (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	somurray@umn.edu						Boynton GM, 2003, J NEUROSCI, V23, P8781; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	37	242	246	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					70	74		10.1038/nn1161	http://dx.doi.org/10.1038/nn1161			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14647291				2022-12-28	WOS:000187636000015
J	Mehring, C; Rickert, J; Vaadia, E; de Oliveira, SC; Aertsen, A; Rotter, S				Mehring, C; Rickert, J; Vaadia, E; de Oliveira, SC; Aertsen, A; Rotter, S			Inference of hand movements from local field potentials in monkey motor cortex	NATURE NEUROSCIENCE			English	Article							OSCILLATIONS	The spiking of neuronal populations in motor cortex provides accurate information about movement parameters. Here we show that hand movement target and velocity can be inferred from multiple local field potentials (LFPs) in single trials approximately as efficiently as from multiple single-unit activity (SUA) recorded from the same electrodes. Our results indicate that LFPs can be used as an additional signal for decoding brain activity, particularly for new neuroprosthetic applications.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Interdisciplinary Ctr Neural Computat, IL-91120 Jerusalem, Israel; Univ Dortmund, Inst Arbeitsphysiol, D-44139 Dortmund, Germany; Inst Frontier Areas Psychol & Mental Hlth, D-79098 Freiburg, Germany	University of Freiburg; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Dortmund University of Technology	Mehring, C (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.	carsten.mehring@biologie.uni-freiburg.de	Vaadia, Eilon/E-9347-2011; Mehring, Carsten/R-8986-2019	Mehring, Carsten/0000-0001-8125-5205				Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; de Oliveira SC, 2001, EUR J NEUROSCI, V14, P1881, DOI 10.1046/j.0953-816x.2001.01801.x; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; Donchin O, 2001, EXP BRAIN RES, V140, P46, DOI 10.1007/s002210100784; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	10	298	318	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1253	1254		10.1038/nn1158	http://dx.doi.org/10.1038/nn1158			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14634657				2022-12-28	WOS:000186725600008
J	Liegeois, F; Baldeweg, T; Connelly, A; Gadian, DG; Mishkin, M; Vargha-Khadem, F				Liegeois, F; Baldeweg, T; Connelly, A; Gadian, DG; Mishkin, M; Vargha-Khadem, F			Language fMRI abnormalities associated with FOXP2 gene mutation	NATURE NEUROSCIENCE			English	Article							INHERITED SPEECH; BRAIN ABNORMALITIES; COGNITIVE DEFICITS; PREFRONTAL CORTEX; WORD GENERATION; FRONTAL LESIONS; VERB GENERATION; BASAL GANGLIA; MRI-ANALYSIS; DISORDER	Half the members of the KE family suffer from a speech and language disorder caused by a mutation in the FOXP2 gene. We examined functional brain abnormalities associated with this mutation using two fMRI language experiments, one involving covert (silent) verb generation and the other overt (spoken) verb generation and word repetition. The unaffected family members showed a typical left-dominant distribution of activation involving Broca's area in the generation tasks and a more bilateral distribution in the repetition task, whereas the affected members showed a more posterior and more extensively bilateral pattern of activation in all tasks. Consistent with previously reported bilateral morphological abnormalities, the affected members showed significant underactivation relative to the unaffected members in Broca's area and its right homolog, as well as in other cortical language-related regions and in the putamen. Our findings suggest that the FOXP2 gene is critically involved in the development of the neural systems that mediate speech and language.	UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, Wolfson Ctr, London WC1N 2AP, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; UCL, Inst Child Hlth, Radiol & Phys Unit, London WC1N 1EH, England; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Liegeois, F (corresponding author), UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, Wolfson Ctr, Mecklenburgh Sq, London WC1N 2AP, England.	F.Liegeois@ich.ucl.ac.uk	Vargha-Khadem, Faraneh/C-2558-2008; Gadian, David G/C-4961-2008; Connelly, Alan/A-9065-2013; Liegeois, Frederique/A-6351-2009	Connelly, Alan/0000-0001-7159-8079; Liegeois, Frederique/0000-0002-8640-6217; vargha-khadem, faraneh/0000-0003-4890-8379				Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; ALEXANDER GE, 1994, J CLIN NEUROPHYSIOL, V11, P420, DOI 10.1097/00004691-199407000-00004; Arbib MA, 2002, FROM ANIM ANIMAT, P229; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Friedman L, 1998, BRAIN LANG, V64, P231, DOI 10.1006/brln.1998.1953; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Liegeois F, 2002, NEUROIMAGE, V17, P1861, DOI 10.1006/nimg.2002.1327; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Pickett ER, 1998, NEUROPSYCHOLOGIA, V36, P173, DOI 10.1016/S0028-3932(97)00065-1; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Salmond CH, 2000, HUM BRAIN MAPP, V11, P223; Thierry G, 1999, NEUROREPORT, V10, P2599, DOI 10.1097/00001756-199908200-00029; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VARGHAKHADEM F, 1985, BRAIN LANG, V25, P167, DOI 10.1016/0093-934X(85)90128-2; Warburton E, 1996, BRAIN, V119, P159, DOI 10.1093/brain/119.1.159; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057	34	245	252	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1230	1237		10.1038/nn1138	http://dx.doi.org/10.1038/nn1138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555953				2022-12-28	WOS:000186229200024
J	Tsao, DY; Freiwald, WA; Knutsen, TA; Mandeville, JB; Tootell, RBH				Tsao, DY; Freiwald, WA; Knutsen, TA; Mandeville, JB; Tootell, RBH			Faces and objects in macaque cerebral cortex	NATURE NEUROSCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; CONTRAST AGENT; RECOGNITION; FMRI; AREA; REPRESENTATION; SUBDIVISIONS; ORGANIZATION; SELECTIVITY; FEATURES	How are different object categories organized by the visual system? Current evidence indicates that monkeys and humans process object categories in fundamentally different ways. Functional magnetic resonance imaging (fMRI) studies suggest that humans have a ventral temporal face area, but such evidence is lacking in macaques. Instead, face-responsive neurons in macaques seem to be scattered throughout temporal cortex, with some relative concentration in the superior temporal sulcus (STS). Here, using fMRI in alert fixating macaque monkeys and humans, we found that macaques do have discrete face-selective patches, similar in relative size and number to face patches in humans. The face patches were embedded within a large swath of object-selective cortex extending from V4 to rostral TE. This large region responded better to pictures of intact objects compared to scrambled objects, with different object categories eliciting different patterns of activity, as in the human. Overall, our results suggest that humans and macaques share a similar brain architecture for visual object processing.	Athinoula A Martinos Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Bremen, Ctr Adv Imaging, Bremen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Hanse Inst Adv Study, Delmenhorst, Germany; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Bremen; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Tsao, DY (corresponding author), Athinoula A Martinos Ctr, Charlestown, MA 02129 USA.	doris@nmr.mgh.harvard.edu	Tudusciuc, Oana/C-1339-2011		Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41RR14075, P41 RR014075] Funding Source: Medline; NIBIB NIH HHS [R01 EB00790 A01, R01 EB000790] Funding Source: Medline; NIMH NIH HHS [R01 MH067529, R01 MH67529 A01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067529] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLMAN JM, 1988, COMP PRIMATE BIOL, V4, P279; BAYLIS GC, 1987, J NEUROSCI, V7, P330; Biederman I., 1995, VIS COGN, P121; Cavanagh P, 1995, PERCEPTION, V24, P1227, DOI 10.1068/p241227; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Gauthier I, 2000, COGN NEUROPSYCHOL, V17, P125, DOI 10.1080/026432900380535; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; TURK M, 1991, J COGNITIVE NEUROSCI, V1995, P71; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Van Essen D. C., 2003, VISUAL NEUROSCIENCES; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665	39	434	442	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					989	995		10.1038/nn1111	http://dx.doi.org/10.1038/nn1111			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	715KH	12925854	Green Accepted			2022-12-28	WOS:000184970400019
J	Turkeltaub, PE; Gareau, L; Flowers, DL; Zeffiro, TA; Eden, GF				Turkeltaub, PE; Gareau, L; Flowers, DL; Zeffiro, TA; Eden, GF			Development of neural mechanisms for reading	NATURE NEUROSCIENCE			English	Article							INFERIOR PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; WORD FORM AREA; WORKING-MEMORY; BRAIN; CHILDREN; FMRI; LANGUAGE; DYSLEXIA; SPECIALIZATION	The complexities of pediatric brain imaging have precluded studies that trace the neural development of cognitive skills acquired during childhood. Using a task that isolates reading-related brain activity and minimizes confounding performance effects, we carried out a cross-sectional functional magnetic resonance imaging (fMRI) study using subjects whose ages ranged from 6 to 22 years. We found that learning to read is associated with two patterns of change in brain activity: increased activity in left-hemisphere middle temporal and inferior frontal gyri and decreased activity in right inferotemporal cortical areas. Activity in the left-posterior superior temporal sulcus of the youngest readers was associated with the maturation of their phonological processing abilities. These findings inform current reading models and provide strong support for Orton's 1925 theory of reading development.	Georgetown Univ, Med Ctr, Washington, DC 20057 USA; Wake Forest Univ, Med Ctr Bowman Gray, Winston Salem, NC 27157 USA	Georgetown University; Wake Forest University	Eden, GF (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd,Bldg D,Suite 150, Washington, DC 20057 USA.		Zeffiro, Thomas/AAE-3441-2019	Zeffiro, Thomas/0000-0002-0846-4577; Turkeltaub, Peter/0000-0003-2080-6055	NICHD NIH HHS [HD40095] Funding Source: Medline; NIMH NIH HHS [F31 MH6500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD040095] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Balsamo LM, 2002, ARCH NEUROL-CHICAGO, V59, P1168, DOI 10.1001/archneur.59.7.1168; Becker JT, 1999, BRAIN COGNITION, V41, P27, DOI 10.1006/brcg.1999.1094; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chall J. S., 1983, STAGES READING DEV; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Conel J. L., 1963, POSTNATAL DEV HUMAN; Ehri L.C., 1999, READING DEV TEACHING, P79; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Flowers L, 2001, ANN DYSLEXIA, V51, P49, DOI 10.1007/s11881-001-0005-2; Friedman RF, 1993, CLIN NEUROPSYCHOLOGY, P37; FRITH U, 1985, SURFACE DYSLEXIA; Gaillard WD, 2003, NEUROLOGY, V60, P94, DOI 10.1212/WNL.60.1.94; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jonides J, 1998, J NEUROSCI, V18, P5026; Orton ST., 1937, READING WRITING SPEE; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; PETERSEN SE, 1988, NATURE, V331, P385; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Poldrack Russell A, 2002, Top Magn Reson Imaging, V13, P61, DOI 10.1097/00002142-200202000-00005; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 1996, NEUROIMAGE, V3, P40, DOI 10.1006/nimg.1996.0005; Price CJ, 1997, HUM BRAIN MAPP, V5, P264, DOI 10.1002/(SICI)1097-0193(1997)5:4<264::AID-HBM11>3.0.CO;2-E; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Simos PG, 2001, DEV NEUROPSYCHOL, V19, P191, DOI 10.1207/S15326942DN1902_4; SNYDER AZ, 1995, P NATL ACAD SCI USA, V92, P1689, DOI 10.1073/pnas.92.5.1689; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Talairach J., 1988, COPLANAR STEREOTAXIC; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468; Wolf M, 1999, ANN DYSLEXIA, V49, P3; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	50	491	496	3	115	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					767	773		10.1038/nn1065	http://dx.doi.org/10.1038/nn1065			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	694NJ	12754516				2022-12-28	WOS:000183780400026
J	Lee, RC; Clandinin, TR; Lee, CH; Chen, PL; Meinertzhagen, IA; Zipursky, SL				Lee, RC; Clandinin, TR; Lee, CH; Chen, PL; Meinertzhagen, IA; Zipursky, SL			The protocadherin Flamingo is required for axon target selection in the Drosophila visual system	NATURE NEUROSCIENCE			English	Article							LAMINA-SPECIFIC CONNECTIVITY; GLIAL-CELLS; N-CADHERIN; POLARITY; EXPRESSION; GUIDANCE; EYE; ULTRASTRUCTURE; MELANOGASTER; RECEPTORS	Photoreceptor neurons (R cells) in the Drosophila visual system elaborate a precise map of visual space in the brain. The eye contains some 750 identical modules called ommatidia, each containing eight photoreceptor cells (R1-R8). Cells R1-R6 synapse in the lamina; R7 and R8 extend through the lamina and terminate in the underlying medulla. In a screen for visual behavior mutants, we identified alleles of flamingo (fmi) that disrupt the precise maps elaborated by these neurons. These mutant R1-R6 neurons select spatially inappropriate targets in the lamina. During target selection, Flamingo protein is dynamically expressed in R1-R6 growth cones. Loss of fmi function in R cells also disrupts the local pattern of synaptic terminals in the medulla, and Flamingo is transiently expressed in R8 axons as they enter the target region. We propose that Flamingo-mediated interactions between R-cell growth cones within the target field regulate target selection.	Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Dalhousie Univ, Life Sci Ctr, Inst Neurosci, Halifax, NS B3H 4J1, Canada	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; Dalhousie University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Dept Biol Chem, Box 951662, Los Angeles, CA 90095 USA.		Lee, Chi-Hon/G-9190-2012	Meinertzhagen, Ian/0000-0002-6578-4526; Chen, Pei-Ling/0000-0001-6025-4318; Zipursky, Stephen/0000-0001-5630-7181; Lee, Chi-Hon/0000-0002-6138-711X	NEI NIH HHS [EY03592] Funding Source: Medline; NIGMS NIH HHS [GM08042] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008754] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chae J, 1999, DEVELOPMENT, V126, P5421; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; FROHLICH A, 1993, J NEUROBIOL, V24, P1642; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen IA, 1996, J NEUROSCI METH, V69, P59, DOI 10.1016/S0165-0270(96)00021-0; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; STARK WS, 1986, CELL TISSUE RES, V246, P481, DOI 10.1007/BF00215187; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; White NM, 2000, DEVELOPMENT, V127, P1681; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	39	136	136	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					557	563		10.1038/nn1063	http://dx.doi.org/10.1038/nn1063			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754514				2022-12-28	WOS:000183140400011
J	Carlson, GA				Carlson, GA			A welcoming environment for amyloid plaques	NATURE NEUROSCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; TRANSGENIC MICE; BETA PROTEIN; MOUSE MODEL	Transplantation studies using mouse models for Alzheimer's disease reveal that diffusible Abeta peptide is sufficient for amyloid plaque formation but is influenced by the local environment.	McLaughlin Res Inst, Great Falls, MT 59404 USA	McLaughlin Research Institute for Biomedical Sciences, Inc.	Carlson, GA (corresponding author), McLaughlin Res Inst, 1520 23rd St S, Great Falls, MT 59404 USA.							Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	13	8	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					328	330		10.1038/nn0403-328	http://dx.doi.org/10.1038/nn0403-328			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12658277				2022-12-28	WOS:000181833100004
J	Gauthier, I; Curran, T; Curby, KM; Collins, D				Gauthier, I; Curran, T; Curby, KM; Collins, D			Perceptual interference supports a non-modular account of face processing	NATURE NEUROSCIENCE			English	Article							EXPERT OBJECT RECOGNITION; SELECTIVE ATTENTION; BRAIN; MECHANISMS; COMPONENT; AREA	The perception of faces and of nonface objects share common early visual processing stages. Some argue, however, that the brain eventually processes faces separately from other objects, within a domain-specific module dedicated to face perception. This apparent specialization for faces could, alternatively, result from people's expertise with this category of stimuli. Here we used behavioral and electrophysiological measures of interference to address the functional independence of face and object processing. If the expert processing of faces and cars depend on common mechanisms related to holistic perception (obligatory processing of all parts), then for human subjects who are presumed to be face experts, car perception should interfere with concurrent face perception. Furthermore, such interference should increase with greater expertise in car identification, and indeed this is what we found. Event-related potentials (ERPs) suggest that this interference arose from perceptual processes contributing to the holistic processing of both objects of expertise and faces.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, Nashville, TN 37203 USA; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA	Vanderbilt University; University of Colorado System; University of Colorado Boulder	Gauthier, I (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, 301 Wilson Hall, Nashville, TN 37203 USA.			Gauthier, Isabel/0000-0002-6249-4769; Curby, Kim/0000-0001-7830-2533	NATIONAL EYE INSTITUTE [R01EY013441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064812] Funding Source: NIH RePORTER; NEI NIH HHS [EY13441] Funding Source: Medline; NIMH NIH HHS [MH64812] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Velleman P. F., 1981, APPL BASICS COMPUTIN; Wenger MJ, 2002, J EXP PSYCHOL LEARN, V28, P872, DOI 10.1037//0278-7393.28.5.872	20	301	306	1	25	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					428	432		10.1038/nn1029	http://dx.doi.org/10.1038/nn1029			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627167				2022-12-28	WOS:000181833100022
J	Riddoch, MJ; Humphreys, GW; Edwards, S; Baker, T; Willson, K				Riddoch, MJ; Humphreys, GW; Edwards, S; Baker, T; Willson, K			Seeing the action: neuropsychological evidence for action-based effects on object selection	NATURE NEUROSCIENCE			English	Article							VISUAL SELECTION; EXTINCTION; NEGLECT	Previous studies have shown that selection for perceptual report is often limited to one object at a time, with elements being selected together if they belong to part of the same perceptual group. Here we used the neuropsychological phenomenon of extinction in human patients with parietal lesions to show that selection is influenced also by action relations between objects. Performance was better for objects that were positioned spatially so that they could be used together, relative to objects that were positioned inappropriately for their combined use. The action relation was critical, as performance for pictures did not improve if the items were only verbally associated. We found the opposite result with words. Effects of action relations emerged even on trials where only one object could be reported, showing implicit coding of 'action' units for selection. The effects of verbal associations may instead reflect priming between lexical entries.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Riddoch, MJ (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England.		Riddoch, Jane/F-7968-2010					Allport D.A., 1985, CURRENT PERSPECTIVES, P32; COSLETT HB, 1991, BRAIN, V114, P1523, DOI 10.1093/brain/114.4.1523; Critchley M., 1953, PARIETAL LOBES; Driver J., 1996, CONVERGENT OPERATION, P193; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; Duncan J., 1996, ATTENTION PERFORM, P549; GADO M, 1979, J COMPUT ASSIST TOMO, V3, P1, DOI 10.1097/00004728-197902000-00001; Gilchrist ID, 1996, COGNITIVE NEUROPSYCH, V13, P1223, DOI 10.1080/026432996381737; Humphreys GW, 1998, PHILOS T R SOC B, V353, P1341, DOI 10.1098/rstb.1998.0288; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; HUMPHREYS GW, 1993, ATTENTION PERFORM, V14, P143; Kumada T, 2001, COGNITIVE NEUROPSYCH, V18, P465, DOI 10.1080/02643290042000224; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; Moss Helen, 1996, BIRKBECK WORD ASS NO; Oppenheim H., 1885, NEUROLOGISCHES CENTR, V4, P529; SERON X, 1989, COGNITIVE NEUROPSYCH, V6, P475, DOI 10.1080/02643298908253427; Shalev L, 2000, COGNITIVE NEUROPSYCH, V17, P339, DOI 10.1080/026432900380436; Ward R., 1994, VIS COGN, V1, P101, DOI DOI 10.1080/13506289408402295; Wilson B. A., 1987, BEHAV INATTENTION TE	19	128	129	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					82	89		10.1038/nn984	http://dx.doi.org/10.1038/nn984			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469129				2022-12-28	WOS:000180089300019
J	Sakai, K; Passingham, RE				Sakai, K; Passingham, RE			Prefrontal interactions reflect future task operations	NATURE NEUROSCIENCE			English	Article							FRONTAL-LOBE DAMAGE; WORKING-MEMORY; PREMOTOR CORTEX; EPISODIC MEMORY; LONDON TASK; ORGANIZATION; RETRIEVAL; DISSOCIATION; PERFORMANCE; NEURONS	When task instructions are given, the human brain establishes a task set before the task is actually performed. By introducing a delay between the instruction and the task, we have identified the neural correlates of task sets using functional magnetic resonance imaging (fMRI). Subjects were instructed to remember a sequence of positions or letters, either in the order presented or in the reverse order. Spatial or verbal processing areas were active during the delay, depending on whether positions or letters were to be remembered, whereas the anterior region of the prefrontal cortex (PFC) was active regardless of the domain of the items. Furthermore, the nature of the interaction between the anterior PFC and the domain-specific posterior prefrontal areas (superior frontal sulcus and left inferior frontal gyrus) depended on whether the items were to be remembered in the forward or backward order. Thus we have identified inter-regional interactions that reflect preparation for task performance.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of Oxford	Sakai, K (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.							Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Dagher A, 1999, BRAIN, V122, P1973, DOI 10.1093/brain/122.10.1973; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KURATA K, 1988, EXP BRAIN RES, V69, P327; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Pochon JB, 2001, CEREB CORTEX, V11, P260, DOI 10.1093/cercor/11.3.260; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; RUSHWORTH MFS, IN PRESS J COGN NEUR; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003	35	304	306	2	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					75	81		10.1038/nn987	http://dx.doi.org/10.1038/nn987			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469132				2022-12-28	WOS:000180089300018
J	Farah, MJ				Farah, MJ			Emerging ethical issues in neuroscience	NATURE NEUROSCIENCE			English	Article							PERSONALITY; FLUOXETINE; MEMORY; METHYLPHENIDATE; ENHANCEMENT; PERFORMANCE; DISORDERS; BEHAVIOR; AMYGDALA	There is growing public awareness of the ethical issues raised by progress in many areas of neuroscience. This commentary reviews the issues, which are triaged in terms of their novelty and their imminence, with an exploration of the relevant ethical principles in each case.	Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Farah, MJ (corresponding author), Univ Penn, Ctr Cognit Neurosci, 3815 Walnut St, Philadelphia, PA 19104 USA.	mfarah@psych.upenn.edu						American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDERSON J, 1990, ADAPTIVE CHARACTERIS; Armstrong K, 1999, NEW ENGL J MED, V341, P1389, DOI 10.1056/NEJM199910283411810; Babcock Q, 2000, J AM COLL HEALTH, V49, P143, DOI 10.1080/07448480009596296; BERMAN RM, 1999, NEUROBIOLOGY MENTAL, P419; Blank R. H., 1999, BRAIN POLICY NEW NEU; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Caldwell JA, 2000, PSYCHOPHARMACOLOGY, V150, P272, DOI 10.1007/s002130000450; Campbell ML, 2001, AM J HEALTH-SYST PH, V58, P1301, DOI 10.1093/ajhp/58.14.1301; CANLI T, IN PRESS BRAIN COGN; Capron AM, 1999, NEW ENGL J MED, V340, P1430, DOI 10.1056/NEJM199905063401812; Cherek DR, 2002, PSYCHOPHARMACOLOGY, V159, P266, DOI 10.1007/s002130100915; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Churchland Paul M., 1995, ENGINE REASON SEAT S; Coccaro EF, 1997, BIOL PSYCHIAT, V42, P546, DOI 10.1016/S0006-3223(97)00309-0; Coccaro EF, 1997, ARCH GEN PSYCHIAT, V54, P1081; Craik F.I.M., 1992, HDB AGING COGNITION; Diller LD, 1996, HASTINGS CENT REP, V26, P12, DOI 10.2307/3528571; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Flett GL, 1997, PSYCHOL BULL, V121, P395, DOI 10.1037/0033-2909.121.3.395; FUKUYAMA F, 2002, OUR PSOTHUMAN FUTURE; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; George MS, 1996, J NEUROPSYCH CLIN N, V8, P373; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Grossman LS, 1999, PSYCHIATR SERV, V50, P349, DOI 10.1176/ps.50.3.349; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Ingvar M, 1997, EXP NEUROL, V146, P553, DOI 10.1006/exnr.1997.6581; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Kramer P. D., 1993, LISTENING PROZAC; Lagarde D., 1995, FUND CLIN PHARM, V9, P1; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Luria A., 1968, MIND MNEMONIST; Malhi GS, 2002, J PSYCHOSOM RES, V53, P709, DOI 10.1016/S0022-3999(02)00423-3; Manuck SB, 1998, NEUROPSYCHOPHARMACOL, V19, P287, DOI 10.1038/sj.npp.1395199; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Morse SJ, 2000, LAW PHILOS, V19, P3; NEAUREGARD M, 2001, J NEUROSCI, V21, P1; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; OVSVIEW F, 1997, J NEUROL NEUROSUR PS, V63, P701; Parens E, 1998, ENHANCING HUMAN TRAI; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Redmond G, 1997, INT J FERTIL WOMEN M, V42, P67; SALZMAN C, 1995, J CLIN PSYCHOPHARM, V15, P23, DOI 10.1097/00004714-199502000-00005; Shastry BS, 1997, BIOESSAYS, V19, P199, DOI 10.1002/bies.950190304; Solomon PR, 2002, JAMA-J AM MED ASSOC, V288, P835, DOI 10.1001/jama.288.7.835; Truog RD, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3528024; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Valenstein E. S., 1986, GREAT DESPERATE CURE; Walsh MT, 2001, ACTA PSYCHIAT SCAND, V104, P84, DOI 10.1034/j.1600-0447.2001.00357.x	52	134	136	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1123	1129		10.1038/nn1102-1123	http://dx.doi.org/10.1038/nn1102-1123			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	609CG	12404006	Green Submitted			2022-12-28	WOS:000178884600014
J	Kirschenbaum, SR				Kirschenbaum, SR			Patenting basic research: myths and realities	NATURE NEUROSCIENCE			English	Article									Salk Inst Biol Studies, Off Technol Management, La Jolla, CA 92037 USA	Salk Institute	Kirschenbaum, SR (corresponding author), Salk Inst Biol Studies, Off Technol Management, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.								0	3	3	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1025	1027		10.1038/nn932	http://dx.doi.org/10.1038/nn932			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403976				2022-12-28	WOS:000179041300004
J	Thoenen, H; Sendtner, M				Thoenen, H; Sendtner, M			Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches	NATURE NEUROSCIENCE			English	Review							NERVE GROWTH-FACTOR; PLACEBO-CONTROLLED TRIAL; FACTOR-I; GENE-EXPRESSION; SURVIVAL; EXERCISE; DELIVERY; CELLS; BDNF; NEURODEGENERATION	Despite high enthusiasm, early attempts to develop clinical treatments based on animal research with neurotrophins were not successful. Here we survey clinical trials with neurotrophins, compared with neurotrophic factors of other gene families, and delineate the most likely reasons for their failure. We then suggest improved methods for regulated local supply of NTs to specific populations of neurons and discuss future therapeutic procedures evolving from the more detailed knowledge of the signal transduction pathways activated by neurotrophins via their receptors.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Inst Clin Neurobiol, D-97080 Wurzburg, Germany	Max Planck Society; University of Wurzburg	Thoenen, H (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Sendtner, Michael/M-8137-2014; Sendtner, Michael/J-1542-2012	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974				Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Apfel SC, 2000, JAMA-J AM MED ASSOC, V284, P2215, DOI 10.1001/jama.284.17.2215; Apfel SC, 1998, NEUROLOGY, V51, P695, DOI 10.1212/WNL.51.3.695; Bachoud-Levi AC, 2000, HUM GENE THER, V11, P1723, DOI 10.1089/10430340050111377; Baekelandt V, 2000, CURR OPIN MOL THER, V2, P540; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Carro E, 2000, J NEUROSCI, V20, P2926; CEDARBAUM JM, 1995, CLIN NEUROPHARMACOL, V18, P515; Chaudhry V, 2000, MUSCLE NERVE, V23, P189, DOI 10.1002/(SICI)1097-4598(200002)23:2<189::AID-MUS7>3.3.CO;2-#; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dittrich F, 1996, EXP NEUROL, V141, P225, DOI 10.1006/exnr.1996.0157; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302; Hefti F, 1997, ANNU REV PHARMACOL, V37, P239, DOI 10.1146/annurev.pharmtox.37.1.239; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; KERSCHENSTEINER M, IN PRESS ANN NEUROL; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Lotz B, 1996, NEUROLOGY, V46, P1244; Lowenstein PR, 1996, PROTOCOLS GENE TRANS; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; MCALLISTER AK, 2001, NAT NEUROSCI S, V4, P1207; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Miller RG, 1996, ANN NEUROL, V39, P256, DOI 10.1002/ana.410390215; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Penn RD, 1997, NEUROSURGERY, V40, P94, DOI 10.1097/00006123-199701000-00021; Rossi FMV, 1998, CURR OPIN BIOTECH, V9, P451, DOI 10.1016/S0958-1669(98)80028-1; Schifitto G, 2001, NEUROLOGY, V57, P1313, DOI 10.1212/WNL.57.7.1313; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Swain C, 1999, HANDB EXP PHARM, V134, P281; THOENEN H, 2000, AXONAL REGENERATION, P675; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Wellmer A, 2001, J PERIPHER NERV SYST, V6, P204, DOI 10.1046/j.1529-8027.2001.01019.x	54	260	292	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1046	1050		10.1038/nn938	http://dx.doi.org/10.1038/nn938			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403983				2022-12-28	WOS:000179041300011
J	Daw, MI; Bortolotto, ZA; Saulle, E; Zaman, S; Collingridge, GL; Isaac, JTR				Daw, MI; Bortolotto, ZA; Saulle, E; Zaman, S; Collingridge, GL; Isaac, JTR			Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression	NATURE NEUROSCIENCE			English	Article							PHOSPHOINOSITIDE 3-KINASE; POTENTIATION; INHIBITOR; INDUCTION; MEMORY; RAT		Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Isaac, JTR (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Univ Walk, Bristol BS8 1TD, Avon, England.	j.t.r.isaac@bris.ac.uk	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015	Collingridge, Graham L/0000-0002-9572-5359; Daw, Michael/0000-0002-8374-5977; Zaman, Shahid/0000-0003-1639-6014				Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sanna PP, 2002, J NEUROSCI, V22, P3359; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	14	50	52	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					835	836		10.1038/nn903	http://dx.doi.org/10.1038/nn903			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161757				2022-12-28	WOS:000177656300009
J	Colbert, CM; Pan, EH				Colbert, CM; Pan, EH			Ion channel properties underlying axonal action potential initiation in pyramidal neurons	NATURE NEUROSCIENCE			English	Article							SODIUM-CHANNELS; SPIKE-INITIATION; RAT HIPPOCAMPUS; CELL DENDRITES; GANGLION-CELLS; PROPAGATION; CA1; SEGMENT; SITE; BACKPROPAGATION	A high density of Na+ channels in the axon hillock, or initial segment, is believed to determine the threshold for action potential initiation in neurons. Here we report evidence for an alternative mechanism that lowers the threshold in the axon. We investigated properties and distributions of ion channels in outside-out patches from axons and somata of layer 5 pyramidal neurons in rat neocortical slices. Na+ channels in axonal patches (>30 mum from the soma) were activated by 7 mV less depolarization than were somatic Na+ channels. A-type K+ channels, which were prominent in somatic and dendritic patches, were rarely seen in axonal patches. We incorporated these findings into numerical simulations which indicate that biophysical properties of axonal channels, rather than a high density of channels in the initial segment, are most likely to determine the lowest threshold for action potential initiation.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Colbert, CM (corresponding author), Univ Houston, Dept Biol & Biochem, 4800 Calhoun Rd, Houston, TX 77204 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS036982] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36982] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams Paul R., 1992, Current Biology, V2, P625, DOI 10.1016/0960-9822(92)90093-P; Alessandri-Haber N, 1999, J PHYSIOL-LONDON, V518, P203, DOI 10.1111/j.1469-7793.1999.0203r.x; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; [Anonymous], [No title captured]; Astman N, 1998, J NEUROPHYSIOL, V80, P1547, DOI 10.1152/jn.1998.80.3.1547; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; CARRAS PL, 1992, J NEUROPHYSIOL, V67, P292, DOI 10.1152/jn.1992.67.2.292; CATTERALL WA, 1981, J NEUROSCI, V1, P777, DOI 10.1523/JNEUROSCI.01-07-00777.1981; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colbert CM, 1996, J NEUROSCI, V16, P6676; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; EDWARDS C, 1958, J PHYSIOL-LONDON, V143, P138, DOI 10.1113/jphysiol.1958.sp006049; FARINAS I, 1991, J COMP NEUROL, V304, P70, DOI 10.1002/cne.903040106; GOGAN P, 1983, J PHYSIOL-LONDON, V335, P205, DOI 10.1113/jphysiol.1983.sp014529; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kloosterman F, 2001, J NEUROPHYSIOL, V86, P2435, DOI 10.1152/jn.2001.86.5.2435; Luscher HR, 1998, J NEUROPHYSIOL, V80, P715, DOI 10.1152/jn.1998.80.2.715; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; MATSUMOTO E, 1985, J NEUROCYTOL, V14, P731, DOI 10.1007/BF01170825; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P285, DOI 10.1113/jphysiol.1983.sp014581; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; REGEHR WG, 1994, CURR BIOL, V4, P436, DOI 10.1016/S0960-9822(00)00096-8; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TURNER RW, 1991, J NEUROSCI, V11, P2270; Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0	40	196	199	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					533	538		10.1038/nn857	http://dx.doi.org/10.1038/nn857			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992119				2022-12-28	WOS:000175874600012
J	Hooper, SL; Buchman, E; Hobbs, KH				Hooper, SL; Buchman, E; Hobbs, KH			A computational role for slow conductances: single-neuron models that measure duration	NATURE NEUROSCIENCE			English	Article								Humans effortlessly interpret speech and music, whose patterns can contain sound durations up to thousands of milliseconds. How nervous systems measure such long durations is unclear. We show here that model neurons containing physiological slow conductances are 'naturally' sensitive to duration, replicate known duration-sensitive neurons and can be 'tuned' to respond to a wide range of specific durations. In addition, these models reproduce several other properties of duration-sensitive neurons not selected for in model construction. These data, and the widespread presence of slow conductances in nervous systems, suggest that slow conductances might play a major role in duration measurement.	Ohio Univ, Dept Biol Sci, Program Neurosci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Hooper, SL (corresponding author), Ohio Univ, Dept Biol Sci, Program Neurosci, Athens, OH 45701 USA.							POTTER HD, 1965, J NEUROPHYSIOL, V28, P1155, DOI 10.1152/jn.1965.28.6.1155	1	37	36	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					552	556		10.1038/nn838	http://dx.doi.org/10.1038/nn838			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992113				2022-12-28	WOS:000175874600015
J	Semendeferi, K; Lu, A; Schenker, N; Damasio, H				Semendeferi, K; Lu, A; Schenker, N; Damasio, H			Humans and great apes share a large frontal cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; VOLUMETRIC-ANALYSIS; CEREBRAL-CORTEX; BRAIN; EVOLUTION; HOMINOIDS; LOBES	Some of the outstanding cognitive capabilities of humans are commonly attributed to a disproportionate enlargement of the human frontal lobe during evolution. This claim is based primarily on comparisons between the brains of humans and of other primates, to the exclusion of most great apes. We compared the relative size of the frontal cortices in living specimens of several primate species, including all extant hominoids, using magnetic resonance imaging. Human frontal cortices were not disproportionately large in comparison to those of the great apes. We suggest that the special cognitive abilities attributed to a frontal advantage may be due to differences in individual cortical areas and to a richer interconnectivity, none of which required an increase in the overall relative size of the frontal lobe during hominid evolution.	Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of California System; University of California San Diego; University of Iowa	Semendeferi, K (corresponding author), Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA.	ksemende@ucsd.edu	Schenker-Ahmed, Natalie M/B-7470-2011	Schenker-Ahmed, Natalie M/0000-0002-2651-1576; Semendeferi, Katerina/0000-0002-9867-9554				AIELLO LC, 1992, J HUM EVOL, V22, P127, DOI 10.1016/0047-2484(92)90034-7; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Blinkov SM, 1968, ZENTRALNERVENSYSTEM; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Buxhoeveden DP, 2001, AM J PHYS ANTHROPOL, V115, P361, DOI 10.1002/ajpa.1092; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; DAMASIO AR, 1994, DESCARTES ERROR; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Deacon T., 1997, SYMBOLIC SPECIES; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Fuster J., 2015, PREFRONTAL CORTEX, V5th; GOLDMANRAKIC PS, 1984, TRENDS NEUROSCI, V7, P425, DOI 10.1016/S0166-2236(84)80147-2; HOLLOWAY RALPH L., 1968, BRAIN RES, V7, P121, DOI 10.1016/0006-8993(68)90094-2; Jerison HJ, 1997, DEV PREFRONTAL CORTE, P9; McBride T, 1999, BRAIN BEHAV EVOLUT, V54, P159, DOI 10.1159/000006620; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; Preuss TM, 1999, P NATL ACAD SCI USA, V96, P11601, DOI 10.1073/pnas.96.20.11601; RADINSKY L, 1974, AM J PHYS ANTHROPOL, V41, P15, DOI 10.1002/ajpa.1330410104; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Semendeferi K, 2000, J HUM EVOL, V38, P317, DOI 10.1006/jhev.1999.0381; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Semendeferi K, 1998, AM J PHYS ANTHROPOL, V106, P129, DOI 10.1002/(SICI)1096-8644(199806)106:2<129::AID-AJPA3>3.0.CO;2-L; SMITH RJ, 1994, J HUM EVOL, V26, P239, DOI 10.1006/jhev.1994.1013; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	29	313	320	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					272	276		10.1038/nn814	http://dx.doi.org/10.1038/nn814			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850633				2022-12-28	WOS:000174146000019
J	Ding, YQ; Marklund, U; Yuan, WL; Yin, J; Wegman, L; Ericson, J; Deneris, E; Johnson, RL; Chen, ZF				Ding, YQ; Marklund, U; Yuan, WL; Yin, J; Wegman, L; Ericson, J; Deneris, E; Johnson, RL; Chen, ZF			Lmx1b is essential for the development of serotonergic neurons	NATURE NEUROSCIENCE			English	Article							ETS DOMAIN FACTOR; MOUSE-BRAIN; SPECIFICATION; TRANSPORTER; PET-1; TRANSCRIPTION; IDENTITY; SIGNALS; SYSTEM; PLATE	The specification and differentiation of serotonergic (5-HT) neurons require both extrinsic signaling molecules and intrinsic transcription factors to work in concert or in cascade. Here we identify the genetic cascades that control the specification and differentiation of 5-HT neurons in mice. A major determinant in the cascades is an LIM homeodomain-containing gene, Lmx1b, which is required for the development of all 5-HT neurons in the central nervous system. Our results suggest that, during development of 5-HT neurons, Lmx1b is a critical intermediate factor that couples Nkx2-2-mediated early specification with Pet1-mediated terminal differentiation. Moreover, our data indicate that genetic cascades controlling the caudal and rostral 5-HT neurons are distinct, despite their shared components.	Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Karolinska Institutet; Case Western Reserve University; University of Texas System; UTMD Anderson Cancer Center	Chen, ZF (corresponding author), Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.		Marklund, Ulrika/I-8814-2012	Marklund, Ulrika/0000-0003-1426-1271; Ding, Yu-Qiang/0000-0003-1202-4635; Ericson, Johan/0000-0002-8019-7127				BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Bruning G, 1997, CELL TISSUE RES, V289, P211, DOI 10.1007/s004410050868; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.0.CO;2-1; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Halliday Glenda, 1995, P929; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LAUDER JM, 1982, BRAIN RES BULL, V9, P605, DOI 10.1016/0361-9230(82)90165-4; MILLS HA, 1974, AGRON J, V66, P355, DOI 10.2134/agronj1974.00021962006600030005x; Nakamoto H, 2000, MOL BRAIN RES, V76, P93, DOI 10.1016/S0169-328X(99)00335-6; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pfaar H, 2002, DEV GENES EVOL, V212, P43, DOI 10.1007/s00427-001-0208-x; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Stockmeier CA, 1997, ANN NY ACAD SCI, V836, P220, DOI 10.1111/j.1749-6632.1997.tb52362.x; van Doorninck J H, 1999, J Neurosci, V19, pRC12; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	27	206	209	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					933	938		10.1038/nn1104	http://dx.doi.org/10.1038/nn1104			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897786				2022-12-28	WOS:000184970400011
J	Heynen, AJ; Yoon, BJ; Liu, CH; Chung, HJ; Huganir, RL; Bear, MF				Heynen, AJ; Yoon, BJ; Liu, CH; Chung, HJ; Huganir, RL; Bear, MF			Molecular mechanism for loss of visual cortical responsiveness following brief monocular deprivation	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; OCULAR DOMINANCE PLASTICITY; KITTEN STRIATE CORTEX; RECEPTIVE-FIELD PROPERTIES; SOURCE DENSITY ANALYSIS; HIPPOCAMPUS IN-VIVO; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; POSTNATAL-DEVELOPMENT; PROTEIN-KINASE	A dramatic form of experience-dependent synaptic plasticity is revealed in visual cortex when one eye is temporarily deprived of vision during early postnatal life. Monocular deprivation (MD) alters synaptic transmission such that cortical neurons cease to respond to stimulation of the deprived eye, but how this occurs is poorly understood. Here we show in rat visual cortex that brief MD sets in motion the same molecular and functional changes as the experimental model of homosynaptic long-term depression (LTD), and that prior synaptic depression by MD occludes subsequent induction of LTD. The mechanisms of LTD, about which there is now a detailed understanding, therefore contribute to visual cortical plasticity.	MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Bear, MF (corresponding author), MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Yoon, Bong June/L-7126-2017	Chung, Hee Jung/0000-0002-5555-9907; Bear, Mark/0000-0002-9903-2541				Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Antonini A, 1999, J NEUROSCI, V19, P4388; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1990, J NEUROSCI, V10, P909; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blais BS, 1999, P NATL ACAD SCI USA, V96, P1083, DOI 10.1073/pnas.96.3.1083; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dodt HU, 1999, SCIENCE, V286, P110, DOI 10.1126/science.286.5437.110; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1996, NEURON, V16, P1; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; FREEMAN RD, 1981, J NEUROPHYSIOL, V45, P1074, DOI 10.1152/jn.1981.45.6.1074; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; KENANVAKNIN G, 1994, BRAIN RES, V635, P37, DOI 10.1016/0006-8993(94)91421-4; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KOSSUT M, 1991, EXP BRAIN RES, V85, P519; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mitchell DE, 2001, P NATL ACAD SCI USA, V98, P11662, DOI 10.1073/pnas.201392698; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YINON U, 1973, EXP NEUROL, V38, P231, DOI 10.1016/0014-4886(73)90148-9	50	237	246	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					854	862		10.1038/nn1100	http://dx.doi.org/10.1038/nn1100			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12886226				2022-12-28	WOS:000184413700015
J	Xiao, J; Zhen, XG; Yang, J				Xiao, J; Zhen, XG; Yang, J			Localization of PIP2 activation gate in inward rectifier K+ channels	NATURE NEUROSCIENCE			English	Article							SHAKER POTASSIUM CHANNELS; BETA-GAMMA-SUBUNITS; SELECTIVITY FILTER; STRUCTURAL DETERMINANTS; DEPENDENT CHANGES; ION PERMEATION; G-PROTEINS; PORE; ATP; RECTIFICATION	Ion channels respond to changes in transmembrane voltage or ligand concentration by opening or closing an activation gate. In voltage-gated K+ channels, this gate has been localized to an intracellular bundle crossing. Here we examined whether this bundle crossing, or the more internal cytoplasmic pore, acts as a gate for PIP2 activation of inward rectifier K+ (Kir) channels expressed in Xenopus laevis oocytes. We studied the open/closed state-dependence of the accessibility of intracellular cationic modifiers to a position (residue Ile176 in the TM2 helix of Kir2.1) more external to the bundle crossing. Cd2+ blocked I176C mutant channels much more weakly in the closed state than in the open state, but Ag+ and sulfhydryl-specific methanethiosulfonate reagents modified the channels with similar rates in both states. These results suggest that the TM2 helices undergo conformation changes upon PIP2 binding/unbinding, but neither they nor the cytoplasmic pore close fully to form a physical gate for K+ conduction.	Columbia Univ, Dept Biol Sci, Fairchild Ctr 915, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr 915, MC2462, New York, NY 10027 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045383] Funding Source: NIH RePORTER; NINDS NIH HHS [NS45383] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Immke D, 1999, J GEN PHYSIOL, V113, P819, DOI 10.1085/jgp.113.6.819; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Lu T, 1999, P NATL ACAD SCI USA, V96, P9926, DOI 10.1073/pnas.96.17.9926; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu T, 2001, J GEN PHYSIOL, V118, P509, DOI 10.1085/jgp.118.5.509; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; So I, 2001, J PHYSIOL-LONDON, V531, P37, DOI 10.1111/j.1469-7793.2001.0037j.x; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	50	70	72	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					811	818		10.1038/nn1090	http://dx.doi.org/10.1038/nn1090			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12858177				2022-12-28	WOS:000184413700009
J	Vuilleumier, P; Armony, JL; Driver, J; Dolan, RJ				Vuilleumier, P; Armony, JL; Driver, J; Dolan, RJ			Distinct spatial frequency sensitivities for processing faces and emotional expressions	NATURE NEUROSCIENCE			English	Article							BILATERAL AMYGDALA DAMAGE; RETINAL GANGLION-CELLS; SUPERIOR COLLICULUS; MEDIAL PULVINAR; RECOGNITION; PERCEPTION; CORTEX; MONKEY; INPUT; IDENTIFICATION	High and low spatial frequency information in visual images is processed by distinct neural channels. Using event-related functional magnetic resonance imaging (fMRI) in humans, we show dissociable roles of such visual channels for processing faces and emotional fearful expressions. Neural responses in fusiform cortex, and effects of repeating the same face identity upon fusiform activity, were greater with intact or high-spatial-frequency face stimuli than with low-frequency faces, regardless of emotional expression. In contrast, amygdala responses to fearful expressions were greater for intact or low-frequency faces than for high-frequency faces. An activation of pulvinar and superior colliculus by fearful expressions occurred specifically with low-frequency faces, suggesting that these subcortical pathways may provide coarse fear-related inputs to the amygdala.	Univ Geneva, Ctr Med, Dept Clin Neurosci & Physiol, Lab Neurol & Imaging Cognit, CH-1211 Geneva, Switzerland; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; McGill Univ, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of Geneva; University of London; University College London; McGill University; University of London; University College London	Vuilleumier, P (corresponding author), Univ Geneva, Ctr Med, Dept Clin Neurosci & Physiol, Lab Neurol & Imaging Cognit, 1 Michel Servet, CH-1211 Geneva, Switzerland.	patrik.vuilleumier@medecine.unige.ch	Driver, Jon/A-4779-2010; Vuilleumier, Patrik/AAJ-1839-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; BENEVENTO LA, 1983, J COMP NEUROL, V217, P307, DOI 10.1002/cne.902170307; BERSON DM, 1988, PROG BRAIN RES, V75, P17; BISTI S, 1976, VISION RES, V16, P247, DOI 10.1016/0042-6989(76)90107-3; BRUCE V, 1991, PERCEPTION, V20, P755, DOI 10.1068/p200755; Burton AM, 2001, VISION RES, V41, P3185, DOI 10.1016/S0042-6989(01)00186-9; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; COWEY A, 1994, NEUROSCIENCE, V61, P691, DOI 10.1016/0306-4522(94)90445-6; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; FIORENTINI A, 1983, PERCEPTION, V12, P195, DOI 10.1068/p120195; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Goshen-Gottstein Y, 2000, J EXP PSYCHOL LEARN, V26, P1198, DOI 10.1037//0278-7393.26.5.1198; Hamann SB, 1999, NEUROPSYCHOLOGIA, V37, P1135, DOI 10.1016/S0028-3932(99)00027-5; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAYES T, 1986, PERCEPTION, V15, P595, DOI 10.1068/p150595; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hill H, 1997, COGNITION, V62, P201, DOI 10.1016/S0010-0277(96)00785-8; JOHNSON MH, 1993, CORTICAL PARCELLATIO; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; KLINE DW, 1993, HUM FACTORS, V35, P25, DOI 10.1177/001872089303500102; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEVENTHAL AG, 1985, J COMP NEUROL, V237, P216, DOI 10.1002/cne.902370206; Linke R, 2000, EXP BRAIN RES, V134, P520, DOI 10.1007/s002210000475; Liu CH, 2000, J EXP PSYCHOL HUMAN, V26, P956, DOI 10.1037//0096-1523.26.3.956; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Lomber SG, 2002, P NATL ACAD SCI USA, V99, P4049, DOI 10.1073/pnas.062551899; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MORRIS JS, 1998, J COMP NEUROL, V394, P91; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; NORMAN J, 1987, VISION RES, V27, P87, DOI 10.1016/0042-6989(87)90145-3; O'Brien BJ, 2001, NEUROSCI LETT, V312, P145, DOI 10.1016/S0304-3940(01)02220-0; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Sahraie A, 2002, EXP BRAIN RES, V143, P249, DOI 10.1007/s00221-001-0989-1; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SERGENT J, 1985, J EXP PSYCHOL HUMAN, V11, P846, DOI 10.1037/0096-1523.11.6.846; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Whalen PJ, 1998, J NEUROSCI, V18, P411	50	805	824	4	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					624	631		10.1038/nn1057	http://dx.doi.org/10.1038/nn1057			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12740580	Green Published			2022-12-28	WOS:000183140400020
J	Mattson, MP				Mattson, MP			Insulating axons via NF-kappa B	NATURE NEUROSCIENCE			English	Editorial Material							SCHWANN-CELLS; TRANSCRIPTION; SURVIVAL		NIA, Neurosci Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattson, MP (corresponding author), NIA, Neurosci Lab, Gerontol Res Ctr, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE ON AGING [Z01AG000314, Z01AG000313] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartsch U, 2003, FRONT BIOSCI-LANDMRK, V8, pD477, DOI 10.2741/1028; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; FERNANDEZVALLE C, 1994, J NEUROBIOL, V25, P1207, DOI 10.1002/neu.480251004; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Nicholas RS, 2001, EUR J NEUROSCI, V13, P959, DOI 10.1046/j.0953-816x.2001.01470.x; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Stewart HJS, 1995, GLIA, V15, P419, DOI 10.1002/glia.440150406	12	12	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					105	106		10.1038/nn0203-105	http://dx.doi.org/10.1038/nn0203-105			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12555100				2022-12-28	WOS:000180669100004
J	Barborica, A; Ferrera, VP				Barborica, A; Ferrera, VP			Estimating invisible target speed from neuronal activity in monkey frontal eye field	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS; PREFRONTAL CORTEX; MACAQUE; MOVEMENTS; SACCADES; SELECTIVITY; MODULATION; DECISION	Working memory involves transient storage of information and the ability to manipulate that information for short-range planning and prediction. The computational aspect of working memory can be probed using dynamic sensorimotor behavior requiring complex stimulus-response mappings. Such a transformation occurs when extrapolating the future location of a moving target that is rendered temporarily invisible. Estimating the trajectory of an invisible moving target requires encoding and storing several target features, including the direction and speed of motion. We trained monkeys to make saccades to the estimated position of invisible targets moving at various speeds. The activity of neurons in the frontal eye field (FEF) was consistently modulated according to the speed of target motion. A reconstruction algorithm showed that estimates of target speed based on FEF activity were similar to behavioral speed estimates. FEF may therefore be involved in updating an internal representation of target trajectory for predictive saccades.	Columbia Univ, Dept Psychiat, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, David Mahoney Ctr Mind & Brain, New York, NY 10032 USA	Columbia University; Columbia University	Ferrera, VP (corresponding author), Columbia Univ, Dept Psychiat, Ctr Neurobiol & Behav, 1051 Riverside Dr,Kolb Annex 504, New York, NY 10032 USA.		Barborica, Andrei/N-6204-2017	Barborica, Andrei/0000-0001-6783-3769; Ferrera, Vincent/0000-0002-6599-7740	NIMH NIH HHS [MH59244, R01 MH059244] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059244] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARBAS H, 1981, J COMP NEUROL, V200, P407, DOI 10.1002/cne.902000309; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Filion CM, 1996, J COMP PSYCHOL, V110, P386, DOI 10.1037/0735-7036.110.4.386; Fukushima K, 2002, EXP BRAIN RES, V145, P104, DOI 10.1007/s00221-002-1088-7; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hooker C, 2000, SCHIZOPHR RES, V45, P83, DOI 10.1016/S0920-9964(99)00166-8; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KEATING EG, 1991, EXP BRAIN RES, V86, P311; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; Opris I, 2001, EXP BRAIN RES, V138, P1, DOI 10.1007/s002210100686; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; SCHALL JD, 1995, J NEUROSCI, V15, P6905; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SEGRAVES MA, 1993, J NEUROPHYSIOL, V69, P1880, DOI 10.1152/jn.1993.69.6.1880; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2684, DOI 10.1152/jn.2002.87.6.2684; Wurtz Robert H., 1994, Current Opinion in Neurobiology, V4, P857, DOI 10.1016/0959-4388(94)90134-1	28	82	82	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					66	74		10.1038/nn990	http://dx.doi.org/10.1038/nn990			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483216				2022-12-28	WOS:000180089300017
J	Carter, AG; Regehr, WG				Carter, AG; Regehr, WG			Quantal events shape cerebellar interneuron firing	NATURE NEUROSCIENCE			English	Article							NEOSTRIATAL CHOLINERGIC INTERNEURONS; SYNAPTIC CURRENTS; PYRAMIDAL CELLS; PURKINJE-CELLS; STELLATE CELLS; NEOCORTICAL NEURONS; MEMBRANE-PROPERTIES; CORTICAL-NEURONS; INHIBITORY CELLS; INVITRO	Many small synaptic inputs or one large input are needed to influence principal cell firing, whereas individual quanta exert little influence. However, the role of a quantum may be greater for small interneurons with high input resistances. Using dynamic clamp recordings, we found that individual quanta strongly influence rat cerebellar stellate cell firing. When the frequency of synaptic inputs was low, the timing of recent spikes regulated the influence of excitatory quanta. In contrast, when input frequency was high, spike timing was less important than interactions with other inputs. Inhibitory quanta rapidly terminated firing, whereas small numbers of coincident excitatory quanta reliably and rapidly triggered firing. Our results suggest that stellate cells achieve temporal precision through coincidence detection and disynaptic inhibition, despite their high resistances and long membrane time constants. Thus, we propose that small interneurons can process synaptic inputs in a fundamentally different way from principal cells.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02215 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [N01-NS32405-01] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; [Anonymous], [No title captured]; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; Eccles J. C, 1957, PHYSL NERVE CELLS; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann-Metzer P, 2002, J NEUROPHYSIOL, V87, P149, DOI 10.1152/jn.00310.2001; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; MASON A, 1991, J NEUROSCI, V11, P72; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P355, DOI 10.1113/jphysiol.1992.sp019382; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Palay SL, 1974, CEREBELLAR CORTEX CY, P348; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SAYER RJ, 1989, J NEUROSCI, V9, P840; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705; [No title captured]	50	168	169	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1309	1318		10.1038/nn970	http://dx.doi.org/10.1038/nn970			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411959				2022-12-28	WOS:000179447500014
J	Athos, J; Impey, S; Pineda, VV; Chen, X; Storm, DR				Athos, J; Impey, S; Pineda, VV; Chen, X; Storm, DR			Hippocampal CRE-mediated gene expression is required for contextual memory formation	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; CONSOLIDATION; TRANSCRIPTION; DROSOPHILA; INDUCTION; CASCADE; MICE; BETA		Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,Hlth Sci Bldg, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH064311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, F31NS042475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004158] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC 04158] Funding Source: Medline; NIGMS NIH HHS [T32 GM07270] Funding Source: Medline; NIMH NIH HHS [1F31MH064311-01] Funding Source: Medline; NINDS NIH HHS [NS 20498, 1F31NS042475-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Gass P, 1998, LEARN MEMORY, V5, P274; Graves L, 2002, HIPPOCAMPUS, V12, P18, DOI 10.1002/hipo.10003; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	15	116	118	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1119	1120		10.1038/nn951	http://dx.doi.org/10.1038/nn951			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368807				2022-12-28	WOS:000178884600012
J	Heemskerk, J; Tobin, AJ; Ravina, B				Heemskerk, J; Tobin, AJ; Ravina, B			From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL MUSCULAR-ATROPHY; HUNTINGTONS-DISEASE; MOUSE MODELS; GABAPENTIN; EQUIPOISE		NINDS, Technol Dev Program, NIH, Bethesda, MD 20892 USA; NINDS, Clin Trials Program, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of California System; University of California Los Angeles	Heemskerk, J (corresponding author), NINDS, Technol Dev Program, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	jill_heemskerk@ninds.nih.gov						Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Ashcroft R, 1999, BIOETHICS, V13, P314, DOI 10.1111/1467-8519.00160; Bates GP, 1997, MOL MED TODAY, V3, P508, DOI 10.1016/S1357-4310(97)01142-8; Ferrel K, 1999, NETW COMPUT, V10, P22; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Heemskerk Jill, 2002, Trends in Neurosciences, V25, P494, DOI 10.1016/S0166-2236(02)02236-1; Kieburtz K, 2001, NEUROLOGY, V57, P397; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Loscher W, 1998, EUR J PHARMACOL, V342, P1, DOI 10.1016/S0014-2999(97)01514-8; Miller RG, 2001, NEUROLOGY, V56, P843, DOI 10.1212/WNL.56.7.843; MILLER RG, 2001, COCHRANE DB SYST REV, V4, P1447; Monani UR, 2000, HUM MOL GENET, V9, P2451, DOI 10.1093/hmg/9.16.2451; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Shoulson I, 1998, ANN NEUROL, V44, pS160, DOI 10.1002/ana.410440724; Smith A, 2002, NATURE, V418, P453, DOI 10.1038/418453a; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; WU RM, 1995, J NEURAL TRANSM-GEN, V100, P53, DOI 10.1007/BF01276865	20	29	38	3	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5						1027	1029		10.1038/nn931	http://dx.doi.org/10.1038/nn931			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403977				2022-12-28	WOS:000179041300005
J	Werhahn, KJ; Mortensen, J; Van Boven, RW; Zeuner, KE; Cohen, LG				Werhahn, KJ; Mortensen, J; Van Boven, RW; Zeuner, KE; Cohen, LG			Enhanced tactile spatial acuity and cortical processing during acute hand deafferentation	NATURE NEUROSCIENCE			English	Article							RESOLUTION; ATTENTION; CORTEX; REPRESENTATION		NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA; NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Cohen, LG (corresponding author), NINDS, Human Cort Physiol Sect, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.							Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1192, DOI 10.1152/jn.1981.46.6.1192; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; SADATO N, 1995, ANN NEUROL, V37, P74, DOI 10.1002/ana.410370114; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Van Boven RW, 2000, NEUROLOGY, V54, P2230; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Werhahn KJ, 2002, BRAIN, V125, P1402, DOI 10.1093/brain/awf140	12	114	115	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					936	938		10.1038/nn917	http://dx.doi.org/10.1038/nn917			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219095				2022-12-28	WOS:000178242200011
J	Gardner, JL; Lisberger, SG				Gardner, JL; Lisberger, SG			Serial linkage of target selection for orienting and tracking eye movements	NATURE NEUROSCIENCE			English	Article							MST NEURONAL-ACTIVITY; CORTICAL AREAS MT; SMOOTH-PURSUIT; SPATIAL ATTENTION; VISUAL-MOTION; NEURAL BASIS; FIELD; MICROSTIMULATION; MODULATION; INITIATION	Many natural actions require the coordination of two different kinds of movements. How are targets chosen under these circumstances: do central commands instruct different movement systems in parallel, or does the execution of one movement activate a serial chain that automatically chooses targets for the other movement? We examined a natural eye tracking action that consists of orienting saccades and tracking smooth pursuit eye movements, and found strong physiological evidence for a serial strategy. Monkeys chose freely between two identical spots that appeared at different sites in the visual field and moved in orthogonal directions. If a saccade was evoked to one of the moving targets by microstimulation in either the frontal eye field (FEF) or the superior colliculus (SC), then the same target was automatically chosen for pursuit. Our results imply that the neural signals responsible for saccade execution can also act as an internal command of target choice for other movement systems.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Bioengn Grad Grp, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gardner, JL (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, Box 0444, San Francisco, CA 94143 USA.			Gardner, Justin/0000-0003-2220-5050	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [EY03878, R01 EY003878] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY003878, R01EY003878] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Chou IH, 2002, J NEUROSCI, V22, P4728, DOI 10.1523/JNEUROSCI.22-11-04728.2002; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ferrera VP, 2000, J NEUROPHYSIOL, V84, P2725, DOI 10.1152/jn.2000.84.6.2725; FERRERA VP, 1995, J NEUROSCI, V15, P7472; Gardner JL, 2001, J NEUROSCI, V21, P2075, DOI 10.1523/JNEUROSCI.21-06-02075.2001; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; GOTTLIEB JP, 1993, J NEUROPHYSIOL, V69, P786, DOI 10.1152/jn.1993.69.3.786; GREEN DM, 1966, SIGNAL DETECTION THE; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kahlon M, 1999, J NEUROSCI, V19, P9039, DOI 10.1523/JNEUROSCI.19-20-09039.1999; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOWLER E, 1984, VISION RES, V24, P1789, DOI 10.1016/0042-6989(84)90010-5; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 1999, J COGNITIVE NEUROSCI, V11, P641, DOI 10.1162/089892999563706; KRAUZLIS RJ, IN PRESS NEURON; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; Lisberger SG, 1997, J NEUROSCI, V17, P7490; MILES FA, 1991, REPRESENTATIONS VISI, P185; Missal M, 2000, J NEUROPHYSIOL, V83, P2080, DOI 10.1152/jn.2000.83.4.2080; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MORRIS EJ, 1987, J NEUROPHYSIOL, V58, P1351, DOI 10.1152/jn.1987.58.6.1351; Recanzone GH, 1999, J NEUROPHYSIOL, V82, P1710, DOI 10.1152/jn.1999.82.4.1710; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2700, DOI 10.1152/jn.2002.87.6.2700; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; von Helmholtz H., 1867, HELMHOLTZS TREATISE; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI	50	40	40	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					892	899		10.1038/nn897	http://dx.doi.org/10.1038/nn897			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12145637	Green Accepted			2022-12-28	WOS:000177656300020
J	Zatorre, RJ; Bouffard, M; Ahad, P; Belin, P				Zatorre, RJ; Bouffard, M; Ahad, P; Belin, P			Where is 'where' in the human auditory cortex?	NATURE NEUROSCIENCE			English	Article							CORTICAL-NEURONS; SPATIAL LOCALIZATION; PARIETAL CORTEX; MACAQUE MONKEY; NEARBY SOURCES; HUMAN BRAIN; LOCATION; MOVEMENT; AREAS; ATTENTION	We examine the functional characteristics of auditory cortical areas that are sensitive to spatial cues in the human brain, and determine whether they can be dissociated from parietal lobe mechanisms. Three positron emission tomography (PET) experiments were conducted using a speaker array permitting quasi free-field sound presentation within the scanner. Posterior auditory cortex responded to sounds that varied in their spatial distribution, but only when multiple complex stimuli were presented simultaneously, implicating this cortical system in disambiguation of overlapping auditory sources. We also found that the right inferior parietal cortex is specifically recruited in localization tasks, and that its activity predicts behavioral performance, consistent with its involvement in sensorimotor integration and spatial transformation. These findings clarify the functional roles of posterior auditory and parietal cortices, and help to reconcile competing models of auditory cortical organization.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	robert.zatorre@mcgill.ca	Belin, Pascal/C-6247-2009	Belin, Pascal/0000-0002-7578-6365				Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Belin P, 2000, NAT NEUROSCI, V3, P965, DOI 10.1038/79890; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brugge JF, 2001, AUDIOL NEURO-OTOL, V6, P173, DOI 10.1159/000046827; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; Brungart DS, 1999, J ACOUST SOC AM, V106, P1956, DOI 10.1121/1.427943; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Cohen YE, 1999, NEURON, V24, P769, DOI 10.1016/S0896-6273(00)81024-7; EFRON R, 1983, BRAIN LANG, V19, P254, DOI 10.1016/0093-934X(83)90069-X; Furukawa S, 2000, J NEUROSCI, V20, P1216, DOI 10.1523/JNEUROSCI.20-03-01216.2000; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Middlebrooks JC, 1999, J ACOUST SOC AM, V106, P1493, DOI 10.1121/1.427147; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Mondor TA, 1998, J EXP PSYCHOL HUMAN, V24, P66, DOI 10.1037/0096-1523.24.1.66; Mrsic-Flogel TD, 2001, J NEUROPHYSIOL, V86, P1043, DOI 10.1152/jn.2001.86.2.1043; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Talairach J., 1988, COPLANAR STEREOTAXIC; Thivard L, 2000, NEUROREPORT, V11, P2969, DOI 10.1097/00001756-200009110-00028; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Weeks R, 2000, J NEUROSCI, V20, P2664; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; WHITFIELD IC, 1985, CEREB CORTEX, V4, P329; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zatorre RJ, 2001, J NEUROSCI, V21, P6321, DOI 10.1523/JNEUROSCI.21-16-06321.2001; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	44	266	270	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					905	909		10.1038/nn904	http://dx.doi.org/10.1038/nn904			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195426				2022-12-28	WOS:000177656300022
J	Calton, JL; Dickinson, AR; Snyder, LH				Calton, JL; Dickinson, AR; Snyder, LH			Non-spatial, motor-specific activation in posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; MACAQUE MONKEY; PREMOTOR CORTEX; PARIETOOCCIPITAL CORTEX; NEURONAL-ACTIVITY; REFERENCE FRAMES; CEREBRAL-CORTEX; VISUAL PATHWAYS; RESPONSES; REPRESENTATION	A localized cluster of neurons in macaque posterior parietal cortex, termed the parietal reach region (PRR), is activated when a reach is planned to a visible or remembered target. To explore the role of PRR in sensorimotor transformations, we tested whether cells would be activated when a reach is planned to an as-yet unspecified goal. Over one-third of PRR cells increased their firing after an instruction to prepare a reach, but not after an instruction to prepare a saccade, when the target of the movement remained unknown. A partially overlapping population (two-thirds of cells) was activated when the monkey was informed of the target location but not the type of movement to be made. Thus a subset of PRR neurons separately code spatial and effector-specific information, consistent with a role in specifying potential motor responses to particular targets.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Snyder, LH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.		Snyder, Lawrence H/A-4593-2017		NIMH NIH HHS [F32 MH012145, F32 MH012145-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012145] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLBY CL, 1991, NEUROPSYCHOLOGIA, V29, P517, DOI 10.1016/0028-3932(91)90008-V; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; Dorris MC, 1998, J NEUROSCI, V18, P7015; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Ferraina S, 1997, J NEUROPHYSIOL, V77, P1034, DOI 10.1152/jn.1997.77.2.1034; Ferraina S, 2001, J NEUROPHYSIOL, V85, P462, DOI 10.1152/jn.2001.85.1.462; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Linden JF, 1999, J NEUROPHYSIOL, V82, P343, DOI 10.1152/jn.1999.82.1.343; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Obayashi S, 2001, NEUROIMAGE, V14, P853, DOI 10.1006/nimg.2001.0878; Paxinos G., 2000, RHESUS MONKEY BRAIN; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Tanne J, 1995, NEUROREPORT, V7, P267, DOI 10.1097/00001756-199512000-00064; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WISE SP, 1989, SOMATOSENS MOT RES, V6, P455, DOI 10.3109/08990228909144687	48	163	164	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					580	588		10.1038/nn862	http://dx.doi.org/10.1038/nn862			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021766				2022-12-28	WOS:000175874600019
J	Thomas, OM; Cumming, BG; Parker, AJ				Thomas, OM; Cumming, BG; Parker, AJ			A specialization for relative disparity in V2	NATURE NEUROSCIENCE			English	Article							RANDOM-DOT STEREOGRAMS; INFERIOR TEMPORAL CORTEX; VISUAL-CORTEX; DEPTH DISCRIMINATION; BINOCULAR DISPARITY; V1; RESPONSES; NEURONS; MOTION; REPRESENTATION	Stereoscopic depth perception relies on binocular disparities, or small geometric differences between the retinal images of each eye. The most reliable binocular depth judgments are those that are based on relative disparities between two simultaneously visible features in a scene. Many cortical areas contain neurons that are sensitive to disparity, but it is unclear whether any areas show a specific sensitivity to relative disparity. We recorded from neurons in the early cortical visual area V2 of the awake macaque during presentation of random-dot patterns. The depth of a central region ('center'), and that of an annular surrounding region ('surround'), were manipulated independently in these stimuli. Some cells were fully selective for the resulting relative disparities. Most showed partial selectivity, which nonetheless indicated a sensitivity for the depth relationship between center and surround. Both types of neural response could support psychophysical judgments of relative depth.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Thomas, OM (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Parker, Andrew J/I-7867-2013	Parker, Andrew J/0000-0001-5800-0407; Thomas, Owen/0000-0003-2877-3075	NATIONAL EYE INSTITUTE [Z01EY000404, ZIAEY000404] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bakin JS, 2000, J NEUROSCI, V20, P8188; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Bradley DC, 1998, J NEUROSCI, V18, P7552; Cumming BG, 1999, J NEUROSCI, V19, P5602; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; ERKELENS CJ, 1985, VISION RES, V25, P1689, DOI 10.1016/0042-6989(85)90141-5; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KUMAR T, 1992, VISION RES, V32, P1667, DOI 10.1016/0042-6989(92)90159-G; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; REGAN D, 1986, INVEST OPHTH VIS SCI, V27, P584; ROE AW, 1995, J NEUROSCI, V15, P3689; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; WESTHEIMER G, 1979, EXP BRAIN RES, V36, P585; [No title captured]	23	147	151	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					472	478		10.1038/nn837	http://dx.doi.org/10.1038/nn837			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967544				2022-12-28	WOS:000175272000019
J	Beedle, AM; McRory, JE; Poirot, O; Doering, CJ; Altier, C; Barrere, C; Hamid, J; Nargeot, J; Bourinet, E; Zamponi, GW				Beedle, AM; McRory, JE; Poirot, O; Doering, CJ; Altier, C; Barrere, C; Hamid, J; Nargeot, J; Bourinet, E; Zamponi, GW			Agonist-independent modulation of N-type calcium channels by ORL1 receptors	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; 2ND INTRACELLULAR LOOP; RAT SPINAL-CORD; NOCICEPTIN/ORPHANIN FQ; MORPHINE-TOLERANCE; SENSORY NEURONS; CA2+ CHANNELS; ORPHANIN FQ; INHIBITION; EXPRESSION	We have investigated modulation of voltage-gated calcium channels by nociceptin (ORL1) receptors. In rat DRG neurons and in tsA-201 cells, nociceptin mediated a pronounced inhibition of N-type calcium channels, whereas other calcium channel subtypes were unaffected. In tsA-201 cells, expression of N-type channels with human ORL1 resulted in a voltage-dependent G-protein inhibition of the channel that occurred in the absence of nociceptin, the ORL1 receptor agonist. Consistent with this observation, native N-type channels of small nociceptive dorsal root ganglion (DRG) neurons also had tonic inhibition by G proteins. Biochemical characterization showed the existence of an N-type calcium channel-ORL1 receptor signaling complex, which efficiently exposes N-type channels to constitutive ORL1 receptor activity. Calcium channel activity is thus regulated by changes in ORL1 receptor expression, which provides a possible molecular mechanism for the development of tolerance to opioid receptor agonists.	Univ Calgary, Dept Physiol & Biophys, Cellular & Mol Neurobiol Res Grp, Calgary, AB T2N 4N1, Canada; CNRS, UPR2580, LGF, Dept Physiol, F-34396 Montpellier, France	University of Calgary; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Biophys, Cellular & Mol Neurobiol Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Zamponi, Gerald W./0000-0002-0644-9066; Barrere, Christian/0000-0001-8710-0976; Nargeot, Joel/0000-0003-2893-5636; bourinet, emmanuel/0000-0001-8021-0419				Abdulla FA, 1997, J NEUROSCI, V17, P8721; Ahmadi S, 2001, EUR J PHARMACOL, V412, P39, DOI 10.1016/S0014-2999(00)00946-8; Albert PR, 1998, ANN NY ACAD SCI, V861, P146, DOI 10.1111/j.1749-6632.1998.tb10186.x; Arnot MI, 2000, J PHYSIOL-LONDON, V527, P203, DOI 10.1111/j.1469-7793.2000.00203.x; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; Beedle A. M., 2003, CALCIUM CHANNEL PHAR; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Bertorelli R, 1999, BRIT J PHARMACOL, V128, P1252, DOI 10.1038/sj.bjp.0702884; Borgland SL, 2001, J PHYSIOL-LONDON, V536, P35, DOI 10.1111/j.1469-7793.2001.t01-1-00035.x; Briscini L, 2002, EUR J PHARMACOL, V447, P59, DOI 10.1016/S0014-2999(02)01833-2; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; Connell J., 1998, NEW APPROACHES EVALU; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; Emmerson PJ, 1999, J PHYSIOL-LONDON, V517, P431, DOI 10.1111/j.1469-7793.1999.0431t.x; Gouarderes C, 1999, BRAIN RES, V838, P85, DOI 10.1016/S0006-8993(99)01713-8; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jia YP, 1998, NEUROSCI LETT, V250, P21, DOI 10.1016/S0304-3940(98)00430-3; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Kaneko S, 2002, J NEUROSCI, V22, P82, DOI 10.1523/JNEUROSCI.22-01-00082.2002; Kest B, 2001, NEUROSCIENCE, V104, P217, DOI 10.1016/S0306-4522(01)00037-9; Knoflach F, 1996, J NEUROSCI, V16, P6657; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Larsson KP, 2000, NEUROSCI LETT, V296, P121, DOI 10.1016/S0304-3940(00)01640-2; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lembo PMC, 1997, MOL PHARMACOL, V52, P164, DOI 10.1124/mol.52.1.164; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Manabe T, 1998, NATURE, V394, P577, DOI 10.1038/29073; Meis S, 2001, J PHYSIOL-LONDON, V532, P701, DOI 10.1111/j.1469-7793.2001.0701e.x; Mollereau C, 1996, FEBS LETT, V395, P17, DOI 10.1016/0014-5793(96)00993-3; Monteil A, 2000, J BIOL CHEM, V275, P16530, DOI 10.1074/jbc.C000090200; Monteillet-Agius G, 1998, J COMP NEUROL, V399, P373, DOI 10.1002/(SICI)1096-9861(19980928)399:3<373::AID-CNE6>3.0.CO;2-Y; Morikawa H, 1998, EUR J PHARMACOL, V351, P247, DOI 10.1016/S0014-2999(98)00306-9; Neal CR, 1999, J COMP NEUROL, V406, P503; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Schiff ML, 2000, NATURE, V408, P723, DOI 10.1038/35047093; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Tallent MK, 2001, J NEUROSCI, V21, P6940, DOI 10.1523/JNEUROSCI.21-17-06940.2001; Ueda H, 2000, J NEUROSCI, V20, P7640; Venkatesan P, 2002, J PHARMACOL EXP THER, V300, P78, DOI 10.1124/jpet.300.1.78; WICK MJ, 1994, MOL BRAIN RES, V27, P37, DOI 10.1016/0169-328X(94)90181-3; Wu X, 2002, J PHYSIOL-LONDON, V538, P41, DOI 10.1113/jphysiol.2001.012668; Xu XJ, 1996, NEUROREPORT, V7, P2092; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79	50	111	114	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					118	125		10.1038/nn1180	http://dx.doi.org/10.1038/nn1180			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730309				2022-12-28	WOS:000188468500009
J	de Quervain, DJF; Henke, K; Aerni, A; Coluccia, D; Wollmer, MA; Hock, C; Nitsch, RM; Papassotiropoulos, A				de Quervain, DJF; Henke, K; Aerni, A; Coluccia, D; Wollmer, MA; Hock, C; Nitsch, RM; Papassotiropoulos, A			A functional genetic variation of the 5-HT2a receptor affects human memory	NATURE NEUROSCIENCE			English	Article								Human memory capacity is highly variable across individuals and is influenced by both genetic and environmental factors. A roughly 50% heritability estimate(1) indicates that naturally occurring genetic variations have an important impact on this cognitive ability. Therefore, we investigated a functional variation of a memory-related serotonin receptor in 349 healthy young volunteers, and found 21% poorer memory performance in subjects with the rare variant.	Univ Zurich, Div Psychiat Res, CH-8029 Zurich, Switzerland	University of Zurich	de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8029 Zurich, Switzerland.		Wollmer, Marc A/B-5038-2009	Papassotiropoulos, Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464				Buhot MC, 1997, CURR OPIN NEUROBIOL, V7, P243, DOI 10.1016/S0959-4388(97)80013-X; Gothert M, 1998, ANN NY ACAD SCI, V861, P26, DOI 10.1111/j.1749-6632.1998.tb10169.x; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Meneses A, 2002, CELL MOL NEUROBIOL, V22, P675, DOI 10.1023/A:1021800822997; Ozaki N, 1996, BIOL PSYCHIAT, V40, P1267, DOI 10.1016/0006-3223(95)00649-4; Ozaki N, 1997, J NEUROCHEM, V68, P2186; Rey A., 1958, LEXAMEN CLINIQUE PSY; Sheline YI, 2002, AM J PSYCHIAT, V159, P430, DOI 10.1176/appi.ajp.159.3.430; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9	10	114	117	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1141	1142		10.1038/nn1146	http://dx.doi.org/10.1038/nn1146			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14566344				2022-12-28	WOS:000186229200011
J	Fischer, MH; Castel, AD; Dodd, MD; Pratt, J				Fischer, MH; Castel, AD; Dodd, MD; Pratt, J			Perceiving numbers causes spatial shifts of attention	NATURE NEUROSCIENCE			English	Article								Number symbols are part of our everyday visual world. Here we show that merely looking at numbers causes a shift in covert attention to the left or right side, depending upon the number's magnitude. This observation implies obligatory activation of number meaning and signals a tight coupling of internal and external representations of space.	Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada	University of Dundee; University of Toronto	Fischer, MH (corresponding author), Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland.	m.h.fischer@dundee.ac.uk	Fischer, Martin H./D-9965-2017	Pratt, Jay/0000-0002-4902-5095; Fischer, Martin H./0000-0003-3818-7272				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 2001, PSYCHOL SCI, V12, P244, DOI 10.1111/1467-9280.00343; DEHAENE S, 2000, NEW COGNITIVE NEUROS, P987; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	12	512	537	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					555	556		10.1038/nn1066	http://dx.doi.org/10.1038/nn1066			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12754517				2022-12-28	WOS:000183140400010
J	Carleton, A; Petreanu, LT; Lansford, R; Alvarez-Buylla, A; Lledo, PM				Carleton, A; Petreanu, LT; Lansford, R; Alvarez-Buylla, A; Lledo, PM			Becoming a new neuron in the adult olfactory bulb	NATURE NEUROSCIENCE			English	Article							ANTERIOR SUBVENTRICULAR ZONE; POSTNATAL-DEVELOPMENT; PROGENITOR CELLS; PRECURSOR CELLS; DENTATE GYRUS; STEM-CELLS; IN-VITRO; NEUROGENESIS; MIGRATION; HIPPOCAMPUS	New neurons are continually recruited throughout adulthood in certain regions of the adult mammalian brain. How these cells mature and integrate into preexisting functional circuits remains unknown. Here we describe the physiological properties of newborn olfactory bulb interneurons at five different stages of their maturation in adult mice. Patch-clamp recordings were obtained from tangentially and radially migrating young neurons and from neurons in three subsequent maturation stages. Tangentially migrating neurons expressed extrasynaptic GABA(A) receptors and then AMPA receptors, before NMDA receptors appeared in radially migrating neurons. Spontaneous synaptic activity emerged soon after migration was complete, and spiking activity was the last characteristic to be acquired. This delayed excitability is unique to cells born in the adult and may protect circuits from uncontrolled neurotransmitter release and neural network disruption. Our results show that newly born cells recruited into the olfactory bulb become neurons, and a unique sequence of events leads to their functional integration.	Inst Pasteur, Lab Percept & Memory, CNRS UMR 2182, F-75015 Paris, France; Rockefeller Univ, New York, NY 10021 USA; CALTECH, Beckman Inst, Div Biol, Biol Imaging Ctr, Pasadena, CA 91125 USA; UCSF, San Francisco, CA 94134 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University; California Institute of Technology; University of California System; University of California San Francisco	Lledo, PM (corresponding author), Inst Pasteur, Lab Percept & Memory, CNRS UMR 2182, 25 Rue Dr Roux, F-75015 Paris, France.	pmlledo@pasteur.fr	Lansford, Rusty/C-6956-2014; Carleton, Alan/C-9721-2010	Carleton, Alan/0000-0001-5633-9159; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Petreanu, Leopoldo/0000-0003-1434-4691; Lansford, Rusty/0000-0002-2159-3699	NICHD NIH HHS [HD32116] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alonso G, 1999, J COMP NEUROL, V405, P508, DOI 10.1002/(SICI)1096-9861(19990322)405:4<508::AID-CNE5>3.0.CO;2-5; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Castillo PE, 1999, J NEUROSCI, V19, P9180; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; De Marchis S, 2001, J NEUROBIOL, V49, P326, DOI 10.1002/neu.10012; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gutierrez R, 2002, J NEUROPHYSIOL, V87, P2562, DOI 10.1152/jn.2002.87.5.2562; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; Koester J., 1991, PRINCIPLES NEURAL SC, V3, P81; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Liu RH, 1999, EXP NEUROL, V158, P143, DOI 10.1006/exnr.1999.7078; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pirchio M, 1997, J NEUROSCI, V17, P5428; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roy NS, 2000, NAT MED, V6, P271; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; Stewart RR, 1999, J NEUROPHYSIOL, V81, P95, DOI 10.1152/jn.1999.81.1.95; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Tyzio R, 1999, J NEUROSCI, V19, P10372; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	47	618	641	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					507	518		10.1038/nn1048	http://dx.doi.org/10.1038/nn1048			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704391				2022-12-28	WOS:000182553200018
J	Battaglia, AA; Sehayek, K; Grist, J; McMahon, SB; Gavazzi, I				Battaglia, AA; Sehayek, K; Grist, J; McMahon, SB; Gavazzi, I			EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing	NATURE NEUROSCIENCE			English	Article							NEURAL DEVELOPMENT; NMDA; EXPRESSION		Kings Coll London, Neurosci Res Ctr, London SE1 1UL, England	University of London; King's College London	Gavazzi, I (corresponding author), Kings Coll London, Neurosci Res Ctr, Guys Campus, London SE1 1UL, England.	Isabella.Gavazzi@kcl.ac.uk		Gavazzi, Isabella/0000-0002-7728-7682; McMahon, Stephen/0000-0003-4656-5536				Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; HONORE P, 1995, EUR J PHARMACOL, V272, P249, DOI 10.1016/0014-2999(94)00656-R; McMahon S B, 1993, Curr Opin Neurobiol, V3, P602, DOI 10.1016/0959-4388(93)90062-4; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515	13	95	102	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					339	340		10.1038/nn1034	http://dx.doi.org/10.1038/nn1034			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640461				2022-12-28	WOS:000181833100008
J	Allen, CB; Celikel, T; Feldman, DE				Allen, CB; Celikel, T; Feldman, DE			Long-term depression induced by sensory deprivation during cortical map plasticity in vivo	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; RAT BARREL CORTEX; OCULAR DOMINANCE PLASTICITY; SYNAPTIC PLASTICITY; CRITICAL PERIOD; MONOCULAR DEPRIVATION; ALPHA-CAMKII; AREA CA1; POTENTIATION; LTP	Cortical map plasticity is thought to involve long-term depression (LTD) of cortical synapses, but direct evidence for LTD during plasticity or learning in vivo is lacking. One putative role for LTD is in the reduction of cortical responsiveness to behaviorally irrelevant or unused sensory stimuli, a common feature of map plasticity. Here we show that whisker deprivation, a manipulation that drives map plasticity in rat somatosensory cortex (S1), induces detectable LTD-like depression at intracortical excitatory synapses between cortical layer 4 (L4) and L2/3 pyramidal neurons. This synaptic depression occluded further LTD, enhanced LTP, was column specific, and was driven in part by competition between active and inactive whiskers. The synaptic locus of LTD and these properties suggest that LTD underlies the reduction of cortical responses to deprived whiskers, a major component of S1 map plasticity.	Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Feldman, DE (corresponding author), Univ Calif San Diego, Program Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dfeldman@ucsd.edu	Celikel, Tansu/P-4235-2018		NCRR NIH HHS [P41-RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Hensch TK, 1996, SCIENCE, V272, P554, DOI 10.1126/science.272.5261.554; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lebel D, 2001, CEREB CORTEX, V11, P485, DOI 10.1093/cercor/11.6.485; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Rema V, 1998, J NEUROSCI, V18, P10196; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Walcott EC, 2002, NEUROSCIENCE, V112, P815, DOI 10.1016/S0306-4522(02)00131-8; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029	50	187	191	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					291	299		10.1038/nn1012	http://dx.doi.org/10.1038/nn1012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577061				2022-12-28	WOS:000181178300018
J	Lloyd, DM; Shore, DI; Spence, C; Calvert, GA				Lloyd, DM; Shore, DI; Spence, C; Calvert, GA			Multisensory representation of limb position in human premotor cortex	NATURE NEUROSCIENCE			English	Article							VIBROTACTILE REACTION-TIMES; HAND; TOUCH; ARM		McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	McMaster University; University of Oxford; University of Oxford; University of Oxford	Shore, DI (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.		Shore, David I/F-5109-2010	Lloyd, Donna/0000-0003-3589-7383; Calvert, Gemma/0000-0002-5487-8076				Beltramello A, 1998, ITAL J NEUROL SCI, V19, P277, DOI 10.1007/BF00713853; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRADSHAW JL, 1988, CAN J PSYCHOL, V42, P44, DOI 10.1037/h0084178; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; Ladavas E, 2000, EXP BRAIN RES, V131, P458, DOI 10.1007/s002219900264; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; PIERSONSAVAGE JM, 1988, BRAIN, V111, P1531, DOI 10.1093/brain/111.6.1531; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Spence C, 2001, PSYCHOL SCI, V12, P90, DOI 10.1111/1467-9280.00316; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	14	170	172	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					17	18		10.1038/nn991	http://dx.doi.org/10.1038/nn991			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483217				2022-12-28	WOS:000180089300009
J	Webster, MA; Georgeson, MA; Webster, SM				Webster, MA; Georgeson, MA; Webster, SM			Neural adjustments to image blur	NATURE NEUROSCIENCE			English	Article							CONTRAST CONSTANCY; PERCEIVED CONTRAST; NATURAL SCENES; HUMAN-VISION; SENSITIVITY; STATISTICS; ADAPTATION; COLOR		Univ Nevada, Dept Psychol, Reno, NV 89557 USA; Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	Nevada System of Higher Education (NSHE); University of Nevada Reno; Aston University	Webster, MA (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.			Webster, Michael/0000-0001-8262-7525; Georgeson, Mark/0000-0002-8173-9522	NEI NIH HHS [R01 EY010834, EY10834] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010834, R29EY010834] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRADY N, 1995, VISION RES, V35, P739, DOI 10.1016/0042-6989(94)00172-I; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; DeValois RL, 1988, SPATIAL VISION; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; PESUDOVS K, 1993, OPTOMETRY VISION SCI, V70, P528, DOI 10.1097/00006324-199307000-00002; TADMOR Y, 1994, VISION RES, V34, P541, DOI 10.1016/0042-6989(94)90167-8; WATT RJ, 1987, PATTERN RECOGN LETT, V5, P139, DOI 10.1016/0167-8655(87)90035-3; Webster MA, 1996, NETWORK-COMP NEURAL, V7, P587, DOI 10.1088/0954-898X/7/4/002; Webster MA, 1999, P SOC PHOTO-OPT INS, V3644, P58, DOI 10.1117/12.348468	14	196	209	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					839	840		10.1038/nn906	http://dx.doi.org/10.1038/nn906			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195427				2022-12-28	WOS:000177656300011
J	Kaminker, JS; Canon, J; Salecker, I; Banerjee, U				Kaminker, JS; Canon, J; Salecker, I; Banerjee, U			Control of photoreceptor axon target choice by transcriptional repression of Runt	NATURE NEUROSCIENCE			English	Article							RETINAL AXONS; EPH RECEPTORS; GLIAL-CELLS; DROSOPHILA; GROWTH; GENE; HEMATOPOIESIS; DOWNSTREAM; BRAKELESS; GUIDANCE	Drosophila photoreceptor neurons (R cells) project their axons to one of two layers in the optic lobe, the lamina or the medulla. The transcription factor Runt (Run) is normally expressed in the two inner R cells (R7 and R8) that project their axons to the medulla. Here we examine the relationship between Run and the ubiquitously expressed nuclear protein Brakeless (Bks), which has previously been shown to be important for axon termination in the lamina. We report that Bks represses Run in two of the outer R cells: R2 and R5. Expression of Run in R2 and R5 causes axonal mistargeting of all six outer R cells (R1-R6) to the inappropriate layer, without altering expression of cell-specific developmental markers.	Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Human Genet, Los Angeles, CA 90095 USA; Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; MRC National Institute for Medical Research	Banerjee, U (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Downing JR, 2001, LEUKEMIA, V15, P664, DOI 10.1038/sj.leu.2402035; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Kaminker JS, 2001, DEVELOPMENT, V128, P2639; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; LEVANON D, IN PRESS EMBO J; Meinertzhagen I.A., 1991, P341; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Schmucker D, 2001, CELL, V105, P701, DOI 10.1016/S0092-8674(01)00391-9; Senti KA, 2000, DEVELOPMENT, V127, P2291; Speck NA, 1999, CANCER RES, V59, p1789S; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Tissot M, 1997, J NEUROBIOL, V32, P281, DOI 10.1002/(SICI)1097-4695(199703)32:3<281::AID-NEU3>3.0.CO;2-3; White NM, 2000, DEVELOPMENT, V127, P1681; WIJMENGA C, 1995, GENOMICS, V26, P611, DOI 10.1016/0888-7543(95)80185-O	35	49	49	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					746	750		10.1038/nn889	http://dx.doi.org/10.1038/nn889			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118258				2022-12-28	WOS:000177088900017
J	Panov, AV; Gutekunst, CA; Leavitt, BR; Hayden, MR; Burke, JR; Strittmatter, WJ; Greenamyre, JT				Panov, AV; Gutekunst, CA; Leavitt, BR; Hayden, MR; Burke, JR; Strittmatter, WJ; Greenamyre, JT			Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines	NATURE NEUROSCIENCE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; WILD-TYPE; CELLULAR TOXICITY; MOUSE MODEL; IN-VIVO; BRAIN; PROTEIN; TRANSCRIPTION; NEURODEGENERATION	Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown. Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls. We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathological or behavioral abnormalities by months. By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein containing an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals. Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.	Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5C 4H4, Canada; Duke Univ, Med Ctr, Div Neurol, Durham, NC 27616 USA	Emory University; University of British Columbia; Duke University	Greenamyre, JT (corresponding author), Emory Univ, Sch Med, Dept Neurol, Whitehead Biomed Res Bldg,615 Michael St, Atlanta, GA 30322 USA.		Leavitt, Blair R/G-1934-2012; Greenamyre, J. Timothy/B-4049-2011; Hayden, Michael R/D-8581-2011; Burke, James R/E-4245-2016	Hayden, Michael R/0000-0001-5159-1419; Burke, James R/0000-0002-3408-7787; Greenamyre, J. Timothy/0000-0003-3468-7878	NATIONAL INSTITUTE ON AGING [R01AG014648] Funding Source: NIH RePORTER; NIA NIH HHS [AG14648] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Monoi H, 2000, BIOPHYS J, V78, P2892, DOI 10.1016/S0006-3495(00)76830-5; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	34	780	805	2	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					731	736		10.1038/nn884	http://dx.doi.org/10.1038/nn884			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089530				2022-12-28	WOS:000177088900015
J	Chen, SZ; Rio, C; Ji, RR; Dikkes, P; Coggeshall, RE; Woolf, CJ; Corfas, G				Chen, SZ; Rio, C; Ji, RR; Dikkes, P; Coggeshall, RE; Woolf, CJ; Corfas, G			Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR GDNF; SPINAL-CORD; SURVIVAL FACTOR; UP-REGULATION; EXPRESSION; NEURONS; NEUREGULIN; PROTEIN; PAIN; PHOSPHORYLATION	Here we studied the role of signaling through ErbB-family receptors in interactions between unmyelinated axons and non-myelinating Schwann cells in adult nerves. We generated transgenic mice that postnatally express a dominant-negative ErbB receptor in non-myelinating but not in myelinating Schwann cells. These mutant mice present a progressive peripheral neuropathy characterized by extensive Schwann cell proliferation and death, loss of unmyelinated axons and marked heat and cold pain insensitivity. At later stages, C-fiber sensory neurons die by apoptosis, a process that may result from reduced GDNF (glial cell line-derived neurotrophic factor) expression in the sciatic nerve. Neuregulin 1 (NRG1)-ErbB signaling mediates, therefore, reciprocal interactions between non-myelinating Schwann cells and unmyelinated sensory neuron axons that are critical for Schwann cell and C-fiber sensory neuron survival. This study provides new insights into ErbB signaling in adult Schwann cells, the contribution of non-myelinating Schwann cells in maintaining trophic support of sensory neurons, and the possible role of disrupted ErbB signaling in peripheral sensory neuropathies.	Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Medical Branch Galveston	Corfas, G (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@tch.harvard.edu	Woolf, Clifford/A-9784-2010; Ji, Ru-Rong/L-7070-2017; Corfas, Gabriel/AAH-2378-2020; Río, Carlos/GQA-4045-2022	Ji, Ru-Rong/0000-0002-9355-3688; Corfas, Gabriel/0000-0001-5412-9473; Río, Carlos/0000-0003-2666-7746	NICHD NIH HHS [P30-HD 18655] Funding Source: Medline; NIDCD NIH HHS [R01 DC04820] Funding Source: Medline; NINDS NIH HHS [NS40698, R01 NS35884, NS38253, NS39518] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R01NS035884, R01NS039518, R37NS039518, R01NS040698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004820] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barbieri S, 1995, Electromyogr Clin Neurophysiol, V35, P39; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; BROWN MJ, 1976, ARCH NEUROL-CHICAGO, V33, P164, DOI 10.1001/archneur.1976.00500030020004; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COHEN JA, 1992, J NEUROSCI RES, V31, P622, DOI 10.1002/jnr.490310406; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Crone SA, 2003, NEURON, V37, P29, DOI 10.1016/S0896-6273(02)01128-5; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Hammarberg H, 1996, NEUROREPORT, V7, P857, DOI 10.1097/00001756-199603220-00004; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 1997, J NEUROSCI, V17, P1776; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; Lewis SE, 1999, J NEUROSCI, V19, P8945, DOI 10.1523/JNEUROSCI.19-20-08945.1999; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Matheson CR, 1997, J NEUROBIOL, V32, P22, DOI 10.1002/(SICI)1097-4695(199701)32:1<22::AID-NEU3>3.3.CO;2-B; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; POVER CM, 1993, J NEUROSCI METH, V49, P123, DOI 10.1016/0165-0270(93)90116-9; Prevot V, 2003, J NEUROSCI, V23, P230; Rio C, 2002, J COMP NEUROL, V442, P156, DOI 10.1002/cne.10085; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sanchez RM, 2001, J NEUROSCI, V21, P8154, DOI 10.1523/JNEUROSCI.21-20-08154.2001; Scherer S.S., 1996, GLIAL CELL DEV, P165; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Syroid DE, 1996, P NATL ACAD SCI USA, V93, P9229, DOI 10.1073/pnas.93.17.9229; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Trupp M, 1997, J NEUROSCI, V17, P3554; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	49	135	136	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1186	1193		10.1038/nn1139	http://dx.doi.org/10.1038/nn1139			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555954				2022-12-28	WOS:000186229200018
J	Shin, JB; Martinez-Salgado, C; Heppenstall, PA; Lewin, GR				Shin, JB; Martinez-Salgado, C; Heppenstall, PA; Lewin, GR			A T-type calcium channel required for normal function of a mammalian mechanoreceptor	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; HAIRY SKIN; POTASSIUM CHANNELS; AFFERENT FIBRES; CA2+ CURRENTS; GENE FAMILY; RECEPTOR; DISTINCT; TOUCH; MICE	The dorsal root ganglia (DRG) contain a variety of mechanoreceptors, but no molecular markers uniquely identify specific mechanoreceptor subtypes. We have used DNA microarrays and subtracted cDNA libraries to isolate genes that are specifically expressed by one type of mouse mechanoreceptor. The T-type calcium channel Ca(v)3.2 was exclusively expressed in the DRG by D-hair receptors, a very sensitive mechanoreceptor. Pharmacological blockade of T-type calcium channels indicated that this channel may be essential for normal D-hair receptor excitability including mechanosensitivity. This is the first evidence that a calcium channel is required for normal function of a vertebrate mechanoreceptor.	Max Delbruck Ctr Mol Med, Growth Factors & Regenerat Grp, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Growth Factors & Regenerat Grp, Robert Rossle Str 10, D-13092 Berlin, Germany.		Lewin, Gary R/B-8028-2011; Martinez-Salgado, Carlos/E-7299-2012	Martinez-Salgado, Carlos/0000-0003-4641-6717; Lewin, Gary/0000-0002-2890-6352				AKOPIAN AN, 1995, J BIOL CHEM, V270, P21264, DOI 10.1074/jbc.270.36.21264; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; Brown AG, 1981, ORG SPINAL CORD; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; Calabrese B, 2002, BIOPHYS J, V83, P2560, DOI 10.1016/S0006-3495(02)75267-3; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FYFFE REW, 1992, SENSORY NEURONS DIVE, P3; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kawai F, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0002.2001; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; KOERBER HR, 1988, J NEUROPHYSIOL, V60, P1584, DOI 10.1152/jn.1988.60.5.1584; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; Lambert RC, 1998, J NEUROSCI, V18, P8605; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Lewin GR, 1996, PHILOS T ROY SOC B, V351, P405, DOI 10.1098/rstb.1996.0035; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Mannsfeldt AG, 1999, MOL CELL NEUROSCI, V13, P391, DOI 10.1006/mcne.1999.0761; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; PERL ER, 1968, J PHYSIOL-LONDON, V197, P593, DOI 10.1113/jphysiol.1968.sp008576; Perl ER, 1992, SENSORY NEURONS DIVE, P3; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Stucky CL, 1998, J NEUROSCI, V18, P7040; Stucky CL, 2002, CURR BIOL, V12, P1401, DOI 10.1016/S0960-9822(02)01072-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Talley EM, 1999, J NEUROSCI, V19, P1895; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; TOREBJORK HE, 1987, BRAIN, V110, P1509, DOI 10.1093/brain/110.6.1509; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	45	113	120	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					724	730		10.1038/nn1076	http://dx.doi.org/10.1038/nn1076			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12808460				2022-12-28	WOS:000183780400020
J	Bissiere, S; Humeau, Y; Luthi, A				Bissiere, S; Humeau, Y; Luthi, A			Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT BASOLATERAL AMYGDALA; LASTING POTENTIATION; SYNAPTIC PLASTICITY; CONSCIOUS CATS; FEAR; NEURONS; INTERNEURONS; MODULATION; RESPONSES	Fear conditioning involves the induction of long-term potentiation (LTP) of excitatory synaptic transmission in the lateral amygdala, a brain structure which is tightly controlled by GABAergic inhibition. Here we show that dopamine gates the induction of LTP in the mouse lateral amygdala by suppressing feedforward inhibition from local interneurons. Our findings provide a cellular mechanism for the dopaminergic modulation of fear conditioning and indicate that suppression of feedforward inhibition represents a key mechanism for the induction of associative synaptic plasticity in the lateral amygdala.	Univ Basel, Bioctr, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland	University of Basel	Luthi, A (corresponding author), Univ Basel, Bioctr, Dept Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	andreas.luthi@unibas.ch						Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brinley-Reed M, 1999, BRAIN RES, V850, P127, DOI 10.1016/S0006-8993(99)02112-5; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DAVIS M, 2000, AMYGDALA, P231; El-Ghundi M, 2001, BRAIN RES, V892, P86, DOI 10.1016/S0006-8993(00)03234-0; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; Heidbreder CA, 2000, NEUROSCIENCE, V100, P749, DOI 10.1016/S0306-4522(00)00336-5; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Kemppainen S, 2000, J COMP NEUROL, V426, P441, DOI 10.1002/1096-9861(20001023)426:3<441::AID-CNE8>3.0.CO;2-7; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McDonald AJ, 2001, NEUROSCIENCE, V105, P681, DOI 10.1016/S0306-4522(01)00214-7; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P986, DOI 10.1152/jn.1991.66.3.986; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	45	295	300	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					587	592		10.1038/nn1058	http://dx.doi.org/10.1038/nn1058			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12740581				2022-12-28	WOS:000183140400015
J	Halpain, S				Halpain, S			Actin in a supporting role	NATURE NEUROSCIENCE			English	Editorial Material							RELEASE		Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Halpain, S (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shelley@scripps.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037311] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037311] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Doussau F, 2000, BIOCHIMIE, V82, P353, DOI 10.1016/S0300-9084(00)00217-0; Kaech S, 1997, J NEUROSCI, V17, P9565; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; May RC, 2001, J CELL SCI, V114, P1061; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	13	37	37	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					101	102		10.1038/nn0203-101	http://dx.doi.org/10.1038/nn0203-101			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12555098				2022-12-28	WOS:000180669100002
J	Chang, YC; Weiss, DS				Chang, YC; Weiss, DS			Site-specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism	NATURE NEUROSCIENCE			English	Article							ACETYLCHOLINE BINDING-SITE; GLYCINE RECEPTOR; K+ CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR DISSECTION; SUBUNIT INTERFACES; AGONIST-BINDING; BETA-STRAND; IDENTIFICATION; RESIDUES	Neurotransmitter-operated ion channels, such as the GABA (gamma-aminobutyric acid) receptor, are important in fast synaptic transmission between neurons. Using site-specific fluorescent labeling and simultaneous electrophysiological analysis in Xenopus laevis oocytes expressing recombinant rho1 GABA receptors, we identified agonist-mediated molecular rearrangements at three positions within and near the agonist-binding pocket that were highly correlated with receptor activation. We also show that competitive antagonists induced distinct rearrangements on their own that stabilized the receptor in a closed state. Finally, the allosteric antagonist picrotoxin induced a global conformational change that was sensed in the subunit-subunit interface of the amino (N)-terminal domain, distant from its presumed site of action within the transmembrane domains. This first detection in real time of molecular rearrangements of a ligand-activated receptor provides insights into the structural correlates of activation, antagonism and allosteric modulation.	Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Weiss, DS (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Neurobiol, 1719 6th Ave S CIRC410, Birmingham, AL 35294 USA.	dweiss@nrc.uab.edu			PHS HHS [07545, 35291] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amin J, 1996, P ROY SOC B-BIOL SCI, V263, P273, DOI 10.1098/rspb.1996.0042; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CALVO DJ, 1995, NEUROREPORT, V6, P1118, DOI 10.1097/00001756-199505300-00011; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chang YC, 1996, J NEUROSCI, V16, P5415; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; FU DX, 1994, J BIOL CHEM, V269, P26152; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; OLSEN RW, 1982, ANNU REV PHARMACOL, V22, P245, DOI 10.1146/annurev.pa.22.040182.001333; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Sorensen JB, 2000, J GEN PHYSIOL, V115, P209, DOI 10.1085/jgp.115.2.209; Teissere JA, 2001, J NEUROSCI, V21, P4977, DOI 10.1523/JNEUROSCI.21-14-04977.2001; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; YOON KW, 1993, J PHYSIOL-LONDON, V464, P423, DOI 10.1113/jphysiol.1993.sp019643	42	81	83	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1163	1168		10.1038/nn926	http://dx.doi.org/10.1038/nn926			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368804				2022-12-28	WOS:000178884600019
J	Eden, GF; Moats, L				Eden, GF; Moats, L			The role of neuroscience in the remediation of students with dyslexia	NATURE NEUROSCIENCE			English	Review							DEVELOPMENTAL DYSLEXIA; SPATIAL-FREQUENCY; CHILDREN; BRAIN; DISRUPTION; LANGUAGE; OUTCOMES; SPEECH; WORDS	Dyslexia is a specific learning disability that is neurobiological in origin. It is characterized by difficulties with accurate and/or fluent word recognition, spelling and decoding abilities. Research findings agree that these and other observed behavioral manifestations largely result from a deficit in the phonological component of language. However, conflicting theories on the exact nature of the phonological deficit have given rise to divergent treatment approaches. Recent advances in functional brain imaging and genetics have allowed these theories to be examined more closely. If implemented appropriately, commercial programs can be effective in identifying dyslexia. Treatment of dyslexia has been advanced through neuroscience, yet further study is needed to provide rigorous, reproducible findings that will sustain commercial approaches.	Georgetown Univ, Med Ctr, Ctr Study Learning, Washington, DC 20057 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77030 USA	Georgetown University; University of Texas System; University of Texas Health Science Center Houston	Eden, GF (corresponding author), Georgetown Univ, Med Ctr, Ctr Study Learning, Bldg D,4000 Reservoir Rd, Washington, DC 20057 USA.	edeng@georgetown.edu						BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; BRONNER AF, 1917, PSYCHOL SPECIAL ABIL; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; CRITCHLEY M, 1970, DYSLEXIC CHILD; Eden GF, 1998, NEURON, V21, P279, DOI 10.1016/S0896-6273(00)80537-1; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Grigorenko EL, 2001, J CHILD PSYCHOL PSYC, V42, P91, DOI 10.1017/S0021963001006564; HALL HL, 2002, PARENTING STRUGGLING; Hook PE, 2001, ANN DYSLEXIA, V51, P75; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; *INT DYSL ASS, 2001, PERSPECTIVES, V27, P5; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LOVEGROVE W, 1986, PERCEPT PSYCHOPHYS, V40, P440, DOI 10.3758/BF03208204; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; National Reading Panel, 2000, TEACH CHILDR READ EV; Orton ST., 1937, READING WRITING SPEE; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Petersson KM, 2001, SCAND J PSYCHOL, V42, P251, DOI 10.1111/1467-9450.00235; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Poeppel D, 1996, BRAIN LANG, V55, P317, DOI 10.1006/brln.1996.0108; Rayner K, 2001, PSYCHOL SCI, P31, DOI 10.1111/1529-1006.00004; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Simos PG, 2002, NEUROLOGY, V58, P1203, DOI 10.1212/WNL.58.8.1203; StuddertKennedy M, 1995, PSYCHON B REV, V2, P508, DOI 10.3758/BF03210986; Swanson HL, 1999, J LEARN DISABIL-US, V32, P504, DOI 10.1177/002221949903200605; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Temple E, 2000, P NATL ACAD SCI USA, V97, P13907, DOI 10.1073/pnas.240461697; Torgesen JK, 2001, J LEARN DISABIL-US, V34, P33, DOI 10.1177/002221940103400104; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468; WOLFF PH, 1993, ANN NY ACAD SCI, V682, P87, DOI 10.1111/j.1749-6632.1993.tb22962.x	34	55	56	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1080	1084		10.1038/nn946	http://dx.doi.org/10.1038/nn946			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	611WT	12403991				2022-12-28	WOS:000179041300019
J	Sapolsky, RM				Sapolsky, RM			Chickens, eggs and hippocampal atrophy	NATURE NEUROSCIENCE			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; BRAIN	A new study provides the strongest evidence yet that a smaller hippocampus may be a predisposing factor toward, rather than a consequence of, post-traumatic stress disorder.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Sapolsky, RM (corresponding author), Stanford Univ, Dept Biol Sci, MC 5020, Stanford, CA 94305 USA.							Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Galea S, 2002, J URBAN HEALTH, V79, P340, DOI 10.1093/jurban/79.3.340; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; GURVITS TV, 1993, J NEUROPSYCH CLIN N, V5, P183; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Pitman RK, 2001, HIPPOCAMPUS, V11, P73, DOI 10.1002/hipo.1022; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581	13	46	48	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1111	1113		10.1038/nn1102-1111	http://dx.doi.org/10.1038/nn1102-1111			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404003				2022-12-28	WOS:000178884600009
J	Inoue, K; Ozaki, S; Shiga, T; Ito, K; Masuda, T; Okado, N; Iseda, T; Kawaguchi, S; Ogawa, M; Bae, SC; Yamashita, N; Itohara, S; Kudo, N; Ito, Y				Inoue, K; Ozaki, S; Shiga, T; Ito, K; Masuda, T; Okado, N; Iseda, T; Kawaguchi, S; Ogawa, M; Bae, SC; Yamashita, N; Itohara, S; Kudo, N; Ito, Y			Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD; NERVOUS-SYSTEM; SENSORY AFFERENTS; CELL-DEATH; GROUP-IA; EXPRESSION; GROWTH; RAT; RECEPTORS; MUSCLES	Dorsal root ganglion (DRG) neurons specifically project axons to central and peripheral targets according to their sensory modality. The Runt-related genes Runx1 and Runx3 are expressed in DRG neuronal subpopulations, suggesting that they may regulate the trajectories of specific axons. Here we report that Runx3-deficient (Runx3(-/-)) mice displayed severe motor discoordination and that few DRG neurons synthesized the proprioceptive neuronal marker parvalbumin. Proprioceptive afferent axons failed to project to their targets in the spinal cord as well as those in the muscle. NT-3-responsive Runx3(-/-) DRG neurons showed less neurite outgrowth in vitro. However, we found no changes in the fate specification of Runx3(-/-) DRG neurons or in the number of DRG neurons that expressed trkC. Our data demonstrate that Runx3 is critical in regulating the axonal projections of a specific subpopulation of DRG neurons.	Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Cell Regulat,Sakyo Ku, Kyoto 6068507, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Physiol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Anat, Tsukuba, Ibaraki 3058575, Japan; Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Kyoto 6068501, Japan; RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan; Chungbuk Natl Univ, Inst Med Res, Coll Med, Dept Biochem, Cheongju 361763, South Korea; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; Inst Mol & Cell Biol, Singapore 117609, Singapore	Kyoto University; University of Tsukuba; University of Tsukuba; Kyoto University; RIKEN; Chungbuk National University; RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ito, Y (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Cell Regulat,Sakyo Ku, Kyoto 6068507, Japan.		Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989				AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Brown AG, 1981, ORG SPINAL CORD; BRUHN S, 1998, CELLS LAB MANUAL, V3; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X; Fyffe RE, 1992, SENSORY NEURONS DIVE, P131; GERGEN JP, 1986, CELL, V45, P289, DOI 10.1016/0092-8674(86)90393-4; HONGO T, 1987, J COMP NEUROL, V262, P159, DOI 10.1002/cne.902620202; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Masuda T, 2000, DEV BIOL, V224, P112, DOI 10.1006/dbio.2000.9813; Matsumoto I, 2001, MOL BRAIN RES, V93, P105, DOI 10.1016/S0169-328X(01)00129-2; Nakayama K, 1998, J COMP NEUROL, V398, P459; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Ozaki S, 1997, J COMP NEUROL, V380, P215; Perrin FE, 2001, NEURON, V30, P707, DOI 10.1016/S0896-6273(01)00315-4; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Senti KA, 2000, DEVELOPMENT, V127, P2291; Sharma K, 1998, DEVELOPMENT, V125, P635; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; White FA, 1998, J NEUROSCI, V18, P1428; Zelena J, 1994, NERVES MECHANORECEPT; [No title captured]	36	242	248	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					946	954		10.1038/nn925	http://dx.doi.org/10.1038/nn925			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352981	Green Submitted			2022-12-28	WOS:000178242200013
J	Shewan, D; Dwivedy, A; Anderson, R; Holt, CE				Shewan, D; Dwivedy, A; Anderson, R; Holt, CE			Age-related changes underlie switch in netrin-1 responsiveness as growth cones advance along visual pathway	NATURE NEUROSCIENCE			English	Article							ADENOSINE A2B RECEPTOR; AXON GUIDANCE; INTERMEDIATE TARGET; PROTEIN-SYNTHESIS; CYCLIC-AMP; DCC; EXPRESSION; ATTRACTION; NEURONS; XENOPUS	Retinal axons are led out of the eye by netrin-1, an attractive guidance cue which is secreted at the optic nerve head. In the optic pathway, however, netrin-1 is expressed in areas that exclude retinal axon growth. This suggests that axons may change in their responsiveness to netrin-1 as they advance along the pathway. Indeed, in our 'whole-pathway' preparation in Xenopus, a gradual change from attraction to repulsion occurred as retinal axons emerged from progressively distal points along the pathway. We also found that axons that were aged in culture without pathway experience underwent a similar change, which correlated with a decline in cyclic AMP (cAMP) and netrin-1 receptor expression. Cyclic AMP elevators and adenosine A2b receptor agonists rejuvenated the behavior of old growth cones, causing them to regain attraction to netrin-1, whereas antagonists caused young growth cones to be repelled. These findings show that netrin-1 responsiveness is developmentally regulated and suggest that intrinsic changes that lower cAMP levels underlie this regulation.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk		Holt, Christine Elizabeth/0000-0003-2829-121X				ANDERSON RB, IN PRESS MECH DEV; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Diefenbach TJ, 2000, J NEUROSCI, V20, P1484; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Erskine L, 2000, J NEUROSCI, V20, P4975; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; GRANT P, 1986, DEV BIOL, V114, P475, DOI 10.1016/0012-1606(86)90212-5; HENDERSON LP, 1986, DEV BIOL, V113, P381, DOI 10.1016/0012-1606(86)90173-9; HOLT CE, 1989, J NEUROSCI, V9, P3123; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Johansson K, 2001, DEV BRAIN RES, V130, P133, DOI 10.1016/S0165-3806(01)00221-8; Kvanta A, 1997, EXP EYE RES, V65, P595, DOI 10.1006/exer.1996.0352; Lee SMK, 1997, DEVELOPMENT, V124, P959; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ringstedt T, 2000, J NEUROSCI, V20, P4983; SHEWAN D, 1995, J NEUROSCI, V15, P2057, DOI 10.1523/JNEUROSCI.15-03-02057.1995; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Trousse F, 2001, DEVELOPMENT, V128, P3927; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	41	148	153	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					955	962		10.1038/nn919	http://dx.doi.org/10.1038/nn919			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352982				2022-12-28	WOS:000178242200014
J	Shady, S; MacLeod, DIA				Shady, S; MacLeod, DIA			Color from invisible patterns	NATURE NEUROSCIENCE			English	Article							ADAPTATION PROCESS; NONLINEARITY		Univ Calif San Diego, Dept Psychol, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Shady, S (corresponding author), Univ Calif San Diego, Dept Psychol, 9500 Gilman Dr,MC 0109, La Jolla, CA 92037 USA.				NEI NIH HHS [EY-01711] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001711] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BURTON GJ, 1973, VISION RES, V13, P1211, DOI 10.1016/0042-6989(73)90198-3; BYFORD GH, 1962, IRE T BIOMED ELECTR, VBME9, P236, DOI 10.1109/TBMEL.1962.4323015; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; Ditchburn R.W., 1973, EYE MOVEMENTS VISUAL; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; HAYHOE MM, 1987, VISION RES, V27, P1981, DOI 10.1016/0042-6989(87)90062-9; He S, 1998, VISION RES, V38, P985, DOI 10.1016/S0042-6989(97)00290-3; He S, 1996, J OPT SOC AM A, V13, P1139, DOI 10.1364/JOSAA.13.001139; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; KRAUSKOPF J, 1963, J OPT SOC AM, V53, P741, DOI 10.1364/JOSA.53.000741; MACLEOD DIA, 1992, VISION RES, V32, P347, DOI 10.1016/0042-6989(92)90144-8; McMahon MJ, 2000, J NEUROSCI, V20, P2043; RIGGS LA, 1954, J OPT SOC AM, V44, P315, DOI 10.1364/JOSA.44.000315; SEKIGUCHI N, 1993, J OPT SOC AM A, V10, P2118, DOI 10.1364/JOSAA.10.002118; WILLIAMS DR, 1985, VISION RES, V25, P195, DOI 10.1016/0042-6989(85)90113-0	15	7	7	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					729	730		10.1038/nn894	http://dx.doi.org/10.1038/nn894			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134154				2022-12-28	WOS:000177088900014
J	Smith, TC; Jahr, CE				Smith, TC; Jahr, CE			Self-inhibition of olfactory bulb neurons	NATURE NEUROSCIENCE			English	Article							DENDRODENDRITIC INHIBITION; PERIGLOMERULAR CELLS; NMDA RECEPTORS; GRANULE CELLS; RECIPROCAL SYNAPSES; GLOMERULAR LAYER; NERVE-TERMINALS; GABA RELEASE; MITRAL CELLS; RAT-BRAIN	The GABA (gamma-aminobutyric- acid)-containing periglomerular (PG) cells provide the first level of inhibition to mitral and tufted (M/T) cells, the output neurons of the olfactory bulb. We find that stimulation of PG cells of the rat olfactory bulb results in self-inhibition: release of GABA from an individual PG cell activates GABA(A) receptors on the same neuron. PG cells normally contain high concentrations of intracellular chloride and consequently are depolarized by GABA. Despite this, GABA inhibits PG cell firing by shunting excitatory signals. Finally, GABA released during self-inhibition may spill over to neighboring PG cells, resulting in a lateral spread of inhibition. Given the gatekeeping role of PG cells in the olfactory network, GABA-mediated self-inhibition will favor M/T cell excitation during intense sensory stimulation.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NINDS NIH HHS [F32 NS11093, NS21419] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021419, F32NS011093] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Christie JM, 2001, J NEUROPHYSIOL, V85, P169, DOI 10.1152/jn.2001.85.1.169; ECCLES JC, 1962, J PHYSL, V160, P532; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Halabisky B, 2000, J NEUROSCI, V20, P5124; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, NATURE, V297, P227, DOI 10.1038/297227a0; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lu T, 2001, J PHYSIOL-LONDON, V535, P125, DOI 10.1111/j.1469-7793.2001.t01-1-00125.x; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NICOLL RA, 1969, BRAIN RES, V14, P157, DOI 10.1016/0006-8993(69)90037-7; NICOLL RA, 1979, J PHYSIOL-LONDON, V290, P113, DOI 10.1113/jphysiol.1979.sp012763; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Pouzat C, 1999, J NEUROSCI, V19, P1675; PRICE JL, 1970, J CELL SCI, V7, P125; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RIBAK CE, 1977, BRAIN RES, V126, P1, DOI 10.1016/0006-8993(77)90211-6; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SHEPHERD GM, 1963, J PHYSIOL-LONDON, V168, P101, DOI 10.1113/jphysiol.1963.sp007180; SIKLOS L, 1995, NEUROSCIENCE, V64, P165, DOI 10.1016/0306-4522(94)00382-F; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WHITE EL, 1972, BRAIN RES, V37, P69, DOI 10.1016/0006-8993(72)90346-0; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	44	63	63	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					760	766		10.1038/nn882	http://dx.doi.org/10.1038/nn882			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089528				2022-12-28	WOS:000177088900019
J	Arnth-Jensen, N; Jabaudon, D; Scanziani, M				Arnth-Jensen, N; Jabaudon, D; Scanziani, M			Cooperation between independent hippocampal synapses is controlled by glutamate uptake	NATURE NEUROSCIENCE			English	Article							EXCITATORY SYNAPTIC CURRENTS; MULTIPLE RELEASE SITES; MOSSY FIBER SYNAPSES; PARALLEL FIBER; TRANSPORTERS; SPILLOVER; RECEPTORS; CELLS; TRANSMISSION; POTENTIATION	Localized action of released neurotransmitters is the basis for synaptic independence. In the hippocampal neuropil, where synapses are densely packed, it has been postulated that released glutamate, by diffusing out of the synaptic cleft, may also activate postsynaptic receptors at neighboring synapses. Here we show that neighboring excitatory synapses on hippocampal CA1 pyramidal cells can cooperate in the activation of postsynaptic receptors through the confluence of released glutamate, and that this cooperation is controlled by glutamate uptake. Furthermore, glutamate transporters control temporal interactions between transmitter transients originating from the same axon. Thus, cooperative interactions between excitatory synapses are modulated in space and time by glutamate uptake.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva, Switzerland	University of Zurich; University of Geneva	Scanziani, M (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Jabaudon, Denis/B-8802-2014	Jabaudon, Denis/0000-0003-2438-4769				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; FOX SE, 1975, EXP NEUROL, V49, P299, DOI 10.1016/0014-4886(75)90213-7; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lozovaya NA, 1999, NEUROSCIENCE, V91, P1321, DOI 10.1016/S0306-4522(98)00638-1; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118	34	202	205	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					325	331		10.1038/nn825	http://dx.doi.org/10.1038/nn825			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896395				2022-12-28	WOS:000174606900012
J	Subramaniam, JR; Lyons, WE; Liu, J; Bartnikas, TB; Rothstein, J; Price, DL; Cleveland, DW; Gitlin, JD; Wong, PC				Subramaniam, JR; Lyons, WE; Liu, J; Bartnikas, TB; Rothstein, J; Price, DL; Cleveland, DW; Gitlin, JD; Wong, PC			Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN SUPEROXIDE-DISMUTASE; CU,ZN-SUPEROXIDE DISMUTASE; HYDROGEN-PEROXIDE; MOUSE MODEL; CELL-DEATH; K-M; MICE; ALS; BINDING	Copper-mediated oxidative damage is proposed to play a critical role in the pathogenesis of Cu/Zn superoxide dismutase (SOD1)-linked familial amyotrophic lateral sclerosis (FALS). We tested this hypothesis by ablating the gene encoding the copper chaperone for SOD1 (CCS) in a series of FALS-linked SOD1 mutant mice. Metabolic Cu-64 labeling in SOD1-mutant mice lacking the CCS showed that the incorporation of copper into mutant SOD1 was significantly diminished in the absence of CCS. Motor neurons in CCS-/- mice showed increased rate of death after facial nerve axotomy, a response documented for SOD1(-/-) mice. Thus, CCS is necessary for the efficient incorporation of copper into SOD1 in motor neurons. Although the absence of CCS led to a significant reduction in the amount of copper-loaded mutant SOD1, however, it did not modify the onset and progression of motor neuron disease in SOD1-mutant mice. Hence, CCS-dependent copper loading of mutant SOD1 plays no role in the pathogenesis of motor neuron disease in these mouse models.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 558 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	wong@jhmi.edu	Cleveland, Don/AAN-9783-2021; rothstein, jeffrey d/C-9470-2013	Subramaniam, Jamuna R/0000-0003-0343-2469; Cleveland, Don/0000-0002-1934-3682				Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Crapo J D, 1978, Methods Enzymol, V53, P382; Crow JP, 1997, J NEUROCHEM, V69, P1945; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Doroudchi MM, 2001, NEUROREPORT, V12, P1239, DOI 10.1097/00001756-200105080-00037; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; LYONS WE, 1995, J NEUROSCI, V15, P2985; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mouton PR, 1998, NEUROBIOL AGING, V19, P371, DOI 10.1016/S0197-4580(98)00080-3; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; PROHASKA JR, 1993, J NUTR, V123, P1226, DOI 10.1093/jn/123.7.1226; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sankarapandi S, 1999, J BIOL CHEM, V274, P34576, DOI 10.1074/jbc.274.49.34576; Singh RJ, 1998, P NATL ACAD SCI USA, V95, P6675, DOI 10.1073/pnas.95.12.6675; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Torres AS, 2001, J BIOL CHEM, V276, P38410, DOI 10.1074/jbc.M104790200; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Williamson T L, 2000, Science, V288, P399; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	42	195	207	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					301	307		10.1038/nn823	http://dx.doi.org/10.1038/nn823			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889469				2022-12-28	WOS:000174606900009
J	Viana, F; de la Pena, E; Belmonte, C				Viana, F; de la Pena, E; Belmonte, C			Specificity of cold thermotransduction is determined by differential ionic channel expression	NATURE NEUROSCIENCE			English	Article							ACTIVATED CATION CURRENT; NEURONS; HEAT; RECEPTORS; MENTHOL; RAT; CAPSAICIN; CORNEA; FIBERS	Sensations of cold are mediated by specific thermoreceptor nerve endings excited by low temperature and menthol. Here we identify a population of cold-sensitive cultured mouse trigeminal ganglion neurons with a unique set of biophysical properties. Their impulse activity during cooling and menthol application was similar to that of cold thermoreceptor fibers in vivo. We show that cooling closes a background K+ channel, causing depolarization and firing that is limited by the slower reduction of a cationic inward current (I-h). In cold-insensitive neurons, firing is prevented by a slow, transient, 4-AP-sensitive K+ current (IKD) that acts as an excitability brake. In addition, pharmacological blockade of IKD induced thermosensitivity in cold-insensitive neurons, a finding that may explain cold allodynia in neuropathic pain. These results suggest that cold sensitivity is not associated to a specific transduction molecule but instead results from a favorable blend of ionic channels expressed in a small subset of sensory neurons.	Univ Miguel Hernandez, Inst Neurociencias, CSIC, San Juan De Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Viana, F (corresponding author), Univ Miguel Hernandez, Inst Neurociencias, CSIC, Apartado 18, San Juan De Alicante 03550, Spain.		Viana, Felix/U-8533-2017; Elvira, De la Pena/O-7380-2015	Viana, Felix/0000-0003-1439-949X; Elvira, De la Pena/0000-0001-5961-5067				BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; Brock JA, 2001, J PHYSIOL-LONDON, V533, P493, DOI 10.1111/j.1469-7793.2001.0493a.x; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; CARPENTER DO, 1981, FED PROC, V40, P2808; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Craig AD, 2001, J NEUROPHYSIOL, V86, P1459, DOI 10.1152/jn.2001.86.3.1459; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; GALLAR J, 1993, J PHYSIOL-LONDON, V468, P609, DOI 10.1113/jphysiol.1993.sp019791; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Grafe P, 1997, J NEUROPHYSIOL, V77, P421, DOI 10.1152/jn.1997.77.1.421; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235, DOI 10.3109/08990229209144774; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; HENSEL H, 1951, ACTA PHYSIOL SCAND, V22, P96, DOI 10.1111/j.1748-1716.1951.tb00758.x; HENSEL H, 1960, J PHYSIOL-LONDON, V153, P113, DOI 10.1113/jphysiol.1960.sp006522; Hensel H, 1976, Prog Brain Res, V43, P105; HENSEL H, 1974, PFLUG ARCH EUR J PHY, V352, P1, DOI 10.1007/BF01061945; HENSEL H, 1971, PFLUG ARCH EUR J PHY, V329, P1, DOI 10.1007/BF00586896; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; IGGO A, 1975, SOMATOSENSORY SYSTEM, P5; KENSHALO DR, 1967, SCIENCE, V158, P1064, DOI 10.1126/science.158.3804.1064; Koerber HR, 1992, SENSORY NEURONS DIVE, P77; LAMOTTE RH, 1982, BRAIN RES, V244, P279, DOI 10.1016/0006-8993(82)90086-5; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McCleskey EW, 1997, CURR BIOL, V7, pR679, DOI 10.1016/S0960-9822(06)00354-X; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PIERAU FK, 1975, PFLUG ARCH EUR J PHY, V359, P349, DOI 10.1007/BF00581445; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271, DOI 10.1152/jn.1994.71.1.271; SPRAY DC, 1986, ANNU REV PHYSIOL, V48, P625; SPRAY DC, 1974, BRAIN RES, V72, P354, DOI 10.1016/0006-8993(74)90881-6; STANSFELD CE, 1986, NEUROSCI LETT, V64, P299, DOI 10.1016/0304-3940(86)90345-9; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Takigawa T, 1998, NEUROSCIENCE, V82, P631; Viana F, 2001, EUR J NEUROSCI, V13, P722, DOI 10.1046/j.0953-816x.2000.01441.x; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819	47	258	271	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					254	260		10.1038/nn809	http://dx.doi.org/10.1038/nn809			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836533				2022-12-28	WOS:000174146000016
J	Johansson, RS; Birznieks, I				Johansson, RS; Birznieks, I			First spikes in ensembles of human tactile afferents code complex spatial fingertip events	NATURE NEUROSCIENCE			English	Article							GLABROUS SKIN; HUMAN HAND; PRECISION GRIP; MECHANORECEPTIVE UNITS; CEREBRAL-CORTEX; STIMULUS LOCATION; OBJECT SHAPE; RESPONSES; DIRECTION; RECEPTORS	It is generally assumed that primary sensory neurons transmit information by their firing rates. However, during natural object manipulations, tactile information from the fingertips is used faster than can be readily explained by rate codes. Here we show that the relative timing of the first impulses elicited in individual units of ensembles of afferents reliably conveys information about the direction of fingertip force and the shape of the surface contacting the fingertip. The sequence in which different afferents initially discharge in response to mechanical fingertip events provides information about these events faster than the fastest possible rate code and fast enough to account for the use of tactile signals in natural manipulation.	Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden	Umea University	Johansson, RS (corresponding author), Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden.	roland.s.johansson@physiol.umu.se	B, Ingvars/Q-8634-2019; Johansson, Roland S/A-5890-2009; Birznieks, Ingvars/D-4181-2012	B, Ingvars/0000-0003-4916-1254; Johansson, Roland S/0000-0003-3288-8326; Birznieks, Ingvars/0000-0003-4916-1254				ADKINS RJ, 1966, SCIENCE, V153, P1020, DOI 10.1126/science.153.3739.1020; Adrian E.D., 1928, BASIS SENSATION; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; Gerstner W, 2002, SPIKING NEURON MODEL; GOODWIN AW, 1995, J NEUROSCI, V15, P798; HagerRoss C, 1996, EXP BRAIN RES, V110, P142; HARRIS F, 1965, NATURE, V208, P1215, DOI 10.1038/2081215a0; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jenmalm P, 2003, EUR J NEUROSCI, V18, P164, DOI 10.1046/j.1460-9568.2003.02721.x; Jenmalm P, 1997, J NEUROSCI, V17, P4486; JOHANSSON RS, 1994, J PHYSIOL-LONDON, V481, P761, DOI 10.1113/jphysiol.1994.sp020480; Johansson RS, 1998, NOVART FDN SYMP, V218, P45; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1980, BRAIN RES, V184, P353, DOI 10.1016/0006-8993(80)90804-5; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P192, DOI 10.1007/BF00229016; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; KAKUDA N, 1992, NEUROSCI RES, V15, P179, DOI 10.1016/0168-0102(92)90003-U; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Macefield VG, 1996, EXP BRAIN RES, V108, P155; Maeno T, 1998, JSME INT J C-MECH SY, V41, P94, DOI 10.1299/jsmec.41.94; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nakazawa N, 2000, BIOL CYBERN, V82, P207, DOI 10.1007/s004220050020; Nielsen J, 1997, J PHYSIOL-LONDON, V501, P473, DOI 10.1111/j.1469-7793.1997.473bn.x; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Pawluk DTV, 1999, J BIOMECH ENG-T ASME, V121, P178, DOI 10.1115/1.2835100; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; PHILLIPS JR, 1992, J NEUROSCI, V12, P827; PUBOLS BH, 1982, J NEUROPHYSIOL, V47, P530, DOI 10.1152/jn.1982.47.3.530; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rowe MJ, 2002, BEHAV BRAIN RES, V135, P197, DOI 10.1016/S0166-4328(02)00166-3; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Trulsson M, 1997, J NEUROPHYSIOL, V77, P737, DOI 10.1152/jn.1997.77.2.737; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; VALLBO AB, 1968, EXP NEUROL, V21, P270, DOI 10.1016/0014-4886(68)90041-1; WESTLING G, 1987, EXP BRAIN RES, V66, P128; Zar J. H., 1996, BIOSTATISTICAL ANAL	48	363	373	2	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					170	177		10.1038/nn1177	http://dx.doi.org/10.1038/nn1177			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730306				2022-12-28	WOS:000188468500015
J	Brown, SP; Brenowitz, SD; Regehr, WG				Brown, SP; Brenowitz, SD; Regehr, WG			Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; PARALLEL FIBER; CALCIUM TRANSIENTS; DEPRESSION; RELEASE; SPINES; SIGNAL; ENDOCANNABINOIDS; DENDRITES	Many types of neurons can release endocannabinoids that act as retrograde signals to inhibit neurotransmitter release from presynaptic terminals. Little is known, however, about the properties or role of such inhibition under physiological conditions. Here we report that brief bursts of presynaptic activity evoked endocannabinoid release, which strongly inhibited parallel fiber-to-Purkinje cell synapses in rat cerebellar slices. This retrograde inhibition was triggered by activation of either postsynaptic metabotropic or ionotropic glutamate receptors and was restricted to synapses activated with high-frequency bursts. Thus, endocannabinoids allow neurons to inhibit specific synaptic inputs in response to a burst, thereby dynamically fine-tuning the properties of synaptic integration.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu	Brown, Solange/H-1615-2012		NINDS NIH HHS [R01 NS 32405, 5 T32 NS07484-02, R01 NS 44396] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405, R01NS044396, T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LEVENES C, 1998, J PHYSL, V510, P876; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Neale SA, 2001, EUR J NEUROSCI, V14, P1313, DOI 10.1046/j.0953-816x.2001.01769.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; PITLER TA, 1992, J NEUROSCI, V12, P4122; REGEHR WG, 2000, IMAGING NEURONS LAB; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANABE Y, 1993, J NEUROSCI, V13, P1372; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	176	184	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1048	1057		10.1038/nn1126	http://dx.doi.org/10.1038/nn1126			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502290				2022-12-28	WOS:000185633600016
J	Geleoc, GSG; Holt, JR				Geleoc, GSG; Holt, JR			Developmental acquisition of sensory transduction in hair cells of the mouse inner ear	NATURE NEUROSCIENCE			English	Article							MECHANOELECTRICAL TRANSDUCTION; TIP LINKS; ADAPTATION; CHANNELS; MICE	Sensory transduction in hair cells requires assembly of membrane-bound transduction channels, extracellular tip-links and intracellular adaptation motors with sufficient precision to confer nanometer displacement sensitivity. Here we present evidence based on FM1-43 fluorescence, scanning electron microscopy and RT-PCR that these three essential elements are acquired concurrently between embryonic day 16 and 17, several days after the appearance of hair bundles(1), and that their acquisition coincides with the onset of mechanotransduction.	Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Holt, JR (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Box 801392, Charlottesville, VA 22908 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC005439, R01DC005439] Funding Source: NIH RePORTER; NIDCD NIH HHS [R56 DC005439, DC05439-03, R01 DC005439, R01 DC005439-03] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 1997, J NEUROSCI, V17, P8739; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Meyers JR, 2003, J NEUROSCI, V23, P4054; RATTO GM, 1991, NATURE, V351, P654, DOI 10.1038/351654a0; Sahly I, 1997, ANAT EMBRYOL, V196, P159, DOI 10.1007/s004290050088; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171	14	108	112	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1019	1020		10.1038/nn1120	http://dx.doi.org/10.1038/nn1120			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973354	Green Accepted			2022-12-28	WOS:000185633600011
J	Musso, M; Moro, A; Glauche, V; Rijntjes, M; Reichenbach, J; Buchel, C; Weiller, C				Musso, M; Moro, A; Glauche, V; Rijntjes, M; Reichenbach, J; Buchel, C; Weiller, C			Broca's area and the language instinct	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; EPISODIC MEMORY; SPEECH; ACQUISITION; RETRIEVAL; BRAIN	Language acquisition in humans relies on abilities like abstraction and use of syntactic rules, which are absent in other animals. The neural correlate of acquiring new linguistic competence was investigated with two functional magnetic resonance imaging (fMRI) studies. German native speakers learned a sample of 'real' grammatical rules of different languages (Italian or Japanese), which, although parametrically different, follow the universal principles of grammar (UG). Activity during this task was compared with that during a task that involved learning 'unreal' rules of language. 'Unreal' rules were obtained manipulating the original two languages; they used the same lexicon as Italian or Japanese, but were linguistically illegal, as they violated the principles of UG. Increase of activation over time in Broca's area was specific for 'real' language acquisition only, independent of the kind of language. Thus, in Broca's area, biological constraints and language experience interact to enable linguistic competence for a new language.	Univ Hamburg, Dept Neurol, D-20246 Hamburg, Germany; Univ Vita Salute San Raffaele, Milan, Italy; Univ Jena, Inst Diagnost & Intervent Radiol, D-6900 Jena, Germany	University of Hamburg; Vita-Salute San Raffaele University; Friedrich Schiller University of Jena	Musso, M (corresponding author), Univ Hamburg, Dept Neurol, Martinistr 52, D-20246 Hamburg, Germany.	musso@uke.uni-hamburg.de	moro, andrea/ABG-9796-2020; Reichenbach, Jürgen R./B-4333-2011	moro, andrea/0000-0002-6602-5871; Reichenbach, Jürgen R./0000-0002-2640-0630				Alcock KJ, 2000, BRAIN LANG, V75, P34, DOI 10.1006/brln.2000.2323; Allan K, 2000, NEUROIMAGE, V11, P217, DOI 10.1006/nimg.2000.0531; Anderson M., 1992, INTELLIGENCE DEV COG; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; BUCKNER RL, 2000, NEW COGNITIVE NEUROS, P817; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky N., 2002, JANUA LINGUARUM; Chomsky Noam, 1981, LECT GOVT BINDING; CHOMSKY Noam, 1986, KNOWLEDGE LANGUAGE I; Darwin Charles, 1871, DESCENT MAN; Delis K, 1987, CALIFORNIA VERBAL LE; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Glitter G., 1998, INTELLIGENZ STRUKTUR; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; HOLMES AP, 1998, NEUROIMAGE, V7, pS574; Illes J, 1999, BRAIN LANG, V70, P347, DOI 10.1006/brln.1999.2186; Jensvold MLA, 2000, J COMP PSYCHOL, V114, P335, DOI 10.1037/0735-7036.114.4.335; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; MORO A, 2002, LINGUE LINGUAGGIO, V1, P39; MORO A, 2000, DYNAMICS ANTISYMMETR; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, V9; Piattelli-Palmarini M., 1980, LANGUAGE LEARNING DE; Pinker S, 2001, NATURE, V413, P465, DOI 10.1038/35097173; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Sakai KL, 2002, NEURON, V35, P1177, DOI 10.1016/S0896-6273(02)00873-5; Seger CA, 1997, CONSCIOUS COGN, V6, P108, DOI 10.1006/ccog.1996.0285; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SMITH N, 1996, MIND SAVANT; Tettamanti M, 2002, NEUROIMAGE, V17, P700, DOI 10.1006/nimg.2002.1201; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; WALKER AE, 1940, J COMP NEUROL, V262, P256	50	245	247	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					774	781		10.1038/nn1077	http://dx.doi.org/10.1038/nn1077			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12819784				2022-12-28	WOS:000183780400027
J	Li, SM; Cullen, WK; Anwyl, R; Rowan, MJ				Li, SM; Cullen, WK; Anwyl, R; Rowan, MJ			Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACETYLCHOLINE-RELEASE; SYNAPTIC PLASTICITY; BRAIN TEMPERATURE; RAT HIPPOCAMPUS; MOTOR-ACTIVITY; DENTATE GYRUS; MEMORY; RECEPTORS; NEURONS	In addition to its role in memory formation, the hippocampus may act as a novelty detector. Here we investigated whether attention to novel events can promote the associative synaptic plasticity mechanisms believed to be necessary for storing those events in memory. We therefore examined whether exposure to a novel spatial environment promoted the induction of activity-dependent persistent increases in glutamatergic transmission (long-term potentiation, LTP) at CA1 synapses in the rat hippocampus. We found that brief exposure to a novel environment lowered the threshold for the induction of LTP. This facilitatory effect was present for a short period following novelty exposure but was absent in animals that explored a familiar environment. Furthermore, the facilitation was dependent on activation of D1/D5 receptors. These findings support an important role for dopamine-regulated synaptic plasticity in the storage of unpredicted information in the CA1 area.	Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Physiol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Rowan, MJ (corresponding author), Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Biotechnol Bldg, Dublin 2, Ireland.			Rowan, Michael Joseph/0000-0002-3867-9536				Abraham WC, 2002, J NEUROSCI, V22, P9626; Acquas E, 1996, J NEUROSCI, V16, P3089; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Dong HW, 2001, BRAIN RES, V893, P1, DOI 10.1016/S0006-8993(00)03036-5; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; HARGREAVES EL, 1990, J NEUROSCI, V10, P1472; HERSI AI, 1995, NEUROSCIENCE, V69, P1067, DOI 10.1016/0306-4522(95)00319-E; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; Kim JH, 2001, J NEUROSCI, V21, P1327; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Kulla A, 2000, CEREB CORTEX, V10, P614, DOI 10.1093/cercor/10.6.614; Kusuki T, 1997, NEUROREPORT, V8, P2037, DOI 10.1097/00001756-199705260-00046; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; LEUNG LS, 1980, BRAIN RES, V198, P95; LI S, 2001, BRIT J PHARM S, V34, P150; LI S, 2002, IRISH J MED SCI, V171, P172; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; MOSER EI, 1994, LEARN MEMORY, V1, P55; Moses SN, 2002, BRAIN RES BULL, V58, P517, DOI 10.1016/S0361-9230(02)00820-1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Oswald CJP, 2002, EUR J NEUROSCI, V15, P1983, DOI 10.1046/j.1460-9568.2002.02028.x; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Sah P, 1996, J NEUROSCI, V16, P4537; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Swanson-Park JL, 1999, NEUROSCIENCE, V92, P485, DOI 10.1016/S0306-4522(99)00010-X; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0	48	372	388	1	38	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					526	531		10.1038/nn1049	http://dx.doi.org/10.1038/nn1049			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704392				2022-12-28	WOS:000182553200020
J	Machens, CK; Schutze, H; Franz, A; Kolesnikova, O; Stemmler, MB; Ronacher, B; Herz, AVM				Machens, CK; Schutze, H; Franz, A; Kolesnikova, O; Stemmler, MB; Ronacher, B; Herz, AVM			Single auditory neurons rapidly discriminate conspecific communication signals	NATURE NEUROSCIENCE			English	Article							ACOUSTIC COMMUNICATION		Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; Humboldt Univ, Dept Biol, D-10099 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Herz, AVM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	a.herz@biologie.hu-berlin.de	Kolesnikova, Olga/F-2283-2011	Machens, Christian/0000-0003-1717-1562				Haykin S., 1994, COMMUNICATION SYSTEM; KRIEGBAUM H, 1992, ETHOLOGY, V76, P248; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; vonHelversen D, 1997, J COMP PHYSIOL A, V180, P373, DOI 10.1007/s003590050056; VONHELVERSEN O, 1994, FORTS ZOOL, V39, P253	8	91	91	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					341	342		10.1038/nn1036	http://dx.doi.org/10.1038/nn1036			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12652305				2022-12-28	WOS:000181833100009
J	Ulanovsky, N; Las, L; Nelken, I				Ulanovsky, N; Las, L; Nelken, I			Processing of low-probability sounds by cortical neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; MISMATCH NEGATIVITY; VISUAL-CORTEX; INTRACORTICAL MECHANISMS; STIMULUS DEVIANCE; ACOUSTIC CHANGE; CAT; ADAPTATION; FREQUENCY; PLASTICITY	The ability to detect rare auditory events can be critical for survival. We report here that neurons in cat primary auditory cortex (A1) responded more strongly to a rarely presented sound than to the same sound when it was common. For the rare stimuli, we used both frequency and amplitude deviants. Moreover, some A1 neurons showed hyperacuity for frequency deviants-a frequency resolution one order of magnitude better than receptive field widths in A1. In contrast, auditory thalamic neurons were insensitive to the probability of frequency deviants. These phenomena resulted from stimulus-specific adaptation in A1, which may be a single-neuron correlate of an extensively studied cortical potential-mismatch negativity-that is evoked by rare sounds. Our results thus indicate that A1 neurons, in addition to processing the acoustic features of sounds, may also be involved in sensory memory and novelty detection.	Hebrew Univ Jerusalem, Dept Physiol, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Nelken, I (corresponding author), Hebrew Univ Jerusalem, Dept Physiol, Hadassah Med Sch, Box 12272, IL-91120 Jerusalem, Israel.		Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Ulanovsky, Nachum/0000-0001-8598-4667				Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; CSEPE V, 1989, SLEEP 88, P210; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; Deouell LY, 2000, AUDIOL NEURO-OTOL, V5, P225, DOI 10.1159/000013884; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; GREEN DM, 1966, SIGNAL DETECTION THE; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1111/1469-8986.3840723; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 2000, AUDIOL NEURO-OTOL, V5, P207, DOI 10.1159/000013882; KING C, 1995, HEARING RES, V85, P45, DOI 10.1016/0378-5955(95)00028-3; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; Kujala T, 2001, NEUROSCI BIOBEHAV R, V25, P535, DOI 10.1016/S0149-7634(01)00032-X; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; Malone BJ, 2001, J NEUROPHYSIOL, V86, P1113, DOI 10.1152/jn.2001.86.3.1113; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; MASTERTON RB, 1992, HEARING RES, V63, P57, DOI 10.1016/0378-5955(92)90074-W; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; Moore BCJ., 1993, HUMAN PSYCHOPHYSICS, P56, DOI 10.1007/978-1-4612-2728-1_3; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PHILLIPS DP, 1985, EXP BRAIN RES, V58, P443; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Sanes DH, 1998, J NEUROSCI, V18, P794; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0	42	703	721	3	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					391	398		10.1038/nn1032	http://dx.doi.org/10.1038/nn1032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12652303				2022-12-28	WOS:000181833100017
J	Liu, L; Yermolaieva, O; Johnson, WA; Abboud, FM; Welsh, MJ				Liu, L; Yermolaieva, O; Johnson, WA; Abboud, FM; Welsh, MJ			Identification and function of thermosensory neurons in Drosophila larvae	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; EXPRESSION; MELANOGASTER; RECEPTOR; SPECIFICITY; INDICATORS; FIBERS; GENE; SKIN	Although the ability to sense temperature is critical for many organisms, the underlying mechanisms are poorly understood. Using the calcium reporter yellow cameleon 2.1 and electrophysiological recordings, we identified thermosensitive neurons and examined their physiologic response in Drosophila melanogaster larvae. In the head, terminal sensory organ neurons showed increased activity in response to cooling by less than or equal to1 degreesC, heating reduced their basal activity, and different units showed distinct response patterns. Neither cooling nor heating affected dorsal organ neurons. Body wall neurons showed a variety of distinct response patterns to both heating and cooling; the diverse thermal responses were strikingly similar to those described in mammals. These data establish a functional map of thermoresponsive neurons in Drosophila larvae and provide a foundation for understanding mechanisms of thermoreception in both insects and mammals.	Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, EMRB 500, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.			Welsh, Michael/0000-0002-1646-6206; Johnson, Wayne/0000-0002-6961-5498; Abboud, Francois/0000-0002-7284-9148	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL14388] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; DYKES RW, 1975, BRAIN RES, V98, P485, DOI 10.1016/0006-8993(75)90368-6; Grueber WB, 2002, DEVELOPMENT, V129, P2867; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hart S, 1998, BIOSCIENCE, V48, P3, DOI 10.2307/1313221; Heimbeck G, 1999, J NEUROSCI, V19, P6599; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; LONG RR, 1977, J NEUROPHYSIOL, V40, P489, DOI 10.1152/jn.1977.40.3.489; Martin J. H., 1991, PRINCIPLES NEURAL SC, V3, P341; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Oppliger FY, 2000, J INSECT PHYSIOL, V46, P135, DOI 10.1016/S0022-1910(99)00109-2; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; RUBIN GM, 1985, COLD SPRING HARB SYM, V50, P329, DOI 10.1101/SQB.1985.050.01.042; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schmitz H, 1998, J COMP PHYSIOL A, V182, P647, DOI 10.1007/s003590050210; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; WU CF, 1983, J NEUROSCI, V3, P1888	29	135	137	2	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					267	273		10.1038/nn1009	http://dx.doi.org/10.1038/nn1009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563263				2022-12-28	WOS:000181178300015
J	Moores, E; Laiti, L; Chelazzi, L				Moores, E; Laiti, L; Chelazzi, L			Associative knowledge controls deployment of visual selective attention	NATURE NEUROSCIENCE			English	Article							FIGURE GROUND ORGANIZATION; INFERIOR TEMPORAL CORTEX; OBJECT IDENTIFICATION; NEURAL MECHANISMS; SCENE PERCEPTION; WORKING-MEMORY; SEARCH; RECOGNITION; V4; NEURONS	According to some models of visual selective attention, objects in a scene activate corresponding neural representations, which compete for perceptual awareness and motor behavior. During a visual search for a target object, top-down control exerted by working memory representations of the target's defining properties resolves competition in favor of the target. These models, however, ignore the existence of associative links among object representations. Here we show that such associations can strongly influence deployment of attention in humans. In the context of visual search, objects associated with the target were both recalled more often and recognized more accurately than unrelated distractors. Notably, both target and associated objects competitively weakened recognition of unrelated distractors and slowed responses to a luminance probe. Moreover, in a speeded search protocol, associated objects rendered search both slower and less accurate. Finally, the first saccades after onset of the stimulus array were more often directed toward associated than control items.	Univ Verona, Dept Neurol & Vis Sci, Physiol Sect, I-37134 Verona, Italy; Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	University of Verona; Aston University	Chelazzi, L (corresponding author), Univ Verona, Dept Neurol & Vis Sci, Physiol Sect, Strada Le Grazie 8, I-37134 Verona, Italy.	leonardo.chelazzi@univr.it	Chelazzi, Leonardo/B-6084-2011	Chelazzi, Leonardo/0000-0001-8566-0611; moores, elisabeth/0000-0003-3997-0832				Anderson J.R., 1973, HUMAN ASS MEMORY; Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; BIEDERMAN I, 1973, J EXP PSYCHOL, V97, P22, DOI 10.1037/h0033776; BOYCE SJ, 1989, J EXP PSYCHOL HUMAN, V15, P556, DOI 10.1037/0096-1523.15.3.556; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Butter CM, 2000, VIS COGN, V7, P769, DOI 10.1080/13506280050144425; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Deese J., 1965, STRUCTURE ASS LANGUA; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Estes W.K., 1994, CLASSIFICATION COGNI; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Fodor J. A, 1983, MODULARITY MIND; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Hebb Donald O., 1949, ORG BEHAV; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hollingworth A, 1998, J EXP PSYCHOL GEN, V127, P398, DOI 10.1037/0096-3445.127.4.398; Humphreys GW, 1997, PHILOS T R SOC B, V352, P1275, DOI 10.1098/rstb.1997.0110; ISHAI A, 1995, SCIENCE, V268, P1712; LaBerge D., 1995, ATTENTIONAL PROCESSI; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McClelland James L, 2000, OXFORD HDB MEMORY, P583; OCHSNER KN, 1994, CURR OPIN NEUROBIOL, V4, P189, DOI 10.1016/0959-4388(94)90071-X; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Parasuraman R, 2001, VIS COGN, V8, P103, DOI 10.1080/13506280042000045; PETERSON MA, 1994, PERCEPT PSYCHOPHYS, V56, P551, DOI 10.3758/BF03206951; PETERSON MA, 1993, COGNITIVE PSYCHOL, V25, P383, DOI 10.1006/cogp.1993.1010; Peterson MA, 2001, VIS COGN, V8, P329, DOI 10.1080/13506280143000034; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Roediger H. L., 1993, HANDB NEUR, P63; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VANDERHEIDEN AHC, 1992, SELECTIVE ATTENTION; WOLFE JM, 1999, FLEETING MEMORIES; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812	48	214	229	4	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					182	189		10.1038/nn996	http://dx.doi.org/10.1038/nn996			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12514738				2022-12-28	WOS:000180669100019
J	Choi, DW				Choi, DW			Exploratory clinical testing of neuroscience drugs	NATURE NEUROSCIENCE			English	Article									Merck Res Labs, West Point, PA 19486 USA	Merck & Company	Choi, DW (corresponding author), Merck Res Labs, WP42-212,770 Sumneytown Pike, West Point, PA 19486 USA.	dennis_choi@merck.com						Albers GW, 2001, NEUROLOGY, V57, pS77, DOI 10.1212/WNL.57.suppl_2.S77; Curtis VA, 2001, J AFFECT DISORDERS, V66, P111, DOI 10.1016/S0165-0327(00)00240-8; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Fillit HN, 2002, ALZ DIS ASSOC DIS, V16, pS1, DOI 10.1097/00002093-200200001-00001; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; Kundera Milan., 1999, UNBEARABLE LIGHTNESS; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Marcus R, 2002, ENDOCR REV, V23, P16, DOI 10.1210/er.23.1.16	8	14	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1023	1025		10.1038/nn930	http://dx.doi.org/10.1038/nn930			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403975				2022-12-28	WOS:000179041300003
J	Gilbertson, MW; Shenton, ME; Ciszewski, A; Kasai, K; Lasko, NB; Orr, SP; Pitman, RK				Gilbertson, MW; Shenton, ME; Ciszewski, A; Kasai, K; Lasko, NB; Orr, SP; Pitman, RK			Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma	NATURE NEUROSCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ERA TWIN REGISTRY; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; SEXUAL ABUSE; PTSD; BRAIN; MRI; DAMAGE; SIZE	In animals, exposure to severe stress can damage the hippocampus. Recent human studies show smaller hippocampal volume in individuals with the stress-related psychiatric condition posttraumatic stress disorder (PTSD). Does this represent the neurotoxic effect of trauma, or is smaller hippocampal volume a pre-existing condition that renders the brain more vulnerable to the development of pathological stress responses? In monozygotic twins discordant for trauma exposure, we found evidence that smaller hippocampi indeed constitute a risk factor for the development of stress-related psychopathology. Disorder severity in PTSD patients who were exposed to trauma was negatively correlated with the hippocampal volume of both the patients and the patients' trauma-unexposed identical co-twin. Furthermore, severe PTSD twin pairs-both the trauma-exposed and unexposed members-had significantly smaller hippocampi than non-PTSD pairs.	Vet Adm Med Ctr, Res Serv, Manchester, NH 03104 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Vet Adm Boston Healthcare Syst, Psychiat Serv, Brockton, MA 02301 USA; Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02129 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Gilbertson, MW (corresponding author), Vet Adm Med Ctr, Res Serv, 718 Smyth Rd, Manchester, NH 03104 USA.	mark.gilbertson@med.va.gov	Shenton, Martha/V-8780-2019	Kasai, Kiyoto/0000-0002-4443-4535	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054636, K02MH001110] Funding Source: NIH RePORTER; NIMH NIH HHS [R01-MH54636, K02-MH01110, R01 MH054636, K02 MH001110-10] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTELMAN SM, 1972, PHYSIOL BEHAV, V9, P15, DOI 10.1016/0031-9384(72)90257-0; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2001, HIPPOCAMPUS, V11, P75, DOI 10.1002/hipo.1023; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; BRESLAU N, 1992, AM J PSYCHIAT, V149, P671; CRUSIO WE, 1989, BEHAV BRAIN RES, V32, P81, DOI 10.1016/S0166-4328(89)80075-0; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; EISEN S, 1987, ACTA GENET MED GEMEL, V36, P61, DOI 10.1017/S0001566000004591; EISEN S, 1989, CLIN GENET, V35, P423, DOI 10.1111/j.1399-0004.1989.tb02967.x; Falls William A., 1995, P177; Freeman TW, 1998, MAGNET RESON MED, V40, P66, DOI 10.1002/mrm.1910400110; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; HENDERSON WG, 1990, PUBLIC HEALTH REP, V105, P368; JANES GR, 1991, J CLIN PSYCHOL, V47, P80, DOI 10.1002/1097-4679(199101)47:1<80::AID-JCLP2270470112>3.0.CO;2-9; Keane TM, 1997, ANN NY ACAD SCI, V821, P24, DOI 10.1111/j.1749-6632.1997.tb48266.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Laakso MP, 2000, BEHAV BRAIN RES, V109, P177, DOI 10.1016/S0166-4328(99)00172-2; Lyons DM, 2001, ARCH GEN PSYCHIAT, V58, P1145, DOI 10.1001/archpsyc.58.12.1145; McEwen Bruce S., 1995, P1117; McEwen BS, 2001, HIPPOCAMPUS, V11, P82, DOI 10.1002/hipo.1024; MELLMAN TA, 1992, AM J PSYCHIAT, V149, P1568; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; ORR SP, IN PRESS ARCH GEN PS; Pennington BF, 2000, J COGNITIVE NEUROSCI, V12, P223, DOI 10.1162/089892900561850; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitman RK, 2001, HIPPOCAMPUS, V11, P73, DOI 10.1002/hipo.1022; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Schuff N, 1997, ANN NY ACAD SCI, V821, P516, DOI 10.1111/j.1749-6632.1997.tb48319.x; SCHWEGLER H, 1983, BEHAV BRAIN RES, V7, P1, DOI 10.1016/0166-4328(83)90002-5; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Sheline YI, 1999, J NEUROSCI, V19, P5034; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; SPITZER R. L., 1994, STRUCTURED CLIN INTE; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; WIMER CC, 1971, J COMP PHYSIOL PSYCH, V76, P57, DOI 10.1037/h0031036; WIMER RE, 1981, DEV BRAIN RES, V2, P129, DOI 10.1016/0165-3806(81)90064-X; Yehuda R, 2001, HIPPOCAMPUS, V11, P85, DOI 10.1002/hipo.1025; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	50	1028	1054	1	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1242	1247		10.1038/nn958	http://dx.doi.org/10.1038/nn958			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	609CG	12379862	Green Accepted, Green Submitted			2022-12-28	WOS:000178884600029
J	Nestler, EJ				Nestler, EJ			From neurobiology to treatment: progress against addiction	NATURE NEUROSCIENCE			English	Review							MU-OPIOID RECEPTOR; HEROIN-ADDICTION; COCAINE-SEEKING; WITHDRAWAL; DOPAMINE; BEHAVIOR; IMMUNIZATION; MODULATION; TOLERANCE; MORPHINE	Most advances in addiction treatment to date have addressed the physical dependence and withdrawal that accompany addiction to some drugs of abuse. In contrast, it has proven more difficult to develop medications that effectively treat drug craving and relapse, the core features of addictive disorders. Current efforts focus on developing medications that prevent a drug from getting to its protein target, that mimic drug action and thereby partially alleviate drug craving, or that affect the addiction process per se. The latter approach is the most speculative, but also the most promising in terms of translating basic knowledge of addiction into clinical progress.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu						AGHAJANIAN GK, 1978, NATURE, V276, P186, DOI 10.1038/276186a0; [Anonymous], 1998, JAMA, V280, P1936; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Carlezon WA, 2000, J NEUROSCI, V20; Cohen PJ, 1997, DRUG ALCOHOL DEPEN, V48, P167, DOI 10.1016/S0376-8716(97)00075-6; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; Everitt BJ, 2002, J NEUROSCI, V22, P3312; GOLD MS, 1978, LANCET, V2, P599; Hutcheson DM, 2001, NAT NEUROSCI, V4, P943, DOI 10.1038/nn0901-943; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kantak KM, 2001, PSYCHOPHARMACOLOGY, V153, P334, DOI 10.1007/s002130000555; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Ling W, 1998, ADDICTION, V93, P475, DOI 10.1046/j.1360-0443.1998.9344753.x; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; Potenza MN, 1999, J PHARMACOL EXP THER, V291, P482; PULVIRENTI L, 1994, TRENDS PHARMACOL SCI, V15, P374, DOI 10.1016/0165-6147(94)90158-9; Self DW, 2002, NEUROPSYCHOPHARMACOL, V26, P14, DOI 10.1016/S0893-133X(01)00373-6; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shalev U, 2001, PSYCHOPHARMACOLOGY, V156, P98, DOI 10.1007/s002130100748; SILAGY C, 2001, COCHRANE DB SYST REV, V3; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5	28	88	91	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1076	1079		10.1038/nn945	http://dx.doi.org/10.1038/nn945			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403990				2022-12-28	WOS:000179041300018
J	Sinha, P				Sinha, P			Recognizing complex patterns	NATURE NEUROSCIENCE			English	Review							FACE-RECOGNITION; IDENTIFICATION; EIGENFACES; FEATURES	How the brain recognizes complex patterns in the environment is a central, but little understood question in neuroscience. The problem is of great significance for a host of applications such as biometric-based access control, autonomous robots and content-based information management. Although some headway in these directions has been made, the current artificial systems do not match the robustness and versatility of their biological counterparts. Here I examine recognition tasks drawn from two different sensory modalities-face recognition and speaker/speech recognition. The goal is to characterize the present state of artificial recognition technologies for these tasks, the influence of neuroscience on the design of these systems and the key challenges they face.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sinha, P (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.							BACHMANN T, 1991, European Journal of Cognitive Psychology, V3, P87, DOI 10.1080/09541449108406221; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Bruce V., 1998, EYE BEHOLDER SCI FAC; CAMPBELL JP, 1995, P INT C AC SPEECH SI, P341; CAMPBELL RA, 1987, P C MOD SIM MICR, P62; Collishaw SM, 2000, PERCEPTION, V29, P893, DOI 10.1068/p2949; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Duda R. O., 1973, PATTERN CLASSIFICATI; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; ETERNAD K, 1994, P INT C AC SPEECH SI, P2148; FRASER IH, 1990, PERCEPTION, V19, P661, DOI 10.1068/p190661; Gish H, 1994, IEEE SIGNAL PROC MAG, V11, P18, DOI 10.1109/79.317924; GOULD JL, 1985, SCIENCE, V227, P1492, DOI 10.1126/science.227.4693.1492; Greenberg S, 1999, SPEECH COMMUN, V29, P159, DOI 10.1016/S0167-6393(99)00050-3; HAIG ND, 1986, PERCEPTION, V15, P235, DOI 10.1068/p150235; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; HERMANSKY H, 1990, J ACOUST SOC AM, V87, P1738, DOI 10.1121/1.399423; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; Higgins A., 1991, Digital Signal Processing, V1, P89, DOI 10.1016/1051-2004(91)90098-6; Jones MJ, 1997, CURR BIOL, V7, P991, DOI 10.1016/S0960-9822(06)00419-2; Kanade T., 1977, COMPUTER RECOGNITION, VVolume 47; Kaya Y., 1972, FRONTIERS PATTERN RE, V1, P265; Lee TS, 1996, IEEE T PATTERN ANAL, V18, P959, DOI 10.1109/34.541406; PHILLIPS PJ, 1997, IEEE P COMP VIS PATT, P137; Rabiner L., 1993, FUNDAMENTALS SPEECH; SAKOE H, 1980, IEEE T ACOUSTICS SPE, V26, P623; Sheperd J., 1981, PERCEIVING REMEMBERI, P105; Sinha P, 1996, NATURE, V384, P404, DOI 10.1038/384404a0; Sinha P, 2002, PERCEPTION, V31, P133, DOI 10.1068/p3101no; Sinha P, 2002, PERCEPTUAL LEARNING, P273; Sinha P, 2002, PROC SPIE, V4662, P12, DOI 10.1117/12.469529; SOONG FK, 1987, AT&T TECH J, V66, P14, DOI 10.1002/j.1538-7305.1987.tb00198.x; Swets DL, 1996, PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, P192, DOI 10.1109/AFGR.1996.557263; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376	37	46	46	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1093	1097		10.1038/nn949	http://dx.doi.org/10.1038/nn949			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	611WT	12403994				2022-12-28	WOS:000179041300022
J	Yonelinas, AP; Kroll, NEA; Quamme, JR; Lazzara, MM; Sauve, MJ; Widaman, KF; Knight, RT				Yonelinas, AP; Kroll, NEA; Quamme, JR; Lazzara, MM; Sauve, MJ; Widaman, KF; Knight, RT			Effects of extensive temporal lobe damage or mild hypoxia on recollection and familiarity	NATURE NEUROSCIENCE			English	Article							ENDURING MEMORY IMPAIRMENT; RECOGNITION MEMORY; EPISODIC MEMORY; IMPLICIT MEMORY; HIPPOCAMPAL; AMNESIA; EXPLICIT; LESIONS; BASES; ITEM	Memory for past events can be based on recollection or on assessments of familiarity. These two forms of human memory have been studied extensively by philosophers and psychologists, but their neuroanatomical substrates are largely unknown. Here we examined the brain regions that are involved in these two forms of memory by studying patients with damage to different temporal lobe regions. Our results come from (i) structural covariance modeling of recall and recognition, (ii) introspective reports during recognition and (iii) analysis of receiver operating characteristics. In sum, we found that the regions disrupted in mild hypoxia, such as the hippocampus, are centrally involved in conscious recollection, whereas the surrounding temporal lobe supports familiarity-based memory discrimination.	Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; Vet Adm Res Serv, Martinez, CA 94553 USA; Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yonelinas, AP (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	apyonelinas@ucdavis.edu	Widaman, Keith/Y-3051-2019	Widaman, Keith/0000-0002-6424-3998; Yonelinas, Andrew/0000-0002-9580-4997	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813, R01NS021135] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59352] Funding Source: Medline; NINDS NIH HHS [NS40813, NS21135] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aggleton JP, 1996, NEUROPSYCHOLOGIA, V34, P51, DOI 10.1016/0028-3932(95)00150-6; Amaral DG, 1999, HIPPOCAMPUS, V9, P1; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; CUMMINGS JL, 1984, NEUROLOGY, V34, P679, DOI 10.1212/WNL.34.5.679; Duvernoy HM, 1998, HUMAN HIPPOCAMPUS FU; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Hamann SB, 1997, BEHAV NEUROSCI, V111, P850, DOI 10.1037/0735-7044.111.4.850; Henson RNA, 1999, J NEUROSCI, V19, P3962; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; JENNINGS JM, 1993, PSYCHOL AGING, V8, P283, DOI 10.1037/0882-7974.8.2.283; JORESKOG KG, 1974, MULTIVAR BEHAV RES, V9, P498; KARTSOUNIS LD, 1995, J NEUROL NEUROSUR PS, V59, P95, DOI 10.1136/jnnp.59.1.95; KUWERT T, 1993, J NEUROL SCI, V118, P10, DOI 10.1016/0022-510X(93)90238-T; Macmillan N.A., 1991, DETECTION THEORY USE, P407; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Markowitsch HJ, 1997, EUR J NEUROL, V4, P178, DOI 10.1111/j.1468-1331.1997.tb00324.x; Mishkin M, 1998, HIPPOCAMPUS, V8, P212; Nunally J. C., 1994, PSYCHOMETRIC THEORY; NYBERG L, 1994, J EXP PSYCHOL LEARN, V20, P485, DOI 10.1037/0278-7393.20.2.485; Parkin AJ, 1993, NEUROPSYCHOLOGY AMNE; PRESS GA, 1998, NATURE, V7, P54; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rey A, 1964, LEXAMEN CLINIQUE PSY; Sauve M J, 1996, Am J Crit Care, V5, P127; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; Wechsler D., 1945, WECHSLER MEMORY SCAL; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028; Zola S.M., 2000, OXFORD HDB MEMORY, P485; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	48	391	396	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1236	1241		10.1038/nn961	http://dx.doi.org/10.1038/nn961			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379865				2022-12-28	WOS:000178884600028
J	Wilson, CA; Doms, RW; Zheng, H; Lee, VMY				Wilson, CA; Doms, RW; Zheng, H; Lee, VMY			Presenilins are not required for A beta 42 production in the early secretory pathway	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; BETA-PROTEIN; ALZHEIMERS-DISEASE; SENILE PLAQUES; ENDOPLASMIC-RETICULUM; CELL-SURFACE; ACCUMULATION; CLEAVAGE; MICE	Presenilins 1 and 2 (PS1/PS2) have been suggested to be gamma-secretases responsible for the proteolytic cleavage of amyloid precursor protein (APP) to form amyloid-beta (Abeta), a protein implicated in the development of Alzheimer's disease. Here we examined whether these presenilins are required for the generation of multiple Abeta species by analyzing the production of several forms of secreted and intracellular Abeta in mouse cells lacking PS1, PS2 or both proteins. Although most Abeta species were abolished in PS1/PS2(-/-) cells, the production of intracellular Abeta42 generated in the endoplasmic reticulum/intermediate compartment was unaffected by the absence of these proteins, either singly or in combination. These results indicate that production of this pool of Abeta occurs independently of PS1/PS2, and therefore, another gamma-secretase activity must be responsible for cleavage of APP within the early secretory compartments.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Merck Res Labs, Rahway, NJ 07065 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Merck & Company	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.							Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Bahr BA, 1998, J COMP NEUROL, V397, P139; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; Masliah E, 1996, J NEUROSCI, V16, P5795; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1997, MOL GENETIC BASIS NE, P601; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Sisodia SS, 2002, SCIENCE, V295, P805, DOI 10.1126/science.1069661; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	50	87	90	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					849	855		10.1038/nn898	http://dx.doi.org/10.1038/nn898			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12145638				2022-12-28	WOS:000177656300014
J	Everling, S; Tinsley, CJ; Gaffan, D; Duncan, J				Everling, S; Tinsley, CJ; Gaffan, D; Duncan, J			Filtering of neural signals by focused attention in the monkey prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SELECTIVE VISUAL-ATTENTION; GO/NO-GO DISCRIMINATION; FRONTAL EYE FIELD; TARGET SELECTION; PARIETAL CORTEX; UNIT-ACTIVITY; HUMAN BRAIN; NEURONS; MACAQUE; MECHANISMS	Prefrontal cortex is thought to be important in attention and awareness. Here we recorded the activity of prefrontal neurons in monkeys carrying out a focused attention task. Having directed attention to one location, monkeys monitored a stream of visual objects, awaiting a predefined target. Although neurons rarely discriminated between one non-target and another, they commonly discriminated between targets and non-targets. From the onset of the visual response, this target/non-target discrimination was effectively eliminated when the same objects appeared at an unattended location in the opposite visual hemifield. The results show that, in prefrontal cortex, filtering of ignored locations is strong, early and spatially global. Such filtering may be important in blindness to unattended signals-a conspicuous aspect of human selective attention.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Duncan, J (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.		Everling, Stefan/AAR-8687-2020; Everling, Stefan/K-5208-2013	Everling, Stefan/0000-0001-9714-9757; Duncan, John/0000-0002-9695-2764; Tinsley, Chris/0000-0002-9369-443X				BAYNES K, 1986, BRAIN, V109, P99, DOI 10.1093/brain/109.1.99; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dell'Acqua R, 2001, PERCEPT PSYCHOPHYS, V63, P777, DOI 10.3758/BF03194437; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Reynolds JH, 1999, J NEUROSCI, V19, P1736; ROCK I, 1992, COGNITIVE PSYCHOL, V24, P502, DOI 10.1016/0010-0285(92)90017-V; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; SATO T, 1988, J NEUROPHYSIOL, V60, P344, DOI 10.1152/jn.1988.60.1.344; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8	37	163	166	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					671	676		10.1038/nn874	http://dx.doi.org/10.1038/nn874			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068302				2022-12-28	WOS:000176414300017
J	Drier, EA; Tello, MK; Cowan, M; Wu, P; Blace, N; Sacktor, TC; Yin, JCP				Drier, EA; Tello, MK; Cowan, M; Wu, P; Blace, N; Sacktor, TC; Yin, JCP			Memory enhancement and formation by atypical PKM activity in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; LONG-TERM POTENTIATION; CAENORHABDITIS-ELEGANS; PERSISTENT ACTIVATION; CONSOLIDATED MEMORY; CELL-POLARITY; M-ZETA; MAINTENANCE; BAZOOKA; FACILITATION	Synaptic stimulation activates signal transduction pathways, producing persistently active protein kinases. PKMzeta is a truncated, persistently active isoform of atypical protein kinase C-zeta (aPKCzeta), which lacks the N-terminal pseudosubstrate regulatory domain. Using a Pavlovian olfactory learning task in Drosophila, we found that induction of the mouse aPKMzeta (MaPKMzeta) transgene enhanced memory. The enhancement required persistent kinase activity and was temporally specific, with optimal induction at 30 minutes after training. Induction also enhanced memory after massed training and corrected the memory defect of radish mutants, but did not improve memory produced by spaced training. The 'M' isoform of the Drosophila homolog of MaPKCzeta (DaPKM) was present and active in fly heads. Chelerythrine, an inhibitor of PKMzeta, and the induction of a dominant-negative MaPKMzeta transgene inhibited memory without affecting learning. Finally, induction of DaPKM after training also enhanced memory. These results show that atypical PKM is sufficient to enhance memory in Drosophila and suggest that it is necessary for normal memory maintenance.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Downstate Med Ctr, Dept Physiol, Lab Mol Neurosci, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Pharmacol, Lab Mol Neurosci, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Neurol, Lab Mol Neurosci, Brooklyn, NY 11203 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Yin, JCP (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Blace, Nancy/0000-0002-6174-6004	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015753] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Angenstein F, 1997, PROG NEURO-PSYCHOPH, V21, P427, DOI 10.1016/S0278-5846(97)00012-2; Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; BOYNTON S, 1992, GENETICS, V131, P655; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CONNOLLY JB, 1998, DROSOPHILA PRACTICAL, P265; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Grunbaum L, 1998, J NEUROSCI, V18, P4384; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hrabetova S, 1996, J NEUROSCI, V16, P5324; INOUE M, 1977, J BIOL CHEM, V252, P7610; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Osten P, 1996, J NEUROSCI, V16, P2444; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; SCHWARTZ JH, 1993, P NATL ACAD SCI USA, V90, P8310, DOI 10.1073/pnas.90.18.8310; Sossin W S, 1994, Learn Mem, V1, P189; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; TAKAI Y, 1977, BIOCHEM BIOPH RES CO, V77, P542, DOI 10.1016/S0006-291X(77)80013-2; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VanderZee EA, 1997, PROG NEURO-PSYCHOPH, V21, P379, DOI 10.1016/S0278-5846(97)00010-9; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	49	133	139	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					316	324		10.1038/nn820	http://dx.doi.org/10.1038/nn820			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914720				2022-12-28	WOS:000174606900011
J	Arikawa-Hirasawa, E; Rossi, SG; Rotundo, RL; Yamada, Y				Arikawa-Hirasawa, E; Rossi, SG; Rotundo, RL; Yamada, Y			Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice	NATURE NEUROSCIENCE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; COLLAGEN-TAILED ACETYLCHOLINESTERASE; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES; SKELETAL-MUSCLE; ALPHA-DYSTROGLYCAN; BASAL LAMINA; CHOLINESTERASE; CARTILAGE; DIAPHRAGM	The collagen-tailed form of acetylcholinesterase (AChE) is concentrated at the vertebrate neuromuscular junction (NMJ), where it is responsible for rapidly terminating neurotransmission. This unique oligomeric form of AChE, consisting of three tetramers covalently attached to a collagen-like tail, is more highly expressed in innervated regions of skeletal muscle fibers, where it is externalized and attached to the synaptic basal lamina interposed between the nerve terminal and the receptor-rich postsynaptic membrane. Although it is clear that the enzyme is preferentially synthesized in regions of muscle contacted by the motoneuron, the molecular events underlying its localization to the NMJ are not known. Here we show that perlecan, a multifunctional heparan sulfate proteoglycan concentrated at the NMJ, is the unique acceptor molecule for collagen-tailed AChE at sites of nerve-muscle contact and is the principal mechanism for localizing AChE to the synaptic basal lamina.	Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; Univ Miami, Sch Med, Neurosci Program, Miami, FL 33136 USA; Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Rotundo, RL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol & Anat, 1600 NW 10th Ave, Miami, FL 33136 USA.				NIA NIH HHS [R01 AG005917] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BON S, 1978, EUR J BIOCHEM, V85, P1, DOI 10.1111/j.1432-1033.1978.tb12207.x; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; BRANDAN E, 1987, FEBS LETT, V213, P159, DOI 10.1016/0014-5793(87)81483-7; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; LWEBUGAMUKASA JS, 1976, BIOCHEMISTRY-US, V15, P1425, DOI 10.1021/bi00652a012; MARNA A, 1938, J PHYSIOL-LONDON, V92, P34; MASSOULIE J, 1969, EUR J BIOCHEM, V11, P441, DOI 10.1111/j.1432-1033.1969.tb00794.x; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MCMAHAN UJ, 1978, NATURE, V271, P172, DOI 10.1038/271172a0; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; PEREZTUR J, 1991, FEBS LETT, V286, P25, DOI 10.1016/0014-5793(91)80932-S; ROSSI SG, 1992, J CELL BIOL, V119, P1657, DOI 10.1083/jcb.119.6.1657; Rossi SG, 1996, J BIOL CHEM, V271, P1979, DOI 10.1074/jbc.271.4.1979; ROSSI SG, 1993, J BIOL CHEM, V268, P19152; Rotundo RL, 1997, J CELL BIOL, V136, P367, DOI 10.1083/jcb.136.2.367; Rotundo RL, 1994, MYOLOGY, P607; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; SANES JR, 1994, MYOLOGY, P242; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; TORRES JC, 1985, CELL MOL NEUROBIOL, V5, P303, DOI 10.1007/BF00711015; VIGNY M, 1983, J BIOL CHEM, V258, P8794	39	128	135	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					119	123		10.1038/nn801	http://dx.doi.org/10.1038/nn801			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802174				2022-12-28	WOS:000173558400013
J	Lee, I; Kesner, RP				Lee, I; Kesner, RP			Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory	NATURE NEUROSCIENCE			English	Article							ANTAGONIST; BLOCKADE; ENVIRONMENT; IMPAIRMENT; INDUCTION; SYNAPSES; INFUSION; NEURONS; CONTEXT; RATS	N-methyl-D-aspartate (NMDA) receptor-dependent synaptic plasticity in the mammalian hippocampus is essential for learning and memory. Although computational models and anatomical studies have emphasized functional differences among hippocampal subregions, subregional specificity of NMDA receptor function is largely unknown. Here we present evidence that NMDA receptors in CA3 are required in a situation in which spatial representation needs to be reorganized, whereas the NMDA receptors in CA1 and/or the dentate gyrus are more involved in acquiring memory that needs to be retrieved after a delay period exceeding a short-term range. Our data, with data from CA1-specific knockout mice, suggest the possibility of heterogeneous mnemonic function of NMDA receptors in different subregions of the hippocampus.	Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84132 USA; Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kesner, RP (corresponding author), Univ Utah, Med Ctr, Program Neurosci, 50 N Med Dr, Salt Lake City, UT 84132 USA.	rpkesner@behsci.utah.edu						Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BAWIN SM, 1993, EPILEPSY RES, V15, P7, DOI 10.1016/0920-1211(93)90003-P; BOLHUIS JJ, 1992, BEHAV BRAIN RES, V47, P151, DOI 10.1016/S0166-4328(05)80121-4; Borroni AM, 2000, J NEUROSCI, V20, P9272; CARAMANOS Z, 1994, BEHAV NEUROSCI, V108, P30, DOI 10.1037/0735-7044.108.1.30; Cassel JC, 1998, NEUROBIOL LEARN MEM, V69, P22, DOI 10.1006/nlme.1997.3807; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DERRICK BE, 1991, BRAIN RES BULL, V27, P219, DOI 10.1016/0361-9230(91)90071-Q; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Granger R, 1996, HIPPOCAMPUS, V6, P567, DOI 10.1002/(SICI)1098-1063(1996)6:6<567::AID-HIPO2>3.0.CO;2-E; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hetherington PA, 1997, BEHAV NEUROSCI, V111, P20, DOI 10.1037/0735-7044.111.1.20; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Kawabe K, 1998, BRAIN RES, V781, P300, DOI 10.1016/S0006-8993(97)01256-0; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Kesner RP, 2001, HIPPOCAMPUS, V11, P240, DOI 10.1002/hipo.1040; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mizumori SJY, 1999, HIPPOCAMPUS, V9, P444, DOI 10.1002/(SICI)1098-1063(1999)9:4<444::AID-HIPO10>3.0.CO;2-Z; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; MULLER RU, 1987, J NEUROSCI, V7, P1951; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PEINADOMANZANO MA, 1990, BEHAV BRAIN RES, V38, P117, DOI 10.1016/0166-4328(90)90010-C; RAWLINS JNP, 1983, BEHAV BRAIN RES, V10, P233, DOI 10.1016/0166-4328(83)90033-5; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wiebe SP, 1997, HIPPOCAMPUS, V7, P656, DOI 10.1002/(SICI)1098-1063(1997)7:6<656::AID-HIPO7>3.0.CO;2-C; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19	38	192	204	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					162	168		10.1038/nn790	http://dx.doi.org/10.1038/nn790			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11780144				2022-12-28	WOS:000173558400019
J	Huk, AC; Heeger, DJ				Huk, AC; Heeger, DJ			Pattern-motion responses in human visual cortex	NATURE NEUROSCIENCE			English	Article							AREA MT; COHERENCE; FMRI; PERCEPTION; NEURONS; MACAQUE; SIGNAL; BRAIN; MRI; V5	Physiological models of visual motion processing posit that 'pattern-motion cells' represent the direction of moving objects independent of their particular spatial pattern. We performed fMRI experiments to identify neuronal activity in the human brain selective for pattern motion. A protocol using adaptation to moving 'plaid' stimuli allowed us to separate pattern-motion responses from other types of motion-related activity within the same brain structures, and revealed strong pattern-motion selectivity in human visual area MT+. Reducing the perceptual coherence of the plaids yielded a corresponding decrease in pattern-motion responsivity, providing evidence that percepts of coherent motion are closely linked to the activity of pattern-motion cells in human MT+.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Huk, AC (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290,Hlth Sci Bldg,Room G-424, Seattle, WA 98195 USA.		Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935	NATIONAL EYE INSTITUTE [R01EY012741] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY12741] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Chawla D, 1998, NEUROIMAGE, V7, P86, DOI 10.1006/nimg.1997.0319; Chawla D, 1999, NEUROIMAGE, V9, P508, DOI 10.1006/nimg.1999.0432; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; KOOI FL, 1992, PERCEPT PSYCHOPHYS, V52, P415, DOI 10.3758/BF03206701; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Li B, 2001, EUR J NEUROSCI, V14, P690, DOI 10.1046/j.0953-816x.2001.01689.x; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SMITH AT, 1992, VISION RES, V32, P393, DOI 10.1016/0042-6989(92)90148-C; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; WELCH L, 1990, PERCEPTION, V19, P425, DOI 10.1068/p190425; ZEKI S, 1991, J NEUROSCI, V11, P641	30	141	141	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					72	75		10.1038/nn774	http://dx.doi.org/10.1038/nn774			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11731801				2022-12-28	WOS:000173031800018
J	Nishida, A; Furukawa, A; Koike, C; Tano, Y; Aizawa, S; Matsuo, I; Furukawa, T				Nishida, A; Furukawa, A; Koike, C; Tano, Y; Aizawa, S; Matsuo, I; Furukawa, T			Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development	NATURE NEUROSCIENCE			English	Article							CONE-ROD DYSTROPHY; ANTERIOR NEUROECTODERM; CIRCADIAN ENTRAINMENT; HOMEODOMAIN PROTEIN; XENOPUS-RETINA; NEURAL RETINA; ROSTRAL BRAIN; MOUSE RETINA; BHLH GENES; CRX	Understanding the molecular mechanisms by which distinct cell fate is determined during organogenesis is a central issue in development and disease. Here, using conditional gene ablation in mice, we show that the transcription factor Otx2 is essential for retinal photoreceptor cell fate determination and development of the pineal gland. Otx2-deficiency converted differentiating photoreceptor cells to amacrine-like neurons and led to a total lack of pinealocytes in the pineal gland. We also found that Otx2 transactivates the cone-rod homeobox gene Crx, which is required for terminal differentiation and maintenance of photoreceptor cells. Furthermore, retroviral gene transfer of Otx2 steers retinal progenitor cells toward becoming photoreceptors. Thus, Otx2 is a key regulatory gene for the cell fate determination of retinal photoreceptor cells. Our results reveal the key molecular steps required for photoreceptor cell-fate determination and pinealocyte development.	Osaka Biosci Inst, Osaka 5650874, Japan; Osaka Univ, Sch Med, Dept Ophthalmol, Osaka 5650871, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama, Japan	Osaka University; RIKEN; Japan Science & Technology Agency (JST)	Furukawa, T (corresponding author), Osaka Biosci Inst, 6-2-4 Furuedai, Osaka 5650874, Japan.	furukawa@obi.or.jp		Koike, Chieko/0000-0002-1927-017X; Matsuo, Isao/0000-0002-5916-6246				ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Ang SL, 1996, DEVELOPMENT, V122, P243; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Brown NL, 2001, DEVELOPMENT, V128, P2497; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Courtois V, 2003, J NEUROCHEM, V84, P840, DOI 10.1046/j.1471-4159.2003.01583.x; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Dyer MA, 2001, J COMP NEUROL, V429, P601; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Inoue T, 2002, DEVELOPMENT, V129, P831; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; Liu CT, 1998, CANCER GENE THER, V5, P3; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morrow EM, 1999, DEVELOPMENT, V126, P23; Nothias F, 1998, CURR BIOL, V8, P459, DOI 10.1016/S0960-9822(98)70189-7; Plouhinec JL, 2003, MOL BIOL EVOL, V20, P513, DOI 10.1093/molbev/msg085; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Viczian AS, 2003, DEVELOPMENT, V130, P1281, DOI 10.1242/dev.00343; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Yan RT, 1998, J NEUROBIOL, V36, P485	46	432	447	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1255	1263		10.1038/nn1155	http://dx.doi.org/10.1038/nn1155			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625556				2022-12-28	WOS:000186725600009
J	Beg, AA; Jorgensen, EM				Beg, AA; Jorgensen, EM			EXP-1 is an excitatory GABA-gated cation channel	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; ACETYLCHOLINE-RECEPTOR CHANNEL; CAENORHABDITIS-ELEGANS; GLYCINE RECEPTOR; ION CHANNELS; AMINO-ACID; NICOTINIC RECEPTOR; ALPHA(1) SUBUNIT; POINT MUTATIONS; LINING RESIDUES	gamma-aminobutyric acid (GABA) mediates fast inhibitory neurotransmission by activating anion-selective ligand-gated ion channels. Although electrophysiological studies indicate that GABA may activate cation-selective ligand-gated ion channels in some cell types, such a channel has never been characterized at the molecular level. Here we show that GABA mediates enteric muscle contraction in the nematode Caenorhabditis elegans via the EXP-1 receptor, a cation-selective ligand-gated ion channel. The EXP-1 protein resembles ionotropic GABA receptor subunits in almost all domains. In the pore-forming domain of EXP-1, however, the residues that confer anion selectivity are exchanged for those that specify cation selectivity. When expressed in Xenopus laevis oocytes, EXP-1 forms a GABA receptor that is permeable to cations and not anions. We conclude that some of the excitatory functions assigned to GABA are mediated by cation channels rather than by anion channels.	Univ Utah, Neurosci Program, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Neurosci Program, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu						AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Bamber BA, 1999, J NEUROSCI, V19, P5348; BARNARD EA, 1995, ADV BIOCHEM PSYCHOPH, V48, P1; BENARI Y, 1990, PROG BRAIN RES, V83, P313; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CLARK SG, 1994, GENETICS, V137, P987; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Goldmakher GV, 2000, BRAIN RES, V871, P7, DOI 10.1016/S0006-8993(00)02282-4; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; GURLEY D, 1995, RECEPTOR CHANNEL, V3, P13; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jin YS, 1999, J NEUROSCI, V19, P539; Kaila K, 1997, J NEUROSCI, V17, P7662; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moorhouse AJ, 2002, J GEN PHYSIOL, V119, P411, DOI 10.1085/jgp.20028553; Norekian TP, 1999, J NEUROSCI, V19, P1863; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Perkins KL, 1999, J NEUROPHYSIOL, V82, P768, DOI 10.1152/jn.1999.82.2.768; REINER DJ, 1995, J NEUROSCI, V15, P6094; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Swensen AM, 2000, J EXP BIOL, V203, P2075; THOMAS JH, 1990, GENETICS, V124, P855; VARANDA WA, 1985, MOL PHARMACOL, V28, P128; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; WANG TL, 1995, P NATL ACAD SCI USA, V92, P11751, DOI 10.1073/pnas.92.25.11751; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Westh-Hansen SE, 1999, NEUROREPORT, V10, P2417, DOI 10.1097/00001756-199908020-00036; WesthHansen SE, 1997, EUR J PHARMACOL, V329, P253, DOI 10.1016/S0014-2999(97)89186-8; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YAROWSKY PJ, 1978, BRAIN RES, V144, P75, DOI 10.1016/0006-8993(78)90436-5; ZHANG DX, 1995, P NATL ACAD SCI USA, V92, P11756, DOI 10.1073/pnas.92.25.11756; Zhang W, 1997, GEN PHARMACOL-VASC S, V28, P45, DOI 10.1016/S0306-3623(96)00152-8	50	120	131	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1145	1152		10.1038/nn1136	http://dx.doi.org/10.1038/nn1136			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555952				2022-12-28	WOS:000186229200013
J	Khalilov, I; Holmes, GL; Ben-Ari, Y				Khalilov, I; Holmes, GL; Ben-Ari, Y			In vitro formation of a secondary epileptogenic mirror focus by interhippocampal propagation of seizures	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; CA3 HIPPOCAMPAL-NEURONS; EXCITATORY ACTIONS; DEVELOPING BRAIN; NMDA RECEPTORS; GABAERGIC INHIBITION; NEONATAL SEIZURES; KAINIC ACID; GABA; ANTAGONISTS	We have determined whether seizures generate an epileptogenic focus in distal structures using an in vitro preparation composed of three independent chambers that accommodate two intact hippocampi and their connecting commissures. This enabled us to apply a convulsive agent to one hippocampus, allow the propagation of a given number of seizures to the other side and block the connections reversibly by applying tetrodotoxin (TTX) to the commissural chamber. The propagation of seizures from the kainate-treated side to the naive side transformed the latter into an independent epileptogenic focus that was capable of generating spontaneous and evoked seizures. The induction mechanism required activation of NMDA receptors and the epileptogenic transformation was associated with long-term alterations in GABAergic synapses, which became excitatory because of a shift in the chloride reversal potential, E-Cl. These data indicate that the excitatory actions of GABA may be a fundamental property of epileptogenic structures.	INSERM, INMED, U29, F-13273 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ben-Ari, Y (corresponding author), INSERM, INMED, U29, 163 Route Luminy, F-13273 Marseille, France.	ben-ari@inmed.univ-mrs.fr	Khalilov, Ilgam/B-5267-2015	Khalilov, Ilgam/0000-0002-9468-4778; Ben-Ari, Yehezkel/0000-0001-6208-8480				BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BENARI Y, 1979, CAN J PHYSIOL PHARM, V57, P1462, DOI 10.1139/y79-218; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; CLANCY RR, 1987, EPILEPSIA, V28, P537, DOI 10.1111/j.1528-1157.1987.tb03685.x; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; HAUSER WA, 1995, NEUROSURG CLIN N AM, V6, P419; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Khalilov I, 1999, DEV NEUROSCI-BASEL, V21, P310, DOI 10.1159/000017380; Khazipov R, 1999, J NEUROPHYSIOL, V81, P921, DOI 10.1152/jn.1999.81.2.921; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lemos T, 1996, Epilepsy Res Suppl, V12, P137; Louvel J, 2001, NEUROSCIENCE, V105, P803, DOI 10.1016/S0306-4522(01)00247-0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MODY I, 1987, NATURE, V326, P701, DOI 10.1038/326701a0; MOSHE SL, 1983, DEV BRAIN RES, V7, P81, DOI 10.1016/0165-3806(83)90083-4; MOSHE SL, 1982, DEV BRAIN RES, V4, P67, DOI 10.1016/0165-3806(82)90097-9; NEUMAN R, 1988, BRAIN RES, V459, P265, DOI 10.1016/0006-8993(88)90642-7; RAFIQ A, 1993, J NEUROPHYSIOL, V70, P1962, DOI 10.1152/jn.1993.70.5.1962; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shinnar S, 1996, PEDIATRICS, V98, P216; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; SZENTE MB, 1994, BRAIN RES, V648, P203, DOI 10.1016/0006-8993(94)91119-3; TROMMER BL, 1990, DEV BRAIN RES, V53, P248, DOI 10.1016/0165-3806(90)90014-P; Villeneuve N, 2000, ANN NEUROL, V47, P729, DOI 10.1002/1531-8249(200006)47:6<729::AID-ANA5>3.3.CO;2-3; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Wieser HG, 2003, J NEUROSURG, V98, P751, DOI 10.3171/jns.2003.98.4.0751	45	218	231	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1079	1085		10.1038/nn1125	http://dx.doi.org/10.1038/nn1125			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502289				2022-12-28	WOS:000185633600020
J	Strassmaier, M; Gillespie, PG				Strassmaier, M; Gillespie, PG			Fast adaptation in the mammalian cochlea: a conserved mechanism for cochlear amplification	NATURE NEUROSCIENCE			English	Editorial Material							AUDITORY HAIR-CELLS; MOTOR PROTEIN; PRESTIN; TRANSDUCTION; AMPLIFIER	In fish and amphibians, auditory cells use a rapid channel reclosure mechanism to amplify and discriminate sound stimuli. New evidence from Kennedy et. al. suggests that mammalian outer hair cells also use a similar form of fast adaptation.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Strassmaier, M (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.			Barr-Gillespie, Peter/0000-0002-9787-5860				Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Weber T, 2003, P NATL ACAD SCI USA, V100, P7690, DOI 10.1073/pnas.1330557100	12	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					790	791		10.1038/nn0803-790	http://dx.doi.org/10.1038/nn0803-790			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12886223				2022-12-28	WOS:000184413700004
J	van Swinderen, B; Greenspan, RJ				van Swinderen, B; Greenspan, RJ			Salience modulates 20-30 Hz brain activity in Drosophila	NATURE NEUROSCIENCE			English	Article							TARGETED EXPRESSION; NEURAL ACTIVITY; MINI-BRAIN; SHIBIRE; MELANOGASTER; INFORMATION; MECHANISM; ATTENTION; BEHAVIOR; CIRCUIT	Fruit flies selectively orient toward the visual stimuli that are most salient in their environment. We recorded local field potentials (LFPs) from the brains of Drosophila melanogaster as they responded to the presentation of visual stimuli. Coupling of salience effects (odor, heat or novelty) to these stimuli modulated LFPs in the 20-30 Hz range by evoking a transient, selective increase. We demonstrated the association of these responses with behavioral tracking and initiated a genetic approach to investigating neural correlates of perception.	Inst Neurosci, San Diego, CA 92121 USA		Greenspan, RJ (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	greenspan@nsi.edu		van Swinderen, Bruno/0000-0001-6552-7418	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR09754] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Bushnell PJ, 1998, PSYCHOPHARMACOLOGY, V138, P231, DOI 10.1007/s002130050668; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COLLETT TS, 1980, J COMP PHYSIOL, V138, P271, DOI 10.1007/BF00657045; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crick F., 1990, Seminars in the Neurosciences, V2, P263; DILL M, 1995, PHILOS T ROY SOC B, V349, P143, DOI 10.1098/rstb.1995.0100; Edelman G. M, 1989, REMEMBERED PRESENT; Egelhaaf M, 2002, TRENDS NEUROSCI, V25, P96, DOI 10.1016/S0166-2236(02)02063-5; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; GOETZ KG, 1994, NEURAL BASIS BEHAV A, P47; Guo A, 1997, LEARN MEMORY, V4, P192, DOI 10.1101/lm.4.2.192; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; MIMURA K, 1982, J COMP PHYSIOL, V146, P229, DOI 10.1007/BF00610242; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wolf R, 1998, LEARN MEMORY, V5, P166; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wu ZH, 2000, BIOL CYBERN, V82, P61, DOI 10.1007/s004220050006	42	127	129	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					579	586		10.1038/nn1054	http://dx.doi.org/10.1038/nn1054			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12717438				2022-12-28	WOS:000183140400014
J	Yang, ZY; Purves, D				Yang, ZY; Purves, D			A statistical explanation of visual space	NATURE NEUROSCIENCE			English	Article							DISTANCE PERCEPTION; EGOCENTRIC DISTANCE; IMAGE STATISTICS; NATURAL IMAGES; OCULOMOTOR; ILLUSIONS; MODELS; CUES	The subjective visual space perceived by humans does not reflect a simple transformation of objective physical space; rather, perceived space has an idiosyncratic relationship with the real world. To date, there is no consensus about either the genesis of perceived visual space or the implications of its peculiar characteristics for visually guided behavior. Here we used laser range scanning to measure the actual distances from the image plane of all unoccluded points in a series of natural scenes. We then asked whether the differences between real and apparent distances could be explained by the statistical relationship of scene geometry and the observer. We were able to predict perceived distances in a variety of circumstances from the probability distribution of physical distances. This finding lends support to the idea that the characteristics of human visual space are determined probabilistically.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Yang, ZY (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	yang@neuro.duke.edu						Belhumeur PN, 1996, INT J COMPUT VISION, V19, P237, DOI 10.1007/BF00055146; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; EPSTEIN W, 1969, PERCEPT PSYCHOPHYS, V6, P269, DOI 10.3758/BF03210096; FOLEY JM, 1985, J EXP PSYCHOL HUMAN, V11, P133, DOI 10.1037/0096-1523.11.2.133; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Geisler WS, 2002, NAT NEUROSCI, V5, P508, DOI 10.1038/nn0602-508; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gillam B., 1995, PERCEPTION SPACE MOT, P23; GOGEL W C, 1965, Psychol Bull, V64, P153, DOI 10.1037/h0022197; GOGEL WC, 1979, VISION RES, V19, P1161, DOI 10.1016/0042-6989(79)90013-0; Hershenson M., 1999, VISUAL SPACE PERCEPT; Howe CQ, 2002, P NATL ACAD SCI USA, V99, P13184, DOI 10.1073/pnas.162474299; Huang JG, 2000, PROC CVPR IEEE, P324, DOI 10.1109/CVPR.2000.855836; INDOW T, 1991, PSYCHOL REV, V98, P430, DOI 10.1037/0033-295X.98.3.430; Kersten D, 1999, NEW COGNITIVE NEUROS, P353; Knill DC, 1996, PERCEPTION BAYESIAN; Loomis JM, 1996, CURR DIR PSYCHOL SCI, V5, P72, DOI 10.1111/1467-8721.ep10772783; Luneberg RK., 1947, MATH ANAL BINOCULAR; Meng JC, 2001, PERCEPT PSYCHOPHYS, V63, P1, DOI 10.3758/BF03200497; MORRISON JD, 1984, PERCEPTION, V13, P555, DOI 10.1068/p130555; Mumford D, 2001, Q APPL MATH, V59, P85, DOI 10.1090/qam/1811096; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; OWENS DA, 1976, PERCEPT PSYCHOPHYS, V20, P2, DOI 10.3758/BF03198694; Philbeck JW, 1997, J EXP PSYCHOL HUMAN, V23, P72, DOI 10.1037/0096-1523.23.1.72; Purves D., 2003, WHY WE SEE WHAT WE D; Sedgwick H., 1986, HDB PERCEPTION HUMAN, V1; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sinai MJ, 1998, NATURE, V395, P497, DOI 10.1038/26747; Todd JT, 2001, PSYCHOL SCI, V12, P191, DOI 10.1111/1467-9280.00335; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WAGNER M, 1985, PERCEPT PSYCHOPHYS, V38, P483, DOI 10.3758/BF03207058; WALLACH H, 1982, PERCEPT PSYCHOPHYS, V31, P145, DOI 10.3758/BF03206214; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	37	107	109	5	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					632	640		10.1038/nn1059	http://dx.doi.org/10.1038/nn1059			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12754512				2022-12-28	WOS:000183140400021
J	Moore, DR				Moore, DR			Cortical neurons signal sound novelty	NATURE NEUROSCIENCE			English	Editorial Material							ATTENTION	Primary auditory cortex neurons are now shown to respond to the probabillity of a sound's occurrence-perhaps a correlate of the mismatch negativity implicated in novelty detection.	MRC, Inst Hearing Res, Nottingham NG7 2RD, England		Moore, DR (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.	davem@ihr.mrc.ac.uk						CALFORD MB, 1983, HEARING RES, V11, P395, DOI 10.1016/0378-5955(83)90070-9; GALBRAITH GC, 1993, BIOL PSYCHOL, V37, P3, DOI 10.1016/0301-0511(93)90024-3; Green DM, 1966, SIGNAL DETECTION THE; MCARTHUR GM, IN PRESS BEHAV RES M; NAATANEN R, 1995, EAR HEARING, V16, P6; Nothdurft HC, 2002, VISION RES, V42, P1287, DOI 10.1016/S0042-6989(02)00016-0; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032	9	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					330	332		10.1038/nn0403-330	http://dx.doi.org/10.1038/nn0403-330			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12658278				2022-12-28	WOS:000181833100005
J	Rivera, JF; Ahmad, S; Quick, MW; Liman, ER; Arnold, DB				Rivera, JF; Ahmad, S; Quick, MW; Liman, ER; Arnold, DB			An evolutionarily conserved dileucine motif in Shal K+ channels mediates dendritic targeting	NATURE NEUROSCIENCE			English	Article							HUMAN TRANSFERRIN RECEPTOR; KINESIN SUPERFAMILY MOTOR; A-TYPE; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; POTASSIUM CHANNEL; MDCK CELLS; STRUCTURAL REQUIREMENTS; PYRAMIDAL NEURONS; SORTING SIGNALS	The molecular mechanisms underlying polarized sorting of proteins in neurons are poorly understood. Here we report the identification of a 16 amino-acid, dileucine-containing motif that mediates dendritic targeting in a variety of neuronal cell types in slices of rat brain. This motif is present in the carboxy (C) termini of Shal-family K+ channels and is highly conserved from C. elegans to humans. It is necessary for dendritic targeting of potassium channel Kv4.2 and is sufficient to target the axonally localized channels Kv1.3 and Kv1.4 to the dendrites. It can also mediate dendritic targeting of a non-channel protein, CD8.	Univ So Calif, Program Mol Biol, Los Angeles, CA 90089 USA; Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Arnold, DB (corresponding author), Univ So Calif, Program Mol Biol, 835 W 37th St, Los Angeles, CA 90089 USA.		Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496	NIDCD NIH HHS [DC04213] Funding Source: Medline; NINDS NIH HHS [NS41963] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041963] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; Cooper EC, 1998, J NEUROSCI, V18, P965; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Song WJ, 1998, J NEUROSCI, V18, P3124; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	43	100	103	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					243	250		10.1038/nn1020	http://dx.doi.org/10.1038/nn1020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592409				2022-12-28	WOS:000181178300012
J	Sakai, K; Rowe, JB; Passingham, RE				Sakai, K; Rowe, JB; Passingham, RE			Active maintenance in prefrontal area 46 creates distractor-resistant memory	NATURE NEUROSCIENCE			English	Article							SPATIAL WORKING-MEMORY; DELAYED-RESPONSE PERFORMANCE; POSTERIOR PARIETAL CORTEX; EVENT-RELATED FMRI; NEURONAL-ACTIVITY; EXECUTIVE CONTROL; FRONTAL-CORTEX; FUNCTIONAL MRI; BRAIN ACTIVITY; RHESUS-MONKEY	How does the brain maintain information in working memory while challenged by incoming distractions? Using functional magnetic resonance imaging (fMRI), we measured human brain activity during the memory delay of a spatial working memory task with distraction. We found that, in the prefrontal cortex (PFC), the magnitude of activity sustained throughout the memory delay was significantly higher on correct trials than it was on error trials. By contrast, the magnitude of sustained activity in posterior areas did not differ between correct and error trials. The correlation of activity between posterior areas was, however, associated with correct memory performance after distraction. On the basis of these findings, we propose that memory representations gain resistance against distraction during a period of active maintenance within working memory. This may be mediated by interactions between prefrontal and posterior areas.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of Oxford	Sakai, K (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	ksakai@fil.ion.ucl.ac.uk	Tick, Beata/ABA-1728-2020; rowe, james B/C-3661-2013	rowe, james B/0000-0001-7216-8679	Wellcome Trust [077029] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; CHAO LL, 1995, NEUROREPORT, V6, P1605, DOI 10.1097/00001756-199508000-00005; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Frith C, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P549; Funahashi S, 1997, BEHAV BRAIN RES, V84, P203, DOI 10.1016/S0166-4328(96)00151-9; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Gopher D, 2000, J EXP PSYCHOL GEN, V129, P308, DOI 10.1037/0096-3445.129.3.308; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; KATO M, 1995, J NEUROSCI, V15, P912; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; Malmo RB, 1942, J NEUROPHYSIOL, V5, P295, DOI 10.1152/jn.1942.5.4.295; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Petrides M, 1998, PREFRONTAL CORTEX EX, P103; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sawaguchi T, 1999, J NEUROPHYSIOL, V82, P2070, DOI 10.1152/jn.1999.82.5.2070; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3	46	288	293	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					479	484		10.1038/nn846	http://dx.doi.org/10.1038/nn846			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953754				2022-12-28	WOS:000175272000020
J	Zhang, C; Zhou, Z				Zhang, C; Zhou, Z			Ca2+-independent but voltage-dependent secretion in mammalian dorsal root ganglion neurons	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; TRANSMITTER RELEASE; AMPEROMETRIC DETECTION; QUANTAL SECRETION; EXOCYTOSIS; CATECHOLAMINES; COMPETENT; KINETICS; PATHWAYS; CALCIUM	We have investigated the Ca2+ dependence of vesicular secretion from the soma of dorsal root ganglion (DRG) neurons, which secrete neuropeptides by exocytosis of dense-core vesicles. In patch-clamped somata of rat DRG neurons, we found a depolarization-induced membrane capacitance increase (DeltaC(m)) in the absence of extracellular Ca2+ and in the presence of a Ca2+ chelator (BAPTA) in the intracellular solution. Depletion of internal Ca2+ stores by thapsigargin in the Ca2+-free bath also did not block the DeltaC(m), indicating that Ca2+ release from internal Ca2+ stores may not have been involved. Furthermore, the Ca2+-independent DeltaC(m) was blocked by whole-cell dialysis with tetanus toxin and was accompanied by pulsatile secretion of false transmitters, as detected by amperometric measurements. These results indicate the existence of Ca2+-independent but voltage-dependent vesicular secretion (CIVDS) in a mammalian sensory neuron.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, Z (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zzhou@ion.ac.cn	zhou, zhuan/A-8285-2011					BERS DM, 1991, EXCITATION CONTRACTI; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gillis Kevin D., 1995, P155; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Hu ZH, 1997, J PHYSIOL-LONDON, V501, P67, DOI 10.1111/j.1469-7793.1997.067bo.x; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Katz B., 1969, RELEASE NEURAL TRANS; Kim KY, 2000, PROTEIN EXPRES PURIF, V20, P1, DOI 10.1006/prep.2000.1300; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; Neher E., 1986, EXPT BRAIN RES SERIE, P80; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Xu GY, 2000, J PHYSIOL-LONDON, V528, P339, DOI 10.1111/j.1469-7793.2000.00339.x; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; You ZD, 2000, NEUROREPORT, V11, P3113, DOI 10.1097/00001756-200009280-00015; ZHANG X, 1995, J COMP NEUROL, V352, P481, DOI 10.1002/cne.903520402; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938; Zhou Z, 1996, J BIOL CHEM, V271, P270, DOI 10.1074/jbc.271.1.270; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	28	104	108	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					425	430		10.1038/nn845	http://dx.doi.org/10.1038/nn845			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953753				2022-12-28	WOS:000175272000012
J	Gisselmann, G; Pusch, H; Hovemann, BT; Hatt, H				Gisselmann, G; Pusch, H; Hovemann, BT; Hatt, H			Two cDNAs coding for histamine-gated ion channels in D-melanogaster	NATURE NEUROSCIENCE			English	Article							CHLORIDE CHANNEL; DROSOPHILA; RECEPTORS; CELLS		Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany; Ruhr Univ Bochum, AG Mol Zellbiochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Univ Str 150, D-44780 Bochum, Germany.							Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; HARDIE RC, 1988, J EXP BIOL, V138, P221; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HASHEMZADEHGARGARI H, 1992, J NEUROPHYSIOL, V68, P9, DOI 10.1152/jn.1992.68.1.9; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; Melzig J, 1998, J NEUROSCI, V18, P7160; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SKINGSLEY DR, 1995, J COMP PHYSIOL A, V176, P611, DOI 10.1007/BF01021581; Stuart AE, 1999, NEURON, V22, P431, DOI 10.1016/S0896-6273(00)80699-6; van der Goot H, 2000, EUR J MED CHEM, V35, P5, DOI 10.1016/S0223-5234(00)00101-X; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999	15	107	112	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					11	12		10.1038/nn787	http://dx.doi.org/10.1038/nn787			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753412				2022-12-28	WOS:000173031800006
J	Xiao, ZJ; Suga, N				Xiao, ZJ; Suga, N			Modulation of cochlear hair cells by the auditory cortex in the mustached bat	NATURE NEUROSCIENCE			English	Article							CROSSED OLIVOCOCHLEAR BUNDLE; MIDBRAIN FREQUENCY MAP; PTERONOTUS-P-PARNELLII; MOUSTACHED BAT; INFERIOR COLLICULUS; CORTICOFUGAL MODULATION; ELECTRICAL-STIMULATION; NERVE RESPONSE; SYSTEM; MECHANICS	The corticofugal (descending) auditory system forms multiple feedback loops, and adjusts and improves auditory signal processing in the subcortical auditory nuclei. However, the mechanism by which the corticofugal system modulates cochlear hair cells has been unexplored. We found that electric stimulation of cortical neurons via the corticofugal system modulates cochlear hair cells in a highly specific way according to the relationship in terms of best frequency between cortical neurons and hair cells. Such frequency-specific effects can be explained by selective corticofugal modulation of individual olivocochlear efferent fibers.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Suga, N (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000175] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-00175] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BISHOP AL, 1987, HEARING RES, V31, P175, DOI 10.1016/0378-5955(87)90124-9; DESMEDT JE, 1961, NATURE, V193, P1263; DEWSON JH, 1968, J NEUROPHYSIOL, V31, P122, DOI 10.1152/jn.1968.31.1.122; DOLAN DF, 1988, J ACOUST SOC AM, V83, P1081, DOI 10.1121/1.396052; GAIONI SJ, 1990, J NEUROPHYSIOL, V64, P1801, DOI 10.1152/jn.1990.64.6.1801; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; GEISLER CD, 1974, J ACOUST SOC AM, V56, P1908, DOI 10.1121/1.1903532; Goldberg RL, 1998, HEARING RES, V122, P71, DOI 10.1016/S0378-5955(98)00078-1; GOLDMAN LJ, 1977, BEHAV ECOL SOCIOBIOL, V2, P411, DOI 10.1007/BF00299509; HENSON OW, 1972, PHYSIOL BEHAV, V8, P1185, DOI 10.1016/0031-9384(72)90220-X; HENSON OW, 1982, HEARING RES, V7, P127, DOI 10.1016/0378-5955(82)90010-7; Henson OW., 1980, ANIMAL SONAR SYSTEMS, P913, DOI [10.1007/978-1-4684-7254-7_56, DOI 10.1007/978-1-4684-7254-7_56]; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; HUFFMAN RF, 1991, HEARING RES, V56, P79, DOI 10.1016/0378-5955(91)90156-4; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P725, DOI 10.1007/BF00213069; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; Liu W, 1997, J COMP PHYSIOL A, V181, P599, DOI 10.1007/s003590050143; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; MANABE T, 1978, SCIENCE, V200, P339, DOI 10.1126/science.635594; MOUNTAIN DC, 1980, SCIENCE, V210, P71, DOI 10.1126/science.7414321; Mulders WHA, 2000, HEARING RES, V149, P11, DOI 10.1016/S0378-5955(00)00157-X; NIEDER P, 1970, NATURE, V227, P184, DOI 10.1038/227184a0; OATMAN LC, 1977, EXP NEUROL, V57, P200, DOI 10.1016/0014-4886(77)90057-7; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1275, DOI 10.1152/jn.1991.65.6.1275; POLLAK G, 1972, SCIENCE, V176, P66, DOI 10.1126/science.176.4030.66; PUEL JL, 1988, BRAIN RES, V447, P380, DOI 10.1016/0006-8993(88)91144-4; RAJAN R, 1990, BRAIN RES, V506, P192, DOI 10.1016/0006-8993(90)91251-B; RIQUIMAROUX H, 1991, SCIENCE, V251, P565, DOI 10.1126/science.1990432; SCHNITZLER HU, 1970, Z VERGL PHYSIOL, V68, P25, DOI 10.1007/BF00297809; SIEGEL JH, 1982, HEARING RES, V6, P171, DOI 10.1016/0378-5955(82)90052-1; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1975, J EXP BIOL, V62, P277; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; SUGA N, 1985, J NEUROPHYSIOL, V53, P1109, DOI 10.1152/jn.1985.53.4.1109; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; SUGA N, 1977, J EXP BIOL, V69, P207; Warr WB, 1992, MAMMALIAN AUDITORY P, P410; WIEDERHOLD ML, 1970, J ACOUST SOC AM, V48, P966, DOI 10.1121/1.1912235; Xie DH, 1998, HEARING RES, V124, P60, DOI 10.1016/S0378-5955(98)00122-1; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489	47	128	130	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					57	63		10.1038/nn786	http://dx.doi.org/10.1038/nn786			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753417				2022-12-28	WOS:000173031800016
J	Op de Beeck, H; Wagemans, J; Vogels, R				Op de Beeck, H; Wagemans, J; Vogels, R			Inferotemporal neurons represent low-dimensional configurations of parameterized shapes	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; SIMILARITY; RECOGNITION; SENSITIVITY; COMPONENTS; NETWORK; CORTEX; CELLS	Behavioral studies with parameterized shapes have shown that the similarities among these complex stimuli can be represented using a low number of dimensions. Using psychophysical measurements and single-cell recordings in macaque inferotemporal (IT) cortex, we found an agreement between low-dimensional parametric configurations of shapes and the representation of shape similarity at the behavioral and neuronal level. The shape configurations, computed from both the perceived and neuron-based similarities, revealed a low number of dimensions and contained the same stimulus order as the parametric configurations. However, at a metric level, the behavioral and neural representations deviated consistently from the parametric configurations. These findings suggest an ordinally faithful but metrically biased representation of shape similarity in IT.	Katholieke Univ Leuven, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Expt Psychol Lab, B-3000 Louvain, Belgium	KU Leuven; KU Leuven	Vogels, R (corresponding author), Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	rufin.vogels@med.kuleuven.ac.be	Rohlf, F J/A-8710-2008; Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541; Op de Beeck, Hans/0000-0002-2250-212X				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; ASHBY FG, 1988, PSYCHOL REV, V95, P124, DOI 10.1037/0033-295X.95.1.124; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BORG I, 1985, MULTIVAR BEHAV RES, V20, P325, DOI 10.1207/s15327906mbr2003_6; Cortese JM, 1996, J EXP PSYCHOL HUMAN, V22, P133, DOI 10.1037/0096-1523.22.1.133; CORTESE JM, 1992, PERCEPTUAL SIMILARIT; Cutzu F, 1998, VISION RES, V38, P2229, DOI 10.1016/S0042-6989(97)00186-7; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Edelman GM, 1987, NEURAL DARWINISM THE; Edelman S, 1998, BEHAV BRAIN SCI, V21, P449, DOI 10.1017/S0140525X98001253; Edelman S., 1999, REPRESENTATION RECOG; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Gross CG, 1990, P INT C FUZZ LOG NEU, P375; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Marr D., 1982, VISION COMPUTATIONAL, DOI [10.7551/mitpress/9780262514620.001.0001, DOI 10.7551/MITPRESS/9780262514620.001.0001]; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; NOSOFSKY RM, 1984, J EXP PSYCHOL LEARN, V10, P104, DOI 10.1037/0278-7393.10.1.104; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rieke F., 1997, SPIKES EXPLORING NEU; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; SHEPARD RN, 1973, COGNITIVE PSYCHOL, V4, P351, DOI 10.1016/0010-0285(73)90018-2; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Smith EE, 1981, CATEGORIES CONCEPTS; Sugihara T, 1998, BIOL CYBERN, V78, P1, DOI 10.1007/s004220050407; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 2001, J COGNITIVE NEUROSCI, V13, P444, DOI 10.1162/08989290152001871; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wilkinson F, 1998, VISION RES, V38, P3555, DOI 10.1016/S0042-6989(98)00039-X; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949	46	190	191	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1244	1252		10.1038/nn767	http://dx.doi.org/10.1038/nn767			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498RV	11713468	Green Published			2022-12-28	WOS:000172525000022
J	Zhou, FM; Liang, Y; Dani, JA				Zhou, FM; Liang, Y; Dani, JA			Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum	NATURE NEUROSCIENCE			English	Article							ACETYLCHOLINE-RECEPTORS; NUCLEUS-ACCUMBENS; CIGARETTE-SMOKING; BRAIN; SCHIZOPHRENIA; MICRODIALYSIS; DIVERSITY; NEURONS; REWARD; PHARMACOLOGY	Dopamine is vital for coordinated motion and for association learning linked to behavioral reinforcement. Here we show that the precise overlap of striatal dopaminergic and cholinergic fibers underlies potent control of dopamine release by ongoing nicotinic receptor activity. In mouse striatal slices, nicotinic antagonists or depletion of endogenous acetylcholine decreased evoked dopamine release by 90%. Nicotine at the concentration experienced by smokers also regulated dopamine release. In mutant mice lacking the beta2 nicotinic subunit, evoked dopamine release was dramatically suppressed, and those mice did not show cholinergic regulation of dopamine release. The results offer new perspectives when considering nicotine addiction and the high prevalence of smoking in schizophrenics.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021229, R01NS021229, R23NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012661, R01DA009411] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12661, DA09411] Funding Source: Medline; NINDS NIH HHS [NS21229] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P306, DOI 10.1111/j.1748-1716.1966.tb03317.x; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Balfour DJK, 2000, BEHAV BRAIN RES, V113, P73, DOI 10.1016/S0166-4328(00)00202-3; Bennett BD, 1999, J NEUROSCI, V19, P5586; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BJORKLUND A, 1984, CLASSICAL TRANSMIT 1, P55; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; BUTCHER LL, 1984, CLASSICAL TRANSMITTE, P1; CHANG HT, 1988, BRAIN RES BULL, V21, P295, DOI 10.1016/0361-9230(88)90244-4; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; Dalack GW, 1998, AM J PSYCHIAT, V155, P1490, DOI 10.1176/ajp.155.11.1490; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Fenster CP, 1997, J NEUROSCI, V17, P5747; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HILL JA, 1993, J NEUROSCI, V13, P1551; HODGE AS, 1992, MOL PHARMACOL, V41, P937; Johnson JH, 2000, BRAIN RES BULL, V51, P249, DOI 10.1016/S0361-9230(99)00226-9; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Marshall DL, 1997, J NEUROCHEM, V68, P1511; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; PARSONS LH, 1992, J NEUROCHEM, V58, P212, DOI 10.1111/j.1471-4159.1992.tb09298.x; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PRIOR C, 1992, GEN PHARMACOL, V23, P1017, DOI 10.1016/0306-3623(92)90280-W; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; SACAAN AI, 1995, J PHARMACOL EXP THER, V274, P224; SCHENK JO, 1982, BRAIN RES, V277, P1; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARTZ ML, 1993, J COMP NEUROL, V327, P48, DOI 10.1002/cne.903270105; SCHWARTZ RD, 1984, J NEUROCHEM, V42, P1495, DOI 10.1111/j.1471-4159.1984.tb02818.x; Vinson PN, 1997, J NEUROSCI METH, V73, P61, DOI 10.1016/S0165-0270(96)02213-3; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Wu Y, 2000, NEUROSCIENCE, V96, P65, DOI 10.1016/S0306-4522(99)00539-4; Xu W, 1999, J NEUROSCI, V19, P9298	48	411	416	1	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1224	1229		10.1038/nn769	http://dx.doi.org/10.1038/nn769			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713470				2022-12-28	WOS:000172525000019
J	Baker-Herman, TL; Fuller, DD; Bavis, RW; Zabka, AG; Golder, FJ; Doperalski, NJ; Johnson, RA; Watters, JJ; Mitchell, GS				Baker-Herman, TL; Fuller, DD; Bavis, RW; Zabka, AG; Golder, FJ; Doperalski, NJ; Johnson, RA; Watters, JJ; Mitchell, GS			BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia	NATURE NEUROSCIENCE			English	Article							LONG-TERM FACILITATION; TRANSIENT FOREBRAIN ISCHEMIA; NEUROTROPHIC FACTOR; GENOMIC CONSEQUENCES; PHRENIC MOTONEURONS; RECEPTOR ACTIVATION; GENE-EXPRESSION; MESSENGER-RNA; MOTOR CONTROL; NEURONS	Intermittent hypoxia causes a form of serotonin-dependent synaptic plasticity in the spinal cord known as phrenic long-term facilitation (pLTF). Here we show that increased synthesis of brain-derived neurotrophic factor (BDNF) in the spinal cord is necessary and sufficient for pLTF in adult rats. We found that intermittent hypoxia elicited serotonin-dependent increases in BDNF synthesis in ventral spinal segments containing the phrenic nucleus, and the magnitude of these BDNF increases correlated with pLTF magnitude. We used RNA interference (RNAi) to interfere with BDNF expression, and tyrosine kinase receptor inhibition to block BDNF signaling. These disruptions blocked pLTF, whereas intrathecal injection of BDNF elicited an effect similar to pLTF. Our findings demonstrate new roles and regulatory mechanisms for BDNF in the spinal cord and suggest new therapeutic strategies for treating breathing disorders such as respiratory insufficiency after spinal injury. These experiments also illustrate the potential use of RNAi to investigate functional consequences of gene expression in the mammalian nervous system in vivo.	Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; Univ Wisconsin, Ctr Neurosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mitchell, GS (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.	mitchell@svm.vetmed.wisc.edu			NHLBI NIH HHS [HL 65383, HL 07654] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065383] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Bach KB, 1998, J APPL PHYSIOL, V84, P2099, DOI 10.1152/jappl.1998.84.6.2099; Baker TL, 2001, RESP PHYSIOL, V129, P25, DOI 10.1016/S0034-5687(01)00280-8; Baker-Herman TL, 2002, J NEUROSCI, V22, P6239; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Basura GJ, 2001, EXP NEUROL, V169, P255, DOI 10.1006/exnr.2001.7682; Bavis RW, 2003, J APPL PHYSIOL, V94, P399, DOI 10.1152/japplphysiol.00374.2002; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; Blitz DM, 2002, J NEUROPHYSIOL, V87, P2964, DOI 10.1152/jn.2002.87.6.2964; Bodineau L, 2001, NEUROSCIENCE, V108, P643, DOI 10.1016/S0306-4522(01)00442-0; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FELDMAN JL, 1908, ANNU REV NEUROSCI, V26, P239; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fuller DD, 2003, J NEUROSCI, V23, P2993; Fuller DD, 2001, J APPL PHYSIOL, V90, P2001, DOI 10.1152/jappl.2001.90.5.2001; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; JACKSON AB, 1994, ARCH PHYS MED REHAB, V75, P270, DOI 10.1016/0003-9993(94)90027-2; Johnson RA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-10-j0005.2000; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kinkead R, 1998, J NEUROSCI, V18, P8436; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Kokaia Z, 1996, MOL BRAIN RES, V38, P139, DOI 10.1016/0169-328X(96)00002-2; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Li YX, 1998, J NEUROSCI, V18, P10231; Ling LM, 2001, J NEUROSCI, V21, P5381, DOI 10.1523/JNEUROSCI.21-14-05381.2001; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MANSEL JK, 1990, CHEST, V97, P1446, DOI 10.1378/chest.97.6.1446; Mitchell GS, 2003, J APPL PHYSIOL, V94, P358, DOI 10.1152/japplphysiol.00523.2002; Mitchell GS, 2001, J APPL PHYSIOL, V90, P2466, DOI 10.1152/jappl.2001.90.6.2466; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Prabhakar NR, 2001, J APPL PHYSIOL, V90, P1986, DOI 10.1152/jappl.2001.90.5.1986; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Solomon IC, 2000, RESP PHYSIOL, V121, P101, DOI 10.1016/S0034-5687(00)00122-5; Strollo PJ, 1996, NEW ENGL J MED, V334, P99, DOI 10.1056/NEJM199601113340207; Tanaka T, 1997, J NEUROSCI, V17, P2959; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Uchino H, 1997, J CEREBR BLOOD F MET, V17, P1303, DOI 10.1097/00004647-199712000-00005; Veasey SC, 1996, AM J RESP CRIT CARE, V153, P776, DOI 10.1164/ajrccm.153.2.8564132; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zabka AG, 2001, J PHYSIOL-LONDON, V531, P509, DOI 10.1111/j.1469-7793.2001.0509i.x	50	369	386	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					48	55		10.1038/nn1166	http://dx.doi.org/10.1038/nn1166			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699417				2022-12-28	WOS:000187636000012
J	Sabo, SL; McAllister, AK				Sabo, SL; McAllister, AK			Mobility and cycling of synaptic protein-containing vesicles in axonal growth cone filopodia	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; ACTIN-FILAMENTS; NMDA RECEPTORS; TRANSPORT; MICROTUBULES; DYNAMICS; RELEASE; SYNAPTOGENESIS; ORGANIZATION; ORGANELLES	The spatial distribution and coordination of vesicular dynamics within growth cones are poorly understood. It has long been thought that membranous organelles are concentrated in the central regions of growth cones and excluded from filopodia; this view has dramatically shaped conceptual models of the cellular mechanisms of axonal growth and presynaptic terminal formation. To begin to test these models, we studied membrane dynamics within axonal growth cones of living rat cortical neurons. We demonstrate that growth cone filopodia contain vesicles that transport synaptic vesicle proteins bidirectionally along filopodia and fuse with the filopodial surface in response to focal stimulation, allowing for both local secretion of vesicular contents and rapid changes in the plasma membrane composition of individual filopodia. Our results suggest a new model in which growth cone filopodia are actively involved in both emitting and responding to local signals related to axon growth and early synapse formation.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.			Sabo, Shasta/0000-0001-6386-7443; McAllister, A. Kimberley/0000-0001-9177-9889				BANKER G, 1998, CULTURING NERVE CELL; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; BUNGE MB, 1977, J NEUROCYTOL, V6, P407, DOI 10.1007/BF01178226; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; CHENG TP, 1987, J NEUROSCI, V7, P752; CHENG TPO, 1985, J CELL BIOL, V101, P1473, DOI 10.1083/jcb.101.4.1473; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; DAILEY ME, 1993, J NEUROSCI, V13, P3375; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Diefenbach TJ, 1999, J NEUROSCI, V19, P9436; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gallo G, 1999, J NEUROSCI, V19, P3860; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gordon-Weeks P. R., 2000, NEURONAL GROWTH CONE; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LANDIS SC, 1978, J CELL BIOL, V78, P8; Lin SY, 1998, J NEUROSCI, V18, P3725; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; NUTTALL RP, 1979, EXP CELL RES, V119, P163, DOI 10.1016/0014-4827(79)90345-8; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; REES RP, 1981, NEUROSCIENCE, V6, P247, DOI 10.1016/0306-4522(81)90060-9; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; TAYLOR J, 1990, J NEUROCHEM, V54, P1689, DOI 10.1111/j.1471-4159.1990.tb01223.x; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077	38	83	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1264	1269		10.1038/nn1149	http://dx.doi.org/10.1038/nn1149			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14608359				2022-12-28	WOS:000186725600010
J	Doetsch, F				Doetsch, F			The glial identity of neural stem cells	NATURE NEUROSCIENCE			English	Review							ADULT MAMMALIAN BRAIN; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIA; SUBVENTRICULAR ZONE; PROGENITOR CELLS; VENTRICULAR ZONE; PRECURSOR CELLS; CEREBRAL-CORTEX; SPINAL-CORD	Glia are the most numerous cells in the brain, and their many diverse functions highlight their essential role in the nervous system. Recent studies have revealed an unexpected new role for glia in a wide variety of species, that of stem cells/progenitors in the adult and embryonic brain. Differentiation along the glial lineage may be a default state of development reflected in the progression of stem cells along the neuroepithelial radial glia astrocyte lineage.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Doetsch, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.	fkd2101@columbia.edu						Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; BIGNAMI A, 1974, NATURE, V252, P55, DOI 10.1038/252055a0; CAJAL RY, 1995, HISTOLOGY NERVOUS SY, V1; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7; COHEN E, 1987, INT J DEV NEUROSCI, V5, P43, DOI 10.1016/0736-5748(87)90047-5; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Delaney CL, 1996, J NEUROSCI, V16, P6908; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 2001, BRAIN BEHAV EVOLUT, V58, P306, DOI 10.1159/000057572; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; ECKENHOFF MF, 1988, J NEUROSCI, V8, P2729; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Font E, 1997, BRAIN RES, V754, P245, DOI 10.1016/S0006-8993(97)00085-1; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; GOMEZPINILLA F, 1995, J NEUROSCI, V15, P2021, DOI 10.1523/JNEUROSCI.15-03-02021.1995; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GRAY GE, 1992, DEVELOPMENT, V114, P271; Gritti A, 1999, J NEUROSCI, V19, P3287; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Imura T, 2003, J NEUROSCI, V23, P2824; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Koketsu D, 2003, J NEUROSCI, V23, P937; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lie DC, 2002, J NEUROSCI, V22, P6639; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marino S, 2000, GENE DEV, V14, P994; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Matthias K, 2003, J NEUROSCI, V23, P1750; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Palmer TD, 1999, J NEUROSCI, V19, P8487; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Peters A., 1991, FINE STRUCTURE NERVO; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Sakakibara S, 1997, J NEUROSCI, V17, P8300; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shibata T, 1997, J NEUROSCI, V17, P9212; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Weiss S, 1996, J NEUROSCI, V16, P7599; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; YAZAKI N, 1994, J NEUROSCI RES, V37, P445, DOI 10.1002/jnr.490370403; Yuasa S, 2001, ARCH HISTOL CYTOL, V64, P119, DOI 10.1679/aohc.64.119; Zhou M, 2001, J NEUROSCI, V21, P7901, DOI 10.1523/JNEUROSCI.21-20-07901.2001; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	100	564	583	3	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1127	1134		10.1038/nn1144	http://dx.doi.org/10.1038/nn1144			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14583753				2022-12-28	WOS:000186229200008
J	Fine, I; Wade, AR; Brewer, AA; May, MG; Goodman, DF; Boynton, GM; Wandell, BA; MacLeod, DIA				Fine, I; Wade, AR; Brewer, AA; May, MG; Goodman, DF; Boynton, GM; Wandell, BA; MacLeod, DIA			Long-term deprivation affects visual perception and cortex	NATURE NEUROSCIENCE			English	Article							EARLY BLINDNESS; REHABILITATION; NEURONS; AREA		Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; Stanford Univ, Dept Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Sendero Grp LLC, Concord, CA 94520 USA; Calif Pacific Med Ctr, San Francisco, CA 94109 USA; Salk Inst Biol Studies, La Jolla, CA 93037 USA	University of California System; University of California San Diego; The Smith-Kettlewell Eye Research Institute; Stanford University; Stanford University; California Pacific Medical Center; Salk Institute	Fine, I (corresponding author), Univ Calif San Diego, Dept Psychol, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Wade, Alex/B-5473-2010	Wade, Alexander Robert/0000-0003-4871-2747	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS044759] Funding Source: NIH RePORTER; NINDS NIH HHS [F30 NS044759] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKROYD C, 1974, Q J EXP PSYCHOL, V26, P114, DOI 10.1080/14640747408400393; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; CARLSON S, 1983, ACTA OPHTHALMOL, V61, P701; CARLSON S, 1986, BRIT J OPHTHALMOL, V70, P607, DOI 10.1136/bjo.70.8.607; CHESELDEN W, 1728, PHILOS T, V402, P447; Collins CE, 2003, J NEUROSCI, V23, P2251; GREGORY RL, 1963, EXP PSYCHOL SOC MONO, V2; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Lewis TL, 2002, VISION RES, V42, P939, DOI 10.1016/S0042-6989(02)00041-X; MAYER DL, 1982, VISION RES, V22, P1141, DOI 10.1016/0042-6989(82)90079-7; Morgan MichaelJ., 1977, MOLYNEUXS QUESTION V; PASTERNAK T, 1981, NATURE, V292, P834, DOI 10.1038/292834a0; SACKS O., 1995, ANTHR MARS, P108; VAEGAN TD, 1979, T OPHTHAL SOC UK, V99, P432; Valvo A., 1971, SIGHT RESTORATION LO	15	193	194	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					915	916		10.1038/nn1102	http://dx.doi.org/10.1038/nn1102			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12937420				2022-12-28	WOS:000184970400008
J	Becherer, U; Moser, T; Stuhmer, W; Oheim, M				Becherer, U; Moser, T; Stuhmer, W; Oheim, M			Calcium regulates exocytosis at the level of single vesicles	NATURE NEUROSCIENCE			English	Article							BUFFERED CA2+ DIFFUSION; CHROMAFFIN CELLS; SYNAPTIC VESICLES; TIME-COURSE; SECRETION; RELEASE; MEMBRANE; MICRODOMAINS; GRANULES; CHANNELS	Ca2+ microdomains that form during the opening of voltage-gated Ca2+ channels have been implicated in regulating the kinetics of hormone and transmitter release. Direct assessment of the interaction between a single Ca2+ microdomain and a single secretory vesicle has been impossible because of technical limitations. Using evanescent field imaging of near-membrane micromolar Ca2+ concentration ([Ca2+]) and fluorescently labeled vesicles, we have observed exocytosis of individual chromaffin dense-core vesicles that was triggered by Ca2+ microdomains. Ca2+ microdomains selectively triggered the release of vesicles that were docked within 300 nm. Not all vesicles exposed to a Ca2+ microdomain were released, indicating that some vesicles are docked but are not ready for release. In addition to its established role as a trigger for release, elevated near-membrane [Ca2+] reduced the distance between docked vesicles and Ca2+ entry sites. Our results suggest a new mechanism for stimulation-dependent facilitation of exocytosis, whereby vesicles are moved closer to Ca2+ entry sites, thereby increasing a Ca2+ microdomain's efficacy to trigger vesicle fusion.	Ecole Super Phys & Chim Ind Ville Paris, CNRS, FRE 2500, INSERM,EPI 0002, F-75005 Paris, France; Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Univ Gottingen, Dept Otolaryngol, D-37075 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Max Planck Society; University of Gottingen	Oheim, M (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, FRE 2500, INSERM,EPI 0002, 10 Rue Vauquelin, F-75005 Paris, France.	martin.oheim@espci.fr	Becherer, Ute/AGW-2576-2022; Stuehmer, Walter/A-2176-2009; Moser, Tobias/L-5068-2014; Becherer, Ute/F-6711-2010	Stuehmer, Walter/0000-0002-0642-7764; Moser, Tobias/0000-0001-7145-0533; Becherer, Ute/0000-0001-6005-7517				ADLER EM, 1991, J NEUROSCI, V11, P1496; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cleemann L, 1997, ADV EXP MED BIOL, V430, P57; ETTER EF, 1994, J BIOL CHEM, V269, P10141; GHOSH RN, 1994, BIOPHYS J, V66, P1301, DOI 10.1016/S0006-3495(94)80939-7; Gomis A, 1999, J NEUROSCI, V19, P6309; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Khanna B, 2002, BIOPHYS J, V82, p10A; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Melamed-Book N, 1999, P NATL ACAD SCI USA, V96, P15217, DOI 10.1073/pnas.96.26.15217; MONCK JR, 1994, BIOPHYS J, V67, P505, DOI 10.1016/S0006-3495(94)80554-5; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Oheim M, 1999, EUR BIOPHYS J BIOPHY, V28, P91, DOI 10.1007/s002490050188; Omann GM, 1996, BIOPHYS J, V71, P2885, DOI 10.1016/S0006-3495(96)79485-7; Parnas I, 1999, J PHYSIOL-LONDON, V517, P629, DOI 10.1111/j.1469-7793.1999.0629s.x; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SCHROEDER TJ, 1994, J BIOL CHEM, V269, P17215; Schulte A, 1998, ANAL CHEM, V70, P985, DOI 10.1021/ac970934e; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Wick PF, 1997, NEUROSCIENCE, V80, P847, DOI 10.1016/S0306-4522(97)00062-6; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538	49	112	116	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					846	853		10.1038/nn1087	http://dx.doi.org/10.1038/nn1087			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12845327				2022-12-28	WOS:000184413700014
J	Menz, MD; Freeman, RD				Menz, MD; Freeman, RD			Stereoscopic depth processing in the visual cortex: a coarse-to-fine mechanism	NATURE NEUROSCIENCE			English	Article							BINOCULAR DISPARITY; STRIATE CORTEX; COMPLEX CELLS; NEURAL REPRESENTATION; SPATIAL SCALES; CONNECTIVITY; SENSITIVITY; COMPUTATION; DYNAMICS; NEURONS	For binocular animals viewing a three-dimensional scene, the left and right eyes receive slightly different information, and the brain uses this 'binocular disparity' to interpret stereoscopic depth. An important theoretical conjecture in this mechanism is that coarse processing precedes and constrains finely detailed processing. We present three types of neurophysiological data from the cat's visual cortex that are consistent with a temporal coarse-to-fine tuning of disparity information. First, the disparity tuning of cortical cells generally sharpened during the time course of response. Second, cells responsive to large and small spatial scale had relatively shorter and longer temporal latencies, respectively. Third, cross-correlation analysis between simultaneously recorded pairs of cortical cells showed that connections between disparity-tuned neurons were generally stronger for coarse-to-fine processing than for fine-to-coarse processing. These results are consistent with theoretical and behavioral studies and suggest that rapid, coarse percepts are refined over time in stereoscopic depth perception.	Univ Calif Berkeley, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Menz, MD (corresponding author), Smith Kettlewell Eye Res Inst, 2318 Fillmore St, San Francisco, CA 94115 USA.				NATIONAL EYE INSTITUTE [R01EY003716, R01EY001175] Funding Source: NIH RePORTER; NEI NIH HHS [EY01175, EY03716] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Li G., 1985, EXPLORING DATA TABLE, P281; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; NISHIHARA HK, 1984, OPT ENG, V23, P536, DOI 10.1117/12.7973334; NOMURA M, 1993, BIOL CYBERN, V69, P165, DOI 10.1007/BF00226200; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Parker DM, 1997, PERCEPTION, V26, P1169, DOI 10.1068/p261169; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PRESS WH, 1992, NUMERICAL RECIPES; Qian N, 1997, VISION RES, V37, P1811, DOI 10.1016/S0042-6989(96)00331-8; Quam L. H., 1987, READINGS COMPUT VIS, P80; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; ROHALY AM, 1994, VISION RES, V34, P1315, DOI 10.1016/0042-6989(94)90205-4; ROHALY AM, 1993, J OPT SOC AM A, V10, P2433, DOI 10.1364/JOSAA.10.002433; SANGER TD, 1988, BIOL CYBERN, V59, P405, DOI 10.1007/BF00336114; SMALLMAN HS, 1995, VISION RES, V35, P1047, DOI 10.1016/0042-6989(94)00197-T; Smallman HS, 1997, PERCEPTION, V26, P977, DOI 10.1068/p260977; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WILSON HR, 1991, J OPT SOC AM A, V8, P229, DOI 10.1364/JOSAA.8.000229	30	85	85	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					59	65		10.1038/nn986	http://dx.doi.org/10.1038/nn986			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469131				2022-12-28	WOS:000180089300016
J	Godenschwege, TA; Hu, HL; Shan-Crofts, X; Goodman, CS; Murphey, RK				Godenschwege, TA; Hu, HL; Shan-Crofts, X; Goodman, CS; Murphey, RK			Bi-directional signaling by Semaphorin 1a during central synapse formation in Drosophila	NATURE NEUROSCIENCE			English	Article							GIANT-FIBER SYSTEM; OUTGROWTH-RELATED PROTEIN; ABL TYROSINE KINASE; TRANSMEMBRANE SEMAPHORIN; NEURITE-OUTGROWTH; HUMAN CD100; SYNAPTOGENESIS; EXPRESSION; MUTATIONS; INTERACTS	Semaphorins have been intensively studied for their role in dendritic and axonal pathfinding, but less is known about their potential role in synapse formation. In the adult giant fiber (GF) system of fruit flies (Drosophila melanogaster), we show that transmembrane Semaphorin 1a (Sema-1a) is involved in synapse formation in addition to its role in guidance during pathfinding. Cell-autonomous rescue experiments showed that Sema-1a is involved in assembly of a central synapse and that it is required both pre- and postsynaptically. We also found that pre- but not postsynaptic gain-of-function Sema-la was able to disrupt the GF-motor neuron synapse and that the phenotype depended on a proline-rich intracellular domain that contains a putative Enabled binding site. We suggest that transmembrane Sema-1a is part of a bi-directional signaling system that leads to the formation of the GF synapse and possibly acts as both a ligand and a receptor.	Univ Massachusetts, Dept Biol, Morrill Sci Ctr, Amherst, MA 01003 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Massachusetts System; University of Massachusetts Amherst; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Murphey, RK (corresponding author), Univ Massachusetts, Dept Biol, Morrill Sci Ctr, Amherst, MA 01003 USA.	rmurphey@bio.umass.edu	Godenschwege, Tanja A/A-2830-2010	Godenschwege, Tanja A/0000-0003-3322-4134; Hu, Hailan/0000-0002-0425-5057	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044609] Funding Source: NIH RePORTER; NINDS NIH HHS [NS44609] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen MJ, 1999, J NEUROSCI, V19, P9374; Allen MJ, 2000, MOL CELL NEUROSCI, V16, P754, DOI 10.1006/mcne.2000.0903; Allen MJ, 1998, J COMP NEUROL, V397, P519, DOI 10.1002/(SICI)1096-9861(19980810)397:4<519::AID-CNE5>3.0.CO;2-4; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Billard C, 2000, BLOOD, V95, P965, DOI 10.1182/blood.V95.3.965.003k39_965_972; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Harris BZ, 2001, J CELL SCI, V114, P3219; HARRIS WA, 1987, DEVELOPMENT, V101, P123; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Herold C, 1996, J IMMUNOL, V157, P5262; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Jacobs K, 2000, DEVELOPMENT, V127, P5203; KING DG, 1980, J NEUROCYTOL, V9, P753, DOI 10.1007/BF01205017; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Ohoka Y, 2001, BIOCHEM BIOPH RES CO, V280, P237, DOI 10.1006/bbrc.2000.4080; Phelan P, 1996, J NEUROSCI, V16, P1101; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Schultze W, 2001, J NEUROCHEM, V78, P482, DOI 10.1046/j.1471-4159.2001.00447.x; Shinozaki K, 1999, MOL BRAIN RES, V71, P364, DOI 10.1016/S0169-328X(99)00181-3; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu HH, 2000, GENETICS, V156, P723	33	100	100	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1294	1301		10.1038/nn976	http://dx.doi.org/10.1038/nn976			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12436113				2022-12-28	WOS:000179447500012
J	Suzuki, R; Morcuende, S; Webber, M; Hunt, SP; Dickenson, AH				Suzuki, R; Morcuende, S; Webber, M; Hunt, SP; Dickenson, AH			Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways	NATURE NEUROSCIENCE			English	Article							SUBSTANCE-P RECEPTOR; NOXIOUS INHIBITORY CONTROLS; CENTRAL-NERVOUS-SYSTEM; LAMINA I NEURONS; PAIN-CONTROL; DORSAL-HORN; 5-HT3 RECEPTORS; NEUROKININ-1 RECEPTOR; PROJECTION NEURONS; RAT	The increase in pain sensitivity that follows injury is regulated by superficially located projection neurons in the dorsal horn of the spinal cord that express the neurokinin-1 (NK1) receptor. After selective ablation of these neurons in rats, we identified changes in receptive field size, mechanical and thermal coding and central sensitization of deeper dorsal horn neurons that are important for both pain sensations and reflexes. We were able to reproduce these changes by pharmacological block of descending serotonergic facilitatory pathways. Using Fos histochemistry, we found changes in the activation of serotonergic neurons in the brainstem as well as evidence for a loss of descending control of spinal excitability. We conclude that NK1-positive spinal projection neurons, activated by primary afferent input, project to higher brain areas that control spinal excitability- and therefore pain sensitivity-primarily through descending pathways from the brainstem.	UCL, Dept Pharmacol, London WC1E 6BT, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Suzuki, R (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	ucklrsu@ucl.ac.uk	Morcuende, Sara/G-8672-2015; HUNT, STEPHEN P/C-1646-2008	Morcuende, Sara/0000-0003-1471-7005; Hunt, Stephen/0000-0001-9453-5505				Ali Z, 1996, NEUROSCI LETT, V208, P203, DOI 10.1016/0304-3940(95)12600-7; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Bernard JF, 1998, J COMP NEUROL, V401, P429; Bernard JF, 1996, PROG BRAIN RES, V107, P243; Bester H, 2001, J NEUROSCI, V21, P1039, DOI 10.1523/JNEUROSCI.21-03-01039.2001; BOUHASSIRA D, 1992, BRAIN RES, V595, P353, DOI 10.1016/0006-8993(92)91071-L; BOWKER RM, 1983, BRAIN RES, V288, P33, DOI 10.1016/0006-8993(83)90079-3; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; Chung F, 1999, EUR J ANAESTH, V16, P669, DOI 10.1046/j.1365-2346.1999.00547.x; Cui M, 1999, J PHARMACOL EXP THER, V289, P868; DEEGAN R, 1992, AM J MED SCI, V304, P373, DOI 10.1097/00000441-199212000-00009; DICKENSON AH, 1995, BRIT J ANAESTH, V75, P193, DOI 10.1093/bja/75.2.193; DING YQ, 1995, BRAIN RES, V674, P336, DOI 10.1016/0006-8993(95)00022-I; DUBNER R, 1999, PAIN S, V6, pS27; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Hunt SP, 2000, TRENDS PHARMACOL SCI, V21, P284, DOI 10.1016/S0165-6147(00)01496-6; Janusonis S, 2001, J COMP NEUROL, V440, P31, DOI 10.1002/cne.1368; KIA HK, 1995, NEUROREPORT, V6, P257, DOI 10.1097/00001756-199501000-00008; KIDD EJ, 1993, BRAIN RES, V612, P289, DOI 10.1016/0006-8993(93)91674-H; Laporte AM, 1996, J CHEM NEUROANAT, V11, P67, DOI 10.1016/0891-0618(96)00130-5; LIGHT AR, 1993, SOMATOSENS MOT RES, V10, P309, DOI 10.3109/08990229309028840; Lima D, 2002, PROG NEUROBIOL, V66, P81, DOI 10.1016/S0301-0082(01)00025-9; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Marshall GE, 1996, NEUROSCIENCE, V72, P255, DOI 10.1016/0306-4522(95)00558-7; Mason P, 1997, J NEUROPHYSIOL, V77, P1087, DOI 10.1152/jn.1997.77.3.1087; McLeod AL, 1998, P NATL ACAD SCI USA, V95, P15775, DOI 10.1073/pnas.95.26.15775; Miquel MC, 2002, EUR J NEUROSCI, V15, P449, DOI 10.1046/j.0953-816x.2001.01872.x; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Oyama T, 1996, NEUROSCI RES, V25, P129; Polgar E, 2002, NEUROSCIENCE, V109, P799, DOI 10.1016/S0306-4522(01)00304-9; Roila F, 1997, EUR J CANCER, V33, P1364, DOI 10.1016/S0959-8049(97)00003-8; Satoh O, 1996, BRAIN RES, V728, P27, DOI 10.1016/0006-8993(96)00371-x; SCHOUENBORG J, 1985, BRAIN RES, V328, P23, DOI 10.1016/0006-8993(85)91318-6; Suzuki R, 2000, EXP NEUROL, V163, P408, DOI 10.1006/exnr.2000.7371; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; THOMPSON SWN, 1990, EUR J NEUROSCI, V2, P638, DOI 10.1111/j.1460-9568.1990.tb00453.x; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; URBAN M, 1999, P NATL ACAD SCI USA, V95, P2630; Villanueva Luis, 1995, Biological Research, V28, P113; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yu XH, 1999, J NEUROSCI, V19, P3545; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	47	319	333	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1319	1326		10.1038/nn966	http://dx.doi.org/10.1038/nn966			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402039				2022-12-28	WOS:000179447500015
J	Kemp, JA; McKernan, RM				Kemp, JA; McKernan, RM			NMDA receptor pathways as drug targets	NATURE NEUROSCIENCE			English	Review							D-SERINE; GLYCINE ANTAGONIST; ACUTE STROKE; IFENPRODIL; NEUROPROTECTION; DYSFUNCTION; MECHANISMS; SUBUNIT; SITE	Since the mid 1980s, there has been a great deal of enthusiasm within both academia and industry about the therapeutic potential of drugs targeting the NMDA subtype of glutamate receptors. That early promise is just beginning to translate into approvable drugs. Here we review the reasons for this slow progress and critically assess the future prospects for drugs that act on NMDA receptor pathways, including potential treatments for some major disorders such as stroke and Alzheimer's disease, for which effective therapies are still lacking.	Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Merck Res Labs, Harlow CM20 2QR, Essex, England; EVOTEC Neurosci GmbH, D-22525 Hamburg, Germany	Merck & Company; Evotec	McKernan, RM (corresponding author), Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Merck Res Labs, Terlings Pk,Eastwick Rd, Harlow CM20 2QR, Essex, England.	ruth_mckernan@merck.com						Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Chase TN, 2000, J NEUROL, V247, P36, DOI 10.1007/PL00007759; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; Del Dotto P, 2001, MOVEMENT DISORD, V16, P515, DOI 10.1002/mds.1112; Gill R, 2002, J PHARMACOL EXP THER, V302, P940, DOI 10.1124/jpet.102.034322; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Heresco-Levy U, 2002, AM J PSYCHIAT, V159, P480, DOI 10.1176/appi.ajp.159.3.480; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kemp JA, 1999, HANDB EXP PHARM, V141, P495; KEMP JA, 1998, DRUGS PHARM SCI, V89, P297; Kew JNC, 1996, J PHYSIOL-LONDON, V497, P761, DOI 10.1113/jphysiol.1996.sp021807; Krystal JH, 1999, HARVARD REV PSYCHIAT, V7, P125, DOI 10.1093/hrp/7.3.125; LEDERER R, 1993, BEHAV NEURAL BIOL, V60, P220, DOI 10.1016/0163-1047(93)90409-B; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malayev A, 2002, BRIT J PHARMACOL, V135, P901, DOI 10.1038/sj.bjp.0704543; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONDADORI C, 1989, EXP BRAIN RES, V75, P449; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Parsons CG, 2001, EUR J PHARMACOL, V429, P71, DOI 10.1016/S0014-2999(01)01307-3; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; SCHWARCZ RJ, 2001, PHARM EXP THER, V296, P659; Sheng M, 2001, J CELL SCI, V114, P1251; Tamminga CA, 1998, CRIT REV NEUROBIOL, V12, P21, DOI 10.1615/CritRevNeurobiol.v12.i1-2.20; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tranquillini, 1999, Expert Opin Investig Drugs, V8, P1837, DOI 10.1517/13543784.8.11.1837; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; WATKINS JC, 1994, NMDA RECEPTOR, P1; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409	37	394	429	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1039	1042		10.1038/nn936	http://dx.doi.org/10.1038/nn936			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403981				2022-12-28	WOS:000179041300009
J	Fournier, AE; Strittmatter, SM				Fournier, AE; Strittmatter, SM			Regenerating nerves follow the road more traveled	NATURE NEUROSCIENCE			English	Editorial Material							NEURITE OUTGROWTH; AXON GUIDANCE; INHIBITOR		Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA	Yale University; Yale University	Fournier, AE (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA.		Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; CAJAL R, 1991, DEGENERATION REGENER, V1, P66; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang XX, 2002, J NEUROSCI, V22, P5505; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	12	18	20	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					821	822		10.1038/nn0902-821	http://dx.doi.org/10.1038/nn0902-821			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12196804				2022-12-28	WOS:000177656300003
J	Olausson, H; Lamarre, Y; Backlund, H; Morin, C; Wallin, BG; Starck, G; Ekholm, S; Strigo, I; Worsley, K; Vallbo, AB; Bushnell, MC				Olausson, H; Lamarre, Y; Backlund, H; Morin, C; Wallin, BG; Starck, G; Ekholm, S; Strigo, I; Worsley, K; Vallbo, AB; Bushnell, MC			Unmyelinated tactile afferents signal touch and project to insular cortex	NATURE NEUROSCIENCE			English	Article							HAIRY SKIN; PAIN MECHANISMS; UNITS; FIBERS; MECHANORECEPTORS; NEURONS; SENSIBILITY; ACTIVATION; STIMULI; FIELDS	There is dual tactile innervation of the human hairy skin: in addition to fast-conducting myelinated afferent fibers, there is a system of slow-conducting unmyelinated (C) afferents that respond to light touch. In a unique patient lacking large myelinated afferents, we found that activation of C tactile (CT) afferents produced a faint sensation of pleasant touch. Functional magnetic resonance imaging (fMRI) analysis during CT stimulation showed activation of the insular region, but not of somatosensory areas S1 and S2. These findings identify CT as a system for limbic touch that may underlie emotional, hormonal and affiliative responses to caress-like, skin-to-skin contact between individuals.	Sahlgrens Univ Hosp, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Gothenburg Univ, Dept Physiol, S-41345 Gothenburg, Sweden; McGill Univ, Dept Anesthesia, Montreal, PQ H3G 1Y6, Canada; Sahlgrens Univ Hosp, Dept Radiat Phys, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, S-41345 Gothenburg, Sweden; McGill Univ, Dept Math & Stat, Montreal, PQ H3G 1Y6, Canada	Sahlgrenska University Hospital; Universite de Montreal; University of Gothenburg; McGill University; Sahlgrenska University Hospital; Sahlgrenska University Hospital; McGill University	Olausson, H (corresponding author), Sahlgrens Univ Hosp, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden.	olausson@physiol.gu.se	strigo, irina A/L-9882-2016	strigo, irina A/0000-0002-8799-716X; Starck, Goran/0000-0002-7917-012X				Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Brooks JCW, 2002, NEUROIMAGE, V15, P293, DOI 10.1006/nimg.2001.0974; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; COGHILL RC, 1994, J NEUROSCI, V14, P4095; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Craig AD, 1996, PROG BRAIN RES, V107, P225; Craig AD, 2002, J NEUROPHYSIOL, V87, P1902, DOI 10.1152/jn.00578.2001; Craig AD, 2000, J PAIN, V1, P33, DOI 10.1016/S1526-5900(00)90086-5; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Damasio A.R., 2000, FEELING WHAT HAPPENS; Disbrow E, 1998, HUM BRAIN MAPP, V6, P150, DOI 10.1002/(SICI)1097-0193(1998)6:3<150::AID-HBM4>3.3.CO;2-V; DOUGLAS WW, 1957, J PHYSIOL-LONDON, V139, P385, DOI 10.1113/jphysiol.1957.sp005899; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; FORGET R, 1995, CAN J PHYSIOL PHARM, V73, P285, DOI 10.1139/y95-039; FRIEDMAN DP, 1986, J COMP NEUROL, V252, P323, DOI 10.1002/cne.902520304; GEORGOPOULOS AP, 1976, J NEUROPHYSIOL, V39, P71, DOI 10.1152/jn.1976.39.1.71; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; JARVILEHTO T, 1976, EXP BRAIN RES, V25, P45; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; KAKUDA N, 1992, NEUROSCI RES, V15, P179, DOI 10.1016/0168-0102(92)90003-U; Kandel E., 2000, PRINCIPLES NEURAL SC; KONIETZNY F, 1977, PFLUG ARCH EUR J PHY, V368, P39, DOI 10.1007/BF01063452; KUMAZAWA T, 1977, J NEUROPHYSIOL, V40, P1325, DOI 10.1152/jn.1977.40.6.1325; KUMAZAWA T, 1977, J PHYSIOLOGY PARIS, V73, P287; Light AR, 1999, J NEUROPHYSIOL, V82, P3316, DOI 10.1152/jn.1999.82.6.3316; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; MACKENZIE RA, 1975, J NEUROL NEUROSUR PS, V38, P865, DOI 10.1136/jnnp.38.9.865; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2001, BRAIN, V124, P916, DOI 10.1093/brain/124.5.916; Olausson H, 1997, MUSCLE NERVE, V20, P1414, DOI 10.1002/(SICI)1097-4598(199711)20:11<1414::AID-MUS9>3.0.CO;2-D; PERL ER, 1968, J PHYSIOL-LONDON, V197, P593, DOI 10.1113/jphysiol.1968.sp008576; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; TALAIRACH Y, 1988, COPLANAR STEREOTAXIC; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VALLBO AB, 1995, J PHYSIOL-LONDON, V483, P783, DOI 10.1113/jphysiol.1995.sp020622; White J., 1969, PAIN NEUROSURGEON 40; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1	49	610	626	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					900	904		10.1038/nn896	http://dx.doi.org/10.1038/nn896			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12145636				2022-12-28	WOS:000177656300021
J	Oertner, TG; Sabatini, BL; Nimchinsky, EA; Svoboda, K				Oertner, TG; Sabatini, BL; Nimchinsky, EA; Svoboda, K			Facilitation at single synapses probed with optical quantal analysis	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; CULTURED HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; MULTIVESICULAR RELEASE; SILENT SYNAPSES; NMDA RECEPTORS; SYNAPTIC TRANSMISSION; EXCITATORY SYNAPSES; PYRAMIDAL NEURONS; CA1 SYNAPSES	Many synapses can change their strength rapidly in a use-dependent manner, but the mechanisms of such short-term plasticity remain unknown. To understand these mechanisms, measurements of neurotransmitter release at single synapses are required. We probed transmitter release by imaging transient increases in [Ca2+] mediated by synaptic N-methyl-D-aspartate receptors (NMDARs) in individual dendritic spines of CA1 pyramidal neurons in rat brain slices, enabling quantal analysis at single synapses. We found that changes in release probability, produced by paired-pulse facilitation (PPF) or by manipulation of presynaptic adenosine receptors, were associated with changes in glutamate concentration in the synaptic cleft, indicating that single synapses can release a variable amount of glutamate per action potential. The relationship between release probability and response size is consistent with a binomial model of vesicle release with several (> 5) independent release sites per active zone, suggesting that multivesicular release contributes to facilitation at these synapses.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Nimchinsky, Esther/GXF-5277-2022; Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Isaac JTR, 1998, NEUROPHARMACOLOGY, V37, P1399, DOI 10.1016/S0028-3908(98)00140-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Regehr WG, 2001, SYNAPSES, P135; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Schikorski T, 1997, J NEUROSCI, V17, P5858; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stuart G, 1998, J NEUROSCI, V18, P3501; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	50	237	242	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					657	664		10.1038/nn867	http://dx.doi.org/10.1038/nn867			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055631				2022-12-28	WOS:000176414300015
J	Lei, H; Christensen, TA; Hildebrand, JG				Lei, H; Christensen, TA; Hildebrand, JG			Local inhibition modulates odor-evoked synchronization of glomerulus-specific output neurons	NATURE NEUROSCIENCE			English	Article							CONTEXT-DEPENDENT MODULATION; SPHINX MOTH; ANTENNAL LOBES; OLFACTORY-BULB; PROJECTION NEURONS; MITRAL CELLS; INFORMATION; OSCILLATIONS; PHEROMONE; RESPONSES	At the first stage of olfactory processing in the brain, synchronous firing across glomeruli may help to temporally bind multiple and spatially distributed input streams activated by a given odor. This hypothesis, however, has never been tested in an organism in which the odor-tuning properties of several spatially identifiable glomeruli are known. Using the sphinx moth, an insect that meets these specific criteria, we recorded odor-evoked responses simultaneously from pairs of projection neurons (PNs) innervating the same or different glomeruli in the macroglomerular complex (MGC), which is involved in processing pheromonal information. PNs that branched in the same glomerulus and were activated by the same pheromone component also showed the strongest coincident responses to each odor pulse. Glomerulus-specific PN pairs were also inhibited by the pheromone component that selectively activated PNs in the neighboring glomerulus, and about 70% of all intraglomerular pairs showed increased synchronization when stimulated with a mixture of the two odorants. Thus, when two adjacent glomeruli receive their inputs simultaneously, the temporal tuning of output from each glomerulus is enhanced by reciprocal and inhibitory interglomerular interactions.	Univ Arizona, Div Neurobiol, Arizona Res Labs, Tucson, AZ 85721 USA	University of Arizona	Christensen, TA (corresponding author), Univ Arizona, Div Neurobiol, Arizona Res Labs, POB 210077, Tucson, AZ 85721 USA.	tc@neurobio.arizona.edu	Lei, Hong/ABH-1356-2020					Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; Carlson GC, 2000, J NEUROSCI, V20, P2011; Christensen TA, 1998, J NEUROSCI, V18, P5999; Christensen TA, 1997, J NEUROPHYSIOL, V77, P775, DOI 10.1152/jn.1997.77.2.775; Christensen TA, 1997, INSECT PHEROMONE RESEARCH, P184; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; CHRISTENSEN TA, 2000, NEUROBIOLOGY TASTE S, P201; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Fuss SH, 2001, J NEUROSCI, V21, P8396, DOI 10.1523/JNEUROSCI.21-21-08396.2001; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Gelperin A, 1999, J EXP BIOL, V202, P1855; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Heinbockel T, 1999, J COMP NEUROL, V409, P1; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; King JR, 2000, J NEUROSCI, V20, P2391; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 1996, J NEUROSCI, V16, P3837; Lei H, 2001, J COMP NEUROL, V432, P356, DOI 10.1002/cne.1108; Maynard EM, 1999, J NEUROSCI, V19, P8083; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; Nowak LG, 1999, J NEUROPHYSIOL, V81, P1057, DOI 10.1152/jn.1999.81.3.1057; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rieke F., 1997, SPIKES EXPLORING NEU; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Rospars JP, 2000, CHEM SENSES, V25, P119, DOI 10.1093/chemse/25.2.119; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; SHEPHERD GM, 1990, SYNAPTIC ORG BRAIN, P139; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Shipley MT, 1996, J NEUROBIOL, V30, P123; SINGER MS, 1994, NEUROREPORT, V5, P1297, DOI 10.1097/00001756-199406020-00036; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; VAADIA E, 1991, NEURONAL COOPERATIVI, P205; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; WALDROP B, 1987, J COMP PHYSIOL A, V161, P23, DOI 10.1007/BF00609452	50	104	106	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					557	565		10.1038/nn859	http://dx.doi.org/10.1038/nn859			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006983				2022-12-28	WOS:000175874600016
J	Trevisani, M; Smart, D; Gunthorpe, MJ; Tognetto, M; Barbieri, M; Campi, B; Amadesi, S; Gray, J; Jerman, JC; Brough, SJ; Owen, D; Smith, GD; Randall, AD; Harrison, S; Bianchi, A; Davis, JB; Geppetti, P				Trevisani, M; Smart, D; Gunthorpe, MJ; Tognetto, M; Barbieri, M; Campi, B; Amadesi, S; Gray, J; Jerman, JC; Brough, SJ; Owen, D; Smith, GD; Randall, AD; Harrison, S; Bianchi, A; Davis, JB; Geppetti, P			Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CAPSAICIN RECEPTOR; SENSORY NEURONS; PAIN; BRADYKININ; CHANNEL; HEAT; SENSITIZATION; CAPSAZEPINE; ANANDAMIDE	The vanilloid receptor-1 (VR1) is a heat-gated ion channel that is responsible for the burning sensation elicited by capsaicin. A similar sensation is reported by patients with esophagitis when they consume alcoholic beverages or are administered alcohol by injection as a medical treatment. We report here that ethanol activates primary sensory neurons, resulting in neuropeptide release or plasma extravasation in the esophagus, spinal cord or skin. Sensory neurons from trigeminal or dorsal root ganglia as well as VR1-expressing HEK293 cells responded to ethanol in a concentration-dependent and capsazepine-sensitive fashion. Ethanol potentiated the response of VR1 to capsaicin, protons and heat and lowered the threshold for heat activation of VR1 from similar to42degreesC to similar to34degreesC. This provides a likely mechanistic explanation for the ethanol-induced sensory responses that occur at body temperature and for the sensitivity of inflamed tissues to ethanol, such as might be found in esophagitis, neuralgia or wounds.	GlaxoSmithKline, Neurol CEDD, Harlow CM19 5AW, Essex, England; Univ Ferrara, Headache Ctr, Dept Expt & Clin Med, I-44100 Ferrara, Italy; Univ Catania, Dept Pharmacol, I-95123 Catania, Italy; GlaxoSmithKline, Discovery Res, Harlow CM19 5AW, Essex, England	GlaxoSmithKline; University of Ferrara; University of Catania; GlaxoSmithKline	Davis, JB (corresponding author), GlaxoSmithKline, Neurol CEDD, 3rd Ave, Harlow CM19 5AW, Essex, England.		barbieri, mario/AAJ-1477-2021; Geppetti, Pierangelo/AHA-7897-2022	barbieri, mario/0000-0001-9074-764X; Randall, Andrew/0000-0001-8852-3671				BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; BOLANOWSKI SJ, 1995, J PERIODONTAL RES, V30, P192, DOI 10.1111/j.1600-0765.1995.tb01273.x; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Docherty RJ, 1997, BRIT J PHARMACOL, V121, P1461, DOI 10.1038/sj.bjp.0701272; FARDY MJ, 1994, BRIT J ORAL MAX SURG, V32, P387, DOI 10.1016/0266-4356(94)90031-0; Forman SA, 1999, MOL PHARMACOL, V55, P102, DOI 10.1124/mol.55.1.102; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; HOLZER P, 1991, PHARMACOL REV, V43, P143; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Liang YF, 2001, J PHYSIOL-LONDON, V532, P229, DOI 10.1111/j.1469-7793.2001.0229g.x; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; SARIA A, 1983, N-S ARCH PHARMACOL, V324, P212, DOI 10.1007/BF00503897; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smid SD, 1998, NEUROGASTROENT MOTIL, V10, P403; Stubbs CD, 1999, ALCOHOL CLIN EXP RES, V23, P1552; Tognetto M, 2001, J NEUROSCI, V21, P1104; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	24	333	353	1	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					546	551		10.1038/nn852	http://dx.doi.org/10.1038/nn852			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992116				2022-12-28	WOS:000175874600014
J	Wei, F; Qiu, CS; Liauw, J; Robinson, DA; Ho, N; Chatila, T; Zhuo, M				Wei, F; Qiu, CS; Liauw, J; Robinson, DA; Ho, N; Chatila, T; Zhuo, M			Calcium-calmodulin-dependent protein kinase IV is required for fear memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; CREB PHOSPHORYLATION; GENETIC ENHANCEMENT; LATE-PHASE; POTENTIATION; AMYGDALA; NUCLEUS; CONSOLIDATION; TRANSCRIPTION	The ability to remember potential dangers in an environment is necessary to the survival of animals and humans. The cyclic AMP-responsive element binding protein (CREB) is a key transcription factor in synaptic plasticity and memory consolidation. We have found that in CaMKIV-/- mice-which are deficient in a component of the calcium-calmodulin-dependent protein kinase (CaMK) pathway, a major pathway of CREB activation-fear memory, but not persistent pain, was significantly reduced. CREB activation by fear conditioning and synaptic potentiation in the amygdala and cortical areas was reduced or blocked. We propose that cognitive memory related to a noxious shock can be disassociated from behavioral responses to tissue injury and inflammation.	Washington Univ, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Anat, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Neurobiol, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.	zhuom@morpheus.wustl.edu	Zhuo, Min/A-2072-2008	Zhuo, Min/0000-0001-9062-3241; Chatila, Talal/0000-0001-7439-2762; Robinson, Daphne/0000-0002-8817-6937	PHS HHS [10833, 38680] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BARTON O, 1979, COMPREHENSIVE ORGANI, V2, P83; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Davis M, 1997, PHILOS T ROY SOC B, V352, P1675, DOI 10.1098/rstb.1997.0149; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Falls WA, 2000, BEHAV NEUROSCI, V114, P998, DOI 10.1037//0735-7044.114.5.998; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kerchner GA, 2001, NAT NEUROSCI, V4, P453, DOI 10.1038/87396; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	186	201	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					573	579		10.1038/nn0602-855	http://dx.doi.org/10.1038/nn0602-855			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006982				2022-12-28	WOS:000175874600018
J	Kao, HT; Song, HJ; Porton, B; Ming, GL; Hoh, J; Abraham, M; Czernik, AJ; Pieribone, VA; Poo, MM; Greengard, P				Kao, HT; Song, HJ; Porton, B; Ming, GL; Hoh, J; Abraham, M; Czernik, AJ; Pieribone, VA; Poo, MM; Greengard, P			A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLE PHOSPHOPROTEINS; GROWTH CONE GUIDANCE; NEUROTRANSMITTER RELEASE; NEURONAL DIFFERENTIATION; NEUROMUSCULAR SYNAPSES; ACTIN POLYMERIZATION; AXONAL GROWTH; PHOSPHORYLATION; CELLS; RAT	Cyclic AMP (cAMP) promotes neurite outgrowth in a variety of neuronal cell lines through the activation of protein kinase A (PKA). We show here, using both Xenopus laevis embryonic neuronal culture and intact X. laevis embryos, that the nerve growth-promoting action of cAMP/PKA is mediated in part by the phosphorylation of synapsins at a single amino acid residue. Expression of a mutated form of synapsin that prevents phosphorylation at this site, or introduction of phospho-specific antibodies directed against this site, decreased basal and dibutyryl cAMP-stimulated neurite outgrowth. Expression of a mutation mimicking constitutive phosphorylation at this site increased neurite outgrowth, both under basal conditions and in the presence of a PKA inhibitor. These results provide a potential molecular approach for stimulating neuron regeneration, after injury and in neuro-degenerative diseases.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; NYU, Med Ctr, Dept Psychiat, New York, NY 10016 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06510 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Rockefeller University; Rockefeller University; New York University; Salk Institute; University of California System; University of California San Diego; Yale University; The John B Pierce Laboratory, Inc; University of California System; University of California Berkeley	Kao, HT (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.	kaoh@rockvax.rockefeller.edu	Ming, Guo-li/J-7880-2013	Pieribone, Vincent/0000-0002-5836-5454; Ming, Guo-li/0000-0002-2517-6075	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039327, R01MH039327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035941, R01NS037831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015072] Funding Source: NIH RePORTER; NIA NIH HHS [AG15072] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NINDS NIH HHS [NS37831, R29 NS35941] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CACERES A, 1991, J NEUROSCI, V11, P1515; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; CZERNIK AJ, 1991, METHOD ENZYMOL, P264; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Ferreira A, 2000, J NEUROSCI, V20, P3736, DOI 10.1523/JNEUROSCI.20-10-03736.2000; FERREIRA A, 1995, P NATL ACAD SCI USA, V92, P9225, DOI 10.1073/pnas.92.20.9225; FESCE R, 1992, J BIOL CHEM, V267, P11289; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GRANT P, 1986, DEV BIOL, V114, P475, DOI 10.1016/0012-1606(86)90212-5; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; JOHNSON EM, 1972, J BIOL CHEM, V247, P5650; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; LEVITAN IB, 1997, NEURON; LIESI P, 1983, NATURE, V306, P265, DOI 10.1038/306265a0; Lin WC, 1995, J NEUROSCI, V15, P8331; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Lu B, 1996, NEUROSCIENCE, V74, P1087, DOI 10.1016/0306-4522(96)00187-X; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nielander HB, 1997, EUR J NEUROSCI, V9, P2712, DOI 10.1111/j.1460-9568.1997.tb01700.x; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; Porton B, 1999, J NEUROCHEM, V73, P2266, DOI 10.1046/j.1471-4159.1999.0732266.x; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCHAEFFER E, 1994, P NATL ACAD SCI USA, V91, P3882, DOI 10.1073/pnas.91.9.3882; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Tabti N, 1998, CULTURING NERVE CELL, P237; Zhong ZG, 1999, NEUROSCI LETT, V260, P93, DOI 10.1016/S0304-3940(98)00969-0	45	119	124	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					431	437		10.1038/nn840	http://dx.doi.org/10.1038/nn840			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976703				2022-12-28	WOS:000175272000013
J	Tong, JY; Hannan, F; Zhu, YH; Bernards, A; Zhong, Y				Tong, JY; Hannan, F; Zhu, YH; Bernards, A; Zhong, Y			Neurofibromin regulates G protein-stimulated adenylyl cyclase activity	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NF1; GENE; DEFICITS; MODEL		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11790 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Massachusetts General Hospital	Zhong, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.org		Zhong, Yi/0000-0001-7810-9899; Zhong, Yi/0000-0002-7927-5976; Hannan, Frances/0000-0002-9958-3706	NINDS NIH HHS [NS34779] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034779] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Hsueh YP, 2001, J NEUROSCI, V21, P3764, DOI 10.1523/JNEUROSCI.21-11-03764.2001; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097	14	153	160	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					95	96		10.1038/nn792	http://dx.doi.org/10.1038/nn792			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788835				2022-12-28	WOS:000173558400007
J	Chiao, CC; Masland, RH				Chiao, CC; Masland, RH			Contextual tuning of direction-selective retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							RABBIT RETINA; RESPONSES	A direction-selective (DS) retinal ganglion cell responds well to a small object moving within its receptive field center, but less well when there is also a moving stimulus in the surrounding area; this has been described as tuning for local motion. We show here an additional selectivity, such that the surround has less effect if there is a discontinuity-that is, a difference in spatial phase, spatial frequency or velocity-between the center stimulus and that present in the surround.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; National Tsing Hua University	Masland, RH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, 50 Blossom St,Wellman 429, Boston, MA 02114 USA.		Chiao, Chuan-Chin/L-7708-2019					BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Chiao CC, 2002, J NEUROSCI, V22, P10509; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; He SG, 2000, NEUROSCI LETT, V285, P25, DOI 10.1016/S0304-3940(00)01030-2; Stasheff SF, 2002, J NEUROPHYSIOL, V88, P1026, DOI 10.1152/jn.2002.88.2.1026; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; WERBLIN F, 1988, VISUAL NEUROSCI, V1, P317, DOI 10.1017/S0952523800001978; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; WYATT HJ, 1975, J NEUROPHYSIOL, V38, P613, DOI 10.1152/jn.1975.38.3.613	11	35	35	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1251	1252		10.1038/nn1147	http://dx.doi.org/10.1038/nn1147			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14595442				2022-12-28	WOS:000186725600007
J	Kingsbury, MA; Rehen, SK; Contos, JJA; Higgins, CM; Chun, J				Kingsbury, MA; Rehen, SK; Contos, JJA; Higgins, CM; Chun, J			Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; NEURAL STEM-CELLS; POSTMITOTIC REGIONS; DECREASED APOPTOSIS; LYSOPHOSPHOLIPASE-D; RECEPTOR GENE; CYCLE; EXPRESSION	Lysophosphatidic acid (LPA) is a phospholipid that has extracellular signaling properties mediated by G protein-coupled receptors. Two LPA receptors, LPA(1) and LPA(2), are expressed in the embryonic cerebral cortex, suggesting roles for LPA signaling in cortical formation. Here we report that intact cerebral cortices exposed to extracellular LPA ex vivo rapidly increased in width and produced folds resembling gyri, which are not normally present in mouse brains and are absent in LPA(1) LPA(2) double-null mice. Mechanistically, growth was not due to increased proliferation but rather to receptor-dependent reduced cell death and increased terminal mitosis of neural progenitor cells (NPCs). Our results implicate extracellular lipid signals as new influences on brain formation during embryonic development.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Chun, J (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,ICND 118, La Jolla, CA 92037 USA.		Rehen, Stevens/J-5874-2012; Chun, Jerold/Y-4670-2019	Rehen, Stevens/0000-0003-4216-9501; 				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; BARRON DH, 1950, J EXP ZOOL, V113, P553, DOI 10.1002/jez.1401130304; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Cai L, 1997, J NEUROSCI, V17, P2079; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; Dubin AE, 1999, J NEUROSCI, V19, P1371; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ghosh MM, 1995, BIOREMED SER, V3, P15; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; ISHII I, IN PRESS ANN REV BIO; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Le Gros Clark W.E., 1945, ESSAYS GROWTH FORM, P1, DOI DOI 10.1016/J.JPEDSURG.2010.11.028; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; McGiffert C, 2002, FEBS LETT, V531, P103, DOI 10.1016/S0014-5793(02)03404-X; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Pompeiano M, 2000, J COMP NEUROL, V423, P1; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2002, BRAIN RES, V947, P78, DOI 10.1016/S0006-8993(02)02909-8; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Takahashi T, 1996, J NEUROSCI, V16, P5762; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X	50	198	204	1	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1292	1299		10.1038/nn1157	http://dx.doi.org/10.1038/nn1157			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625558				2022-12-28	WOS:000186725600014
J	Meffert, MK; Chang, JM; Wiltgen, BJ; Fanselow, MS; Baltimore, D				Meffert, MK; Chang, JM; Wiltgen, BJ; Fanselow, MS; Baltimore, D			NF-kappa B functions in synaptic signaling and behavior	NATURE NEUROSCIENCE			English	Article							CALMODULIN KINASE-II; TRANSCRIPTION FACTOR; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; CREB PHOSPHORYLATION; INHIBITOR PROTEIN; MICE LACKING; CALCIUM; BRAIN	Ca2+-regulated gene transcription is essential to diverse physiological processes, including the adaptive plasticity associated with learning. We found that basal synaptic input activates the NF-kappaB transcription factor by a pathway requiring the Ca2+ /calmodulin-dependent kinase CaMKII and local submembranous Ca2+ elevation. The p65: p50 NF-kappaB form is selectively localized at synapses; p65-deficient mice have no detectable synaptic NF-kappaB. Activated NF-kappaB moves to the nucleus and could directly transmute synaptic signals into altered gene expression. Mice lacking p65 show a selective learning deficit in the spatial version of the radial arm maze. These observations suggest that long-term changes to adult neuronal function caused by synaptic stimulation can be regulated by NF-kappaB nuclear translocation and gene activation.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles	Baltimore, D (corresponding author), CALTECH, Div Biol, MC204-31, Pasadena, CA 91125 USA.			Rudell, Jolene/0000-0003-3022-4649				Albensi BC, 2000, SYNAPSE, V35, P151; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FINK CC, IN PRESS NEURON; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goslin K., 1990, CULTURING NERVE CELL; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guerrini L, 1997, J NEUROSCI, V17, P6057; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Lerant A, 2001, BRAIN RES, V904, P259, DOI 10.1016/S0006-8993(01)02470-2; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu D, 1998, J NEUROSCI, V18, P1329; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Nelson G, 2002, J CELL SCI, V115, P1137; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; VAN AD, 1996, SCIENCE, V274, P787; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	47	534	552	2	42	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1072	1078		10.1038/nn1110	http://dx.doi.org/10.1038/nn1110			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947408				2022-12-28	WOS:000185633600019
J	Kingdom, FAA				Kingdom, FAA			Color brings relief to human vision	NATURE NEUROSCIENCE			English	Article							PERCEPTION; SHAPE	In natural scenes, chromatic variations, and the luminance variations that are aligned with them, mainly arise from surfaces such as flowers or painted objects. Pure or near-pure luminance variations, on the other hand, mainly arise from inhomogeneous illumination such as shadows or shading. Here, I provide evidence that knowledge of these color-luminance relationships is built into the machinery of the human visual system. When a pure-luminance grating is added to a differently oriented chromatic grating, the resulting 'plaid' appears to spring into three-dimensional relief, an example of 'shape-from-shading'. By psychophysical measurements, I found that the perception of shape-from-shading in the plaid was triggered when the chromatic and luminance gratings were not aligned, and suppressed when the gratings were aligned. This finding establishes a new role for color vision in determining the three-dimensional structure of an image: one that exploits the natural relationships that exist between color and luminance in the visual world.	McGill Vis Res Unit, Montreal, PQ H3A 1A1, Canada	McGill University	Kingdom, FAA (corresponding author), McGill Vis Res Unit, 687 Pine Ave W,Room H4-14, Montreal, PQ H3A 1A1, Canada.							ATTICK JJ, 1996, NEURAL COMPUT, V8, P1321; BARLOW HB, 1989, COMPUTING NEURON, P217; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; CAVANAGH P, 1991, VISION VISUAL DYSFUN, V5, P234; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FINE I, IN PRESS J OPT SOC A; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; GREGORY RL, 1977, PERCEPTION, V6, P113, DOI 10.1068/p060113; JOHNSTON A, 1992, PERCEPTION, V21, P365, DOI 10.1068/p210365; KINGDOM FAA, 2000, J SOC 3D BROADCASTIN, V1, P10; Knill DC, 1996, PERCEPTION BAYESIAN; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LU C, 1972, INVEST OPHTH VISUAL, V11, P482; MOLLON JD, 1989, J EXP BIOL, V146, P21; Mullen K. T., 1991, VISION VISUAL DYSFUN, V6, P198; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; RAMACHANDRAN VS, 1978, NATURE, V275, P55, DOI 10.1038/275055a0; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Regan David, 2000, HUMAN PERCEPTION OBJ; RUBIN JM, 1982, BIOL CYBERN, V45, P215, DOI 10.1007/BF00336194; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sumner P, 2000, J EXP BIOL, V203, P1963; Sun J, 1997, PERCEPTION, V26, P519, DOI 10.1068/p260519; SWITKES E, 1988, J OPT SOC AM A, V5, P1149, DOI 10.1364/JOSAA.5.001149	26	94	94	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					641	644		10.1038/nn1060	http://dx.doi.org/10.1038/nn1060			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12740582				2022-12-28	WOS:000183140400022
J	Trinh, K; Storm, DR				Trinh, K; Storm, DR			Vomeronasal organ detects odorants in absence of signaling through main olfactory epithelium	NATURE NEUROSCIENCE			English	Article							ADENYLYL-CYCLASE; PHEROMONE RECEPTOR; MICE DEFICIENT; NEURONS; TRANSDUCTION; EXPRESSION; SYSTEM; PROTEIN; ANOSMIA; CHANNEL	It is commonly assumed that odorants are detected by the main olfactory epithelium (MOE) and pheromones are sensed through the vomeronasal organ (VNO). The complete loss of MOE-mediated olfaction in type-3 adenylyl cyclase knockout mice (AC3(-/-)) allowed us to examine chemosensory functions of the VNO in the absence of signaling through the MOE. Here we report that AC3(-/-) mice are able to detect certain volatile odorants via the VNO. These same odorants elicited electro-olfactogram transients in the VNO and MOE of wild-type mice, but only VNO responses in AC3(-/-) mice. This indicates that some odorants are detected through an AC3-independent pathway in the VNO.	Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Program Mol & Cellular Biol, Box 357750,1959 NE Pacific St, Seattle, WA 98195 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07312-22] Funding Source: Medline; NIDCD NIH HHS [DC04156] Funding Source: Medline; NIGMS NIH HHS [T32 GMO7270] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amoore J E, 1970, MOL BASIS ODOR, P28; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Berghard A, 1996, J NEUROSCI, V16, P909; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Briand L, 2000, FEBS LETT, V476, P179, DOI 10.1016/S0014-5793(00)01719-1; BROWN RE, 1987, PHYSIOL BEHAV, V40, P65, DOI 10.1016/0031-9384(87)90186-7; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dudley CA, 2001, BRAIN RES, V915, P32, DOI 10.1016/S0006-8993(01)02820-7; Dulac C, 1998, CHEM SENSES, V23, P467, DOI 10.1093/chemse/23.4.467; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fewell GD, 2002, BRAIN RES, V941, P91, DOI 10.1016/S0006-8993(02)02613-6; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gore AC, 2000, J NEUROENDOCRINOL, V12, P1200, DOI 10.1046/j.1365-2826.2000.00578.x; GREGG B, 1981, PHYSIOL BEHAV, V26, P1133, DOI 10.1016/0031-9384(81)90221-3; Hagino-Yamagishi K, 2001, J BIOCHEM-TOKYO, V129, P509, DOI 10.1093/oxfordjournals.jbchem.a002884; HALPERN M, 1984, TRENDS NEUROSCI, V7, P472, DOI 10.1016/S0166-2236(84)80258-1; HARDING JW, 1978, BRAIN RES, V140, P271, DOI 10.1016/0006-8993(78)90460-2; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kolunie JM, 1995, HORM BEHAV, V29, P492, DOI 10.1006/hbeh.1995.1285; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; Petrulis A, 1999, PHYSIOL BEHAV, V66, P73, DOI 10.1016/S0031-9384(98)00259-5; Puche AC, 1999, J NEUROSCI, V19, P1359; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SIPOS ML, 1995, PHYSIOL BEHAV, V58, P529, DOI 10.1016/0031-9384(95)00089-2; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Wei Y, 1996, Chin Med Sci J, V11, P1; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; YAMAZAKI F, 1989, PHYSL ECOL JPN SPEC, V1, P529; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	48	169	173	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					519	525		10.1038/nn1039	http://dx.doi.org/10.1038/nn1039			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665798				2022-12-28	WOS:000182553200019
J	Wu, P; Tarasenko, YI; Gu, YP; Huang, LYM; Coggeshall, RE; Yu, YJ				Wu, P; Tarasenko, YI; Gu, YP; Huang, LYM; Coggeshall, RE; Yu, YJ			Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat	NATURE NEUROSCIENCE			English	Article							PROGENITOR CELLS; IN-VITRO; NERVOUS-SYSTEM; SPINAL-CORD; HUMAN BRAIN; HUMAN CNS; TRANSPLANTATION; GROWTH; DIFFERENTIATION; ESTABLISHMENT	Pluripotent or multipotent stem cells isolated from human embryos or adult central nervous system (CNS) may provide new neurons to ameliorate neural disorders. A major obstacle, however, is that the majority of such cells do not differentiate into neurons when grafted into non-neurogenic areas of the adult CNS. Here we report a new in vitro priming procedure that generates a nearly pure population of neurons from fetal human neural stem cells (hNSCs) transplanted into adult rat CNS. Furthermore, the grafted cells differentiated by acquiring a cholinergic phenotype in a region-specific manner. This technology may advance stem cell-based therapy to replace lost neurons in neural injury or neurodegenerative disorders.	Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wu, P (corresponding author), Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA.	piwu@utmb.edu	wu, Ping/G-8958-2011					Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bonfanti L, 2001, CONT NEUROS, P49; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Fannon M, 2000, BIOCHEMISTRY-US, V39, P1434, DOI 10.1021/bi991895z; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Isacson O, 1997, TRENDS NEUROSCI, V20, P477, DOI 10.1016/S0166-2236(97)01081-3; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Roy NS, 2000, NAT MED, V6, P271; Schmitz HD, 2001, HISTOCHEM CELL BIOL, V116, P89; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Shihabuddin LS, 1999, ARCH NEUROL-CHICAGO, V56, P29, DOI 10.1001/archneur.56.1.29; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621; Wu P, 2002, GENE THER, V9, P245, DOI 10.1038/sj.gt.3301646; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	38	178	207	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1271	1278		10.1038/nn974	http://dx.doi.org/10.1038/nn974			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426573				2022-12-28	WOS:000179447500009
J	Blight, AR				Blight, AR			Miracles and molecules - progress in spinal cord repair	NATURE NEUROSCIENCE			English	Review							FUNCTIONAL RECOVERY; NEURITE GROWTH; AXONAL REGENERATION; CORTICOSPINAL TRACT; INJURY; MYELIN; TRANSPLANTATION; 4-AMINOPYRIDINE; REMYELINATION; GLYCOPROTEIN	Severe spinal cord injury (SCI) leads to devastating loss of neurological function below the level of injury and adversely affects multiple body systems. Most basic research on SCI is designed to find ways to improve the unsatisfactory cellular and molecular responses of spinal cord to injury, which include an array of early processes of autodestruction and a subsequent lack of functional tissue repair. This research has brought us to the threshold of practical application along three lines of approach, derived from animal model studies: acute neuroprotection, enhanced axonal regeneration or plasticity, and treatment of demyelination. There is a growing commercial interest in this previously neglected therapeutic area.	Acorda Therapeut, Hawthorne, NY 10532 USA		Blight, AR (corresponding author), Acorda Therapeut, 15 Skyline Dr, Hawthorne, NY 10532 USA.	ablight@acorda.com						Allen AR, 1911, JAMA 57, P878, DOI [10.1001/jama.1911.04260090100008, DOI 10.1001/JAMA.1911.04260090100008]; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; BLIGHT AR, 1983, NEUROSCIENCE, V10, P1471, DOI 10.1016/0306-4522(83)90128-8; BLIGHT AR, 1996, NEUROTRAUMA, P1367; Borgens RB, 1999, J NEUROTRAUM, V16, P639, DOI 10.1089/neu.1999.16.639; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cajal S., 1928, DEGENERATION REGENER; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Franklin RJM, 2002, BRAIN RES BULL, V57, P827, DOI 10.1016/S0361-9230(01)00765-1; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; GLEDHILL RF, 1973, EXP NEUROL, V38, P472, DOI 10.1016/0014-4886(73)90169-6; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Grill R, 1997, J NEUROSCI, V17, P5560; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Potter PJ, 1998, J NEUROTRAUM, V15, P837, DOI 10.1089/neu.1998.15.837; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wernig A, 1999, J NEUROTRAUM, V16, P719, DOI 10.1089/neu.1999.16.719; Wirth ED, 2001, J NEUROTRAUM, V18, P911, DOI 10.1089/089771501750451839	31	79	128	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1051	1054		10.1038/nn939	http://dx.doi.org/10.1038/nn939			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403984				2022-12-28	WOS:000179041300012
J	Nemeroff, CB; Owens, MJ				Nemeroff, CB; Owens, MJ			Treatment of mood disorders	NATURE NEUROSCIENCE			English	Review							SEROTONIN REUPTAKE INHIBITORS; NATIONAL-COMORBIDITY-SURVEY; MAJOR DEPRESSIVE DISORDER; ANTIDEPRESSANT TREATMENT; MYOCARDIAL-INFARCTION; REMISSION RATES; PHARMACOLOGY; VENLAFAXINE; PREVALENCE; RECEPTOR	Depression is a leading cause of morbidity and mortality, and its treatment includes a high percentage of the medications prescribed by physicians. Available antidepressant drugs are safe and effective, but less than half of all patients attain complete remission after therapy with a single antidepressant. Others exhibit partial, refractory or intolerant responses to treatment, emphasizing the need to discover new antidepressants. The mechanisms of action of available medications are directing the field toward new research avenues. This review highlights those areas we believe will influence the field and soon lead to better treatment.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Lab Neuropsychopharmacol, Atlanta, GA 30322 USA	Emory University	Nemeroff, CB (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Lab Neuropsychopharmacol, 1639 Pierce Dr,Suite 4000, Atlanta, GA 30322 USA.		Owens, Michael J/G-5191-2012	Nemeroff, Charles/0000-0001-7867-1160	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058922, R01MH042088] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58922, MH42088] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Blier P, 2001, J CLIN PSYCHIAT, V62, P12; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GILMOR ML, IN PRESS AM J PSYCHI; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KLERMAN GL, 1985, ARCH GEN PSYCHIAT, V42, P689; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; Meyer JH, 2001, AM J PSYCHIAT, V158, P1843, DOI 10.1176/appi.ajp.158.11.1843; MURAY CJL, 1996, GLOBAL BURDEN DIS; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Owens M J, 1998, Depress Anxiety, V8 Suppl 1, P5, DOI 10.1002/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Rabiner EA, 2001, AM J PSYCHIAT, V158, P2080, DOI 10.1176/appi.ajp.158.12.2080; Ressler KJ, 1999, BIOL PSYCHIAT, V46, P1219, DOI 10.1016/S0006-3223(99)00127-4; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Sanders A. R., 1999, NEUROBIOLOGY MENTAL, P299; Stout SC, 2001, ANNU REV PHARMACOL, V41, P877, DOI 10.1146/annurev.pharmtox.41.1.877; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Thome J, 2000, J NEUROSCI, V20, P4030; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	27	191	202	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1068	1070		10.1038/nn943	http://dx.doi.org/10.1038/nn943			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403988				2022-12-28	WOS:000179041300016
J	Hack, I; Bancila, M; Loulier, K; Carroll, P; Cremer, H				Hack, I; Bancila, M; Loulier, K; Carroll, P; Cremer, H			Reelin is a detachment signal in tangential chain-migration during postnatal neurogenesis	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; CAJAL-RETZIUS CELLS; RADIAL GLIAL-CELLS; NEURONAL MIGRATION; OLFACTORY-BULB; SUBVENTRICULAR ZONE; NERVOUS-SYSTEM; VLDL RECEPTOR; ADULT-MOUSE; FOREBRAIN	During development, Reelin acts on migrating neuronal precursors and controls correct cell positioning in the cortex and other brain structures by a hitherto unidentified mechanism. Here we show that in the postnatal mouse brain, Reelin acts as a detachment signal for chain-migrating interneuron precursors in the olfactory bulb. Neuronal precursors cultured in Matrigel detached from chains and migrated individually in the presence of exogenously added Reelin protein or Reelin-expressing brain tissues. Furthermore, we found that in reeler mutant mice, neuronal precursors accumulated in the olfactory bulb and remained in clusters, indicating that they did not change from tangential chain-migration to radial individual migration. Our data provide direct evidence that Reelin acts as a detachment signal, but not a stop or guidance cue. We propose that Reelin may have comparable functions during development.	Univ Mediterranee, INSERM, CNRS, NMDA,IBDM, F-13288 Marseille 9, France; CNRS, UPR 9040, F-91198 Gif Sur Yvette, France; Univ Montpellier 2, INSERM, U432, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Cremer, H (corresponding author), Univ Mediterranee, INSERM, CNRS, NMDA,IBDM, Campus Luminy, F-13288 Marseille 9, France.		Carroll, Patrick/AAL-7773-2021; Loulier, Karine/E-5529-2017	Loulier, Karine/0000-0001-6216-2708; Cremer, Harold/0000-0002-8673-5176				Alcantara S, 1998, J NEUROSCI, V18, P7779; Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Braids OC, 2001, ENVIRON FORENSICS, V2, P189, DOI 10.1006/enfo.2000.0040; Carroll P, 2001, MOL CELL NEUROSCI, V17, P611, DOI 10.1006/mcne.2001.0966; Chazal G, 2000, J NEUROSCI, V20, P1446; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Derer P, 2001, J COMP NEUROL, V440, P136, DOI 10.1002/cne.1375; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; JACOBOWITZ DM, 1991, J COMP NEUROL, V304, P198, DOI 10.1002/cne.903040205; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Miyata T, 1997, J NEUROSCI, V17, P3599; Murase S, 2002, J NEUROSCI, V22, P3568; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; Quattrocchi CC, 2002, J BIOL CHEM, V277, P303, DOI 10.1074/jbc.M106996200; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6	42	242	260	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					939	945		10.1038/nn923	http://dx.doi.org/10.1038/nn923			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244323				2022-12-28	WOS:000178242200012
J	Turk, DJ; Heatherton, TF; Kelley, WM; Funnell, MG; Gazzaniga, MS; Macrae, CN				Turk, DJ; Heatherton, TF; Kelley, WM; Funnell, MG; Gazzaniga, MS; Macrae, CN			Mike or me? Self-recognition in a split-brain patient	NATURE NEUROSCIENCE			English	Article									Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Turk, DJ (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Moore Hall, Hanover, NH 03755 USA.	david.j.turk@dartmouth.edu	Turk, David/C-5201-2008; Turk, David J/G-8878-2013; Heatherton, Todd F/H-5478-2011; Macrae, Neil/C-4761-2008		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031443] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS031443, R01 NS31443] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 1999, MEMORY, V7, P679, DOI 10.1080/096582199387805; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; GAZZANIGA MS, 1983, ANN NEUROL, V13, P536, DOI 10.1002/ana.410130511; Gazzaniga MS, 1998, SCI AM, V279, P50, DOI 10.1038/scientificamerican0798-50; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O	14	134	143	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					841	842		10.1038/nn907	http://dx.doi.org/10.1038/nn907			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195428				2022-12-28	WOS:000177656300012
J	Xiang, Y; Li, Y; Zhang, Z; Cui, K; Wang, S; Yuan, XB; Wu, CP; Poo, MM; Duan, SM				Xiang, Y; Li, Y; Zhang, Z; Cui, K; Wang, S; Yuan, XB; Wu, CP; Poo, MM; Duan, SM			Nerve growth cone guidance mediated by G protein-coupled receptors	NATURE NEUROSCIENCE			English	Article							LYMPHOCYTE CHEMOATTRACTANT; PHOSPHOINOSITIDE 3-KINASE; NEURONAL MIGRATION; MOLECULAR-BIOLOGY; CHEMOKINE; CHEMOTAXIS; SYSTEM; CELLS; PROLIFERATION; ATTRACTION	Growing axons navigate by responding to chemical guidance cues. Here we report that growth cones of rat cerebellar axons in culture turned away from a gradient of SDF-1, a chemokine that attracts migrating leukocytes and cerebellar granule cells via a G protein-coupled receptor (GPCR). Similarly, Xenopus spinal growth cones turned away from a gradient of baclofen, an agonist of the GABA(B) receptor. This response was mediated by G(i) and subsequent activation of phospholipase C (PLC), which triggered two pathways: protein kinase C (PKC) led to repulsion, and inositol 1,4,5-triphosphate (IP3) receptor activation led to attractive turning. Under normal culture conditions, PKC-dependent repulsion dominated, but the repulsion could be converted to attraction by inhibiting PKC or by elevating cytosolic cGMP. Thus, GPCRs can mediate both repulsive and attractive axon guidance in vitro, and chemokines may serve as guidance cues for axon pathfinding.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Cell & Mol Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn	Zhang, Zhe/C-2685-2011; wang, sheng/B-1969-2010	Yuan, Xiaobing/0000-0002-1632-8460				BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Klein RS, 2001, DEVELOPMENT, V128, P1971; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	43	184	192	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					843	848		10.1038/nn899	http://dx.doi.org/10.1038/nn899			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161754				2022-12-28	WOS:000177656300013
J	Hernandez-Deviez, DJ; Casanova, JE; Wilson, JM				Hernandez-Deviez, DJ; Casanova, JE; Wilson, JM			Regulation of dendritic development by the ARF exchange factor ARNO	NATURE NEUROSCIENCE			English	Article							RHO-GTPASES; NEURONS; GROWTH; RAC		Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ 85718 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Arizona; University of Virginia	Wilson, JM (corresponding author), Univ Arizona, Coll Med, Dept Cell Biol & Anat, Box 245044, Tucson, AZ 85718 USA.	jeanw@email.arizona.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032991, R29AI032991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA043329] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32991] Funding Source: Medline; NIDA NIH HHS [DA43329] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Suzuki I, 2002, MOL BRAIN RES, V98, P41, DOI 10.1016/S0169-328X(01)00312-6; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1	13	94	95	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					623	624		10.1038/nn865	http://dx.doi.org/10.1038/nn865			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12032543				2022-12-28	WOS:000176414300006
J	Maldve, RE; Zhang, TA; Ferrani-Kile, K; Schreiber, SS; Lippmann, MJ; Snyder, GL; Fienberg, AA; Leslie, SW; Gonzales, RA; Morrisett, RA				Maldve, RE; Zhang, TA; Ferrani-Kile, K; Schreiber, SS; Lippmann, MJ; Snyder, GL; Fienberg, AA; Leslie, SW; Gonzales, RA; Morrisett, RA			DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTORS; GENE-EXPRESSION; DOPAMINE; PHOSPHORYLATION; PHOSPHOPROTEIN; DEPHOSPHORYLATION; ATTENUATION; INHIBITION; ACTIVATION; PATHWAY	The medium spiny neurons of the nucleus accumbens receive both an excitatory glutamatergic input from forebrain and a dopaminergic input from the ventral tegmental area. This integration point may constitute a locus whereby the N-methyl-D-aspartate (NMDA)-subtype of glutamate receptors promotes drug reinforcement. Here we investigate how dopaminergic inputs alter the ethanol sensitivity of NMDA receptors in rats and mice and report that previous dopamine receptor-1 (D1) activation, culminating in dopamine and cAMP-regulated phosphoprotein-32 kD (DARPP-32) and NMDA receptor subunit-1 (NR1)-NMDA receptor phosphorylation, strongly decreases ethanol inhibition of NMDA responses. The regulation of ethanol sensitivity of NMDA receptors by D1 receptors was absent in DARPP-32 knockout mice. We propose that DARPP-32 mediated blunting of the response to ethanol subsequent to activation of ventral tegmental area dopaminergic neurons initiates molecular alterations that influence synaptic plasticity in this circuit, thereby promoting the development of ethanol reinforcement.	Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Austin, TX 78712 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Rockefeller University	Morrisett, RA (corresponding author), Univ Texas, Waggoner Ctr Alcohol & Addict Res, 2500 Speedway, Austin, TX 78712 USA.	ramorris@mail.utexas.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011836, T32AA007471, R01AA011852, R01AA011845] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01AA11845, U01AA13CR, R01AA11836, R01AA11852, T32AA07471] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anders DL, 2000, J BIOL CHEM, V275, P15019, DOI 10.1074/jbc.275.20.15019; Biala G, 1999, ALCOHOL ALCOHOLISM, V34, P175, DOI 10.1093/alcalc/34.2.175; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; FEDOROV NB, 1993, J NEUROSCI METH, V50, P83, DOI 10.1016/0165-0270(93)90058-Y; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Givens B, 2000, HIPPOCAMPUS, V10, P111, DOI 10.1002/(SICI)1098-1063(2000)10:1<111::AID-HIPO12>3.0.CO;2-1; Gonzales RA, 1998, J NEUROSCI, V18, P10663; GRANT KA, 1991, BEHAV PHARMACOL, V2, P87; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; Kalluri HSG, 1999, MOL BRAIN RES, V68, P159, DOI 10.1016/S0169-328X(99)00057-1; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; MORRISETT RA, 1993, J NEUROSCI, V13, P2264; Nestler EJ, 2001, SCIENCE, V292, P2266, DOI 10.1126/science.1063024; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Snyder GL, 1998, J NEUROSCI, V18, P10297; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Thomas MP, 2000, NEUROPHARMACOLOGY, V39, P218, DOI 10.1016/S0028-3908(99)00107-0; Thomas MP, 1998, J PHARMACOL EXP THER, V287, P87; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Woodward JJ, 2000, CRIT REV NEUROBIOL, V14, P69	30	116	121	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					641	648		10.1038/nn877	http://dx.doi.org/10.1038/nn877			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068305				2022-12-28	WOS:000176414300013
J	Mazurek, ME; Shadlen, MN				Mazurek, ME; Shadlen, MN			Limits to the temporal fidelity of cortical spike rate signals	NATURE NEUROSCIENCE			English	Article							ORNSTEIN-UHLENBECK PROCESS; VISUAL AREA MT; FIRING RATE; SENSORY DISCRIMINATION; INPUT SYNCHRONY; NEURAL CODES; NEURONS; CORTEX; VARIABILITY; DISCHARGE	The cerebral cortex processes information primarily through changes in the spike rates of neurons within local ensembles. To evaluate how reliably the average spike rate of a group of cortical neurons can represent a time-varying signal, we simulated an ensemble with realistic spike discharge behavior. We found that weak interneuronal correlation, or synchrony, allows the variability in spike rates of individual neurons to compromise the ensemble representation of time-varying signals. Brief cycles of sinusoidal modulation at frequencies above 115 Hz could not be represented by an ensemble of hundreds of neurons whose interneuronal correlation mimics that of the visual cortex. The spike variability and correlation assumed in our simulations are likely to apply to many areas of cortex and therefore may constrain the fidelity of neural computations underlying higher brain function.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Reg Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Reg Primate Res Ctr, Box 357290, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Braitenberg V, 1991, ANATOMY CORTEX STAT; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brody CD, 1999, NEURAL COMPUT, V11, P1527, DOI 10.1162/089976699300016124; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Di Lorenzo PM, 2000, BRAIN RES, V852, P383, DOI 10.1016/S0006-8993(99)02187-3; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; FETZ E, 1991, CEREB CORTEX, P1; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Green DM, 1966, SIGNAL DETECTION THE; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee D, 1998, J NEUROSCI, V18, P1161; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MURTHY VN, 1994, NEURAL COMPUT, V6, P1111, DOI 10.1162/neco.1994.6.6.1111; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; PRESS WH, 1992, NUMERICAL RECIPES; RICCIARDI LM, 1979, BIOL CYBERN, V35, P1, DOI 10.1007/BF01845839; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shinomoto S, 1999, NEURAL COMPUT, V11, P935, DOI 10.1162/089976699300016511; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; TSO DY, 1986, J NEUROSCI, V6, P1160; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; WERNER G, 1963, J NEUROPHYSIOL, V26, P958, DOI 10.1152/jn.1963.26.6.958; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; ZOHARY E, 1994, NATURE, V371, P358, DOI 10.1038/371358c0	50	106	106	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					463	471		10.1038/nn836	http://dx.doi.org/10.1038/nn836			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976706				2022-12-28	WOS:000175272000018
J	Star, EN; Kwiatkowski, DJ; Murthy, VN				Star, EN; Kwiatkowski, DJ; Murthy, VN			Rapid turnover of actin in dendritic spines and its regulation by activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GEL-SOL TRANSFORMATION; F-ACTIN; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; SMALL GTPASES; GELSOLIN; PLASTICITY; FILAMENT; PROTEIN	Dendritic spines are motile structures that contain high concentrations of filamentous actin. Using hippocampal neurons expressing fluorescent actin and the method of fluorescence recovery after photobleaching, we found that 85+/-2% of actin in the spine was dynamic, with a turnover time of 44.2+/-4.0 s. The rapid turnover is not compatible with current models invoking a large population of stable filaments and static coupling of filaments to postsynaptic components. Low-frequency stimulation known to induce long-term depression in these neurons stabilized nearly half the dynamic actin in the spine. This effect depended on the activation of N-methyl-D-aspartate (NMDA) receptors and the influx of calcium. In neurons from mice lacking gelsolin, a calcium-dependent actin-binding protein, activity-dependent stabilization of actin was impaired. Our studies provide new information on the kinetics of actin turnover in spines, its regulation by neural activity and the mechanisms involved in this regulation.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Hematol, Genet Lab, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Murthy, Venkatesh/0000-0003-2443-4252				Allison DW, 1998, J NEUROSCI, V18, P2423; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CAJAL SRY, 1891, CELLULE, V7, P125; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kim CH, 1999, J NEUROSCI, V19, P4314; Kinosian HJ, 1998, BIOPHYS J, V75, P3101, DOI 10.1016/S0006-3495(98)77751-3; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; Sund SE, 2000, BIOPHYS J, V79, P1655, DOI 10.1016/S0006-3495(00)76415-0; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Xia ZG, 1996, J NEUROSCI, V16, P5425; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	50	362	371	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					239	246		10.1038/nn811	http://dx.doi.org/10.1038/nn811			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850630				2022-12-28	WOS:000174146000014
J	Kourtzi, Z; Bulthoff, HH; Erb, M; Grodd, W				Kourtzi, Z; Bulthoff, HH; Erb, M; Grodd, W			Object-selective responses in the human motion area MT/MST	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; CORTICAL AREA; PERCEPTION; NEURONS; DEPTH; MT; DISPARITY		Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Clin, D-72076 Tubingen, Germany	Max Planck Society; Massachusetts Institute of Technology (MIT); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kourtzi, Z (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Erb, Michael/0000-0002-9311-4693; Kourtzi, Zoe/0000-0001-9441-7832				BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; QIAN N, 1994, J NEUROSCI, V14, P7367; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Xiao DK, 1997, EUR J NEUROSCI, V9, P956, DOI 10.1111/j.1460-9568.1997.tb01446.x; ZEKI S, 1991, J NEUROSCI, V11, P641	15	100	100	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					17	18		10.1038/nn780	http://dx.doi.org/10.1038/nn780			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740503				2022-12-28	WOS:000173031800009
J	Ramnani, N; Miall, RC				Ramnani, N; Miall, RC			A system in the human brain for predicting the actions of others	NATURE NEUROSCIENCE			English	Article							PREMOTOR CORTEX; CORTICAL MECHANISMS; PREFRONTAL CORTEX; BIOLOGICAL MOTION; NEURONAL-ACTIVITY; RHESUS-MONKEY; MIND; AREAS; PERCEPTION; MOVEMENT	The ability to attribute mental states to others, and therefore to predict others' behavior, is particularly advanced in humans. A controversial but untested idea is that this is achieved by simulating the other person's mental processes in one's own mind. If this is the case, then the same neural systems activated by a mental function should re-activate when one thinks about that function performed by another. Here, using functional magnetic resonance imaging (fMRI), we tested whether the neural processes involved in preparing one's own actions are also used for predicting the future actions of others. We provide compelling evidence that areas within the action control system of the human brain are indeed activated when predicting others' actions, but a different action sub-system is activated when preparing one's own actions.	Univ Oxford, John Radcliffe Hosp, Ctr FMRI Brain, Oxford OX3 9DU, England; Univ Oxford, Physiol Lab, Oxford OX1 3TP, England	University of Oxford; University of Oxford	Ramnani, N (corresponding author), Univ Oxford, John Radcliffe Hosp, Ctr FMRI Brain, Headley Way, Oxford OX3 9DU, England.		Miall, R. Chris/B-7449-2013	Miall, R. Chris/0000-0003-3002-1251; Ramnani, Narender/0000-0003-0425-203X				Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; CARRUTHERS P, 1996, THEORIES THEORIES MI; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; CHEN CT, 1991, J CHEM ENG JPN, V24, P284, DOI 10.1252/jcej.24.284; Davies M., 1995, FOLK PSYCHOL THEORY; Davies M., 1995, FOLK PSYCHOL; Dennett, 1987, INTENTIONAL STANCE; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Hoshi E, 2002, J NEUROPHYSIOL, V87, P1123, DOI 10.1152/jn.00496.2001; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; LU T, 1994, J COMP NEUROL, V341, P375; Luppino G, 2001, EUR J NEUROSCI, V14, P1035, DOI 10.1046/j.0953-816x.2001.01734.x; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; MITZ AR, 1991, J NEUROSCI, V11, P1855; Passingham R., 1995, FRONTAL LOBES VOLUNT; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; PASSINGHAM RE, 1986, BEHAV NEUROSCI, V100, P695, DOI 10.1037/0735-7044.100.5.695; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Stich S., 1992, MIND LANG, V7, P35, DOI [DOI 10.1111/J.1468-0017.1992.TB00196, DOI 10.1111/J.1468-0017.1992.TB00196.X]; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469	50	197	199	0	20	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					85	90		10.1038/nn1168	http://dx.doi.org/10.1038/nn1168			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699420				2022-12-28	WOS:000187636000018
J	McClung, CA; Nestler, EJ				McClung, CA; Nestler, EJ			Regulation of gene expression and cocaine reward by CREB and Delta FosB	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS SHELL; MOLECULAR-MECHANISMS; TRANSCRIPTION; BRAIN; DOPAMINE; INDUCTION; STRIATUM; FORM; JUN	DeltaFosB (a truncated form of FosB) and CREB (cAMP response element binding protein) are transcription factors induced in the brain's reward pathways after chronic exposure to drugs of abuse. However, their mechanisms of action and the genes they regulate remain unclear. Using microarray analysis in the nucleus accumbens of inducible transgenic mice, we found that CREB and a dominant-negative CREB have opposite effects on gene expression, as do prolonged expression of DeltaFosB and the activator protein-1 (AP-1) antagonist DeltacJun. However, unlike CREB, short-term and prolonged DeltaFosB induction had opposing effects on gene expression. Gene expression induced by short-term DeltaFosB and by CREB was strikingly similar, and both reduced the rewarding effects of cocaine, whereas prolonged DeltaFosB expression increased drug reward. Gene expression after a short cocaine treatment was more dependent on CREB, whereas gene expression after a longer cocaine treatment became increasingly DeltaFosB dependent. These findings help define the molecular functions of CREB and DeltaFosB and identify clusters of genes that contribute to cocaine addiction.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Eric.Nestler@UTSouthwestern.edu	McClung, Colleen/AAA-5943-2019					Andersson M, 2001, J NEUROSCI, V21, P9930, DOI 10.1523/JNEUROSCI.21-24-09930.2001; Ang E, 2001, J NEUROCHEM, V79, P221, DOI 10.1046/j.1471-4159.2001.00563.x; Bannon MJ, 2002, P NATL ACAD SCI USA, V99, P6382, DOI 10.1073/pnas.092654299; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Beinfeld MC, 2002, J NEUROCHEM, V81, P1021, DOI 10.1046/j.1471-4159.2002.00894.x; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Beurrier C, 2002, J NEUROSCI, V22, P5817; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Chen JS, 2000, J NEUROSCI, V20, P8965; Chen JS, 1997, J NEUROSCI, V17, P4933; Colby CR, 2003, J NEUROSCI, V23, P2488; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; DOBRZANSKI P, 1991, MOL CELL BIOL, V11, P5470, DOI 10.1128/MCB.11.11.5470; Duman RS, 2002, MOL PSYCHIATR, V7, pS29, DOI 10.1038/sj.mp.4001016; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Freeman WM, 2001, J NEUROCHEM, V77, P542, DOI 10.1046/j.1471-4159.2001.00252.x; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Josselyn SA, 1996, NEUROSCI LETT, V209, P85, DOI 10.1016/0304-3940(96)12610-0; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Korutla L, 2002, NEUROSCIENCE, V110, P421, DOI 10.1016/S0306-4522(01)00518-8; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Newton SS, 2002, J NEUROSCI, V22, P10883; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Self DW, 1998, J NEUROSCI, V18, P1848; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; SIMPSON JN, 1995, SYNAPSE, V19, P151, DOI 10.1002/syn.890190302; Tanganelli S, 2001, PEPTIDES, V22, P1229, DOI 10.1016/S0196-9781(01)00446-6; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Turgeon SM, 1997, BRAIN RES, V749, P120, DOI 10.1016/S0006-8993(96)01316-9; UNTERWALD EM, 1993, SYNAPSE, V15, P33, DOI 10.1002/syn.890150104; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; YEN J, 1991, P NATL ACAD SCI USA, V88, P5077, DOI 10.1073/pnas.88.12.5077; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198	50	471	497	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1208	1215		10.1038/nn1143	http://dx.doi.org/10.1038/nn1143			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14566342				2022-12-28	WOS:000186229200021
J	Muller, MB; Zimmermann, S; Sillaber, I; Hagemeyer, TP; Deussing, JM; Timpl, P; Kormann, MSD; Droste, SK; Kuhn, R; Reul, JMHM; Holsboer, F; Wurst, W				Muller, MB; Zimmermann, S; Sillaber, I; Hagemeyer, TP; Deussing, JM; Timpl, P; Kormann, MSD; Droste, SK; Kuhn, R; Reul, JMHM; Holsboer, F; Wurst, W			Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress	NATURE NEUROSCIENCE			English	Article							PARAVENTRICULAR NUCLEUS; MINERALOCORTICOID RECEPTOR; ANTAGONIST R121919; CHRONIC INFUSION; REDUCED ANXIETY; MICE DEFICIENT; NERVOUS-SYSTEM; MATERNAL-CARE; PITUITARY; AMYGDALA	Corticotropin-releasing hormone (CRH) is centrally involved in coordinating responses to a variety of stress-associated stimuli. Recent clinical data implicate CRH in the pathophysiology of human affective disorders. To differentiate the CNS pathways involving CRH and CRH receptor 1 (Crhr1) that modulate behavior from those that regulate neuroendocrine function, we generated a conditional knockout mouse line (Crhr1(loxP/loxP) Camk2a-cre) in which Crhr1 function is inactivated postnatally in anterior forebrain and limbic brain structures, but not in the pituitary. This leaves the hypothalamic-pituitary-adrenocortical (HPA) system intact. Crhr1(loxP/loxP) Camk2a-cre mutants showed reduced anxiety, and the basal activity of their HPA system was normal. In contrast to Crhr1 null mutants, conditional mutants were hypersensitive to stress corticotropin and corticosterone levels remained significantly elevated after stress. Our data clearly show that limbic Crhr1 modulates anxiety-related behavior and that this effect is independent of HPA system function. Furthermore, we provide evidence for a new role of limbic Crhr1 in neuroendocrine adaptation to stress.	Max Planck Inst Psychiat, D-80804 Munich, Germany; GSF Forschungszentrum, Inst Dev Genet, D-85764 Neuherberg, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wurst, W (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	wurst@gsf.de	Reul, Johannes/B-4132-2019; Kühn, Ralf/U-1278-2017; Kormann, Michael SD/C-7723-2014; Deussing, Jan M/ABB-5993-2021; Müller, Marianne B./AAL-8911-2021	Reul, Johannes/0000-0002-8787-4012; Kühn, Ralf/0000-0003-1694-9803; Müller, Marianne B./0000-0002-0269-6131; Wurst, Wolfgang/0000-0003-4422-7410; Deussing, Jan/0000-0002-9329-5252				Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Brunson KL, 2001, MOL PSYCHIATR, V6, P647, DOI 10.1038/sj.mp.4000942; Caldji C, 2000, BIOL PSYCHIAT, V48, P1164, DOI 10.1016/S0006-3223(00)01084-2; Chen JC, 2000, J COMP NEUROL, V420, P305, DOI 10.1002/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8; COLE JC, 1995, PHARMACOL BIOCHEM BE, V52, P473, DOI 10.1016/0091-3057(95)00163-Q; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Gray TS, 1996, CRIT REV NEUROBIOL, V10, P155, DOI 10.1615/CritRevNeurobiol.v10.i2.10; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; HERMAN JP, 1992, BRAIN RES, V592, P228, DOI 10.1016/0006-8993(92)91680-D; HILL DP, 1993, METHOD ENZYMOL, V225, P664; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; Joels M, 2001, J NEUROENDOCRINOL, V13, P657, DOI 10.1046/j.1365-2826.2001.00688.x; Keck ME, 2001, EUR J NEUROSCI, V13, P373, DOI 10.1046/j.0953-816X.2000.01383.x; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Korte SM, 1996, PHARMACOL BIOCHEM BE, V54, P261, DOI 10.1016/0091-3057(95)02172-8; KRESSE A, 1995, BRAIN RES BULL, V36, P261, DOI 10.1016/0361-9230(94)00201-B; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; LIEBSCH G, 1995, REGUL PEPTIDES, V59, P229, DOI 10.1016/0167-0115(95)00099-W; Liebsch G, 1999, J PSYCHIAT RES, V33, P153, DOI 10.1016/S0022-3956(98)80047-2; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lopez JF, 1998, BIOL PSYCHIAT, V43, P547, DOI 10.1016/S0006-3223(97)00484-8; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Muller MB, 2000, ENDOCRINOLOGY, V141, P4262, DOI 10.1210/en.141.11.4262; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Preil J, 2001, ENDOCRINOLOGY, V142, P4946, DOI 10.1210/en.142.11.4946; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Sola C, 1999, J NEUROSCI RES, V57, P651, DOI 10.1002/(SICI)1097-4547(19990901)57:5<651::AID-JNR7>3.0.CO;2-G; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	44	353	364	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1100	1107		10.1038/nn1123	http://dx.doi.org/10.1038/nn1123			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973355				2022-12-28	WOS:000185633600023
J	Comoli, E; Coizet, V; Boyes, J; Bolam, JP; Canteras, NS; Quirk, RH; Overton, PG; Redgrave, P				Comoli, E; Coizet, V; Boyes, J; Bolam, JP; Canteras, NS; Quirk, RH; Overton, PG; Redgrave, P			A direct projection from superior colliculus to substantia nigra for detecting salient visual events	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; DOPAMINERGIC-NEURONS; BASAL GANGLIA; REWARD; RAT; RESPONSES; CORTEX; BRAIN; CAT; ORGANIZATION	Midbrain dopaminergic neurons respond to unexpected and biologically salient events, but little is known about the sensory systems underlying this response. Here we describe, in the rat, a direct projection from a primary visual structure, the midbrain superior colliculus (SC), to the substantia nigra pars compacta (SNc) where direct synaptic contacts are made with both dopaminergic and non-dopaminergic neurons. Complementary electrophysiological data reveal that short-latency visual responses in the SNc are abolished by ipsilateral lesions of the SC and increased by local collicular stimulation. These results show that the tectonigral projection is ideally located to relay short-latency visual information to dopamine-containing regions of the ventral midbrain. We conclude that it is within this afferent sensory circuitry that the critical perceptual discriminations that identify stimuli as both unpredicted and biologically salient are made.	Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil	University of Sheffield; University of Oxford; Universidade de Sao Paulo	Redgrave, P (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.		Canteras, Newton/F-2402-2013; Comoli, Eliane/D-4405-2012; Coizet, Véronique/T-1601-2019	Coizet, Véronique/0000-0001-5192-6610; Canteras, Newton/0000-0002-7205-5372; Comoli, Eliane/0000-0002-3254-7487; Overton, Paul/0000-0003-4334-261X; Bolam, J Paul/0000-0002-5008-8405				ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Bar-Gad I, 2001, CURR OPIN NEUROBIOL, V11, P689, DOI 10.1016/S0959-4388(01)00270-7; Basso MA, 1998, NEURON, V21, P665, DOI 10.1016/S0896-6273(00)80583-8; BOLAM JP, 1992, EXPT NEUROANATOMY PR, P1; CAMERON AA, 1995, J COMP NEUROL, V351, P568, DOI 10.1002/cne.903510407; Ciaramitaro VM, 1997, J COMP NEUROL, V387, P568, DOI 10.1002/(SICI)1096-9861(19971103)387:4<568::AID-CNE7>3.0.CO;2-0; Clarke NP, 1996, EUR J NEUROSCI, V8, P1363, DOI 10.1111/j.1460-9568.1996.tb01599.x; Coizet V, 2003, EUR J NEUROSCI, V17, P28, DOI 10.1046/j.1460-9568.2003.02415.x; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; FREEMAN AS, 1985, LIFE SCI, V36, P1983, DOI 10.1016/0024-3205(85)90448-5; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; GOODALE MA, 1973, EXP BRAIN RES, V17, P75; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; HARDY SC, 1988, J COMP NEUROL, V273, P527, DOI 10.1002/cne.902730408; Heilman K, 1994, NEUROPSYCHOLOGY, P139; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; Mana S, 2001, NEUROSCIENCE, V103, P673, DOI 10.1016/S0306-4522(01)00026-4; Matsuura T, 1999, JPN J PHYSIOL, V49, P289, DOI 10.2170/jjphysiol.49.289; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; REDGRAVE P, 1993, PROG BRAIN RES, V95, P69, DOI 10.1016/S0079-6123(08)60358-1; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Stein BE., 1993, MERGING SENSES; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Tsumori T, 2001, BRAIN RES, V903, P168, DOI 10.1016/S0006-8993(01)02437-4; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WEINBERG RJ, 1991, J HISTOCHEM CYTOCHEM, V39, P1143, DOI 10.1177/39.8.1906909; Wittmann M, 1999, CHRONOBIOL INT, V16, P17, DOI 10.3109/07420529908998709; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	43	206	209	0	19	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					974	980		10.1038/nn1113	http://dx.doi.org/10.1038/nn1113			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12925855				2022-12-28	WOS:000184970400017
J	Monnier, P; Shevell, SK				Monnier, P; Shevell, SK			Large shifts in color appearance from patterned chromatic backgrounds	NATURE NEUROSCIENCE			English	Article							INDUCTION; CONTRAST	The perceived color of a light varies with the background on which it is seen. In the present study, patterned backgrounds composed of two different chromaticities caused larger shifts in perceived color than did a uniform background at either chromaticity within the pattern. Cortical receptive-field organization, but not optical factors or known retinal neurons, can account for the color shifts from patterned backgrounds.	Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Shevell, SK (corresponding author), Univ Chicago, Dept Psychol, 940 E 57th St, Chicago, IL 60637 USA.				NATIONAL EYE INSTITUTE [R01EY004802] Funding Source: NIH RePORTER; NEI NIH HHS [EY-04802] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Dacey DM, 1996, P NATL ACAD SCI USA, V93, P582, DOI 10.1073/pnas.93.2.582; FLITCROFT DI, 1990, VISUAL NEUROSCI, V5, P547, DOI 10.1017/S0952523800000705; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; MALONEY LT, 1986, J OPT SOC AM A, V3, P29, DOI 10.1364/JOSAA.3.000029; MARIMONT DH, 1994, J OPT SOC AM A, V11, P3113, DOI 10.1364/JOSAA.11.003113; POIRSON AB, 1993, J OPT SOC AM A, V10, P2458, DOI 10.1364/JOSAA.10.002458; Shevell SK, 1998, VISION RES, V38, P1561, DOI 10.1016/S0042-6989(98)00006-6; Smith VC, 2001, VISION RES, V41, P1007, DOI 10.1016/S0042-6989(01)00031-1; THOMSON LC, 1947, J PHYSIOL-LONDON, V105, P316, DOI 10.1113/jphysiol.1947.sp004173; WARE C, 1982, VISION RES, V22, P1353, DOI 10.1016/0042-6989(82)90225-5; WILLIAMS DR, 1994, J OPT SOC AM A, V11, P3123, DOI 10.1364/JOSAA.11.003123; ZAIDI Q, 1993, VISION RES, V33, P1281, DOI 10.1016/0042-6989(93)90214-H	13	60	60	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					801	802		10.1038/nn1099	http://dx.doi.org/10.1038/nn1099			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872129				2022-12-28	WOS:000184413700007
J	Francis, DD; Szegda, K; Campbell, G; Martin, WD; Insel, TR				Francis, DD; Szegda, K; Campbell, G; Martin, WD; Insel, TR			Epigenetic sources of behavioral differences in mice	NATURE NEUROSCIENCE			English	Article							PREPULSE INHIBITION; MATERNAL-BEHAVIOR; MOUSE; RESPONSES; GENETICS; STRAIN; STRESS; CARE		NIMH, Bethesda, MD 20892 USA; Emory Univ, Ctr Behav Neurosci, Yerkes Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Transgen Mouse Core, Sch Med, Atlanta, GA 30329 USA; Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30329 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Emory University; Emory University; Emory University	Insel, TR (corresponding author), NIMH, 6001 Execut Blvd,Room 8235,MSC 9669, Bethesda, MD 20892 USA.	insel@mail.nih.gov						Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; CARLIER M, 1983, PHYSIOL BEHAV, V30, P837, DOI 10.1016/0031-9384(83)90245-7; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; DeFries J. C., 1967, PSYCHON SCI, V8, P207; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Le Isabelle R, 2001, BEHAV BRAIN RES, V125, P57, DOI 10.1016/S0166-4328(01)00279-0; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Rhees BK, 1999, GENETICS, V153, P905; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130	13	269	273	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					445	446		10.1038/nn1038	http://dx.doi.org/10.1038/nn1038			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665797				2022-12-28	WOS:000182553200007
J	Herson, PS; Virk, M; Rustay, NR; Bond, CT; Crabbe, JC; Adelman, JP; Maylie, J				Herson, PS; Virk, M; Rustay, NR; Bond, CT; Crabbe, JC; Adelman, JP; Maylie, J			A mouse model of episodic ataxia type-1	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; POTASSIUM CHANNEL; GABA(A) RECEPTORS; K+ CHANNELS; KV1.1; MUTATIONS; NEURONS; HIPPOCAMPUS; ALTER; POTENTIALS	Episodic ataxia type-1 (EA1) is a dominant human neurological disorder characterized by stress-induced attacks of ataxia. EA1 is caused by mutations in the voltage-gated potassium channel Kv1.1, and affected individuals are heterozygous. Here we introduced the V408A EA1 mutation into mice using homologous recombination. In contrast to Kv1.1 null mice, homozygous V408A/V408A mice died after embryonic day 3 (E3). V408A/+ mice showed stress-induced loss of motor coordination that was ameliorated by acetazolamide, a carbonic anhydrase inhibitor that minimizes EA1 symptoms in human patients. We made electrophysiological recordings from cerebellar Purkinje cells in both V408A/+ mice and their wild-type littermates. V408A/+ mice showed a greater frequency and amplitude of spontaneous GABAergic inhibitory postsynaptic currents (IPSCs) than did wild type; however, the amplitude or frequency of miniature IPSCs and the basket cell firing frequency did not differ between groups. The stress-induced motor dysfunction in V408A mice is similar to that of family members harboring the EA1 allele, and our findings suggest that these behavioral changes are linked to changes in GABA release.	Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; Vet Affairs Med Ctr, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.				NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; D'Adamo MC, 1998, EMBO J, V17, P1200, DOI 10.1093/emboj/17.5.1200; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; Hallows JL, 1998, J NEUROSCI, V18, P5682; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Maylie B, 2002, J NEUROSCI, V22, P4786, DOI 10.1523/JNEUROSCI.22-12-04786.2002; MICHELSON HB, 1991, SCIENCE, V253, P1420, DOI 10.1126/science.1654594; Munsch T, 1999, J PHYSIOL-LONDON, V519, P505, DOI 10.1111/j.1469-7793.1999.0505m.x; RUSTAY NR, IN PRESS BEHAV BRAIN; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Sun MK, 2001, J PHARMACOL EXP THER, V296, P811; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Zerr P, 1998, J NEUROSCI, V18, P2842; Zhang CL, 1999, J NEUROSCI, V19, P2852; Zhou L, 2001, J NEUROPHYSIOL, V85, P197, DOI 10.1152/jn.2001.85.1.197	27	105	107	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					378	383		10.1038/nn1025	http://dx.doi.org/10.1038/nn1025			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12612586				2022-12-28	WOS:000181833100015
J	Puglielli, L; Tanzi, RE; Kovacs, DM				Puglielli, L; Tanzi, RE; Kovacs, DM			Alzheimer's disease: the cholesterol connection	NATURE NEUROSCIENCE			English	Review							AMYLOID PRECURSOR PROTEIN; LOW-DENSITY-LIPOPROTEIN; TRANSGENIC MOUSE MODEL; APOLIPOPROTEIN-E POLYMORPHISM; RECEPTOR-RELATED PROTEIN; BETA-PEPTIDE; A-BETA; CEREBROTENDINOUS XANTHOMATOSIS; CEREBROSPINAL-FLUID; PLAQUE-FORMATION	A hallmark of all forms of Alzheimer's disease (AD) is an abnormal accumulation of the beta-amyloid protein (AD) in specific brain regions. Both the generation and clearance of A-beta are regulated by cholesterol. Elevated cholesterol levels increase A-beta in cellular and most animals models of AD, and drugs that inhibit cholesterol synthesis lower A-beta in these models. Recent studies show that not only the total amount, but also the distribution of cholesterol within neurons, impacts A-beta biogenesis. The identification of a variant of the apolipoprotein E (APOE) gene as a major genetic risk factor for AD is also consistent with a role for cholesterol in the pathogenesis of AD. Clinical trials have recently been initiated to test whether lowering plasma and/or neuronal cholesterol levels is a viable strategy for treating and preventing AD. In this review, we describe recent findings concerning the molecular mechanisms underlying the cholesterol-AD connection.	Harvard Univ, Sch Med, Neurobiol Dis Lab, CAGN,Massachusetts Gen Hosp, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Genet & Aging Res Unit, CAGN,Massachusetts Gen Hosp, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kovacs, DM (corresponding author), Harvard Univ, Sch Med, Neurobiol Dis Lab, CAGN,Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	kovacs@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454				Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bjorkhem I., 1995, METABOLIC MOL BASES, P2073; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang TY, 2001, J LIPID RES, V42, P1933; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Corsini Alberto, 2000, Journal of Cardiovascular Pharmacology and Therapeutics, V5, P161, DOI 10.1177/107424840000500304; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; EHNHOLM C, 1986, J LIPID RES, V27, P227; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fernandes MAS, 1999, BBA-MOL BASIS DIS, V1454, P89, DOI 10.1016/S0925-4439(99)00030-7; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Fukumoto H, 2002, J BIOL CHEM, V277, P48508, DOI 10.1074/jbc.M209085200; Haley RW, 2000, ARCH NEUROL-CHICAGO, V57, P1410, DOI 10.1001/archneur.57.10.1410; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; KNEBL J, 1994, MECH AGEING DEV, V73, P69, DOI 10.1016/0047-6374(94)90039-6; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mori T, 2001, J NEUROPATH EXP NEUR, V60, P778, DOI 10.1093/jnen/60.8.778; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; PETANCESKA S, 2003, CURR MED CHEM IMUN E, V3, P233; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Racchi M, 1997, BIOCHEM J, V322, P893, DOI 10.1042/bj3220893; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; REFOLO LM, 1991, J NEUROSCI, V11, P3888; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; SALEN G, 1973, J CLIN INVEST, V52, P2822, DOI 10.1172/JCI107478; SALEN G, 1987, NEW ENGL J MED, V316, P1233, DOI 10.1056/NEJM198705143162002; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Snipes G J, 1997, Subcell Biochem, V28, P173; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Thinakaran G, 1999, J CLIN INVEST, V104, P1321, DOI 10.1172/JCI8728; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Uden E, 2000, J BIOL CHEM, V275, P30525, DOI 10.1074/jbc.M001151200; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P793, DOI 10.1001/archneur.57.6.793; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1997, FEBS LETT, V420, P43, DOI 10.1016/S0014-5793(97)01484-1; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2	70	627	673	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					345	351		10.1038/nn0403-345	http://dx.doi.org/10.1038/nn0403-345			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12658281				2022-12-28	WOS:000181833100011
J	Tomizawa, K; Iga, N; Lu, YF; Moriwaki, A; Matsushita, M; Li, ST; Miyamoto, O; Itano, T; Matsui, H				Tomizawa, K; Iga, N; Lu, YF; Moriwaki, A; Matsushita, M; Li, ST; Miyamoto, O; Itano, T; Matsui, H			Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade	NATURE NEUROSCIENCE			English	Article							RAT-BRAIN; SYNAPTIC PLASTICITY; TERM POTENTIATION; MATERNAL-BEHAVIOR; RECEPTOR GENE; ESTROUS-CYCLE; LATE-PHASE; EXPRESSION; MOUSE; TRANSCRIPTION	Oxytocin is an essential hormone for mammalian labor and lactation. Here, we show a new function of oxytocin in causing plastic changes in hippocampal synapses during motherhood. In oxytocin-perfused hippocampal slices, one-train tetanus stimulation induced long-lasting, long-term potentiation (L-LTP) and phosphorylation of cyclic AMP-responsive element binding protein (CREB), and MAP kinase inhibitors blocked these inductions. An increase in CREB phosphorylation and L-LTP induced by one-train tetanus were observed in the multiparous mouse hippocampus without oxytocin application. Furthermore, intracerebroventricular injection of oxytocin in virgin mice improved long-term spatial learning in vivo, whereas an injection of oxytocin antagonist in multiparous mice significantly inhibited the improved spatial memory, L-LTP and CREB phosphorylation. These findings indicate that oxytocin is critically involved in improving hippocampus-dependent learning and memory during motherhood in mice.	Okayama Univ, Grad Sch Med & Dent, Dept Physiol, Okayama 7008558, Japan; Kagawa Med Univ, Dept Biol, Kagawa 7610793, Japan; Japan Sci & Technol Corp, New Technoventure Oriented Res & Dev, Prot Therapy, Okayama 7008558, Japan	Okayama University; Kagawa University; Japan Science & Technology Agency (JST)	Tomizawa, K (corresponding author), Okayama Univ, Grad Sch Med & Dent, Dept Physiol, Shikata Cho 2-5-1, Okayama 7008558, Japan.		Tomizawa, Kazuhito/F-2405-2015	Tomizawa, Kazuhito/0000-0002-5663-2627; Li, Sheng Tian/0000-0002-2836-3802				ABLE T, 1997, CELL, V88, P615; ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; BALE TL, 1995, ENDOCRINOLOGY, V136, P27, DOI 10.1210/en.136.1.27; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; Borroni AM, 2000, J NEUROSCI, V20, P9272; Breton C, 1997, ENDOCRINOLOGY, V138, P1857, DOI 10.1210/en.138.5.1857; Diaz-Cabiale Z, 2000, BRAIN RES, V887, P421, DOI 10.1016/S0006-8993(00)03017-1; DURHAM DA, 1991, NEUROENDOCRINOLOGY, V53, P447, DOI 10.1159/000125756; FAHRBACH SE, 1985, NEUROENDOCRINOLOGY, V40, P526, DOI 10.1159/000124125; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Gainer Harold, 1994, P1099; Gass P, 1998, LEARN MEMORY, V5, P274; Grattan DR, 2002, REPRODUCTION, V123, P497, DOI 10.1530/rep.0.1230497; Guerra-Araiza C, 2000, LIFE SCI, V66, P1743, DOI 10.1016/S0024-3205(00)00497-5; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; JIRIKOWSKI GF, 1991, CELL TISSUE RES, V266, P399, DOI 10.1007/BF00318196; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; KREMARIK P, 1993, J COMP NEUROL, V333, P343, DOI 10.1002/cne.903330304; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Masaki T, 2001, DIABETES, V50, P376, DOI 10.2337/diabetes.50.2.376; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Olton D.S., 1983, NEUROBIOLOGY HIPPOCA, P335; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; PERDERSEN CA, 1988, P NATL ACAD SCI USA, V76, P6661; Pi XJ, 2002, MOL BRAIN RES, V103, P130, DOI 10.1016/S0169-328X(02)00194-8; Schulkin J, 1999, NEUROENDOCRINE REGUL, P123; SHAPIRO ML, 1992, BEHAV NEUROSCI, V106, P604, DOI 10.1037/0735-7044.106.4.604; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	40	277	289	4	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					384	390		10.1038/nn1023	http://dx.doi.org/10.1038/nn1023			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12598900				2022-12-28	WOS:000181833100016
J	Tan, J; Town, T; Crawford, F; Mori, T; DelleDonne, A; Crescentini, R; Obregon, D; Flavell, RA; Mullan, MJ				Tan, J; Town, T; Crawford, F; Mori, T; DelleDonne, A; Crescentini, R; Obregon, D; Flavell, RA; Mullan, MJ			Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice	NATURE NEUROSCIENCE			English	Article							PRECURSOR PROTEIN; MICROGLIAL ACTIVATION; ENDOTHELIAL-CELLS; BETA-SECRETASE; SMOOTH-MUSCLE; MOUSE MODEL; DISEASE; PATHOLOGY; ATHEROSCLEROSIS; INFLAMMATION	We have shown that interaction of CD40 with CD40L enables microglial activation in response to amyloid-beta peptide (Abeta), which is associated with Alzheimer's disease (AD)-like neuronal tau hyperphosphorylation in vivo. Here we report that transgenic mice overproducing Abeta, but deficient in CD40L, showed decreased astrocytosis and microgliosis associated with diminished Abeta levels and beta-amyloid plaque load. Furthermore, in the PSAPP transgenic mouse model of AD, a depleting antibody against CD40L caused marked attenuation of Abeta/beta-amyloid pathology, which was associated with decreased amyloidogenic processing of amyloid precursor protein (APP) and increased circulating levels of Abeta. Conversely, in neuroblastoma cells overexpressing wild-type human APP, the CD40-CD40L interaction resulted in amyloidogenic APP processing. These findings suggest several possible mechanisms underlying mitigation of AD pathology in response to CD40L depletion, and validate the CD40-CD40L interaction as a target for therapeutic intervention in AD.	Univ S Florida, Roskamp Inst, Dept Psychiat, Tampa, FL 33613 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	State University System of Florida; University of South Florida; Howard Hughes Medical Institute; Yale University	Mullan, MJ (corresponding author), Univ S Florida, Roskamp Inst, Dept Psychiat, 3515 E Fletcher Ave, Tampa, FL 33613 USA.		Tan, Jun/I-5339-2012	Mullan, Michael/0000-0002-1473-7527				BALL MJ, 1985, LANCET, V1, P14; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Giulian D, 1999, AM J HUM GENET, V65, P13, DOI 10.1086/302477; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Johnson D, 1997, EDN, V42, P94; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0; Qiao XX, 2001, EUR J NEUROSCI, V14, P474, DOI 10.1046/j.0953-816x.2001.01666.x; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Schonbeck U, 1997, J BIOL CHEM, V272, P19569, DOI 10.1074/jbc.272.31.19569; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Togo T, 2000, BRAIN RES, V885, P117, DOI 10.1016/S0006-8993(00)02984-X; Wilcock DM, 2001, DNA CELL BIOL, V20, P731, DOI 10.1089/10445490152717596; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	35	175	182	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1288	1293		10.1038/nn968	http://dx.doi.org/10.1038/nn968			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402041				2022-12-28	WOS:000179447500011
J	Baker, CI; Behrmann, M; Olson, CR				Baker, CI; Behrmann, M; Olson, CR			Impact of learning on representation of parts and wholes in monkey inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; SHAPE REPRESENTATION; RECOGNITION MEMORY; PERIRHINAL NEURONS; ADULT MONKEYS; VISUAL IMAGES; MACAQUE; OBJECTS; FAMILIARITY; RESPONSES	Here we investigated the impact of visual discrimination training on neuronal responses to parts of images and to whole images in inferotemporal (IT) cortex. Monkeys were trained to discriminate among 'baton' stimuli consisting of discrete top and bottom parts joined by a vertical stem. With separate features at each end, we were able to manipulate the two parts of each baton independently. After training the monkeys, we used single-cell recording to compare neuronal responses to learned and unlearned batons. Responses to learned batons, though not enhanced in strength, were enhanced in selectivity for both individual parts and for whole batons. Whole-baton selectivity arose from a form of conjunctive encoding whereby two parts together exerted a greater influence on neuronal activity than predicted by the additive influence of each part considered individually. These results indicate a possible neural mechanism for holistic or configural effects in expert versus novice observers.	Ctr Neural Basis Cognit, Mellon Inst 115, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Baker, CI (corresponding author), Ctr Neural Basis Cognit, Mellon Inst 115, 4400 5th Ave, Pittsburgh, PA 15213 USA.		Baker, Chris/P-8442-2019	Baker, Chris/0000-0001-6861-8964; Behrmann, Marlene/0000-0002-3814-1015	NATIONAL EYE INSTITUTE [R01EY011831] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11831] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bussey TJ, 2002, EUR J NEUROSCI, V15, P355, DOI 10.1046/j.0953-816x.2001.01850.x; Bussey TJ, 2002, EUR J NEUROSCI, V15, P365, DOI 10.1046/j.0953-816x.2001.01851.x; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Erickson CA, 1999, J NEUROSCI, V19, P10404; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Goldstone RL, 2000, J EXP PSYCHOL HUMAN, V26, P86, DOI 10.1037/0096-1523.26.1.86; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hasegawa I, 2002, NAT NEUROSCI, V5, P90, DOI 10.1038/nn0202-90; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Sheinberg DL, 2002, PERCEPTUAL LEARNING, P95; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Tanaka J. W., 1997, PSYCHOL LEARN MOTIV, V36, P83, DOI DOI 10.1016/S0079-7421(08)60282-0; TANAKA JW, IN PRESS ANAL HOLIST; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; VOGELS R, 1994, EUR J NEUROSCI, V6, P1680, DOI 10.1111/j.1460-9568.1994.tb00560.x; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674; Zar JH., 1999, BIOSTAT ANAL, V663rd	43	225	227	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1210	1216		10.1038/nn960	http://dx.doi.org/10.1038/nn960			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379864	Green Published			2022-12-28	WOS:000178884600025
J	Irie, F; Yamaguchi, Y				Irie, F; Yamaguchi, Y			EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP	NATURE NEUROSCIENCE			English	Article							ARP2/3 COMPLEX; ACTIN; MORPHOGENESIS; PROTEINS; NEURONS; GTPASES; RAC; RHO		Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25938] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Takenawa T, 2001, J CELL SCI, V114, P1801	14	220	224	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1117	1118		10.1038/nn964	http://dx.doi.org/10.1038/nn964			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12389031				2022-12-28	WOS:000178884600011
J	Lewicki, MS				Lewicki, MS			Efficient coding of natural sounds	NATURE NEUROSCIENCE			English	Article							INDEPENDENT COMPONENT ANALYSIS; AUDITORY-NERVE FIBERS; INFORMATION-TRANSMISSION; REPRESENTATIONS; SEPARATION; FRAMEWORK; FILTERS; SPARSE	The auditory system encodes sound by decomposing the amplitude signal arriving at the ear into multiple frequency bands whose center frequencies and bandwidths are approximately exponential functions of the distance from the stapes. This organization is thought to result from the adaptation of cochlear mechanisms to the animal's auditory environment. Here we report that several basic auditory nerve fiber tuning properties can be accounted for by adapting a population of filter shapes to encode natural sounds efficiently. The form of the code depends on sound class, resembling a Fourier transformation when optimized for animal vocalizations and a wavelet transformation when optimized for non-biological environmental sounds. Only for the combined set does the optimal code follow scaling characteristics of physiological data. These results suggest that auditory nerve fibers encode a broad set of natural sounds in a manner consistent with information theoretic principles.	Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lewicki, MS (corresponding author), Carnegie Mellon Univ, Dept Comp Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.							Amari S, 1996, ADV NEUR IN, V8, P757; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTIAS H, 1997, ADV NEURAL INFORMATI, V9; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bell AJ, 1996, NETWORK-COMP NEURAL, V7, P261, DOI 10.1088/0954-898X/7/2/005; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Box G.E., 2011, BAYESIAN INFERENCE S, V40; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARDOSO JF, 1997, IEEE SIGNAL PROCESS, V4, P109; CARNEY LH, 1988, J NEUROPHYSIOL, V60, P1653, DOI 10.1152/jn.1988.60.5.1653; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; Emmons LH, 1997, SOUNDS NEOTROPICAL R; EVANS EF, 1977, PSYCHOPHYSICS PHYSL, P185; EVANS EF, 1975, HDB SENSORY PHYSIOLO, V5, P1; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FURTH PM, 1995, IEEE T CIRCUITS-I, V42, P966, DOI 10.1109/81.477209; Irino T, 1997, J ACOUST SOC AM, V101, P412, DOI 10.1121/1.417975; Kiang NYS, 1965, DISCHARGE PATTERNS S; Laughlin S.B., 1983, PHYS BIOLOGICAL PROC, P42; Lewicki MS, 1999, ADV NEUR IN, V11, P730; Lewicki MS, 1999, J OPT SOC AM A, V16, P1587, DOI 10.1364/JOSAA.16.001587; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; LINSKER R, 1990, ANNU REV NEUROSCI, V13, P257, DOI 10.1146/annurev.neuro.13.1.257; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Moore B, 1986, FREQUENCY SELECTIVIT; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pearlmutter B. A., 1996, Progress in Neural Information Processing. Proceedings of the International Conference on Neural Information Processing, P151; RHODE WS, 1985, HEARING RES, V18, P159, DOI 10.1016/0378-5955(85)90008-5; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SIMONS J, 1979, THEOR CHEM ADV PERSP, V3, P1; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; ZOHARIAN AS, 1981, J ACOUST SOC AM, V69, P832	38	417	423	3	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					356	363		10.1038/nn831	http://dx.doi.org/10.1038/nn831			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896400	Green Submitted			2022-12-28	WOS:000174606900016
J	Zella, JC; Brugge, JF; Schnupp, JWH				Zella, JC; Brugge, JF; Schnupp, JWH			Passive eye displacement alters auditory spatial receptive fields of cat superior colliculus neurons	NATURE NEUROSCIENCE			English	Article							SENSORIMOTOR INTEGRATION; POSITION; SPACE		Univ Wisconsin, Dept Physiol, Madison, WI 53705 USA; Univ Wisconsin, Waisman Ctr 627, Madison, WI 53705 USA; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Oxford	Schnupp, JWH (corresponding author), Univ Wisconsin, Dept Physiol, Madison, WI 53705 USA.		schnupp, jan/A-3006-2012	schnupp, jan w h/0000-0002-2604-0057	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NICHD NIH HHS [HD03352] Funding Source: Medline; NIDCD NIH HHS [DC00116] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abrahams V C, 1979, Prog Brain Res, V50, P325; Brugge JF, 1996, J NEUROSCI, V16, P4420; Groh JM, 2001, NEURON, V29, P509, DOI 10.1016/S0896-6273(01)00222-7; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HARTLINE PH, 1995, EXP BRAIN RES, V104, P402; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; NELSON JS, 1989, J NEUROPHYSIOL, V62, P1360, DOI 10.1152/jn.1989.62.6.1360; PECK CK, 1995, EXP BRAIN RES, V103, P227; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999	13	15	15	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1167	1169		10.1038/nn773	http://dx.doi.org/10.1038/nn773			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713474				2022-12-28	WOS:000172525000009
J	Jin, P; Zarnescu, DC; Ceman, S; Nakamoto, M; Mowrey, J; Jongens, TA; Nelson, DL; Moses, K; Warren, ST				Jin, P; Zarnescu, DC; Ceman, S; Nakamoto, M; Mowrey, J; Jongens, TA; Nelson, DL; Moses, K; Warren, ST			Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway	NATURE NEUROSCIENCE			English	Article							RNA INTERFERENCE; MESSENGER-RNA; DENDRITIC SPINES; KNOCKOUT MICE; MOUSE MODEL; TRANSLATION; HOMOLOG; IDENTIFICATION; ARGONAUTE1; DEFICITS	Fragile X syndrome is caused by a loss of expression of the fragile X mental retardation protein (FMRP). FMRP is a selective RNA-binding protein which forms a messenger ribonucleoprotein (mRNP) complex that associates with polyribosomes. Recently, mRNA ligands associated with FMRP have been identified. However, the mechanism by which FMRP regulates the translation of its mRNA ligands remains unclear. MicroRNAs are small noncoding RNAs involved in translational control. Here we show that in vivo mammalian FMRP interacts with microRNAs and the components of the microRNA pathways including Dicer and the mammalian ortholog of Argonaute 1 (AGO1). Using two different Drosophila melanogaster models, we show that AGO1 is critical for FMRP function in neural development and synaptogenesis. Our results suggest that FMRP may regulate neuronal translation via microRNAs and links microRNAs with human disease.	Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Emory University; Emory University; University of Pennsylvania; Baylor College of Medicine	Warren, ST (corresponding author), Emory Univ, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012					Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cerutti H, 2003, TRENDS GENET, V19, P39, DOI 10.1016/S0168-9525(02)00010-0; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Feng Y, 1997, J NEUROSCI, V17, P1539; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	39	479	521	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					113	117		10.1038/nn1174	http://dx.doi.org/10.1038/nn1174			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14703574				2022-12-28	WOS:000188468500008
J	Micheva, KD; Buchanan, J; Holz, RW; Smith, SJ				Micheva, KD; Buchanan, J; Holz, RW; Smith, SJ			Retrograde regulation of synaptic vesicle endocytosis and recycling	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; HIPPOCAMPAL SYNAPSES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; NERVE-TERMINALS; GTPASE ACTIVITY; CALCIUM; PHOSPHOINOSITIDES; BINDING; DOMAIN	Sustained release of neurotransmitter depends upon the recycling of synaptic vesicles. Until now, it has been assumed that vesicle recycling is regulated by signals from the presynaptic bouton alone, but results from rat hippocampal neurons reported here indicate that this need not be the case. Fluorescence imaging and pharmacological analysis show that a nitric oxide (NO) signal generated postsynaptically can regulate endocytosis and at least one later step in synaptic vesicle recycling. The proposed retrograde pathway involves an NMDA receptor (NMDAR)-dependent postsynaptic production of NO, diffusion of NO to a presynaptic site, and a cGMP-dependent increase in presynaptic phosphatidylinositol 4,5-biphosphate (PIP2). These results indicate that the regulation of synaptic vesicle recycling may integrate a much broader range of neural activity signals than previously recognized, including postsynaptic depolarization and the activation of NMDARs at both immediate and nearby postsynaptic active zones.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Stanford University; University of Michigan System; University of Michigan	Micheva, KD (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.		Micheva, Kristina/ABH-6913-2020	Micheva, Kristina/0000-0003-1138-3732				ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Burette A, 2002, J NEUROSCI, V22, P8961; CLEMENTI E, 1995, J BIOL CHEM, V270, P22277, DOI 10.1074/jbc.270.38.22277; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 2001, J CELL SCI, V114, P1041; De Camilli P, 2001, SYNAPSES, P217; EICHBERG J, 1965, BIOCHEM J, V96, P644, DOI 10.1042/bj0960644; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Goslin K., 1998, CULTURING NERVE CELL, P339; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; HOKIN LE, 1964, BIOCHIM BIOPHYS ACTA, V84, P563, DOI 10.1016/0926-6542(64)90126-X; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Khvotchev M, 1998, J BIOL CHEM, V273, P21451, DOI 10.1074/jbc.273.34.21451; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2001, NEURON, V31, P1015, DOI 10.1016/S0896-6273(01)00449-4; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lin HC, 1996, J BIOL CHEM, V271, P27979, DOI 10.1074/jbc.271.45.27979; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Rao A, 1998, J NEUROSCI, V18, P1217; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Sporns O, 1997, NEUROSCIENCE, V80, P1057, DOI 10.1016/S0306-4522(97)00152-8; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; WENDLAND B, 1994, P NATL ACAD SCI USA, V91, P2151, DOI 10.1073/pnas.91.6.2151; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	42	95	98	1	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					925	932		10.1038/nn1114	http://dx.doi.org/10.1038/nn1114			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12910242				2022-12-28	WOS:000184970400010
J	Kennedy, HJ; Evans, MG; Crawford, AC; Fettiplace, R				Kennedy, HJ; Evans, MG; Crawford, AC; Fettiplace, R			Fast adaptation of mechanoelectrical transducer channels in mammalian cochlear hair cells	NATURE NEUROSCIENCE			English	Article							POSTNATAL-DEVELOPMENT; BUNDLE MOVEMENTS; CURRENTS; CALCIUM; EXPRESSION; INNER; RAT; ELECTROMOTILITY; STIMULI; PRESTIN	Outer hair cells are centrally involved in the amplification and frequency tuning of the mammalian cochlea, but evidence about their transducing properties in animals with fully developed hearing is lacking. Here we describe measurements of mechanoelectrical transducer currents in outer hair cells of rats between postnatal days 5 and 18, before and after the onset of hearing. Deflection of hair bundles using a new rapid piezoelectric stimulator evoked transducer currents with ultra-fast activation and adaptation kinetics. Fast adaptation resembled the same process in turtle hair cells, where it is regulated by changes in stereociliary calcium. It is argued that sub-millisecond transducer adaptation can operate in outer hair cells under the ionic, driving force and temperature conditions that prevail in the intact mammalian cochlea.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Keele, Sch Life Sci, MacKay Inst Commun & Neurosci, Keele ST5 5BG, Staffs, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; University of Bristol; Keele University; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	fettiplace@physiology.wisc.edu	Evans, Michael/C-4980-2009	Evans, Michael/0000-0002-8755-0034	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 01362] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASHMORE JF, 1993, BIOPHYSICS HAIR CELL, P151; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Benser ME, 1996, J NEUROSCI, V16, P5629; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BOSHER SK, 1978, NATURE, V273, P377, DOI 10.1038/273377a0; BOSHER SK, 1971, J PHYSIOL-LONDON, V212, P739, DOI 10.1113/jphysiol.1971.sp009354; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CROWLEY DE, 1966, J COMP PHYSIOL PSYCH, V62, P427, DOI 10.1037/h0023953; DALLOS P, 1986, HEARING RES, V22, P185, DOI 10.1016/0378-5955(86)90095-X; DALLOS P, 1992, J NEUROSCI, V12, P4575; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Fettiplace R, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P65, DOI 10.1142/9789812704931_0007; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Meyer J, 1998, J NEUROSCI, V18, P6748; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Nenov AP, 1997, HEARING RES, V105, P146, DOI 10.1016/S0378-5955(96)00207-9; Nobili R, 1998, TRENDS NEUROSCI, V21, P159, DOI 10.1016/S0166-2236(97)01192-2; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; UZIEL A, 1981, AUDIOLOGY, V20, P89; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; YATES GK, 1992, TRENDS NEUROSCI, V15, P57, DOI 10.1016/0166-2236(92)90027-6; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	50	189	194	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					832	836		10.1038/nn1089	http://dx.doi.org/10.1038/nn1089			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872124				2022-12-28	WOS:000184413700012
J	Jin, SN; Cornwall, MC; Oprian, DD				Jin, SN; Cornwall, MC; Oprian, DD			Opsin activation as a cause of congenital night blindness	NATURE NEUROSCIENCE			English	Article							TRANSGENIC XENOPUS-LAEVIS; ROD OUTER SEGMENTS; RHODOPSIN GENE; VISUAL PIGMENT; MOLECULAR-MECHANISM; PHOTORECEPTOR NOISE; DARK-ADAPTATION; FUSION PROTEIN; RETINAL RODS; MUTATION	Three different mutations of rhodopsin are known to cause autosomal dominant congenital night blindness in humans. Although the mutations have been studied for 10 years, the molecular mechanism of the disease is still a subject of controversy. We show here, using a transgenic Xenopus laevis model, that the photoreceptor cell desensitization that is a hallmark of the disease results from persistent signaling by constitutively active mutant opsins.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Brandeis University; Brandeis University; Boston University	Cornwall, MC (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.		Jin, Shengnan/I-6264-2012	Jin, Shengnan/0000-0003-0467-6502; Cornwall, M./0000-0002-0847-939X	NEI NIH HHS [R01 EY007965] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		al-Jandal N, 1999, HUM MUTAT, V13, P75, DOI 10.1002/(SICI)1098-1004(1999)13:1<75::AID-HUMU9>3.0.CO;2-4; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; BIRGE RR, 1995, BIOPHYS CHEM, V55, P115, DOI 10.1016/0301-4622(94)00145-A; Cornwall MC, 2000, METHOD ENZYMOL, V316, P224; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; Dryja TP, 2000, AM J OPHTHALMOL, V130, P547, DOI 10.1016/S0002-9394(00)00737-6; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Firsov ML, 2002, J PHYSIOL-LONDON, V539, P837, DOI 10.1113/jphysiol.2001.013207; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; Kefalov VJ, 1999, J GEN PHYSIOL, V113, P491, DOI 10.1085/jgp.113.3.491; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; KLEINSCHMIDT J, 1975, J GEN PHYSIOL, V66, P617, DOI 10.1085/jgp.66.5.617; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Moritz OL, 1999, INVEST OPHTH VIS SCI, V40, P3276; Rao VR, 1996, ANNU REV BIOPH BIOM, V25, P287; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; SEARS RC, 1989, VISION RES, V29, P1485, DOI 10.1016/0042-6989(89)90132-6; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; Sieving PA, 2001, J NEUROSCI, V21, P5449, DOI 10.1523/JNEUROSCI.21-15-05449.2001; STEINBERG G, 1993, BIOPHYS J, V64, P1499, DOI 10.1016/S0006-3495(93)81518-2; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Zvyaga TA, 1996, BIOCHEMISTRY-US, V35, P7536, DOI 10.1021/bi960391n	31	53	55	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					731	735		10.1038/nn1070	http://dx.doi.org/10.1038/nn1070			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12778053				2022-12-28	WOS:000183780400021
J	Gleason, MR; Higashijima, S; Dallman, J; Liu, K; Mandel, G; Fetcho, JR				Gleason, MR; Higashijima, S; Dallman, J; Liu, K; Mandel, G; Fetcho, JR			Translocation of CaM kinase II to synaptic sites in vivo	NATURE NEUROSCIENCE			English	Article							TRANSGENIC ZEBRAFISH; LARVAL ZEBRAFISH; XENOPUS-LAEVIS; NEURONS; INTERNEURONS; EMBRYOS		SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mandel, G (corresponding author), SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA.		Dallman, Julia/I-1414-2019; Dallman, Julia/AGG-3507-2022	Dallman, Julia/0000-0002-5839-807X; Higashijima, Shin-ichi/0000-0001-6350-4992	NINDS NIH HHS [NS26539, R01 NS026539, R01 NS026539-25] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026539, R29NS026539, R37NS026539] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; CLARKE JDW, 1984, J PHYSIOL-LONDON, V348, P511, DOI 10.1113/jphysiol.1984.sp015122; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; ROBERTS A, 1990, EUR J NEUROSCI, V2, P1051, DOI 10.1111/j.1460-9568.1990.tb00017.x; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SILLAR KT, 1988, NATURE, V331, P262, DOI 10.1038/331262a0; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467	12	64	67	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					217	218		10.1038/nn1011	http://dx.doi.org/10.1038/nn1011			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563265				2022-12-28	WOS:000181178300007
J	Adams, DL; Horton, JC				Adams, DL; Horton, JC			Capricious expression of cortical columns in the primate brain	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; LATERAL GENICULATE-NUCLEUS; SQUIRREL-MONKEY; VISUAL-CORTEX; STRIATE CORTEX; OLD-WORLD; ENUCLEATION; AFFERENTS; MACAQUE		Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Adams, DL (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, 10 Kirkham St, San Francisco, CA 94143 USA.	dadams@itsa.ucsf.edu	Adams, Daniel L/A-5229-2009	Adams, Daniel L/0000-0003-0376-4949; Horton, Jonathan/0000-0002-3952-435X				Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; HENDRICKSON AE, 1985, BRAIN RES, V333, P340, DOI 10.1016/0006-8993(85)91589-6; Horton JC, 1996, J NEUROSCI, V16, P5510; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; Horton JC, 1996, J NEUROSCI, V16, P7228; Hubel D H, 1976, Cold Spring Harb Symp Quant Biol, V40, P581; HUBEL DH, 1969, NATURE, V221, P747, DOI 10.1038/221747a0; Kaschube M, 2002, J NEUROSCI, V22, P7206; Livingstone MS, 1996, J NEUROSCI, V16, P2086; LIVINGSTONE MS, 1995, VISION RES, V35, P345, DOI 10.1016/0042-6989(94)00133-7; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PURVES D, 1992, TRENDS NEUROSCI, V15, P362, DOI 10.1016/0166-2236(92)90180-G; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; TIGGES J, 1977, J COMP NEUROL, V176, P87, DOI 10.1002/cne.901760106	15	76	76	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					113	114		10.1038/nn1004	http://dx.doi.org/10.1038/nn1004			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536211				2022-12-28	WOS:000180669100008
J	Zonta, M; Angulo, MC; Gobbo, S; Rosengarten, B; Hossmann, KA; Pozzan, T; Carmignoto, G				Zonta, M; Angulo, MC; Gobbo, S; Rosengarten, B; Hossmann, KA; Pozzan, T; Carmignoto, G			Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; SOMATOSENSORY STIMULATION; INTRACELLULAR CALCIUM; FUNCTIONAL HYPEREMIA; NMDA RECEPTORS; GLUTAMATE; MICROVESSELS; RAT; ACTIVATION	The cellular mechanisms underlying functional hyperemia-the coupling of neuronal activation to cerebral blood vessel responses-are not yet known. Here we show in rat cortical slices that the dilation of arterioles triggered by neuronal activity is dependent on glutamate-mediated [Ca2+](i) oscillations in astrocytes. Inhibition of these Ca2+ responses resulted in the impairment of activity-dependent vasodilation, whereas selective activation-by patch pipette-of single astrocytes that were in contact with arterioles triggered vessel relaxation. We also found that a cyclooxygenase product is centrally involved in this astrocyte-mediated control of arterioles. In vivo blockade of glutamate-mediated [Ca2+](i) elevations in astrocytes reduced the blood flow increase in the somatosensory cortex during contralateral forepaw stimulation. Taken together, our findings show that neuron-to-astrocyte signaling is a key mechanism in functional hyperemia.	Univ Padua, CNR, Ist Neurosci, I-35121 Padua, Italy; Univ Padua, Dipartimento Sci Biomed Sperimentali, I-35121 Padua, Italy; Ciudad Univ, Ed manuel Ancizar, Ctr Int Fis, Bogota, Colombia; Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Universidad Nacional de Colombia; Max Planck Society	Carmignoto, G (corresponding author), Univ Padua, CNR, Ist Neurosci, Viale G Colombo 3, I-35121 Padua, Italy.	gcarmi@bio.unipd.it	Zonta, Micaela/AAX-3505-2020; Angulo, Maria Cecilia/B-8236-2014; Carmignoto, Giorgio/A-8375-2018	Zonta, Micaela/0000-0002-9982-6405; Angulo, Maria Cecilia/0000-0002-0758-0496; Carmignoto, Giorgio/0000-0003-3063-6774	Telethon [1095] Funding Source: Medline	Telethon(Fondazione Telethon)		Alkayed NJ, 1997, STROKE, V28, P1066, DOI 10.1161/01.STR.28.5.1066; Araque A, 1998, J NEUROSCI, V18, P6822; Bakalova R, 2002, EXP BIOL MED, V227, P465, DOI 10.1177/153537020222700710; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Brinker G, 1999, MAGNET RESON MED, V41, P469, DOI 10.1002/(SICI)1522-2594(199903)41:3<469::AID-MRM7>3.0.CO;2-9; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Farber NE, 1997, ANESTHESIOLOGY, V87, P1191, DOI 10.1097/00000542-199711000-00024; FERGUS A, 1995, BRAIN RES, V694, P78, DOI 10.1016/0006-8993(95)00768-L; Fergus A, 1997, BRAIN RES, V754, P35, DOI 10.1016/S0006-8993(97)00040-1; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Gartner R, 2001, BIOFACTORS, V14, P199; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GOLANOV EV, 1994, J CEREBR BLOOD F MET, V14, P492, DOI 10.1038/jcbfm.1994.61; Golgi C, 1885, RIV SPER FREMIAT MED, V11, P72; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; IADECOLA C, 1993, AM J PHYSIOL, V264, pR738, DOI 10.1152/ajpregu.1993.264.4.R738; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Paspalas CD, 1998, BRAIN RES BULL, V45, P247, DOI 10.1016/S0361-9230(97)00327-4; Pasti L, 1997, J NEUROSCI, V17, P7817; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PETERS A, 1991, FINE STRUCTURE NERVO, P276; Porter JT, 1996, J NEUROSCI, V16, P5073; Raichle ME, 2001, NATURE, V412, P128, DOI 10.1038/35084300; REINHARD JF, 1979, SCIENCE, V206, P85, DOI 10.1126/science.482930; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Roy C S, 1890, J Physiol, V11, P85; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schmitz B, 1997, J CEREBR BLOOD F MET, V17, P1202, DOI 10.1097/00004647-199711000-00009; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; VAUCHER E, 1995, J NEUROSCI, V15, P7427; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; White RP, 1998, STROKE, V29, P467, DOI 10.1161/01.STR.29.2.467; Yang G, 1999, AM J PHYSIOL-REG I, V277, pR1760, DOI 10.1152/ajpregu.1999.277.6.R1760; Yang G, 2000, J NEUROSCI, V20, P6968, DOI 10.1523/JNEUROSCI.20-18-06968.2000	48	1084	1114	3	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					43	50		10.1038/nn980	http://dx.doi.org/10.1038/nn980			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469126				2022-12-28	WOS:000180089300014
J	Connor, CE				Connor, CE			Representing whole objects: temporal neurons learn to play their parts	NATURE NEUROSCIENCE			English	Editorial Material							INFEROTEMPORAL CORTEX; RECOGNITION; PRIMATE		Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA.							Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Edelman S., 1999, REPRESENTATION RECOG; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; PASUPATHY A, IN PRESS NAT NEUROSC; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547	15	2	2	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1105	1106		10.1038/nn1102-1105	http://dx.doi.org/10.1038/nn1102-1105			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12403999				2022-12-28	WOS:000178884600005
J	Horch, HW; Katz, LC				Horch, HW; Katz, LC			BDNF release from single cells elicits local dendritic growth in nearby neurons	NATURE NEUROSCIENCE			English	Article							RETROGRADE AXONAL-TRANSPORT; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; TRKB RECEPTORS; FULL-LENGTH; VISUAL-CORTEX; POSTSYNAPTIC NEURONS; TRUNCATED RECEPTORS; SYMPATHETIC NEURONS; STRIATE CORTEX	In cultured neurons, the exogenous application of neurotrophins (in homogenous concentrations) alters many features of axonal and dendritic arbors. In vivo, however, release of endogenous neurotrophins from neuronal processes creates spatially heterogeneous neurotrophin distributions. To probe the consequences of such endogenous neurotrophin distribution, we produced 'donor neurons' in ferret cortex brain slices that co-expressed brain-derived neurotrophic factor (BDNF) and red fluorescent protein (RFP). Using two-photon microscopy, we analyzed their effects on 'recipient neurons' that expressed green fluorescent protein (GFP) alone. BDNF released from dendrites and cell bodies acted directly on nearby recipient neurons to increase dendritic branching in a distance-dependent manner. Three-dimensional analysis of donor and recipient dendrites indicated that the BDNF source had to be within 4.5 mum to induce dendritic growth in the recipient neuron. Thus, BDNF released from an individual cell alters the structure of nearby dendrites on an exquisitely local scale.	Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Horch, HW (corresponding author), Bowdoin Coll, Dept Biol, 6500 Coll Stn, Brunswick, ME 04011 USA.	hhorch@bowdoin.edu			NEI NIH HHS [EY-11553] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BIFFO S, 1995, DEVELOPMENT, V121, P2461; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; Horch HW, 1999, NEURON, V23, P353; Jarvis CR, 1997, J NEUROPHYSIOL, V78, P2363, DOI 10.1152/jn.1997.78.5.2363; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KATZ LC, 1988, J NEUROSCI, V8, P3160; KATZ LC, 1987, J NEUROSCI, V7, P1223; KATZ LC, 1991, EUR J NEUROSCI, V3, P1, DOI 10.1111/j.1460-9568.1991.tb00805.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Kossel AH, 1997, J NEUROSCI, V17, P9634; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lom B, 1999, J NEUROSCI, V19, P9928; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Murphy DD, 1998, P NATL ACAD SCI USA, V95, P11412, DOI 10.1073/pnas.95.19.11412; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Ozdinler PH, 2001, J COMP NEUROL, V438, P377; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Shimada A, 1998, J NEUROSCI, V18, P8559; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zervas M, 1999, J COMP NEUROL, V413, P429, DOI 10.1002/(SICI)1096-9861(19991025)413:3<429::AID-CNE6>3.0.CO;2-7	50	301	307	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1177	1184		10.1038/nn927	http://dx.doi.org/10.1038/nn927			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368805				2022-12-28	WOS:000178884600021
J	Nelson, LE; Guo, TZ; Lu, J; Saper, CB; Franks, NP; Maze, M				Nelson, LE; Guo, TZ; Lu, J; Saper, CB; Franks, NP; Maze, M			The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway	NATURE NEUROSCIENCE			English	Article							FOS-LIKE IMMUNOREACTIVITY; C-FOS; TUBEROMAMMILLARY NUCLEUS; NITROUS-OXIDE; RAT-BRAIN; NEURONS; PROPOFOL; ACTIVATION; HYPOTHALAMUS; WAKEFULNESS	We investigated the role of regionally discrete GABA (gamma-aminobutyric acid) receptors in the sedative response to pharmacological agents that act on GABA(A) receptors (muscimol, propofol and pentobarbital; 'GABAergic agents') and to ketamine, a general anesthetic that does not affect GABA(A) receptors. Behavioral studies in rats showed that the sedative response to centrally administered GABAergic agents was attenuated by the GABA(A) receptor antagonist gabazine (systemically administered). The sedative response to ketamine, by contrast, was unaffected by gabazine. Using c-Fos as a marker of neuronal activation, we identified a possible role for the tuberomammillary nucleus (TMN): when gabazine was microinjected directly into the TMN, it attenuated the sedative response to GABAergic agents. Furthermore, the GABA(A) receptor agonist muscimol produced a dose-dependent sedation when it was administered into the TMN. We conclude that the TMN is a discrete neural locus that has a key role in the sedative response to GABAergic anesthetics.	Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Anaesthet & Intens Care, London SW10 9NH, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Blackett Lab, Biophys Sect, London SW7 2BW, England; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Imperial College London; Imperial College London; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Franks, NP (corresponding author), Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Anaesthet & Intens Care, London SW10 9NH, England.	n.franks@ic.ac.uk	Saper, Clifford/L-3815-2019	Franks, Nicholas/0000-0003-4874-4212	NHLBI NIH HHS [HL60292] Funding Source: Medline; NIA NIH HHS [AG09975] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; AIRAKSINEN MS, 1992, J COMP NEUROL, V323, P103, DOI 10.1002/cne.903230109; AKAIKE N, 1990, AM J PHYSIOL, V258, pC452, DOI 10.1152/ajpcell.1990.258.3.C452; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; BARKER JL, 1973, SCIENCE, V182, P720, DOI 10.1126/science.182.4113.720; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; CHENG SC, 1985, ANESTHESIOLOGY, V63, P147, DOI 10.1097/00000542-198508000-00005; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; CIRELLI C, 1993, ARCH ITAL BIOL, V131, P327; Cirelli C, 2000, SLEEP, V23, P453; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; CORREASALES C, 1992, ANESTHESIOLOGY, V76, P948, DOI 10.1097/00000542-199206000-00013; Depczynski B, 1998, ANN NY ACAD SCI, V863, P120, DOI 10.1111/j.1749-6632.1998.tb10689.x; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; ERICSON H, 1991, J COMP NEUROL, V305, P462, DOI 10.1002/cne.903050309; Fiset P, 1999, J NEUROSCI, V19, P5506; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; GAGE PW, 1985, BRIT J PHARMACOL, V85, P229, DOI 10.1111/j.1476-5381.1985.tb08851.x; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; HALES TG, 1991, BRIT J PHARMACOL, V104, P619, DOI 10.1111/j.1476-5381.1991.tb12479.x; HARA M, 1993, ANESTHESIOLOGY, V79, P781, DOI 10.1097/00000542-199310000-00021; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Lam DW, 1998, BRAIN RES, V784, P179, DOI 10.1016/S0006-8993(97)01334-6; Lin JS, 1996, J NEUROSCI, V16, P1523; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; LIN LH, 1993, J NEUROCHEM, V60, P1548, DOI 10.1111/j.1471-4159.1993.tb03320.x; MONTI JM, 1993, LIFE SCI, V53, P1331, DOI 10.1016/0024-3205(93)90592-Q; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pompeiano M, 1995, NEUROPHYSIOL CLIN, V25, P329, DOI 10.1016/0987-7053(96)84906-9; SAPER CB, 1985, J COMP NEUROL, V237, P21, DOI 10.1002/cne.902370103; Sawamura S, 2000, J NEUROSCI, V20, P9242; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; Steininger TL, 2001, J COMP NEUROL, V429, P638; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; VILLAR MJ, 1990, NEUROSCIENCE, V36, P181, DOI 10.1016/0306-4522(90)90361-7; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577	45	422	436	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					979	984		10.1038/nn913	http://dx.doi.org/10.1038/nn913			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12195434				2022-12-28	WOS:000178242200017
J	Tadin, D; Lappin, JS; Blake, R; Grossman, ED				Tadin, D; Lappin, JS; Blake, R; Grossman, ED			What constitutes an efficient reference frame for vision?	NATURE NEUROSCIENCE			English	Article							BIOLOGICAL MOTION PERCEPTION; EYE-MOVEMENTS; VISUAL-MOTION; IMAGE SEGMENTATION; SPACE; CORTEX; MODEL; COHERENCE; RESPONSES; CONTRAST	Vision requires a reference frame. To what extent does this reference frame depend on the structure of the visual input, rather than just on retinal landmarks? This question is particularly relevant to the perception of dynamic scenes, when keeping track of external motion relative to the retina is difficult. We tested human subjects' ability to discriminate the motion and temporal coherence of changing elements that were embedded in global patterns and whose perceptual organization was manipulated in a way that caused only minor changes to the retinal image. Coherence discriminations were always better when local elements were perceived to be organized as a global moving form than when they were perceived to be unorganized, individually moving entities. Our results indicate that perceived form influences the neural representation of its component features, and from this, we propose a new method for studying perceptual organization.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Vanderbilt University	Tadin, D (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, 301 Wilson Hall,111 21st Ave S, Nashville, TN 37203 USA.			Tadin, Duje/0000-0003-1571-5589	NEI NIH HHS [T32-EY07135, EY07760, P30-EY08126, P30 EY008126, R01 EY007760, T32 EY007135] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007760, T32EY007135, P30EY008126] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Blake R, 1997, P NATL ACAD SCI USA, V94, P7115, DOI 10.1073/pnas.94.13.7115; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Croner LJ, 1997, VISION RES, V37, P1415, DOI 10.1016/S0042-6989(96)00299-4; Croner LJ, 1999, J NEUROSCI, V19, P3935; Crowell JA, 1998, NAT NEUROSCI, V1, P732, DOI 10.1038/3732; DAY RH, 1971, NATURE, V230, P55, DOI 10.1038/230055a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Gibson JJ, 1950, PERCEPTION VISUAL WO; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Haarmeier T, 2001, NEURON, V32, P527, DOI 10.1016/S0896-6273(01)00486-X; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; JOHANSSON G, 1994, PERCEIVING EVENTS AND OBJECTS, P29; Lappin JS, 2000, PSYCHOL REV, V107, P6, DOI 10.1037/0033-295X.107.1.6; Lappin JS, 2001, VISION RES, V41, P1631, DOI 10.1016/S0042-6989(01)00035-9; Lee SH, 1999, SCIENCE, V284, P1165, DOI 10.1126/science.284.5417.1165; LEGGE GE, 1981, VISION RES, V21, P205, DOI 10.1016/0042-6989(81)90114-0; Lorenceau J, 2001, NAT NEUROSCI, V4, P745, DOI 10.1038/89543; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; MARR D, 1981, P R SOC LOND B, V211, P150; MORGAN MJ, 1982, Q J EXP PSYCHOL-A, V34, P211, DOI 10.1080/14640748208400837; MURAKAMI I, 1995, VISION RES, V35, P1835, DOI 10.1016/0042-6989(94)00269-R; NAKAYAMA K, 1978, VISION RES, V18, P1663, DOI 10.1016/0042-6989(78)90258-4; NAWROT M, 1990, VISION RES, V30, P1439, DOI 10.1016/0042-6989(90)90025-G; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Regan David, 2000, HUMAN PERCEPTION OBJ; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; Turano KA, 1999, VISION RES, V39, P1177, DOI 10.1016/S0042-6989(98)00174-6; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; Wade NJ, 1996, PERCEPTION, V25, P187, DOI 10.1068/p250187; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	44	49	49	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					1010	1015		10.1038/nn914	http://dx.doi.org/10.1038/nn914			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	597VV	12219092	Green Accepted			2022-12-28	WOS:000178242200021
J	Muzio, L; DiBenedetto, B; Stoykova, A; Boncinelli, E; Gruss, P; Mallamaci, A				Muzio, L; DiBenedetto, B; Stoykova, A; Boncinelli, E; Gruss, P; Mallamaci, A			Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice	NATURE NEUROSCIENCE			English	Article							DORSAL TELENCEPHALON; TRANSCRIPTION FACTOR; AREA IDENTITY; GENE; MOUSE; NEURONS; EMX2; EXPRESSION; PAX6; HOMEODOMAIN	The molecular mechanisms that activate morphogenesis of cerebral cortex are currently the subject of intensive experimental analysis. Transcription factor genes of the homeobox, basic helix-loop-helix (bHLH) and zinc-finger families have recently been shown to have essential roles in this process. However, the actual selector genes activating corticogenesis have not yet been identified. Here we show that high-level expression of at least one functional allele of either of the homeobox genes Emx2 or Pax6 in the dorsal telencephalon is necessary and sufficient to stably activate morphogenesis of cerebral cortex and to repress that of adjacent structures, such as striatum.	Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, I-20132 Milan, Italy; Max Planck Inst Biophys Chem, D-37018 Gottingen, Germany; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Max Planck Society; International School for Advanced Studies (SISSA)	Mallamaci, A (corresponding author), Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	mallamaci.antonio@hsr.it	Di Benedetto, Barbara/B-7190-2016; Muzio, Luca/AAB-2308-2022; Mallamaci, Antonello/A-2975-2015; Di Benedetto, Barbara/E-2315-2013	Di Benedetto, Barbara/0000-0001-6537-9072; Muzio, Luca/0000-0002-1068-865X; Mallamaci, Antonello/0000-0002-3621-1307; 				Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Fode C, 2000, GENE DEV, V14, P67; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Grove EA, 1998, DEVELOPMENT, V125, P2315; HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x; Hallonet M, 1998, DEVELOPMENT, V125, P2599; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Inoue T, 2001, DEVELOPMENT, V128, P561; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee SMK, 2000, DEVELOPMENT, V127, P457; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Shimamura K, 1997, DEVELOPMENT, V124, P2709; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takahashi T, 1996, J NEUROSCI, V16, P5762; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Theil T, 1999, DEVELOPMENT, V126, P3561; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tole S, 2000, J NEUROSCI, V20, P2618; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Toresson H, 2000, DEVELOPMENT, V127, P4361; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yoshida M, 1997, DEVELOPMENT, V124, P101; Yun K, 2001, DEVELOPMENT, V128, P193	50	129	130	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					737	745		10.1038/nn892	http://dx.doi.org/10.1038/nn892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118260	Green Published			2022-12-28	WOS:000177088900016
J	Vuilleumier, P; Henson, RN; Driver, J; Dolan, RJ				Vuilleumier, P; Henson, RN; Driver, J; Dolan, RJ			Multiple levels of visual object constancy revealed by event-related fMRI of repetition priming	NATURE NEUROSCIENCE			English	Article							LATERAL OCCIPITAL COMPLEX; INFEROTEMPORAL CORTEX; 3-DIMENSIONAL OBJECTS; VIEWPOINT INVARIANCE; TEMPORAL CORTEX; TIME-COURSE; RECOGNITION; MEMORY; BRAIN; SPECIFICITY	We conducted two event-related functional magnetic resonance imaging (fMRI) experiments to investigate the neural substrates of visual object recognition in humans. We used a repetition-priming method with visual stimuli recurring at unpredictable intervals, either with the same appearance or with changes in size, viewpoint or exemplar. Lateral occipital and posterior inferior temporal cortex showed lower activity for repetitions of both real and non-sense objects; fusiform and left inferior frontal regions showed decreases for repetitions of only real objects. Repetition of different exemplars with the same name affected only the left inferior frontal cortex. Crucially, priming-induced decreases in activity of the right fusiform cortex depended on whether the three-dimensional objects were repeated with the same viewpoint, regardless of whether retinal image size changed; left fusiform decreases were independent of both viewpoint and size. These data show that dissociable subsystems in ventral visual cortex maintain distinct view-dependent and view-invariant object representations.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Wellcome Dept Cognit Neurol, Funct Imaging Lab, London WC1N 3BG, England; Royal Free Hosp & Univ Coll Sch Med, London NW3 2PF, England	University of London; University College London; University of London; University College London; University of London; University College London	Vuilleumier, P (corresponding author), UCL, Inst Cognit Neurosci, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	p.vuilleumier@ucl.ac.uk	Vuilleumier, Patrik/AAJ-1839-2021; Driver, Jon/A-4779-2010; Henson, Richard/H-8822-2019	Vuilleumier, Patrik/0000-0002-8198-9214; Henson, Richard/0000-0002-0712-2639; Dolan, Ray/0000-0001-9356-761X				Ashbridge E, 2000, COGN NEUROPSYCHOL, V17, P13, DOI 10.1080/026432900380463; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Biederman I, 1999, VISION RES, V39, P2885, DOI 10.1016/S0042-6989(98)00309-5; BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Blaxton TA, 1996, CAN J EXP PSYCHOL, V50, P42, DOI 10.1037/1196-1961.50.1.42; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Cave CB, 1996, J EXP PSYCHOL LEARN, V22, P639, DOI 10.1037/0278-7393.22.3.639; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; ELLIS R, 1989, Q J EXP PSYCHOL-A, V41, P775, DOI 10.1080/14640748908402393; FARAH MJ, 1990, DISORDERS OBJECT REC; Fiser J, 2001, VISION RES, V41, P221, DOI 10.1016/S0042-6989(00)00234-0; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Furmanski CS, 2000, VISION RES, V40, P473, DOI 10.1016/S0042-6989(99)00134-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grusser O. J., 1991, VISUAL AGNOSIA OTHER; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; James TW, 1999, NEUROREPORT, V10, P1019, DOI 10.1097/00001756-199904060-00023; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marr D., 1982, VISION; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Turnbull O H, 1997, J Int Neuropsychol Soc, V3, P288; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; WARRINGTON EK, 1978, PERCEPTION, V7, P695, DOI 10.1068/p070695; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	50	398	402	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					491	499		10.1038/nn839	http://dx.doi.org/10.1038/nn839			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967545	Green Published			2022-12-28	WOS:000175272000022
J	Oviedo, H; Reyes, AD				Oviedo, H; Reyes, AD			Boosting of neuronal firing evoked with asynchronous and synchronous inputs to the dendrite	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; ACTION-POTENTIALS; APICAL DENDRITES; CORTICAL-NEURONS; CHANNELS; RAT; EPSPS; AMPLIFICATION; SOMA; INACTIVATION	Dendritic conductances have previously been shown to boost excitatory postsynaptic potentials (EPSPs). To determine whether this boosting translates to an increase in the efficacy for evoking action potentials, we injected barrages of EPSPs that simulate the inputs generated by a population of presynaptic cells into either the dendrite or the soma of pyramidal neurons in vitro. Although the individual dendritic and somatic EPSPs were identical, barrages delivered to the dendrite generated much higher firing rates. Boosting occurred when the simulated cells fired asynchronously and synchronously. This Na+-mediated boosting, which was manifested during repetitive firing, may compensate functionally for electrotonic attenuation of EPSPs.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Reyes, AD (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.							Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 1997, J NEUROSCI, V17, P6512; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; GRANIT R, 1966, J PHYSIOL-LONDON, V187, P379, DOI 10.1113/jphysiol.1966.sp008097; Kang J, 1996, J NEUROPHYSIOL, V76, P188, DOI 10.1152/jn.1996.76.1.188; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1998, J NEUROSCI, V18, P7613; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Poolos NP, 1999, J NEUROSCI, V19, P5205; Rall W, 1964, NEURAL THEORY MODELI, P73; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes AD, 1996, J NEUROSCI, V16, P993; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt P, 1996, J NEUROPHYSIOL, V76, P3731, DOI 10.1152/jn.1996.76.6.3731; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	30	41	42	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					261	266		10.1038/nn807	http://dx.doi.org/10.1038/nn807			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836531				2022-12-28	WOS:000174146000017
J	Featherstone, DE; Rushton, E; Broadie, K				Featherstone, DE; Rushton, E; Broadie, K			Developmental regulation of glutamate receptor field size by nonvesicular glutamate release	NATURE NEUROSCIENCE			English	Article							DROSOPHILA-MELANOGASTER; SYNAPTIC TRANSMISSION; NEUROMUSCULAR-JUNCTIONS; TRANSMITTER RELEASE; GENETIC-ANALYSIS; SYNTHETASE; NEUROTRANSMITTER; EXPRESSION; SYNTAXIN; CURRENTS	We hypothesized that presynaptic glutamate regulates postsynaptic ionotropic glutamate receptor number during synaptogenesis. To test this idea, we genetically manipulated presynaptic glutamate levels at the glutamatergic Drosophila neuromuscular junction (NMJ), then microscopically and electrophysiologically measured postsynaptic glutamate receptor field size and function. Our data show that presynaptic glutamate is a strong negative regulator of postsynaptic receptor field size and function during development. Glutamate-triggered receptor downregulation was not affected by block of synaptic vesicle fusion, demonstrating that receptors are regulated by nonvesicular glutamate release. Our results reveal an elegant mechanism for receptor field regulation during synaptogenesis and reveal a nonpathological role for nonvesicular glutamate release at the synapse.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Featherstone, DE (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.				NIGMS NIH HHS [GM54544] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Besson MT, 2000, CURR BIOL, V10, P207, DOI 10.1016/S0960-9822(00)00339-0; Besson MT, 1999, FEBS LETT, V449, P293; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; CAGGESE C, 1988, BIOCHEM GENET, V26, P571, DOI 10.1007/BF02399602; CAGGESE C, 1994, GENETICA, V94, P275, DOI 10.1007/BF01443441; CAGGESE C, 1992, DEV GENET, V13, P359, DOI 10.1002/dvg.1020130506; CAIZZI R, 1990, J MOL BIOL, V212, P17, DOI 10.1016/0022-2836(90)90301-2; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHASE BA, 1987, J NEUROBIOL, V18, P15, DOI 10.1002/neu.480180104; DAVIS GW, 1994, J NEUROBIOL, V25, P740, DOI 10.1002/neu.480250612; DEPINTO V, 1987, BIOCHEM GENET, V25, P821, DOI 10.1007/BF00502602; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Featherstone DE, 2000, BRAIN RES BULL, V53, P501, DOI 10.1016/S0361-9230(00)00383-X; Heckmann M, 1998, NEUROSCI LETT, V256, P77, DOI 10.1016/S0304-3940(98)00756-3; IKEDA K, 1976, NATURE, V259, P489, DOI 10.1038/259489a0; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LANGLEY CH, 1981, GENETICS, V99, P151; Lissin DV, 1999, J NEUROSCI, V19, P3275; Nishikawa K, 1995, J NEUROSCI, V15, P7905; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Saitoe M, 1998, J NEUROSCI METH, V80, P163, DOI 10.1016/S0165-0270(97)00203-3; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; WHITE RAH, 1998, DROSOPHILA PRACTICAL, P215; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9	42	83	86	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					141	146		10.1038/nn789	http://dx.doi.org/10.1038/nn789			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11753421				2022-12-28	WOS:000173558400016
J	Mack, TGA; Reiner, M; Beirowski, B; Mi, WQ; Emanuelli, M; Wagner, D; Thomson, D; Gillingwater, T; Court, F; Conforti, L; Fernando, FS; Tarlton, A; Andressen, C; Addicks, K; Magni, G; Ribchester, RR; Perry, VH; Coleman, MP				Mack, TGA; Reiner, M; Beirowski, B; Mi, WQ; Emanuelli, M; Wagner, D; Thomson, D; Gillingwater, T; Court, F; Conforti, L; Fernando, FS; Tarlton, A; Andressen, C; Addicks, K; Magni, G; Ribchester, RR; Perry, VH; Coleman, MP			Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD INJURY; NEUROMUSCULAR-JUNCTIONS; C57BL/OLA MICE; POLY(ADP-RIBOSE) POLYMERASE; BCL-2 OVEREXPRESSION; CELLULAR REACTIONS; MUTATION WLD(S); WILD-TYPE; MOUSE; NERVE	Axons and their synapses distal to an injury undergo rapid Wallerian degeneration, but axons in the C57BL/Wld(S) mouse are protected. The degenerative and protective mechanisms are unknown. We identified the protective gene, which encodes an N-terminal fragment of ubiquitination factor E4B (Ube4b) fused to nicotinamide mononucleotide adenylyltransferase (Nmnat), and showed that it confers a dose-dependent block of Wallerian degeneration. Transected distal axons survived for two weeks, and neuromuscular junctions were also protected. Surprisingly, the Wld protein was located predominantly in the nucleus, indicating an indirect protective mechanism. Nmnat enzyme activity, but not NAD(+) content, was increased fourfold in Wld(S) tissues. Thus, axon protection is likely to be mediated by altered ubiquitination or pyridine nucleotide metabolism.	Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Cologne, Dept Anat 1, D-50931 Cologne, Germany; Univ Ancona, Inst Biochem, I-60131 Ancona, Italy; Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Mario Negri Inst Pharmacol Res, Mol Neurobiol Lab, I-20157 Milan, Italy; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of Cologne; University of Cologne; University of Cologne; Marche Polytechnic University; University of Edinburgh; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; University of Oxford; University of Southampton	Coleman, MP (corresponding author), Univ Cologne, Ctr Mol Med, Zuelpicher Str 47, D-50674 Cologne, Germany.	michael.coleman@uni-koeln.de	Perry, V. Hugh/Y-2935-2019	Ribchester, Richard/0000-0003-2670-6995; Court, Felipe/0000-0002-9394-7601; Gillingwater, Thomas/0000-0002-0306-5577				BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; BROWN MC, 1991, NEUROSCIENCE, V43, P279, DOI 10.1016/0306-4522(91)90435-Q; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; Burne JF, 1996, J NEUROSCI, V16, P2064; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 1999, MAMM GENOME, V10, P617, DOI 10.1007/s003359901056; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Costanzo EM, 2000, NAT NEUROSCI, V3, P694, DOI 10.1038/76649; Costanzo EM, 1999, J PHYSIOL-LONDON, V521, P365, DOI 10.1111/j.1469-7793.1999.00365.x; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Finn JT, 2000, J NEUROSCI, V20, P1333; Frei R, 1999, J NEUROSCI, V19, P6058, DOI 10.1523/JNEUROSCI.19-14-06058.1999; Fujiki M, 1996, J COMP NEUROL, V371, P469; Gillingwater TH, 2000, J PHYSIOL-LONDON, V523, p53P; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Houseweart MK, 1999, J NEUROSCI, V19, P6446; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; MI W, IN PRESS J NEUROSCI; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Perry VH, 1999, PHILOS T ROY SOC B, V354, P1641, DOI 10.1098/rstb.1999.0509; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RIBCHESTER RR, 1995, EUR J NEUROSCI, V7, P1641, DOI 10.1111/j.1460-9568.1995.tb01159.x; RIBCHESTER RR, 1994, P ROY SOC B-BIOL SCI, V255, P61, DOI 10.1098/rspb.1994.0009; Sagot Y, 1996, J NEUROSCI, V16, P2335; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Smith KJ, 2001, ANN NEUROL, V49, P470; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang NS, 2001, NEUROBIOL DIS, V8, P155; Zhang ZY, 1996, J COMP NEUROL, V371, P485; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	48	468	481	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1199	1206		10.1038/nn770	http://dx.doi.org/10.1038/nn770			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11770485	Green Published			2022-12-28	WOS:000172525000016
J	Bishop, S; Duncan, J; Lawrence, AD				Bishop, S; Duncan, J; Lawrence, AD			Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; EMOTION; FMRI; SELECTION; MODEL; FEAR	Threat-related stimuli are strong competitors for attention, particularly in anxious individuals. We used functional magnetic resonance imaging (fMRI) with healthy human volunteers to study how the processing of threat-related distractors is controlled and whether this alters as anxiety levels increase. Our work builds upon prior analyses of the cognitive control functions of lateral prefrontal cortex (lateral PFC) and anterior cingulate cortex (ACC). We found that rostral ACC was strongly activated by infrequent threat-related distractors, consistent with a role for this area in responding to unexpected processing conflict caused by salient emotional stimuli. Participants with higher anxiety levels showed both less rostral ACC activity overall and reduced recruitment of lateral PFC as expectancy of threat- related distractors was established. This supports the proposal that anxiety is associated with reduced top-down control over threat- related distractors. Our results suggest distinct roles for rostral ACC and lateral PFC in governing the processing of task-irrelevant, threat- related stimuli, and indicate reduced recruitment of this circuitry in anxiety.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England		Bishop, S (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.	sonia.bishop@mrc-cbu.cam.ac.uk	Bishop, Sonia J/I-7729-2012; Lawrence, Andrew/A-1673-2010	Duncan, John S/0000-0002-1373-0681; Duncan, John/0000-0002-9695-2764	Medical Research Council [G9439390, G0001237] Funding Source: Medline; MRC [G9439390, G0001237] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armony J.L., 1999, COGNITIVE NEUROSCIEN, P1067; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M, 2001, NEUROIMAGE, V13, pS85; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ekman P., 1976, PICTURES FACIAL AFFE; Eysenck M. W., 1997, ANXIETY COGNITION UN; Henik A., 1997, 2 ABSTRACTS PSYCHONO, P57; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LANZETTA JT, 1986, J PERS SOC PSYCHOL, V50, P190, DOI 10.1037/0022-3514.50.1.190; LAWRENCE AD, 2001, HDB NEUROPSYCHOLOGY, V5, P235; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Posner MI, 1998, ATTENTIVE BRAIN, P401; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Spielberger C. D., 1973, MANUAL STATE TRAIT I; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VOGT BA, 1997, HAND CHEM N, V13, P455; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	36	667	689	3	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					184	188		10.1038/nn1173	http://dx.doi.org/10.1038/nn1173			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	767TJ	14703573				2022-12-28	WOS:000188468500017
J	Wang, JM; Jing, Z; Zhang, LL; Zhou, GD; Braun, J; Yao, Y; Wang, ZZ				Wang, JM; Jing, Z; Zhang, LL; Zhou, GD; Braun, J; Yao, Y; Wang, ZZ			Regulation of acetylcholine receptor clustering by the tumor suppressor APC	NATURE NEUROSCIENCE			English	Article							PHOSPHORYLATION	At the developing neuromuscular junction, motor neuron-derived agrin triggers the differentiation of postsynaptic membrane into a highly specialized structure, where the nicotinic acetylcholine receptors (AChRs) are aggregated into high-density clusters. Agrin acts by activating the muscle-specific kinase MuSK and inducing coaggregation of the 43-kDa protein rapsyn with AChRs on muscle cell membrane(1,2). The signaling mechanism downstream of MuSK is poorly defined. We report here that the mouse tumor suppressor protein adenomatous polyposis coli (APC) has a role in AChR clustering and that the Wnt/beta-catenin pathway may crosstalk with agrin signaling cascade during synapse formation.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, ZZ (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3500 Terrace St,Room E1440 BST, Pittsburgh, PA 15261 USA.	zzwang@pitt.edu						Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Borges LS, 2001, J CELL BIOL, V153, P1, DOI 10.1083/jcb.153.1.1; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	14	92	95	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1017	1018		10.1038/nn1128	http://dx.doi.org/10.1038/nn1128			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502292				2022-12-28	WOS:000185633600010
J	Carrasco, M; McElree, B; Denisova, K; Giordano, AM				Carrasco, M; McElree, B; Denisova, K; Giordano, AM			Speed of visual processing increases with eccentricity	NATURE NEUROSCIENCE			English	Article							FEEDFORWARD; MONKEY; FIELD	The visual system has a duplex design to meet conflicting environmental demands: the fovea has the resolution required to process fine spatial information, but the periphery is more sensitive to temporal properties(1-3). To investigate whether the periphery's sensitivity is partly due to the speed with which information is processed, we measured the full timecourse of visual information processing by deriving joint measures of discriminability and speed, and found that speed of information processing varies with eccentricity: processing was faster when same-size stimuli appeared at 9degrees than 4degrees eccentricity, and this difference was attenuated when the 9degrees stimuli were magnified to equate cortical representation size. At the same eccentricity, larger stimuli are processed more slowly. These temporal differences are greater than expected from neurophysiological constraints(4-6).	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Dept Neural Sci, New York, NY 10003 USA	New York University; New York University	Carrasco, M (corresponding author), NYU, Dept Psychol, 4 Washington Pl, New York, NY 10003 USA.				NIMH NIH HHS [R01 MH057458-03, MH57458] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057458] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Azzopardi P, 1999, VISION RES, V39, P2179, DOI 10.1016/S0042-6989(98)00319-8; BREITMEYER BG, 1984, VISUAL MASKING; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; DeValois RL, 1988, SPATIAL VISION; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; HARTMANN E, 1979, VISION RES, V19, P1019, DOI 10.1016/0042-6989(79)90227-X; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; McElree B, 1999, J EXP PSYCHOL HUMAN, V25, P1517, DOI 10.1037/0096-1523.25.6.1517; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; REED AV, 1973, SCIENCE, V181, P574, DOI 10.1126/science.181.4099.574; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; VIRSU V, 1982, VISION RES, V22, P1211, DOI 10.1016/0042-6989(82)90087-6	15	94	95	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					699	700		10.1038/nn1079	http://dx.doi.org/10.1038/nn1079			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12819786	Green Accepted			2022-12-28	WOS:000183780400016
J	Miyamoto, H; Katagiri, H; Hensch, T				Miyamoto, H; Katagiri, H; Hensch, T			Experience-dependent slow-wave sleep development	NATURE NEUROSCIENCE			English	Article							RECEPTOR EPSILON-1 SUBUNIT; CAT VISUAL-CORTEX; MICE LACKING; PLASTICITY; STIMULATION; EEG	Sleep enhances plasticity in neocortex, and thereby improves sensory learning(1). Here we show that sleep itself undergoes changes as a consequence of waking experience during a late critical period in cats and mice. Dark-rearing produced a robust and reversible decrement of slow-wave electrical activity during sleep that was restricted to visual cortex and impaired by gene-targeted reduction of NMDA receptor function.	RIKEN, Inst Brain Res, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan	RIKEN	Hensch, T (corresponding author), RIKEN, Inst Brain Res, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Hensch, Takao/L-4182-2019					Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW N, 1995, VISUAL DEV; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gordon JA, 1996, J NEUROSCI, V16, P3274; Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; MOWER GD, 1985, J COMP NEUROL, V235, P448, DOI 10.1002/cne.902350404; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x	15	69	69	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					553	554		10.1038/nn1064	http://dx.doi.org/10.1038/nn1064			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754515				2022-12-28	WOS:000183140400009
J	Nickols, JC; Valentine, W; Kanwal, S; Carter, BD				Nickols, JC; Valentine, W; Kanwal, S; Carter, BD			Activation of the transcription factor NF-kappa B in Schwann cells is required for peripheral myelin formation	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; NERVOUS-SYSTEM; KROX-20; DIFFERENTIATION; INHIBITION; MEDIATORS; APOPTOSIS; SURVIVAL; GROWTH; OCT-6	Peripheral myelin formation is initiated by axonal cues that trigger a differentiation program in associated Schwann cells. Here, we define one essential differentiation signal: activation of the transcription factor NF-kappaB. In rat sciatic nerves, NF-kappaB was highly upregulated in pre-myelinating Schwann cells, and then its expression progressively declined until it was nearly absent in adults. Similarly, in co-cultures of Schwann cells and sensory neurons, NF-kappaB activation paralleled myelination, and blocking its activity or using cells from mice lacking the NF-kappaB subunit p65 markedly attenuated myelination. Inhibiting NF-kappaB also prevented activation of Oct-6, a transcription factor induced by axonal contact and required for proper myelin formation. These results show that the activation of NF-kappaB is an essential signal for the progression of axon-associated Schwann cells into a myelinating phenotype.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06387] Funding Source: Medline; NIMH NIH HHS [MH19732] Funding Source: Medline; NINDS NIH HHS [NS38220] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arroyo EJ, 1998, J NEUROSCI, V18, P7891; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Forghani R, 1999, J NEUROSCI METH, V89, P129, DOI 10.1016/S0165-0270(99)00043-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Haggiag S, 2001, J NEUROSCI RES, V64, P564, DOI 10.1002/jnr.1108; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Xu JH, 1998, J CELL BIOL, V140, P709, DOI 10.1083/jcb.140.3.709; Zorick TS, 1999, DEVELOPMENT, V126, P1397	28	147	150	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					161	167		10.1038/nn995	http://dx.doi.org/10.1038/nn995			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12514737				2022-12-28	WOS:000180669100016
J	Anagnostaras, SG; Murphy, GG; Hamilton, SE; Mitchell, SL; Rahnama, NP; Nathanson, NM; Silva, AJ				Anagnostaras, SG; Murphy, GG; Hamilton, SE; Mitchell, SL; Rahnama, NP; Nathanson, NM; Silva, AJ			Selective cognitive dysfunction in acetylcholine M-1 muscarinic receptor mutant mice	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CONTEXTUAL FEAR; CHOLINERGIC MODULATION; RETROGRADE-AMNESIA; DORSAL HIPPOCAMPUS; RATS; SCOPOLAMINE; LESIONS; ACQUISITION; BRAIN	Blockade of cholinergic neurotransmission by muscarinic receptor antagonists produces profound deficits in attention and memory. However, the antagonists used in previous studies bind to more than one of the five muscarinic receptor subtypes. Here we examined memory in mice with a null mutation of the gene coding the M, receptor, the most densely distributed muscarinic receptor in the hippocampus and forebrain. In contrast with previous studies using nonselective pharmacological antagonists, the M-1 receptor deletion produced a selective phenotype that included both enhancements and deficits in memory. Long-term potentiation (LTP) in response to theta burst stimulation in the hippocampus was also reduced in mutant mice. M-1 null mutant mice showed normal or enhanced memory for tasks that involved matching-to-sample problems, but they were severely impaired in nonmatching-to-sample working memory as well as consolidation. Our results suggest that the M-1 receptor is specifically involved in memory processes for which the cortex and hippocampus interact.	Univ Calif Los Angeles, Inst Brain Res, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Dept Psychiat, Los Angeles, CA 90095 USA; Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Ctr Behav Neurosci, Atlanta, GA 30322 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Emory University; University of Washington; University of Washington Seattle	Silva, AJ (corresponding author), Univ Calif Los Angeles, Inst Brain Res, Dept Neurobiol, 2554 Gonda Ctr,Box 951761, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Nathanson, Neil/0000-0002-9216-121X; Anagnostaras, Stephan/0000-0002-6906-1181	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010932, R01NS026920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005858, R01AG017499] Funding Source: NIH RePORTER; NIA NIH HHS [F32 AG5858, R01 AG17499] Funding Source: Medline; NINDS NIH HHS [R01 NS26920, F32 NS10932] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alreja M, 2000, J NEUROSCI, V20, P8103; Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bussiere T, 2002, NEUROSCIENCE, V112, P75, DOI 10.1016/S0306-4522(02)00056-8; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cain DP, 1998, NEUROSCI BIOBEHAV R, V22, P181, DOI 10.1016/S0149-7634(97)00005-5; Caulfield MP, 1998, PHARMACOL REV, V50, P279; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fornari RV, 2000, LEARN MEMORY, V7, P287, DOI 10.1101/lm.34900; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; Gale GD, 2001, HIPPOCAMPUS, V11, P371, DOI 10.1002/hipo.1051.abs; Gerber DJ, 2001, P NATL ACAD SCI USA, V98, P15312, DOI 10.1073/pnas.261583798; HAGEN JJ, 1986, BEHAV NEUROSCI, V100, P483; Hamilton SE, 2001, LIFE SCI, V68, P2489, DOI 10.1016/S0024-3205(01)01043-8; Hamilton SE, 2001, J BIOL CHEM, V276, P15850, DOI 10.1074/jbc.M011563200; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Konorski J., 1967, INTEGRATIVE ACTIVITY; LEVEY AI, 1991, J NEUROSCI, V11, P3218; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LEVY A, 1983, BEHAV NEURAL BIOL, V39, P229, DOI 10.1016/S0163-1047(83)90893-2; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 1998, TRENDS COGN SCI, V2, P39, DOI 10.1016/S1364-6613(98)01123-1; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1972, PHYSIOL BEHAV, V9, P353, DOI 10.1016/0031-9384(72)90158-8; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rudy JW, 1996, NEUROBIOL LEARN MEM, V65, P73, DOI 10.1006/nlme.1996.0008; Shiozaki K, 2001, J NEUROL SCI, V193, P23, DOI 10.1016/S0022-510X(01)00638-4; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Wallenstein GV, 2001, NEUROBIOL LEARN MEM, V75, P245, DOI 10.1006/nlme.2001.4005; Wallis RM, 1999, LIFE SCI, V64, P395, DOI 10.1016/S0024-3205(98)00585-2; WEI J, 1994, J NEUROCHEM, V63, P815; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626	50	405	415	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					51	58		10.1038/nn992	http://dx.doi.org/10.1038/nn992			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483218				2022-12-28	WOS:000180089300015
J	Lynch, G				Lynch, G			Memory enhancement: the search for mechanism-based drugs	NATURE NEUROSCIENCE			English	Review							LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; AMPA RECEPTORS; POSITIVE MODULATION; SYNAPTIC PLASTICITY; BINDING PROTEIN; HIPPOCAMPAL; EXPRESSION; NEURONS; CYCLOTHIAZIDE	Rapid progress has been made in understanding the synaptic changes required for memory encoding. Several companies are now attempting to use information about the induction and consolidation phases of this process to build memory-enhancing drugs. These efforts have produced novel compounds that improve retention scores across a broad range of tests and species. Initial clinical results are encouraging. Issues now arise about appropriate applications of candidate drugs and optimal cellular targets for future development.	Univ Calif Irvine, Dept Psychiat, Irvine, CA 92612 USA	University of California System; University of California Irvine	Lynch, G (corresponding author), Univ Calif Irvine, Dept Psychiat, Irvine, CA 92612 USA.	glynch@uci.edu						Arai A, 1998, BRAIN RES, V799, P230, DOI 10.1016/S0006-8993(98)00446-6; Arai A, 1996, J PHARMACOL EXP THER, V278, P627; Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BARRIONUEVO G, 1980, LIFE SCI, V27, P2385, DOI 10.1016/0024-3205(80)90509-3; Baumbarger PJ, 2001, J PHARMACOL EXP THER, V298, P86; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Gates M, 2001, NEUROPHARMACOLOGY, V40, P984, DOI 10.1016/S0028-3908(01)00040-5; Goff DC, 2001, J CLIN PSYCHOPHARM, V21, P484, DOI 10.1097/00004714-200110000-00005; Hampson RE, 1998, J NEUROSCI, V18, P2748; Ingvar M, 1997, EXP NEUROL, V146, P553, DOI 10.1006/exnr.1997.6581; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kramar EA, 2002, NEUROSCIENCE, V110, P29, DOI 10.1016/S0306-4522(01)00540-1; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Lynch G, 1997, EXP NEUROL, V145, P89, DOI 10.1006/exnr.1997.6447; MACKOWIAK M, IN PRESS NEUROPHARMA; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nagakura A, 2002, BRIT J PHARMACOL, V135, P1783, DOI 10.1038/sj.bjp.0704629; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Pirotte B, 1998, J MED CHEM, V41, P2946, DOI 10.1021/jm970694v; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhu J, 2001, CNS DRUG REV, V7, P387	34	111	114	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1035	1038		10.1038/nn935	http://dx.doi.org/10.1038/nn935			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403980				2022-12-28	WOS:000179041300008
J	Mignot, E; Taheri, S; Nishino, S				Mignot, E; Taheri, S; Nishino, S			Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders	NATURE NEUROSCIENCE			English	Review							CIRCADIAN-RHYTHM; WAKEFULNESS; RAT; HUMANS; ACID	Delineating the basic mechanisms that regulate sleep will likely result in the development of better treatments for sleep disorders. The hypothalamus is now recognized as a key center for sleep regulation, with hypothalamic neurotransmitter systems providing the framework for therapeutic advances. An increased awareness of the close interaction between sleep and homeostatic systems is also emerging. Progress has occurred in the understanding of narcolepsy-molecular techniques have identified the lateral hypothalamic hypocretin (orexin) neuropeptide system as key to the disorder. Other sleep disorders are now being tackled in the same way and are likely to yield to efforts combining basic and clinical research. Here we highlight the role of the hypothalamus in sleep physiology and discuss neurotransmitter systems, such as adenosine, dopamine, GABA, histamine and hypocretin, that may have therapeutic applications for sleep disorders.	Stanford Univ, Ctr Narcolepsy, Palo Alto, CA 94304 USA	Stanford University	Mignot, E (corresponding author), Stanford Univ, Ctr Narcolepsy, 701 Welch Rd B,Room 145, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Taheri, Shahrad/O-9721-2016	Taheri, Shahrad/0000-0001-8314-1500				Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Bernasconi R, 1999, TRENDS PHARMACOL SCI, V20, P135, DOI 10.1016/S0165-6147(99)01341-3; Beuckmann CT, 2002, J MOL MED, V80, P329, DOI 10.1007/s00109-002-0322-x; Borbely A.A., 2000, PRINCIPLES PRACTICE; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Dugovic C, 2002, SLEEP, V25, pA114; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kubin L, 1996, SLEEP, V19, P187; Lu J, 2002, SLEEP, V25, pA290; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Naylor E, 2000, J NEUROSCI, V20, P8138; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Parmentier R, 2002, J NEUROSCI, V22, P7695; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rechtschaffen A, 2002, SLEEP, V25, p68B, DOI 10.1093/sleep/25.1.68; Rye DB, 2002, NEUROLOGY, V58, P341, DOI 10.1212/WNL.58.3.341; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Smith TAD, 2001, BRIT J BIOMED SCI, V58, P111; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Suntsova N, 2002, J PHYSIOL-LONDON, V543, P665, DOI 10.1113/jphysiol.2002.023085; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; Tobler I, 2001, P NATL ACAD SCI USA, V98, P6464, DOI 10.1073/pnas.111055398; VANECONOMO C, 1930, J NERV MENT DIS, V71, P249; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	36	221	235	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1071	1075		10.1038/nn944	http://dx.doi.org/10.1038/nn944			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403989				2022-12-28	WOS:000179041300017
J	Perez, CA; Huang, LQ; Rong, MQ; Kozak, JA; Preuss, AK; Zhang, HL; Max, M; Margolskee, RF				Perez, CA; Huang, LQ; Rong, MQ; Kozak, JA; Preuss, AK; Zhang, HL; Max, M; Margolskee, RF			A transient receptor potential channel expressed in taste receptor cells	NATURE NEUROSCIENCE			English	Article							CAPACITATIVE CA2+ ENTRY; TRP GENE FAMILY; SWEET TASTE; ACTIVATED CHANNEL; PLASMA-MEMBRANE; XENOPUS OOCYTES; TRANSDUCTION; BITTER; GUSTDUCIN; MOUSE	We used differential screening of cDNAs from individual taste receptor cells to identify candidate taste transduction elements in mice. Among the differentially expressed clones, one encoded Trpm5, a member of the mammalian family of transient receptor potential (TRP) channels. We found Trpm5 to be expressed in a restricted manner, with particularly high levels in taste tissue. In taste cells, Trpm5 was coexpressed with taste-signaling molecules such as alpha-gustducin, Ggamma(13), phospholipase C-beta(2) (PLC-beta(2)) and inositol 1,4,5-trisphosphate receptor type III (IP(3)R3). Our heterologous expression studies of Trpm5 indicate that it functions as a cationic channel that is gated when internal calcium stores are depleted. Trpm5 may be responsible for capacitative calcium entry in taste receptor cells that respond to bitter and/or sweet compounds.	NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Cellular Genom Inc, Branford, CT 06405 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei Province, Peoples R China	Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; University of California System; University of California Irvine; Hebei Medical University	Margolskee, RF (corresponding author), NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	margolskee@msvax.mssm.edu	Perez, Cristian A./A-2341-2008	Margolskee, Robert/0000-0002-9572-2887; Huang, Liquan/0000-0003-3400-0685	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155, R01DC003055] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC03155, DC03055, DC00310] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Enklaar T, 2000, GENOMICS, V67, P179, DOI 10.1006/geno.2000.6234; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Gillo B, 1996, P NATL ACAD SCI USA, V93, P14146, DOI 10.1073/pnas.93.24.14146; Halaszovich CR, 2000, J BIOL CHEM, V275, P37423, DOI 10.1074/jbc.M007010200; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Lomax RB, 1998, CELL CALCIUM, V23, P229, DOI 10.1016/S0143-4160(98)90121-X; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 2002, J NEUROPHYSIOL, V87, P3152, DOI 10.1152/jn.2002.87.6.3152; Ogura T, 1997, J NEUROSCI, V17, P3580; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Putney JW, 1999, BIOESSAYS, V21, P38; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Yatsuki H, 2000, DNA RES, V7, P195, DOI 10.1093/dnares/7.3.195	50	428	454	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1169	1176		10.1038/nn952	http://dx.doi.org/10.1038/nn952			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368808				2022-12-28	WOS:000178884600020
J	Reisel, D; Bannerman, DM; Schmitt, WB; Deacon, RMJ; Flint, J; Borchardt, T; Seeburg, PH; Rawlins, JNP				Reisel, D; Bannerman, DM; Schmitt, WB; Deacon, RMJ; Flint, J; Borchardt, T; Seeburg, PH; Rawlins, JNP			Spatial memory dissociations in mice lacking GluR1	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPUS; IMPAIRMENT; ANTAGONIST; LESIONS; COMPONENTS; BLOCKADE; RATS; AP5	Gene-targeted mice lacking the AMPA receptor subunit GluR1 (GluR-A) have deficits in hippocampal CA3-CA1 long-term potentiation. We now report that they showed normal spatial reference learning and memory, both on the hidden platform watermaze task and on an appetitively motivated Y-maze task. In contrast, they showed a specific spatial working memory impairment during tests of non-matching to place on both the Y-maze and an elevated T-maze. In addition, successful watermaze and Y-maze reference memory performance depended on hippocampal function in both wild-type and mutant mice; bilateral hippocampal lesions profoundly impaired performance on both tasks, to a similar extent in both groups. These results suggest that different forms of hippocampus-dependent spatial memory involve different aspects of neural processing within the hippocampus.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society	Bannerman, DM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.		Borchardt, Thilo/E-7844-2011	Borchardt, Thilo/0000-0002-2960-0267; Bannerman, David/0000-0002-3024-7595; Reisel, Dan/0000-0001-9018-4621; Flint, Jonathan/0000-0002-9427-4429				BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TONKISS J, 1991, EXP BRAIN RES, V85, P349; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	26	265	276	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					868	873		10.1038/nn910	http://dx.doi.org/10.1038/nn910			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195431				2022-12-28	WOS:000177656300017
J	Leopold, DA; Wilke, M; Maier, A; Logothetis, NK				Leopold, DA; Wilke, M; Maier, A; Logothetis, NK			Stable perception of visually ambiguous patterns	NATURE NEUROSCIENCE			English	Article							BINOCULAR-RIVALRY; MOTION; MODEL; TIME	During the viewing of certain patterns, widely known as ambiguous or puzzle figures, perception lapses into a sequence of spontaneous alternations, switching every few seconds between two or more visual interpretations of the stimulus. Although their nature and origin remain topics of debate, these stochastic switches are generally thought to be the automatic and inevitable consequence of viewing a pattern without a unique solution. We report here that in humans such perceptual alternations can be slowed, and even brought to a standstill, if the visual stimulus is periodically removed from view. We also show, with a visual illusion, that this stabilizing effect hinges on perceptual disappearance rather than on actual removal of the stimulus. These findings indicate that uninterrupted subjective perception of an ambiguous pattern is required for the initiation of the brain-state changes underlying multistable vision.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Leopold, DA (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	david.leopold@tuebingen.mpg.de	Maier, Alexander/B-7489-2009; Logothetis, Nikos/U-9282-2019	Maier, Alexander/0000-0002-7250-502X; Leopold, David/0000-0002-1345-6360				ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; BLAKE R, 1990, PERCEPT PSYCHOPHYS, V48, P593, DOI 10.3758/BF03211605; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; BORSELLINO A, 1972, KYBERNETIK, V10, P139, DOI 10.1007/BF00290512; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; CARLSON VR, 1953, J EXP PSYCHOL, V45, P442, DOI 10.1037/h0054794; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Du Tour EF., 1760, MIM MATH PHYS ACAD R, V3, P514; FOX R, 1967, PERCEPT PSYCHOPHYS, V2, P432, DOI 10.3758/BF03208783; Gregory R. L., 1997, EYE BRAIN PSYCHOL SE; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Miller SM, 2000, CURR BIOL, V10, P383, DOI 10.1016/S0960-9822(00)00416-4; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Necker LA., 1832, LONDON EDINBURGH, V1, P329, DOI [10.1080/14786443208647909, DOI 10.1080/14786443208647909]; Pettigrew J D, 2001, BRAIN MIND, V2, P85, DOI [10.1023/A:1017929617197, DOI 10.1023/A:1017929617197]; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rock I., 1984, PERCEPTION; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; von Schiller P, 1933, PSYCHOL FORSCH, V17, P179; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	29	291	296	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					605	609		10.1038/nn0602-851	http://dx.doi.org/10.1038/nn0602-851			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992115				2022-12-28	WOS:000175874600022
J	Zhu, JJ; Malinow, R				Zhu, JJ; Malinow, R			Acute versus chronic NMDA receptor blockade and synaptic AMPA receptor delivery	NATURE NEUROSCIENCE			English	Article							SILENT SYNAPSES; POTENTIATION; MATURATION; ACTIVATION; NUMBER		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org						Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	15	50	52	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					513	514		10.1038/nn0602-850	http://dx.doi.org/10.1038/nn0602-850			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11967548				2022-12-28	WOS:000175874600008
J	Bradley, SR; Pieribone, VA; Wang, WG; Severson, CA; Jacobs, RA; Richerson, GB				Bradley, SR; Pieribone, VA; Wang, WG; Severson, CA; Jacobs, RA; Richerson, GB			Chemosensitive serotonergic neurons are closely associated with large medullary arteries	NATURE NEUROSCIENCE			English	Article							INFANT-DEATH-SYNDROME; RAPHE NEURONS; IMMUNOREACTIVITY; NUCLEI; SYSTEM; CATS; RAT		Yale Univ, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Dept Cell & Mol Physiol, New Haven, CT 06510 USA; J Pierce Lab, New Haven, CT 06510 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; Salk Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Richerson, GB (corresponding author), Yale Univ, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.			Richerson, George/0000-0001-5696-1554; Pieribone, Vincent/0000-0002-5836-5454	NHLBI NIH HHS [HL-52539] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bernard DG, 1996, J APPL PHYSIOL, V80, P108, DOI 10.1152/jappl.1996.80.1.108; FELTEN DL, 1979, AM J ANAT, V155, P467, DOI 10.1002/aja.1001550405; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; LALLEY PM, 1986, J PHYSIOL-LONDON, V380, P373, DOI 10.1113/jphysiol.1986.sp016291; LARNICOL N, 1994, J PHYSIOLOGY-PARIS, V88, P81, DOI 10.1016/0928-4257(94)90094-9; MITCHELL RA, 1963, J APPL PHYSIOL, V18, P523, DOI 10.1152/jappl.1963.18.3.523; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; SCHEIBEL ME, 1975, EXP NEUROL, V47, P316, DOI 10.1016/0014-4886(75)90260-5; SCHLAEFKE ME, 1970, RESP PHYSIOL, V10, P198, DOI 10.1016/0034-5687(70)90083-6; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Wang WG, 1998, J PHYSIOL-LONDON, V511, P433, DOI 10.1111/j.1469-7793.1998.433bh.x; Wang WG, 2001, J NEUROPHYSIOL, V85, P2224, DOI 10.1152/jn.2001.85.5.2224	15	123	125	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					401	402		10.1038/nn848	http://dx.doi.org/10.1038/nn848			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967547				2022-12-28	WOS:000175272000008
J	Gerdeman, GL; Ronesi, J; Lovinger, DM				Gerdeman, GL; Ronesi, J; Lovinger, DM			Postsynaptic endocannabinoid release is critical to long-term depression in the striatum	NATURE NEUROSCIENCE			English	Article							CB1 CANNABINOID RECEPTOR; EXCITATORY SYNAPTIC TRANSMISSION; ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOIDS; KNOCKOUT MICE; DORSAL STRIATUM; PURKINJE-CELLS; BASAL GANGLIA; RAT; NEURONS	The striatum functions critically in movement control and habit formation. The development and function of cortical input to the striatum are thought to be regulated by activity-dependent plasticity of corticostriatal glutamatergic synapses. Here we show that the induction of a form of striatal synaptic plasticity, long-term depression (LTD), is dependent on activation of the CB1 cannabinoid receptor. LTD was facilitated by blocking cellular endocannabinoid uptake, and postsynaptic loading of anandamide (AEA) produced presynaptic depression. The endocannabinoid necessary for striatal LTD is thus likely to be released postsynaptically as a retrograde messenger. These findings demonstrate a new role for endocannabinoids in the induction of long-term synaptic plasticity in a circuit necessary for habit formation and motor control.	Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lovinger, DM (corresponding author), NIAAA, Lab Integrat Neurosci, 158H Pk 5 Bldg, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA005923] Funding Source: NIH RePORTER; NIDA NIH HHS [DA05923] Funding Source: Medline; NINDS NIH HHS [NS30470] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auclair N, 2000, J NEUROPHYSIOL, V83, P3287, DOI 10.1152/jn.2000.83.6.3287; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Cadas H, 1996, J NEUROSCI, V16, P3934; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1999, J NEUROSCI, V19, P2489; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; Choi SK, 1997, J NEUROSCI, V17, P8613; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GOUGH AL, 1978, NEUROPHARMACOLOGY, V17, P137, DOI 10.1016/0028-3908(78)90126-0; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Gubellini P, 2001, NEUROPHARMACOLOGY, V40, P839, DOI 10.1016/S0028-3908(01)00021-1; HERKENHAM M, 1991, BRAIN RES, V547, P267, DOI 10.1016/0006-8993(91)90970-7; Hillard CJ, 2000, CHEM PHYS LIPIDS, V108, P123, DOI 10.1016/S0009-3084(00)00191-2; Huang CC, 2001, J PHYSIOL-LONDON, V532, P731, DOI 10.1111/j.1469-7793.2001.0731e.x; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Leckman JF, 2000, NEURON, V28, P349, DOI 10.1016/S0896-6273(00)00114-8; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; Maccarrone M, 2000, J BIOL CHEM, V275, P13484, DOI 10.1074/jbc.275.18.13484; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Steiner H, 1999, P NATL ACAD SCI USA, V96, P5786, DOI 10.1073/pnas.96.10.5786; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; WALSH JP, 1993, BRAIN RES, V608, P123, DOI 10.1016/0006-8993(93)90782-I; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	48	542	557	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					446	451		10.1038/nn832	http://dx.doi.org/10.1038/nn832			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976704				2022-12-28	WOS:000175272000015
J	Haggard, P; Clark, S; Kalogeras, J				Haggard, P; Clark, S; Kalogeras, J			Voluntary action and conscious awareness	NATURE NEUROSCIENCE			English	Article							INTENTION	Humans have the conscious experience of 'free will': we feel we can generate our actions, and thus affect our environment. Here we used the perceived time of intentional actions and of their sensory consequences as a means to study consciousness of action. These perceived times were attracted together in conscious awareness, so that subjects perceived voluntary movements as occurring later and their sensory consequences as occurring earlier than they actually did. Comparable involuntary movements caused by magnetic brain stimulation reversed this attraction effect. We conclude that the CNS applies a specific neural mechanism to produce intentional binding of actions and their effects in conscious awareness.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Haggard, P (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.haggard@ucl.ac.uk	Haggard, Patrick/A-5081-2010	Haggard, Patrick/0000-0001-7798-793X				Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; BREITMEYER BG, 1985, BEHAV BRAIN SCI, V8, P539, DOI 10.1017/S0140525X00044915; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	15	889	898	7	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					382	385		10.1038/nn827	http://dx.doi.org/10.1038/nn827			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	534UQ	11896397				2022-12-28	WOS:000174606900020
J	Nabekura, J; Katsurabayashi, S; Kakazu, Y; Shibata, S; Matsubara, A; Jinno, S; Mizoguchi, Y; Sasaki, A; Ishibashi, H				Nabekura, J; Katsurabayashi, S; Kakazu, Y; Shibata, S; Matsubara, A; Jinno, S; Mizoguchi, Y; Sasaki, A; Ishibashi, H			Developmental switch from GABA to glycine release in single central synaptic terminals	NATURE NEUROSCIENCE			English	Article							LATERAL SUPERIOR OLIVE; AUDITORY BRAIN-STEM; GAMMA-AMINOBUTYRIC-ACID; POSTSYNAPTIC CURRENTS; NEURONS; RECEPTORS; INHIBITION; MOTONEURONS; GLUTAMATE; SYSTEM	Early in postnatal development, inhibitory inputs to rat lateral superior olive (LSO) neurons change from releasing predominantly GABA to releasing predominantly glycine into the synapse. Here we show that spontaneous miniature inhibitory postsynaptic currents (mIPSCs) also change from GABAergic to glycinergic over the first two postnatal weeks. Many 'mixed' mIPSCs, resulting from co-release of glycine and GABA from the same vesicles, are seen during this transition. Immunohistochemistry showed that a large number of terminals contained both GABA and glycine at postnatal day 8 (P8). By P14, both the content of GABA in these mixed terminals and the contribution of GABA to the mixed mIPSCs had decreased. The content of glycine in terminals increased over the same period. Our results indicate that switching from GABAergic to glycinergic inputs to the LSO may occur at the level of a single presynaptic terminal. This demonstrates a new form of developmental plasticity at the level of a single central synapse.	Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Fukuoka 8128582, Japan; Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 0368562, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Fukuoka 8128582, Japan	Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Hirosaki University; Kyushu University	Nabekura, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Fukuoka 8128582, Japan.							Akaike N, 2003, TRENDS PHARMACOL SCI, V24, P44, DOI 10.1016/S0165-6147(02)00010-X; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Chang EH, 2003, J NEUROPHYSIOL, V90, P1479, DOI 10.1152/jn.00386.2003; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Friauf E, 1997, J COMP NEUROL, V385, P117, DOI 10.1002/(SICI)1096-9861(19970818)385:1<117::AID-CNE7>3.0.CO;2-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gao XB, 2001, J NEUROPHYSIOL, V85, P425, DOI 10.1152/jn.2001.85.1.425; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; HABECKER BA, 1995, DEV BIOL, V167, P307, DOI 10.1006/dbio.1995.1025; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; KANDLER K, 1995, J NEUROSCI, V15, P6890; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Korada S, 1999, J COMP NEUROL, V409, P664, DOI 10.1002/(SICI)1096-9861(19990712)409:4<664::AID-CNE10>3.0.CO;2-S; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kotak VC, 2001, J NEUROPHYSIOL, V86, P536, DOI 10.1152/jn.2001.86.1.536; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Lauder JM, 1998, PERSPECT DEV NEUROBI, V5, P247; Levi S, 1999, J NEUROSCI, V19, P7434, DOI 10.1523/JNEUROSCI.19-17-07434.1999; Matsubara A, 1996, J NEUROSCI, V16, P4457; Nabekura J, 1996, J NEUROPHYSIOL, V76, P2447, DOI 10.1152/jn.1996.76.4.2447; O'Brien JA, 1999, J NEUROPHYSIOL, V82, P1638, DOI 10.1152/jn.1999.82.3.1638; Ornung G, 1996, J COMP NEUROL, V365, P413; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Russier M, 2002, J PHYSIOL-LONDON, V541, P123, DOI 10.1113/jphysiol.2001.016063; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; Smith AJ, 2000, J PHYSIOL-LONDON, V529, P681, DOI 10.1111/j.1469-7793.2000.00681.x; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Yang HW, 1997, BRAIN RES, V749, P301, DOI 10.1016/S0006-8993(96)01326-1	40	171	177	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					17	23		10.1038/nn1170	http://dx.doi.org/10.1038/nn1170			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699415				2022-12-28	WOS:000187636000008
J	Severson, CA; Wang, WG; Pieribone, VA; Dohle, CI; Richerson, GB				Severson, CA; Wang, WG; Pieribone, VA; Dohle, CI; Richerson, GB			Midbrain serotonergic neurons are central pH chemoreceptors	NATURE NEUROSCIENCE			English	Article							FREELY MOVING CATS; PANIC DISORDER; RAPHE NEURONS; HYPOTHESIS	Serotonergic neurons in the medulla are central respiratory chemoreceptors. Here we show that serotonergic neurons in the midbrain of rats are also highly chemosensitive to small changes in CO2/pH and are closely associated with large penetrating arteries. We propose that midbrain raphe neurons are sensors of blood CO2 that maintain pH homeostasis by inducing arousal, anxiety and changes in cerebrovascular tone in response to respiratory acidosis.	Yale Univ, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; John BL Pierce Lab, New Haven, CT 06510 USA; Ruhr Univ Bochum, Dept Neurophysiol, D-44801 Bochum, Germany; Vet Affairs Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; Ruhr University Bochum; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Richerson, GB (corresponding author), Yale Univ, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.			Richerson, George/0000-0001-5696-1554; Pieribone, Vincent/0000-0002-5836-5454				Azmitia EC, 1999, NEUROPSYCHOPHARMACOL, V21, pS33; Berry RB, 1997, SLEEP, V20, P654, DOI 10.1093/sleep/20.8.654; Bradley SR, 2002, NAT NEUROSCI, V5, P401, DOI 10.1038/nn848; Eldridge F.L., 1991, EXERCISE PULMONARY P, V52, P309; GORMAN JM, 1989, AM J PSYCHIAT, V146, P148; Grove G, 1997, J NEUROPSYCH CLIN N, V9, P198; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jacobs BL, 1997, CURR OPIN NEUROBIOL, V7, P820, DOI 10.1016/S0959-4388(97)80141-9; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; SCHEIBEL ME, 1975, EXP NEUROL, V47, P316, DOI 10.1016/0014-4886(75)90260-5; Veasey SC, 1997, NEUROSCIENCE, V79, P161, DOI 10.1016/S0306-4522(96)00673-2; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Wang WG, 2001, J NEUROPHYSIOL, V85, P2224, DOI 10.1152/jn.2001.85.5.2224; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658	15	157	161	1	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1139	1140		10.1038/nn1130	http://dx.doi.org/10.1038/nn1130			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14517544				2022-12-28	WOS:000186229200010
J	Mayer, EA; Fanselow, MS				Mayer, EA; Fanselow, MS			Dissecting the components of the central response to stress	NATURE NEUROSCIENCE			English	Editorial Material							CORTICOTROPIN-RELEASING-FACTOR; ANXIETY; BRAIN		Univ Calif Los Angeles, Ctr Neurovisceral Sci & Womens Hlth, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mayer, EA (corresponding author), Univ Calif Los Angeles, Ctr Neurovisceral Sci & Womens Hlth, Los Angeles, CA 90095 USA.	fanselow@ucla.edu						Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Habib KE, 2000, P NATL ACAD SCI USA, V97, P6079, DOI 10.1073/pnas.97.11.6079; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Maillot C, 2003, BRAIN RES, V974, P70, DOI 10.1016/S0006-8993(03)02553-8; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; MULUGETA M, 2003, BRAIN RES, V985, P32; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	15	22	22	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1011	1012		10.1038/nn1003-1011	http://dx.doi.org/10.1038/nn1003-1011			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14513035				2022-12-28	WOS:000185633600008
J	Trehub, SE				Trehub, SE			The developmental origins of musicality	NATURE NEUROSCIENCE			English	Review							ABSOLUTE PITCH; INFANTS PERCEPTION; LANGUAGE; ADULTS; PREFERENCES; CONSONANCE; MOTHERESE; FACULTY	The study of musical abilities and activities in infancy has the potential to shed light on musical biases or dispositions that are rooted in nature rather than nurture. The available evidence indicates that infants are sensitive to a number of sound features that are fundamental to music across cultures. Their discrimination of pitch and timing differences and their perception of equivalence classes are similar, in many respects, to those of listeners who have had many years of exposure to music. Whether these perceptual skills are unique to human listeners is not known. What is unique is the intense human interest in music, which is evident from the early days of life. Also unique is the importance of music in social contexts. Current ideas about musical timing and interpersonal synchrony are considered here, along with proposals for future research.	Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Trehub, SE (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	sandra.trehub@utoronto.ca						[Anonymous], 1998, ADV INFANCY RES; Benzon W, 2001, BEETHOVENS ANVIL MUS; Bergeson TR, 2002, PSYCHOL SCI, V13, P72, DOI 10.1111/1467-9280.00413; Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; Burns EdwardM., 1999, PSYCHOL MUSIC, V2nd, P215, DOI DOI 10.1016/B978-012213564-4/50008-1; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; DAVIDSON L, 1985, MUSIC PERCEPT, V2, P361; Dissanayake, 1992, HOMO AESTHETICUS ART; Dowling W. J., 1986, MUSIC COGNITION; Fernald A., 1991, ANN CHILD DEV, V8, P43; Freeman W, 2000, ORIGINS OF MUSIC, P411; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hockett C.F., 1966, UNIVERSALS LANG, P1; HULSE SH, 1985, J COMP PSYCHOL, V99, P176, DOI 10.1037/0735-7036.99.2.176; HURLY TA, 1992, J COMP PSYCHOL, V106, P388, DOI 10.1037/0735-7036.106.4.388; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; JUSLIN Patrik N., 2001, MUSIC EMOTION THEORY, P309; KRUMHANSL CL, 1982, MEM COGNITION, V10, P243, DOI 10.3758/BF03197636; LYNCH MP, 1990, PSYCHOL SCI, V1, P272, DOI 10.1111/j.1467-9280.1990.tb00213.x; MacDougallShackleton SA, 1996, J COMP PSYCHOL, V110, P139, DOI 10.1037/0735-7036.110.2.139; Mache FB, 2000, ORIGINS OF MUSIC, P473; MARLER P, 1990, DEV PSYCHOBIOL, V23, P557, DOI 10.1002/dev.420230703; Masataka N, 1996, DEV PSYCHOL, V32, P874, DOI 10.1037/0012-1649.32.5.874; Masataka N, 1998, DEV PSYCHOL, V34, P241, DOI 10.1037/0012-1649.34.2.241; Masataka N, 1999, DEV PSYCHOL, V35, P1001, DOI 10.1037/0012-1649.35.4.1001; McNeill W. H., 1995, KEEPING TOGETHER TIM; Merker B, 2000, ORIGINS OF MUSIC, P315; Merriam AlanP., 1964, ANTHR MUSIC; Moody D. B., 1990, COMP PERCEPTION, VII, P311; Nettl B, 2000, ORIGINS OF MUSIC, P463; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Pinker S., 1997, MIND WORKS; Rubin David C., 1995, MEMORY ORAL TRADITIO; Sachs J., 2022, STEEP RISE GAG ORDER; Saffran JR, 2003, DEVELOPMENTAL SCI, V6, P35, DOI 10.1111/1467-7687.00250; Saffran JR, 2000, COGNITION, V77, pB15, DOI 10.1016/S0010-0277(00)00095-0; Schellenberg EG, 1996, PSYCHOL SCI, V7, P272, DOI 10.1111/j.1467-9280.1996.tb00373.x; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; SIOBODA JA, 2001, MUSIC EMOTION THEORY, P415; SMITH JD, 1994, COGNITION, V52, P23; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; Trainor LJ, 1996, INFANT BEHAV DEV, V19, P83, DOI 10.1016/S0163-6383(96)90046-6; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; TRAINOR LJ, 1993, J EXP PSYCHOL HUMAN, V19, P615, DOI 10.1037/0096-1523.19.3.615; TRAINOR LJ, 1993, MUSIC PERCEPT, V11, P185; TRAINOR LJ, 1994, PERCEPT PSYCHOPHYS, V56, P125, DOI 10.3758/BF03213891; Trehub S, 2000, ORIGINS OF MUSIC, P427; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; TREHUB SE, 1995, J ACOUST SOC AM, V98, P2532, DOI 10.1121/1.414396; Trehub SE, 1999, J EXP PSYCHOL HUMAN, V25, P965, DOI 10.1037/0096-1523.25.4.965; TREHUB SE, 1987, CHILD DEV, V58, P741, DOI 10.1111/j.1467-8624.1987.tb01414.x; TREHUB SE, 1993, INFANT BEHAV DEV, V16, P193, DOI 10.1016/0163-6383(93)80017-3; TREHUB SE, 1990, PSYCHOMUSICOLOGY, V0009, P00005; TREHUB SE, 2001, MUSIC SCI, P37; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437; Wallin Nils., 1991, BIOMUSICOLOGY; Werker JF, 1999, ANNU REV PSYCHOL, V50, P509, DOI 10.1146/annurev.psych.50.1.509; WERNER LA, 1992, DEV PSYCHOACOUSTICS, P47; Wright AA, 2000, J EXP PSYCHOL GEN, V129, P291, DOI 10.1037/0096-3445.129.3.291; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	63	238	244	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					669	673		10.1038/nn1084	http://dx.doi.org/10.1038/nn1084			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830157				2022-12-28	WOS:000183780400010
J	Reyes, AD				Reyes, AD			Synchrony-dependent propagation of firing rate in iteratively constructed networks in vitro	NATURE NEUROSCIENCE			English	Article							CAT NEOCORTICAL NEURONS; CORTICAL-NEURONS; IN-VIVO; PYRAMIDAL NEURONS; BEHAVING MONKEYS; NEURAL NETWORKS; CORTEX NEURONS; VISUAL-CORTEX; MOTOR CORTEX; MODULATION	The precise role of synchronous neuronal firing in signal encoding remains unclear. To examine what kinds of signals can be carried by synchrony, I reproduced a multilayer feedforward network of neurons in an in vitro slice preparation of rat cortex using an iterative procedure. When constant and time-varying frequency signals were delivered to the network, the firing of neurons in successive layers became progressively more synchronous. Notably, synchrony in the in vitro network developed even with uncorrelated input, persisted under a wide range of physiological conditions and was crucial for the stable propagation of rate signals. The firing rate was represented by a classical rate code in the initial layers, but switched to a synchrony-based code in the deeper layers.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Reyes, AD (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	reyes@cns.nyu.edu						ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Azouz R, 1999, J NEUROSCI, V19, P2209; Baker SN, 2001, J NEUROPHYSIOL, V85, P869, DOI 10.1152/jn.2001.85.2.869; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Baker SN, 1997, J PHYSIOL-LONDON, V504P, pP116; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Cateau H, 2001, NEURAL NETWORKS, V14, P675, DOI 10.1016/S0893-6080(01)00065-X; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; DIESMANN M, 2001, NEUROCOMPUTING, V565, P38; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; FETZ E, 1991, CEREB CORTEX, V9, P1; Gewaltig MO, 2001, NEURAL NETWORKS, V14, P657, DOI 10.1016/S0893-6080(01)00070-3; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Litvak V, 2003, J NEUROSCI, V23, P3006; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Oviedo H, 2002, NAT NEUROSCI, V5, P261, DOI 10.1038/nn807; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PINSKY PF, 1995, BIOL CYBERN, V73, P129, DOI 10.1007/BF00204051; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Reyes AD, 1996, J NEUROSCI, V16, P993; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; REYES AD, 1993, J NEUROPHYSIOL, V69, P1673, DOI 10.1152/jn.1993.69.5.1673; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SCHWARTZ K, 1984, EUR HEART J, V5, P77, DOI 10.1093/eurheartj/5.suppl_F.77; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852	49	239	243	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					593	599		10.1038/nn1056	http://dx.doi.org/10.1038/nn1056			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730700				2022-12-28	WOS:000183140400016
J	Nicholson, DA; Freeman, JH				Nicholson, DA; Freeman, JH			Addition of inhibition in the olivocerebellar system and the ontogeny of a motor memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CLIMBING FIBERS; DEVELOPMENTAL-CHANGES; MULTIPLE INNERVATION; NEURONAL-ACTIVITY; PURKINJE-CELLS; RAT CEREBELLUM; INFERIOR OLIVE; MUTANT MICE; ORGANIZATION	The developmental emergence of learning has traditionally been attributed to the maturation of single brain regions necessary for learning in adults, rather than to the maturation of synaptic interactions within neural systems. Acquisition and retention of a simple form of motor learning, classical conditioning of the eyeblink reflex, depends on the cerebellum and interconnected brainstem structures, including the inferior olive. Here, we combined unit recordings from Purkinje cells in eye regions of the cerebellar cortex and quantitative electron microscopy of the inferior olive to show that the developmental emergence of eyeblink conditioning in rats is associated with the maturation of inhibitory feedback from the cerebellum to the inferior olive. The results are consistent with previous work in adult animals and indicate that the maturation of cerebellar inhibition within the inferior olive may be a critical factor for the formation and retention of learning-specific cerebellar plasticity and eyeblink conditioning.	Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Iowa	Freeman, JH (corresponding author), Univ Iowa, Dept Psychol, E11 Seashore Hall, Iowa City, IA 52242 USA.			Nicholson, Dan/0000-0002-1963-0569	NINDS NIH HHS [NS38890, F31 NS041713, R01 NS038890, NS41713] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS041713, R01NS038890] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; BLOEDEL JR, 1984, J PHYSIOL-LONDON, V352, P129, DOI 10.1113/jphysiol.1984.sp015282; CAREW TJ, 1989, TRENDS NEUROSCI, V12, P389, DOI 10.1016/0166-2236(89)90078-7; CAREW TJ, 1998, MECH RELATIONSHIPS D; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DIAMOND A, 1990, DEV NEURAL BASES HIG, V8; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; FREDETTE BJ, 1991, ANAT EMBRYOL, V184, P225, DOI 10.1007/BF01673258; Freeman JH, 2001, INTEGR PHYS BEH SCI, V36, P15, DOI 10.1007/BF02733945; Freeman JH, 2000, J NEUROSCI, V20, P813, DOI 10.1523/JNEUROSCI.20-02-00813.2000; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; GORMEZANO I, 1983, PROG PSYCHOB PHYSIOL, V10, P197; Hesslow G, 1996, EXP BRAIN RES, V110, P36; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; LANG E, IN PRESS J NEUROPHYS; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; Nicholson DA, 2000, J NEUROSCI, V20, P8218; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Peters A., 1991, FINE STRUCTURE NERVO; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; STANTON ME, 1992, BEHAV NEUROSCI, V106, P657, DOI 10.1037/0735-7044.106.4.657; STANTON ME, 2003, EYE BLINK CLASSICAL, P105; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Thompson RF, 1998, NEUROBIOL LEARN MEM, V70, P150, DOI 10.1006/nlme.1998.3845; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0	48	46	46	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					532	537		10.1038/nn1042	http://dx.doi.org/10.1038/nn1042			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692555	Green Accepted			2022-12-28	WOS:000182553200021
J	Lucas, G; Hendolin, P; Harkany, T; Agerman, K; Paratcha, G; Holmgren, C; Zilberter, Y; Sairanen, M; Minichiello, L; Castren, E; Ernfors, P				Lucas, G; Hendolin, P; Harkany, T; Agerman, K; Paratcha, G; Holmgren, C; Zilberter, Y; Sairanen, M; Minichiello, L; Castren, E; Ernfors, P			Neurotrophin-4 mediated TrkB activation reinforces morphine-induced analgesia	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; AUTOPHOSPHORYLATION SITES; TYROSINE PHOSPHORYLATION; RECEPTORS; LOCALIZATION; EFFICACY; NEURONS; KINASE; RAT		Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Univ Kuopio, Dept Neurobiol, AI Virtanen Inst, FIN-70211 Kuopio, Finland; European Mol Biol Lab, I-00016 Monterotondo, Rome, Italy	Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; European Molecular Biology Laboratory (EMBL)	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.		Lucas, Guilherme/N-8827-2014; Castrén, Eero/A-4618-2010; Minichiello, Liliana/AAA-7190-2022	Lucas, Guilherme/0000-0002-1656-9571; Ernfors, Patrik/0000-0002-1140-3986; Paratcha, Gustavo/0000-0002-0804-4433; Castren, Eero/0000-0002-1402-2791				Appleyard SM, 2000, J BIOL CHEM, V275, P38281, DOI 10.1074/jbc.M006756200; Ding YQ, 1996, J COMP NEUROL, V367, P375; GUITON M, 1995, BIOCHEM SOC T, V23, pS176, DOI 10.1042/bst023176s; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; McLaughlin JP, 2001, MOL PHARMACOL, V59, P1360, DOI 10.1124/mol.59.6.1360; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Saarelainen T, 2000, MOL CELL NEUROSCI, V16, P87, DOI 10.1006/mcne.2000.0863; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; SIUCIAK JA, 1994, BRAIN RES, V633, P326, DOI 10.1016/0006-8993(94)91556-3; Yan Q, 1997, J COMP NEUROL, V378, P135	14	16	16	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					221	222		10.1038/nn1021	http://dx.doi.org/10.1038/nn1021			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12601381				2022-12-28	WOS:000181178300009
J	Maguire, EA; Valentine, ER; Wilding, JM; Kapur, N				Maguire, EA; Valentine, ER; Wilding, JM; Kapur, N			Routes to remembering: the brains behind superior memory	NATURE NEUROSCIENCE			English	Article							HUMAN NAVIGATION; MORPHOMETRY; HANDEDNESS; MNEMONICS; ASYMMETRY; IMAGERY	Why do some people have superior memory capabilities? We addressed this age-old question by examining individuals renowned for outstanding memory feats in forums such as the World Memory Championships. Using neuropsychological measures, as well as structural and functional brain imaging, we found that superior memory was not driven by exceptional intellectual ability or structural brain differences. Rather, we found that superior memorizers; used a spatial learning strategy, engaging brain regions such as the hippocampus that are critical for memory and for spatial memory in particular. These results illustrate how functional neuroimaging might prove valuable in delineating the neural substrates of mnemonic techniques, which could broaden the scope for memory improvement in the general population and the memory-impaired.	UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ London, Royal Holloway & Bedford New Coll, Dept Psychol, Egham TW20 0EX, Surrey, England; Southampton Gen Hosp, Wessex Neurol Ctr, Dept Clin Neuropsychol, Southampton SO16 6YD, Hants, England; Univ Southampton, Dept Psychol, Southampton SO16 6YD, Hants, England	University of London; University College London; University of London; Royal Holloway University London; University of Southampton; University of Southampton	Maguire, EA (corresponding author), UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	e.maguire@fil.ion.ucl.ac.uk	Valentine, Elizabeth/AAY-1032-2021		Wellcome Trust [071173] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amidzic O, 2001, NATURE, V412, P603, DOI 10.1038/35088119; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BELLEZZA FS, 1981, REV EDUC RES, V51, P247, DOI 10.2307/1170198; BENDER BG, 1978, J EDUC PSYCHOL, V70, P583, DOI 10.1037/0022-0663.70.4.583; BENNETTLEVY J, 1980, CORTEX, V16, P543, DOI 10.1016/S0010-9452(80)80002-5; Bentley W. A., 1962, SNOW CRYSTALS; BOWER GH, 1970, AM SCI, V58, P496; BROWN E, 1975, J HIST BEHAV SCI, V11, P342, DOI 10.1002/1520-6696(197510)11:4<342::AID-JHBS2300110404>3.0.CO;2-D; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Butcher J, 2000, LANCET, V356, P836; Chase W.G., 1982, PSYCHOL LEARN MOTIV, V16, P1, DOI [10.1016/S0079-7421(08)60546-0, DOI 10.1016/S0079-7421(08)60546-0]; COUGHLAN AK, 1985, ADULT MEMORY INFORMA; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Luria A.R., 1975, MIND MNEMONIST; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; MCMILLAN TM, 1984, CORTEX, V20, P333, DOI 10.1016/S0010-9452(84)80002-7; NEISSER U, 1982, MEMORY OBSERVED REME, P377; Nelson H., 1991, NATL ADULT READING T; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Pesenti M, 2001, NAT NEUROSCI, V4, P103, DOI 10.1038/82831; *PSYCH CORP, 1986, WECHSL AD INT SCAL R; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; ROEDIGER HL, 1980, J EXP PSYCHOL-HUM L, V6, P558, DOI 10.1037/0278-7393.6.5.558; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; Wilding J. M., 1997, SUPERIOR MEMORY; Wilson B. A., 2002, NEUROPSYCHOLOGY MEMO, P263; Yates Frances A., 1966, ART MEMORY	41	190	194	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					90	95		10.1038/nn988	http://dx.doi.org/10.1038/nn988			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	630CE	12483214				2022-12-28	WOS:000180089300020
J	Finkelstein, R; Miller, T; Baughman, R				Finkelstein, R; Miller, T; Baughman, R			The challenge of translational research - a perspective from the NINDS	NATURE NEUROSCIENCE			English	Article									NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Finkelstein, R (corresponding author), NINDS, NIH, 6001 Execut Blvd, Bethesda, MD 20892 USA.		Baughman, Robert/O-9078-2014	Baughman, Robert/0000-0002-8557-9458					0	10	10	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1029	1030		10.1038/nn933	http://dx.doi.org/10.1038/nn933			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403978				2022-12-28	WOS:000179041300006
J	Gilbert, AN; Firestein, S				Gilbert, AN; Firestein, S			Dollars and scents: commercial opportunities in olfaction and taste	NATURE NEUROSCIENCE			English	Review							7-TRANSMEMBRANE PROTEINS; ODORANT RECEPTORS; FAMILY; MOOD	Research successes over the past decade have provided a broad outline of the neuroscience of olfaction and taste. Our understanding of these systems now spans the molecular to the psychological. It will soon reach critical mass and begin to generate a variety of practical applications with commercial potential. Given the ubiquity of smell and taste and their importance to health, nutrition and quality of life, these applications could have a major impact on consumer product markets and create entirely new ones. Sensory biotechnology could be the first post-genomic application to break through to the consumer market. We describe odor modulation technologies with implications for food intake, health care and other arenas. Our deeper understanding of olfaction and taste in animal behavior and reproduction provides opportunities in pest control and animal husbandry, where environmentally neutral interventions are much in demand.	Columbia Univ, New York, NY 10027 USA; Sense Smell Inst, New York, NY 10016 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, New York, NY 10027 USA.	sjf24@columbia.edu		Gilbert, Avery/0000-0002-8806-8557				BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Gilbert AN, 1996, CHEM SENSES, V21, P411, DOI 10.1093/chemse/21.4.411; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Graham CA, 2000, PSYCHOPHYSIOLOGY, V37, P76, DOI 10.1017/S0048577200981964; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; SEGAL NL, 1995, PHYSIOL BEHAV, V57, P605, DOI 10.1016/0031-9384(94)00328-3; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WYSOCKI CJ, 1984, P NATL ACAD SCI-BIOL, V81, P4899, DOI 10.1073/pnas.81.15.4899; Wysocki CJ, 1991, SMELL TASTE HLTH DIS, P287; ZHAO H, 1998, SCIENCE, V279, P327; Zozulya S, 2001, GENOME BIOL, V2	20	32	35	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1043	1045		10.1038/nn937	http://dx.doi.org/10.1038/nn937			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403982				2022-12-28	WOS:000179041300010
J	Turnley, AM; Faux, CH; Rietze, RL; Coonan, JR; Bartlett, PF				Turnley, AM; Faux, CH; Rietze, RL; Coonan, JR; Bartlett, PF			Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELL; VENTRICULAR ZONE; SOCS PROTEINS; MOUSE-BRAIN; RECEPTOR; GENES; PRECURSORS; MECHANISMS; PROLIFERATION	The intracellular mechanisms that determine the response of neural progenitor cells to growth factors and regulate their differentiation into either neurons or astrocytes remain unclear. We found that expression of SOCS2, an intracellular regulator of cytokine signaling, was restricted to mouse progenitor cells and neurons in response to leukemia inhibitory factor (LIF)-like cytokines. Progenitors lacking SOCS2 produced fewer neurons and more astrocytes in vitro, and Socs2(-/-) mice had fewer neurons and neurogenin-1 (Ngn1)-expressing cells in the developing cortex, whereas overexpression of SOCS2 increased neuronal differentiation. We also report that growth hormone inhibited Ngn1 expression and neuronal production, and this action was blocked by SOCS2 overexpression. These findings indicate that SOCS2 promotes neuronal differentiation by blocking growth hormone-mediated downregulation of Ngn1.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Queensland, Inst Brain Res, Brisbane, Qld 4072, Australia; Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Queensland; University of Melbourne	Bartlett, PF (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	bartlett@wehi.edu.au	Bartlett, Perry/F-3813-2012; Turnley, Ann/A-8125-2010	Turnley, Ann/0000-0002-8442-127X				Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Cai L, 2000, DEVELOPMENT, V127, P3021; DELFS J, 1980, NATURE, V283, P676, DOI 10.1038/283676a0; EDENS A, 1994, ENDOCRINOLOGY, V135, P2802, DOI 10.1210/en.135.6.2802; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Fode C, 2000, GENE DEV, V14, P67; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HOJVAT S, 1982, BRAIN RES, V239, P543, DOI 10.1016/0006-8993(82)90529-7; HOJVAT S, 1982, DEV BRAIN RES, V4, P427, DOI 10.1016/0165-3806(82)90186-9; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; KRULICH L, 1968, ENDOCRINOLOGY, V83, P783, DOI 10.1210/endo-83-4-783; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li WW, 1998, J NEUROSCI, V18, P8853; LOBIE PE, 1993, DEV BRAIN RES, V74, P225, DOI 10.1016/0165-3806(93)90008-X; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Rajan P, 1998, J NEUROSCI, V18, P3620; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Thomas HE, 1997, J NEUROIMMUNOL, V78, P132, DOI 10.1016/S0165-5728(97)00091-X; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4	41	133	138	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1155	1162		10.1038/nn954	http://dx.doi.org/10.1038/nn954			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368809				2022-12-28	WOS:000178884600018
J	Edwards, CJ; Alder, TB; Rose, GJ				Edwards, CJ; Alder, TB; Rose, GJ			Auditory midbrain neurons that count	NATURE NEUROSCIENCE			English	Article							INTEGRATION; INFORMATION		Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Rose, GJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.							Alder TB, 1998, NAT NEUROSCI, V1, P519, DOI 10.1038/2237; Alder TB, 2000, J COMP PHYSIOL A, V186, P923, DOI 10.1007/s003590000144; Fortune ES, 2000, J NEUROSCI, V20, P7122, DOI 10.1523/JNEUROSCI.20-18-07122.2000; Gerhardt H.C., 1988, P455; KEELE SW, 1989, PSYCHOL RES-PSYCH FO, V50, P251, DOI 10.1007/BF00309261; KLUMP GM, 1987, NATURE, V326, P286, DOI 10.1038/326286a0; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; ONEILL WE, 1979, SCIENCE, V203, P69, DOI 10.1126/science.758681; Rose GJ, 2002, ANIM BEHAV, V63, P1183, DOI 10.1006/anbe.2002.3025; SUGA N, 1989, J EXP BIOL, V146, P277; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212	12	89	89	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					934	936		10.1038/nn916	http://dx.doi.org/10.1038/nn916			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219094				2022-12-28	WOS:000178242200010
J	Hagell, P; Piccini, P; Bjorklund, A; Brundin, P; Rehncrona, S; Widner, H; Crabb, L; Pavese, N; Oertel, WH; Quinn, N; Brooks, DJ; Lindvall, O				Hagell, P; Piccini, P; Bjorklund, A; Brundin, P; Rehncrona, S; Widner, H; Crabb, L; Pavese, N; Oertel, WH; Quinn, N; Brooks, DJ; Lindvall, O			Dyskinesias following neural transplantation in Parkinson's disease	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS		Wallenberg Neurosci Ctr, Sect Restorat Neurol, SE-22184 Lund, Sweden; Wallenberg Neurosci Ctr, Div Neurobiol, SE-22184 Lund, Sweden; Wallenberg Neurosci Ctr, Sect Neuronal Survival, SE-22184 Lund, Sweden; Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-22185 Lund, Sweden; Univ Hosp, Dept Clin Neurosci, Div Neurosurg, SE-22185 Lund, Sweden; Hammersmith Hosp, Imperial Coll, Fac Med, MRC,Clin Sci Ctr, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Fac Med, Div Neurosci, London W12 0NN, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; Univ Marburg, Dept Neurol, DE-35033 Marburg, Germany	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Imperial College London; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Philipps University Marburg	Lindvall, O (corresponding author), Wallenberg Neurosci Ctr, Sect Restorat Neurol, SE-22184 Lund, Sweden.	olle.lindvall@neurol.lu.se	Hagell, Peter/G-9559-2014; Hagell, Peter/F-5915-2010; Björklund, Anders/ABA-1326-2020	Hagell, Peter/0000-0003-2174-372X; Hagell, Peter/0000-0003-2174-372X; Pavese, Nicola/0000-0002-6801-6194; Brooks, David/0000-0003-2602-2518; Piccini, Paola/0000-0003-4162-6141; Bjorklund, Anders/0000-0002-5676-6203	MRC [MC_U120036861] Funding Source: UKRI; Medical Research Council [MC_U120036861] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BOYCE S, 1990, CLIN NEUROPHARMACOL, V13, P448, DOI 10.1097/00002826-199010000-00006; Cubo E, 2001, ARCH NEUROL-CHICAGO, V58, P1379, DOI 10.1001/archneur.58.9.1379; Fahn S., 1987, RECENT DEV PARKINSON, P153; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Hagell P, 1999, MOVEMENT DISORD, V14, P448, DOI 10.1002/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0; Hauser RA, 1999, ARCH NEUROL-CHICAGO, V56, P179, DOI 10.1001/archneur.56.2.179; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Lee CS, 2000, BRAIN, V123, P1365, DOI 10.1093/brain/123.7.1365; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; Lindvall O, 2000, Prog Brain Res, V127, P299; LUQUIN MR, 1992, MOVEMENT DISORD, V7, P117, DOI 10.1002/mds.870070204; Nutt JG, 2000, ANN NEUROL, V47, pS160; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203	13	324	341	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					627	628		10.1038/nn863	http://dx.doi.org/10.1038/nn863			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12042822	Green Published			2022-12-28	WOS:000176414300009
J	Ward, R; Danziger, S; Owen, V; Rafal, R				Ward, R; Danziger, S; Owen, V; Rafal, R			Deficits in spatial coding and feature binding following damage to spatiotopic maps in the human pulvinar	NATURE NEUROSCIENCE			English	Article							ILLUSORY CONJUNCTIONS; ATTENTION; PATIENT		Univ Wales, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel	Bangor University; Ben Gurion University	Ward, R (corresponding author), Univ Wales, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales.		Danziger, Shai/AAE-8799-2019					BENDER DB, 1981, J NEUROPHYSIOL, V46, P672, DOI 10.1152/jn.1981.46.3.672; COHEN A, 1989, J EXP PSYCHOL HUMAN, V15, P650, DOI 10.1037/0096-1523.15.4.650; COHEN A, 1991, PSYCHOL SCI, V2, P106, DOI 10.1111/j.1467-9280.1991.tb00109.x; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PRINZMETAL W, 1995, J EXP PSYCHOL HUMAN, V21, P1362, DOI 10.1037/0096-1523.21.6.1362; ROBINSON DL, 1989, NEUROBIOLOGY SACCADI, P337; Talairach J., 1988, COPLANAR STEREOTAXIC; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5	11	94	96	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					99	100		10.1038/nn794	http://dx.doi.org/10.1038/nn794			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11780145				2022-12-28	WOS:000173558400009
J	Olesen, PJ; Westerberg, H; Klingberg, T				Olesen, PJ; Westerberg, H; Klingberg, T			Increased prefrontal and parietal activity after training of working memory	NATURE NEUROSCIENCE			English	Article							NEURAL MECHANISMS; ACTIVATION; PERFORMANCE; CHILDREN	Working memory capacity has traditionally been thought to be constant. Recent studies, however, suggest that working memory can be improved by training. In this study, we have investigated the changes in brain activity that are induced by working memory training. Two experiments were carried out in which healthy, adult human subjects practiced working memory tasks for 5 weeks. Brain activity was measured with functional magnetic resonance imaging (fMRI) before, during and after training. After training, brain activity that was related to working memory increased in the middle frontal gyrus and superior and inferior parietal cortices. The changes in cortical activity could be evidence of training-induced plasticity in the neural systems that underlie working memory.	Karolinska Inst, Dept Neuropediat, Astrid Lindgrens Childrens Hosp Q2 07, S-17176 Stockholm, Sweden	Karolinska Institutet	Olesen, PJ (corresponding author), Karolinska Inst, Dept Neuropediat, Astrid Lindgrens Childrens Hosp Q2 07, S-17176 Stockholm, Sweden.	pernille.olesen@kbh.ki.se		Olesen, Jes/0000-0002-6712-2702; Klingberg, Torkel/0000-0002-3175-2171				[Anonymous], 1981, WAIS R MANUAL; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Fletcher P, 1999, CEREB CORTEX, V9, P168, DOI 10.1093/cercor/9.2.168; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hale S, 1997, DEV PSYCHOL, V33, P364, DOI 10.1037/0012-1649.33.2.364; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kemps E, 2001, MEMORY, V9, P13, DOI 10.1080/09658210042000012; Klingberg T, 1998, CEREB CORTEX, V8, P593, DOI 10.1093/cercor/8.7.593; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 1998, CEREB CORTEX, V8, P73, DOI 10.1093/cercor/8.1.73; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Raven J.C, 1990, ADV PROGR MATRICES S; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694	33	827	855	7	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					75	79		10.1038/nn1165	http://dx.doi.org/10.1038/nn1165			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	758LN	14699419				2022-12-28	WOS:000187636000016
J	Sirigu, A; Daprati, E; Ciancia, S; Giraux, P; Nighoghossian, N; Posada, A; Haggard, P				Sirigu, A; Daprati, E; Ciancia, S; Giraux, P; Nighoghossian, N; Posada, A; Haggard, P			Altered awareness of voluntary action after damage to the parietal cortex	NATURE NEUROSCIENCE			English	Article							GRIP-FORCE ADJUSTMENTS; SENSORIMOTOR INTEGRATION; MOVEMENTS; ABNORMALITIES	A central question in the study of human behavior is the origin of willed action. EEG recordings of surface brain activity from human subjects performing a self-initiated movement show that the subjective experience of wanting to move follows, rather than precedes, the 'readiness potential'-an electrophysiological mark of motor preparation. This raises the issue of how conscious experience of willed action is generated. Here we show that patients with parietal lesions can report when they started moving, but not when they first became aware of their intention to move. This stands in contrast with the performance of cerebellar patients who behaved as normal subjects. We thus propose that when a movement is planned, activity in the parietal cortex, as part of a cortico-cortical sensorimotor processing loop, generates a predictive internal model of the upcoming movement. This model might form the neural correlate of motor awareness.	Inst Cognit Sci, CNRS, F-69675 Bron, France; IRCCS, Fdn Santa Lucia, I-00179 Rome, Italy; Hop Neurol, Cerebrovasc Unit, F-69394 Lyon, France; UCL, Inst Cognit Neurosci, London, England	Centre National de la Recherche Scientifique (CNRS); IRCCS Santa Lucia; CHU Lyon; University of London; University College London	Sirigu, A (corresponding author), Inst Cognit Sci, CNRS, 67 Blv Pinel, F-69675 Bron, France.	sirigu@isc.cnrs.fr	Giraux, Pascal/D-8105-2018; Haggard, Patrick/A-5081-2010; Sirigu, Angela/L-4683-2017; Nighoghossian, Norbert/H-7492-2014; daprati, elena/AAA-2224-2019	Giraux, Pascal/0000-0002-8581-1472; Haggard, Patrick/0000-0001-7798-793X				Babin-Ratte S, 1999, EXP BRAIN RES, V128, P81, DOI 10.1007/s002210050821; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; BLAKEMORE SJ, IN PRESS EXP BRAIN R; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; McCallum W., 1988, HDB ELECTROENCEPHALO, V3, P427; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Weinstein E.A., 1955, DENIAL ILLNESS SYMBO; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	24	221	224	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					80	84		10.1038/nn1160	http://dx.doi.org/10.1038/nn1160			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14647290				2022-12-28	WOS:000187636000017
J	Brauer, AU; Savaskan, NE; Kuhn, H; Prehn, S; Ninnemann, O; Nitsch, R				Brauer, AU; Savaskan, NE; Kuhn, H; Prehn, S; Ninnemann, O; Nitsch, R			A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting	NATURE NEUROSCIENCE			English	Article							INDUCED NEURITE RETRACTION; PERFORANT PATH LESION; ADULT-RAT HIPPOCAMPUS; LYSOPHOSPHATIDIC ACID; DENTATE GYRUS; ENTORHINAL CORTEX; MOLECULES; GUIDANCE; CELLS; LYSOPHOSPHOLIPIDS	Outgrowth of axons in the central nervous system is governed by specific molecular cues. Molecules detected so far act as ligands that bind to specific receptors. Here, we report a new membrane-associated lipid phosphate phosphatase that we have named plasticity-related gene 1 (PRG-1), which facilitates axonal outgrowth during development and regenerative sprouting. PRG-1 is specifically expressed in neurons and is located in the membranes of outgrowing axons. There, it acts as an ectoenzyme and attenuates phospholipid-induced axon collapse in neurons and facilitates outgrowth in the hippocampus. Thus, we propose a novel mechanism by which axons are able to control phospholipid-mediated signaling and overcome the growth-inhibiting, phospholipid-rich environment of the extracellular space.	Humboldt Univ, Med Sch Charite, Dept Cell Biol & Neurobiol, Inst Anat, D-10115 Berlin, Germany; Humboldt Univ, Med Sch Charite, Dept Biochem, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nitsch, R (corresponding author), Humboldt Univ, Med Sch Charite, Dept Cell Biol & Neurobiol, Inst Anat, Philippstr 12, D-10115 Berlin, Germany.	robert.nitsch@charite.de	Bräuer, Anja/N-3692-2019; Braeuer, Anja/K-8339-2013; Nitsch, Robert/AAI-9129-2021; Savaskan, Nicolai/D-2923-2018	Savaskan, Nicolai/0000-0003-1348-094X				BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BOTHMER J, 1992, NEUROCHEM INT, V21, P223, DOI 10.1016/0197-0186(92)90151-G; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Brauer AU, 2000, HIPPOCAMPUS, V10, P632, DOI 10.1002/1098-1063(2000)10:6<632::AID-HIPO1001>3.0.CO;2-6; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COTMAN C, 1977, J NEUROCYTOL, V6, P455, DOI 10.1007/BF01178228; DELLER T, 1995, J NEUROSCI, V15, P6868; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HAWKINS JW, 1993, ANTISENSE RES DEV, V3, P233; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hooks SB, 2001, J BIOL CHEM, V276, P4611, DOI 10.1074/jbc.M007782200; Imai A, 2000, J CLIN ENDOCR METAB, V85, P3370, DOI 10.1210/jc.85.9.3370; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; JALINK K, 1994, BBA-REV CANCER, V1198, P185, DOI 10.1016/0304-419X(94)90013-2; Kanoh H, 1997, BBA-LIPID LIPID MET, V1348, P56, DOI 10.1016/S0005-2760(97)00094-5; Kobayashi H, 1997, J NEUROSCI, V17, P8339; MEIER S, 2003, FASEB J         0408; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Savaskan NE, 2001, REV NEUROSCIENCE, V12, P195; Savaskan NE, 2000, EUR J NEUROSCI, V12, P1024, DOI 10.1046/j.1460-9568.2000.00998.x; Skutella T, 2001, TRENDS NEUROSCI, V24, P107, DOI 10.1016/S0166-2236(00)01717-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tigyi G, 1996, J NEUROCHEM, V66, P549; VanDoren M, 1997, CURR BIOL, V7, pR148, DOI 10.1016/S0960-9822(97)70075-7; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	37	97	102	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					572	578		10.1038/nn1052	http://dx.doi.org/10.1038/nn1052			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730698				2022-12-28	WOS:000183140400013
J	Bates, E; Wilson, SM; Saygin, AP; Dick, F; Sereno, MI; Knight, RT; Dronkers, NF				Bates, E; Wilson, SM; Saygin, AP; Dick, F; Sereno, MI; Knight, RT; Dronkers, NF			Voxel-based lesion-symptom mapping	NATURE NEUROSCIENCE			English	Article							ARTICULATION; TOMOGRAPHY; PARIETAL; APHASIA; ANATOMY; CORTEX		VA No Calif Hlth Care Syst, Ctr Aphasia & Related Disorders, Martinez, CA 94553 USA; Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; Univ Calif Davis, Dept Linguist, Davis, CA 95616 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Diego	Dronkers, NF (corresponding author), VA No Calif Hlth Care Syst, Ctr Aphasia & Related Disorders, Martinez, CA 94553 USA.		Saygin, Ayse Pinar/A-7126-2009; Saygin, Ayse Pinar/B-1494-2010; Sereno, Martin I/F-7657-2012; Dronkers, Nina F/K-6312-2015; Hoogkamer, Wouter/G-4498-2010	Saygin, Ayse Pinar/0000-0002-0859-9500; Sereno, Martin I/0000-0002-7598-7829; Wilson, Stephen/0000-0001-9884-2852; Dick, Frederic/0000-0002-2933-3912	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017778, P01NS040813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000216] Funding Source: NIH RePORTER; NIDCD NIH HHS [2 R01 DC00216] Funding Source: Medline; NINDS NIH HHS [P01 NS17778, P01 NS40813] Funding Source: Medline; PHS HHS [21135] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adolphs R, 2000, J NEUROSCI, V20, P2683; Blank SC, 2002, BRAIN, V125, P1829, DOI 10.1093/brain/awf191; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; DRONKERS NF, IN PRESS COGNITION; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; KERTESZ A, 1979, APHASIA ASS DISORDER; KNIGHT RT, 1988, ELECTROEN CLIN NEURO, V70, P499, DOI 10.1016/0013-4694(88)90148-4; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; METTER EJ, 1990, ARCH NEUROL-CHICAGO, V47, P1235, DOI 10.1001/archneur.1990.00530110097024; NAESER MA, 1978, NEUROLOGY, V28, P545, DOI 10.1212/WNL.28.6.545; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1	15	955	959	0	74	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					448	450		10.1038/nn1050	http://dx.doi.org/10.1038/nn1050			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704393				2022-12-28	WOS:000182553200009
J	Bradley, D; Wallisch, P				Bradley, D; Wallisch, P			Hide, remember, seek	NATURE NEUROSCIENCE			English	Editorial Material							DORSOLATERAL PREFRONTAL CORTEX; FRONTAL EYE FIELDS; MOVEMENTS; DECISION; MACAQUE	A new study shows persistent activity in frontal eye field neurons while monkeys track the imagined motion of a dot that has disappeared, and finds this activity Is tuned for speed.	Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Bradley, D (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave,MC G314, Chicago, IL 60637 USA.							Barborica A, 2003, NAT NEUROSCI, V6, P66, DOI 10.1038/nn990; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gardner JL, 2002, NAT NEUROSCI, V5, P892, DOI 10.1038/nn897; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2	12	0	0	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					11	12		10.1038/nn0103-11	http://dx.doi.org/10.1038/nn0103-11			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12494243				2022-12-28	WOS:000180089300007
J	Hillis, AE; Wityk, RJ; Barker, PB; Caramazza, A				Hillis, AE; Wityk, RJ; Barker, PB; Caramazza, A			Neural regions essential for writing verbs	NATURE NEUROSCIENCE			English	Article							ACUTE STROKE; RETRIEVAL; NOUNS; IMPAIRMENT; APHASIA; BRAIN; WORDS		Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University	Hillis, AE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St, Baltimore, MD 21287 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005375] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR15241] Funding Source: Medline; NIDCD NIH HHS [R01 DC05375, R01 DC005375] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barber PA, 1998, NEUROLOGY, V51, P418, DOI 10.1212/WNL.51.2.418; Berndt RS, 1997, BRAIN LANG, V56, P68; CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; DAMASIO AR, 1993, P NATL ACAD SCI USA, V90, P4957, DOI 10.1073/pnas.90.11.4957; DANIELE A, 1994, NEUROPSYCHOLOGIA, V32, P1325, DOI 10.1016/0028-3932(94)00066-2; Hillis AE, 2001, ANN NEUROL, V50, P561, DOI 10.1002/ana.1265; HILLIS AE, 1995, J COGNITIVE NEUROSCI, V7, P396, DOI 10.1162/jocn.1995.7.3.396; Hillis AE, 2002, J COGNITIVE NEUROSCI, V14, P1099, DOI 10.1162/089892902320474544; MCCARTHY R, 1985, NEUROPSYCHOLOGIA, V23, P709, DOI 10.1016/0028-3932(85)90079-X; Miceli G., 1984, CORTEX, V20, P217; Rordorf G, 1997, STROKE, V28, P2133, DOI 10.1161/01.STR.28.11.2133; Tranel D, 2001, COGN NEUROPSYCHOL, V18, P655, DOI 10.1080/02643290126377; ZINGESER LB, 1990, BRAIN LANG, V39, P14, DOI 10.1016/0093-934X(90)90002-X	14	60	62	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					19	20		10.1038/nn982	http://dx.doi.org/10.1038/nn982			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469127				2022-12-28	WOS:000180089300010
J	Boschat, C; Pelofi, C; Randin, O; Roppolo, D; Luscher, C; Broillet, MC; Rodriguez, I				Boschat, C; Pelofi, C; Randin, O; Roppolo, D; Luscher, C; Broillet, MC; Rodriguez, I			Pheromone detection mediated by a V1r vomeronasal receptor	NATURE NEUROSCIENCE			English	Article							MULTIGENE FAMILY; MAMMALS; NEURONS; SYSTEM; MOUSE		Univ Geneva, Dep Zool & Anim Biol, CH-1211 Geneva, Switzerland; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Univ Geneva, Dept Physiol & Neurol, CH-1211 Geneva, Switzerland	University of Geneva; University of Lausanne; University of Geneva	Rodriguez, I (corresponding author), Univ Geneva, Dep Zool & Anim Biol, CH-1211 Geneva, Switzerland.		Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Broillet, Marie-Christine/0000-0002-0487-6638; rodriguez, ivan/0000-0002-6468-0565				Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; JEMIOLO B, 1989, PHYSIOL BEHAV, V46, P293, DOI 10.1016/0031-9384(89)90270-9; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137	14	177	182	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1261	1262		10.1038/nn978	http://dx.doi.org/10.1038/nn978			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12436115				2022-12-28	WOS:000179447500006
J	Pasupathy, A; Connor, CE				Pasupathy, A; Connor, CE			Population coding of shape in area V4	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; INFEROTEMPORAL CORTEX; 3-DIMENSIONAL SHAPES; OBJECT RECOGNITION; VISUAL-CORTEX; MACAQUE; REPRESENTATION; FEATURES; SELECTIVITY; MONKEY	Shape is represented in the visual system by patterns of activity across populations of neurons. We studied the population code for shape in area V4 of macaque monkeys, which is part of the ventral (object-related) pathway in primate visual cortex. We have previously found that many macaque V4 neurons are tuned for the curvature and object-centered position of boundary fragments (such as 'concavity on the right'). Here we tested the hypothesis that populations of such cells represent complete shapes as aggregates of boundary fragments. To estimate the population representation of a given shape, we scaled each cell's tuning peak by its response to that shape, summed across cells and smoothed. The resulting population response surface contained 3-8 peaks that represented major boundary features and could be used to reconstruct (approximately) the original shape. This exemplifies how a multi-peaked neural population response can represent a complex stimulus in terms of its constituent elements.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA.							Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bartels RH, 1987, INTRO SPLINES USE CO; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DICKINSON SJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P130, DOI 10.1016/1049-9660(92)90013-S; Edelman S, 2000, SPATIAL VISION, V13, P255, DOI 10.1163/156856800741072; Edelman S., 1999, REPRESENTATION RECOG; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GATTASS R, 1988, J NEUROSCI, V8, P1831; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Hanazawa A, 2001, J NEUROSCI, V21, P4490, DOI 10.1523/JNEUROSCI.21-12-04490.2001; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; MARDIA KV, 1976, BIOMETRIKA, V63, P403, DOI 10.2307/2335637; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; MOUNTCASTLE VB, 1995, CEREB CORTEX, V5, P377, DOI 10.1093/cercor/5.5.377; Olson CR, 1996, CURR OPIN NEUROBIOL, V6, P165, DOI 10.1016/S0959-4388(96)80069-9; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SUTHERLAND NS, 1968, PROC R SOC SER B-BIO, V171, P297, DOI 10.1098/rspb.1968.0072; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; [No title captured]; [No title captured]	49	362	366	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1332	1338		10.1038/nn972	http://dx.doi.org/10.1038/nn972			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426571				2022-12-28	WOS:000179447500017
J	O'Connor, DH; Fukui, MM; Pinsk, MA; Kastner, S				O'Connor, DH; Fukui, MM; Pinsk, MA; Kastner, S			Attention modulates responses in the human lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; INTERMODAL SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; DIRECTED ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; FUNCTIONAL MRI; CORTICAL AREAS; HUMAN BRAIN; ACTIVATION	Attentional mechanisms are important for selecting relevant information and filtering out irrelevant information from cluttered visual scenes. Selective attention has previously been shown to affect neural activity in both extrastriate and striate visual cortex. Here, evidence from functional brain imaging shows that attentional response modulation is not confined to cortical processing, but can occur as early as the thalamic level. We found that attention modulated neural activity in the human lateral geniculate nucleus (LGN) in several ways: it enhanced neural responses to attended stimuli, attenuated responses to ignored stimuli and increased baseline activity in the absence of visual stimulation. The LGN, traditionally viewed as the gateway to visual cortex, may also serve as a 'gatekeeper' in controlling attentional response gain.	Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University	Kastner, S (corresponding author), Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Green Hall, Princeton, NJ 08544 USA.			Kastner, Sabine/0000-0002-9742-965X				Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; Chen W, 1999, P NATL ACAD SCI USA, V96, P2430, DOI 10.1073/pnas.96.5.2430; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jones EG, 1985, THALAMUS; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOCH C, 1985, HUM NEUROBIOL, V4, P219; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; Mehta AD, 2000, CEREB CORTEX, V10, P359, DOI 10.1093/cercor/10.4.359; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach I., 1988, COPLANAR STEREOTACTI; Vanduffel W, 2000, CEREB CORTEX, V10, P109, DOI 10.1093/cercor/10.2.109; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	42	452	460	7	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1203	1209		10.1038/nn957	http://dx.doi.org/10.1038/nn957			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379861				2022-12-28	WOS:000178884600024
J	Cook, EP; Maunsell, JHR				Cook, EP; Maunsell, JHR			Dynamics of neuronal responses in macaque MT and VIP during motion detection	NATURE NEUROSCIENCE			English	Article							TEMPORAL VISUAL AREA; SENSITIVE NEURONS; CORTICAL AREA; SINGLE NEURON; MONKEY; CORTEX; DISCRIMINATION; SIGNALS; CHOICE; TIME	We examined how the relationship between neuronal activity and behavior evolved over time during a motion-detection task. Recording from two regions of visual cortex that process motion, the middle temporal (MT) and ventral intraparietal (VIP) areas, we used the time it took subjects to detect a motion stimulus to evaluate the dynamics of the underlying neuronal signals. Single-neuron activity was correlated with stimulus detection and reaction time (RT) in both areas. The rising edge of the population response from both areas was highly predictive of RT using a simple threshold-detection model. The time course of the population responses, however, differed between MT and VIP. For MT, the onset of the neuronal response was relatively constant, whereas for VIP the onset of the neuronal responses increased with RT. In contrast to previous studies, we found that single neurons were not reliable detectors of the motion signal when constrained by realistic detection times.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Cook, EP (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.		Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439	NATIONAL EYE INSTITUTE [R01EY005911] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY05911] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Croner LJ, 1999, J NEUROSCI, V19, P3935; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Efron B., 1994, MONOGRAPHS STAT APPL; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LAMARRE Y, 1981, CAN J PHYSIOL PHARM, V59, P748, DOI 10.1139/y81-111; Luce RD, 1986, RESPONSE TIMES THEIR; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; PARKER A, 1985, J OPT SOC AM A, V2, P1101, DOI 10.1364/JOSAA.2.001101; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Townsend J. T., 1983, STOCHASTIC MODELING; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302	40	213	215	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					985	994		10.1038/nn924	http://dx.doi.org/10.1038/nn924			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244324				2022-12-28	WOS:000178242200018
J	Dragoi, V; Sharma, J; Miller, EK; Sur, M				Dragoi, V; Sharma, J; Miller, EK; Sur, M			Dynamics of neuronal sensitivity in visual cortex and local feature discrimination	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; SYNAPTIC DEPRESSION; RECEPTIVE-FIELDS; NATURAL SCENES; ADAPTATION; STATISTICS; V1; CONTRAST; INHIBITION; PLASTICITY	A striking aspect of natural scenes is that image features such as line orientation are strongly correlated at neighboring spatial locations but not at distant locations. Thus, during the viewing of a scene, eye movements are often accompanied by a change in the orientation structure of the image. How does this behavior influence the discrimination of local features and their encoding by visual cortical neurons? Here we examined the perceived changes in orientation induced by brief exposure to oriented image patterns in monkeys and humans, and then used reverse correlation to investigate dynamic changes in neuronal sensitivity in the primary visual cortex (V1) of behaving monkeys. Whereas brief adaptation to an oriented grating impaired identification of nearby orientations by broadening orientation selectivity and changing the preferred orientation of individual V1 neurons, it actually enhanced the identification of orthogonal orientations by sharpening neuronal selectivity. Hence, successive exposure to image patches of dissimilar spatial structure enhances both the ability to discriminate local features and the encoding of these features by V1 neurons.	MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, 45 Carleton St, Cambridge, MA 02139 USA.	vdragoi@ai.mit.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NEURON, V32, P1181, DOI 10.1016/S0896-6273(01)00540-2; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; FERSTER D, 1986, J NEUROSCI, V6, P1284; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Green DM, 1966, SIGNAL DETECTION THE; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NELSON SB, 1991, J NEUROSCI, V11, P344; Rainer G, 1999, J NEUROSCI, V19, P5493; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Troyer TW, 1998, J NEUROSCI, V18, P5908; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Varela JA, 1999, J NEUROSCI, V19, P4293; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; Yarbus A.L., 1967, EYE MOVEMENT VISION	47	157	160	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					883	891		10.1038/nn900	http://dx.doi.org/10.1038/nn900			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161755				2022-12-28	WOS:000177656300019
J	Smolders, I; Bortolotto, ZA; Clarke, VRJ; Warre, R; Khan, GM; O'Neill, MJ; Ornstein, PL; Bleakman, D; Ogden, A; Weiss, B; Stables, JP; Ho, KH; Ebinger, G; Collingridge, GL; Lodge, D; Michotte, Y				Smolders, I; Bortolotto, ZA; Clarke, VRJ; Warre, R; Khan, GM; O'Neill, MJ; Ornstein, PL; Bleakman, D; Ogden, A; Weiss, B; Stables, JP; Ho, KH; Ebinger, G; Collingridge, GL; Lodge, D; Michotte, Y			Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; KAINIC ACID; EPILEPTIFORM ACTIVITY; ANTIEPILEPTIC DRUGS; CEREBRAL-ISCHEMIA; PYRAMIDAL CELLS; GLUR5 SUBTYPE	Developments in the molecular biology and pharmacology of GLU(K5), a subtype of the kainate class of ionotropic glutamate receptors, have enabled insights into the roles of this subunit in synaptic transmission and plasticity. However, little is known about the possible functions of GLU(K5)-containing kainate receptors in pathological conditions. We report here that, in hippocampal slices, selective antagonists of GLU(K5)-containing kainate receptors prevented development of epileptiform activity-evoked by the muscarinic agonist, pilocarpine-and inhibited the activity when it was preestablished. In conscious rats, these GLU(K5) antagonists prevented and interrupted limbic seizures induced by intra-hippocampal pilocarpine perfusion, and attenuated accompanying rises in extracellular L-glutamate and GABA. This anticonvulsant activity occurred without overt side effects. GLU(K5) antagonism also prevented epileptiform activity induced by electrical stimulation, both in vitro and in vivo. Therefore, we propose that subtype-selective GLU(K5) kainate receptor antagonists offer a potential new therapy for epilepsy.	Free Univ Brussels, Inst Pharmaceut, Dept Pharmaceut Chem & Drug Anal, B-1090 Brussels, Belgium; Univ Bristol, Sch Med, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Eli Lilly & Co, Lilly Res Ctr, Windlesham GU20 6PH, Surrey, England; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; NINDS, Epilepsy Branch, NIH, Bethesda, MD 20892 USA; Allelix Pharmaceut, Mississauga, ON L4V 1V7, Canada; Univ Hosp AZ VUB, Dept Neurol, B-1090 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Bristol; Eli Lilly; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Vrije Universiteit Brussel	Lodge, D (corresponding author), Free Univ Brussels, Inst Pharmaceut, Dept Pharmaceut Chem & Drug Anal, Laarbeeklaan 103, B-1090 Brussels, Belgium.		Smolders, Ilse J/J-9399-2013; Collingridge, Graham L/C-4605-2015; Ornstein, Paul/E-4212-2016; Michotte, Yvette/G-9818-2013; collingridge, graham/AAI-8362-2020	Smolders, Ilse J/0000-0003-2140-0751; Collingridge, Graham L/0000-0002-9572-5359; Ornstein, Paul/0000-0002-4335-1877; Clarke, Vernon/0000-0002-6154-6555				ASHWOOD TJ, 1986, EXP BRAIN RES, V62, P189; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Bleakman D, 1996, MOL PHARMACOL, V49, P581; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Curry WJ, 1998, AM FAM PHYSICIAN, V57, P513; De Sarro G, 1999, PHARMACOL BIOCHEM BE, V63, P621, DOI 10.1016/S0091-3057(99)00027-1; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Huettner JE, 2001, TRENDS NEUROSCI, V24, P365, DOI 10.1016/S0166-2236(00)01830-0; KEHL SJ, 1984, NEUROSCIENCE, V11, P111, DOI 10.1016/0306-4522(84)90217-3; KRNJEVIC K, 1991, GABA MECH EPILEPSY, P47; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; LODGE D, 2000, IUPHAR COMPENDIUM RE, P189; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; MATTSON RH, 1995, EPILEPSIA S2, V36, P13; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; O'Neill MJ, 1998, NEUROPHARMACOLOGY, V37, P1211, DOI 10.1016/S0028-3908(98)00134-8; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rogawski MA, 2001, NEUROPHARMACOLOGY, V40, P28, DOI 10.1016/S0028-3908(00)00112-X; RogviHansen BA, 1995, PHARMACOL THERAPEUT, V68, P425, DOI 10.1016/0163-7258(95)02014-4; Rutecki PA, 1998, J NEUROPHYSIOL, V79, P3019, DOI 10.1152/jn.1998.79.6.3019; Sander T, 1997, AM J MED GENET, V74, P416; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Smolders I, 1997, BRIT J PHARMACOL, V121, P1171, DOI 10.1038/sj.bjp.0701231; SMOLDERS I, 1995, J NEUROSCI METH, V57, P47, DOI 10.1016/0165-0270(94)00124-Y; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Vignes M, 1997, NEUROPHARMACOLOGY, V36, P1477, DOI 10.1016/S0028-3908(97)00158-5; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wilding TJ, 2001, J PHYSIOL-LONDON, V532, P411, DOI 10.1111/j.1469-7793.2001.0411f.x; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	50	121	126	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					796	804		10.1038/nn880	http://dx.doi.org/10.1038/nn880			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080343				2022-12-28	WOS:000177088900024
J	Nicolelis, MAL; Fanselow, EE				Nicolelis, MAL; Fanselow, EE			Thalamcortical optimization of tactile processing according to behavioral state	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RAT BARREL CORTEX; PARTIAL DIRECTED COHERENCE; INTRINSIC FIRING PATTERNS; LAYER-5 PYRAMIDAL NEURONS; THALAMIC RELAY CELLS; CORTICOTHALAMIC FEEDBACK; CEREBRAL-CORTEX; SOMATOSENSORY SYSTEM; VISUAL INFORMATION	We propose a conceptual model that describes the operation of the main thalamocortical loop of the rat somatosensory system. According to this model, the asynchronous convergence of ascending and descending projections dynamically alters the physiological properties of thalamic neurons in the ventral posterior medial (VPM) nucleus as rats shift between three behavioral states. Two of these states are characterized by distinct modes of rhythmic whisker movements. We posit that these simultaneous shifts in exploratory behavioral strategy and in the physiological properties of VPM neurons allow rats to either (i) optimize the detection of stimuli that are novel or difficult to sense or (ii) process complex patterns of multi-whisker stimulation.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychol & Brain Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Ctr Neuroengn, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Nicolelis, MAL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	nicoleli@neuro.duke.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013810] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE13810-01, DE11121-01] Funding Source: Medline; NIMH NIH HHS [MH-12316-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; Ahissar E., 2001, ADV NEURAL POPULATIO, P75; ANDERSEN P, 1964, J PHYSIOL-LONDON, V174, P348, DOI 10.1113/jphysiol.1964.sp007492; ANDERSEN P, 1964, J PHYSIOL-LONDON, V174, P370, DOI 10.1113/jphysiol.1964.sp007493; Baccala L A, 2001, Prog Brain Res, V130, P33; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Carden WB, 1999, J COMP NEUROL, V410, P431; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CHAPIN JK, 1981, EXP NEUROL, V72, P164, DOI 10.1016/0014-4886(81)90135-7; CHATRIAN GE, 1959, ELECTROEN CLIN NEURO, V11, P497, DOI 10.1016/0013-4694(59)90048-3; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; DESCHENES M, 1982, BRAIN RES, V239, P289, DOI 10.1016/0006-8993(82)90854-X; Destexhe A, 2000, J PHYSIOLOGY-PARIS, V94, P391, DOI 10.1016/S0928-4257(00)01093-7; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Edeline JM, 2000, J NEUROPHYSIOL, V84, P934, DOI 10.1152/jn.2000.84.2.934; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; FOURMENT A, 1985, NEUROSCIENCE, V14, P1061, DOI 10.1016/0306-4522(85)90277-5; GASTAUT MH, 1952, REV NEUROL, V87, P176; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Ghazanfar AA, 2001, EXP BRAIN RES, V141, P88, DOI 10.1007/s002210100849; Ghazanfar AA, 1999, CEREB CORTEX, V9, P348, DOI 10.1093/cercor/9.4.348; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kleinfeld D, 1997, J COMP NEUROL, V378, P594; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; MAFFEI L, 1965, ARCH ITAL BIOL, V103, P596; MAFFEI L, 1965, ARCH ITAL BIOL, V103, P609; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Masino SA, 1996, P NATL ACAD SCI USA, V93, P4942, DOI 10.1073/pnas.93.10.4942; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; MCCORMICK DA, 1992, J NEUROSCI, V12, P278; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MORISON RS, 1945, J NEUROPHYSIOL, V8, P309, DOI 10.1152/jn.1945.8.5.309; NICOLELIS MAL, 1993, NATURE, V361, P533, DOI 10.1038/361533a0; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Petersen CCH, 2000, J NEUROSCI, V20, P7579; PFURTSCHELLER G, 1994, NEUROSCI LETT, V174, P93, DOI 10.1016/0304-3940(94)90127-9; PFURTSCHELLER G, 1992, NEUROREPORT, V3, P1057, DOI 10.1097/00001756-199212000-00006; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; Plummer KL, 1999, J COMP NEUROL, V404, P408; POGGIO GF, 1963, J NEUROPHYSIOL, V26, P775, DOI 10.1152/jn.1963.26.5.775; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Polley DB, 1999, J NEUROPHYSIOL, V81, P692, DOI 10.1152/jn.1999.81.2.692; Ramcharan EJ, 2000, J NEUROPHYSIOL, V84, P1982, DOI 10.1152/jn.2000.84.4.1982; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; RICE FL, 1995, BARREL CORTEX RODENT, P1; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; Sheth BR, 1998, J NEUROPHYSIOL, V79, P464, DOI 10.1152/jn.1998.79.1.464; SILLITO AM, 1983, BRAIN RES, V280, P299, DOI 10.1016/0006-8993(83)90059-8; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M., 1988, CELLULAR THALAMIC ME, P51; Steriade M., 1990, THALAMIC OSCILLATION; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhu JJ, 1998, NEUROSCIENCE, V87, P767, DOI 10.1016/S0306-4522(98)00209-7; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	86	102	110	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					517	523		10.1038/nn0602-517	http://dx.doi.org/10.1038/nn0602-517			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12037519				2022-12-28	WOS:000175874600010
J	Weiss, Y; Simoncelli, EP; Adelson, EH				Weiss, Y; Simoncelli, EP; Adelson, EH			Motion illusions as optimal percepts	NATURE NEUROSCIENCE			English	Article								The pattern of local image velocities on the retina encodes important environmental information. Although humans are generally able to extract this information, they can easily be deceived into seeing incorrect velocities. We show that these 'illusions' arise naturally in a system that attempts to estimate local image velocity. We formulated a model of visual motion perception using standard estimation theory, under the assumptions that (i) there is noise in the initial measurements and (ii) slower motions are more likely to occur than faster ones. We found that specific instantiation of such a velocity estimator can account for a wide variety of psychophysical phenomena.	Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel; NYU, Howard Hughes Med Inst, Ctr Neural Sci, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Hebrew University of Jerusalem; Howard Hughes Medical Institute; New York University; New York University; Massachusetts Institute of Technology (MIT)	Weiss, Y (corresponding author), Hebrew Univ Jerusalem, Sch Engn & Comp Sci, Givat Ram Campus, IL-91904 Jerusalem, Israel.			Simoncelli, Eero/0000-0002-1206-527X	NEI NIH HHS [R01 EY11005] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011005] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Lucas BD., 1981, P 7 INT JOINT C ART, V81; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; MORGAN MJ, 1992, NATURE, V355, P344, DOI 10.1038/355344a0; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Schrater PR, 2000, NAT NEUROSCI, V3, P64, DOI 10.1038/71134; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317	12	644	645	1	51	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					598	604		10.1038/nn858	http://dx.doi.org/10.1038/nn858			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021763	Green Submitted			2022-12-28	WOS:000175874600021
J	Yang, B; Slonimsky, JD; Birren, SJ				Yang, B; Slonimsky, JD; Birren, SJ			A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; AFFINITY NGF RECEPTOR; SIGNAL-TRANSDUCTION; CHOLINERGIC DIFFERENTIATION; SYNAPTIC TRANSMISSION; NEURONAL APOPTOSIS; CARDIAC MYOCYTES; DOPAMINE NEURONS; CELL-SURVIVAL	Cardiac function is modulated by norepinephrine release from innervating sympathetic neurons. These neurons also form excitatory connections onto cardiac myocytes in culture. Here we report that brain-derived neurotrophic factor (BDNF) altered the neurotransmitter release properties of these sympathetic neuron-myocyte connections in rodent cell culture, leading to a rapid shift from excitatory to inhibitory cholinergic transmission in response to neuronal stimulation. Fifteen minutes of BDNF perfusion was sufficient to cause this shift to inhibitory transmission, indicating that BDNF promotes preferential release of acetylcholine in response to neuronal stimulation. We found that p75(-/-) neurons did not release acetylcholine in response to BDNF and that neurons overexpressing p75 showed increased cholinergic transmission, indicating that the actions of BDNF are mediated through the p75 neurotrophin receptor. Our findings indicate that p75 is involved in modulating the release of distinct neurotransmitter pools, resulting in a functional switch between excitatory and inhibitory neurotransmission in individual neurons.	Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University	Birren, SJ (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, 415 South St,M-S 008, Waltham, MA 02454 USA.	birren@brandeis.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040168] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS40168] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Blochl A, 1996, J BIOL CHEM, V271, P21100; Brodski C, 2000, P NATL ACAD SCI USA, V97, P9683, DOI 10.1073/pnas.160080697; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CHUN LLY, 1977, J CELL BIOL, V75, P712, DOI 10.1083/jcb.75.3.712; Collin C, 2001, EUR J NEUROSCI, V13, P1273, DOI 10.1046/j.0953-816x.2001.01500.x; CONFORTI L, 1991, J DEV PHYSIOL, V15, P237; DePotter WP, 1997, NEUROCHEM RES, V22, P911, DOI 10.1023/A:1022458322406; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Fagan AM, 1996, J NEUROSCI, V16, P6208; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Gottschalk W, 1998, J NEUROSCI, V18, P6830; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jiang H, 1999, J BIOL CHEM, V274, P26209, DOI 10.1074/jbc.274.37.26209; JOHNSON MI, 1985, J CELL BIOL, V101, P217, DOI 10.1083/jcb.101.1.217; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; LANDIS SC, 1976, P NATL ACAD SCI USA, V73, P4220, DOI 10.1073/pnas.73.11.4220; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Lockhart ST, 2000, J NEUROBIOL, V42, P460, DOI 10.1002/(SICI)1097-4695(200003)42:4<460::AID-NEU7>3.3.CO;2-R; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MacPhee I, 1999, J NEUROCHEM, V72, P1423, DOI 10.1046/j.1471-4159.1999.721423.x; Majdan M, 1997, J NEUROSCI, V17, P6988; MARTIN DP, 1990, J NEUROSCI, V10, P184; Martinez A, 1998, J NEUROSCI, V18, P7336; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Numakawa T, 1999, BRAIN RES, V842, P431, DOI 10.1016/S0006-8993(99)01867-3; POTTER DD, 1986, J NEUROSCI, V6, P1080; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Stoop R, 1996, J NEUROSCI, V16, P3256; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Sulzer D, 2000, AMINO ACIDS, V19, P45, DOI 10.1007/s007260070032; Takei N, 1997, J NEUROCHEM, V68, P370; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; YAN H, 1991, J BIOL CHEM, V266, P12099; Yoon SO, 1998, J NEUROSCI, V18, P3273	50	94	98	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					539	545		10.1038/nn853	http://dx.doi.org/10.1038/nn853			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992117				2022-12-28	WOS:000175874600013
J	Greschner, M; Bongard, M; Rujan, P; Ammermuller, J				Greschner, M; Bongard, M; Rujan, P; Ammermuller, J			Retinal ganglion cell synchronization by fixational eye movements improves feature estimation	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; TURTLE; CLASSIFICATION; POPULATION; RESPONSES; NEURONS; MACAQUE; NETWORK; MONKEYS; STRIATE	Image movements relative to the retina are essential for the visual perception of stationary objects during fixation. Here we have measured fixational eye and head movements of the turtle, and determined their effects on the activity of retinal ganglion cells by simulating the movements on the isolated retina. We show that ganglion cells respond mainly to components of periodic eye movement that have amplitudes of roughly the diameter of a photoreceptor. Drift or small head movements have little effect. Driven cells that are located along contrast borders are synchronized, which reliably signals a preceding movement. In an artificial neural network, the estimation of spatial frequencies for various square wave gratings improves when timelocked to this synchronization. This could potentially improve stimulus feature estimation by the brain.	Univ Oldenburg, Dept Biol, Neurobiol Grp, D-26111 Oldenburg, Germany; Univ Oldenburg, Dept Phys, Complex Syst Grp, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Ammermuller, J (corresponding author), Univ Oldenburg, Dept Biol, Neurobiol Grp, D-26111 Oldenburg, Germany.							Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; BOWLING DB, 1980, J PHYSIOL-LONDON, V299, P173, DOI 10.1113/jphysiol.1980.sp013118; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; COAKLEY D, 1983, MINUTE EYE MOVEMENT; EIZENMAN M, 1985, VISION RES, V25, P1635, DOI 10.1016/0042-6989(85)90134-8; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; FAHLE M, 1991, VISION RES, V31, P209, DOI 10.1016/0042-6989(91)90112-I; Fernandez E, 2000, BRAIN RES, V887, P222, DOI 10.1016/S0006-8993(00)03072-9; Ferrandez JM, 1999, LECT NOTES COMPUT SC, V1607, P289; GRANDA AM, 1989, J NEUROPHYSIOL, V62, P723, DOI 10.1152/jn.1989.62.3.723; Gur M, 1997, J NEUROSCI, V17, P2914; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; JONES KE, 1992, ANN BIOMED ENG, V20, P423, DOI 10.1007/BF02368134; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; KOLB H, 1987, VISION RES, V27, P1445, DOI 10.1016/0042-6989(87)90154-4; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Normann RA, 2001, VISION RES, V41, P1261, DOI 10.1016/S0042-6989(00)00273-X; NOTHMORE DPM, 1991, VISUAL NEUROSCI, V7, P627; RIGGS LA, 1952, J OPT SOC AM, V42, P872; ROSENBERG AF, 1991, J NEUROPHYSIOL, V65, P1022, DOI 10.1152/jn.1991.65.5.1022; RUJAN P, 1993, J PHYS I, V3, P277, DOI 10.1051/jp1:1993129; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SHAPLEY R, 1986, SCIENCE, V231, P999, DOI 10.1126/science.3945816; Shoham S, 1997, LECT NOTES COMPUT SC, V1240, P44, DOI 10.1007/BFb0032462; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Steinman R M, 1990, Rev Oculomot Res, V4, P115; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	35	93	96	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					341	347		10.1038/nn821	http://dx.doi.org/10.1038/nn821			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914721				2022-12-28	WOS:000174606900014
J	Nunn, JA; Gregory, LJ; Brammer, M; Williams, SCR; Parslow, DM; Morgan, MJ; Morris, RG; Bullmore, ET; Baron-Cohen, S; Gray, JA				Nunn, JA; Gregory, LJ; Brammer, M; Williams, SCR; Parslow, DM; Morgan, MJ; Morris, RG; Bullmore, ET; Baron-Cohen, S; Gray, JA			Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words	NATURE NEUROSCIENCE			English	Article							GENERIC BRAIN ACTIVATION; VERBAL MEMORY; VISUAL-MOTION; COLOR-CENTER; SYNAESTHESIA; CORTEX; FMRI; INFORMATION; PERCEPTION; ANATOMY	In 'colored-hearing' synesthesia, individuals report color experiences when they hear spoken words. If the synesthetic color experience resembles that of normal color perception, one would predict activation of parts of the visual system specialized for such perception, namely the human 'color center', referred to as either V4 or V8. Using functional magnetic resonance imaging (fMRI), we here locate the region activated by speech in synesthetes to area V4/V8 in the left hemisphere, and demonstrate overlap with V4/V8 activation in normal controls in response to color. No activity was detected in areas V1 or V2, suggesting that activity in primary visual cortex is not necessary for such experience. Control subjects showed no activity in V4/V8 when imagining colors in response to spoken words, despite over-training on word-color associations similar to those spontaneously reported by synesthetes.	Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England; Inst Psychiat, Brain Image Anal Unit, London SE5 8AF, England; Inst Psychiat, Dept Psychol, London SE5 8AF, England; City Univ London, Appl Vis Res Ctr, London EC1V 0HB, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Manchester, Manchester M13 9PL, Lancs, England	University of London; Goldsmiths University London; University of London; King's College London; University of London; King's College London; City University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Manchester	Nunn, JA (corresponding author), Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England.		Bullmore, Ed/C-1706-2012; Brammer, Michael J/B-7128-2012; Williams, Steve C/D-6979-2011	Bullmore, Ed/0000-0002-8955-8283; Brammer, Michael J/0000-0001-9800-2052; Williams, Steve C/0000-0003-4299-1941; opoku, anita/0000-0001-7243-8157	Medical Research Council [G0600977] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Bailey M. E. S., 1997, SYNAESTHESIA CLASSIC, P182; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; Barnes J, 1999, NEUROREPORT, V10, P195, DOI 10.1097/00001756-199901180-00037; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Cytowic Richard, 1997, SYNAESTHESIA CLASSIC, P17; DEHAY C, 1984, EXP BRAIN RES, V57, P208; Ffytche DH, 1998, NAT NEUROSCI, V1, P738, DOI 10.1038/3738; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Gray J. A., 1997, SYNAESTHESIA CLASSIC, P173; GRAY JA, 1999, NEURONAL BASES PSYCH, V8, P450; Grossenbacher P. G., 1997, SYNAESTHESIA CLASSIC, P148; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; JOHANSSON S, 1982, FREQUENCY ANAL ENGLI; Kiehl KA, 1999, HUM BRAIN MAPP, V7, P225, DOI 10.1002/(SICI)1097-0193(1999)7:4<225::AID-HBM1>3.0.CO;2-P; Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8; Milner A. D., 1995, VISUAL BRAIN ACTION; Nelson H., 1991, NATL ADULT READING T; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Talairach I., 1988, COPLANAR STEREOTACTI; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; [No title captured]	41	257	260	0	131	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					371	375		10.1038/nn818	http://dx.doi.org/10.1038/nn818			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914723				2022-12-28	WOS:000174606900018
J	Dalton, P; Doolittle, N; Breslin, PAS				Dalton, P; Doolittle, N; Breslin, PAS			Gender-specific induction of enhanced sensitivity to odors	NATURE NEUROSCIENCE			English	Article							OLFACTORY SENSITIVITY; CYCLE		Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Dalton, P (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pdalton@pobox.upenn.edu		Breslin, Paul/0000-0001-5988-8401				CAIN WS, 1982, CHEM SENSES, V7, P129, DOI 10.1093/chemse/7.2.129; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; Dhong HJ, 1999, BRAIN RES, V824, P312, DOI 10.1016/S0006-8993(99)01241-X; Dorries K. M., 1992, SCI OLFACTION, P245; DOTY RL, 1981, J COMP PHYSIOL PSYCH, V95, P45, DOI 10.1037/h0077755; Fiedler Nancy, 1997, Environmental Health Perspectives, V105, P409, DOI 10.2307/3433347; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; PIETRAS RJ, 1974, PHYSIOL BEHAV, V12, P475, DOI 10.1016/0031-9384(74)90125-5; PORTER RH, 1983, PHYSIOL BEHAV, V30, P151, DOI 10.1016/0031-9384(83)90051-3; STEVENS JC, 1988, CHEM SENSES, V13, P643, DOI 10.1093/chemse/13.4.643; Voznessenskaya VV, 1995, ADV BIOSCI, V93, P399; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976	13	152	157	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					199	200		10.1038/nn803	http://dx.doi.org/10.1038/nn803			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865309				2022-12-28	WOS:000174146000008
J	Critchley, HD; Wiens, S; Rotshtein, P; Ohman, A; Dolan, RJ				Critchley, HD; Wiens, S; Rotshtein, P; Ohman, A; Dolan, RJ			Neural systems supporting interoceptive awareness	NATURE NEUROSCIENCE			English	Article							VOXEL-BASED MORPHOMETRY; VISCERAL PERCEPTION; BRAIN ACTIVATION; HEARTBEAT; FEAR; EMOTION; AROUSAL	Influential theories of human emotion argue that subjective feeling states involve representation of bodily responses elicited by emotional events. Within this framework, individual differences in intensity of emotional experience reflect variation in sensitivity to internal bodily responses. We measured regional brain activity by functional magnetic resonance imaging (fMRI) during an interoceptive task wherein subjects judged the timing of their own heartbeats. We observed enhanced activity in insula, somatomotor and cingulate cortices. In right anterior insular/opercular cortex, neural activity predicted subjects' accuracy in the heartbeat detection task. Furthermore, local gray matter volume in the same region correlated with both interoceptive accuracy and subjective ratings of visceral awareness. Indices of negative emotional experience correlated with interoceptive accuracy across subjects. These findings indicate that right anterior insula supports a representation of visceral responses accessible to awareness, providing a substrate for subjective feeling states.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL Hosp, Natl Hosp Neurol & Neurosurg, Auton Unit, London WC1N 3BG, England; Karolinska Hosp, Dept Clin Neurosci, Psychol Sect, SE-17176 Stockholm, Sweden	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Karolinska Institutet; Karolinska University Hospital	Critchley, HD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	h.critchley@fil.ion.ucl.ac.uk	critchley, hugo d/G-9267-2011; Wiens, Stefan/D-1268-2017	critchley, hugo d/0000-0002-2445-9284; Wiens, Stefan/0000-0003-4531-4313; Dolan, Ray/0000-0001-9356-761X; Rotshtein, Pia/0000-0002-0301-9511				Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Barsky AJ, 2001, ANN INTERN MED, V134, P832, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00006; Beck A, 1993, MANUAL BECK DEPRESSI; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; DAMASIO AR, 1994, DESCARTES ERROR; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Ehlers A, 1996, BIOL PSYCHOL, V42, P165, DOI 10.1016/0301-0511(95)05153-8; Ferguson ML, 1996, BIOL PSYCHOL, V42, P131, DOI 10.1016/0301-0511(95)05151-1; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hamilton M. C., 1995, SOURCEBOOK ADULT ASS, P154; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; James W., 1922, EMOTIONS; JENNINGS JR, 1992, PSYCHOPHYSIOLOGY, V29, P369, DOI 10.1111/j.1469-8986.1992.tb01710.x; Jennings JR, 2002, PSYCHOL RES-PSYCH FO, V66, P337, DOI 10.1007/s00426-002-0106-5; Jones G. E., 1994, ADV PSYCHOP, V5, P55; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; LUDWICKROSENTHAL R, 1985, INT J PSYCHOPHYSIOL, V3, P57, DOI 10.1016/0167-8760(85)90020-0; MELMED RN, 2002, MIND BODY MED; MUMFORD DB, 1991, BRIT J PSYCHIAT, V158, P379, DOI 10.1192/bjp.158.3.379; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Porges, 1993, BODY PERCEPTION QUES; Stewart SH, 2001, J ANXIETY DISORD, V15, P535, DOI 10.1016/S0887-6185(01)00080-9; Van TK, 2000, J AQUAT PLANT MANAGE, V38, P62; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1020, DOI 10.1037/0022-3514.54.6.1020; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Wiens S, 2001, BIOL PSYCHOL, V58, P159, DOI 10.1016/S0301-0511(01)00110-7; YATES AJ, 1985, PSYCHOPHYSIOLOGY, V22, P561, DOI 10.1111/j.1469-8986.1985.tb01651.x; Zoellner LA, 1999, BEHAV RES THER, V37, P1141, DOI 10.1016/S0005-7967(98)00202-2	47	2219	2246	2	204	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					189	195		10.1038/nn1176	http://dx.doi.org/10.1038/nn1176			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	767TJ	14730305	Green Submitted			2022-12-28	WOS:000188468500018
J	Yu, X; Malenka, RC				Yu, X; Malenka, RC			beta-catenin is critical for dendritic morphogenesis	NATURE NEUROSCIENCE			English	Article							NMDA RECEPTOR; CELL-ADHESION; IN-VIVO; HIPPOCAMPAL-NEURONS; RHO GTPASES; N-CADHERIN; WNT; GROWTH; GENE; TRANSCRIPTION	Regulated growth and arborization of dendritic processes are critical to the formation of functional neuronal networks. Here we identify beta-catenin as a critical mediator of dendritic morphogenesis. We found that increasing the intracellular levels of beta-catenin and other members of the cadherin/catenin complex, namely N-cadherin and N-catenin, enhances dendritic arborization in rat hippocampal neurons, an effect that does not require Wnt/beta-catenin-dependent transcription. Conversely, proteins that sequester beta-catenin decreased dendritic branch tip number and total dendritic branch length. Enhancement of dendritic growth elicited by depolarization requires beta-catenin and increased Wnt release. These results identify Wnt/beta-catenin signaling as an important mediator of dendritic development and suggest that the intracellular level of the cadherin/catenin complex is a limiting factor during critical stages of dendritic morphogenesis.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Yu, X (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA.							BANKER G, 1998, CULTURING NERVE CELL; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Benson DL, 1998, J NEUROSCI, V18, P6892; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brault V, 2001, DEVELOPMENT, V128, P1253; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Galceran J, 2000, DEVELOPMENT, V127, P469; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MANSOUR SL, 1990, P NATL ACAD SCI USA, V87, P7688, DOI 10.1073/pnas.87.19.7688; MARETTO S, 1993, P NATL ACAD SCI USA, V100, P3299; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Montross WT, 2000, J CELL SCI, V113, P1759; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Polakis P, 2000, GENE DEV, V14, P1837; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2000, J NEUROSCI, V20, P5024; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	49	378	389	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1169	1177		10.1038/nn1132	http://dx.doi.org/10.1038/nn1132			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14528308				2022-12-28	WOS:000186229200016
J	Wiest, MC; Nicolelis, MAL				Wiest, MC; Nicolelis, MAL			Behavioral detection of tactile stimuli during 7-12 Hz cortical oscillations in awake rats	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY SYSTEM; ABSENCE EPILEPSY; BURSTS	Prominent 7-12 Hz oscillations in the primary somatosensory cortex (S1) of awake but immobile rats might represent a seizure-like state(1) in which neuronal burst firing renders animals unresponsive to incoming tactile stimuli; others have proposed(2-4) that these oscillations are analogous to human mu rhythm(5-7). To test whether rats can respond to tactile stimuli during(7-12) Hz oscillatory activity, we trained head-immobilized awake animals to indicate whether they could detect the occurrence of transient whisker deflections while we recorded local field potentials (LFPs) from microelectrode arrays implanted bilaterally in the S1 whisker representation area. They responded rapidly and reliably, suggesting that this brain rhythm represents normal physiological activity that does not preclude perception.	Duke Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Ctr Neuroengn, Duke Med Ctr, Durham, NC 27710 USA; Dept Psychol & Brain Sci, Durham, NC 27708 USA; Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Nicolelis, MAL (corresponding author), Duke Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	nicoleli@neuro.duke.edu	Wiest, Michael/ABC-8101-2020		NIDCR NIH HHS [DE11451, DE13810] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013810, R01DE011451] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; GASTAUT MH, 1952, REV NEUROL, V87, P176; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054	13	100	102	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					913	914		10.1038/nn1107	http://dx.doi.org/10.1038/nn1107			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897789				2022-12-28	WOS:000184970400007
J	Paz, R; Boraud, T; Natan, C; Bergman, H; Vaadia, E				Paz, R; Boraud, T; Natan, C; Bergman, H; Vaadia, E			Preparatory activity in motor cortex reflects learning of local visuomotor skills	NATURE NEUROSCIENCE			English	Article							ADULT SQUIRREL-MONKEYS; REACHING MOVEMENTS; PREMOTOR CORTEX; INTERNAL-MODELS; NEURONAL-ACTIVITY; REPRESENTATIONS; DYNAMICS; ADAPTATION; DIRECTION; CONSOLIDATION	In humans, learning to produce correct visually guided movements to adapt to new sensorimotor conditions requires the formation of an internal model that represents the new transformation between visual input and the required motor command. When the new environment requires adaptation to directional errors, learning generalizes poorly to untrained locations and directions, indicating that such learning is local. Here we replicated these behavioral findings in rhesus monkeys using a visuomotor rotation task and simultaneously recorded neuronal activity. Specific changes in activity were observed only in a subpopulation of cells in the motor cortex with directional properties corresponding to the locally learned rotation. These changes adhered to the dynamics of behavior during learning and persisted between learning and relearning of the same rotation. These findings suggest a neural mechanism for the locality of newly acquired sensorimotor tasks and provide electrophysiological evidence for their retention in working memory.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Univ Victor Segalen, Neurophysiol Lab, CNRS, UMR 5543, Bordeaux, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Paz, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, Box 12272, IL-91120 Jerusalem, Israel.		Boraud, Thomas/A-6260-2008; Vaadia, Eilon/E-9347-2011					ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Baraduc P, 2002, J NEUROPHYSIOL, V88, P973, DOI 10.1152/jn.2002.88.2.973; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KARNI A, 1995, NATURE, V377, P155; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; MITZ AR, 1991, J NEUROSCI, V11, P1855; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Nezafat R, 2001, EXP BRAIN RES, V140, P66, DOI 10.1007/s002210100787; Nudo RJ, 1996, J NEUROSCI, V16, P785; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schaal S, 1998, NEURAL COMPUT, V10, P2047, DOI 10.1162/089976698300016963; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Yin PB, 2001, EXP BRAIN RES, V141, P250, DOI 10.1007/s002210100892	46	148	148	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					882	890		10.1038/nn1097	http://dx.doi.org/10.1038/nn1097			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872127				2022-12-28	WOS:000184413700019
J	Hauser, MD; McDermott, J				Hauser, MD; McDermott, J			The evolution of the music faculty: a comparative perspective	NATURE NEUROSCIENCE			English	Review							PERCEPTION; LANGUAGE; INFANTS; PREFER; RECOGNITION; CONSONANCE; NEWBORNS; STRENGTH; RHYTHM	We propose a theoretical framework for exploring the evolution of the music faculty from a comparative perspective. This framework addresses questions of phylogeny, adaptive function, innate biases and perceptual mechanisms. We argue that comparative studies can make two unique contributions to investigations of the origins of music. First, musical exposure can be controlled and manipulated to an extent not possible in humans. Second, any features of music perception found in nonhuman animals must not be part of an adaptation for music, and must rather be side effects of more general features of perception or cognition. We review studies that use animal research to target specific aspects of music perception (such as octave generalization), as well as studies that investigate more general and shared systems of the mind/brain that may be relevant to music (such as rhythm perception and emotional encoding). Finally, we suggest several directions for future work, following the lead of comparative studies on the language faculty.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Program Neurosci, Cambridge, MA 02138 USA; Harvard Univ, Primate Cognit Neurosci Lab, Cambridge, MA 02138 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT)	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdhauser@wjh.harvard.edu; jhm@mit.edu						Abercrombie D., 1967, ELEMENTS GEN PHONETI; ATTNEAVE F, 1971, AM J PSYCHOL, V84, P147, DOI 10.2307/1421351; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; BARTLETT JC, 1980, J EXP PSYCHOL HUMAN, V6, P501, DOI 10.1037/0096-1523.6.3.501; Brown S, 2000, ORIGINS OF MUSIC, P3; CARTERETTE EC, 1999, PSYCHOL MUSIC; Catchpole CK, 1995, BIRD SONG BIOL THEME; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; CUTLER A, 1994, COGNITION, V50, P79, DOI 10.1016/0010-0277(94)90021-3; Darwin C., 1871, P475; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Dehaene S., 1997, NUMBER SENSE; Dowling W. J., 1981, PSYCHOMUSICOLOGY, V1, P30, DOI [10.1037/h0094275, DOI 10.1037/H0094275]; DOWLING WJ, 1991, PERCEPT PSYCHOPHYS, V50, P305, DOI 10.3758/BF03212222; FERNALD A, 1993, CHILD DEV, V64, P657, DOI 10.2307/1131209; Fernald A, 1992, NONVERBAL VOCAL COMM, P262; Fernald A., 1992, ADAPTED MIND EVOLUTI, P391, DOI DOI 10.1007/BF00852474; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; HAGEN EH, IN PRESS HUM NAT; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HULSE SH, 1988, MUSIC PERCEPT, V5, P427; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Lerdahl Fred, 1983, GENERATIVE THEORY TO; Marler P, 2000, ORIGINS OF MUSIC, P31; MCCONNELL PB, 1985, Z TIERPSYCHOL, V67, P302; MCCONNELL PB, 1990, ANIM BEHAV, V39, P897, DOI 10.1016/S0003-3472(05)80954-6; MCGONIGLE B, IN PRESS ANIM COGN; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; MIKHAIL JM, 2000, THESIS CORNELL U; Miller G., 2000, MATING MIND; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Patel AD, 1998, MUSIC PERCEPT, V16, P27; Payne K, 2000, ORIGINS OF MUSIC, P135; Pinker S., 1997, MIND WORKS; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Schellenberg EG, 1996, PSYCHOL SCI, V7, P272, DOI 10.1111/j.1467-9280.1996.tb00373.x; Shofner WP, 2002, HEARING RES, V173, P69, DOI 10.1016/S0378-5955(02)00612-3; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; TREHUB SE, 1990, PSYCHOMUSICOLOGY, V0009, P00005; TREHUB SE, 1999, BIOL FDN MUSIC; Wright AA, 2000, J EXP PSYCHOL GEN, V129, P291, DOI 10.1037/0096-3445.129.3.291; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	48	118	122	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					663	668		10.1038/nn1080	http://dx.doi.org/10.1038/nn1080			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830156				2022-12-28	WOS:000183780400009
J	Frye, MA; Dickinson, MH				Frye, MA; Dickinson, MH			A signature of salience in the Drosophila brain	NATURE NEUROSCIENCE			English	Editorial Material							LOCALIZATION; EXPRESSION; VISION; FLIGHT	Electrophysiological recordings coupled with genetic manipulations in fruit flies reveal activity patterns in the brain associated with the conspicuousness of visual objects, providing an elusive physiological link between gene products and behavior.	CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology	Frye, MA (corresponding author), CALTECH, Dept Bioengn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	markfrye@socrates.berkeley.edu		Frye, Mark/0000-0003-3277-3094				BRAND AH, 1993, DEVELOPMENT, V118, P401; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Egelhaaf M, 2002, CURR OPIN NEUROBIOL, V12, P699, DOI 10.1016/S0959-4388(02)00390-2; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Frye MA, 2003, J EXP BIOL, V206, P843, DOI 10.1242/jeb.00175; Gotz K G, 1980, Basic Life Sci, V16, P391; Ito K, 1998, LEARN MEMORY, V5, P52; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Trimarchi JR, 1999, INT REV NEUROBIOL, V43, P241, DOI 10.1016/S0074-7742(08)60548-6; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054	15	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					544	546		10.1038/nn0603-544	http://dx.doi.org/10.1038/nn0603-544			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12771957				2022-12-28	WOS:000183140400005
J	Williams, ZM; Elfar, JC; Eskandar, EN; Toth, LJ; Assad, JA				Williams, ZM; Elfar, JC; Eskandar, EN; Toth, LJ; Assad, JA			Parietal activity and the perceived direction of ambiguous apparent motion	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL DECISION; VISUAL GUIDANCE; MACAQUE MONKEY; CORTICAL AREAS; MT; CORTEX; ATTENTION; SIGNALS; PERFORMANCE; MODULATION	We recorded from parietal neurons in monkeys (Macacca mulatta) trained to report the direction of an apparent motion stimulus consisting of regularly spaced columns of dots surrounded by an aperture. Displacing the dots by half their inter-column spacing produced vivid apparent motion that could be perceived in either the preferred or anti-preferred direction for each neuron. Many neurons in the lateral intraparietal area (LIP) responded more strongly on trials in which the animals reported perceiving the neurons' preferred direction, independent of the hand movement used to report their percept. This selectivity was less common in the medial superior temporal area (MST) and virtually absent in the middle temporal area (MT). Variations in activity of LIP and MST neurons just before motion onset were also predictive of the animals' subsequent perceived direction. These data suggest a hierarchy of representation in parietal cortex, whereby neuronal responses become more aligned with subjective perception in higher parietal areas.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jassad@hms.harvard.edu	Elfar, J./Q-7371-2017	Elfar, J./0000-0002-4438-7118; Toth, Louis/0000-0003-4986-7046	NATIONAL EYE INSTITUTE [R01EY012106] Funding Source: NIH RePORTER; NEI NIH HHS [EY12106] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1993, REV OCULOMOT RES, V51, P77; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; Basso MA, 1998, J NEUROSCI, V18, P7519; Battelli L, 2001, NEURON, V32, P985, DOI 10.1016/S0896-6273(01)00536-0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Dorris MC, 2000, J NEUROSCI, V20; Eskandar EN, 2002, J NEUROPHYSIOL, V88, P1777, DOI 10.1152/jn.2002.88.4.1777; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7	30	128	128	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					616	623		10.1038/nn1055	http://dx.doi.org/10.1038/nn1055			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730699				2022-12-28	WOS:000183140400019
J	Ehlers, MD				Ehlers, MD			Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system	NATURE NEUROSCIENCE			English	Article							LONG-TERM FACILITATION; NMDA RECEPTORS; GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; AMPA RECEPTORS; DENSITY; SYNAPSES; CREB; MODULATION; ACTIVATION	Experience-dependent remodeling of the postsynaptic density (PSD) is critical for synapse formation and plasticity in the mammalian brain. Here, in cultured rat hippocampal neurons, I found long-lasting, global changes in the molecular composition of the PSD dictated by synaptic activity. These changes were bidirectional, reversible, modular, and involved multiple classes of PSD proteins. Moreover, activity-dependent remodeling was accompanied by altered protein turnover, occurred with corresponding increases or decreases in ubiquitin conjugation of synaptic proteins and required proteasome-mediated degradation. These modifications, in turn, reciprocally altered synaptic signaling to the downstream effectors CREB (cyclic AMP response element binding protein) and ERK-MAPK (extracellular signal regulated kinase-MAP kinase). These results indicate that activity regulates postsynaptic composition and signaling through the ubiquitin-proteasome system, providing a mechanistic link between synaptic activity, protein turnover and the functional reorganization of synapses.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu			NIMH NIH HHS [MH64748] Funding Source: Medline; NINDS NIH HHS [NS39402] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Meyer T, 2000, TRENDS CELL BIOL, V10, P238, DOI 10.1016/S0962-8924(00)01764-5; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tovar KR, 2002, NEURON, V34, P253; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WILSON SM, 2002, NAT GENET, V7, P7; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	50	777	802	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					231	242		10.1038/nn1013	http://dx.doi.org/10.1038/nn1013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577062				2022-12-28	WOS:000181178300011
J	Kim, G; Kandler, K				Kim, G; Kandler, K			Elimination and strengthening of glycinergic/GABAergic connections during tonotopic map formation	NATURE NEUROSCIENCE			English	Article							SUPERIOR OLIVARY NUCLEUS; CENTRAL AUDITORY-SYSTEM; VISUAL-CORTEX; DEVELOPMENTAL-CHANGES; DEPENDENT REFINEMENT; SYNAPSE ELIMINATION; DOMINANCE COLUMNS; SPINAL NEURONS; PLASTICITY; GLYCINE	Synapse elimination and strengthening are central mechanisms for the developmental organization of excitatory neuronal networks. Little is known, however, about whether these processes are also involved in establishing precise inhibitory circuits. We examined the development of functional connectivity before hearing onset in rats in the tonotopically organized, glycinergic pathway from the medial nucleus of the trapezoid body (MNTB) to the lateral superior olive (LSO), which is part of the mammalian sound localization system. We found that LSO neurons became functionally disconnected from similar to75% of their initial inputs, resulting in a two-fold sharpening of functional topography. This was accompanied by a 12-fold increase in the synaptic conductance generated by maintained individual inputs. Functional elimination of MNTB-LSO synapses was restricted to the period when these glycinergic/GABAergic synapses are excitatory. These results provide new insights into the mechanisms by which precisely organized inhibitory circuits are established during development.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3500 Terrace St, Pittsburgh, PA 15261 USA.	kkarl@pitt.edu		Kandler, Karl/0000-0002-6053-6400; Kim, Gunsoo/0000-0001-9318-8329	NIDCD NIH HHS [DC04199, R01 DC004199] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRANTYN R, 1995, PERSPECT DEV NEUROBI, V2, P387; Gubellini P, 2001, EUR J NEUROSCI, V14, P1937, DOI 10.1046/j.0953-816x.2001.01823.x; HELFERT RH, 1986, J COMP NEUROL, V244, P533, DOI 10.1002/cne.902440409; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; IRVINE DRF, 1992, SPRINGER HDB AUDITOR, V2, P153; JACKSON H, 1982, J NEUROSCI, V2, P1736; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KANDLER K, 1995, EUR J NEUROSCI, V7, P1773, DOI 10.1111/j.1460-9568.1995.tb00697.x; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1998, IMAGING NEURONS, P271; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kotak VC, 1996, J NEUROSCI, V16, P1836; Kotak VC, 2000, J NEUROSCI, V20, P5820, DOI 10.1523/JNEUROSCI.20-15-05820.2000; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohmann C, 1998, J NEUROBIOL, V34, P97, DOI 10.1002/(SICI)1097-4695(19980205)34:2<97::AID-NEU1>3.0.CO;2-6; Purves, 1985, PRINCIPLES NEURAL DE; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705	50	172	179	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					282	290		10.1038/nn1015	http://dx.doi.org/10.1038/nn1015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577063				2022-12-28	WOS:000181178300017
J	Bushara, KO; Hanakawa, T; Immisch, I; Toma, K; Kansaku, K; Hallett, M				Bushara, KO; Hanakawa, T; Immisch, I; Toma, K; Kansaku, K; Hallett, M			Neural correlates of cross-modal binding	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; ATTENTION; CORTEX	Little is known about how the brain binds together signals from multiple sensory modalities to produce unified percepts of objects and events in the external world. Using event-related functional magnetic resonance imaging (fMRI) in humans, we measured transient brain responses to auditory/visual binding, as evidenced by a sound-induced change in visual motion perception. Identical auditory and visual stimuli were presented in all trials, but in some trials they were perceived to be bound together and in others they were perceived as unbound unimodal events. Cross-modal binding was associated with higher activity in multimodal areas, but lower activity in predominantly unimodal areas. This activation pattern suggests that a reciprocal and 'competitive' interaction between multimodal and unimodal areas underlies the perceptual interpretation of simultaneous signals from multiple sensory modalities.	Minneapolis Vet Affairs Med Ctr, Serv Neurol, Minneapolis, MN 55417 USA; NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bushara, KO (corresponding author), Minneapolis Vet Affairs Med Ctr, Serv Neurol, Room 4B135,1 Vet Dr, Minneapolis, MN 55417 USA.	busha001@umn.edu	Hanakawa, Takashi/A-6536-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002669, ZIANS002669] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MORRELL LK, 1968, J EXP PSYCHOL, V77, P14, DOI 10.1037/h0021289; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; VANGELDEREN P, 1995, P NATL ACAD SCI USA, V92, P6906, DOI 10.1073/pnas.92.15.6906; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	16	171	173	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					190	195		10.1038/nn993	http://dx.doi.org/10.1038/nn993			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12496761				2022-12-28	WOS:000180669100020
J	Yasuda, H; Barth, AL; Stellwagen, D; Malenka, RC				Yasuda, H; Barth, AL; Stellwagen, D; Malenka, RC			A developmental switch in the signaling cascades for LTP induction	NATURE NEUROSCIENCE			English	Article							CALMODULIN-KINASE-II; ADENYLATE-CYCLASE; AREA CA1; BRAIN; ACTIVATION		Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94304 USA.			Yasuda, Hiroki/0000-0001-5911-609X				Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KELLY PT, 1985, DEV BRAIN RES, V18, P211, DOI 10.1016/0165-3806(85)90265-2; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; ROSENBERG GB, 1987, METHOD ENZYMOL, V139, P776; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2	15	235	249	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					15	16		10.1038/nn985	http://dx.doi.org/10.1038/nn985			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469130				2022-12-28	WOS:000180089300008
J	Connolly, JD; Goodale, MA; Menon, RS; Munoz, DP				Connolly, JD; Goodale, MA; Menon, RS; Munoz, DP			Human fMRI evidence for the neural correlates of preparatory set	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE-FIELD; POSITRON EMISSION TOMOGRAPHY; MOVEMENT-RELATED ACTIVITY; LATERAL INTRAPARIETAL AREA; SUPPLEMENTARY MOTOR AREA; EVENT-RELATED FMRI; ANTI-SACCADE TASK; PREMOTOR CORTEX; NEURONAL-ACTIVITY; SUPERIOR COLLICULUS	We used functional magnetic resonance imaging (fMRI) to study readiness and intention signals in frontal and parietal areas that have been implicated in planning saccadic eye movements-the frontal eye fields (FEF) and intraparietal sulcus (IPS). To track fMRI signal changes correlated with readiness to act, we used an event-related design with variable gap periods between disappearance of the fixation point and appearance of the target. To track changes associated with intention, subjects were instructed before the gap period to make either a pro-saccade (look at target) or an anti-saccade (look away from target). FEF activation increased during the gap period and was higher for anti- than for pro-saccade trials. No signal increases were observed during the gap period in the IPS. Our findings suggest that within the frontoparietal networks that control saccade generation, the human FEF, but not the IPS, is critically involved in preparatory set, coding both the readiness and intention to perform a particular movement.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6C 5C2, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada; Queens Univ, Dept Physiol, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Queens University - Canada	Goodale, MA (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6C 5C2, Canada.		Menon, Ravi S/K-5500-2013; Menon, Ravi/ABA-8654-2020; Goodale, Melvyn A/M-5907-2013	Menon, Ravi S/0000-0002-7916-0263; Menon, Ravi/0000-0002-7916-0263; Goodale, Melvyn A/0000-0001-6748-0561				Ben Hamed S, 2002, EXP BRAIN RES, V142, P512, DOI 10.1007/s00221-001-0954-z; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; DIAS EC, 1994, J NEUROPHYSIOL, V72, P2532, DOI 10.1152/jn.1994.72.5.2532; Doricchi F, 1997, EXP BRAIN RES, V116, P50, DOI 10.1007/PL00005744; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; Dorris MC, 1997, J NEUROSCI, V17, P8566; EVARTS EV, 1984, NEUROPHYSIOLOGICAL A; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V80, P1584, DOI 10.1152/jn.1998.80.3.1584; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; FISCHER B, 1992, EXP BRAIN RES, V89, P415; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hebb D. O., 1972, TXB PHYSL, P77; Kollias SS, 2000, NEURORADIOLOGY, V42, P591, DOI 10.1007/s002340000355; Kurata K, 2000, J NEUROPHYSIOL, V84, P1667, DOI 10.1152/jn.2000.84.3.1667; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; KURATA K, 1994, J NEUROPHYSIOL, V71, P1151, DOI 10.1152/jn.1994.71.3.1151; Lee KM, 1999, NEUROIMAGE, V9, P117, DOI 10.1006/nimg.1998.0393; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pierrot-Deseilligny C., 1991, BRAIN, V114, P1472, DOI 10.1093/brain/114.3.1473; Pollmann S, 2000, HUM BRAIN MAPP, V9, P26, DOI 10.1002/(SICI)1097-0193(2000)9:1<26::AID-HBM3>3.3.CO;2-U; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Schluter ND, 1999, NEUROPSYCHOLOGIA, V37, P233; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Toni I, 1999, CEREB CORTEX, V9, P35, DOI 10.1093/cercor/9.1.35; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; WISE SP, 1989, SOMATOSENS MOT RES, V6, P455, DOI 10.3109/08990228909144687	50	260	263	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1345	1352		10.1038/nn969	http://dx.doi.org/10.1038/nn969			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411958				2022-12-28	WOS:000179447500019
J	Bruer, JT				Bruer, JT			Avoiding the pediatrician's error: how neuroscientists can help educators (and themselves)	NATURE NEUROSCIENCE			English	Article							BRAIN-DEVELOPMENT		James S McDonnell Fdn, St Louis, MO 63117 USA		Bruer, JT (corresponding author), James S McDonnell Fdn, 1034 Brentwood Blvd,Suite 1850, St Louis, MO 63117 USA.	bruer@jsmf.org						Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Bruer J., 1999, MYTH 1 3 YEARS NEW U; Bruer J. T., 1997, ED RES, V26, P4, DOI DOI 10.3102/0013189X026008004; Bruer JT, 1999, PHI DELTA KAPPAN, V80, P648; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GREENOUGH WT, 1987, CHILD DEV, V58, P539, DOI 10.2307/1130197; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; KANDEL ER, 1985, PRINCIPLES NEURAL SC, P769; *NAT PUBL RAD, 2000, MORNING EDITION 0502; National Reading Panel, 2000, TEACHING CHILDREN RE; *NIH, 014929 NIH PUBL; PELLIGRINO JW, 2001, KNOWING WHAT STUDENT, P109; SNOW CE, 1998, PREVENTING READING D, P24	14	23	26	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1031	1033		10.1038/nn934	http://dx.doi.org/10.1038/nn934			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	611WT	12403979				2022-12-28	WOS:000179041300007
J	Romo, R; Hernandez, A; Zainos, A; Lemus, L; Brody, CD				Romo, R; Hernandez, A; Zainos, A; Lemus, L; Brody, CD			Neuronal correlates of decision-making in secondary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; PSYCHOPHYSICAL MEASUREMENTS; SENSORY DISCRIMINATION; VISUAL RESPONSES; MONKEY PRIMARY; CONNECTIONS; AREAS; PREMOTOR; CHOICE	The ability to discriminate between two sequential stimuli requires evaluation of current sensory information in reference to stored information. Where and how does this evaluation occur? We trained monkeys to compare two mechanical vibrations applied sequentially to the fingertips and to report which of the two had the higher frequency. We recorded single neurons in secondary somatosensory cortex (S2) while the monkeys performed the task. During the first stimulus period, the firing rate of S2 neurons encoded the stimulus frequency. During the second stimulus period, however, some S2 neurons did not merely encode the stimulus frequency. The responses of these neurons were a function of both the remembered (first) and current (second) stimulus. Moreover, a few hundred milliseconds after the presentation of the second stimulus, these responses were correlated with the monkey's decision. This suggests that some S2 neurons may combine past and present sensory information for decision-making.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Universidad Nacional Autonoma de Mexico; Cold Spring Harbor Laboratory	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Apartado Postal 70-253, Mexico City 04510, DF, Mexico.	rromo@ifisiol.unam.mx	Lemus, Luis/E-6760-2019	Lemus, Luis/0000-0002-6608-3684; romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794				Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Burton H., 1996, PAIN AND TOUCH, P105; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CHAPMAN CE, 1988, EXP BRAIN RES, V72, P316; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GODSCHALK M, 1984, EXP BRAIN RES, V56, P410; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Jiang W, 1997, J NEUROPHYSIOL, V77, P1656, DOI 10.1152/jn.1997.77.3.1656; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MILLER EK, 1993, J NEUROSCI, V13, P1460; MISHKIN M, 1979, NEUROPSYCHOLOGIA, V17, P139, DOI 10.1016/0028-3932(79)90005-8; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; MURRAY EA, 1984, BEHAV BRAIN RES, V11, P67, DOI 10.1016/0166-4328(84)90009-3; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; PREUSS TM, 1989, J COMP NEUROL, V282, P293, DOI 10.1002/cne.902820210; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Ro JY, 2000, EXP BRAIN RES, V135, P1, DOI 10.1007/s002210000496; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SINCLAIR RJ, 1993, J NEUROPHYSIOL, V70, P331, DOI 10.1152/jn.1993.70.1.331; TOKUNO H, 1993, J COMP NEUROL, V333, P199, DOI 10.1002/cne.903330206; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; [No title captured]	37	258	263	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1217	1225		10.1038/nn950	http://dx.doi.org/10.1038/nn950			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368806				2022-12-28	WOS:000178884600026
J	Scholz, J; Woolf, CJ				Scholz, J; Woolf, CJ			Can we conquer pain?	NATURE NEUROSCIENCE			English	Review							MOLECULAR MECHANISMS; NEUROPATHIC PAIN; ACTIVATION; MANAGEMENT; INHIBITION; ANALGESIA; THERAPY	Pain can be an adaptive sensation, an early warning to protect the body from tissue injury. By the introduction of hypersensitivity to normally innocuous stimuli, pain may also aid in repair after tissue damage. Pain can also be maladaptive, reflecting pathological function of the nervous system. Multiple molecular and cellular mechanisms operate alone and in combination within the peripheral and central nervous systems to produce the different forms of pain. Elucidation of these mechanisms is key to the development of treatments that specifically target underlying causes rather than just symptoms. This new approach promises to revolutionize pain diagnosis and management.	Massachusetts Gen Hosp, Dept Anesthesia, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia, Neural Plast Res Grp, Boston, MA 02129 USA.		Woolf, Clifford/A-9784-2010					Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Boddeke EWGM, 2001, EUR J PHARMACOL, V429, P115, DOI 10.1016/S0014-2999(01)01311-5; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Desmeules JA, 1999, J PHARMACOL EXP THER, V288, P607; Fields HL, 2000, PROG BRAIN RES, V122, P245; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Flores CM, 2001, PHARMACOGENOMICS, V2, P177, DOI 10.1517/14622416.2.3.177; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Lynch D, 2000, PRACTICAL MANAGEMENT, P270; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Rose MA, 2002, ANAESTHESIA, V57, P451, DOI 10.1046/j.0003-2409.2001.02399.x; Sarkar S, 2000, LANCET, V356, P1154, DOI 10.1016/S0140-6736(00)02758-6; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Svensson CI, 2002, ANNU REV PHARMACOL, V42, P553, DOI 10.1146/annurev.pharmtox.42.092401.143905; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wood JN, 2000, AM J PHYSIOL-GASTR L, V278, pG507, DOI 10.1152/ajpgi.2000.278.4.G507; Woolf CJ, 2001, ANESTHESIOLOGY, V95, P241, DOI 10.1097/00000542-200107000-00034; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	24	596	626	1	81	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1062	1067		10.1038/nn942	http://dx.doi.org/10.1038/nn942			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403987				2022-12-28	WOS:000179041300015
J	Wang, JM; Zhang, LL; Yao, Y; Viroonchatapan, N; Rothe, E; Wang, ZZ				Wang, JM; Zhang, LL; Yao, Y; Viroonchatapan, N; Rothe, E; Wang, ZZ			A transmembrane motif governs the surface trafficking of nicotinic acetylcholine receptors	NATURE NEUROSCIENCE			English	Article							TRANSFECTED COS CELLS; ENDOPLASMIC-RETICULUM; ALPHA-SUBUNIT; MONOCLONAL-ANTIBODY; GLYCINE RECEPTOR; BINDING-SITE; DETERMINANTS; RETENTION; DOMAINS; COMPLEX	Surface expression of the nicotinic acetylcholine receptor (AChR) requires the assembly of multiple subunits in the endoplasmic reticulum (ER). Little is known, however, about the mechanism by which assembled receptor pentamers are transported to the cell membrane while unassembled subunits are retained in the ER. Here we report that a motif conserved in the transmembrane domain of AChR subunits is critically involved in this process. In COS cells, mutation within this signal allowed surface expression of unassembled subunits. Conversely, insertion of the sequence to unrelated proteins that are normally transported to the surface resulted in ER retention. The signal is buried in AChR pentamers, but is exposed on unassembled subunits in the ER, where it promotes protein degradation. We therefore conclude that this signal ensures surface trafficking of only functional AChRs.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, ZZ (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3500 Terrace St, Pittsburgh, PA 15261 USA.	zzwang+@pitt.edu			NINDS NIH HHS [R01-NS38301] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038301] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnes EM, 2000, LIFE SCI, V66, P1063, DOI 10.1016/S0024-3205(99)00469-5; BLACK R, 1987, J CELL BIOL, V105, P1329, DOI 10.1083/jcb.105.3.1329; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BLOUNT P, 1991, J CELL BIOL, V113, P1125, DOI 10.1083/jcb.113.5.1125; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; CHANDLER LP, 1985, J BIOL CHEM, V260, P3360; Dineley KT, 2000, J BIOL CHEM, V275, P13974, DOI 10.1074/jbc.275.18.13974; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; Lindstrom J, 1996, Ion Channels, V4, P377; MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MURAKAMI K, 1994, J BIOCHEM, V116, P164, DOI 10.1093/oxfordjournals.jbchem.a124489; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2621, DOI 10.1021/bi00357a051; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SINE SM, 1991, J BIOL CHEM, V266, P13679; SMITH MM, 1987, J BIOL CHEM, V262, P4367; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Wang ZZ, 1996, J BIOL CHEM, V271, P27575, DOI 10.1074/jbc.271.44.27575; Wang ZZ, 1996, J CELL BIOL, V135, P809, DOI 10.1083/jcb.135.3.809; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729	39	83	83	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					963	970		10.1038/nn918	http://dx.doi.org/10.1038/nn918			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219096				2022-12-28	WOS:000178242200015
J	Liu, J; Harris, A; Kanwisher, N				Liu, J; Harris, A; Kanwisher, N			Stages of processing in face perception: an MEG study	NATURE NEUROSCIENCE			English	Article							OCCIPITOTEMPORAL CORTEX; VISUAL-CORTEX; TIME-COURSE; RESPONSES; HUMANS; RECOGNITION; CATEGORIES; EXPERTISE; STIMULI; OBJECTS	Here we used magnetoencephalography (MEG) to investigate stages of processing in face perception in humans. We found a face-selective MEG response occurring only 100 ms after stimulus onset (the 'M100'), 70 ms earlier than previously reported. Further, the amplitude of this M100 response was correlated with successful categorization of stimuli as faces, but not with successful recognition of individual faces, whereas the previously-described face-selective 'M170' response was correlated with both processes. These data suggest that face processing proceeds through two stages: an initial stage of face categorization, and a later stage at which the identity of the individual face is extracted.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, J (corresponding author), MIT, Dept Brain & Cognit Sci, NE20-443, Cambridge, MA 02139 USA.		Liu, Jia/C-5630-2011	Liu, Jia/0000-0003-0383-0934; Harris, Alison/0000-0002-0559-2821	NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BENTIN S, IN PRESS ENCY COGNIT; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Farah M.J., 1995, VISUAL COGNITION INV, P101; George N, 1997, NEUROREPORT, V8, P1417, DOI 10.1097/00001756-199704140-00019; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; GRILLSPECTOR K, 2001, J VISION, V1, pA474; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; ORAM MW, 1992, J NEUROPHYSIOL, V68, P70, DOI 10.1152/jn.1992.68.1.70; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; SADR J, IN PRESS COGNIT SCI; SADR J, 2001, 20016 MIT ART INT LA; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Streit M, 2000, NEUROSCI LETT, V278, P13, DOI 10.1016/S0304-3940(99)00884-8; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; THORPE SJ, 1989, CONNECTIONISM IN PERSPECTIVE, P63; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	37	493	499	2	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					910	916		10.1038/nn909	http://dx.doi.org/10.1038/nn909			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195430				2022-12-28	WOS:000177656300023
J	Poolos, NP; Migliore, M; Johnston, D				Poolos, NP; Migliore, M; Johnston, D			Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NA+ CHANNELS; LAMOTRIGINE INHIBITION; PACEMAKER; BACKPROPAGATION; ENHANCEMENT; ATTENUATION; MODULATION; CURRENTS	The dendrites of pyramidal neurons have markedly different electrical properties from those of the soma, owing to the non-uniform distribution of voltage-gated ion channels in dendrites. It is thus possible that drugs acting on ion channels might preferentially alter dendritic, but not somatic, excitability. Using dendritic and somatic whole-cell and cell-attached recordings in rat hippocampal slices, we found that the anticonvulsant lamotrigine selectively reduced action potential firing from dendritic depolarization, while minimally affecting firing at the soma. This regional and input-specific effect resulted from an increase in the hyperpolarization-activated cation current (I-h), a voltage-gated current present predominantly in dendrites. These results demonstrate that neuronal excitability can be altered by drugs acting selectively on dendrites, and suggest an important role for 1 h in controlling dendritic excitability and epileptogenesis.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA; CNR, Inst Adv Diagnost Methodol, I-90146 Palermo, Italy	Baylor College of Medicine; Baylor College of Medicine; Yale University; Consiglio Nazionale delle Ricerche (CNR)	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	dan@ltp.neusc.bcm.tmc.edu	Migliore, Michele/D-7448-2011	Migliore, Michele/0000-0002-7584-6292				[Anonymous], 1999, DENDRITES; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Calabrese JR, 1999, EUR NEUROPSYCHOPHARM, V9, pS107, DOI 10.1016/S0924-977X(99)00022-X; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Colbert CM, 1997, J NEUROSCI, V17, P6512; Coulter DA, 1997, J CHILD NEUROL, V12, pS2, DOI 10.1177/0883073897012001031; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kuo CC, 1997, BRIT J PHARMACOL, V121, P1231, DOI 10.1038/sj.bjp.0701221; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MESSENHEIMER J, 1996, TREATMENT EPILEPSY P, P899; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Poolos NP, 1999, J NEUROSCI, V19, P5205; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shorvon SD, 2000, HDB EPILEPSY TREATME; Stefani A, 1996, EUR J PHARMACOL, V307, P113, DOI 10.1016/0014-2999(96)00265-8; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Wang SJ, 2001, NEUROREPORT, V12, P2255, DOI 10.1097/00001756-200107200-00042; WHITE HS, 1997, EPILEPSIES, V2, P1; XIE XM, 1995, PFLUG ARCH EUR J PHY, V430, P437, DOI 10.1007/BF00373920	30	314	328	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					767	774		10.1038/nn891	http://dx.doi.org/10.1038/nn891			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118259				2022-12-28	WOS:000177088900020
J	Zhao, AZ; Huan, JN; Gupta, S; Pal, R; Sahu, A				Zhao, AZ; Huan, JN; Gupta, S; Pal, R; Sahu, A			A phosphatidylinositol 3kinase-phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding	NATURE NEUROSCIENCE			English	Article							CONCENTRATING HORMONE MCH; NEUROPEPTIDE-Y NPY; GALANIN GAL; FOOD-INTAKE; PHOSPHODIESTERASE; RAT		Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sahu, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, 3550 Terrace St, Pittsburgh, PA 15261 USA.				NIDDK NIH HHS [DK 52844] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052844] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Ahmad M, 2000, CELL SIGNAL, V12, P541, DOI 10.1016/S0898-6568(00)00093-0; AKABAYASHI A, 1994, BRAIN RES, V660, P323, DOI 10.1016/0006-8993(94)91306-4; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gillard ER, 1998, J NEUROSCI, V18, P2646; RAHN T, 1994, FEBS LETT, V350, P314, DOI 10.1016/0014-5793(94)00797-7; Sahu A, 1998, ENDOCRINOLOGY, V139, P4739, DOI 10.1210/en.139.11.4739; SAHU A, 1993, TRENDS ENDOCRIN MET, V4, P217, DOI 10.1016/1043-2760(93)90125-X; Sahu A, 1998, ENDOCRINOLOGY, V139, P795, DOI 10.1210/en.139.2.795; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sheriff S, 1997, MOL PHARMACOL, V51, P597, DOI 10.1124/mol.51.4.597; SHITNIZUALBERGI.M, 2001, J NEUROSCI, V21, P1238; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	14	182	193	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					727	728		10.1038/nn885	http://dx.doi.org/10.1038/nn885			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12101402				2022-12-28	WOS:000177088900013
J	Fortin, NJ; Agster, KL; Eichenbaum, HB				Fortin, NJ; Agster, KL; Eichenbaum, HB			Critical role of the hippocampus in memory for sequences of events	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; OBJECT-RECOGNITION; EPISODIC MEMORY; MONKEYS; DAMAGE; RATS; IMPAIRMENT; ASSOCIATOR; ABLATION; LOCATION	Recent models of hippocampal function emphasize the potential role of this brain structure in encoding and retrieving sequences of events that compose episodic memories. Here we show that hippocampal lesions produce a severe and selective impairment in the capacity of rats to remember the sequential ordering of a series of odors, despite an intact capacity to recognize odors that recently occurred. These findings support the hypothesis that hippocampal networks mediate associations between sequential events that constitute elements of an episodic memory.	Boston Univ, Dept Psychol, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Eichenbaum, HB (corresponding author), Boston Univ, Dept Psychol, Lab Cognit Neurobiol, 64 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Fortin, Norbert/0000-0002-6793-6984	NIA NIH HHS [P01 AG009973-070005, P01 AG009973, AG09973] Funding Source: Medline; NIMH NIH HHS [R01 MH052090, R01 MH052090-05, MH52090] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; GAFFAN D, 1994, EXP BRAIN RES, V99, P411; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; JARRARD LE, 1986, HIPPOCAMPUS, V4, P93; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Kesner RP, 1990, NEUROBIOLOGY COMP CO, P179; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Murray EA, 1996, SEMIN NEUROSCI, V8, P13, DOI 10.1006/smns.1996.0003; Murray EA, 1998, J NEUROSCI, V18, P6568; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Shapiro Matthew L., 1994, P87; Sohal VS, 1998, NEURAL COMPUT, V10, P869, DOI 10.1162/089976698300017539; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1994, HIPPOCAMPUS, V4, P483, DOI 10.1002/hipo.450040410	32	596	604	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					458	462		10.1038/nn834	http://dx.doi.org/10.1038/nn834			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976705	Green Accepted			2022-12-28	WOS:000175272000017
J	Britto, J; Tannahill, D; Keynes, R				Britto, J; Tannahill, D; Keynes, R			A critical role for sonic hedgehog signaling in the early expansion of the developing brain	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURON INDUCTION; DEVELOPING CHICK; NERVOUS-SYSTEM; FEEDBACK LOOP; EXPRESSION; PROLIFERATION; GROWTH; MIDBRAIN; CELLS; FGF4	The mechanisms that coordinate the three-dimensional shape of the vertebrate brain during development are largely unknown. We have found that sonic hedgehog (Shh) is crucial in driving the rapid, extensive expansion of the early vesicles of the developing midbrain and forebrain. Transient displacement of the notochord from the midbrain floor plate resulted in abnormal folding and overall collapse of the vesicles, accompanied by reduced cell proliferation and increased cell death in the midbrain. Simultaneously, expression of Shh decreased locally in the notochord and floor plate, whereas overt patterning and differentiation proceeded normally. Normal midbrain expansion was restored by implantation of Shh-secreting cells in a dose-dependent manner; conversely, expansion was retarded following antagonism of the Shh signaling pathway by cyclopamine. Our results indicate that Shh signaling from the ventral midline is essential for regulating brain morphogenesis during early development.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Keynes, R (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	rjk10@cus.cam.ac.uk		Tannahill, David/0000-0002-3811-6864				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; ALTABA AR, 1995, DEV BIOL, V170, P299; ALVARADOMALLART RM, 1993, J NEUROBIOL, V24, P1341, DOI 10.1002/neu.480241007; Borycki AG, 1999, DEVELOPMENT, V126, P4053; BROWN M, 2001, DEV BRAIN; BURDA DJ, 1968, ANAT REC, V161, P419, DOI 10.1002/ar.1091610403; Carl M, 1999, DEVELOPMENT, V126, P5659; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DESMOND ME, 1986, J EMBRYOL EXP MORPH, V97, P25; DESMOND ME, 1977, DEV BIOL, V57, P188, DOI 10.1016/0012-1606(77)90364-5; Duprez D, 1998, DEVELOPMENT, V125, P495; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein DJ, 1999, DEVELOPMENT, V126, P281; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jensen AM, 1997, DEVELOPMENT, V124, P363; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KALLEN B, 1965, PROGR BRAIN RES, V14, P263; Lee SMK, 1997, DEVELOPMENT, V124, P959; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; MARTI E, 1995, DEVELOPMENT, V121, P2537; Miao NN, 1997, J NEUROSCI, V17, P5891; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Shamim H, 1999, MECH DEVELOP, V85, P189, DOI 10.1016/S0925-4773(99)00093-3; Shamim H, 1999, DEVELOPMENT, V126, P945; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Teillet MA, 1998, DEVELOPMENT, V125, P2019; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; Watanabe Y, 2000, DEVELOPMENT, V127, P1131; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WILSON DB, 1974, BRAIN RES, V69, P41, DOI 10.1016/0006-8993(74)90368-0; WILSON DB, 1978, J COMP NEUROL, V180, P501, DOI 10.1002/cne.901800307; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	47	98	105	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					103	110		10.1038/nn797	http://dx.doi.org/10.1038/nn797			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788837				2022-12-28	WOS:000173558400011
J	Glowatzki, E; Fuchs, PA				Glowatzki, E; Fuchs, PA			Transmitter release at the hair cell ribbon synapse	NATURE NEUROSCIENCE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; GUINEA-PIG COCHLEA; AUDITORY-NERVE; MOUSE COCHLEA; TRANSMISSION; FIBERS; POTENTIALS; ENDOCYTOSIS; EXOCYTOSIS; RECEPTORS	Neurotransmitters are released continuously at ribbon synapses in the retina and cochlea. Notably, a single ribbon synapse of inner hair cells provides the entire input to each cochlear afferent fiber. We investigated hair cell transmitter release in the postnatal rat cochlea by recording excitatory postsynaptic currents (EPSCs) from afferent boutons directly abutting the ribbon synapse. EPSCs were carried by rapidly gating AMPA receptors. EPSCs were clustered in time, indicating the possibility of coordinate release. Amplitude distributions of spontaneous EPSCs were highly skewed, peaking at 0.4 nS and ranging up to 20 times larger. Hair cell depolarization increased EPSC frequency up to 150 Hz without altering the amplitude distribution. We propose that the ribbon synapse operates by multivesicular release, possibly to achieve high-frequency transmission.	Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA	Johns Hopkins University	Glowatzki, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Traylor 521,720 Rutland Ave, Baltimore, MD 21205 USA.			Glowatzki, Elisabeth/0000-0003-3135-658X	PHS HHS [00276] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; ECHTELER SM, 1992, P NATL ACAD SCI USA, V89, P6324, DOI 10.1073/pnas.89.14.6324; EMMERLING MR, 1990, J ELECTRON MICR TECH, V15, P123, DOI 10.1002/jemt.1060150205; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P211, DOI 10.1113/jphysiol.1978.sp012229; GEISLER CD, 1998, FROM SOUND SYNAPSE, P177; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Isaacson JS, 1996, J NEUROPHYSIOL, V76, P1566, DOI 10.1152/jn.1996.76.3.1566; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Locke R, 1999, ANN NY ACAD SCI, V871, P35, DOI 10.1111/j.1749-6632.1999.tb09174.x; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; NAKAGAWA T, 1991, J NEUROPHYSIOL, V65, P715, DOI 10.1152/jn.1991.65.3.715; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; ROSSI ML, 1994, J PHYSIOL-LONDON, V478, P17, DOI 10.1113/jphysiol.1994.sp020227; Ruel J, 1999, J PHYSIOL-LONDON, V518, P667, DOI 10.1111/j.1469-7793.1999.0667p.x; Sahara Y, 2001, J PHYSIOL-LONDON, V536, P189, DOI 10.1111/j.1469-7793.2001.00189.x; SIEGEL JH, 1992, HEARING RES, V59, P85, DOI 10.1016/0378-5955(92)90105-V; SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942; Spassova M, 2001, J PHYSIOL-LONDON, V535, P689, DOI 10.1111/j.1469-7793.2001.00689.x; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; UZIEL A, 1981, AUDIOLOGY, V20, P89; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	41	407	421	0	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					147	154		10.1038/nn796	http://dx.doi.org/10.1038/nn796			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802170				2022-12-28	WOS:000173558400017
J	Morgan, D; Grant, KA; Gage, HD; Mach, RH; Kaplan, JR; Prioleau, O; Nader, SH; Buchheimer, N; Ehrenkaufer, RL; Nader, MA				Morgan, D; Grant, KA; Gage, HD; Mach, RH; Kaplan, JR; Prioleau, O; Nader, SH; Buchheimer, N; Ehrenkaufer, RL; Nader, MA			Social dominance in monkeys: dopamine D-2 receptors and cocaine self-administration	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INDIVIDUAL VULNERABILITY; BINDING CHARACTERISTICS; HOUSING CONDITIONS; RHESUS-MONKEYS; D-AMPHETAMINE; DRUG-ABUSE; RATS; BEHAVIOR; ADDICTION	Disruption of the dopaminergic system has been implicated in the etiology of many pathological conditions, including drug addiction. Here we used positron emission tomography (PET) imaging to study brain dopaminergic function in individually housed and in socially housed cynomolgus macaques (n = 20). Whereas the monkeys did not differ during individual housing, social housing increased the amount or availability of dopamine D-2 receptors in dominant monkeys and produced no change in subordinate monkeys. These neurobiological changes had an important behavioral influence as demonstrated by the finding that cocaine functioned as a reinforcer in subordinate but not dominant monkeys. These data demonstrate that alterations in an organism's environment can produce profound biological changes that have important behavioral associations, including vulnerability to cocaine addiction.	Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Comparat Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Anthropol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Nader, MA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Morgan, Drake/A-6373-2008; Morgan, Drake/F-6664-2012		NIDA NIH HHS [DA-10584] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010584, R01DA010584] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BLANC G, 1980, NATURE, V284, P265, DOI 10.1038/284265a0; Blum K, 1996, AM SCI, V84, P132; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; BOYLE AE, 1991, PHARMACOL BIOCHEM BE, V39, P269, DOI 10.1016/0091-3057(91)90178-5; BOZARTH MA, 1989, PHARMACOL BIOCHEM BE, V33, P903, DOI 10.1016/0091-3057(89)90490-5; Caine SB, 2000, PSYCHOPHARMACOLOGY, V148, P41, DOI 10.1007/s002130050023; Calabresi P, 1997, NEUROSCIENCE, V78, P39; CROWLEY TJ, 1992, DRUG ALCOHOL DEPEN, V29, P205, DOI 10.1016/0376-8716(92)90094-S; CROWLEY TJ, 1974, ARCH GEN PSYCHIAT, V31, P829; Grant KA, 1998, SYNAPSE, V29, P80, DOI 10.1002/(SICI)1098-2396(199805)29:1<80::AID-SYN7>3.0.CO;2-7; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hurd YL, 1999, ANN NY ACAD SCI, V877, P499, DOI 10.1111/j.1749-6632.1999.tb09285.x; Khroyan TV, 2000, J PHARMACOL EXP THER, V294, P680; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; LeSage MG, 1999, NEUROSCI BIOBEHAV R, V23, P717, DOI 10.1016/S0149-7634(99)00015-9; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lucas LR, 1998, EUR J NEUROSCI, V10, P3153, DOI 10.1046/j.1460-9568.1998.00321.x; Mach RH, 1996, SYNAPSE, V24, P322, DOI 10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; Marinelli M, 2000, J NEUROSCI, V20, P8876; MARTIN SP, 1990, PHARMACOL BIOCHEM BE, V37, P493, DOI 10.1016/0091-3057(90)90018-D; MICZEK KA, 1983, PSYCHOPHARMACOLOGY, V81, P183, DOI 10.1007/BF00427259; Morgan D, 2000, AM J PRIMATOL, V52, P115, DOI 10.1002/1098-2345(200011)52:3<115::AID-AJP1>3.0.CO;2-Z; Nader MA, 1999, PSYCHOPHARMACOLOGY, V147, P143, DOI 10.1007/s002130051154; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Nader MA, 1999, NEUROPSYCHOPHARMACOL, V21, P589, DOI 10.1016/S0893-133X(98)00101-8; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V115, P407, DOI 10.1007/BF02245084; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; RILKE O, 1995, PHARMACOL BIOCHEM BE, V52, P23, DOI 10.1016/0091-3057(95)00093-C; SCHENK S, 1987, NEUROSCI LETT, V81, P227, DOI 10.1016/0304-3940(87)91003-2; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Verhoeff NPLG, 1999, PSYCHOPHARMACOLOGY, V147, P217, DOI 10.1007/s002130051163; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Woods R.P., 1998, J COMPUT ASSIST TOMO, V22, P141	42	447	458	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					169	174		10.1038/nn798	http://dx.doi.org/10.1038/nn798			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802171				2022-12-28	WOS:000173558400020
J	Lin, JC; Ho, WH; Gurney, A; Rosenthal, A				Lin, JC; Ho, WH; Gurney, A; Rosenthal, A			The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; EXPRESSION; RECEPTOR; IDENTIFICATION; PROTEINS; LAMININ; FAMILY; UNC-5; CHEMOREPELLENT; MIGRATIONS	Netrin-G1 is a lipid-anchored protein that is structurally related to the netrin family of axon guidance molecules. Netrin-G1 does not bind any of the known netrin receptors and its function is not known. Here we identify human netrin-G1 ligand (NGL-1), a transmembrane protein containing leucine-rich repeat (LRR) and immunoglobulin (Ig) domains that specifically interacts with netrin-G1 through its LRR region. Whereas netrin-G1 is expressed highly in mouse thalamic axons, NGL-1 is most abundant in the striatum and the cerebral cortex the intermediate and final targets, respectively, of thalamocortical axons (TCAs). Surface-bound NGL-1 stimulates, but soluble NGL-1 disrupts, the growth of embryonic thalamic axons, and in vitro data indicate that NGL-1 activity may be mediated at least partially by netrin-G1. Our findings provide evidence that netrin-G1 functions as an important component of the NGL-1 receptor to promote TCA outgrowth and that membrane-bound netrins can participate in receiving axonal signaling pathways.	Rinat Neurosci Corp, Palo Alto, CA 94304 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Lin, JC (corresponding author), Rinat Neurosci Corp, 3155 Porter Dr, Palo Alto, CA 94304 USA.							Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Metin C, 1996, J NEUROSCI, V16, P3219; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Redies C, 1997, J COMP NEUROL, V381, P230, DOI 10.1002/(SICI)1096-9861(19970505)381:2<230::AID-CNE9>3.0.CO;2-4; Rosenthal A, 1999, NEURON, V22, P201, DOI 10.1016/S0896-6273(00)81077-6; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Yin Y, 2000, MECH DEVELOP, V96, P115, DOI 10.1016/S0925-4773(00)00369-5; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	24	140	148	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1270	1276		10.1038/nn1148	http://dx.doi.org/10.1038/nn1148			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14595443				2022-12-28	WOS:000186725600011
J	Rogers, C; Reale, V; Kim, K; Chatwin, H; Li, C; Evans, P; de Bono, M				Rogers, C; Reale, V; Kim, K; Chatwin, H; Li, C; Evans, P; de Bono, M			Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1	NATURE NEUROSCIENCE			English	Article							NEUROPEPTIDE-Y RECEPTOR; NEMATODE ASCARIS-SUUM; C-ELEGANS; DROSOPHILA-MELANOGASTER; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; NATURAL VARIATION; NERVOUS-SYSTEM; GENE; NEURONS	Social and solitary feeding in natural Caenorhabditis elegans isolates are associated with two alleles of the orphan G-protein-coupled receptor (GPCR) NPR-1: social feeders contain NPR-1 215F, whereas solitary feeders contain NPR-1 215V. Here we identify FMRFamide-related neuropeptides (FaRPs) encoded by the flp-18 and flp-21 genes as NPR-1 ligands and show that these peptides can differentially activate the NPR-1 215F and NPR-1 215V receptors. Multicopy overexpression of flp-21 transformed wild social animals into solitary feeders. Conversely, a flp-21 deletion partially phenocopied the npr-1(null) phenotype, which is consistent with NPR-1 activation by FLP-21 in vivo but also implicates other ligands for NPR-1. Phylogenetic studies indicate that the dominant npr-1 215V allele likely arose from an ancestral npr-1 215F gene in C. elegans. Our data suggest a model in which solitary feeding evolved in an ancestral social strain of C. elegans by a gain-of-function mutation that modified the response of NPR-1 to FLP-18 and FLP-21 ligands.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Babraham Inst, Signalling Programme, Cambridge CB2 4AT, England; Boston Univ, Dept Biol, Boston, MA 02215 USA	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Boston University	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	debono@mrc-lmb.cam.ac.uk		de Bono, Mario/0000-0001-8347-0443				AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery L, 1995, CAENORHABDITIS ELEGA, P251; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BLUML K, 1994, J BIOL CHEM, V269, P11537; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHEUNG AH, 1992, MOL PHARMACOL, V41, P1061; Choe JC, 1997, EVOLUTION SOCIAL BEH; CLARK SG, 1994, GENETICS, V137, P987; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; COWDEN C, 1995, PEPTIDES, V16, P491, DOI 10.1016/0196-9781(94)00211-N; Davis MW, 1995, J NEUROSCI, V15, P8408; Davis RE, 1996, PARASITOLOGY, V113, pS97, DOI 10.1017/S0031182000077921; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; DRISCOLL M, 1997, C ELEGANS, V2, P645; Edison AS, 1997, PEPTIDES, V18, P929, DOI 10.1016/S0196-9781(97)00047-8; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Feng GP, 1996, J NEUROSCI, V16, P3925; FITCH DHA, 1997, C ELEGANS, V2, P815; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hodgkin J, 1997, GENETICS, V146, P149; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kubiak TM, 2003, J BIOL CHEM, V278, P33724, DOI 10.1074/jbc.M304861200; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Marks NJ, 2001, BIOCHEM BIOPH RES CO, V286, P1170, DOI 10.1006/bbrc.2001.5524; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKKEMA PG, 1993, GENETICS, V135, P385; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Silverman SK, 1996, J BIOL CHEM, V271, P30524, DOI 10.1074/jbc.271.48.30524; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sun LJ, 1998, J PHARMACOL EXP THER, V284, P625; Tensen CP, 1998, EUR J NEUROSCI, V10, P3409, DOI 10.1046/j.1460-9568.1998.00350.x; VANRENTERGHEM C, 1987, BRAIN RES, V388, P21; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson E.O., 1975, P1; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691	50	187	200	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1178	1185		10.1038/nn1140	http://dx.doi.org/10.1038/nn1140			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555955				2022-12-28	WOS:000186229200017
J	Ransohoff, RM				Ransohoff, RM			Snip-snip, kill-kill: truncated SDF-1 and HIV-associated neurodegeneration	NATURE NEUROSCIENCE			English	Editorial Material							CHEMOKINE; INACTIVATION; APOPTOSIS; RECEPTORS		Cleveland Clin Fdn, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Ransohoff, RM (corresponding author), Cleveland Clin Fdn, Dept Neurosci, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	ransohr@ccf.org						Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Weber M, 1996, Immunol Today, V17, P205; Weiss RA, 2002, IUBMB LIFE, V53, P201, DOI 10.1080/15216540212652; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	14	9	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1009	1011		10.1038/nn1003-1009	http://dx.doi.org/10.1038/nn1003-1009			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14513034				2022-12-28	WOS:000185633600007
J	Gunhaga, L; Marklund, M; Sjodal, M; Hsieh, JC; Jessell, TM; Edlund, T				Gunhaga, L; Marklund, M; Sjodal, M; Hsieh, JC; Jessell, TM; Edlund, T			Specification of dorsal telencephalic character by sequential Wnt and FGF signaling	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; CENTRAL-NERVOUS-SYSTEM; SONIC HEDGEHOG; CHICK-EMBRYO; MAMMALIAN TELENCEPHALON; GENE-EXPRESSION; FLOOR PLATE; FATE MAP; FOREBRAIN; DIFFERENTIATION	Dorsoventral patterning of the telencephalon is established early in forebrain development and underlies many of the regional subdivisions that are critical to the later organization of neural circuits in the cerebral cortex and basal ganglia. Sonic hedgehog (Shh) is involved in the generation of the ventral-most telencephalic cells, but the identity of the extrinsic signal(s) that induce dorsal character in telencephalic cells is not known. Here we show in chick embryos that sequential Wnt and fibroblast growth factor (FGF) signaling specifies cells of dorsal telencephalic character.	Umea Ctr Mol Med, S-90187 Umea, Sweden; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Ctr Mol Med, Bldg 6M,4th Floor, S-90187 Umea, Sweden.	thomas.edlund@molbiol.umu.se						Bell E, 2001, DEV BIOL, V236, P76, DOI 10.1006/dbio.2001.0301; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Cobos I, 2001, DEV BIOL, V239, P46, DOI 10.1006/dbio.2001.0423; COULY G, 1988, DEVELOPMENT, V103, P101; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Faure S, 2002, DEV BIOL, V244, P44, DOI 10.1006/dbio.2002.0579; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; Gunhaga L, 2000, DEVELOPMENT, V127, P3283; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SMK, 2000, DEVELOPMENT, V127, P457; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Puelles L, 1999, EUR J MORPHOL, V37, P139, DOI 10.1076/ejom.37.2.139.4756; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shimamura K, 1997, DEVELOPMENT, V124, P2709; SMART IHM, 1979, NEOSTRIATUM, P127; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Theil T, 2002, DEVELOPMENT, V129, P3045; Toresson H, 2000, MECH DEVELOP, V94, P183, DOI 10.1016/S0925-4773(00)00324-5; Watanabe Y, 1996, MECH DEVELOP, V57, P69, DOI 10.1016/0925-4773(96)00534-5; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Yun K, 2001, DEVELOPMENT, V128, P193	46	152	152	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					701	707		10.1038/nn1068	http://dx.doi.org/10.1038/nn1068			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12766771				2022-12-28	WOS:000183780400017
J	Fridberger, A; de Monvel, JB				Fridberger, A; de Monvel, JB			Sound-induced differential motion within the hearing organ	NATURE NEUROSCIENCE			English	Article							OUTER HAIR-CELLS; BASILAR-MEMBRANE MOTION; COCHLEA; ELECTROMOTILITY; PRESTIN; CORTI		Karolinska Inst, Ctr Hearing & Communicat Res, Dept Clin Neurosci, Stockholm, Sweden; Karolinska Inst, Dept Otorhinolaryngol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Fridberger, A (corresponding author), Karolinska Inst, Ctr Hearing & Communicat Res, Dept Clin Neurosci, Stockholm, Sweden.		Fridberger, Anders/E-8977-2010	Fridberger, Anders/0000-0002-7960-1559; Boutet de Monvel, Jacques/0000-0001-6182-3527				BRUNDIN L, 1989, NATURE, V342, P814, DOI 10.1038/342814a0; Fridberger A, 2002, J NEUROSCI, V22, P9850; Frolenkov GI, 2001, J PHYSIOL-LONDON, V531, P667, DOI 10.1111/j.1469-7793.2001.0667h.x; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Nilsen KE, 1999, NAT NEUROSCI, V2, P642, DOI 10.1038/10197; Nuttall AL, 1999, HEARING RES, V131, P39, DOI 10.1016/S0378-5955(99)00009-X; RYBALCHENKO V, IN PRESS J PHYSL; ter Kuile E., 1900, PFLUGERS ARCH GES PH, V79, P146, DOI 10.1007/BF01796105; Ulfendahl M, 1996, J NEUROPHYSIOL, V76, P3850, DOI 10.1152/jn.1996.76.6.3850; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	15	44	44	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					446	448		10.1038/nn1047	http://dx.doi.org/10.1038/nn1047			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692558				2022-12-28	WOS:000182553200008
J	Meyer-Luehmann, M; Stalder, M; Herzig, MC; Kaeser, SA; Kohler, E; Pfeifer, M; Boncristiano, S; Mathews, PM; Mercken, M; Abramowski, D; Staufenbiel, M; Jucker, M				Meyer-Luehmann, M; Stalder, M; Herzig, MC; Kaeser, SA; Kohler, E; Pfeifer, M; Boncristiano, S; Mathews, PM; Mercken, M; Abramowski, D; Staufenbiel, M; Jucker, M			Extracellular amyloid formation and associated pathology in neural grafts	NATURE NEUROSCIENCE			English	Article							PROTEIN-TRANSGENIC MICE; DISEASE-LIKE PATHOLOGY; HOST PRION PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; PLAQUE-FORMATION; MOUSE MODEL; CEREBRAL-CORTEX; HUMAN BRAIN	Amyloid precursor protein (APP) processing and the generation of beta-amyloid peptide (Abeta) are important in the pathogenesis of Alzheimer's disease. Although this has been studied extensively at the molecular and cellular levels, much less is known about the mechanisms of amyloid accumulation in vivo. We transplanted transgenic APP23 and wild-type B6 embryonic neural cells into the neocortex and hippocampus of both B6 and APP23 mice. APP23 grafts into wild-type hosts did not develop amyloid deposits up to 20 months after grafting. In contrast, both transgenic and wild-type grafts into young transgenic hosts developed amyloid plaques as early as 3 months after grafting. Although largely diffuse in nature, some of the amyloid deposits in wild-type grafts were congophilic and were surrounded by neuritic changes and gliosis, similar to the amyloid-associated pathology previously described in APP23 mice. Our results indicate that diffusion of soluble Abeta in the extracellular space is involved in the spread of Abeta pathology, and that extracellular amyloid formation can lead to neurodegeneration.	Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland; NYU, Sch Med, Nathan Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium; Novartis Pharma AG, Nervous Syst Res, CH-4002 Basel, Switzerland	University of Basel; Nathan Kline Institute for Psychiatric Research; New York University; Johnson & Johnson; Janssen Pharmaceuticals; Novartis	Jucker, M (corresponding author), Univ Basel, Inst Pathol, Dept Neuropathol, Schonbeinstr 40, CH-4003 Basel, Switzerland.		Herzig, Martin/R-4601-2016	Herzig, Martin/0000-0002-0500-353X; Mathews, Paul/0000-0003-1742-7687; Meyer-Luehmann, Melanie/0000-0003-3661-2220				Bayer TA, 2001, BRAIN PATHOL, V11, P1; Bayer TA, 1996, ACTA NEUROPATHOL, V92, P130, DOI 10.1007/s004010050500; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; CLINTON RJ, 1988, J COMP NEUROL, V277, P557, DOI 10.1002/cne.902770409; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Frautschy SA, 1998, AM J PATHOL, V152, P307; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gates MA, 1996, NEUROSCIENCE, V74, P579, DOI 10.1016/0306-4522(96)00146-7; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HOLTZMAN DM, 1992, P NATL ACAD SCI USA, V89, P1383, DOI 10.1073/pnas.89.4.1383; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Lazarov O, 2002, J NEUROSCI, V22, P9785; MANTIONE JR, 1995, BRAIN RES, V671, P333, DOI 10.1016/0006-8993(94)01400-C; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Ohsawa K, 2000, J CELL SCI, V113, P3073; PALKOVITS M, 1983, METHOD ENZYMOL, V103, P368; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Phinney AL, 1999, J NEUROSCI, V19, P8552; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; RICHARDS SJ, 1991, EMBO J, V10, P297, DOI 10.1002/j.1460-2075.1991.tb07950.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sykova E, 1999, NEUROSCIENCE, V91, P783, DOI 10.1016/S0306-4522(98)00603-4; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; Wong TP, 1999, J NEUROSCI, V19, P2706	50	109	110	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					370	377		10.1038/nn1022	http://dx.doi.org/10.1038/nn1022			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12598899				2022-12-28	WOS:000181833100014
J	Banke, TG; Traynelis, SF				Banke, TG; Traynelis, SF			Activation of NR1/NR2B NMDA receptors	NATURE NEUROSCIENCE			English	Article							GLUTAMATE-RECEPTOR; OPEN PROBABILITY; PROTEIN-KINASE; BINDING-SITE; CHANNEL; PATCH; DEPENDENCE; KINETICS; NUMBER; MUTANT	N-methyl-D-aspartate (NMDA) receptors are highly expressed in the central nervous system and are involved in excitatory synaptic transmission as well as synaptic plasticity. Despite considerable structural and biophysical research, the mechanism behind activation of the NMDA receptor is still poorly understood. By analyzing patch clamp recordings of one channel activated by glutamate, we determined the burst structure and open probability for recombinant rat NR1/NR2B receptors. We used partial agonists at the glutamate and glycine binding sites to show that at least two kinetically distinct subunit-associated conformational changes link co-agonist binding to the opening of the NMDA receptor pore. These data suggest that NR1 and NR2B subunits, respectively, undergo a fast and slow agonist-dependent conformational change that precedes opening of the pore. We propose a new working model of receptor activation that can account for macroscopic as well as microscopic NMDA receptor properties.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Banke, TG (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	tbanke@pharm.emory.edu		Banke, Tue/0000-0001-8417-4400	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036654, R01NS036654] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36654] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; ANTOINE R, 2001, J NEUROSCI, V21, P5574; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BENVENISTE M, 1995, J PHYSIOL-LONDON, V483, P367, DOI 10.1113/jphysiol.1995.sp020591; CAREAGA CL, 1995, BIOCHEMISTRY-US, V34, P3048, DOI 10.1021/bi00009a036; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; COLQUHOUN D, 1990, PROC R SOC SER B-BIO, V240, P453, DOI 10.1098/rspb.1990.0048; Colquhoun David, 1995, P483; Dingledine R, 1999, PHARMACOL REV, V51, P7; EDMONDS B, 1992, P ROY SOC B-BIOL SCI, V250, P279, DOI 10.1098/rspb.1992.0160; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Perozo E, 2002, STRUCTURE, V10, P1027, DOI 10.1016/S0969-2126(02)00812-2; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Premkumar LS, 1997, J GEN PHYSIOL, V109, P181, DOI 10.1085/jgp.109.2.181; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2002, BIOPHYS J, V83, P3304, DOI 10.1016/S0006-3495(02)75331-9; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	34	176	179	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					144	152		10.1038/nn1000	http://dx.doi.org/10.1038/nn1000			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524545	Green Published			2022-12-28	WOS:000180669100014
J	Esteban, JA; Shi, SH; Wilson, C; Nuriya, M; Huganir, RL; Malinow, R				Esteban, JA; Shi, SH; Wilson, C; Nuriya, M; Huganir, RL; Malinow, R			PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; FREQUENCY STIMULATION; ACTIVATION INCREASES; HIPPOCAMPAL SYNAPSES; GLUTAMATE RECEPTORS; LATE-PHASE; AREA CA1; LTP	The regulated incorporation of AMPA receptors into synapses is important for synaptic plasticity. Here we examine the role of protein kinase A (PKA) in this process. We found that PKA phosphorylation of the AMPA receptor subunits GluR4 and GluR1 directly controlled the synaptic incorporation of AMPA receptors in organotypic slices from rat hippocampus. Activity-driven PKA phosphorylation of GluR4 was necessary and sufficient to relieve a retention interaction and drive receptors into synapses. In contrast, PKA phosphorylation of GluR1 and the activity of calcium/calmodulin-dependent kinase II (CaMKII) were both necessary for receptor incorporation. Thus, PKA phosphorylation of AMPA receptor subunits contributes to diverse mechanisms underlying synaptic plasticity.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Johns Hopkins University; Cold Spring Harbor Laboratory	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	estebanj@umich.edu; malinow@cshl.org	Esteban, Jose/L-4944-2014; Nuriya, Mutsuo/J-5928-2013	Esteban, Jose/0000-0002-3759-3300; Nuriya, Mutsuo/0000-0002-5689-8222	NINDS NIH HHS [R01 NS036715, NS32827, NS36715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715, R01NS032827] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Brown GP, 2000, J NEUROSCI, V20, P7880; Carvalho AL, 1999, J NEUROSCI, V19, P4748; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jordan JD, 1998, BIOCHEM PHARMACOL, V55, P1347; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1999, IMAGING LIVING CELLS; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Reed TM, 2002, J NEUROSCI, V22, P5188, DOI 10.1523/JNEUROSCI.22-12-05188.2002; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	48	634	657	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					136	143		10.1038/nn997	http://dx.doi.org/10.1038/nn997			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536214				2022-12-28	WOS:000180669100013
J	Pawlak, R; Magarinos, AM; Melchor, J; McEwen, B; Strickland, S				Pawlak, R; Magarinos, AM; Melchor, J; McEwen, B; Strickland, S			Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL PLASTICITY; LATE-PHASE; GENE; EXPRESSION; RELEASE; MICE; DEGRADATION; PATHWAY; LAMININ	Although neuronal stress circuits have been identified, little is known about the mechanisms that underlie the stress-induced neuronal plasticity leading to fear and anxiety. Here we found that the serine protease tissue-plasminogen activator (tPA) was upregulated in the central and medial amygdala by acute restraint stress, where it promoted stress-related neuronal remodeling and was subsequently inhibited by plasminogen activator inhibitor-1 (PAI-1). These events preceded stress-induced increases in anxiety-like behavior of mice. Mice in which the tPA gene has been disrupted did not show anxiety after up to three weeks of daily restraint and showed attenuated neuronal remodeling as well as a maladaptive hormonal response. These studies support the idea that tPA is critical for the development of anxiety-like behavior after stress.	Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA; Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Strickland, S (corresponding author), Rockefeller Univ, Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	strickland@rockefeller.edu	McEwen, Bruce/Z-1630-2019	Strickland, Sidney/0000-0002-3072-9244	NINDS NIH HHS [NS-35704, NS-38472] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038472, R01NS035704] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; ALLEN JP, 1974, NEUROENDOCRINOLOGY, V15, P220, DOI 10.1159/000122310; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; CHAPMAN PF, 2000, AMYGDALA FUNCTIONAL, P117; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frey U, 1996, J NEUROSCI, V16, P2057; GLOWINSKI J, 1966, BIOCHEM PHARMACOL, V15, P977, DOI 10.1016/0006-2952(66)90175-4; GRAY TS, 1989, NEUROENDOCRINOLOGY, V50, P433, DOI 10.1159/000125260; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Herman JP, 1996, CRIT REV NEUROBIOL, V10, P371, DOI 10.1615/CritRevNeurobiol.v10.i3-4.50; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; Horsell A, 1999, NEUROREPORT, V10, P3003, DOI 10.1097/00001756-199909290-00024; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LUITEN PGM, 1985, BRAIN RES, V332, P283, DOI 10.1016/0006-8993(85)90597-9; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MARS WM, 1993, AM J PATHOL, V143, P949; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Schafe GE, 2000, J NEUROSCI, V20, P8177; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Vyas A, 2002, J NEUROSCI, V22, P6810; Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	46	205	217	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					168	174		10.1038/nn998	http://dx.doi.org/10.1038/nn998			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524546				2022-12-28	WOS:000180669100017
J	Paul, S; Nairn, AC; Wang, P; Lombroso, PJ				Paul, S; Nairn, AC; Wang, P; Lombroso, PJ			NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CASCADE; DUAL-SPECIFICITY PHOSPHATASES; LONG-TERM POTENTIATION; MAP KINASE; DEPENDENT PATHWAY; STRIATAL NEURONS; IN-VIVO; PHOSPHORYLATION; RECEPTOR; HIPPOCAMPAL	The intracellular mechanism(s) by which a cell determines the duration of extracellular signal-regulated kinase (ERK) activation is not well understood. We have investigated the role of STEP, a striatal-enriched tyrosine phosphatase, in the regulation of ERK activity in rat neurons. Glutamate-mediated activation of NMDA receptors leads to the rapid but transient phosphorylation of ERK in cultured neurons. Here we show that activation of NMDA receptors led to activation of STEP, which limited the duration of ERK activity as well as its translocation to the nucleus and its subsequent downstream nuclear signaling. In neurons, STEP is phosphorylated and inactive under basal conditions. NMDA-mediated influx of Ca2+, but not increased intracellular Ca2+ from other sources, leads to activation of the Ca2+-dependent phosphatase calcineurin and the dephosphorylation and activation of STEP. We have identified an important mechanism involved in the regulation of ERK activity in neurons that highlights the complex interplay between serine/threonine and tyrosine kinases and phosphatases.	Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; Rockefeller Univ, New York, NY 10021 USA	Yale University; Yale University; Rockefeller University	Lombroso, PJ (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.			Nairn, Angus/0000-0002-7075-0195	NIDA NIH HHS [P01 DA010044, DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899, MH01527, MH52711] Funding Source: Medline; NINDS NIH HHS [NS35989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052711, R01MH052711, P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abe K, 2000, NEUROSCI LETT, V292, P1, DOI 10.1016/S0304-3940(00)01415-4; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Bult A, 1996, J NEUROSCI, V16, P7821; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kornhauser JM, 1997, NEURON, V18, P839, DOI 10.1016/S0896-6273(00)80322-0; KOTTER R, 1994, PROG NEUROBIOL, V44, P163, DOI 10.1016/0301-0082(94)90037-X; Kuroki Y, 2001, EUR J NEUROSCI, V13, P472, DOI 10.1046/j.0953-816x.2000.01409.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Runden E, 1998, J NEUROSCI, V18, P7296; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schwarzschild MA, 1999, J NEUROCHEM, V72, P2248, DOI 10.1046/j.1471-4159.1999.0722248.x; Sgambato V, 1998, J NEUROSCI, V18, P8814; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vincent SR, 1998, SYNAPSE, V29, P29, DOI 10.1002/(SICI)1098-2396(199805)29:1<29::AID-SYN3>3.3.CO;2-T; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yun HY, 1999, DIABETES RES CLIN PR, V45, P113, DOI 10.1016/S0168-8227(99)00039-X; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	49	261	269	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					34	42		10.1038/nn989	http://dx.doi.org/10.1038/nn989			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483215				2022-12-28	WOS:000180089300013
J	Desai, NS; Cudmore, RH; Nelson, SB; Turrigiano, GG				Desai, NS; Cudmore, RH; Nelson, SB; Turrigiano, GG			Critical periods for experience-dependent synaptic scaling in visual cortex	NATURE NEUROSCIENCE			English	Article							MONOCULAR DEPRIVATION; QUANTAL AMPLITUDE; NMDA-RECEPTOR; PLASTICITY; RAT; EXPRESSION; SYNAPSES; AMPA; MECHANISMS; ZIF268	The mechanisms underlying experience-dependent plasticity and refinement of central circuits are not yet fully understood. A non-Hebbian form of synaptic plasticity, which scales synaptic strengths up or down to stabilize firing rates, has recently been discovered in cultured neuronal networks. Here we demonstrate the existence of a similar mechanism in the intact rodent visual cortex. The frequency of miniature excitatory postsynaptic currents (mEPSCs) in principal neurons increased steeply between post-natal days 12 and 23. There was a concomitant decrease in mEPSC amplitude, which was prevented by rearing rats in complete darkness from 12 days of age. In addition, as little as two days of monocular deprivation scaled up mEPSC amplitude in a layer- and age-dependent manner. These data indicate that mEPSC amplitudes can be globally scaled up or down as a function of development and sensory experience, and suggest that synaptic scaling may be involved in the activity-dependent refinement of cortical connectivity.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	turrigiano@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599; Cudmore, Robert/0000-0002-0440-1704	NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853] Funding Source: NIH RePORTER; NEI NIH HHS [EY 11116] Funding Source: Medline; NINDS NIH HHS [R01 NS 36853] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2001, NAT NEUROSCI, V4, P115, DOI 10.1038/83920; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Caleo M, 1999, NEUROSCIENCE, V91, P1017, DOI 10.1016/S0306-4522(98)00682-4; Caleo M, 1999, EUR J NEUROSCI, V11, P2979, DOI 10.1046/j.1460-9568.1999.00737.x; CHANGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FOX K, 1992, J NEUROSCI, V12, P1826; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; McCormick DA, 1999, SCIENCE, V285, P541, DOI 10.1126/science.285.5427.541; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; REID SNM, 1991, BRAIN RES, V563, P293, DOI 10.1016/0006-8993(91)91549-G; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Varela JA, 1999, J NEUROSCI, V19, P4293; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	49	416	428	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					783	789		10.1038/nn878	http://dx.doi.org/10.1038/nn878			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080341				2022-12-28	WOS:000177088900022
J	Lee, TS; Yang, CF; Romero, RD; Mumford, D				Lee, TS; Yang, CF; Romero, RD; Mumford, D			Neural activity in early visual cortex reflects behavioral experience and higher-order perceptual saliency	NATURE NEUROSCIENCE			English	Article							INTERACTIVE ACTIVATION; CONTEXTUAL MODULATION; MACAQUE MONKEY; AREAS V1; ATTENTION; TEXTURE; SHAPE; MECHANISMS; RESPONSES; VISION	We report here that shape-from-shading stimuli evoked a long-latency contextual pop-out response in V1 and V2 neurons of macaque monkeys, particularly after the monkeys had used the stimuli in a behavioral task. The magnitudes of the pop-out responses were correlated to the monkeys' behavioral performance, suggesting that these signals are neural correlates of perceptual pop-out saliency. The signals changed with the animal's behavioral adaptation to stimulus contingencies, indicating that perceptual saliency is also a function of experience and behavioral relevance. The evidence that higher-order stimulus attributes and task experience can influence early visual processing supports the notion that perceptual computation is an interactive and plastic process involving multiple cortical areas.	Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; Brown Univ, Div Appl Math, Providence, RI 02912 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Brown University	Lee, TS (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, 4400 5th Ave, Pittsburgh, PA 15213 USA.	tai@cnbc.cmu.edu		Yang, Cindy/0000-0001-6144-4658	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NCRR NIH HHS [2P41RR06009-11] Funding Source: Medline; NEI NIH HHS [EY08298] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2001, PSYCHOL SCI, V12, P56, DOI 10.1111/1467-9280.00310; Bakin JS, 2000, J NEUROSCI, V20, P8188; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BRAUN J, 1993, SPATIAL VISION, V7, P311, DOI 10.1163/156856893X00469; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DECO G, IN PRESS NEUROCOMPUT; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; JULESZ B, 1975, SCI AM, V232, P34, DOI 10.1038/scientificamerican0475-34; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V10, P649; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P187, DOI 10.1088/0954-898X/10/2/305; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Sun J, 1996, NATURE, V379, P165, DOI 10.1038/379165a0; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P975, DOI 10.1152/jn.1969.32.6.975; Zipser K, 1996, J NEUROSCI, V16, P7376	37	159	161	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					589	597		10.1038/nn860	http://dx.doi.org/10.1038/nn860			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021764				2022-12-28	WOS:000175874600020
J	Huettel, SA; Mack, PB; McCarthy, G				Huettel, SA; Mack, PB; McCarthy, G			Perceiving patterns in random series: dynamic processing of sequence in prefrontal cortex	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; WORKING-MEMORY; FUNCTIONAL MRI; VISUAL TARGET; ACTIVATION; TASK; STIMULI; SELECTION; NETWORK; BRAIN	We demonstrate that regions within human prefrontal cortex develop moment-to-moment models for patterns of events occurring in the sensory environment. Subjects viewed a random binary sequence of images, each presented singly and each requiring a different button press response. Patterns occurred by chance within the presented series of images. Using functional magnetic resonance imaging (fMRI), we identified activity evoked by viewing a stimulus that interrupted a pattern. Prefrontal activation was evoked by violations of both repeating and alternating patterns, and the amplitude of this activation increased with increasing pattern length. Violations of repeating patterns, but not of alternating patterns, activated the basal ganglia.	Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA	Duke University	McCarthy, G (corresponding author), Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Box 3918, Durham, NC 27710 USA.			Mack, Peter/0000-0002-0627-5334	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-05286, MH-12541] Funding Source: Medline; NINDS NIH HHS [NS-41328] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; BERTELSON P, 1961, Q J EXP PSYCHOL, V13, P90, DOI 10.1080/17470216108416478; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; CANFIELD RL, 1991, DEV PSYCHOL, V27, P198, DOI 10.1037/0012-1649.27.2.198; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Comerchero MD, 1998, COGNITIVE BRAIN RES, V7, P41, DOI 10.1016/S0926-6410(98)00009-3; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; CURRAN T, 1993, J EXP PSYCHOL LEARN, V19, P189, DOI 10.1037/0278-7393.19.1.189; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; Gray Jeffrey A., 1995, P1165; Hardoon KK, 2001, J CLIN PSYCHOL, V57, P749, DOI 10.1002/jclp.1047; Harrington DL, 2000, J COGNITIVE NEUROSCI, V12, P56, DOI 10.1162/08989290051137602; HIKOSAKA O, 1999, NEW COGNITIVE NEUROS, P553; HOLLAND MK, 1968, PERCEPT PSYCHOPHYS, V3, P409, DOI 10.3758/BF03205747; Huettel SA, 1999, PERCEPT PSYCHOPHYS, V61, P1624, DOI 10.3758/BF03213123; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1111/1469-8986.3510023; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Levy R, 1997, J NEUROSCI, V17, P3870; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; SCHVANEV.RW, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027144; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; SQUIRES N, 1975, ELECTROENCEPHALOGR C, V38; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	38	221	223	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					485	490		10.1038/nn841	http://dx.doi.org/10.1038/nn841			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11941373				2022-12-28	WOS:000175272000021
J	Nakamura, W; Honma, S; Shirakawa, T; Honma, K				Nakamura, W; Honma, S; Shirakawa, T; Honma, K			Clock mutation lengthens the circadian period without damping rhythms in individual SCN neurons	NATURE NEUROSCIENCE			English	Article							GENE; BEHAVIOR		Hokkaido Univ, Grad Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Grad Sch Dent, Dept Oral Funct Sci, Sapporo, Hokkaido 0608586, Japan	Hokkaido University; Hokkaido University	Honma, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan.							Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7	10	104	106	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					399	400		10.1038/nn843	http://dx.doi.org/10.1038/nn843			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953751				2022-12-28	WOS:000175272000007
J	Frick, A; Magee, J; Johnston, D				Frick, A; Magee, J; Johnston, D			LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT ATTENUATION; EPSP-SPIKE POTENTIATION; RAT HIPPOCAMPAL SLICES; K+ CHANNELS; NA+ CHANNELS; POTASSIUM CHANNELS; ACTIVE DENDRITES; CA2+ CHANNELS; PLASTICITY	The propagation and integration of signals in the dendrites of pyramidal neurons is regulated, in part, by the distribution and biophysical properties of voltage-gated ion channels. It is thus possible that any modification of these channels in a specific part of the dendritic tree might locally alter these signaling processes. Using dendritic and somatic whole-cell recordings, combined with calcium imaging in rat hippocampal slices, we found that the induction of long-term potentiation (LTP) was accompanied by a local increase in dendritic excitability that was dependent on the activation of NMDA receptors. These changes favored the back-propagation of action potentials into this dendritic region with a subsequent boost in the Ca2+ influx. Dendritic cell-attached patch recordings revealed a hyperpolarized shift in the inactivation curve of transient, A-type K+ currents that can account for the enhanced excitability. These results suggest an important mechanism associated with LTP for shaping signal processing and controlling dendritic function.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Baylor College of Medicine; Marine Biological Laboratory - Woods Hole; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	dan@mossy.bcm.tmc.edu						ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ALKON DL, 1982, SCIENCE, V215, P693, DOI 10.1126/science.7058334; Alonso G, 1997, NEUROSCIENCE, V77, P617; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Colbert CM, 1999, J NEUROSCI, V19, P8163; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; Frick A, 2003, J NEUROSCI, V23, P3243; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Magee J. C., 1999, DENDRITES, P139; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Muller W, 2002, J NEUROPHYSIOL, V87, P2990, DOI 10.1152/jn.00790.2001; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schrader LA, 2002, MOL NEUROBIOL, V25, P51; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Staff NP, 2003, HIPPOCAMPUS, V13, P801, DOI 10.1002/hipo.10129; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Tsubokawa H, 2000, J NEUROSCI, V20, P4878; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	50	311	314	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					126	135		10.1038/nn1178	http://dx.doi.org/10.1038/nn1178			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730307				2022-12-28	WOS:000188468500010
J	Uchida, N; Mainen, ZF				Uchida, N; Mainen, ZF			Speed and accuracy of olfactory discrimination in the rat	NATURE NEUROSCIENCE			English	Article							OSCILLATING NEURAL ASSEMBLIES; ODOR DISCRIMINATION; NETWORK DYNAMICS; BULB; INFORMATION; RESPONSES; MAPS; REPRESENTATIONS; PERCEPTION; SIGNALS	The sense of smell is typically thought of as a 'slow' sense, but the true temporal constraints on the accuracy of olfactory perception are not known. It has been proposed that animals make finer odor discriminations at the expense of additional processing time. To test this idea, we measured the relationship between the speed and accuracy of olfactory discrimination in rats. We found that speed of discrimination was independent of odor similarity, as measured by overlap of glomerular activity patterns. Even when pushed to psychophysical limits using mixtures of two odors, rats needed to take only one sniff (< 200 ms at theta frequency) to make a decision of maximum accuracy. These results show that, for the purpose of odor quality discrimination, a fully refined olfactory sensory representation can emerge within a single sensorimotor or theta cycle, suggesting that each sniff can be considered a snapshot of the olfactory world.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mainen, ZF (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zach@cshl.org		Uchida, Naoshige/0000-0002-5755-9409; Mainen, Zachary/0000-0001-7913-9109	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006104] Funding Source: NIH RePORTER; NIDCD NIH HHS [5R01DC006104-02] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; AMBROSINGERSON J, 1990, SCIENCE, V247, P1344, DOI 10.1126/science.2315702; ATEMA J, 1995, P NATL ACAD SCI USA, V92, P62, DOI 10.1073/pnas.92.1.62; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Cang JH, 2003, J NEUROSCI, V23, P4108; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Chaput MA, 2000, CHEM SENSES, V25, P695, DOI 10.1093/chemse/25.6.695; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; GOLDBERG SJ, 1987, EXP NEUROL, V96, P430, DOI 10.1016/0014-4886(87)90060-4; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Korsching SI, 2001, CELL MOL LIFE SCI, V58, P520, DOI 10.1007/PL00000877; LAING DG, 1986, PHYSIOL BEHAV, V37, P163, DOI 10.1016/0031-9384(86)90400-2; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; Linster C, 2002, J NEUROSCI, V22, P6842; Luce RD, 1986, RESPONSE TIMES THEIR; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2003, BIOCHEM SOC T, V31, P134, DOI 10.1042/bst0310134; NEVITT GA, 1991, J EXP BIOL, V157, P1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; RABINOVICH M, 2001, PHYS REV LETT, V875; Rubin BD, 2001, NAT NEUROSCI, V4, P355, DOI 10.1038/85997; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; SLOTNICK BM, 1990, COMP PERCEPTION, P155; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wise PM, 2000, CHEM SENSES, V25, P247, DOI 10.1093/chemse/25.3.247; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; [No title captured]	47	470	475	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1224	1229		10.1038/nn1142	http://dx.doi.org/10.1038/nn1142			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14566341				2022-12-28	WOS:000186229200023
J	Maeno-Hikichi, Y; Chang, SH; Matsumura, K; Lai, MZ; Lin, H; Nakagawa, N; Kuroda, S; Zhang, JF				Maeno-Hikichi, Y; Chang, SH; Matsumura, K; Lai, MZ; Lin, H; Nakagawa, N; Kuroda, S; Zhang, JF			A PKC epsilon-ENH-channel complex specifically modulates N-type Ca2+ channels	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; DEPENDENT CALCIUM CHANNELS; SYNAPTIC TRANSMISSION; ANCHORING PROTEINS; ION CHANNELS; SIGNAL-TRANSDUCTION; ALPHA(1) SUBUNIT; LIM DOMAINS; BETA-GAMMA; PHOSPHORYLATION	Multiple protein kinase C (PKC) isozymes are present in neurons, where they regulate a variety of cellular functions. Due to the lack of specific PKC isozyme inhibitors, it remains unknown how PKC acts on its selective target(s) and achieves its specific actions. Here we show that a PKC binding protein, enigma homolog (ENH), interacts specifically with both PKCepsilon and N-type Ca2+ channels, forming a PKCepsilon-ENH-Ca2+ channel macromolecular complex. Coexpression of ENH facilitated modulation of N-type Ca2+ channel activity by PKC. Disruption of the complex reduced the potentiation of the channel activity by PKC in neurons. Thus, ENH, by interacting specifically with both PKCepsilon and the N-type Ca2+ channel, targets a specific PKC to its substrate to form a functional signaling complex, which is the molecular mechanism for the specificity and efficiency of PKC signaling.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Neurol Sci, Philadelphia, PA 19104 USA; Osaka Univ, Dept Struct Mol Biol, Inst Sci & Ind Res, Osaka 5670047, Japan	University of Pennsylvania; University of Pennsylvania; Osaka University	Zhang, JF (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	jfzhang@pharm.med.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039355] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39355] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Catterall WA, 1997, ADV SEC MESS PHOSPH, V31, P159; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOLPHIN AC, 1995, EXP PHYSIOL, V80, P1; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; HELL JW, 1994, J BIOL CHEM, V269, P7390; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SAITO N, 1993, BRAIN RES, V607, P241, DOI 10.1016/0006-8993(93)91512-Q; Shapiro MS, 1996, J NEUROPHYSIOL, V76, P311, DOI 10.1152/jn.1996.76.1.311; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Ueki N, 1999, J HUM GENET, V44, P256, DOI 10.1007/s100380050155; Vaughan PFT, 1998, MOL NEUROBIOL, V18, P125, DOI 10.1007/BF02914269; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	49	84	88	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					468	475		10.1038/nn1041	http://dx.doi.org/10.1038/nn1041			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665800				2022-12-28	WOS:000182553200013
J	Otten, LJ; Henson, RNA; Rugg, MD				Otten, LJ; Henson, RNA; Rugg, MD			State-related and item-related neural correlates of successful memory encoding	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; BRAIN ACTIVITY; ACQUISITION; PERFORMANCE; EXPERIENCE; RETRIEVAL; PREDICTS; TASK	Neuroimaging studies show that the efficacy of long-term memory encoding of a stimulus is indexed by transient neural activity elicited by that stimulus. Here, we show that successful memory encoding is also indexed by neural activity that is tonically maintained throughout a study task. Using functional magnetic resonance imaging (fMRI), transient and sustained neural activity were dissociated with a mixed event-related and blocked design. In a series of short task blocks, human subjects made semantic or phonological decisions about visually presented words. After statistically removing item-related activity, we found that the mean level of activity across a task block was correlated with the number of words subsequently remembered from that block. These correlations were found in inferior medial parietal and left prefrontal cortex for the semantic task, and in superior medial parietal cortex for the phonological task. Our findings suggest that state-related activity in these brain regions is involved in memory encoding.	Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Otten, LJ (corresponding author), Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	l.otten@ucl.ac.uk	Henson, Richard/H-8822-2019; Otten, Leun/C-6036-2008	Henson, Richard/0000-0002-0712-2639; 				Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bernstein LJ, 2002, NEUROPSYCHOLOGIA, V40, P86, DOI 10.1016/S0028-3932(01)00070-7; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fernandez G, 2001, BRAIN RES BULL, V55, P1, DOI 10.1016/S0361-9230(01)00494-4; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1997, TRENDS COGN SCI, V1, P21, DOI 10.1016/S1364-6613(97)01001-2; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Henson R, 2001, NEUROIMAGE, V13, pS149; Henson RNA, 1999, J NEUROSCI, V19, P3962; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kucera H., 1967, COMPUTATIONAL ANAL P; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; RUGG MD, IN PRESS HDB MEMORY; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	32	158	161	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1339	1344		10.1038/nn967	http://dx.doi.org/10.1038/nn967			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402040				2022-12-28	WOS:000179447500018
J	Lorincz, A; Notomi, T; Tamas, G; Shigemoto, R; Nusser, Z				Lorincz, A; Notomi, T; Tamas, G; Shigemoto, R; Nusser, Z			Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites	NATURE NEUROSCIENCE			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; CYCLIC-NUCLEOTIDE; RAT HIPPOCAMPUS; GLUTAMATE RECEPTORS; GABA(A) RECEPTORS; I-H; ACTION-POTENTIALS; APICAL DENDRITE; CATION CHANNELS; CA2+ CHANNELS	An ion channel's function depends largely on its location and density on neurons. Here we used high-resolution immunolocalization to determine the subcellular distribution of the hyperpolarization-activated and cyclic-nucleotide-gated channel subunit 1 (HCN1) in rat brain. Light microscopy revealed graded HCN1 immunoreactivity in apical dendrites of hippocampal, subicular and neocortical layer-5 pyramidal cells. Quantitative comparison of immunogold densities showed a 60-fold increase from somatic to distal apical dendritic membranes. Distal dendritic shafts had 16 times more HCN1 labeling than proximal dendrites of similar diameters. At the same distance from the soma, the density of HCN1 was significantly higher in dendritic shafts than in spines. Our results reveal the complex cell surface distribution of voltage-gated ion-channels, and predict its role in increasing the computational power of single neurons via subcellular domain and input-specific mechanisms.	Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary; Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary; Grad Univ Adv Studies, Sch Life Sci, Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi, Japan; Japan Sci & Technol Corp, CREST, Okazaki, Aichi 4448585, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Szeged University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Nusser, Z (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, Szigony St 43, H-1083 Budapest, Hungary.		Tamas, Gabor/AAG-9305-2020; Nusser, Zoltan/K-8587-2014; Shigemoto, Ryuichi/E-3628-2013	Tamas, Gabor/0000-0002-7905-6001; Shigemoto, Ryuichi/0000-0001-8761-9444; Nusser, Zoltan/0000-0001-7004-4111				BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BISCHOFBERGER J, 1995, J PHYSIOL-LONDON, V487, P305, DOI 10.1113/jphysiol.1995.sp020881; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Colbert CM, 1996, J NEUROSCI, V16, P6676; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Petralia RS, 1998, CELL BIOL INT, V22, P603, DOI 10.1006/cbir.1998.0385; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Schwindt PC, 1997, J NEUROPHYSIOL, V78, P187, DOI 10.1152/jn.1997.78.1.187; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Sloviter RS, 2001, J COMP NEUROL, V430, P283; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SOMOGYI P, 1998, PRECISION VARIABILIT, P82; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tsubokawa H, 1999, J PHYSIOL-LONDON, V517, P135, DOI 10.1111/j.1469-7793.1999.0135z.x; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	48	324	329	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1185	1193		10.1038/nn962	http://dx.doi.org/10.1038/nn962			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12389030				2022-12-28	WOS:000178884600022
J	Pardal, R; Lopez-Barneo, J				Pardal, R; Lopez-Barneo, J			Low glucose-sensing cells in the carotid body	NATURE NEUROSCIENCE			English	Article							CHEMORECEPTOR CELLS; GLOMUS CELLS; K+ CURRENT; HYPOGLYCEMIA; HYPOXIA; PLAY		Univ Sevilla, Dept Fisiol, Lab Invest Biomed, E-41013 Seville, Spain; Univ Sevilla, Hosp Univ Virgen Rocio, E-41013 Seville, Spain	University of Sevilla; University of Sevilla; Virgen del Rocio University Hospital	Lopez-Barneo, J (corresponding author), Univ Sevilla, Dept Fisiol, Lab Invest Biomed, E-41013 Seville, Spain.		IBIS, FISIOPATOLOGIA/O-9510-2015; Pardal, Ricardo/C-4370-2015; IBIS, NEUROBIOLOGIA/O-9922-2015	Pardal, Ricardo/0000-0003-1085-0714; 				ALVAREZBUYLLA R, 1994, BRAIN RES, V654, P167, DOI 10.1016/0006-8993(94)91585-7; ALVAREZBUYLLA R, 1988, RESP PHYSIOL, V72, P347, DOI 10.1016/0034-5687(88)90093-X; AUER RN, 1986, STROKE, V17, P699, DOI 10.1161/01.STR.17.4.699; CANE P, 1986, DIABETES, V35, P268, DOI 10.2337/diabetes.35.3.268; DONOVAN CM, 1994, P NATL ACAD SCI USA, V91, P2863, DOI 10.1073/pnas.91.7.2863; GERICH JE, 1988, DIABETES METAB REV, V4, P93, DOI 10.1002/dmr.5610040202; HAVENER AL, 1997, DIABETES, V46, P1521; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; Perez-Garcia MT, 2000, J NEUROSCI, V20, P5689, DOI 10.1523/JNEUROSCI.20-15-05689.2000; ZINKER BA, 1994, AM J PHYSIOL, V266, pE921, DOI 10.1152/ajpendo.1994.266.6.E921	15	159	166	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					197	198		10.1038/nn812	http://dx.doi.org/10.1038/nn812			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850631				2022-12-28	WOS:000174146000007
J	Ignashchenkova, A; Dicke, PW; Haarmeier, T; Thier, P				Ignashchenkova, A; Dicke, PW; Haarmeier, T; Thier, P			Neuron-specific contribution of the superior colliculus to overt and covert shifts of attention	NATURE NEUROSCIENCE			English	Article							SACCADE TARGET SELECTION; EYE-MOVEMENTS; VISUAL-ATTENTION; SPATIAL ATTENTION; LAYER CELLS; MONKEY; RESPONSES; MODULATION; ORGANIZATION; PROBABILITY	The analysis of a peripheral visual location can be improved in two ways: either by orienting one's gaze (usually by making a foveating saccade) or by 'covertly' shifting one's attention to the peripheral location without making an eye movement. The premotor theory of attention holds that saccades and spatial shifts of attention share a common functional module with a distinct neuronal basis. Using single-unit recording from the brains of trained rhesus monkeys, we investigated whether the superior colliculus, the major subcortical center for the control of saccades, is part of this shared network for attention and saccades. Here we show that a distinct type of neuron in the intermediate layer of the superior colliculus, the visuomotor neuron, which is known to be centrally involved in the preparation of saccades, is also active during covert shifts of attention.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, Dept Gen Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Thier, P (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	thier@uni-tuebingen.de	Ignashchenkova, Alla/U-3745-2019	Ignashchenkova, Alla/0000-0002-9444-5945; Thier, Peter/0000-0001-5909-4222				Andersen R A, 1989, Rev Oculomot Res, V3, P315; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Gattass R., 1996, Revista Brasileira de Biologia, V56, P257; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; GRAIGHERO L, 1999, J EXP PSYCHOL HUMAN, V25, P1673; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lunenburger L, 2001, PROG BRAIN RES, V134, P109; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; MOHLER CW, 1976, J NEUROPHYSIOL, V39, P722, DOI 10.1152/jn.1976.39.4.722; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; SHEPARD RN, 1986, J EXP PSYCHOL HUMAN, V12, P383, DOI 10.1037/0096-1523.12.3.383; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Stuphorn V, 2000, J NEUROPHYSIOL, V83, P1283, DOI 10.1152/jn.2000.83.3.1283; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x; Wurtz RH, 1996, INVEST OPHTH VIS SCI, V37, P2131; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	37	288	290	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					56	64		10.1038/nn1169	http://dx.doi.org/10.1038/nn1169			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699418				2022-12-28	WOS:000187636000013
J	Seki, K; Perlmutter, SI; Fetz, EE				Seki, K; Perlmutter, SI; Fetz, EE			Sensory input to primate spinal cord is presynaptically inhibited during voluntary movement	NATURE NEUROSCIENCE			English	Article							PRIMARY AFFERENT DEPOLARIZATION; SOMATOSENSORY-EVOKED-POTENTIALS; POSTSYNAPTIC DORSAL COLUMN; FICTIVE LOCOMOTION; EXCITABILITY CHANGES; CENTRAL TERMINALS; REFLEX RESPONSES; CUNEATE NUCLEUS; MOTOR UNITS; CAT	During normal voluntary movements, re-afferent sensory input continuously converges on the spinal circuits that are activated by descending motor commands. This time-varying input must either be synergistically combined with the motor commands or be appropriately suppressed to minimize interference. The earliest suppression could be produced by presynaptic inhibition, which effectively reduces synaptic transmission at the initial synapse. Here we report evidence from awake, behaving monkeys that presynaptic inhibition decreases the ability of afferent impulses to affect postsynaptic neurons in a behaviorally dependent manner. Evidence indicates that cutaneous afferent input to spinal cord interneurons is inhibited presynaptically during active wrist movement, and this inhibition is effectively produced by descending commands. Our results further suggest that this presynaptic inhibition has appropriate functional consequences for movement generation and may underlie increases in perceptual thresholds during active movement.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Natl Inst Physiol Sci, Dept Integrat Physiol, Aichi 4448585, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Seki, K (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	kazuseki@nips.ac.jp		Seki, Kazuhiko/0000-0002-4262-9590; Perlmutter, Steve/0000-0002-1149-4152	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS012542, R29NS036781, R01NS012542] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00166] Funding Source: Medline; NINDS NIH HHS [NS 12542, NS36781] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P92, DOI 10.1152/jn.1964.27.1.92; ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; BALDISSE.F, 1967, EXPERIENTIA, V23, P398, DOI 10.1007/BF02144542; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; BRINK E, 1984, J NEUROPHYSIOL, V51, P432, DOI 10.1152/jn.1984.51.3.432; BURKE D, 1994, J PHYSIOL-LONDON, V480, P191, DOI 10.1113/jphysiol.1994.sp020352; BURKE RE, 1970, J PHYSIOL-LONDON, V207, P709, DOI 10.1113/jphysiol.1970.sp009090; CAIMS BE, 1996, J NEUROPHYSIOL, V75, P1152; CAPADAY C, 1986, J NEUROSCI, V6, P1308; CARPENTER D, 1963, ACTA PHYSIOL SCAND, V59, P126, DOI 10.1111/j.1748-1716.1963.tb02729.x; CLIFFER KD, 1994, J COMP NEUROL, V345, P84, DOI 10.1002/cne.903450106; Dick SH, 2001, BRAIN RES, V914, P134, DOI 10.1016/S0006-8993(01)02787-1; DUENAS SH, 1988, EXP BRAIN RES, V70, P15; DUYSENS J, 1993, BRAIN RES, V613, P230, DOI 10.1016/0006-8993(93)90903-Z; ECCLES JC, 1963, J NEUROPHYSIOL, V26, P646, DOI 10.1152/jn.1963.26.4.646; ECCLES JC, 1961, J PHYSL, V159, P47; EGGER MD, 1986, BRAIN RES, V383, P68, DOI 10.1016/0006-8993(86)90009-0; EGUIBAR JR, 1994, BRAIN RES, V643, P328, DOI 10.1016/0006-8993(94)90042-6; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; FETZ EE, 1968, J NEUROPHYSIOL, V31, P69, DOI 10.1152/jn.1968.31.1.69; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; FETZ EE, 1989, PROG BRAIN RES, V80, P437; FLAMENT D, 1992, J NEUROPHYSIOL, V67, P875, DOI 10.1152/jn.1992.67.4.875; FRANK K, 1959, IRE T MED ELECTRON, V6, P85, DOI 10.1109/IRET-ME.1959.5007923; GARNETT R, 1980, J PHYSIOL-LONDON, V303, P351, DOI 10.1113/jphysiol.1980.sp013290; GOSSARD JP, 1990, BRAIN RES, V537, P14, DOI 10.1016/0006-8993(90)90334-8; Haugland M., 1996, 18 ANN INT C IEEE EN; HONGO T, 1989, BRAIN RES, V505, P167, DOI 10.1016/0006-8993(89)90132-7; HULLIGER M, 1979, J PHYSIOL-LONDON, V291, P233, DOI 10.1113/jphysiol.1979.sp012809; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; JANIG W, 1968, EXP BRAIN RES, V6, P116; Jankowska E, 2002, J PHYSIOL-LONDON, V542, P287, DOI 10.1113/jphysiol.2001.014068; JENNER JR, 1982, J PHYSIOL-LONDON, V333, P405, DOI 10.1113/jphysiol.1982.sp014461; JIMENEZ I, 1987, EXP BRAIN RES, V69, P195; KRIZ N, 1974, J PHYSIOL-LONDON, V238, P1; Menard A, 2002, J NEUROPHYSIOL, V88, P163, DOI 10.1152/jn.2002.88.1.163; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; MORRISON AR, 1966, NATURE, V210, P201, DOI 10.1038/210201a0; MOSCHOVAKIS AK, 1991, EXP BRAIN RES, V83, P489; NIELSEN J, 1993, J PHYSIOL-LONDON, V464, P575, DOI 10.1113/jphysiol.1993.sp019652; PECCISAA.J, 1966, NATURE, V210, P740, DOI 10.1038/210740a0; Perlmutter SI, 1998, J NEUROPHYSIOL, V80, P2475, DOI 10.1152/jn.1998.80.5.2475; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; RUSHTON DN, 1981, BRAIN, V104, P465, DOI 10.1093/brain/104.3.465; RUSTIONI A, 1977, SCIENCE, V196, P656, DOI 10.1126/science.404704; RUSTIONI A, 1979, BRAIN, V102, P95, DOI 10.1093/brain/102.1.95; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; WALL PD, 1958, J PHYSIOL-LONDON, V142, P1; Willis Jr W. D., 1991, SENSORY MECH SPINAL	50	199	202	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1309	1316		10.1038/nn1154	http://dx.doi.org/10.1038/nn1154			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625555				2022-12-28	WOS:000186725600016
J	Shimojo, S; Simion, C; Shimojo, E; Scheier, C				Shimojo, S; Simion, C; Shimojo, E; Scheier, C			Gaze bias both reflects and influences preference	NATURE NEUROSCIENCE			English	Article							STIMULI; EMOTION; CANNOT	Emotions operate along the dimension of approach and aversion, and it is reasonable to assume that orienting behavior is intrinsically linked to emotionally involved processes such as preference decisions. Here we describe a gaze 'cascade effect' that was present when human observers were shown pairs of human faces and instructed to decide which face was more attractive. Their gaze was initially distributed evenly between the two stimuli, but then gradually shifted toward the face that they eventually chose. Gaze bias was significantly weaker in a face shape discrimination task. In a second series of experiments, manipulation of gaze duration, but not exposure duration alone, biased observers' preference decisions. We thus conclude that gaze is actively involved in preference formation. The gaze cascade effect was also present when participants compared abstract, unfamiliar shapes for attractiveness, suggesting that orienting and preference for objects in general are intrinsically linked in a positive feedback loop leading to the conscious choice.	CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA; NTT Corp, Commun Sci Labs, Human Informat Sci Lab, Kanagawa 2430198, Japan; Bunkyo Gakuin Univ, Dept Human Studies, Oimachi, Saitama 354, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Shimojo, S (corresponding author), CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA.	sshimojo@its.caltech.edu						BIRCH EE, 1985, INVEST OPHTH VIS SCI, V26, P366; BUTTERWORTH G, 1991, BRIT J DEV PSYCHOL, V9, P55, DOI 10.1111/j.2044-835X.1991.tb00862.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; FANTZ RL, 1961, SCI AM, V204, P66, DOI 10.1038/scientificamerican0561-66; James W., 1884, MIND Q REV PSYCHOL P, V9, P188, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188, https://doi.org/10.1093/mind/os-IX.34.188]; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; LAIRD JD, 1974, J PERS SOC PSYCHOL, V29, P475, DOI 10.1037/h0036125; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; MANDLER G, 1987, J EXP PSYCHOL LEARN, V13, P646, DOI 10.1037/0278-7393.13.4.646; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; PATTERSON ML, 1982, PSYCHOL REV, V89, P231, DOI 10.1037/0033-295X.89.3.231; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SCHACHTER S, 1964, ADV EXP SOC PSYCHOL, V1, P49, DOI 10.1016/S0065-2601(08)60048-9; Tomkins SS, 1962, AFFECT IMAGERY CONSC, V1; VESSEL EA, 2002, J VIS, V2, P492, DOI DOI 10.1167/2.7.492; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492	19	503	519	5	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1317	1322		10.1038/nn1150	http://dx.doi.org/10.1038/nn1150			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	746BC	14608360				2022-12-28	WOS:000186725600017
J	Rong, R; Ahn, JY; Huang, HL; Nagata, E; Kalman, D; Kapp, JA; Tu, JC; Worley, PF; Snyder, SH; Ye, KQ				Rong, R; Ahn, JY; Huang, HL; Nagata, E; Kalman, D; Kapp, JA; Tu, JC; Worley, PF; Snyder, SH; Ye, KQ			PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; GROUP-I; PHOSPHOINOSITIDE 3-KINASE; PHOSPHOLIPASE C-GAMMA-1; INOSITOL TRISPHOSPHATE; NUCLEAR GTPASE; PROTEIN; ACTIVATION; FAMILY	Phosphoinositide 3 kinase enhancer (PIKE) is a recently identified nuclear GTPase that activates nuclear phosphoinositide 3-kinase (PI3 kinase). We have identified, cloned and characterized a new form of PIKE, designated PIKE-L, which, unlike the nuclear PIKE-S, localizes to both the cytoplasm and the nucleus. We demonstrate physiologic binding of PIKE-L to Homer, an adaptor protein known to link metabotropic glutamate receptors to multiple intracellular targets including the inositol 1,4,5-trisphosphate receptor (IP3R). We show that activation of group I metabotropic glutamate receptors (mGluRIs) enhances formation of an mGluRI-Homer-PIKE-L complex, leading to activation of PI3 kinase activity and prevention of neuronal apoptosis. Our findings indicate that this complex mediates the well-known ability of agonists of mGluRI to prevent neuronal apoptosis.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Emory University; Johns Hopkins University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Room 145,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu	huang, Honglian/E-8679-2010		NINDS NIH HHS [R01 NS045627] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Anneser JMH, 1998, NEUROREPORT, V9, P2039; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bernstein HG, 1998, CELL MOL BIOL, V44, P973; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; COPANI A, 1995, J NEUROCHEM, V64, P101; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; De Blasi A, 2001, TRENDS PHARMACOL SCI, V22, P114, DOI 10.1016/S0165-6147(00)01635-7; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Ferraguti F, 1999, EUR J NEUROSCI, V11, P2073, DOI 10.1046/j.1460-9568.1999.00626.x; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HUANG PS, 1995, FEBS LETT, V358, P287, DOI 10.1016/0014-5793(94)01453-8; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; Khodakhah K, 1997, BIOPHYS J, V73, P3349, DOI 10.1016/S0006-3495(97)78359-0; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lu YM, 1997, J NEUROSCI, V17, P5196; Maiese K, 1999, NEUROSCI LETT, V264, P17, DOI 10.1016/S0304-3940(99)00199-8; Maiese K, 2000, J NEUROSCI RES, V62, P257, DOI 10.1002/1097-4547(20001015)62:2<257::AID-JNR10>3.0.CO;2-H; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vincent AM, 2000, EXP NEUROL, V166, P65, DOI 10.1006/exnr.2000.7487; Xia CZ, 2003, MOL CELL BIOL, V23, P2476, DOI 10.1128/MCB.23.7.2476-2488.2003; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999	46	225	242	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1153	1161		10.1038/nn1134	http://dx.doi.org/10.1038/nn1134			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14528310				2022-12-28	WOS:000186229200014
J	Zhang, ZZ; Bourque, CW				Zhang, ZZ; Bourque, CW			Osmometry in osmosensory neurons	NATURE NEUROSCIENCE			English	Article							MEMBRANE TENSION; MECHANISMS; CHANNELS	Mechanosensitive channels may act as osmosensory transducers because osmotically evoked changes in cell volume alter forces applied to the channel and affect opening probability(1-4). However, osmotically stimulated cells regulate volume(5) normally, whereas systemic osmoregulatory responses are sustained(6,7). Here we report that osmosensory neurons of rat supraoptic nucleus expressed significant membrane reserves, and could not regulate volume or total membrane surface area during osmotic perturbations, which may allow mechanosensitive channels to encode the amplitude and time course of an osmotic stimulus.	Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Bourque, CW (corresponding author), Montreal Gen Hosp, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.			Bourque, Charles/0000-0002-1594-742X				BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; Colbert HA, 1997, J NEUROSCI, V17, P8259; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; Pasantes-Morales H, 2002, ARCH MED RES, V33, P237, DOI 10.1016/S0188-4409(02)00353-3; PASANTESMORALES H, 1993, J NEUROSCI RES, V34, P219, DOI 10.1002/jnr.490340209; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; ROSS PE, 1994, BIOPHYS J, V66, P169, DOI 10.1016/S0006-3495(94)80754-4; STRANGE K, 1992, AM J PHYSIOL, V263, P412; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; VERBALIS JG, 1986, AM J PHYSIOL, V250, P444; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8	14	79	79	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1021	1022		10.1038/nn1124	http://dx.doi.org/10.1038/nn1124			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973356				2022-12-28	WOS:000185633600012
J	Mrsic-Flogel, TD; Schnupp, JWH; King, AJ				Mrsic-Flogel, TD; Schnupp, JWH; King, AJ			Acoustic factors govern developmental sharpening of spatial tuning in the auditory cortex	NATURE NEUROSCIENCE			English	Article							ANTEROVENTRAL COCHLEAR NUCLEUS; FERRET MUSTELA-PUTORIUS; LATERAL SUPERIOR OLIVE; SOUND-LOCALIZATION; POSTNATAL-DEVELOPMENT; INFERIOR COLLICULUS; RECEPTIVE-FIELDS; CORTICAL-NEURONS; CAT; SENSITIVITY	Auditory localization relies on the detection and interpretation of acoustic cues that change in value as the head and external ears grow. Here we show that the maturation of these structures is an important determinant for the development of spatial selectivity in the ferret auditory cortex. Spatial response fields (SRFs) of high-frequency cortical neurons recorded at postnatal days (P) 33-39 were broader, and transmitted less information about stimulus direction, than in older ferrets. They also exhibited slightly broader frequency tuning than neurons recorded in adult animals. However, when infant neurons were stimulated through virtual ears of adults, SRFs sharpened significantly and the amount of transmitted information increased. This improvement was predicted by a model that generates SRF shape from the localization cue values and the neurons' binaural spectrotemporal response properties. The maturation of spatial response characteristics in auditory cortex therefore seems to be limited by peripheral rather than by central factors.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Oxford	King, AJ (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.	ajk@physiol.ox.ac.uk	King, Andrew J/M-6708-2013; schnupp, jan/A-3006-2012	King, Andrew J/0000-0001-5180-7179; schnupp, jan w h/0000-0002-2604-0057; Mrsic-Flogel, Tom/0000-0002-8947-408X				BLATCHLEY BJ, 1990, J NEUROPHYSIOL, V64, P582, DOI 10.1152/jn.1990.64.2.582; BROWN PE, 1978, J COMP PHYSIOL, V126, P169, DOI 10.1007/BF00666371; BRUGGE JF, 1988, HEARING RES, V34, P127, DOI 10.1016/0378-5955(88)90100-1; Brugge JF, 1996, J NEUROSCI, V16, P4420; BRUGGE JF, 1994, HEARING RES, V73, P67, DOI 10.1016/0378-5955(94)90284-4; BRUGGE JF, 1978, J NEUROPHYSIOL, V41, P1557, DOI 10.1152/jn.1978.41.6.1557; BRUGGE JF, 1981, HEARING RES, V5, P217, DOI 10.1016/0378-5955(81)90047-2; BRUGGE JF, 1985, HEARING RES, V20, P275, DOI 10.1016/0378-5955(85)90032-2; CANT NB, 1998, DEV AUDITORY SYSTEM, P315; CARLILE S, 1991, HEARING RES, V51, P265, DOI 10.1016/0378-5955(91)90043-9; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; CLIFTON RK, 1988, DEV PSYCHOL, V24, P477, DOI 10.1037/0012-1649.24.4.477; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Fitzakerley JL, 1998, J ACOUST SOC AM, V103, P3464, DOI 10.1121/1.423055; Furukawa S, 2002, J NEUROPHYSIOL, V87, P1749, DOI 10.1152/jn.00491.2001; Gao WJ, 1999, J COMP NEUROL, V409, P261, DOI 10.1002/(SICI)1096-9861(19990628)409:2<261::AID-CNE7>3.0.CO;2-R; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; Golomb D, 1997, NEURAL COMPUT, V9, P649, DOI 10.1162/neco.1997.9.3.649; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; JACOBS DS, 1988, VISION RES, V28, P947, DOI 10.1016/0042-6989(88)90104-6; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; KELLY JB, 1986, HEARING RES, V24, P111, DOI 10.1016/0378-5955(86)90054-7; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; King AJ, 2000, P NATL ACAD SCI USA, V97, P11821, DOI 10.1073/pnas.97.22.11821; King Andrew J., 1995, P279; Kiorpes L., 1990, P125; Kotak VC, 2000, J NEUROSCI, V20, P5820, DOI 10.1523/JNEUROSCI.20-15-05820.2000; MIDDLEBROOKS JC, 1990, J ACOUST SOC AM, V87, P2149, DOI 10.1121/1.399183; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MOORE DR, 1979, BRAIN RES, V163, P49, DOI 10.1016/0006-8993(79)90150-1; MOORE DR, 1992, DEV BRAIN RES, V66, P229, DOI 10.1016/0165-3806(92)90084-A; MOORE DR, 1981, EXP BRAIN RES, V41, P301; MOORE DR, 1979, ACTA OTO-LARYNGOL, V87, P434, DOI 10.3109/00016487909126447; Mrsic-Flogel TD, 2001, J NEUROPHYSIOL, V86, P1043, DOI 10.1152/jn.2001.86.2.1043; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; RUBSAMEN R, 1998, DEV AUDITORY SYSTEM, P193; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; SANES DH, 1998, DEV AUDITORY SYSTEM, P271; Schnupp JWH, 2003, J ACOUST SOC AM, V113, P2021, DOI 10.1121/1.1547460; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Werner L. A, 1998, DEV AUDITORY SYSTEM, P12; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WOOLF NK, 1985, DEV BRAIN RES, V17, P131, DOI 10.1016/0165-3806(85)90138-5; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	50	51	52	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					981	988		10.1038/nn1108	http://dx.doi.org/10.1038/nn1108			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12910241				2022-12-28	WOS:000184970400018
J	Behrens, TEJ; Johansen-Berg, H; Woolrich, MW; Smith, SM; Wheeler-Kingshott, CAM; Boulby, PA; Barker, GJ; Sillery, EL; Sheehan, K; Ciccarelli, O; Thompson, AJ; Brady, JM; Matthews, PM				Behrens, TEJ; Johansen-Berg, H; Woolrich, MW; Smith, SM; Wheeler-Kingshott, CAM; Boulby, PA; Barker, GJ; Sillery, EL; Sheehan, K; Ciccarelli, O; Thompson, AJ; Brady, JM; Matthews, PM			Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging	NATURE NEUROSCIENCE			English	Article							RHESUS-MONKEY; WHITE-MATTER; HUMAN BRAIN; CORTICAL CONNECTIONS; AXONAL PROJECTIONS; PREFRONTAL CORTEX; FRONTAL-LOBE; TENSOR; NUCLEUS; TRACTOGRAPHY	Evidence concerning anatomical connectivities in the human brain is sparse and based largely on limited post-mortem observations. Diffusion tensor imaging has previously been used to define large white-matter tracts in the living human brain, but this technique has had limited success in tracing pathways into gray matter. Here we identified specific connections between human thalamus and cortex using a novel probabilistic tractography algorithm with diffusion imaging data. Classification of thalamic gray matter based on cortical connectivity patterns revealed distinct subregions whose locations correspond to nuclei described previously in histological studies. The connections that we found between thalamus and cortex were similar to those reported for non-human primates and were reproducible between individuals. Our results provide the first quantitative demonstration of reliable inference of anatomical connectivity between human gray matter structures using diffusion data and the first connectivity-based segmentation of gray matter.	Univ Oxford, John Radcliffe Hosp, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; Univ Oxford, Dept Engn Sci, Med Vis Lab, Oxford OX1 3PJ, England; UCL, Inst Neurol, London WC1N 3BG, England	University of Oxford; University of Oxford; University of London; University College London	Johansen-Berg, H (corresponding author), Univ Oxford, John Radcliffe Hosp, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England.	heidi@fmrib.ox.ac.uk	Barker, Gareth J/C-9616-2009; Warfield, Simon/B-3352-2009; Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019; Thompson, Alan J/C-2654-2008	Barker, Gareth J/0000-0002-5214-7421; Warfield, Simon/0000-0002-7659-3880; Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Thompson, Alan J/0000-0002-4333-8496; Woolrich, Mark/0000-0001-8460-8854; Smith, Stephen/0000-0001-8166-069X; Matthews, Paul M/0000-0002-1619-8328; Behrens, Timothy/0000-0003-0048-1177; Smith, Shubulade/0000-0002-3797-6985; Johansen-Berg, Heidi/0000-0002-4134-9730				AGGLETON JP, 1984, J COMP NEUROL, V222, P56, DOI 10.1002/cne.902220106; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; ASANUMA C, 1983, BRAIN RES REV, V5, P219, DOI 10.1016/0165-0173(83)90014-0; ASANUMA C, 1983, BRAIN RES REV, V5, P237, DOI 10.1016/0165-0173(83)90015-2; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; CARPENTER M, 1978, NEUROANATOMY; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Gilks W. R., 1996, MARKOV CHAIN MONTE C; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; JONES EG, 1979, J COMP NEUROL, V183, P833, DOI 10.1002/cne.901830410; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; Jones EG, 1985, THALAMUS; KIEVIT J, 1977, EXP BRAIN RES, V29, P299; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Lee P.M., 1997, BAYESIAN STAT INTRO; Magnotta VA, 2000, NEUROIMAGE, V11, P341, DOI 10.1006/nimg.2000.0552; MARKOWITSCH HJ, 1985, J COMP NEUROL, V242, P425, DOI 10.1002/cne.902420310; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Morel A, 1997, J COMP NEUROL, V387, P588, DOI 10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MUFSON EJ, 1990, NEUROBIOL AGING, V11, P649, DOI 10.1016/0197-4580(90)90031-T; PARENT A, 1983, NEUROSCIENCE, V10, P1137, DOI 10.1016/0306-4522(83)90104-5; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pollak P, 2002, MOVEMENT DISORD, V17, pS75, DOI 10.1002/mds.10146; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; RACZKOWSKI D, 1980, J COMP NEUROL, V193, P1, DOI 10.1002/cne.901930102; RUSSCHEN FT, 1987, J COMP NEUROL, V256, P175, DOI 10.1002/cne.902560202; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Speelman JD, 2002, MOVEMENT DISORD, V17, pS84, DOI 10.1002/mds.10147; TANAKA D, 1976, BRAIN RES, V110, P21, DOI 10.1016/0006-8993(76)90206-7; TOBIAS TJ, 1975, BRAIN RES, V83, P191, DOI 10.1016/0006-8993(75)90930-0; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; VANBUREN JM, 1972, VARIATIONS CONNECTIO, V1; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; WEBSTER MJ, 1993, J COMP NEUROL, V335, P73, DOI 10.1002/cne.903350106; YARITA H, 1980, J NEUROPHYSIOL, V43, P69, DOI 10.1152/jn.1980.43.1.69; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	50	1738	1773	5	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					750	757		10.1038/nn1075	http://dx.doi.org/10.1038/nn1075			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12808459				2022-12-28	WOS:000183780400024
J	Xu, BJ; Goulding, EH; Zang, KL; Cepoi, D; Cone, RD; Jones, KR; Tecott, LH; Reichardt, LF				Xu, BJ; Goulding, EH; Zang, KL; Cepoi, D; Cone, RD; Jones, KR; Tecott, LH; Reichardt, LF			Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTROMEDIAL NUCLEUS; FOOD-INTAKE; EFFERENT CONNECTIONS; TARGETED DISRUPTION; OBESITY; HYPOTHALAMUS; LESIONS; MICE; LEPTIN	The melanocortin-4 receptor (MC4R) is critically involved in regulating energy balance, and obesity has been observed in mice with mutations in the gene for brain-derived neurotrophic factor (BDNF). Here we report that BDNF is expressed at high levels in the ventromedial hypothalamus (VMH) where its expression is regulated by nutritional state and by MC4R signaling. In addition, similar to MC4R mutants, mouse mutants that expresses the BDNF receptor TrkB at a quarter of the normal amount showed hyperphagia and excessive weight gain on higher-fat diets. Furthermore, BDNF infusion into the brain suppressed the hyperphagia and excessive weight gain observed on higher-fat diets in mice with deficient MC4R signaling. These results show that MC4R signaling controls BDNF expression in the VMH and support the hypothesis that BDNF is an important effector through which MC4R signaling controls energy balance.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; University of Colorado System; University of Colorado Boulder	Xu, BJ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	bx3@georgetown.edu; lfr@cgl.ucsf.edu		JONES, KEVIN/0000-0002-3802-7562	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-21, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagnol D, 1999, J NEUROSCI, V19; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bennett JL, 1999, INVEST OPHTH VIS SCI, V40, P2996; Benoit SC, 2002, J NEUROSCI, V22, P9048; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; BROOKS CM, 1946, AM J PHYSIOL, V147, P735, DOI 10.1152/ajplegacy.1946.147.4.735; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; DECKNER ML, 1993, NEUROREPORT, V5, P301, DOI 10.1097/00001756-199312000-00030; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fritzsch B, 1997, INT J DEV NEUROSCI, V15, P563, DOI 10.1016/S0736-5748(96)00111-6; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hetherington AW, 1942, J COMP NEUROL, V76, P475, DOI 10.1002/cne.900760308; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; KRIEGER MS, 1979, J COMP NEUROL, V183, P785, DOI 10.1002/cne.901830408; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Nonomura T, 2001, Int J Exp Diabetes Res, V2, P201, DOI 10.1155/EDR.2001.201; Ono M, 1997, BIOCHEM BIOPH RES CO, V238, P633, DOI 10.1006/bbrc.1997.7220; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SHIMIZU N, 1987, BRAIN RES, V416, P153, DOI 10.1016/0006-8993(87)91508-3; SKULTETY FM, 1966, ARCH NEUROL-CHICAGO, V14, P670, DOI 10.1001/archneur.1966.00470120102013; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; TERHORST GJ, 1987, BRAIN RES BULL, V18, P191, DOI 10.1016/0361-9230(87)90190-0; Tsuchida A, 2001, INT J OBESITY, V25, P1286, DOI 10.1038/sj.ijo.0801678; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Zhang CX, 1997, NEUROREPORT, V8, P1013, DOI 10.1097/00001756-199703030-00039	45	646	673	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					736	742		10.1038/nn1073	http://dx.doi.org/10.1038/nn1073			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12796784	Green Accepted			2022-12-28	WOS:000183780400022
J	Derjean, D; Bertrand, S; Le Masson, G; Landry, M; Morisset, V; Nagy, F				Derjean, D; Bertrand, S; Le Masson, G; Landry, M; Morisset, V; Nagy, F			Dynamic balance of metabotropic inputs causes dorsal horn neurons to switch functional states	NATURE NEUROSCIENCE			English	Article							TURTLE SPINAL-CORD; PLATEAU POTENTIALS; RECEPTOR ACTIVATION; GLUTAMATE RECEPTORS; RESPONSE PROPERTIES; INHIBITORY CONTROL; GABA(B) RECEPTOR; NUCLEUS NEURONS; IN-VITRO; RAT	Sensory relay structures in the spinal cord dorsal horn are now thought to be active processing structures that function before supraspinal sensory integration. Dorsal horn neurons directly receive nociceptive (pain) signals from the periphery, express a high degree of functional plasticity and are involved in long-term sensitization and chronic pain. We show here that deep dorsal horn neurons (DHNs) in Wistar rats can switch their intrinsic firing properties from tonic to plateau or endogenous bursting patterns, depending upon the balance of control by metabotropic glutamate (mGlu) and GABA(B) receptors. We further show that this modulation acts on at least one common target, the inwardly rectifying potassium channel (Kir3). Finally, we found that these firing modes correspond to specific functional states of information transfer in which dorsal horn neurons can faithfully transmit, greatly enhance or block the transfer of nociceptive information.	Univ Bordeaux 2, INSERM E0358, Inst Francois Magendie, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Nagy, F (corresponding author), Univ Bordeaux 2, INSERM E0358, Inst Francois Magendie, F-33076 Bordeaux, France.		Bertrand, Sandrine/P-9290-2015	Bertrand, Sandrine S/0000-0002-3020-7980				ADRIAENSEN H, 1983, J NEUROPHYSIOL, V49, P111, DOI 10.1152/jn.1983.49.1.111; Asada H, 1996, NEUROSCI LETT, V213, P99, DOI 10.1016/0304-3940(96)12844-5; Baranauskas G, 1998, PROG NEUROBIOL, V54, P349, DOI 10.1016/S0301-0082(97)00067-1; Bettler B, 1998, CURR OPIN NEUROBIOL, V8, P345, DOI 10.1016/S0959-4388(98)80059-7; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; CALVINO B, 1987, PAIN, V28, P81, DOI 10.1016/0304-3959(87)91063-3; COOK AJ, 1987, NATURE, V325, P151, DOI 10.1038/325151a0; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; DE KONINCK Y, 1991, P NATL ACAD SCI USA, V88, P11344, DOI 10.1073/pnas.88.24.11344; DelgadoLezama R, 1997, J PHYSIOL-LONDON, V504, P97, DOI 10.1111/j.1469-7793.1997.097bf.x; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DiPrisco GV, 1997, SCIENCE, V278, P1122, DOI 10.1126/science.278.5340.1122; HAO JX, 1992, J NEUROPHYSIOL, V68, P392, DOI 10.1152/jn.1992.68.2.392; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; INOKUCHI H, 1992, NEUROSCIENCE, V46, P657, DOI 10.1016/0306-4522(92)90152-R; JIANG MC, 1995, J NEUROPHYSIOL, V74, P1819, DOI 10.1152/jn.1995.74.5.1819; Jiang MC, 1999, J NEUROPHYSIOL, V81, P3078, DOI 10.1152/jn.1999.81.6.3078; KANGRGA I, 1991, BRAIN RES, V562, P265, DOI 10.1016/0006-8993(91)90630-E; Kawasaki H, 1999, J NEUROPHYSIOL, V82, P2590, DOI 10.1152/jn.1999.82.5.2590; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; LeMasson G, 1995, PROG BIOPHYS MOL BIO, V64, P201, DOI 10.1016/S0079-6107(96)00004-1; Levine MW, 1998, BIOSYSTEMS, V48, P139, DOI 10.1016/S0303-2647(98)00059-8; Lin Q, 1996, J NEUROPHYSIOL, V75, P109, DOI 10.1152/jn.1996.75.1.109; Lo FS, 2002, J NEUROPHYSIOL, V88, P794, DOI 10.1152/jn.2002.88.2.794; LOMBARD MC, 1983, ADV PAIN RES THER, P147; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Morisset V, 2000, EUR J NEUROSCI, V12, P3087, DOI 10.1046/j.1460-9568.2000.00188.x; Morisset V, 1999, J NEUROSCI, V19, P7309, DOI 10.1523/JNEUROSCI.19-17-07309.1999; Morisset V, 1998, EUR J NEUROSCI, V10, P3642, DOI 10.1046/j.1460-9568.1998.00370.x; Neugebauer V, 2002, PAIN, V98, P1, DOI 10.1016/S0304-3959(02)00140-9; RUSSO RE, 1994, NEUROSCIENCE, V61, P191, DOI 10.1016/0306-4522(94)90222-4; Russo RE, 1998, J PHYSIOL-LONDON, V506, P795, DOI 10.1111/j.1469-7793.1998.795bv.x; Russo RE, 1999, PROG BIOPHYS MOL BIO, V72, P329, DOI 10.1016/S0079-6107(99)00011-5; Russo RE, 1996, J PHYSIOL-LONDON, V493, P39, DOI 10.1113/jphysiol.1996.sp021363; Russo RE, 1997, J PHYSIOL-LONDON, V499, P459, DOI 10.1113/jphysiol.1997.sp021941; Schneider SP, 1998, J NEUROPHYSIOL, V80, P2954, DOI 10.1152/jn.1998.80.6.2954; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sodickson DL, 1996, J NEUROSCI, V16, P6374; SOTGIU ML, 1995, NEUROREPORT, V6, P1021, DOI 10.1097/00001756-199505090-00018; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tennigkeit F, 1999, J NEUROPHYSIOL, V82, P718, DOI 10.1152/jn.1999.82.2.718; URBAN L, 1994, TRENDS NEUROSCI, V17, P432, DOI 10.1016/0166-2236(94)90018-3; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WOOLF CJ, 1989, J NEUROPHYSIOL, V62, P907, DOI 10.1152/jn.1989.62.4.907	50	96	104	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					274	281		10.1038/nn1016	http://dx.doi.org/10.1038/nn1016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592405				2022-12-28	WOS:000181178300016
J	Dyer, JR; Michel, S; Lee, W; Castellucci, VF; Wayne, NL; Sossin, WS				Dyer, JR; Michel, S; Lee, W; Castellucci, VF; Wayne, NL; Sossin, WS			An activity-dependent switch to cap-independent translation triggered by eIF4E dephosphorylation	NATURE NEUROSCIENCE			English	Article							INITIATION-FACTOR 4E; NERVOUS-SYSTEM; APLYSIA; PHOSPHORYLATION; FACILITATION		McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada	McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universite de Montreal	Sossin, WS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033548] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS 33548] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dyer JR, 2000, J NEUROCHEM, V75, P872, DOI 10.1046/j.1471-4159.2000.0750872.x; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; Lee WJ, 1998, ENDOCRINOLOGY, V139, P5109, DOI 10.1210/en.139.12.5109; MAHON AC, 1985, J NEUROSCI, V5, P1872; Manseau F, 2001, J NEUROSCI, V21, P1247; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Yanow SK, 1998, J NEUROCHEM, V70, P572	10	53	54	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					219	220		10.1038/nn1018	http://dx.doi.org/10.1038/nn1018			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592407				2022-12-28	WOS:000181178300008
J	Tarr, MJ; Warren, WH				Tarr, MJ; Warren, WH			Virtual reality in behavioral neuroscience and beyond	NATURE NEUROSCIENCE			English	Review							FLOW; TECHNOLOGY	Virtual reality (VR) has finally come of age for serious applications in the behavioral neurosciences. After capturing the public imagination a decade ago, enthusiasm for VR flagged due to hardware limitations, an absent commercial market and manufacturers who dropped the mass-market products that normally drive technological development. Recently, however, improvements in computer speed, quality of head-mounted displays and wide-area tracking systems have made VR attractive for both research and real-world applications in neuroscience, cognitive science and psychology. New and exciting applications for VR have emerged in research, training, rehabilitation, teleoperation, virtual archeology and tele-immersion.	Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; Brown Univ, Brain Sci Program, Providence, RI 02912 USA	Brown University; Brown University	Tarr, MJ (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.		Warren, William H./AAX-7781-2021		NATIONAL EYE INSTITUTE [R01EY010923] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010923] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aginsky V, 1997, J ENVIRON PSYCHOL, V17, P317, DOI 10.1006/jevp.1997.0070; [Anonymous], 2002, BBC NEWS ONLINE; Cruz-Neira C., 1994, COMMUN ACM, V35, P65; FOLEY JD, 1987, SCI AM, V257, P126, DOI 10.1038/scientificamerican1087-126; GIBSON JJ, 1979, ECOLOGICAL APPROACH, V3; HAFNER K, 1998, NY TIMES        1119; Kearns MJ, 2002, PERCEPTION, V31, P349, DOI 10.1068/p3311; Lanier J, 2001, SCI AM, V284, P66, DOI 10.1038/scientificamerican0401-66; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; North MM, 1997, PRESENCE-TELEOP VIRT, V6, P127, DOI 10.1162/pres.1997.6.1.127; North MM, 1996, PRESENCE-TELEOP VIRT, V5, P346, DOI 10.1162/pres.1996.5.3.346; NORTH MN, 1998, VIRTUAL ENV CLIN PSY, P112; RIVA G, 1998, VIRTUAL ENV CLIN PSY, P191; Riva G., 1998, VIRTUAL ENV CLIN PSY; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Spiro JE, 2001, NAT NEUROSCI, V4, P120, DOI 10.1038/83930; van Veen HAHC, 1998, FUTURE GENER COMP SY, V14, P231, DOI 10.1016/S0167-739X(98)00027-2; Vote E, 2002, IEEE COMPUT GRAPH, V22, P38, DOI 10.1109/MCG.2002.1028725; Wanke L A, 1998, Pharm Pract Manag Q, V18, P13; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; ZHANG S, IN PRESS IEEE T VISU	22	163	166	2	55	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1089	1092		10.1038/nn948	http://dx.doi.org/10.1038/nn948			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403993				2022-12-28	WOS:000179041300021
J	Yu, TW; Hao, JC; Lim, W; Tessier-Lavigne, M; Bargmann, CI				Yu, TW; Hao, JC; Lim, W; Tessier-Lavigne, M; Bargmann, CI			Shared receptors in axon guidance: SAX-3/Robo signals via UNC-34/enabled and a Netrin-independent UNC-40/DCC function	NATURE NEUROSCIENCE			English	Article							GROWTH CONE MIGRATIONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; LISTERIA-MONOCYTOGENES; COLORECTAL-CANCER; TYROSINE KINASE; SLIT PROTEINS; CNS MIDLINE; DROSOPHILA; GENES	The C. elegans SAX-3/Robo receptor acts in anterior-posterior, dorsal-ventral and midline guidance decisions. Here we show that SAX-3 signaling involves the C. elegans Enabled protein UNC-34 and an unexpected Netrin-independent function of the Netrin receptor UNC-40/DCC. Genetic interactions with gain- and loss-of-function mutations suggest that unc-34 and unc-40 act together with sax-3 in several guidance decisions, but the C. elegans Netrin gene unc-6 does not act in the same genetic pathways. Within the migrating axon, sax-3, unc-34 and unc-40 all act cell-autonomously. Our results support a role for UNC-34/Enabled proteins in SAX-3-mediated repulsion, and show that UNC-40/DCC can potentiate SAX-3/Robo signaling via a mechanism that may involve direct binding of the two guidance receptors. A combinatorial logic dictates alternative functions for UNC-40/DCC, which can act in attraction to UNC-6/Netrin, repulsion from Netrin (with UNC-5), or repulsion from Slit (with SAX-3).	Univ Calif San Francisco, Dept Anat, Program Neurosci, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Dept Anat, Program Neurosci, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu	Yu, Timothy W./AAF-5738-2019	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618				Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Guthrie S, 2001, CURR BIOL, V11, pR300, DOI 10.1016/S0960-9822(01)00169-5; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kim S, 1999, DEVELOPMENT, V126, P3881; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sun Q, 2000, DEVELOPMENT, V127, P801; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	50	122	132	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1147	1154		10.1038/nn956	http://dx.doi.org/10.1038/nn956			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379860				2022-12-28	WOS:000178884600017
J	Saenz, M; Buracas, GT; Boynton, GM				Saenz, M; Buracas, GT; Boynton, GM			Global effects of feature-based attention in human visual cortex	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; SPATIAL ATTENTION; AREA V4; MOTION; NEURONS; FIELD; BRAIN		Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Boynton, GM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Buracas, Giedrius/A-4904-2011		NATIONAL EYE INSTITUTE [R01EY012925] Funding Source: NIH RePORTER; NEI NIH HHS [EY12925] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Lee DK, 1999, PERCEPT PSYCHOPHYS, V61, P1241, DOI 10.3758/BF03206177; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	15	434	441	4	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					631	632		10.1038/nn876	http://dx.doi.org/10.1038/nn876			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068304				2022-12-28	WOS:000176414300011
J	Schneider, P; Scherg, M; Dosch, HG; Specht, HJ; Gutschalk, A; Rupp, A				Schneider, P; Scherg, M; Dosch, HG; Specht, HJ; Gutschalk, A; Rupp, A			Morphology of Heschl's gyrus reflects enhanced activation in the auditory cortex of musicians	NATURE NEUROSCIENCE			English	Article							ABSOLUTE PITCH; CORTICAL REPRESENTATION; VOLUME MEASUREMENT; BRAIN; FREQUENCY; ASYMMETRY; ORGANIZATION; PLASTICITY; POTENTIALS; PERCEPTION	Using magnetoencephalography (MEG), we compared the processing of sinusoidal tones in the auditory cortex of 12 non-musicians, 12 professional musicians and 13 amateur musicians. We found neurophysiological and anatomical differences between groups. In professional musicians as compared to non-musicians, the activity evoked in primary auditory cortex 19-30 ms after stimulus onset was 102% larger, and the gray matter volume of the anteromedial portion of Heschl's gyrus was 130% larger. Both quantities were highly correlated with musical aptitude, as measured by psychometric evaluation. These results indicate that both the morphology and neurophysiology of Heschl's gyrus have an essential impact on musical aptitude.	Heidelberg Univ, Dept Phys, D-69120 Heidelberg, Germany; Univ Heidelberg Hosp, Dept Neurol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schneider, P (corresponding author), Heidelberg Univ, Dept Phys, Philosophenweg 12, D-69120 Heidelberg, Germany.	Peter_Schneider@med.uni-heidelberg.de	Specht, Karsten/C-3762-2009	Specht, Karsten/0000-0002-9946-3704; Schneider, Peter/0000-0002-1920-0438				ALTENMULLER E, 1986, EUR ARCH PSY CLIN N, V235, P342, DOI 10.1007/BF00381003; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; BRAAK H, 1978, ANAT EMBRYOL, V154, P213, DOI 10.1007/BF00304663; CRUMMER GC, 1994, J ACOUST SOC AM, V95, P2720, DOI 10.1121/1.409840; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Gordon EdwinE., 1997, LEARNING SEQUENCES M; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hirata Y, 1999, NEUROREPORT, V10, P999, DOI 10.1097/00001756-199904060-00019; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Meyer A., 1977, MUSIC BRAIN, P255; Monaghan P, 1998, NATURE, V394, P434, DOI 10.1038/28775; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patel AD, 2001, NAT NEUROSCI, V4, P839, DOI 10.1038/90557; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Preis S, 1999, BRAIN COGNITION, V40, P441, DOI 10.1006/brcg.1998.1072; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Rupp A, 2000, NEUROREPORT, V11, P3731, DOI 10.1097/00001756-200011270-00028; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; SCHERG M, 1990, ADV AUDIOL, V6, P165; Schiavetto A, 1999, NEUROREPORT, V10, P2467, DOI 10.1097/00001756-199908200-00006; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SCHNEIDER P, 2000, SOURCE ACTIVITY TONO; SOMOGYI J, 1930, MSCHR PSYCHAT NEUROL, V75, P113; STEINMETZ H, 1989, J COMPUT ASSIST TOMO, V13, P996, DOI 10.1097/00004728-198911000-00011; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Zatorre R. J., 2000, BRAIN MAPPING SYSTEM, P365; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; ZATORRE RJ, 2001, ANN NY ACAD SCI, V930	50	463	475	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					688	694		10.1038/nn871	http://dx.doi.org/10.1038/nn871			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068300				2022-12-28	WOS:000176414300020
J	Born, J; Lange, T; Kern, W; McGregor, GP; Bickel, U; Fehm, HL				Born, J; Lange, T; Kern, W; McGregor, GP; Bickel, U; Fehm, HL			Sniffing neuropeptides: a transnasal approach to the human brain	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; INSULIN; TRANSPORT; BARRIER; PLASMA		Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; Univ Lubeck, Dept Internal Med, D-23538 Lubeck, Germany; Univ Marburg, Dept Physiol, D-35037 Marburg, Germany; Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	University of Lubeck; University of Lubeck; Philipps University Marburg; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Born, J (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.		Born, Jan/K-2596-2016; Bickel, Ulrich/AAZ-1553-2020; Lange, Tanja/Z-1688-2018	Born, Jan/0000-0002-1847-6248; Bickel, Ulrich/0000-0002-2721-299X; mcgregor, gerard/0000-0003-3087-0018; Lange, Tanja/0000-0001-8309-2112				BICKEL U, 1988, EUR J CLIN PHARMACOL, V35, P371, DOI 10.1007/BF00561367; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; de Wied D, 1976, Prog Brain Res, V45, P181, DOI 10.1016/S0079-6123(08)60990-5; Fehm HL, 2000, EUR J PHARMACOL, V405, P43, DOI 10.1016/S0014-2999(00)00540-9; Fehm HL, 2001, J CLIN ENDOCR METAB, V86, P1144, DOI 10.1210/jc.86.3.1144; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Kern W, 1999, DIABETES, V48, P557, DOI 10.2337/diabetes.48.3.557; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; RIEKKINEN P, 1987, PEPTIDES, V8, P261, DOI 10.1016/0196-9781(87)90101-X; SCHWARTZ MW, 1991, J CLIN INVEST, V88, P1272, DOI 10.1172/JCI115431; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sigurdsson P, 1997, DRUG DELIV, V4, P195, DOI 10.3109/10717549709051892; Strand FL, 1999, NEUROPEPTIDES REGULA; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; WALLUM BJ, 1987, J CLIN ENDOCR METAB, V64, P190, DOI 10.1210/jcem-64-1-190	15	996	1044	0	86	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					514	516		10.1038/nn849	http://dx.doi.org/10.1038/nn849			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992114				2022-12-28	WOS:000175874600009
J	Obici, S; Feng, ZH; Karkanias, G; Baskin, DG; Rossetti, L				Obici, S; Feng, ZH; Karkanias, G; Baskin, DG; Rossetti, L			Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; Y MESSENGER-RNA; GENE-EXPRESSION; FOOD-INTAKE; VISCERAL ADIPOSITY; ARCUATE NUCLEUS; DIABETIC RATS; BODY-WEIGHT; LEPTIN; BRAIN	We investigated the role of hypothalamic insulin signaling in the regulation of energy balance and insulin action in rats through selective decreases in insulin receptor expression in discrete hypothalamic nuclei. We generated an antisense oligodeoxynucleotide directed against the insulin receptor precursor protein and administered this directly into the third cerebral ventricle. Immunostaining of rat brains after 7-day administration of the oligodeoxynucleotide showed a selective decrease of insulin receptor protein within cells in the medial portion of the arcuate nucleus (decreased by similar to80% as compared to rats treated with a control oligodeoxynucleotide). Insulin receptors in other hypothalamic and extra-hypothalamic areas were not affected. This selective decrease in hypothalamic insulin receptor protein was accompanied by rapid onset of hyperphagia and increased fat mass. During insulin-clamp studies, physiological hyperinsulinemia decreased glucose production by 55% in rats treated with control oligodeoxynucleotides but by only 25% in rats treated with insulin receptor antisense oligodeoxynucleotides. Thus, insulin receptors in discrete areas of the hypothalamus have a physiological role in the control of food intake, fat mass and hepatic action of insulin.	Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; Univ Washington, Seattle, WA 98108 USA	Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Rossetti, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NIDDK NIH HHS [DK 17047, DK 20541, DK 45024, DK 48321] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045024, R01DK045024, R37DK048321, P60DK020541, P30DK017047, R01DK048321] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Baskin DG, 1999, J HISTOCHEM CYTOCHEM, V47, P353, DOI 10.1177/002215549904700309; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burry RW, 2000, J HISTOCHEM CYTOCHEM, V48, P163, DOI 10.1177/002215540004800201; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DAVIS SN, 1995, J CLIN INVEST, V95, P593, DOI 10.1172/JCI117703; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; LUZI L, 1992, DIABETES, V41, P1632, DOI 10.2337/diabetes.41.12.1632; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 1998, RAT BRAIN STEROTAXIC; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; SCHWARTZ MW, 1991, ENDOCRINOLOGY, V128, P2645, DOI 10.1210/endo-128-5-2645; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; SIPOLS AJ, 1995, DIABETES, V44, P147, DOI 10.2337/diabetes.44.2.147; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; WOODS SC, 1984, AM J PHYSIOL, V247, pR393, DOI 10.1152/ajpregu.1984.247.2.R393; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	530	546	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					566	572		10.1038/nn861	http://dx.doi.org/10.1038/nn861			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021765				2022-12-28	WOS:000175874600017
J	Dodart, JC; Bales, KR; Gannon, KS; Greene, SJ; DeMattos, RB; Mathis, C; DeLong, CA; Wu, S; Wu, X; Holtzman, DM; Paul, SM				Dodart, JC; Bales, KR; Gannon, KS; Greene, SJ; DeMattos, RB; Mathis, C; DeLong, CA; Wu, S; Wu, X; Holtzman, DM; Paul, SM			Immunization reverses memory deficits without reducing brain A beta burden in Alzheimer's disease model	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; APP(V717F) TRANSGENIC MICE; MOUSE MODEL; APOLIPOPROTEIN-E; PEPTIDE; PATHOLOGY; HYPOTHESIS; PLAQUES	We have previously shown that chronic treatment with the monoclonal antibody m266, which is specific for amyloid beta-peptide (Abeta), increases plasma concentrations of Abeta and reduces Abeta burden in the PDAPP transgenic mouse model of Alzheimer's disease (AD). We now report that administration of m266 to PDAPP mice can rapidly reverse memory deficits in both an object recognition task and a holeboard learning and memory task, but without altering brain Abeta burden. We also found that an Abeta/antibody complex was present in both the plasma and the cerebrospinal fluid of m266-treated mice. Our data indicate that passive immunization with this anti-Abeta monoclonal antibody can very rapidly reverse memory impairment in certain learning and memory tasks in the PDAPP mouse model of AD, owing perhaps to enhanced peripheral clearance and (or) sequestration of a soluble brain Abeta species.	Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, Alzheimers Dis Res Ctr,Dept Neurol Mol Biol & Pha, St Louis, MO 63110 USA; Univ Strasbourg 1, CNRS, UMR 7521, F-67000 Strasbourg, France	Eli Lilly; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Paul, SM (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA.		MATHIS, CHANTAL mb/B-6399-2013; Paul, Steve/ABE-5400-2020	MATHIS, CHANTAL mb/0000-0002-6663-5282; 				Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2000, NEUROBIOL DIS, V7, P71, DOI 10.1006/nbdi.1999.0278; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; Dodart JC, 2000, REV NEUROSCIENCE, V11, P75; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Dodart JC, 2000, NEUROREPORT, V11, P603, DOI 10.1097/00001756-200002280-00034; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Johnson D, 1997, EDN, V42, P94; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N	22	747	843	0	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					452	457		10.1038/nn842	http://dx.doi.org/10.1038/nn842			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11941374				2022-12-28	WOS:000175272000016
J	Villarreal, DM; Do, V; Haddad, E; Derrick, BE				Villarreal, DM; Do, V; Haddad, E; Derrick, BE			NMDA receptor antagonists sustain LTP and spatial memory: active processes mediate LTP decay	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; FREELY MOVING RATS; DENTATE GYRUS; ANESTHETIZED RATS; PERFORANT PATH; LATE-PHASE; DEPRESSION; HIPPOCAMPUS; DEPOTENTIATION; STIMULATION	Although long-term potentiation (LTP) is long-lasting, it is not permanent and decays within weeks after its induction. Little is known about the processes underlying this decay. Here we assessed the contribution of synaptic activity to LTP decay by determining the effect of the competitive NMDA receptor antagonist CPP on the decay of perforant path-dentate LTR CPP blocked decay over a one-week period when administered daily following the induction of LTP, and blocked decay of the late, protein-synthesis-dependent phase of LTP when administered two days after LTP induction. CPP administered for a five-day period following spatial memory training enhanced subsequent memory retention. These data suggest that LTP is normally a persistent process that is actively reversed by NMDA receptor activation, and that both the early and late phases of LTP are dynamic processes regulated by NMDA receptors. These data also support the view that LTP is involved in maintaining spatial memory.	Univ Texas, Dept Biol, San Antonio, TX 78249 USA; Univ Texas, Cajal Neurosci Res Ctr, Div Life Sci, San Antonio, TX 78249 USA	University of Texas System; University of Texas System	Derrick, BE (corresponding author), Univ Texas, Dept Biol, 6900 N Loop 1604 W, San Antonio, TX 78249 USA.		Derrick, Brian/P-3005-2014	Derrick, Brian/0000-0001-6940-6509	NIDA NIH HHS [DA01983] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barnes CA, 1996, EUR J NEUROSCI, V8, P565, DOI 10.1111/j.1460-9568.1996.tb01241.x; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; CHRISTIE BR, 1992, NEURON, V9, P79, DOI 10.1016/0896-6273(92)90222-Y; DESMOND NL, 1991, BRAIN RES, V552, P93, DOI 10.1016/0006-8993(91)90664-H; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; EBBINGHAUS H, 1913, MEMORY CONTRIBUTIONS; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Kulla A, 1999, EUR J NEUROSCI, V11, P3864, DOI 10.1046/j.1460-9568.1999.00807.x; LAMBERT JD, 1990, J NEUROPHYSIOL, V4, P119; LAROCHE S, 1989, NEUROSCIENCE, V28, P375, DOI 10.1016/0306-4522(89)90184-X; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MARTENS R, 1975, SPORTWISSENSCHAFT, V5, P9; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Morris RGM, 1991, LONG TERM POTENTIATI, P267; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; OLTON DS, 1977, LEARN MOTIV, V8, P289, DOI 10.1016/0023-9690(77)90054-6; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; PAXINOS G, 1982, STEREOTAXIC ATLAS RA; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; Strack S, 1997, J NEUROCHEM, V68, P2119; Thorndike EL, 1927, AM J PSYCHOL, V39, P212, DOI 10.2307/1415413; Xiao MY, 1996, EUR J NEUROSCI, V8, P1916, DOI 10.1111/j.1460-9568.1996.tb01335.x; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783	37	137	143	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					48	52		10.1038/nn776	http://dx.doi.org/10.1038/nn776			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740500				2022-12-28	WOS:000173031800014
J	Anderson, JC; Martin, KAC				Anderson, JC; Martin, KAC			Does bouton morphology optimize axon length?	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; DENDRITIC SPINES; PLASTICITY; NEURONS; LAYER-4		Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; ETH Zurich, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Anderson, JC (corresponding author), Univ Zurich, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.							Braitenberg V, 1991, ANATOMY CORTEX; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GRAY EG, 1982, TRENDS NEUROSCI, V5, P5, DOI 10.1016/0166-2236(82)90005-4; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574	14	31	31	1	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1166	1167		10.1038/nn772	http://dx.doi.org/10.1038/nn772			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713473				2022-12-28	WOS:000172525000008
J	Gooley, JJ; Lu, J; Chou, TC; Scammell, TE; Saper, CB				Gooley, JJ; Lu, J; Chou, TC; Scammell, TE; Saper, CB			Melanopsin in cells of origin of the retinohypothalamic tract	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; SPECTRAL SENSITIVITY; PHOTORECEPTORS; CONE; MICE		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NHLBI NIH HHS [HL07901, HL60292] Funding Source: Medline; NIMH NIH HHS [MH62589] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062589] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	7	392	408	0	61	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1165	1165		10.1038/nn768	http://dx.doi.org/10.1038/nn768			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713469				2022-12-28	WOS:000172525000007
J	Gupta, A; Sanada, K; Miyamoto, DT; Rovelstad, S; Nadarajah, B; Pearlman, AL; Brunstrom, J; Tsai, LH				Gupta, A; Sanada, K; Miyamoto, DT; Rovelstad, S; Nadarajah, B; Pearlman, AL; Brunstrom, J; Tsai, LH			Layering defect in p35 deficiency is linked to improper neuronal-glial interaction in radial migration	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; REELIN SIGNALING PATHWAY; FETAL MONKEY NEOCORTEX; CELL-MIGRATION; CORTICAL DEVELOPMENT; LIPOPROTEIN RECEPTORS; NERVOUS-SYSTEM; VLDL RECEPTOR; CHICK-EMBRYO; MICE LACKING	Several genes essential for neocortical layering have been identified in recent years, but their precise roles in this process remain to be elucidated. Mice deficient in p35- an activator of cyclin-dependent kinase 5 (Cdk5)- are characterized by a neocortex that has inverted layering. To decipher the physiological mechanisms that underlie this defect, we compared time-lapse recordings between p35(-/-) and wild-type cortical slices. In the p35(-/-) neocortex, the classic modes of radial migration-somal translocation and locomotion-were largely replaced by a distinct mode of migration: branched migration. Branched migration is cell-autonomous, associated with impaired neuronal-glial interaction and rare in neurons of scrambler mice, which are deficient in Dab1. Hence, our findings suggest that inside-out layering requires distinct functions of Reelin and p35/Cdk5 signaling, with the latter being important for proper glia-guided migration.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; Univ Manchester, Sch Biol Sci, Div Neurosci, Manchester M13 9PT, Lancs, England	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL); University of Manchester	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	Li-Huei_Tsai@hms.harvard.edu	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957				ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bar I, 2000, TRENDS NEUROSCI, V23, P633, DOI 10.1016/S0166-2236(00)01675-1; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BOOK KJ, 1991, EXP NEUROL, V111, P228, DOI 10.1016/0014-4886(91)90011-Z; BRITTIS PA, 1995, EXP NEUROL, V134, P1, DOI 10.1006/exnr.1995.1031; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gilmore EC, 2001, J NEUROSCI, V21, P9690, DOI 10.1523/JNEUROSCI.21-24-09690.2001; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; HAGER G, 1995, J NEUROSCI RES, V40, P207, DOI 10.1002/jnr.490400209; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keshvara L, 2002, J NEUROSCI, V22, P4869, DOI 10.1523/JNEUROSCI.22-12-04869.2002; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	50	91	92	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1284	1291		10.1038/nn1151	http://dx.doi.org/10.1038/nn1151			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14608361				2022-12-28	WOS:000186725600013
J	Richeson, JA; Baird, AA; Gordon, HL; Heatherton, TF; Wyland, CL; Trawalter, S; Shelton, JN				Richeson, JA; Baird, AA; Gordon, HL; Heatherton, TF; Wyland, CL; Trawalter, S; Shelton, JN			An fMRI investigation of the impact of interracial contact on executive function	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ERROR-DETECTION; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; PREJUDICE; ACTIVATION; INTERFERENCE; SUPPRESSION; INHIBITION	We investigated whether individual differences in racial bias among white participants predict the recruitment, and potential depletion, of executive attentional resources during contact with black individuals. White individuals completed an unobtrusive measure of racial bias, then interacted with a black individual, and finally completed an ostensibly unrelated Stroop color-naming test. In a separate functional magnetic resonance imaging (fMRI) session, subjects were presented with unfamiliar black male faces, and the activity of brain regions thought to be critical to executive control was assessed. We found that racial bias predicted activity in right dorsolateral prefrontal cortex (DLPFC) in response to black faces. Furthermore, activity in this region predicted Stroop interference after an actual interracial interaction, and it statistically mediated the relation between racial bias and Stroop interference. These results are consistent with a resource depletion account of the temporary executive dysfunction seen in racially biased individuals after interracial contact.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA	Dartmouth College; Princeton University	Richeson, JA (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, 6207 Moore Hall, Hanover, NH 03755 USA.	jriches@dartmouth.edu	Heatherton, Todd F/H-5478-2011					Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baumeister RF, 2000, SOC COGNITION, V18, P130, DOI 10.1521/soco.2000.18.2.130; Blascovich J, 2001, J PERS SOC PSYCHOL, V80, P253, DOI 10.1037//0022-3514.80.2.253; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Chee MWL, 2000, NEUROREPORT, V11, P135; Crandall CS, 2002, J PERS SOC PSYCHOL, V82, P359, DOI 10.1037//0022-3514.82.3.359; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1280, DOI 10.1016/S0028-3932(00)00033-6; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Devine P.G., 1998, CONFRONTING RACISM P, P234; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Fuster JM, 2000, BRAIN RES BULL, V52, P331, DOI 10.1016/S0361-9230(99)00258-0; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Karpinski A, 2001, J PERS SOC PSYCHOL, V81, P774, DOI 10.1037/0022-3514.81.5.774; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Lepore L, 1997, J PERS SOC PSYCHOL, V72, P275, DOI 10.1037/0022-3514.72.2.275; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Richeson JA, 2003, PSYCHOL SCI, V14, P287, DOI 10.1111/1467-9280.03437; Shallice T, 1993, ATTENTION SELECTION, P171; Shelton JN, 2003, GROUP PROCESS INTERG, V6, P171, DOI 10.1177/1368430203006002003; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Talairach P., 1988, STEREOTACTIC COPLANA; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; von Hippel W, 2000, PERS SOC PSYCHOL B, V26, P523, DOI 10.1177/0146167200267001	45	290	294	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1323	1328		10.1038/nn1156	http://dx.doi.org/10.1038/nn1156			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	746BC	14625557				2022-12-28	WOS:000186725600018
J	Amedi, A; Raz, N; Pianka, P; Malach, R; Zohary, E				Amedi, A; Raz, N; Pianka, P; Malach, R; Zohary, E			Early 'visual' cortex activation correlates with superior verbal memory performance in the blind	NATURE NEUROSCIENCE			English	Article							CROSS-MODAL PLASTICITY; ADAPTIVE-CHANGES; MENTAL-IMAGERY; CONNECTIONS; LANGUAGE; AREAS; FMRI; RECOGNITION; GENERATION; PATTERN	The visual cortex may be more modifiable than previously considered. Using functional magnetic resonance imaging (fMRI) in ten congenitally blind human participants, we found robust occipital activation during a verbal-memory task (in the absence of any sensory input), as well as during verb generation and Braille reading. We also found evidence for reorganization and specialization of the occipital cortex, along the anterior-posterior axis. Whereas anterior regions showed preference for Braille, posterior regions (including V1) showed preference for verbal-memory and verb generation (which both require memory of verbal material). No such occipital activation was found in sighted subjects. This difference between the groups was mirrored by superior performance of the blind in various verbal-memory tasks. Moreover, the magnitude of V1 activation during the verbal-memory condition was highly correlated with the blind individual's abilities in a variety of verbal-memory tests, suggesting that the additional occipital activation may have a functional role.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science	Amedi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	amir@lobster.ls.huji.ac.il		Amedi, Amir/0000-0001-5042-2533				Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Arno P, 2001, NEUROIMAGE, V13, P632, DOI 10.1006/nimg.2000.0731; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Baker JT, 2001, NEUROREPORT, V12, P1251, DOI 10.1097/00001756-200105080-00039; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; DEHAY C, 1984, EXP BRAIN RES, V57, P208; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Giraud AL, 2001, BRAIN, V124, P1307, DOI 10.1093/brain/124.7.1307; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HULL T, 1995, J VISUAL IMPAIR BLIN, V89, P166; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; KARNI A, 1995, NATURE, V377, P155; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Maguire EA, 2003, NAT NEUROSCI, V6, P90, DOI 10.1038/nn988; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; POZAR L, 1982, STUD PSYCHOL, V24, P311; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Psychological Corporation, 1997, WECHSL MEM SCAL; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Roder B, 2001, COGNITIVE BRAIN RES, V11, P289, DOI 10.1016/S0926-6410(01)00002-7; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Talairach J., 1988, COPLANAR STEREOTAXIC; TILLMAN MH, 1968, PSYCHOL REP, V23, P523, DOI 10.2466/pr0.1968.23.2.523; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; VanEssen DC, 1997, J NEUROSCI, V17, P7079; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Weeks R, 2000, J NEUROSCI, V20, P2664; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	50	418	425	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					758	766		10.1038/nn1072	http://dx.doi.org/10.1038/nn1072			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	694NJ	12808458				2022-12-28	WOS:000183780400025
J	Baker, DA; McFarland, K; Lake, RW; Shen, H; Tang, XC; Toda, S; Kalivas, PW				Baker, DA; McFarland, K; Lake, RW; Shen, H; Tang, XC; Toda, S; Kalivas, PW			Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; SYSTEM X(C)(-); INDUCED REINSTATEMENT; DRUG-ADDICTION; SEEKING; TRANSMISSION; TRANSPORT; EXPRESSION; RECEPTORS	Repeated cocaine treatment and withdrawal produces changes in brain function thought to be involved in relapse to drug use. Withdrawal from repeated cocaine reduced in vivo extracellular glutamate in the nucleus accumbens of rats by decreasing the exchange of extracellular cystine for intracellular glutamate. In vivo restoration of cystine/glutamate exchange by intracranial perfusion of cystine or systemically administered N-acetylcysteine normalized the levels of glutamate in cocaine-treated subjects. To determine if the reduction in nonvesicular glutamate release is a mediator of relapse, we examined cocaine-primed reinstatement of drug seeking after cocaine self-administration was stopped. Reinstatement was prevented by stimulating cystine/glutamate exchange with N-acetylcysteine and restoring extracellular glutamate. Thus, withdrawal from repeated cocaine increases susceptibility to relapse in part by reducing cystine/glutamate exchange, and restoring exchanger activity prevents cocaine-primed drug seeking.	Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA.	kalivasp@musc.edu	Jansen, Heiko T./A-5770-2008; baker, david/I-6955-2013	Jansen, Heiko T./0000-0003-0178-396X; baker, david/0000-0002-0664-6780	NIDA NIH HHS [DA-07288, DA-06074, DA-03960] Funding Source: Medline; NIMH NIH HHS [MH-40817] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040817] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Baker DA, 2002, J NEUROSCI, V22, P9134; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; COTGREAVE IA, 1994, BBA-MOL CELL RES, V1222, P375, DOI 10.1016/0167-4889(94)90043-4; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Gochenauer GE, 2001, J NEUROCHEM, V78, P276, DOI 10.1046/j.1471-4159.2001.00385.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hotsenpiller G, 2001, EUR J NEUROSCI, V14, P1843, DOI 10.1046/j.0953-816x.2001.01804.x; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Keys AS, 1998, SYNAPSE, V30, P393, DOI 10.1002/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H; Knickelbein RG, 1997, AM J PHYSIOL-LUNG C, V273, pL1147, DOI 10.1152/ajplung.1997.273.6.L1147; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Manzoni O, 1997, EUR J NEUROSCI, V9, P1514, DOI 10.1111/j.1460-9568.1997.tb01506.x; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; MEISTER A, 1985, METHOD ENZYMOL, V113, P571; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pierce RC, 1996, J NEUROSCI, V16, P1550; Reid MS, 1997, SYNAPSE, V27, P95, DOI 10.1002/(SICI)1098-2396(199710)27:2<95::AID-SYN1>3.3.CO;2-L; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2002, J NEUROSCI, V22, P8028; Sato H, 1998, BBA-BIOMEMBRANES, V1414, P85, DOI 10.1016/S0005-2736(98)00159-X; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shih AY, 2001, BIOCHEM BIOPH RES CO, V282, P1132, DOI 10.1006/bbrc.2001.4703; SMITH JA, 1995, BRAIN RES, V683, P264, DOI 10.1016/0006-8993(95)00383-2; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999	41	564	580	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					743	749		10.1038/nn1069	http://dx.doi.org/10.1038/nn1069			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12778052				2022-12-28	WOS:000183780400023
J	Peretz, I; Coltheart, M				Peretz, I; Coltheart, M			Modularity of music processing	NATURE NEUROSCIENCE			English	Review							PURE WORD DEAFNESS; AUDITORY AGNOSIA; CONGENITAL AMUSIA; HEMISPHERE DAMAGE; DISSOCIATIONS; RECOGNITION; DISORDER; SCALE	The music faculty is not a monolithic entity that a person either has or does not. Rather, it comprises a set of neurally isolable processing components, each having the potential to be specialized for music. Here we propose a functional architecture for music processing that captures the typical properties of modular organization. The model rests essentially on the analysis of music-related deficits in neurologically impaired individuals, but provides useful guidelines for exploring the music faculty in normal people, using methods such as neuroimaging.	Univ Montreal, Montreal, PQ H3C 3J7, Canada; Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia	Universite de Montreal; Macquarie University	Peretz, I (corresponding author), Univ Montreal, Box 6128,Succ Centreville, Montreal, PQ H3C 3J7, Canada.			Coltheart, Max/0000-0002-6580-0047				Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Balzano G.J., 1982, MUSIC MIND BRAIN NEU, P321, DOI [10.1007/978-1-4684-8917-0_17, DOI 10.1007/978-1-4684-8917-0]; Bregman A.S., 1990, AUDITORY SCENE ANAL; Coltheart M, 1999, TRENDS COGN SCI, V3, P115, DOI 10.1016/S1364-6613(99)01289-9; Coltheart Max, 2001, HDB COGNITIVE NEUROP, P3; DALLABELLA S, IN PRESS ANN NY ACAD; Dowling WJ, 1982, PSYCHOL MUSIC, P413; Fodor J. A, 2001, MIND DOESNT WORK WAY; Fodor J. A, 1983, MODULARITY MIND; GARDNER H, 1983, FRAMES MIND, P31; GODEFROY O, 1995, CORTEX, V31, P149, DOI 10.1016/S0010-9452(13)80113-X; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; Handel S., 1989, LISTENING INTRO PERC, DOI DOI 10.2307/898748; HEBERT S, IN PRESS BRAIN; Jackendoff R, 1987, CONSCIOUSNESS COMPUT; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; LAIGNELLAVASTIN.M, 1921, SOC NEUROLOGIE, V37, P194; Mendez MF, 2001, CORTEX, V37, P139, DOI 10.1016/S0010-9452(08)70563-X; METZLUTZ MN, 1984, BRAIN LANG, V23, P13, DOI 10.1016/0093-934X(84)90002-6; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 1997, CAN J EXP PSYCHOL, V51, P354, DOI 10.1037/1196-1961.51.4.354; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; PERETZ I, 1993, COGNITIVE NEUROPSYCH, V10, P21, DOI 10.1080/02643299308253455; PERETZ I, 2001, MUSIC EMOTION THEORY, P105; Peretz I., 1989, CONTEMP MUSIC REV, V4, P277, DOI [10.1080/07494468900640361, DOI 10.1080/07494468900640361]; Peretz Isabelle, 2001, HDB COGNITIVE NEUROP, P519; Piccirilli M, 2000, J NEUROL NEUROSUR PS, V69, P541, DOI 10.1136/jnnp.69.4.541; SHEPARD RN, 1984, SCIENCE, V226, P1333, DOI 10.1126/science.226.4680.1333; Steinke WR, 2001, COGN NEUROPSYCHOL, V18, P411, DOI 10.1080/02643290125702; TAKAHASHI N, 1992, CORTEX, V28, P295, DOI 10.1016/S0010-9452(13)80056-1; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; Trehub SE, 1999, J EXP PSYCHOL HUMAN, V25, P965, DOI 10.1037/0096-1523.25.4.965; WILSON SJ, 1999, MUSIC MED MUSIC THER, P47; YAQUB BA, 1988, BRAIN, V111, P457, DOI 10.1093/brain/111.2.457; Zatorre R., 2001, BIOL FDN MUSIC	39	432	450	2	73	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					688	691		10.1038/nn1083	http://dx.doi.org/10.1038/nn1083			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830160				2022-12-28	WOS:000183780400013
J	Wood, ER; Dudchenko, PA				Wood, ER; Dudchenko, PA			Aging, spatial behavior and the cognitive map	NATURE NEUROSCIENCE			English	Editorial Material							PLACE	Hippocampal neurons are thought to form a cognitive map of the environment based on multiple cues. A new study shows that young animals switch between cues more easily than aged animals and also perform better on a spatial learning task.	Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland	University of Edinburgh; University of Edinburgh; University of Stirling	Wood, ER (corresponding author), Univ Edinburgh, Div Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	emma.wood@ed.ac.uk						Gothard KM, 1996, J NEUROSCI, V16, P8027; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; Prusky GT, 2000, BEHAV BRAIN RES, V116, P135, DOI 10.1016/S0166-4328(00)00267-9; Rosenzweig ES, 2003, NAT NEUROSCI, V6, P609, DOI 10.1038/nn1053	9	21	21	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					546	548		10.1038/nn0603-546	http://dx.doi.org/10.1038/nn0603-546			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12771958				2022-12-28	WOS:000183140400006
J	De Paola, V; Arber, S; Caroni, P				De Paola, V; Arber, S; Caroni, P			AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks	NATURE NEUROSCIENCE			English	Article							LONG-LASTING POTENTIATION; TERM SYNAPTIC PLASTICITY; DENDRITIC SPINES; MOSSY FIBERS; TRANSGENIC MICE; LATE-PHASE; SYNAPSES; SYNAPTOGENESIS; PROTEINS; CULTURES	The formation and disassembly of synapses in mature neuropil could provide a substrate to encode experience in the brain. Although there is evidence for postsynaptic spine dynamics in mature systems, contributions to circuit rearrangements by presynaptic terminals have remained unclear. We used hippocampal slice cultures from mice expressing spectral variants of green fluorescent protein (GFP) that are targeted to the membrane and/or synaptic vesicles in neuronal subsets to image identified presynaptic terminals. In mature tissues with no net change in synapse numbers, subpopulations of presynaptic terminals appeared and disappeared within 1-3 days. The three terminal types established by mossy fibers had distinct properties. High-frequency stimulation increased the fraction of dynamic terminals for 1-2 days, a process mediated by activation of AMPA receptors, protein kinase A (PKA) and protein synthesis. Thus, synaptic activity can make stable presynaptic terminals become dynamic, providing a candidate mechanism to convert experience into changes in network connectivity.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Basel, Friedrich Miescher Inst, CH-4056 Basel, Switzerland; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Basel	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		de paola, vincenzo/B-4900-2016	de paola, vincenzo/0000-0001-9987-8291; Arber, Silvia/0000-0002-6261-250X				Acsady L, 1998, J NEUROSCI, V18, P3386; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dailey ME, 1996, J NEUROSCI, V16, P2983; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Hatada Y, 2000, J NEUROSCI, V20, part. no.; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Horch HW, 1999, NEURON, V23, P353; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Smart FM, 2000, HIPPOCAMPUS, V10, P542, DOI 10.1002/1098-1063(2000)10:5<542::AID-HIPO4>3.3.CO;2-Z; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	48	174	176	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					491	500		10.1038/nn1046	http://dx.doi.org/10.1038/nn1046			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692557				2022-12-28	WOS:000182553200016
J	Handy, TC; Grafton, ST; Shroff, NM; Ketay, S; Gazzaniga, MS				Handy, TC; Grafton, ST; Shroff, NM; Ketay, S; Gazzaniga, MS			Graspable objects grab attention when the potential for action is recognized	NATURE NEUROSCIENCE			English	Article							ACTION-DEFINED TEMPLATES; EYE-HAND COORDINATION; ELECTROPHYSIOLOGICAL EVIDENCE; NEUROPSYCHOLOGICAL EVIDENCE; NEURAL MECHANISMS; PARIETAL CORTEX; LATERALIZATION; REPRESENTATION; LOCALIZATION; PERCEPTION	Visually guided grasping movements require a rapid transformation of visual representations into object-specific motor programs. Here we report that graspable objects may facilitate these visuomotor transformations by automatically grabbing visual spatial attention. Human subjects viewed two task-irrelevant objects-one was a 'tool', the other a 'non-tool'-while waiting for a target to be presented in one of the two object locations. Using event-related potentials (ERPs), we found that spatial attention was systematically drawn to tools in the right and lower visual fields, the hemifields that are dominant for visuomotor processing. Using event-related fMRI, we confirmed that tools grabbed spatial attention only when they also activated dorsal regions of premotor and prefrontal cortices, regions associated with visually guided actions and their planning. Although it is widely accepted that visual sensory gain aids perception, our results suggest that it may also have consequences for object-directed actions.	Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Handy, TC (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, 6162 Moore Hall, Hanover, NH 03755 USA.	todd.c.handy@dartmouth.edu						Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; BOLES DB, 1994, BRAIN COGNITION, V24, P184, DOI 10.1006/brcg.1994.1010; Bonfiglioli C, 2002, VIS COGN, V9, P458, DOI 10.1080/13506280143000539; Carey DP, 2000, CURR BIOL, V10, pR416, DOI 10.1016/S0960-9822(00)00508-X; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Danckert J, 2001, EXP BRAIN RES, V137, P303; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Haaland KY, 1996, CURR OPIN NEUROBIOL, V6, P796, DOI 10.1016/S0959-4388(96)80030-4; Handy TC, 2001, J EXP PSYCHOL HUMAN, V27, P303, DOI 10.1037/0096-1523.27.2.303; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; Handy TC, 2000, PERCEPT PSYCHOPHYS, V62, P175, DOI 10.3758/BF03212070; HILLYARD SA, 1999, ATTENTION SPACE ACTI, P311; Hodges JR, 1999, P NATL ACAD SCI USA, V96, P9444, DOI 10.1073/pnas.96.16.9444; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hopfinger JB, 1998, PSYCHOL SCI, V9, P441, DOI 10.1111/1467-9280.00083; Humphreys GW, 2001, NAT NEUROSCI, V4, P84, DOI 10.1038/82940; Humphreys GW, 2001, BEHAV NEUROL, V13, P75; Ivry R.B., 1998, 2 SIDES PERCEPTION; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kenemans JL, 2000, CLIN NEUROPHYSIOL, V111, P1113, DOI 10.1016/S1388-2457(00)00270-4; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Marotta JJ, 2001, J COGNITIVE NEUROSCI, V13, P8, DOI 10.1162/089892901564135; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Milner A. D., 1995, VISUAL BRAIN ACTION; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Riddoch MJ, 2003, NAT NEUROSCI, V6, P82, DOI 10.1038/nn984; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Talairach J., 1988, COPLANAR STEREOTAXIC; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V23, P146; WARD R, 1999, ATTENTION SPACE ACTI, P311; Zani A, 1997, J PSYCHOPHYSIOL, V11, P21	50	187	191	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					421	427		10.1038/nn1031	http://dx.doi.org/10.1038/nn1031			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640459				2022-12-28	WOS:000181833100021
J	Lai, K; Kaspar, BK; Gage, FH; Schaffer, DV				Lai, K; Kaspar, BK; Gage, FH; Schaffer, DV			Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo	NATURE NEUROSCIENCE			English	Article							CNS STEM-CELLS; SUBVENTRICULAR ZONE; DENTATE GYRUS; MAMMALIAN FOREBRAIN; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; SPINAL-CORD; NEURONS; NEUROGENESIS; SIGNALS	Neural stem cells exist in the developing and adult nervous systems of all mammals, but the basic mechanisms that control their behavior are not yet well understood. Here, we investigated the role of Sonic hedgehog (Shh), a factor vital for neural development, in regulating adult hippocampal neural stem cells. We found high expression of the Shh receptor Patched in both the adult rat hippocampus and neural progenitor cells isolated from this region. In addition, Shh elicited a strong, dose-dependent proliferative response in progenitors in vitro. Furthermore, adeno-associated viral vector delivery of shh cDNA to the hippocampus elicited a 3.3-fold increase in cell proliferation. Finally, the pharmacological inhibitor of Shh signaling cyclopamine reduced hippocampal neural progenitor proliferation in vivo. This work identifies Shh as a regulator of adult hippocampal neural stem cells.	Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Salk Inst Biol Studies, Genet Lab, San Diego, CA 92186 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Salk Institute	Schaffer, DV (corresponding author), Univ Calif Berkeley, Dept Chem Engn, 201 Gilman Hall, Berkeley, CA 94720 USA.		Kaspar, Brian/E-6490-2010; Kaspar, Brian/E-3349-2011					Aberg MAI, 2000, J NEUROSCI, V20, P2896; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gould E, 1997, J NEUROSCI, V17, P2492; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Huang Z, 1998, DEVELOPMENT, V125, P3753; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jin KL, 2002, J NEUROSCI, V22, P5365; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Sakurada K, 1999, DEVELOPMENT, V126, P4017; SAMULSKI RJ, 1989, J VIROL, V63, P3822, DOI 10.1128/JVI.63.9.3822-3828.1989; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Traiffort E, 2001, EUR J NEUROSCI, V14, P839, DOI 10.1046/j.0953-816x.2001.01708.x; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weiss S, 1996, J NEUROSCI, V16, P7599; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	50	625	678	2	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					21	27		10.1038/nn983	http://dx.doi.org/10.1038/nn983			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469128				2022-12-28	WOS:000180089300011
J	Citron, M				Citron, M			Alzheimer's disease: treatments in discovery and development	NATURE NEUROSCIENCE			English	Review							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; GAMMA-SECRETASE; MOUSE MODEL; A-BETA; A-BETA-42; PATHOLOGY; CLEAVAGE; NOTCH	Alzheimer's disease is the single biggest unmet medical need in neurology. Current drugs are safe, but of limited benefit to most patients. This review discusses the scientific basis and current status of promising disease-modifying therapies in the discovery and development stages. I describe the major targets of anti-amyloid therapy and the main focus of disease modification approaches. In addition, two new potential treatment approaches supported by retrospective epidemiology are outlined.	Amgen Inc, Dept Neurosci, Thousand Oaks, CA 91320 USA	Amgen	Citron, M (corresponding author), Amgen Inc, Dept Neurosci, M-S 29-2-B,1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mcitron@amgen.com						Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CITRON M, IN PRESS J NEUROSCI; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Doody RS, 1999, ALZ DIS ASSOC DIS, V13, pS20, DOI 10.1097/00002093-199911001-00004; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Golde TE, 2001, DRUG DISCOV TODAY, V6, P1049, DOI 10.1016/S1359-6446(01)01965-1; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Samuels SC, 1998, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P267; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; Steinberg D, 2002, SCIENTIST, V16, P22; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	29	138	175	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1055	1057		10.1038/nn940	http://dx.doi.org/10.1038/nn940			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403985				2022-12-28	WOS:000179041300013
J	Watanabe, T; Nanez, JE; Koyama, S; Mukai, I; Liederman, J; Sasaki, Y				Watanabe, T; Nanez, JE; Koyama, S; Mukai, I; Liederman, J; Sasaki, Y			Greater plasticity in lower-level than higher-level visual motion processing in a passive perceptual learning task	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION TASK; CEREBRAL-CORTEX; V1 NEURONS; ORIENTATION; DIRECTION; SPECIFICITY; ATTENTION; IMPROVEMENT; INTEGRATION; DISPLAYS	Simple exposure is sufficient to sensitize the human visual system to a particular direction of motion, but the underlying mechanisms of this process are unclear. Here, in a passive perceptual learning task, we found that exposure to task-irrelevant motion improved sensitivity to the local motion directions within the stimulus, which are processed at low levels of the visual system. In contrast, task-irrelevant motion had no effect on sensitivity to the global motion direction, which is processed at higher levels. The improvement persisted for at least several months. These results indicate that when attentional influence is limited, lower-level motion processing is more receptive to long-term modification than higher-level motion processing in the visual cortex.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Arizona State Univ W, Dept Social & Behav Sci, Phoenix, AZ 85069 USA; Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA	Boston University; Arizona State University; Arizona State University-Downtown Phoenix; Harvard University; Massachusetts General Hospital	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.		KOYAMA, SHINICHI/H-2754-2019	KOYAMA, SHINICHI/0000-0001-6280-5750; Sasaki, Yuka/0000-0002-0061-0250				AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BEARD BL, 1995, VISION RES, V35, P1679, DOI 10.1016/0042-6989(94)00267-P; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Fahle M, 2002, PERCEPTUAL LEARNING; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; FURMANSKI CS, IN PRESS J VISION S; Gilbert C D, 1993, Curr Opin Neurobiol, V3, P100, DOI 10.1016/0959-4388(93)90042-W; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; Grzywacz N. M., 1989, Proceedings. Workshop on Visual Motion (IEEE Cat. No.89CH2716-9), P148, DOI 10.1109/WVM.1989.47104; GRZYWACZ NM, 1991, COMPUTATIONAL MODELS, P231; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; Jones MJ, 1997, CURR BIOL, V7, P991, DOI 10.1016/S0960-9822(06)00419-2; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KOYAMA S, IN PRESS J VISION S; Liu ZL, 1999, P NATL ACAD SCI USA, V96, P14085, DOI 10.1073/pnas.96.24.14085; Matthews N, 2001, VISION RES, V41, P463, DOI 10.1016/S0042-6989(00)00269-8; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RAMACHANDRAN V, 1994, NATURE, V368, P592; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; VAINA LM, 1995, COGNITIVE BRAIN RES, V2, P155, DOI 10.1016/0926-6410(95)90004-7; WATAMANIUK SNJ, 1989, VISION RES, V29, P47, DOI 10.1016/0042-6989(89)90173-9; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7; WATANABE T, IN PRERSS J VISION S; WILLIAMS D, 1986, NATURE, V324, P253, DOI 10.1038/324253a0; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Zohary E, 1996, VISION RES, V36, P2321, DOI 10.1016/0042-6989(95)00287-1	50	161	165	2	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					1003	1009		10.1038/nn915	http://dx.doi.org/10.1038/nn915			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	597VV	12219093				2022-12-28	WOS:000178242200020
J	Shadlen, MN				Shadlen, MN			Pursuing commitments	NATURE NEUROSCIENCE			English	Editorial Material							TARGET SELECTION; EYE-MOVEMENTS; LOCALIZATION; DECISION		Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Sch Med, Reg Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210				Gardner JL, 2002, NAT NEUROSCI, V5, P892, DOI 10.1038/nn897; Gardner JL, 2001, J NEUROSCI, V21, P2075, DOI 10.1523/JNEUROSCI.21-06-02075.2001; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lisberger SG, 1997, J NEUROSCI, V17, P7490; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Rizzolatti G, 1998, NOVART FDN SYMP, V218, P81; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHLAG J, 1989, EXP BRAIN RES, V76, P548, DOI 10.1007/BF00248911; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2	15	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					819	821		10.1038/nn0902-819	http://dx.doi.org/10.1038/nn0902-819			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12196803				2022-12-28	WOS:000177656300002
J	Koulakov, AA; Raghavachari, S; Kepecs, A; Lisman, JE				Koulakov, AA; Raghavachari, S; Kepecs, A; Lisman, JE			Model for a robust neural integrator	NATURE NEUROSCIENCE			English	Article							OCULOMOTOR SYSTEM; WORKING-MEMORY; PERSISTENT ACTIVITY; EYE-POSITION; PARIETAL CORTEX; HEAD-DIRECTION; NMDA RECEPTORS; NEURONS; NETWORK; CAT	Integrator circuits in the brain show persistent firing that reflects the sum of previous excitatory and inhibitory inputs from external sources. Integrator circuits have been implicated in parametric working memory, decision making and motor control. Previous work has shown that stable integrator function can be achieved by an excitatory recurrent neural circuit, provided synaptic strengths are tuned with extreme precision (better than 1% accuracy). Here we show that integrator circuits can function without fine tuning if the neuronal units have bistable properties. Two specific mechanisms of bistability are analyzed, one based on local recurrent excitation, and the other on the voltage-dependence of the NMDA (N-methyl-D-aspartate) channel. Neither circuit requires fine tuning to perform robust integration, and the latter actually exploits the variability of neuronal conductances.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Salk Institute; Utah System of Higher Education; University of Utah; Brandeis University	Koulakov, AA (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Kepecs, Adam/0000-0003-0049-8120	PHS HHS [461434] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; BLAIR HT, 1995, J NEUROSCI, V15, P6260; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CIMINO A, 1990, FEBS LETT, V263, P199, DOI 10.1016/0014-5793(90)81373-V; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; FUKUSHIMA K, 1992, PROG NEUROBIOL, V39, P609, DOI 10.1016/0301-0082(92)90016-8; Fuster JM, 1995, MEMORY CEREBRAL CORT; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GODAUX E, 1990, NEUROSCI LETT, V116, P162, DOI 10.1016/0304-3940(90)90403-V; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; KEPECS A, 2002, ADV NEURAL INFORMATI, V14; Koulakov AA, 2001, NETWORK-COMP NEURAL, V12, P47, DOI 10.1088/0954-898X/12/1/304; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; METTENS P, 1994, NEUROREPORT, V5, P1333, DOI 10.1097/00001756-199406270-00009; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Priesol AJ, 2000, BRAIN RES, V857, P252, DOI 10.1016/S0006-8993(99)02441-5; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; SEGEL LA, 1995, IMMUNOL TODAY, V16, P80, DOI 10.1016/0167-5699(95)80093-X; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	38	212	215	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					775	782		10.1038/nn893	http://dx.doi.org/10.1038/nn893			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134153				2022-12-28	WOS:000177088900021
J	von Gall, C; Garabette, ML; Kell, CA; Frenzel, S; Dehghani, F; Schumm-Draeger, PM; Weaver, DR; Korf, HW; Hastings, MH; Stehle, JH				von Gall, C; Garabette, ML; Kell, CA; Frenzel, S; Dehghani, F; Schumm-Draeger, PM; Weaver, DR; Korf, HW; Hastings, MH; Stehle, JH			Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin	NATURE NEUROSCIENCE			English	Article							PARS TUBERALIS; PHOTOPERIODIC REGULATION; CIRCADIAN CLOCK; PINEAL-GLAND; MOUSE SCN; MPER1; ADENOSINE; HAMSTER; CLONING; LIGHT	In mammals, many daily cycles are driven by a central circadian clock, which is based on the cell-autonomous rhythmic expression of clock genes. It is not clear, however, how peripheral cells are able to interpret the rhythmic signals disseminated from this central oscillator. Here we show that cycling expression of the clock gene Period1 in rodent pituitary cells depends on the heterologous sensitization of the adenosine A(2b) receptor, which occurs through the nocturnal activation of melatonin mt1 receptors. Eliminating the impact of the neurohormone melatonin simultaneously suppresses the expression of Period1 and evokes an increase in the release of pituitary prolactin. Our findings expose a mechanism by which two convergent signals interact within a temporal dimension to establish high-amplitude, precise and robust cycles of gene expression.	Goethe Univ Frankfurt, Inst Anat 2, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Internal Med, D-60590 Frankfurt, Germany; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA; MRC Ctr, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England	Goethe University Frankfurt; Goethe University Frankfurt; University of Cambridge; University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology	Stehle, JH (corresponding author), Goethe Univ Frankfurt, Inst Anat 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	stehle@em.uni-frankfurt.de	Jansen, Heiko T./A-5770-2008; Korf, Horst/ACX-9860-2022; Von+Gall, Charlotte/AAJ-2160-2021	Jansen, Heiko T./0000-0003-0178-396X; Korf, Horst/0000-0002-5051-0303; Von+Gall, Charlotte/0000-0002-5088-3118; Hastings, Michael Harvey/0000-0001-8576-6651; Weaver, David/0000-0001-7941-6719	NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER; NIA NIH HHS [AG09975] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; CARLSON LL, 1989, ENDOCRINOLOGY, V125, P2670, DOI 10.1210/endo-125-5-2670; Hastings MH, 2001, J BIOL RHYTHM, V16, P424, DOI 10.1177/074873001129002015; HAZLERIGG DG, 1993, ENDOCRINOLOGY, V132, P285, DOI 10.1210/en.132.1.285; Hazlerigg DG, 2001, J ENDOCRINOL, V170, P493, DOI 10.1677/joe.0.1700493; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Korf H.-W., 1998, Advances in Anatomy Embryology and Cell Biology, V146, P1; Li XM, 2000, AM J PHYSIOL-REG I, V278, pR924, DOI 10.1152/ajpregu.2000.278.4.R924; LINCOLN GA, 1995, J NEUROENDOCRINOL, V7, P637, DOI 10.1111/j.1365-2826.1995.tb00802.x; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Maronde E, 1999, J NEUROSCI, V19, P3326; MARQUARDT DL, 1994, J IMMUNOL, V152, P4508; McNulty S, 1996, J NEUROENDOCRINOL, V8, P635; Messager S, 2001, NEUROREPORT, V12, P579, DOI 10.1097/00001756-200103050-00029; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Morgan PJ, 2000, J NEUROENDOCRINOL, V12, P287; Pfeffer M, 1998, EUR J NEUROSCI, V10, P2896, DOI 10.1111/j.1460-9568.1998.00309.x; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; STEHLE JH, 1995, J PINEAL RES, V18, P179, DOI 10.1111/j.1600-079X.1995.tb00158.x; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; STEHLE JH, 1992, MOL ENDOCRINOL, V6, P384, DOI 10.1210/me.6.3.384; Stirland JA, 2001, J NEUROENDOCRINOL, V13, P147, DOI 10.1046/j.1365-2826.2001.00611.x; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takekida S, 2000, EUR J NEUROSCI, V12, P4557, DOI 10.1046/j.0953-816X.2000.01324.x; von Gall C, 1998, J NEUROSCI, V18, P10389; von Gall C, 2000, EUR J NEUROSCI, V12, P964, DOI 10.1046/j.1460-9568.2000.00990.x; von Gall C, 2000, NEUROREPORT, V11, P1803, DOI 10.1097/00001756-200006260-00002; von Gall C, 2001, J NEUROENDOCRINOL, V13, P313, DOI 10.1046/j.1365-2826.2001.00643.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	36	214	217	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					234	238		10.1038/nn806	http://dx.doi.org/10.1038/nn806			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836530				2022-12-28	WOS:000174146000013
J	Weiskrantz, L; Cowey, A; Hodinott-Hill, I				Weiskrantz, L; Cowey, A; Hodinott-Hill, I			Prime-sight in a blindsight subject	NATURE NEUROSCIENCE			English	Article									Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Weiskrantz, L (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	larry.weiskrantz@psy.ox.ac.uk						COWEY A, 1991, TRENDS NEUROSCI, V29, P65; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; James W., 1891, PRINCIPLES PSYCHOL, V2; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Julesz, 1971, FDN CYCLOPEAN PERCEP; KANSKI JJ, 1999, CLIN OPHTHALMOLOGY S; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Weiskrantz L, 1950, Q J EXP PSYCHOL, V2, P170, DOI 10.1080/17470215008416594; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Weiskrantz L., 1998, BLINDSIGHT CASE STUD; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; WEISKRANTZ L, HDB NEUROPSYCHOLOGY, V4	13	35	35	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					101	102		10.1038/nn793	http://dx.doi.org/10.1038/nn793			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788836				2022-12-28	WOS:000173558400010
J	Ojemann, GA; Schoenfield-McNeill, J; Corina, DP				Ojemann, GA; Schoenfield-McNeill, J; Corina, DP			Anatomic subdivisions in human temporal cortical neuronal activity related to recent verbal memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; HIPPOCAMPAL-FORMATION; CORTEX; STIMULATION; RETRIEVAL; LOBE; EXPERIENCE; PRIMATE; BRAIN; WORDS	We identified functional anatomical subdivisions of human lateral and basal temporal cortex related to recent verbal memory for object names, text and auditory words. Extracellular neuronal activity was recorded during memory encoding compared to identification, during encoding, storage or recall retrieval stages of the memory task, during recognition memory, and during implicit memory as measured by repetition priming. Changes in frequency of activity during encoding were recorded from most neurons. In lateral temporal cortex, these encoding changes in the dominant hemisphere were more likely to be polymodal, whereas those in nondominant hemisphere were unimodal. There was substantial separation of neurons with changes in other aspects of memory, defining additional subdivisions. Inferior lateral and basal cortex were related to memory stages, and superior-posterior lateral cortex was related to implicit and recognition memory.	Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ojemann, GA (corresponding author), Univ Washington, Dept Neurol Surg, Box 356470, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036527] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36527] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 1996, J NEUROSCI, V16, P6219; CALVIN WH, 1973, ELECTROEN CLIN NEURO, V34, P337, DOI 10.1016/0013-4694(73)90086-2; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Darley, 1967, BRAIN MECH UNDERLY, P122; Desimone Robert, 1995, P475; Dhond RP, 2001, J NEUROSCI, V21, P3564, DOI 10.1523/JNEUROSCI.21-10-03564.2001; Dodrill, 1987, ADV EPILEPTOL, V16, P327; Dodrill CB, 1997, BRAIN COGNITION, V33, P210, DOI 10.1006/brcg.1997.0893; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; EICHBAUM H, 2001, CONDITIONING CONSCIO; FUSTER JM, 1982, J NEUROSCI, V2, P361; Fuster JM, 1995, MEMORY CEREBRAL CORT; HAGLUND MM, 1994, J NEUROSCI, V14, P1507, DOI 10.1523/JNEUROSCI.14-03-01507.1994; HALGREN E, 1978, ELECTROEN CLIN NEURO, V45, P585, DOI 10.1016/0013-4694(78)90159-1; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Martin A, 1997, HIPPOCAMPUS, V7, P587, DOI 10.1002/(SICI)1098-1063(1997)7:6<587::AID-HIPO1>3.0.CO;2-C; MILLER EK, 1993, J NEUROSCI, V13, P1460; Milner B, 1972, Clin Neurosurg, V19, P421; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; OJEMANN GA, 1985, J NEUROSURG, V62, P101, DOI 10.3171/jns.1985.62.1.0101; Ojemann GA, 1999, J NEUROSCI, V19, P5674; Ojemann GA, 1998, NEUROSCIENTIST, V4, P285, DOI 10.1177/107385849800400417; Ojemann GA, 1998, BRAIN LANG, V64, P317, DOI 10.1006/brln.1998.1982; OJEMANN GA, 1978, BRAIN LANG, V5, P331, DOI 10.1016/0093-934X(78)90030-5; OJEMANN GA, 1988, BRAIN, V111, P1383, DOI 10.1093/brain/111.6.1383; OJEMANN GA, 1995, OPERATIVE NEUROSURGI, P1317; PERRINE K, 1994, NEUROLOGY, V44, P1845, DOI 10.1212/WNL.44.10.1845; RICHES IP, 1991, J NEUROSCI, V11, P1763; Schwartz TH, 1996, COGNITIVE BRAIN RES, V4, P263, DOI 10.1016/S0926-6410(96)00062-6; SHIMAMURA AP, 1989, HDB NEUROPSYCHOLOGY, V3, P35; Squire LR, 2001, NAT NEUROSCI, V4, P867; WEBER PB, 1995, NEUROREPORT, V6, P685, DOI 10.1097/00001756-199503000-00025	38	83	85	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					64	71		10.1038/nn785	http://dx.doi.org/10.1038/nn785			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753418				2022-12-28	WOS:000173031800017
J	Washbourne, P; Thompson, PM; Carta, M; Costa, ET; Mathews, JR; Lopez-Bendito, G; Molnar, Z; Becher, MW; Valenzuela, CF; Partridge, LD; Wilson, MC				Washbourne, P; Thompson, PM; Carta, M; Costa, ET; Mathews, JR; Lopez-Bendito, G; Molnar, Z; Becher, MW; Valenzuela, CF; Partridge, LD; Wilson, MC			Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; SYNAPTIC VESICLES; TETANUS TOXIN; NEUROTRANSMITTER SECRETION; CLOSTRIDIAL NEUROTOXINS; MEMBRANE-FUSION; GROWTH CONES; EXOCYTOSIS	Axon outgrowth during development and neurotransmitter release depends on exocytotic mechanisms, although what protein machinery is common to or differentiates these processes remains unclear. Here we show that the neural t-SNARE (target-membrane-associated-soluble N-ethylmaleimide fusion protein attachment protein (SNAP) receptor) SNAP-25 is not required for nerve growth or stimulus-independent neurotransmitter release, but is essential for evoked synaptic transmission at neuromuscular junctions and central synapses. These results demonstrate that the development of neurotransmission requires the recruitment of a specialized SNARE core complex to meet the demands of regulated exocytosis.	Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Oxford	Wilson, MC (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA.		Carta, Mauro/AAV-3451-2021; Molnar, Zoltan/J-7281-2012; Lopez-Bendito, Guillermina/E-4028-2014	Carta, Mauro/0000-0003-0706-9687; Molnar, Zoltan/0000-0002-6852-6004; Lopez-Bendito, Guillermina/0000-0002-8965-6836; Partridge, Linda/0000-0001-9615-0094; Carta, Mario/0000-0003-1225-2742	NIMH NIH HHS [R01 MH048989, MH 4-8989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048989] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; BARK IC, 1993, J MOL BIOL, V233, P67, DOI 10.1006/jmbi.1993.1485; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Brunger AT, 2000, CURR OPIN NEUROBIOL, V10, P293, DOI 10.1016/S0959-4388(00)00098-2; Capogna M, 1997, J NEUROSCI, V17, P7190; CAPOGNA M, 1996, J NEUROPHYSIOL, V76, P149; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen D, 1999, BRAIN RES, V831, P11, DOI 10.1016/S0006-8993(99)01371-2; Coco S, 1999, J NEUROSCI, V19, P9803; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P220, DOI 10.1097/00000374-200002000-00013; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HESS DT, 1992, J NEUROSCI, V12, P4634; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hua SY, 1998, J NEUROPHYSIOL, V80, P3233, DOI 10.1152/jn.1998.80.6.3233; Katz B., 1969, RELEASE NEURAL TRANS; Lane SR, 1997, J NEUROCHEM, V69, P1864; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mehta PP, 1996, P NATL ACAD SCI USA, V93, P10471, DOI 10.1073/pnas.93.19.10471; Morihara T, 1999, NEUROSCIENCE, V91, P695, DOI 10.1016/S0306-4522(98)00671-X; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507	48	387	399	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					19	26		10.1038/nn783	http://dx.doi.org/10.1038/nn783			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753414				2022-12-28	WOS:000173031800010
J	Mizrahi, A; Katz, LC				Mizrahi, A; Katz, LC			Dendritic stability in the adult olfactory bulb	NATURE NEUROSCIENCE			English	Article							TERM SYNAPTIC PLASTICITY; IN-VIVO; ODORANT REPRESENTATIONS; POSTNATAL NEUROGENESIS; RECEPTOR NEURONS; LIVING MICE; CORTEX; MEMORY; SPINES; SYNAPSES	In many regions of the adult mammalian brain, pronounced changes in synaptic input caused by lesions or severe sensory deprivation induce marked sprouting or retraction of neuronal dendrites. In the adult olfactory bulb, adult neurogenesis produces less pronounced, but continuously ongoing synapse turnover. To test the structural stability of adult dendrites in this context, we used two-photon microscopy to image dendrites of mitral and tufted (M/T) cells over prolonged periods in adult mice. Although pharmacologically increased activity could elicit morphological changes, under natural conditions such as ongoing neurogenesis, an odor-enriched environment or olfactory-based learning, M/T cell dendrites remained highly stable. Thus, in a context of ongoing adult synaptogenesis, dendritic stability could serve as a structural scaffold to maintain the organization of local circuits.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Mizrahi, A (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	mizrahi@neuro.duke.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005671] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC005671] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Brennan PA, 1998, NEUROSCIENCE, V87, P583, DOI 10.1016/S0306-4522(98)00182-1; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dudai Y., 2002, MEMORY A Z; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kosaka K, 2001, J COMP NEUROL, V440, P219, DOI 10.1002/cne.1381; MACKAYSIM A, 1991, EUR J NEUROSCI, V3, P209, DOI 10.1111/j.1460-9568.1991.tb00081.x; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1986, J NEUROSCI, V6, P1051; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SAMANEN DW, 1984, J COMP NEUROL, V225, P201, DOI 10.1002/cne.902250206; Schellinck HM, 2001, CHEM SENSES, V26, P663, DOI 10.1093/chemse/26.6.663; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wu GY, 1999, J NEUROSCI, V19, P4472; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	49	125	128	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1201	1207		10.1038/nn1133	http://dx.doi.org/10.1038/nn1133			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14528309				2022-12-28	WOS:000186229200020
J	Blank, T; Nijholt, I; Kye, MJ; Radulovic, J; Spiess, J				Blank, T; Nijholt, I; Kye, MJ; Radulovic, J; Spiess, J			Small-conductance, Ca2+-activated K+ channel SK3 generates age-related memory and LTP deficits	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RATS; HIPPOCAMPUS; NEURONS	Cognitive deficits are among the most devastating changes associated with the aging process. Age-related decrement in performance on learning tasks(1,2) is correlated with substantial changes in neuronal signal processing in the hippocampus(3-5). Here we show that elevated expression of small-conductance Ca2+-activated K+ channels (SK channels) of the SK3 type in hippocampi of aged mice contributes to reduced long-term potentiation (LTP) and impaired trace fear conditioning, a hippocampus-dependent learning task(6,7).	Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany	Max Planck Society	Blank, T (corresponding author), Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany.	blank@em.mpg.de	Kye, Min Jeong/ABC-3439-2020; Nijholt, Ingrid/AAB-8740-2021	Kye, Min Jeong/0000-0002-1323-7256; Nijholt, Ingrid/0000-0003-4820-7505; Radulovic, Jelena/0000-0002-0268-2426				BARNES CA, 1980, CAN J PSYCHOL, V34, P29, DOI 10.1037/h0081022; Blank T, 2002, J NEUROSCI, V22, P3788; Houston FP, 1999, LEARN MEMORY, V6, P111; Lanahan A, 1997, J NEUROSCI, V17, P2876; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; LANDFIELD PW, 1978, BRAIN RES, V150, P85, DOI 10.1016/0006-8993(78)90655-8; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; MOORE CI, 1993, HIPPOCAMPUS, V3, P57, DOI 10.1002/hipo.450030106; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schumacher M, 2002, NATURE, V417, P501, DOI 10.1038/417501a; STORM JF, 1990, PROG BRAIN RES, V83, P161; Tacconi S, 2001, NEUROSCIENCE, V102, P209, DOI 10.1016/S0306-4522(00)00486-3; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wu WW, 2002, AGEING RES REV, V1, P181, DOI 10.1016/S1568-1637(01)00009-5	15	85	91	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					911	912		10.1038/nn1101	http://dx.doi.org/10.1038/nn1101			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12883553				2022-12-28	WOS:000184970400006
J	Finn, AJ; Feng, GP; Pendergast, AM				Finn, AJ; Feng, GP; Pendergast, AM			Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; NONRECEPTOR TYROSINE KINASE; ACTIN-BINDING DOMAINS; C-ABL; ACETYLCHOLINE-RECEPTOR; SYNAPSE FORMATION; ACTIVATION LOOP; FAMILY KINASES; F-ACTIN; MUSK	Agrin signals through the muscle-specific receptor tyrosine kinase (MuSK) to cluster acetylcholine receptors (AChRs) on the postsynaptic membrane of the neuromuscular junction (NMJ). This stands as the prevailing model of synapse induction by a presynaptic factor, yet the agrin-dependent MuSK signaling cascade is largely undefined. Abl1 (previously known as Abl) and the Abl1-related gene product Abl2 (previously known as Arg) define a family of tyrosine kinases that regulate actin structure and presynaptic axon guidance. Here we show that the Abl kinases are critical mediators of postsynaptic assembly downstream of agrin and MuSK. In mouse muscle, Abl kinases were localized to the postsynaptic membrane of the developing NMJ. In cultured myotubes, Abl kinase activity was required for agrin-induced AChR clustering and enhancement of MuSK tyrosine phosphorylation. Moreover, MuSK and Abl kinases effected reciprocal tyrosine phosphorylation and formed a complex after agrin engagement. Our findings suggest that Abl kinases provide the developing synapse with the kinase activity required for signal amplification and the intrinsic cytoskeletal regulatory capacity required for assembly and remodeling.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Feng, GP (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.		Feng, Guoping/Y-2827-2019	Pendergast, Ann Marie/0000-0002-1250-6880	NCI NIH HHS [CA70940] Funding Source: Medline; NIGMS NIH HHS [GM62375] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062375] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; BENNETT RL, 1992, DEVELOPMENT, V116, P953; Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Glover RT, 2000, J BIOL CHEM, V275, P12725, DOI 10.1074/jbc.275.17.12725; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Koch A, 2000, FEBS LETT, V469, P72, DOI 10.1016/S0014-5793(00)01242-4; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; McConville J, 2002, CURR OPIN PHARMACOL, V2, P296, DOI 10.1016/S1471-4892(02)00156-X; Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001; Moresco EMY, 2003, J NEUROPHYSIOL, V89, P1678, DOI 10.1152/jn.00892.2002; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; ODWYER ME, 2001, BIOCHIM BIOPHYS ACTA, V1551, pM11; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Okuda K, 2001, BLOOD, V97, P2440, DOI 10.1182/blood.V97.8.2440; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; PENDERGAST AM, 2001, CHRONIC MYELOID LEUK, P19; PEREGO R, 1991, ONCOGENE, V6, P1899; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yano H, 2000, J NEUROSCI RES, V59, P356, DOI 10.1002/(SICI)1097-4547(20000201)59:3<356::AID-JNR9>3.0.CO;2-G; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	50	107	111	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					717	723		10.1038/nn1071	http://dx.doi.org/10.1038/nn1071			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12796783				2022-12-28	WOS:000183780400019
J	Zatorre, RJ				Zatorre, RJ			Absolute pitch: a model for understanding the influence of genes and development on neural and cognitive function	NATURE NEUROSCIENCE			English	Review							MUSICAL PITCH; AUDITORY-CORTEX; IDENTIFICATION; RECOGNITION; POSSESSORS; TONES	Absolute pitch (AP), the ability to identify or produce the pitch of a sound without any reference point, is discussed here as a possible model system for understanding the neurobiology of complex cognitive functions. AP is of interest because it may reflect an atypical organization of sensory representations. Indications are that it depends on both genetic factors and exposure to musical training during childhood, supporting the idea of a sensitive period. Functional and structural neuroimaging studies suggest special roles for working memory and associative memory mechanisms in AP, and results from these studies indicate that there may be structural markers of AP in asymmetries of cortical areas. AP seems to depend on the nervous system's response to experiential, maturational and genetic factors, making it a good candidate model for understanding how these interactions play out in cognitive development generally.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	robert.zatorre@mcgill.ca						Bachem A, 1937, J ACOUST SOC AM, V9, P146, DOI 10.1121/1.1915919; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Bornstein MH., 1987, CATEGORICAL PERCEPTI, P287; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Gregersen PK, 2001, AM J MED GENET, V98, P280, DOI 10.1002/1096-8628(20010122)98:3<280::AID-AJMG1083>3.0.CO;2-6; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; KLEIN M, 1984, SCIENCE, V223, P1306, DOI 10.1126/science.223.4642.1306; KRUMHANSI CL, 1990, COGNITIVE FDN MUSICA; Langner G, 2002, HEARING RES, V168, P110, DOI 10.1016/S0378-5955(02)00367-2; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; Miyazaki K, 2002, PERCEPT PSYCHOPHYS, V64, P1337, DOI 10.3758/BF03194776; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Petrides M, 1995, ANN NY ACAD SCI, V769, P85, DOI 10.1111/j.1749-6632.1995.tb38133.x; POLLACK I, 1952, J ACOUST SOC AM, V24, P745, DOI 10.1121/1.1906969; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841; WITELSON SF, 1973, BRAIN, V96, P641, DOI 10.1093/brain/96.3.641; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	29	146	152	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					692	695		10.1038/nn1085	http://dx.doi.org/10.1038/nn1085			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	694NJ	12830161				2022-12-28	WOS:000183780400014
J	Parri, R; Crunelli, V				Parri, R; Crunelli, V			An astrocyte bridge from synapse to blood flow	NATURE NEUROSCIENCE			English	Editorial Material							NEURONS PROJECT; CALCIUM; BRAIN	Neural activity locally Increases cerebral blood flow to deliver oxygen to working neurons. A new paper shows that astrocytes can detect activity at glutamatergic synapses via calcium changes In astrocytic endfeet and directly couple It to blood flow in vitro and In vivo.	Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales	Cardiff University	Parri, R (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave,Box 911, Cardiff CF10 3US, S Glam, Wales.		Parri, Rheinallt/D-1748-2013; Crunelli, Vincenzo/A-7258-2010	Crunelli, Vincenzo/0000-0001-7154-9752; Parri, Rheinallt/0000-0002-1412-2688				Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bonvento G, 2002, TRENDS NEUROSCI, V25, P359, DOI 10.1016/S0166-2236(02)02168-9; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; LADECOLA C, 1993, TRENDS NEUROSCI, V16, P206; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; REINHARD JF, 1979, SCIENCE, V206, P85, DOI 10.1126/science.482930; Roy C S, 1890, J Physiol, V11, P85; VAUCHER E, 1995, J NEUROSCI, V15, P7427; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	15	60	65	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					5	6		10.1038/nn0103-5	http://dx.doi.org/10.1038/nn0103-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12494240				2022-12-28	WOS:000180089300004
J	Mednick, SC; Nakayama, K; Cantero, JL; Atienza, M; Levin, AA; Pathak, N; Stickgold, R				Mednick, SC; Nakayama, K; Cantero, JL; Atienza, M; Levin, AA; Pathak, N; Stickgold, R			The restorative effect of naps on perceptual deterioration	NATURE NEUROSCIENCE			English	Article							LATE NOCTURNAL SLEEP; MEMORY; PERFORMANCE; DISCRIMINATION; ALERTNESS; IMPROVEMENT; STATES; CAFFEINE; CORTEX; SKILL	Human performance on visual texture discrimination tasks improves slowly (over days) in the absence of additional training. This 'slow learning' requires nocturnal sleep after training and is limited to the region of visual space in which training occurred. Here, we tested human subjects four times in one day and found that with repeated, within-day testing, perceptual thresholds actually increased progressively across the four test sessions. This performance deterioration was prevented either by shifting the target stimuli to an untrained region of visual space or by having the subjects take a mid-day nap between the second and third sessions.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Neurophysiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mednick, SC (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.		Cantero, Jose L./ABG-6447-2020; Atienza, Mercedes/L-1805-2014	Atienza, Mercedes/0000-0002-6760-1252; mednick, sara/0000-0002-0906-3097; Pathak, Neha/0000-0002-6078-5482	NIMH NIH HHS [MH 48,832] Funding Source: Medline; NINDS NIH HHS [NS 26,895] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BETTINA BL, 1995, VISION RES, V34, P1679; BONNET MH, 1994, PHYSIOL BEHAV, V56, P103, DOI 10.1016/0031-9384(94)90266-6; BONNET MH, 1991, SLEEP, V14, P307, DOI 10.1093/sleep/14.4.307; Cantero JL, 2002, SLEEP, V25, P238, DOI 10.1093/sleep/25.2.238; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Dinges D., 1989, SLEEP ALERTNESS CHRO; FAHLE M, 1994, PERCEPTION, V23, P411, DOI 10.1068/p230411; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; HARMA M, 1989, INT ARCH OCC ENV HEA, V61, P341, DOI 10.1007/BF00409390; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KARNI A, 1995, NEUROIMAGE, V3, pS543; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; ROSA RR, 1993, SLEEP, V16, P727, DOI 10.1093/sleep/16.8.727; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Smith CT, 1998, NEUROBIOL LEARN MEM, V69, P211, DOI 10.1006/nlme.1997.3809; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; STICKGOLD R, 1998, SLEEP S, V21, P256; Takahashi M, 2000, SLEEP, V23, P813; TAUB JM, 1979, INT J NEUROSCI, V9, P97, DOI 10.3109/00207457909147225; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	33	220	223	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					677	681		10.1038/nn864	http://dx.doi.org/10.1038/nn864			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	566EP	12032542				2022-12-28	WOS:000176414300018
J	Kapfer, C; Seidl, AH; Schweizer, H; Grothe, B				Kapfer, C; Seidl, AH; Schweizer, H; Grothe, B			Experience-dependent refinement of inhibitory inputs to auditory coincidence-detector neurons	NATURE NEUROSCIENCE			English	Article							MEDIAL SUPERIOR OLIVE; SYNAPSE ELIMINATION; PYRAMIDAL CELLS; BRAIN-STEM; HIPPOCAMPAL-NEURONS; CRITICAL PERIOD; TRAPEZOID BODY; GUINEA-PIG; RECEPTORS; NUCLEUS	The spatial arrangement of inputs on to single neurons is assumed to be crucial in accurate signal processing. In mammals, the most precise temporal processing occurs in the context of sound localization. Medial superior olivary neurons can encode microsecond differences in the arrival time of low-frequency sounds at the two ears. Here we show that in mammals with well developed low-frequency hearing, a spatial refinement of ionotropic inhibitory inputs occurs on medial superior olivary neurons during development. This refinement is experience dependent and does not develop in mammals that do not use interaural time differences for sound localization.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Univ Munich, Inst Zool, D-80333 Munich, Germany	Max Planck Society; University of Munich	Grothe, B (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.	bgrothe@neuro.mpg.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615				Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Alvarez FJ, 1997, J COMP NEUROL, V379, P150; ASCHENBERGER H, 2000, J NEUROSCI, V20, P9162; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; CANT NB, 1992, HEARING RES, V58, P26, DOI 10.1016/0378-5955(92)90005-8; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; CLARK GM, 1969, BRAIN RES, V14, P293, DOI 10.1016/0006-8993(69)90111-5; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; ERULKAR SD, 1972, PHYSIOL REV, V52, P237, DOI 10.1152/physrev.1972.52.1.237; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Grothe B, 2000, PROG NEUROBIOL, V61, P581, DOI 10.1016/S0301-0082(99)00068-4; Grothe B, 1998, J NEUROSCI, V18, P6608; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; INBODY SB, 1981, BRAIN RES, V210, P361, DOI 10.1016/0006-8993(81)90910-0; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kakizawa S, 2000, J NEUROSCI, V20, P4954; KANDLER K, 1995, J NEUROSCI, V15, P6890; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Kotak VC, 2000, J NEUROSCI, V20, P5820, DOI 10.1523/JNEUROSCI.20-15-05820.2000; LANGFORD TL, 1984, HEARING RES, V15, P39, DOI 10.1016/0378-5955(84)90223-5; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; PERKINS RE, 1973, J COMP NEUROL, V148, P387, DOI 10.1002/cne.901480306; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; RUSSELL FA, 1995, J COMP NEUROL, V352, P607, DOI 10.1002/cne.903520409; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1992, J COMP NEUROL, V321, P637, DOI 10.1002/cne.903210410; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Simon JZ, 1999, NEUROCOMPUTING, V26-7, P263, DOI 10.1016/S0925-2312(99)00020-X; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; SPITZER MW, 1995, J NEUROPHYSIOL, V73, P1668, DOI 10.1152/jn.1995.73.4.1668; Suneja SK, 1998, EXP NEUROL, V154, P473, DOI 10.1006/exnr.1998.6946; VATER M, 1995, J COMP NEUROL, V358, P155, DOI 10.1002/cne.903580202; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	48	164	168	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					247	253		10.1038/nn810	http://dx.doi.org/10.1038/nn810			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850629				2022-12-28	WOS:000174146000015
J	Lee, A; Westenbroek, RE; Haeseleer, F; Palczewski, K; Scheuer, T; Catterall, WA				Lee, A; Westenbroek, RE; Haeseleer, F; Palczewski, K; Scheuer, T; Catterall, WA			Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-binding protein 1	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC CALCIUM CURRENT; BETA-GAMMA-SUBUNITS; RAT BRAIN-STEM; CA2+ CHANNELS; N-TYPE; SUBCELLULAR-DISTRIBUTION; ALPHA(1A) SUBUNITS; FACILITATION; INACTIVATION; SYNTAXIN	Ca(v)2.1 channels, which mediate P/Q-type Ca2+ currents, undergo Ca2+/calmodulin (CaM) dependent inactivation and facilitation that can significantly alter synaptic efficacy. Here we report that the neuronal Ca2+-binding protein 1 (CaBP1) modulates Ca(v)2.1 channels in a manner that is markedly different from modulation by CaM. CaBP1 enhances inactivation, causes a depolarizing shift in the voltage dependence of activation, and does not support Ca2+-dependent facilitation of Ca(v)2.1 channels. These inhibitory effects of CaBP1 do not require Ca2+, but depend on the CaM-binding domain in the alpha(1) subunit of Ca(v)2.1 channels (alpha(1)2.1). CaBP1 binds to the CaM-binding domain, co-immunoprecipitates with alpha(1)2.1 from transfected cells and brain extracts, and colocalizes with alpha(1)2.1 in discrete microdomains of neurons in the hippocampus and cerebellum. Our results identify an interaction between Ca2+ channels and CaBP1 that may regulate Ca2+-dependent forms of synaptic plasticity by inhibiting Ca2+ influx into neurons.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.			Lee, Amy/0000-0001-8021-0443	NATIONAL EYE INSTITUTE [R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010645, R01NS022625] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY08061, R01 EY008061] Funding Source: Medline; NINDS NIH HHS [F32 NS010645, R01 NS22625, R01 NS022625, F32 NS10645] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Chen XL, 2001, J PHYSIOL-LONDON, V532, P649, DOI 10.1111/j.1469-7793.2001.0649e.x; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; GREENLEE DV, 1982, BIOCHEMISTRY-US, V21, P2759, DOI 10.1021/bi00540a028; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; YAMAKI T, 1980, BIOCHEM BIOPH RES CO, V94, P727, DOI 10.1016/0006-291X(80)91293-0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	39	148	154	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					210	217		10.1038/nn805	http://dx.doi.org/10.1038/nn805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865310	Green Accepted			2022-12-28	WOS:000174146000010
J	Pagnoni, G; Zink, CF; Montague, PR; Berns, GS				Pagnoni, G; Zink, CF; Montague, PR; Berns, GS			Activity in human ventral striatum locked to errors of reward prediction	NATURE NEUROSCIENCE			English	Article							RESPONSES; DOPAMINE; SYSTEMS		Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Emory University; Baylor College of Medicine	Pagnoni, G (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.		anand, amit/A-7222-2009; Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091	NIDA NIH HHS [DA11723, DA00367] Funding Source: Medline; NIMH NIH HHS [MH61010] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Duvernoy HM, 1999, HUMAN BRAIN; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; WARD BD, 2001, AFNI 3DDECONVOLVE DO	13	336	337	2	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					97	98		10.1038/nn802	http://dx.doi.org/10.1038/nn802			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802175				2022-12-28	WOS:000173558400008
J	Roozendaal, B; Phillips, RG; Power, AE; Brooke, SM; Sapolsky, RM; McGaugh, JL				Roozendaal, B; Phillips, RG; Power, AE; Brooke, SM; Sapolsky, RM; McGaugh, JL			Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression	NATURE NEUROSCIENCE			English	Article							STRESS; AXIS		Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Stanford University	Roozendaal, B (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA.		Roozendaal, Benno/B-8403-2013		NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH012526, R01MH053814, R37MH012526, R01MH012526] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH53814, MH12526] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARBEL I, 1994, BRAIN RES, V657, P227, DOI 10.1016/0006-8993(94)90972-5; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; FISCHETTE CT, 1980, BRAIN RES, V195, P105; HERMAN JP, 1989, J NEUROSCI, V9, P3072; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McLaughlin J, 2000, P NATL ACAD SCI USA, V97, P12804, DOI 10.1073/pnas.210350097; Moser MB, 1998, J NEUROSCI, V18, P7535; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Roozendaal B, 1996, PSYCHONEUROENDOCRINO, V21, P681, DOI 10.1016/S0306-4530(96)00028-5; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240	12	102	108	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1169	1171		10.1038/nn766	http://dx.doi.org/10.1038/nn766			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713467				2022-12-28	WOS:000172525000010
J	Pavani, F; Castiello, U				Pavani, F; Castiello, U			Binding personal and extrapersonal space through body shadows	NATURE NEUROSCIENCE			English	Article								Shadows in visual scenes can have profound effects on visual perception. Here we have found that visual distracters distant from the body interfere with human spatial discrimination of tactile targets at a hand, particularly when the shadow of the stimulated hand stretches toward them in extrapersonal space. These findings suggest that shadows cast by a person's own body parts can bridge the gap between personal and extrapersonal space.	Univ Studi Trento, Dipartimento Sci Congniz & Formaz, I-38068 Rovereto, Italy; Royal Holloway Univ London, Dept Psychol, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Pavani, F (corresponding author), Univ Studi Trento, Dipartimento Sci Congniz & Formaz, Via Matteo del Ben 5,3rd Floor, I-38068 Rovereto, Italy.	pavani@form.unitn.it	Pavani, Francesco/B-4836-2010	Pavani, Francesco/0000-0003-0426-5578; Castiello, Umberto/0000-0003-0629-1286				Castiello U, 2001, VISION RES, V41, P2305, DOI 10.1016/S0042-6989(01)00141-9; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Iriki A, 1996, NEUROREPORT, V7, P2325; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Mamassian P, 1998, TRENDS COGN SCI, V2, P288, DOI 10.1016/S1364-6613(98)01204-2; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190	10	67	67	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					14	15		10.1038/nn1167	http://dx.doi.org/10.1038/nn1167			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699414				2022-12-28	WOS:000187636000007
J	Bylund, M; Andersson, E; Novitch, BG; Muhr, J				Bylund, M; Andersson, E; Novitch, BG; Muhr, J			Vertebrate neurogenesis is counteracted by Sox1-3 activity	NATURE NEUROSCIENCE			English	Article							VENTRAL NEURAL-TUBE; NEURONAL DIFFERENTIATION; NERVOUS-SYSTEM; STEM-CELLS; GENE-EXPRESSION; ACHAETE-SCUTE; CHICK-EMBRYO; BHLH PROTEIN; SOX2; FATE	The generation of neurons from stem cells involves the activity of proneural basic helix-loop-helix (bHLH) proteins, but the mechanism by which these proteins irreversibly commit stem cells to neuronal differentiation is not known. Here we report that expression of the transcription factors Sox1, Sox2 and Sox3 (Sox1-3) is a critical determinant of neurogenesis. Using chick in ovo electroporation, we found that Sox1-3 transcription factors keep neural cells undifferentiated by counteracting the activity of proneural proteins. Conversely, the capacity of proneural bHLH proteins to direct neuronal differentiation critically depends on their ability to suppress Sox1-3 expression in CNS progenitors. These data suggest that the generation of neurons from stem cells depends on the inhibition of Sox1-3 expression by proneural proteins.	Karolinska Inst, Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Columbia University; Howard Hughes Medical Institute	Muhr, J (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Box 240, SE-17177 Stockholm, Sweden.			Novitch, Bennett/0000-0002-2696-3708; andersson, elisabet/0000-0003-3095-465X				Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Berk AJ, 1998, COLD SPRING HARB SYM, V63, P243, DOI 10.1101/sqb.1998.63.243; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Buescher M, 2002, DEVELOPMENT, V129, P4193; CACCAMO D, 1989, LAB INVEST, V60, P390; Collignon J, 1996, DEVELOPMENT, V122, P509; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; JASONI CL, 1994, DEVELOPMENT, V120, P769; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Lo LC, 2002, DEVELOPMENT, V129, P1553; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Morrow EM, 1999, DEVELOPMENT, V126, P23; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Overton PM, 2002, DEVELOPMENT, V129, P4219; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Smith ST, 1996, DEVELOPMENT, V122, P3141; STEVANOVIC M, 1993, HUM MOL GENET, V3, P2013; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zappone MV, 2000, DEVELOPMENT, V127, P2367	50	611	635	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1162	1168		10.1038/nn1131	http://dx.doi.org/10.1038/nn1131			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14517545				2022-12-28	WOS:000186229200015
J	Deboer, T; Vansteensel, MJ; Detari, L; Meijer, JH				Deboer, T; Vansteensel, MJ; Detari, L; Meijer, JH			Sleep states alter activity of suprachiasmatic nucleus neurons	NATURE NEUROSCIENCE			English	Article							EEG POWER SPECTRA; SLOW-WAVE SLEEP; CIRCADIAN PACEMAKER; CORTICAL TEMPERATURE; DJUNGARIAN HAMSTER; LESIONED RATS; DEPRIVATION; PERIOD; BRAIN; HOMEOSTASIS	The timing of sleep and wakefulness in mammals is governed by a sleep homeostatic process and by the circadian clock of the suprachiasmatic nucleus (SCN), which has a molecular basis for rhythm generation. By combining SCN electrical activity recordings with electroencephalogram (EEG) recordings in the same animal (the Wistar rat), we discovered that changes in vigilance states are paralleled by strong changes in SCN electrophysiological activity. During rapid eye movement (REM) sleep, neuronal activity in the SCN was elevated, and during non-REM (NREM) sleep, it was lowered. We also carried out selective sleep deprivation experiments to confirm that changes in SCN electrical activity are caused by changes in vigilance state. Our results indicate that the 24-hour pattern in electrical activity that is controlled by the molecular machinery of the SCN is substantially modified by afferent information from the central nervous system.	Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2300 RC Leiden, Netherlands; Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1088 Budapest, Hungary	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eotvos Lorand University	Meijer, JH (corresponding author), Leiden Univ, Med Ctr, Dept Neurophysiol, Box 9604, NL-2300 RC Leiden, Netherlands.	j.h.meijer@lumc.nl	Vansteensel, Mariska/K-8015-2019	Vansteensel, Mariska/0000-0002-9252-5116				ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2000, J NEUROSCI, V20, P9326; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; BENINGTON JH, PROG NEUROBIOL, V45, P347; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; CAMPBELL SS, 1989, PSYCHOPHYSIOLOGY, V26, P580, DOI 10.1111/j.1469-8986.1989.tb00714.x; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Deboer T, 2003, SLEEP, V26, P567, DOI 10.1093/sleep/26.5.567; DEBOER T, 1994, J COMP PHYSIOL A, V174, P145; DEBOER T, 1997, PFLUGERS ARCH, V433, P23; DIJK D J, 1987, Journal of Biological Rhythms, V2, P207, DOI 10.1177/074873048700200304; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1995, BEHAV BRAIN RES, V69, P109, DOI 10.1016/0166-4328(95)00007-G; DIJK DJ, 1987, EUR ARCH PSY CLIN N, V236, P323; DIJK DJ, 1989, AM J PHYSIOL, V156, pR106; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Jouvet M, 1998, J SLEEP RES, V7, P1, DOI 10.1046/j.1365-2869.7.s1.1.x; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; LANCEL M, 1991, BRAIN RES, V548, P206, DOI 10.1016/0006-8993(91)91123-I; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MCCARLEY RW, 1992, J SLEEP RES, V1, P132, DOI 10.1111/j.1365-2869.1992.tb00026.x; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Moore, 2001, HDB BEHAV NEUROBIOLO, V12; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MOSES JM, 1975, PSYCHOPHYSIOLOGY, V12, P141, DOI 10.1111/j.1469-8986.1975.tb01264.x; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Palchykova S, 2002, J SLEEP RES, V11, P313, DOI 10.1046/j.1365-2869.2002.00310.x; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Strijkstra AM, 1998, AM J PHYSIOL-REG I, V275, pR1110, DOI 10.1152/ajpregu.1998.275.4.R1110; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TRACHSEL L, 1992, BRAIN RES, V589, P253, DOI 10.1016/0006-8993(92)91284-L; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20	45	210	216	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1086	1090		10.1038/nn1122	http://dx.doi.org/10.1038/nn1122			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12958601				2022-12-28	WOS:000185633600021
J	Semyanov, A; Walker, MC; Kullmann, DM				Semyanov, A; Walker, MC; Kullmann, DM			GABA uptake regulates cortical excitability via cell type-specific tonic inhibition	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; TEMPORAL-LOBE EPILEPSY; RAT-BRAIN-SLICES; HIPPOCAMPAL-NEURONS; SYNAPTIC INHIBITION; PERSISTENT ACTIVATION; RECEPTOR CHANNELS; PYRAMIDAL NEURONS; DELTA-SUBUNIT; HIGH-AFFINITY	GABA(A) receptors can mediate both 'phasic' synaptic inhibition and a persistent 'tonic' form of signaling. We show that, in the presence of intact GABA uptake, guinea pig hippocampal interneurons, but not pyramidal cells, express a tonic GABA(A) receptor-mediated conductance. This conductance was pharmacologically distinct from spontaneous inhibitory postsynaptic currents (IPSCs). Inhibiting GABA uptake resulted in the expression of a comparable GABA(A) receptor-mediated tonic conductance in pyramidal cells. Reducing the tonic conductance in interneurons enhanced their excitability and the inhibitory drive to pyramidal cells. These results point to a role for cell type-dependent tonic inhibition in regulating cortical excitability.	UCL, Dept Clin & Expt Epilepsy, Neurol Inst, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Dept Clin & Expt Epilepsy, Neurol Inst, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Semyanov, Alexey/A-7654-2010; Kullmann, Dimitri M/A-3162-2009; Walker, Matthew C/C-1577-2008	Semyanov, Alexey/0000-0002-6800-0942; Kullmann, Dimitri M/0000-0001-6696-3545; Walker, Matthew C/0000-0002-0812-0352				Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Birnir B, 2000, J MEMBRANE BIOL, V174, P21, DOI 10.1007/s002320001028; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; CELIO MR, 1993, HIPPOCAMPUS, V3, P55; Chiu CS, 2002, J NEUROSCI, V22, P10251; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; CURMI JP, 1993, J MEMBRANE BIOL, V136, P273; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; DILLON GH, 1995, BRIT J PHARMACOL, V115, P539, DOI 10.1111/j.1476-5381.1995.tb16368.x; Draguhn A, 1996, J NEUROPHYSIOL, V76, P3983, DOI 10.1152/jn.1996.76.6.3983; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Engel D, 1998, J PHYSIOL-LONDON, V512, P643, DOI 10.1111/j.1469-7793.1998.643bd.x; Frahm C, 2001, DEV BRAIN RES, V132, P1, DOI 10.1016/S0165-3806(01)00288-7; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Liu QY, 2000, J NEUROPHYSIOL, V84, P1392, DOI 10.1152/jn.2000.84.3.1392; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; RADIAN R, 1990, J NEUROSCI, V10, P1319; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Vizi ES, 1999, NEUROCHEM INT, V34, P407, DOI 10.1016/S0197-0186(99)00047-9; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Yan XX, 1997, DEV BRAIN RES, V99, P1, DOI 10.1016/S0165-3806(96)00192-7; Yeung JYT, 2003, MOL PHARMACOL, V63, P2, DOI 10.1124/mol.63.1.2	45	328	335	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					484	490		10.1038/nn1043	http://dx.doi.org/10.1038/nn1043			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12679782				2022-12-28	WOS:000182553200015
J	Hosie, AM; Dunne, EL; Harvey, RJ; Smart, TG				Hosie, AM; Dunne, EL; Harvey, RJ; Smart, TG			Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity	NATURE NEUROSCIENCE			English	Article							A RECEPTOR; RAT HIPPOCAMPUS; DENTATE GRANULE; ZN2+ INHIBITION; BETA-SUBUNITS; RELEASED ZINC; CHANNEL; IDENTIFICATION; RECOMBINANT; MODULATION	Zinc ions are concentrated in the central nervous system and regulate GABA(A) receptors, which are pivotal mediators of inhibitory synaptic neurotransmission. Zinc ions inhibit GABA(A) receptor function by an allosteric mechanism that is critically dependent on the receptor subunit composition: alphabeta subunit combinations show the highest sensitivity, and alphabetagamma isoforms are the least sensitive. Here we propose a mechanistic and structural basis for this inhibition and its dependence on the receptor subunit composition. We used molecular modeling to identify three discrete sites that mediate Zn2+ inhibition. One is located within the ion channel, and the other two are on the external amino (N)-terminal face of the receptor at the interfaces between alpha and beta subunits. We found that the characteristically low Zn2+ sensitivity of GABA(A) receptors containing the gamma2 subunit results from disruption to two of the three sites after receptor subunit co-assembly.	UCL, Dept Pharmacol, London WC1E 6BT, England; Univ London Sch Pharm, Dept Pharmacol, London WC1N 1AX, England	University of London; University College London; University of London; University College London; University of London School of Pharmacy	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk	Harvey, Robert/D-3994-2016	Harvey, Robert/0000-0001-5956-6664				AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; Boileau AJ, 1999, J NEUROSCI, V19, P10213; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brickley SG, 1999, J NEUROSCI, V19, P2960; Brooks-Kayal AR, 2001, J NEUROCHEM, V77, P1266, DOI 10.1046/j.1471-4159.2001.00329.x; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; CELENTANO JJ, 1991, MOL PHARMACOL, V40, P766; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Dunne EL, 2002, BRIT J PHARMACOL, V137, P29, DOI 10.1038/sj.bjp.0704835; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Fisher JL, 1998, J NEUROSCI, V18, P2944; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Gingrich KJ, 1998, J PHYSIOL-LONDON, V506, P609, DOI 10.1111/j.1469-7793.1998.609bv.x; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; LEGENDRE P, 1991, MOL PHARMACOL, V39, P267; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Molnar P, 2001, J NEUROPHYSIOL, V85, P1932, DOI 10.1152/jn.2001.85.5.1932; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nagaya N, 2001, J PHYSIOL-LONDON, V532, P17, DOI 10.1111/j.1469-7793.2001.0017g.x; Newell JG, 2002, J BIOL CHEM, V277, P21423, DOI 10.1074/jbc.M110312200; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; Pawelzik H, 1999, EUR J NEUROSCI, V11, P3552, DOI 10.1046/j.1460-9568.1999.00772.x; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; SMART TG, 1992, J PHYSIOL-LONDON, V447, P587, DOI 10.1113/jphysiol.1992.sp019020; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Taketo M, 2000, NEUROSCIENCE, V96, P507, DOI 10.1016/S0306-4522(99)00574-6; Taylor PM, 2000, J NEUROSCI, V20, P1297; Tretter V, 1997, J NEUROSCI, V17, P2728; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; WANG TL, 1995, J NEUROSCI, V15, P7684; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Whiting PJ, 1997, J NEUROSCI, V17, P5027; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	49	201	204	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					362	369		10.1038/nn1030	http://dx.doi.org/10.1038/nn1030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640458				2022-12-28	WOS:000181833100013
J	Monks, DA; Lonstein, JS; Breedlove, SM				Monks, DA; Lonstein, JS; Breedlove, SM			Got milk? Oxytocin triggers hippocampal plasticity	NATURE NEUROSCIENCE			English	Editorial Material							MEMORY; MOTHERHOOD; PREGNANCY	Giving birth improves spatial memory in rodents. A new study shows that oxytocin, which triggers birth and milk release, activates a signaling cascade involved in learning, and that this hormone is necessary and sufficient for memory improvement in mice that have had litters.	Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Monks, DA (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	breedsm@msu.edu		Breedlove, S. Marc/0000-0003-4359-4315				Brett M, 2001, PSYCHONEUROENDOCRINO, V26, P339, DOI 10.1016/S0306-4530(01)00003-8; Bridges RS, 1996, ADV STUD BEHAV, V25, P215; CARMICHAEL MS, 1994, ARCH SEX BEHAV, V23, P59, DOI 10.1007/BF01541618; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Galea LAM, 2001, BEHAV BRAIN RES, V126, P115, DOI 10.1016/S0166-4328(01)00255-8; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; LANDGRAF R, 1991, NEUROENDOCRINOLOGY, V54, P378, DOI 10.1159/000125917; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; STONEHAM MD, 1985, J ENDOCRINOL, V107, P97, DOI 10.1677/joe.0.1070097; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; WILLIAMS CL, 1990, BEHAV NEUROSCI, V104, P84, DOI 10.1037/0735-7044.104.1.84	12	15	15	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					327	328		10.1038/nn0403-327	http://dx.doi.org/10.1038/nn0403-327			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12658276				2022-12-28	WOS:000181833100003
J	Ress, D; Heeger, DJ				Ress, D; Heeger, DJ			Neuronal correlates of perception in early visual cortex	NATURE NEUROSCIENCE			English	Article							SIMPLE CELLS; RESPONSES; VARIABILITY; PERFORMANCE; ACTIVATION; ATTENTION; DISCHARGE; MONKEYS; HUMANS; TARGET	We used functional magnetic resonance imaging (fMRI) to measure activity in human early visual cortex (areas V1, V2 and V3) during a challenging contrast-detection task. Subjects attempted to detect the presence of slight contrast increments added to two kinds of background patterns. Behavioral responses were recorded so that the corresponding cortical activity could be grouped into the usual signal detection categories: hits, false alarms, misses and correct rejects. For both kinds of background patterns, the measured cortical activity was retinotopically specific. Hits and false alarms were associated with significantly more cortical activity than were correct rejects and misses. That false alarms evoked more activity than misses indicates that activity in early visual cortex corresponded to the subjects' percepts, rather than to the physically presented stimulus.	Stanford Univ, Dept Psychol, Stanford, CA 94309 USA; NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Stanford University; New York University; New York University	Ress, D (corresponding author), Stanford Univ, Dept Psychol, 450 Serra Mall,Bldg 420-400, Stanford, CA 94309 USA.	ress@stanford.edu			NEI NIH HHS [R01 EY011794, R01 EY011794-09, R01-EY11794] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011794] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Ahumada AJ, 1996, PERCEPTION, V25, P18; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CAMPBELL FW, 1971, J PHYSIOL-LONDON, V217, pP54; Carandini M, 1997, J NEUROSCI, V17, P8621; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; GRILLSPECTOR K, IN PRESS ATTENTION P, V20; HILLYARD SA, 1971, SCIENCE, V172, P1357, DOI 10.1126/science.172.3990.1357; Hunter M, 2001, BRAIN COGNITION, V46, P342, DOI 10.1006/brcg.2001.1290; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Liang HL, 2000, NEUROREPORT, V11, P2875, DOI 10.1097/00001756-200009110-00009; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pashler HE, 1998, PSYCHOL ATTENTION; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shulman GL, 1999, J NEUROSCI, V19, P9480; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Solomon JA, 2002, J VISION, V2, P105, DOI 10.1167/2.1.7; SQUIRES KC, 1975, BEHAV BIOL, V13, P21, DOI 10.1016/S0091-6773(75)90748-8; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Thompson KG, 2000, VISION RES, V40, P1523, DOI 10.1016/S0042-6989(99)00250-3; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656	49	260	269	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					414	420		10.1038/nn1024	http://dx.doi.org/10.1038/nn1024			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627164	Green Accepted			2022-12-28	WOS:000181833100020
J	Anderson, AK; Christoff, K; Stappen, I; Panitz, D; Ghahremani, DG; Glover, G; Gabrieli, JDE; Sobel, N				Anderson, AK; Christoff, K; Stappen, I; Panitz, D; Ghahremani, DG; Glover, G; Gabrieli, JDE; Sobel, N			Dissociated neural representations of intensity and valence in human olfaction	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; HUMAN AMYGDALA; ORBITOFRONTAL CORTEX; EMOTIONAL AROUSAL; PREFRONTAL CORTEX; ODOR PLEASANTNESS; MOOD DISORDERS; TEMPORAL-LOBE; ACTIVATION; STIMULI	Affective experience has been described in terms of two primary dimensions: intensity and valence. In the human brain, it is intrinsically difficult to dissociate the neural coding of these affective dimensions for visual and auditory stimuli, but such dissociation is more readily achieved in olfaction, where intensity and valence can be manipulated independently. Using event-related functional magnetic resonance imaging (fMRI), we found amygdala activation to be associated with intensity, and not valence, of odors. Activity in regions of orbitofrontal cortex, in contrast, were associated with valence independent of intensity. These findings show that distinct olfactory regions subserve the analysis of the degree and quality of olfactory stimulation, suggesting that the affective representations of intensity and valence draw upon dissociable neural substrates.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Vienna, Inst Pharmaceut Chem, A-1090 Vienna, Austria; Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; University of Vienna; Stanford University; University of California System; University of California Berkeley	Anderson, AK (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 349 Mulford Hall, Berkeley, CA 94720 USA.	adam.k.anderson@stanford.edu; nsobel@socrates.berkeley.edu	Gabrieli, John/AAJ-2869-2020	Sobel, Noam/0000-0002-3232-9391				Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2002, J COGNITIVE NEUROSCI, V14, P709, DOI 10.1162/08989290260138618; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CAIN WS, 1978, PERCEPTION, V7, P459, DOI 10.1068/p070459; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DOTY RL, 1975, PERCEPT PSYCHOPHYS, V17, P492, DOI 10.3758/BF03203300; Dravnieks A., 1985, ATLAS ODOR CHARACTER; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Gallagher M, 2000, AMYGDALA FUNCTIONAL, P311; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; Irwin W, 1996, NEUROREPORT, V7, P1765, DOI 10.1097/00001756-199607290-00014; JonesGotman M, 1997, BRAIN, V120, P1845, DOI 10.1093/brain/120.10.1845; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lazarus R.S., 1991, EMOTION ADAPTATION; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; Pause BM, 1997, CHEM SENSES, V22, P9, DOI 10.1093/chemse/22.1.9; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Rolls ET, 2001, CHEM SENSES, V26, P595, DOI 10.1093/chemse/26.5.595; Royet JP, 2000, J NEUROSCI, V20, P7752; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SAKAMOTO N, 1999, HDB CHEM NEUROANATOM, V15, P15; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Wilson DA, 1997, J NEUROPHYSIOL, V78, P160, DOI 10.1152/jn.1997.78.1.160; Zald DH, 1998, J CEREBR BLOOD F MET, V18, P896, DOI 10.1097/00004647-199808000-00010; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	48	786	796	2	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					196	202		10.1038/nn1001	http://dx.doi.org/10.1038/nn1001			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536208				2022-12-28	WOS:000180669100021
J	Aron, AR; Fletcher, PC; Bullmore, ET; Sahakian, BJ; Robbins, TW				Aron, AR; Fletcher, PC; Bullmore, ET; Sahakian, BJ; Robbins, TW			Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL MRI		Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge	Robbins, TW (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	twr2@cam.ac.uk	Li, Chong/F-4265-2015; Robbins, Trevor W/A-7551-2008; Sahakian, Barbara/AAW-1198-2020; Bullmore, Ed/C-1706-2012; Fletcher, Paul/F-5380-2011	Sahakian, Barbara/0000-0001-7352-1745; Bullmore, Ed/0000-0002-8955-8283; Fletcher, Paul/0000-0001-8257-1517; Robbins, Trevor/0000-0003-0642-5977	Wellcome Trust [064351] Funding Source: Medline; ESRC [ES/F028814/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Logan G. D., 2000, ATTENTION PERFORM, P653; Logan Gordon D., 1994, P189; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396	13	1198	1223	5	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					115	116		10.1038/nn1003	http://dx.doi.org/10.1038/nn1003			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536210				2022-12-28	WOS:000180669100009
J	Crick, F; Koch, C				Crick, F; Koch, C			A framework for consciousness	NATURE NEUROSCIENCE			English	Article							PERCEPTION; VISION; NEUROSCIENCE; MECHANISMS; ILLUSION	Here we summarize our present approach to the problem of consciousness. After an introduction outlining our general strategy, we describe what is meant by the term 'framework' and set it out under ten headings. This framework offers a coherent scheme for explaining the neural correlates of (visual) consciousness in terms of competing cellular assemblies. Most of the ideas we favor have been suggested before, but their combination is original. We also outline some general experimental approaches to the problem and, finally, acknowledge some relevant aspects of the brain that have been left out of the proposed framework.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; CALTECH, Pasadena, CA 91125 USA	Salk Institute; California Institute of Technology	Koch, C (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	koch@klab.caltech.edu		Koch, Christof/0000-0001-6482-8067				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Attneave F., 1961, SENS COMMUN, P777; Baars B.J., 1997, THEATER CONSCIOUSNES; Bachmann Talis, 2000, MICROGENETIC APPROAC; BAYNE T, IN PRESS UNITY CONSC; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; Chalmers D., 1995, CONSCIOUS MIND SEARC; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Crick F, 2000, NEURAL CORRELATES OF CONSCIOUSNESS, P103; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; CRICK F, 1995, SCI AM, V273, P84; CRICK FC, 2003, PROBLEMS SYSTEMS NEU; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DELIMA AD, 1990, J COMP NEUROL, V296, P159, DOI 10.1002/cne.902960110; Dennett D, 2001, COGNITION, V79, P221, DOI 10.1016/S0010-0277(00)00130-X; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Edelman G.M., 1989, REMEMBERED PRESENT B; Edelman G.M., 2000, UNIVERSE CONSCIOUSNE, V1st Edn; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fried I, 1998, NATURE, V391, P650, DOI 10.1038/35536; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; GROSSBERG S, 1995, AM SCI, V83, P438; HEBB D. O., 1949; HESS RH, 1989, J NEUROSCI, V9, P1628; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Jackendoff R, 1987, CONSCIOUSNESS COMPUT; JACKSON AP, 1996, BIOMEMBR, V4, P1; Koch C, 2001, NATURE, V411, P893, DOI 10.1038/35082161; KOCH C, IN PRESS QUEST CONSC; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Milner A. D., 1995, VISUAL BRAIN ACTION; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Purves D, 1996, P NATL ACAD SCI USA, V93, P3693, DOI 10.1073/pnas.93.8.3693; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Revonsuo A, 1997, NEUROREPORT, V8, P3867, DOI 10.1097/00001756-199712220-00006; Rossetti Y, 1998, CONSCIOUS COGN, V7, P520, DOI 10.1006/ccog.1998.0370; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SCHACTER DL, 1992, J COGNITIVE NEUROSCI, V4, P244, DOI 10.1162/jocn.1992.4.3.244; Shadlen M.N., 1999, NEURON, V24.1, P111, DOI DOI 10.1016/S0896-627380822-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shear J., 1997, EXPLAINING CONSCIOUS; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; SIMPSON WA, 1994, VISION RES, V34, P2547, DOI 10.1016/0042-6989(94)90241-0; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Stroud J.M., 1956, INFORMATION THEORY P, P174; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675; Wegner D., 2002, ILLUSION CONSCIOUS W; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; Zeki S, 1999, CONSCIOUS COGN, V8, P225, DOI 10.1006/ccog.1999.0390; Zeki S, 1998, NEUROSCIENTIST, V4, P365, DOI 10.1177/107385849800400518; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	60	796	825	0	224	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					119	126		10.1038/nn0203-119	http://dx.doi.org/10.1038/nn0203-119			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12555104	Green Published			2022-12-28	WOS:000180669100011
J	Izzo, E; Martin-Fardon, R; Koob, GF; Weiss, F; Sanna, PP				Izzo, E; Martin-Fardon, R; Koob, GF; Weiss, F; Sanna, PP			Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization	NATURE NEUROSCIENCE			English	Article							CONTEXT; PATHWAY; DRUG		Scripps Res Inst, Dept Neuropharmacol, San Diego, CA 92103 USA	Scripps Research Institute	Sanna, PP (corresponding author), Scripps Res Inst, Dept Neuropharmacol, 10550 N Torrey Pines Rd, San Diego, CA 92103 USA.	psanna@scripps.edu	Martin-Fardon, R/ABB-7865-2020		NIDA NIH HHS [DA04398, DA13821, DA08467] Funding Source: Medline; NIMH NIH HHS [MH62140] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH062140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008467, R01DA004398, R01DA013821] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bell K, 1996, PSYCHOPHARMACOLOGY, V127, P377, DOI 10.1007/BF02806018; Jackson A, 1998, BEHAV PHARMACOL, V9, P457, DOI 10.1097/00008877-199809000-00009; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; MISCRENDINO MJ, 1995, BRAIN RES, V674, P299; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pierce RC, 1998, J PHARMACOL EXP THER, V286, P1171; Pierce RC, 1999, J NEUROSCI, V19, P8685; POST RM, 1987, PSYCHOPHARMACOL BULL, V23, P425; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sanna PP, 2002, J NEUROSCI, V22, P3359; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	13	51	52	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1263	1264		10.1038/nn977	http://dx.doi.org/10.1038/nn977			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12436114				2022-12-28	WOS:000179447500007
J	Dechant, G; Barde, YA				Dechant, G; Barde, YA			The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system	NATURE NEUROSCIENCE			English	Review							NF-KAPPA-B; GROWTH-FACTOR RECEPTORS; AFFINITY NGF RECEPTOR; SCHWANN-CELL MIGRATION; P75 RECEPTOR; SYMPATHETIC NEURONS; DEATH DOMAIN; INTERACTING PROTEIN; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE	Neurotrophins have long been known to promote the survival and differentiation of vertebrate neurons. However, these growth factors can also induce cell death through the p75 neurotrophin receptor (p75(NTR)), a member of the tumor necrosis factor receptor superfamily. Consistent with a function in controlling the survival and process formation of neurons, p75(NTR) is mainly expressed during early neuronal development. In the adult, p75(NTR) is re-expressed in various pathological conditions, including epilepsy, axotomy and neurodegeneration. Potentially toxic peptides, including the amyloid beta- (Abeta-) peptide that accumulates in Alzheimer's disease, are ligands for p75(NTR). Recent work also implicates p75(NTR) in the regulation of both synaptic transmission and axonal elongation. It associates with the Nogo receptor, a binding protein for axonal growth inhibitors, and appears to be the transducing subunit of this receptor complex.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Friedrich Miescher Institute for Biomedical Research; Max Planck Society	Barde, YA (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X				Agerman K, 2000, MOL CELL NEUROSCI, V16, P258, DOI 10.1006/mcne.2000.0875; Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bentley CA, 2000, J NEUROSCI, V20, P7706; Benzel I, 2001, GENE, V281, P19, DOI 10.1016/S0378-1119(01)00730-2; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brann AB, 1999, J NEUROSCI, V19, P8199; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; CASADEMUNT E, 1999, EMBO J, V18; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Chung JY, 2002, J CELL SCI, V115, P679; COLLINS F, 1984, J NEUROSCI, V4, P1281; Cosgaya JM, 2001, J NEUROCHEM, V79, P391, DOI 10.1046/j.1471-4159.2001.00573.x; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; DeFreitas MF, 2001, J NEUROSCI, V21, P5121, DOI 10.1523/JNEUROSCI.21-14-05121.2001; Della-Bianca V, 2001, J BIOL CHEM, V276, P38929, DOI 10.1074/jbc.M107454200; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dobrowsky RT, 2000, J NEUROSCI RES, V61, P237, DOI 10.1002/1097-4547(20000801)61:3<237::AID-JNR1>3.0.CO;2-M; Dobrowsky RT, 1998, ANN NY ACAD SCI, V845, P32, DOI 10.1111/j.1749-6632.1998.tb09660.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fainzilber M, 1996, SCIENCE, V274, P1540, DOI 10.1126/science.274.5292.1540; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Frade JM, 2000, TRENDS NEUROSCI, V23, P591, DOI 10.1016/S0166-2236(00)01704-5; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Greferath U, 2000, EUR J NEUROSCI, V12, P885, DOI 10.1046/j.1460-9568.2000.00976.x; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Irie S, 1999, FEBS LETT, V460, P191, DOI 10.1016/S0014-5793(99)01324-1; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; LANGEVIN C, 2002, J BIOL CHEM; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; Majdan M, 1997, J NEUROSCI, V17, P6988; Mamidipudi V, 2002, J BIOL CHEM, V277, P28010, DOI 10.1074/jbc.M109730200; McQuillen PS, 2002, J NEUROSCI, V22, P3580; MUFSON EJ, 1992, P NATL ACAD SCI USA, V89, P569, DOI 10.1073/pnas.89.2.569; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Numakawa T, 1999, BRAIN RES, V842, P431, DOI 10.1016/S0006-8993(99)01867-3; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perini G, 2002, J EXP MED, V195, P907, DOI 10.1084/jem.20011797; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; RENDE M, 1993, J COMP NEUROL, V338, P560, DOI 10.1002/cne.903380406; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Susen K, 1999, FEBS LETT, V463, P231, DOI 10.1016/S0014-5793(99)01628-2; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; Thoenen H, 2000, PROG BRAIN RES, V128, P183; TROY CM, 2002, J BIOL CHEM; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; VOLONTE C, 1993, J BIOL CHEM, V268, P21410; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang JJL, 2000, J MOL NEUROSCI, V15, P19, DOI 10.1385/JMN:15:1:19; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; WANG KC, NATURE; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yoon SO, 1998, J NEUROSCI, V18, P3273	103	440	463	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1131	1136		10.1038/nn1102-1131	http://dx.doi.org/10.1038/nn1102-1131			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404007				2022-12-28	WOS:000178884600015
J	Usrey, WM				Usrey, WM			AMPA autoreceptors fill the gap in olfactory temporal coding	NATURE NEUROSCIENCE			English	Editorial Material							BULB; CELLS; SYSTEM; MAP	A new study uncovers a possible mechanism, involving gap junctions and AMPA autoreceptors, to promote near-synchronous activity in mitral cells of the mammalian olfactory bulb.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	Usrey, WM (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.							Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Adrian ED, 1927, J PHYSIOL-LONDON, V63, P378, DOI 10.1113/jphysiol.1927.sp002410; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Hartline HK, 1932, J CELL COMPAR PHYSL, V1, P277, DOI 10.1002/jcp.1030010211; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; PINCHING AJ, 1971, J CELL SCI, V9, P347; PRICE JL, 1970, J CELL SCI, V7, P631; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; WHITE EL, 1972, BRAIN RES, V37, P69, DOI 10.1016/0006-8993(72)90346-0	15	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1108	1109		10.1038/nn1102-1108	http://dx.doi.org/10.1038/nn1102-1108			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404001				2022-12-28	WOS:000178884600007
J	Nguyen, QT; Sanes, JR; Lichtman, JW				Nguyen, QT; Sanes, JR; Lichtman, JW			Pre-existing pathways promote precise projection patterns	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE REGENERATION; DIFFERENT SEGMENTAL LEVELS; GROWTH CONE GUIDANCE; NEUROMUSCULAR-JUNCTIONS; SELECTIVE REINNERVATION; INVIVO VISUALIZATION; POSTSYNAPTIC CHANGES; INTERCOSTAL MUSCLES; SYNAPSE ELIMINATION; TRANSGENIC MICE	A large body of evidence shows that molecular cues promote specific synapse formation by guiding axons and by mediating their association with targets, but much less is known about the contribution of physical cues (such as mechanical constraints) to these processes. Here we used the peripheral motor system to investigate the latter issue. In living mice, we viewed individual motor axons bearing a fluorescent reporter, and mapped the cohort of muscle fibers that they innervated both before and after nerve damage. When gross trauma was minimized (by a nerve-crushing rather than nerve-cutting procedure), regenerating axons retraced their former pathways, bifurcated at original branch points, and formed neuromuscular junctions on the same fibers that they originally innervated. Axonal growth through tubes of non-neural cells seemed to account for this specificity, and specificity degraded when the tubes were cut. These results suggest that nonspecific guidance cues can be sufficient to generate specific synaptic circuitry.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.							Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; [Anonymous], [No title captured]; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; BERNSTEIN J, 1961, EXP NEUROL, V4, P262, DOI 10.1016/0014-4886(61)90047-4; BROWN MC, 1987, BRAIN, V110, P695, DOI 10.1093/brain/110.3.695; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BRUSHART TM, 1980, SCIENCE, V208, P603, DOI 10.1126/science.7367884; BRUSHART TM, 1981, NEUROSCIENCE, V6, P2053, DOI 10.1016/0306-4522(81)90043-9; CAJAL SRY, 1928, DEGENERATION REGENER, V1, P66; Carlstedt T, 2000, CURR OPIN NEUROL, V13, P683, DOI 10.1097/00019052-200012000-00012; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DESANTIS M, 1992, EXP NEUROL, V116, P229, DOI 10.1016/0014-4886(92)90002-8; DESANTIS M, 1993, J COMP NEUROL, V336, P66, DOI 10.1002/cne.903360106; DIAMOND J, 1992, J NEUROSCI, V12, P1467; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gutmann E, 1944, J ANAT, V78, P15; HARDMAN VJ, 1987, J NEUROSCI, V7, P1031; HENDRY IA, 1986, BRAIN RES, V376, P292, DOI 10.1016/0006-8993(86)90192-7; Ide C, 1996, NEUROSCI RES, V25, P101; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; Langley J N, 1897, J Physiol, V22, P215; Laskowski MB, 1998, J NEUROSCI, V18, P7328; LASKOWSKI MB, 1988, J NEUROSCI, V8, P3094; LINGLE CJ, 1988, INT ANESTHESIOL CLIN, V26, P288, DOI 10.1097/00004311-198802640-00007; Melancon E, 1997, J NEUROSCI, V17, P7796; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; NJA A, 1977, J PHYSIOL-LONDON, V272, P633, DOI 10.1113/jphysiol.1977.sp012064; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; SALONEN V, 1988, ACTA NEUROPATHOL, V75, P331, DOI 10.1007/BF00687785; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; Stankovic N, 1996, CELL TISSUE RES, V284, P161, DOI 10.1007/s004410050576; Sunderland S, 1978, NERVES NERVE INJURIE, P69; THOMAS GJ, 1993, ADV BIOPHYS CHEM, V3, P1; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304; WESTERFIELD M, 1987, J EXP BIOL, V132, P161; WIGSTON DJ, 1985, J NEUROSCI, V5, P1208; WIGSTON DJ, 1982, NATURE, V299, P464, DOI 10.1038/299464a0; WIGSTON DJ, 1986, J NEUROSCI, V6, P2757; Young JZ, 1942, PHYSIOL REV, V22, P0318, DOI 10.1152/physrev.1942.22.4.318	49	229	236	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					861	867		10.1038/nn905	http://dx.doi.org/10.1038/nn905			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12172551				2022-12-28	WOS:000177656300016
J	Hiyama, TY; Watanabe, E; Ono, K; Inenaga, K; Tamkun, MM; Yoshida, S; Noda, M				Hiyama, TY; Watanabe, E; Ono, K; Inenaga, K; Tamkun, MM; Yoshida, S; Noda, M			Na-x channel involved in CNS sodium-level sensing	NATURE NEUROSCIENCE			English	Article							NEURONS		Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan; Natl Inst Basic Biol, Ctr Transgen Anim & Plants, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Kyushu Dent Coll, Dept Physiol, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; Colorado State Univ, Dept Physiol, Ft Collins, CO 80523 USA; Natl Inst Physiol Sci, Lab Intracellular Metab, Okazaki, Aichi 4448585, Japan; Nagasaki Univ, Sch Med, Dept Physiol, Nagasaki 8528523, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Kyushu Dental University; Colorado State University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Nagasaki University	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan.		Ono, Kentaro/AAV-5616-2021; Noda, Masaharu/D-7146-2016; Hiyama, Takeshi/X-4134-2018	Ono, Kentaro/0000-0003-0891-7705; Noda, Masaharu/0000-0002-3796-524X; Hiyama, Takeshi/0000-0001-8612-8707; Watanabe, Eiji/0000-0001-9089-8122				Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; JOHNSON AK, 1990, CURRENT TOPICS NEURO, V10, P149; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MINTA A, 1989, J BIOL CHEM, V264, P19449; NOSE H, 1992, J APPL PHYSIOL, V73, P1419, DOI 10.1152/jappl.1992.73.4.1419; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8; Watanabe E, 2000, J NEUROSCI, V20, P7743; Wells T, 1998, MOL CELL ENDOCRINOL, V136, P103, DOI 10.1016/S0303-7207(97)00219-0	11	136	137	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					511	512		10.1038/nn856	http://dx.doi.org/10.1038/nn856			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992118				2022-12-28	WOS:000175874600007
J	Behra, M; Cousin, X; Bertrand, C; Vonesch, JL; Biellmann, D; Chatonnet, A; Strahle, U				Behra, M; Cousin, X; Bertrand, C; Vonesch, JL; Biellmann, D; Chatonnet, A; Strahle, U			Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo	NATURE NEUROSCIENCE			English	Article							MONOCLONAL-ANTIBODIES; MUSCLE DEVELOPMENT; WILD-TYPE; EXPRESSION; CHOLINESTERASES; HINDBRAIN; IDENTIFICATION; MOTONEURONS; VERTEBRATE; OUTGROWTH	The neurotransmitter acetylcholine (ACh) has a crucial role in central and neuromuscular synapses of the cholinergic system. After release into the synaptic cleft, ACh is rapidly degraded by acetylcholinesterase (AChE). We have identified a mutation in the ache gene of the zebrafish, which abolishes ACh hydrolysis in homozygous animals completely. Embryos are initially motile but subsequently develop paralysis. Mutant embryos show defects in muscle fiber formation and innervation, and primary sensory neurons die prematurely. The neuromuscular phenotype in ache mutants is suppressed by a homozygous loss-of-function allele of the alpha-subunit of the nicotinic acetylcholine receptor (nAChR), indicating that the impairment of neuromuscular development is mediated by activation of nAChR in the mutant. Here we provide genetic evidence for non-classical functions of AChE in vertebrate development.	ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France; INRA, Unite Differenciat Cellulaire & Croissance, F-34060 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE	Strahle, U (corresponding author), ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.		Cousin, Xavier/E-2542-2013; Straehle, Uwe/K-7054-2013; BERTRAND-GADAY, Christelle/ABA-8619-2021; Chatonnet, Arnaud/E-2190-2017; Chatonnet, Arnaud/AAM-5569-2021	Cousin, Xavier/0000-0002-8520-3610; BERTRAND-GADAY, Christelle/0000-0003-0461-2402; Chatonnet, Arnaud/0000-0002-4057-3896; Behra, Martine/0000-0001-8107-6565				Bertrand C, 2001, J BIOL CHEM, V276, P464, DOI 10.1074/jbc.M006308200; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; Coronas V, 2000, NEUROSCIENCE, V98, P213, DOI 10.1016/S0306-4522(00)00143-3; Cousin X, 1998, NUCLEIC ACIDS RES, V26, P226, DOI 10.1093/nar/26.1.226; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Devoto SH, 1996, DEVELOPMENT, V122, P3371; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; HANNEMAN E, 1989, J COMP NEUROL, V284, P350, DOI 10.1002/cne.902840303; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Koenigsberger C, 1997, J NEUROCHEM, V69, P1389; LASKOWSKI MB, 1977, EXP NEUROL, V57, P13, DOI 10.1016/0014-4886(77)90041-3; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; LAYER PG, 1990, BIOESSAYS, V12, P415, DOI 10.1002/bies.950120904; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LINTON DM, 1990, DM-DIS MON, V36, P593; LIU DWC, 1992, J NEUROSCI, V12, P1859; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MILLARD CB, 1995, J NEUROCHEM, V64, P1909, DOI 10.1046/j.1471-4159.1995.64051909.x; MILLER JB, 1989, J BIOL CHEM, V264, P13122; Muller F, 1999, DEVELOPMENT, V126, P2103; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PARNETTI L, 1995, CLIN PHARMACOKINET, V29, P110, DOI 10.2165/00003088-199529020-00005; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; Sepich DS, 1998, GENETICS, V148, P361; Silver A., 1974, BIOL CHOLINESTERASES; Simon S, 1999, J BIOL CHEM, V274, P27740, DOI 10.1074/jbc.274.39.27740; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 1998, J NEUROSCI, V18, P1240; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; Ticho BS, 1996, MECH DEVELOP, V59, P205, DOI 10.1016/0925-4773(96)00601-6; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WECKER L, 1986, FUND APPL TOXICOL, V6, P172, DOI 10.1016/0272-0590(86)90273-3; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591; WESTERFIELD M, 1990, NEURON, V4, P867, DOI 10.1016/0896-6273(90)90139-7; WESTERFIELD M, 1993, ZEBRA FISH BOOK; Williams JA, 2000, DEV BIOL, V226, P220, DOI 10.1006/dbio.2000.9860; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896	50	280	289	5	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					111	118		10.1038/nn788	http://dx.doi.org/10.1038/nn788			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11753420				2022-12-28	WOS:000173558400012
J	Rodriguez, I; Del Punta, K; Rothman, A; Ishii, T; Mombaerts, P				Rodriguez, I; Del Punta, K; Rothman, A; Ishii, T; Mombaerts, P			Multiple new and isolated families within the mouse superfamily of V1r vomeronasal receptors	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; NEURONS; GENES; LOCALIZATION; ORGANIZATION; PROJECTIONS; EXPRESSION; SELECTION; PUBERTY	Seven-transmembrane-domain proteins encoded by the vomeronasal receptor V1r and V2r gene superfamilies, and expressed by vomeronasal sensory neurons, are believed to be pheromone receptors in rodents. Four V1r gene families have been described in the mouse (V1ra, V1rb, V1rc and V3r). Here we have screened near-complete mouse genomic databases to obtain a first global draft of the mouse V1r repertoire, including 104 new V1r genes. It comprises eight new and extremely isolated families in addition to the four families previously identified. Members of these new families were expressed in vomeronasal sensory neurons. The genome-wide view revealed great sequence diversity within the V1r superfamily. Phylogenetic analyses suggested an ancient original radiation, followed by the isolation, divergence and expansion of families by extensive gene duplications and frequent gene loss. The isolated nature of these gene families probably reflects a specialization of different receptor classes in the detection of specific types of chemicals.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Rodriguez, I (corresponding author), Univ Geneva, CMU, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland.	Ivan.Rodriguez@zoo.unige.ch; peter@rockefeller.edu		rodriguez, ivan/0000-0002-6468-0565				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Berghard A, 1996, J NEUROSCI, V16, P909; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Cadavid LF, 1997, P NATL ACAD SCI USA, V94, P14536, DOI 10.1073/pnas.94.26.14536; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Giorgi D, 2000, GENOME RES, V10, P1979, DOI 10.1101/gr.10.12.1979; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; HIROTA S, 1992, MOL BRAIN RES, V15, P47, DOI 10.1016/0169-328X(92)90150-A; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Naito T, 1998, P NATL ACAD SCI USA, V95, P5178, DOI 10.1073/pnas.95.9.5178; Norlin EM, 2001, MOL CELL NEUROSCI, V17, P872, DOI 10.1006/mcne.2001.0976; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Otaki JM, 2001, J THEOR BIOL, V211, P77, DOI 10.1006/jtbi.2001.2272; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Saito H, 1998, MOL BRAIN RES, V60, P215, DOI 10.1016/S0169-328X(98)00183-1; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Wallace KJ, 2000, BEHAV NEUROSCI, V114, P912, DOI 10.1037//0735-7044.114.5.912; WANG D, 1993, BRAIN BEHAV EVOLUT, V41, P246, DOI 10.1159/000113846; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	43	154	167	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					134	140		10.1038/nn795	http://dx.doi.org/10.1038/nn795			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802169				2022-12-28	WOS:000173558400015
J	Dean, C; Scholl, FG; Choih, J; DeMaria, S; Berger, J; Isacoff, E; Scheiffele, P				Dean, C; Scholl, FG; Choih, J; DeMaria, S; Berger, J; Isacoff, E; Scheiffele, P			Neurexin mediates the assembly of presynaptic terminals	NATURE NEUROSCIENCE			English	Article							ALPHA-LATROTOXIN RECEPTORS; ADHESION MOLECULE; TRANSMEMBRANE LIGANDS; CELL-ADHESION; EPH RECEPTORS; PROTEIN; SYNAPSE; ACETYLCHOLINESTERASE; PHOSPHORYLATION; NEUROLIGIN-1	Neurexins are a large family of proteins that act as neuronal cell-surface receptors. The function and localization of the various neurexins, however, have not yet been clarified. Beta-neurexins are candidate receptors for neuroligin-1, a postsynaptic membrane protein that can trigger synapse formation at axon contacts. Here we report that neurexins are concentrated at synapses and that purified neuroligin is sufficient to cluster neurexin and to induce presynaptic differentiation. Oligomerization of neuroligin is required for its function, and we find that beta-neurexin clustering is sufficient to trigger the recruitment of synaptic vesicles through interactions that require the cytoplasmic domain of neurexin. We propose a two-step model in which postsynaptic neuroligin multimers initially cluster axonal neurexins. In response to this clustering, neurexins nucleate the assembly of a cytoplasmic scaffold to which the exocytotic apparatus is recruited.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Columbia University; University of California System; University of California Berkeley	Scheiffele, P (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.	ps2018@columbia.edu	isacoff, ehud/AAP-1459-2020; IBIS, NEUROGENETICA/P-2947-2015; Gomez Scholl, Francisco/K-7780-2018	Gomez Scholl, Francisco/0000-0003-1762-0700; Isacoff, Ehud Y./0000-0003-4775-9359	NIMH NIH HHS [R01MH60771, R01 MH060711] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; BON S, 1988, J NEUROCHEM, V51, P776, DOI 10.1111/j.1471-4159.1988.tb01812.x; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hata Y, 1996, J NEUROSCI, V16, P2488; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kurschner C, 1998, MOL CELL NEUROSCI, V11, P161, DOI 10.1006/mcne.1998.0679; Littleton JT, 1997, J CELL BIOL, V137, P793, DOI 10.1083/jcb.137.4.793; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Russell AB, 1997, J NEUROSCI, V17, P4734; Sanchez R, 1997, PROTEINS, P50; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tobaben S, 2002, J BIOL CHEM, V277, P6359, DOI 10.1074/jbc.M111231200; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	37	442	458	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					708	716		10.1038/nn1074	http://dx.doi.org/10.1038/nn1074			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12796785	Green Accepted			2022-12-28	WOS:000183780400018
J	Janata, P; Grafton, ST				Janata, P; Grafton, ST			Swinging in the brain: shared neural substrates for behaviors related to sequencing and music	NATURE NEUROSCIENCE			English	Review							SENSORIMOTOR SYNCHRONIZATION; AUDITORY SEQUENCES; ACTION REPERTOIRES; TEMPORAL PATTERNS; ACCENT PRODUCTION; PHASE CORRECTION; CAUDATE-NUCLEUS; BASAL GANGLIA; MOTOR CONTROL; TIME	Music consists of precisely patterned sequences of both movement and sound that engage the mind in a multitude of experiences. We move in response to music and we move in order to make music. Because of the intimate coupling between perception and action, music provides a panoramic window through which we can examine the neural organization of complex behaviors that are at the core of human nature. Although the cognitive neuroscience of music is still in its infancy, a considerable behavioral and neuroimaging literature has amassed that pertains to neural mechanisms that underlie musical experience. Here we review neuroimaging studies of explicit sequence learning and temporal production-findings that ultimately lay the groundwork for understanding how more complex musical sequences are represented and produced by the brain. These studies are also brought into an existing framework concerning the interaction of attention and time-keeping mechanisms in perceiving complex patterns of information that are distributed in time, such as those that occur in music.	Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Janata, P (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033504, P50NS017778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC005146] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03 DC05146] Funding Source: Medline; NINDS NIH HHS [P50 NS17778-18, NS33504-10] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; BILLON M, 1995, PSYCHOL RES-PSYCH FO, V58, P206, DOI 10.1007/BF00419635; Billon M, 1996, J MOTOR BEHAV, V28, P198, DOI 10.1080/00222895.1996.9941745; BOLTZ MG, 1993, PERCEPT PSYCHOPHYS, V53, P585, DOI 10.3758/BF03211736; Clegg BA, 1998, TRENDS COGN SCI, V2, P275, DOI 10.1016/S1364-6613(98)01202-9; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Drake C, 1998, MUSIC PERCEPT, V16, P11, DOI 10.2307/40285774; ESSENS PJ, 1985, PERCEPT PSYCHOPHYS, V37, P1, DOI 10.3758/BF03207132; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; HAZELTINE E, 2002, COMMON MECH PERCEPTI, V19; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2002, BRAIN COGNITION, V48, P117, DOI 10.1006/brcg.2001.1308; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; JONES MR, 1982, PERCEPT PSYCHOPHYS, V32, P211, DOI 10.3758/BF03206225; Jones MR, 1997, CAN J EXP PSYCHOL, V51, P271, DOI 10.1037/1196-1961.51.4.271; JONES MR, 1987, PERCEPT PSYCHOPHYS, V41, P621, DOI 10.3758/BF03210494; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; JONES MR, 1993, THINKING SOUND COGNI, P69; KEELE SW, 1995, J MOTOR BEHAV, V27, P17, DOI 10.1080/00222895.1995.9941696; KERMADI I, 1993, EXP BRAIN RES, V94, P352; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; Koch I, 2000, PSYCHOL RES-PSYCH FO, V63, P22, DOI 10.1007/PL00008165; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Krampe RT, 2002, BRAIN COGNITION, V48, P1, DOI 10.1006/brcg.2001.1300; Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Large EW, 2000, HUM MOVEMENT SCI, V19, P527, DOI 10.1016/S0167-9457(00)00026-9; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nobre AC, 2001, NEUROSCI BIOBEHAV R, V25, P477, DOI 10.1016/S0149-7634(01)00028-8; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; POVEL DJ, 1982, ACTA PSYCHOL, V52, P107, DOI 10.1016/0001-6918(82)90029-4; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Repp BH, 2002, J MOTOR BEHAV, V34, P291, DOI 10.1080/00222890209601947; Repp BH, 2002, PERCEPT PSYCHOPHYS, V64, P703, DOI 10.3758/BF03194738; Repp BH, 1999, PERCEPT PSYCHOPHYS, V61, P529, DOI 10.3758/BF03211971; Repp BH, 2001, J EXP PSYCHOL HUMAN, V27, P600, DOI 10.1037/0096-1523.27.3.600; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Sakai K, 2000, J NEUROSCI, V20, P2691; Sakai K, 2002, J NEUROPHYSIOL, V88, P2035, DOI 10.1152/jn.2002.88.4.2035; Satoh M, 2001, COGNITIVE BRAIN RES, V12, P101, DOI 10.1016/S0926-6410(01)00044-1; Schellenberg EG, 2000, MUSIC PERCEPT, V18, P155; SCHMUCKLER MA, 1994, PERCEPT PSYCHOPHYS, V56, P313, DOI 10.3758/BF03209765; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Schoner G, 2002, BRAIN COGNITION, V48, P31, DOI 10.1006/brcg.2001.1302; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; SERGENT J, 1992, SCIENCE, V257, P106, DOI 10.1126/science.1621084; Shin JC, 2002, J EXP PSYCHOL LEARN, V28, P445, DOI 10.1037//0278-7393.28.3.445; SLOBODA JA, 1976, Q J EXP PSYCHOL, V28, P1, DOI 10.1080/14640747608400532; Smith GJ, 1999, PERCEPT MOTOR SKILL, V89, P951, DOI 10.2466/PMS.89.7.951-965; STADLER MA, 1993, MEM COGNITION, V21, P819, DOI 10.3758/BF03202749; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; YEE W, 1994, PERCEPT PSYCHOPHYS, V56, P461, DOI 10.3758/BF03206737; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29	70	201	202	1	41	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					682	687		10.1038/nn1081	http://dx.doi.org/10.1038/nn1081			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830159				2022-12-28	WOS:000183780400012
J	Singh, K; Scott, SH				Singh, K; Scott, SH			A motor learning strategy reflects neural circuitry for limb control	NATURE NEUROSCIENCE			English	Article							ARM; DYNAMICS; REPRESENTATION; MOVEMENTS; FEEDBACK; TORQUES; MUSCLES; CORTEX; OUTPUT; INPUT	During motor skill acquisition, the brain learns a mapping between intended limb motion and requisite muscular forces. We propose that regions where sensory and motor representations overlap are crucial for motor learning. In primary motor cortex, for example, cells that modulate their activity for motor actions at a joint tend to receive input from that same portion of the periphery. We predict that this correspondence reflects a default strategy-a Bayesian prior-in which subjects tend to associate loads at a joint with motion at that joint (local sensorimotor association) when there is ambiguity regarding the nature of the load. As predicted, we found that in the presence of uncertainty, humans inappropriately generalized elbow loads as though they were based on elbow velocity. Generalization improved when we reduced uncertainty by decreasing coupling between elbow velocity and load during training. These results illustrate a key link between motor learning and the underlying neural circuitry.	Queens Univ, Dept Anat & Cell Biol, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Dept Anat & Cell Biol, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.							ASANUMA H, 1981, PROG NEUROBIOL, V16, P241, DOI 10.1016/0301-0082(81)90015-0; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Drew W L, 1993, Clin Diagn Virol, V1, P179; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GHEZ C, 1975, BRAIN RES, V98, P93, DOI 10.1016/0006-8993(75)90511-9; GIBSON AR, 1987, J COMP NEUROL, V260, P362, DOI 10.1002/cne.902600304; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Knill DC, 1996, PERCEPTION BAYESIAN; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; MURPHY JT, 1982, BRAIN RES, V236, P429, DOI 10.1016/0006-8993(82)90726-0; Porter R, 1993, CORTICOSPINAL FUNCTI; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; SCOTT SH, 1994, J NEUROSCI, V14, P7529; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Vetter P, 2000, NEUROREPORT, V11, P3783, DOI 10.1097/00001756-200011270-00038; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Winter DA, 1990, BIOMECHANICS MOTOR C; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	29	63	63	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					399	403		10.1038/nn1026	http://dx.doi.org/10.1038/nn1026			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627165				2022-12-28	WOS:000181833100018
J	Nery, S; Fishell, G; Corbin, JG				Nery, S; Fishell, G; Corbin, JG			The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; GABAERGIC NEURONS; BASAL FOREBRAIN; MAMMALIAN FOREBRAIN; PROJECTION NEURONS; CEREBRAL-CORTEX; HOMEOBOX GENE; TELENCEPHALON; MIGRATION; ORIGIN	During development, the mammalian ventral telencephalon is comprised of three major proliferative zones: the medial (MGE), lateral (LGE) and caudal (CGE) ganglionic eminences. Through gene expression studies, in vitro migration assays, genetic mutant analysis and in vivo fate mapping in mice, we found that the CGE is a progenitor region that is distinct from both the MGE and LGE. Notably, CGE cells showed a unique in vivo pattern of migration, and the CGE contributed cells to nuclei distinct from those populated by the MGE and LGE. Moreover, we report that the migratory fate of cells from the CGE is intrinsically determined by embryonic day 13.5 (E13.5). Together, these results provide the first insights into the development and fate of the CGE.	NYU, Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Fishell, G (corresponding author), NYU, Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu	Nery, Susana Vaz/P-4518-2014	Fishell, Gordon/0000-0002-9640-9278; Vaz Nery, Susana/0000-0002-2399-7785	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039007] Funding Source: NIH RePORTER; NINDS NIH HHS [NS10962-03, R01 NS39007-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Casarosa S, 1999, DEVELOPMENT, V126, P525; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Garel S, 1999, DEVELOPMENT, V126, P5285; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Martin J., 1989, NEUROANATOMY TEXT AT; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Nery S, 2001, DEVELOPMENT, V128, P527; Olivier C, 2001, DEVELOPMENT, V128, P1757; Olsson M, 1998, NEUROSCIENCE, V84, P867, DOI 10.1016/S0306-4522(97)00532-0; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OUIMET CC, 1984, J NEUROSCI, V4, P111; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; SMART IHM, 1979, NEOSTRIATUM, P127; Spassky N, 1998, J NEUROSCI, V18, P8331; Sussel L, 1999, DEVELOPMENT, V126, P3359; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Toresson H, 2000, DEVELOPMENT, V127, P4361; Toresson H, 1999, DEVELOPMENT, V126, P1317; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yun K, 2001, DEVELOPMENT, V128, P193	47	408	417	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1279	1287		10.1038/nn971	http://dx.doi.org/10.1038/nn971			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411960				2022-12-28	WOS:000179447500010
J	Ingram, SL; Prasad, BM; Amara, SG				Ingram, SL; Prasad, BM; Amara, SG			Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SUBSTANTIA-NIGRA NEURONS; CHLORIDE CHANNEL; GLUTAMATE TRANSPORTER; D-AMPHETAMINE; RAT; RELEASE; RECEPTORS; COCAINE; BRAIN	Uptake by Na+/Cl- -dependent neurotransmitter transporters is the principal mechanism by which extracellular biogenic amine concentrations are regulated. In addition to uptake, the cloned transporter proteins also elicit ion channel-like currents, but the physiological consequences of these currents are unknown. Here, whole-cell patch clamp and perforated-patch recordings show that substrates of the dopamine transporter (DAT), such as dopamine (DA) and amphetamine, increase the firing activity of rat DA neurons in culture. We found that these substrates elicit inward currents that are Na+-dependent and blocked by cocaine. These currents are primarily comprised of anions and result in an excitatory response in DA neurons at lower DA concentrations than are required for D2 autoreceptor activation. Thus, in addition to clearing extracellular DA, our results suggest that the currents associated with DAT modulate excitability and may regulate release of neurotransmitter from midbrain DA neurons.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Amara, SG (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Amara, Susan/0000-0001-8914-1106	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007595, R37DA007595] Funding Source: NIH RePORTER; NIDA NIH HHS [DAO07595] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ali DW, 1998, J PHYSIOL-LONDON, V509, P211, DOI 10.1111/j.1469-7793.1998.211bo.x; Backus KH, 1998, J PHYSIOL-LONDON, V507, P783, DOI 10.1111/j.1469-7793.1998.783bs.x; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; BUNNEY BS, 1978, N-S ARCH PHARMACOL, V304, P255, DOI 10.1007/BF00507966; Cao YW, 1997, J NEUROSCI, V17, P2257; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; GALLI A, 1995, J EXP BIOL, V198, P2197; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GU H, 1994, J BIOL CHEM, V269, P7124; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Jayanthi LD, 2002, BRIT J PHARMACOL, V135, P1927, DOI 10.1038/sj.bjp.0704658; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MERCURI NB, 1989, BRIT J PHARMACOL, V98, P127, DOI 10.1111/j.1476-5381.1989.tb16872.x; NICHOLSON LFB, 1992, NEUROSCIENCE, V50, P355, DOI 10.1016/0306-4522(92)90429-6; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Paladini CA, 2001, NAT NEUROSCI, V4, P275, DOI 10.1038/85124; Paladini CA, 1999, BRAIN RES, V832, P145, DOI 10.1016/S0006-8993(99)01484-5; Prasad BM, 2001, J NEUROSCI, V21, P7561, DOI 10.1523/JNEUROSCI.21-19-07561.2001; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shi WX, 2000, J NEUROSCI, V20, P3504, DOI 10.1523/JNEUROSCI.20-09-03504.2000; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; TRENT F, 1991, EUR J PHARMACOL, V204, P265, DOI 10.1016/0014-2999(91)90851-G; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	48	173	175	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					971	978		10.1038/nn920	http://dx.doi.org/10.1038/nn920			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352983				2022-12-28	WOS:000178242200016
J	Moita, MAP; Lamprecht, R; Nader, K; LeDoux, JE				Moita, MAP; Lamprecht, R; Nader, K; LeDoux, JE			A-kinase anchoring proteins in amygdala are involved in auditory fear memory	NATURE NEUROSCIENCE			English	Article							AKAP; RECEPTORS; COMPLEX; NEURONS; PKA		NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA	New York University	LeDoux, JE (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA.			Moita, Marta/0000-0002-5144-6905	NIMH NIH HHS [MH00956, MH38774, MH46516] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH000956, R37MH038774, R01MH038774, R01MH046516] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Dodge KL, 1999, MOL ENDOCRINOL, V13, P1977, DOI 10.1210/me.13.12.1977; Feliciello A, 1997, CURR BIOL, V7, P1011, DOI 10.1016/S0960-9822(06)00424-6; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93	15	66	67	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					837	838		10.1038/nn901	http://dx.doi.org/10.1038/nn901			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12172550				2022-12-28	WOS:000177656300010
J	Pesaran, B; Pezaris, JS; Sahani, M; Mitra, PP; Andersen, RA				Pesaran, B; Pezaris, JS; Sahani, M; Mitra, PP; Andersen, RA			Temporal structure in neuronal activity during working memory in macaque parietal cortex	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; LATERAL INTRAPARIETAL AREA; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; UNIT-ACTIVITY; SYNCHRONIZATION; OSCILLATIONS; MONKEY; ATTENTION; AWAKE	Many cortical structures have elevated firing rates during working memory, but it is not known how the activity is maintained. To investigate whether reverberating activity is important, we studied the temporal structure of local field potential (LFP) activity and spiking from area LIP in two awake macaques during a memory-saccade task. Using spectral analysis, we found spatially tuned elevated power in the gamma band (25-90 Hz) in LFP and spiking activity during the memory period. Spiking and LFP activity were also coherent in the gamma band but not at lower frequencies. Finally, we decoded LFP activity on a single-trial basis and found that LFP activity in parietal cortex discriminated between preferred and anti-preferred direction with approximately the same accuracy as the spike rate and predicted the time of a planned movement with better accuracy than the spike rate. This finding could accelerate the development of a cortical neural prosthesis.	CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Alcatel-Lucent; Lucent Technologies; AT&T; California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.			Pesaran, Bijan/0000-0003-4116-0038; Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062528] Funding Source: NIH RePORTER; NEI NIH HHS [EY05522-21] Funding Source: Medline; NIMH NIH HHS [MH62528-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; BRILLINGER DR, 1974, TIME SERIES; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; ECKHORN R, 1993, NEUROREPORT, V4, P243, DOI 10.1097/00001756-199303000-00004; Efron B., 1994, MONOGRAPHS STAT APPL; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; EPRCIVAL DB, 1993, SPECTRAL ANAL PHYSIC; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 1995, MEMORY CEREBRAL CORT; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hebb Donald O., 1949, ORG BEHAV; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; KOCH KW, 1989, EXP BRAIN RES, V76, P292; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lebedev MA, 2000, EXP BRAIN RES, V130, P195, DOI 10.1007/s002210050022; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Miller EK, 1996, J NEUROSCI, V16, P5154; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; NAKAMURA K, 1992, NEUROREPORT, V3, P117, DOI 10.1097/00001756-199201000-00031; Pezaris JS, 1999, NEUROCOMPUTING, V26-7, P471, DOI 10.1016/S0925-2312(99)00053-3; PEZARIS JS, 1996, COMPUTATIONAL NEUROS, P937; Ripley B. D., 1996, PATTERN RECOGNITION; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; ROUGEUL A, 1979, ELECTROEN CLIN NEURO, V46, P310, DOI 10.1016/0013-4694(79)90205-0; Sahani M, 1998, ADV NEUR IN, V10, P222; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Thomson DJ, 1991, ADV SPECTRUM ANAL AR; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	47	702	712	3	49	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					805	811		10.1038/nn890	http://dx.doi.org/10.1038/nn890			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134152	Green Submitted			2022-12-28	WOS:000177088900025
J	Ahmed, SH; Kenny, PJ; Koob, GF; Markou, A				Ahmed, SH; Kenny, PJ; Koob, GF; Markou, A			Neurobiological evidence for hedonic allostasis associated with escalating cocaine use	NATURE NEUROSCIENCE			English	Article							DRUG-ADDICTION; REWARD; BRAIN; WITHDRAWAL; DEPRESSION		Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France; Scripps Res Inst, Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Scripps Research Institute	Ahmed, SH (corresponding author), Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, 146 Rue Leo Saignat, F-33076 Bordeaux, France.		AHMED, Serge H/D-5236-2014	Ahmed, Serge/0000-0002-1225-9234	NIDA NIH HHS [R56 DA011946, DA11946, DA04398] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA011946, R01DA004398, R01DA011946] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; KORNETSKY C, 1979, FED PROC, V38, P2473; LEITH NJ, 1976, PSYCHOPHARMACOLOGIA, V46, P19, DOI 10.1007/BF00421544; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	13	270	279	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					625	626		10.1038/nn872	http://dx.doi.org/10.1038/nn872			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055635				2022-12-28	WOS:000176414300007
J	Rousselet, GA; Fabre-Thorpe, M; Thorpe, SJ				Rousselet, GA; Fabre-Thorpe, M; Thorpe, SJ			Parallel processing in high-level categorization of natural images	NATURE NEUROSCIENCE			English	Article							VISUAL-SEARCH; PERCEPTION; STIMULI; ATTENTION; CORTEX		Fac Med Rangueil, UPS, CNRS, UMR 5549,Ctr Rech Cerveau & Cognit, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rousselet, GA (corresponding author), Fac Med Rangueil, UPS, CNRS, UMR 5549,Ctr Rech Cerveau & Cognit, 133 Route Narbonne, F-31062 Toulouse, France.	guillau@cerco.ups-tlse.fr	Rousselet, Guillaume/AAV-1151-2020; THORPE, Simon J/A-5661-2008; Fabre-Thorpe, Michèle/B-2698-2008; Rousselet, Guillaume/B-4701-2009	Rousselet, Guillaume/0000-0003-0006-8729; THORPE, Simon J/0000-0003-4997-3367; Rousselet, Guillaume/0000-0003-0006-8729				BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Fize D, 2000, NEUROIMAGE, V11, P634, DOI 10.1006/nimg.2000.0585; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; KINCHLA RA, 1992, ANNU REV PSYCHOL, V43, P711, DOI 10.1146/annurev.ps.43.020192.003431; LI FF, IN PRESS P NATL ACAD; McElree B, 1999, J EXP PSYCHOL HUMAN, V25, P1517, DOI 10.1037/0096-1523.25.6.1517; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; SASAKI K, 1993, NEUROSCI RES, V18, P249, DOI 10.1016/0168-0102(93)90062-U; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; WOLFE JM, 1994, VISION RES, V34, P1187, DOI 10.1016/0042-6989(94)90300-X	15	222	224	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					629	630		10.1038/nn866	http://dx.doi.org/10.1038/nn866			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12032544				2022-12-28	WOS:000176414300010
J	Lembo, PMC; Grazzini, E; Groblewski, T; O'Donnell, D; Roy, MO; Zhang, J; Hoffert, C; Cao, J; Schmidt, R; Pelletier, M; Labarre, M; Gosselin, M; Fortin, Y; Banville, D; Shen, SH; Strom, P; Payza, K; Dray, A; Walker, P; Ahmad, S				Lembo, PMC; Grazzini, E; Groblewski, T; O'Donnell, D; Roy, MO; Zhang, J; Hoffert, C; Cao, J; Schmidt, R; Pelletier, M; Labarre, M; Gosselin, M; Fortin, Y; Banville, D; Shen, SH; Strom, P; Payza, K; Dray, A; Walker, P; Ahmad, S			Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; BOVINE ADRENAL-MEDULLA; PEPTIDE-E; CHROMAFFIN CELLS; OPIOID PEPTIDE; SPINAL-CORD; RAT; ENKEPHALIN; NOCICEPTORS; EXPRESSION	Several peptide fragments are produced by proteolytic cleavage of the opioid peptide precursor proenkephalin A, and among these are a number of enkephalin fragments, in particular bovine adrenal medulla peptide 22 (BAM22). These peptide products have been implicated in diverse biological functions, including analgesia. We have cloned a newly identified family of 'orphan' G protein-coupled receptors (GPCRs) and demonstrate that BAM22 and a number of its fragments bind to and activate these receptors with nanomolar affinities. This family of GPCRs is uniquely localized in the human and rat small sensory neuron, and we called this family the sensory neuron-specific G protein-coupled receptors (SNSRs). Receptors of the SNSR family are distinct from the traditional opioid receptors in their insensitivity to the classical opioid antagonist naloxone and poor activation by opioid ligands. The unique localization of SNSRs and their activation by proenkephalin A peptide fragments indicate a possible function for SNSRs in sensory neuron regulation and in the modulation of nociception.	AstraZeneca R&D Montreal, St Laurent, PQ H4S 1Z9, Canada; Biotechnol Res Inst, Pharmaceut Sector, Montreal, PQ H4P 2R2, Canada; AstraZeneca R&D Sodertalje, S-15185 Sodertalje, Sweden	AstraZeneca; National Research Council Canada; AstraZeneca	Lembo, PMC (corresponding author), AstraZeneca R&D Montreal, 7171 Frederick Banting, St Laurent, PQ H4S 1Z9, Canada.		Zhang, Ji/L-5922-2019					AHMAD S, 1998, Patent No. 9932519; BAIRD A, 1984, P SOC EXP BIOL MED, V175, P304; BOARDER MR, 1987, J NEUROCHEM, V49, P1824, DOI 10.1111/j.1471-4159.1987.tb02443.x; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOERSMA GJC, 1994, J NEUROENDOCRINOL, V6, P47; Cao J, 1998, J BIOL CHEM, V273, P32281, DOI 10.1074/jbc.273.48.32281; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DAVIS TP, 1990, EUR J PHARMACOL, V191, P253, DOI 10.1016/0014-2999(90)94157-S; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DORES RM, 1990, BRAIN BEHAV EVOLUT, V36, P80, DOI 10.1159/000115300; DRAY A, 1985, J PHARMACOL EXP THER, V235, P670; Goumon Y, 2000, J BIOL CHEM, V275, P38355, DOI 10.1074/jbc.M007557200; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; Henderson G, 1997, TRENDS PHARMACOL SCI, V18, P293, DOI 10.1016/S0165-6147(97)90645-3; HOLLT V, 1982, EUR J PHARMACOL, V85, P355, DOI 10.1016/0014-2999(82)90226-6; HOLLT V, 1982, LIFE SCI, V31, P1883, DOI 10.1016/0024-3205(82)90234-X; LOH YP, 1984, ANNU REV NEUROSCI, V7, P189, DOI 10.1146/annurev.ne.07.030184.001201; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MIZUNO K, 1980, BIOCHEM BIOPH RES CO, V97, P1283, DOI 10.1016/S0006-291X(80)80005-2; PITTIUS CW, 1984, BRAIN RES, V304, P127, DOI 10.1016/0006-8993(84)90868-0; POHL M, 1994, J NEUROCHEM, V63, P1226; QUIRION R, 1983, PEPTIDES, V4, P445, DOI 10.1016/0196-9781(83)90047-5; RANG HP, 1994, TXB PAIN, P201; Rohrer DK, 1998, PHYSIOL REV, V78, P35, DOI 10.1152/physrev.1998.78.1.35; SANCHEZBLAZQUEZ P, 1984, NEUROPEPTIDES, V5, P181, DOI 10.1016/0143-4179(84)90057-X; SANCHEZBLAZQUEZ P, 1985, NEUROSCI LETT, V61, P267, DOI 10.1016/0304-3940(85)90475-6; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stadel JM, 1997, TRENDS PHARMACOL SCI, V18, P430, DOI 10.1016/S0165-6147(97)01117-6; SWAIN MG, 1994, AM J PHYSIOL, V266, pG201, DOI 10.1152/ajpgi.1994.266.2.G201; WEIHE E, 1992, ANN ANAT, V174, P89, DOI 10.1016/S0940-9602(11)80327-4; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	35	291	336	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					201	209		10.1038/nn815	http://dx.doi.org/10.1038/nn815			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850634				2022-12-28	WOS:000174146000009
J	Meyer-Lindenberg, A; Miletich, RS; Kohn, PD; Esposito, G; Carson, RE; Quarantelli, M; Weinberger, DR; Berman, KF				Meyer-Lindenberg, A; Miletich, RS; Kohn, PD; Esposito, G; Carson, RE; Quarantelli, M; Weinberger, DR; Berman, KF			Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; DOPA DECARBOXYLASE ACTIVITY; VENTRAL TEGMENTAL AREA; CEREBRAL BLOOD-FLOW; CORTICAL REGULATION; WORKING-MEMORY; CORTEX; BRAIN; RECEPTORS; RELEASE	Both dopaminergic neurotransmission and prefrontal cortex (PFC) function are known to be abnormal in schizophrenia. To test the hypothesis that these phenomena are related, we measured presynaptic dopaminergic function simultaneously with regional cerebral blood flow during the Wisconsin Card Sorting Test (WCST) and a control task in unmedicated schizophrenic subjects and matched controls. We show that the dopaminergic uptake constant K-i in the striatum was significantly higher for patients than for controls. Patients had significantly less WCST-related activation in PFC. The two parameters were strongly linked in patients, but not controls. The tight within-patient coupling of these values, with decreased PFC activation predicting exaggerated striatal 6-fluorodopa uptake, supports the hypothesis that prefrontal cortex dysfunction may lead to dopaminergic transmission abnormalities.	NIMH, Unit Integrat Neuroimaging, NIH, Bethesda, MD 20892 USA; NINCDS, NIH, Bethesda, MD 20832 USA; NIH, PET Dept, Ctr Clin, Bethesda, MD 20832 USA; NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20832 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Meyer-Lindenberg, A (corresponding author), NIMH, Unit Integrat Neuroimaging, NIH, 10-4C101,9000 Rockville Pike, Bethesda, MD 20892 USA.		Carson, Richard E/H-3250-2011; Quarantelli, Mario/A-6154-2009; Meyer-Lindenberg, Andreas/H-1076-2011	Carson, Richard E/0000-0002-9338-7966; Quarantelli, Mario/0000-0001-7836-454X; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002652, Z01MH002716, ZIAMH002717, Z01MH002652, Z01MH002717, ZIAMH002716] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Bennett MR, 1998, J PSYCHOPHARMACOL, V12, P289, DOI 10.1177/026988119801200310; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bertolino A, 2000, NEUROPSYCHOPHARMACOL, V22, P125, DOI 10.1016/S0893-133X(99)00096-2; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; CHRISTIE MJ, 1985, BRAIN RES, V333, P169, DOI 10.1016/0006-8993(85)90140-4; CUMMING P, 1995, J NEUROCHEM, V65, P1381; DANIEL DG, 1991, J NEUROSCI, V11, P1907; DaoCastellana MH, 1997, SCHIZOPHR RES, V23, P167, DOI 10.1016/S0920-9964(96)00102-8; DEUTCH AY, 1992, J NEURAL TRANSM-GEN, P61; Elkashef AM, 2000, PSYCHIAT RES-NEUROIM, V100, P1, DOI 10.1016/S0925-4927(00)00064-0; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Hietala J, 1999, SCHIZOPHR RES, V35, P41, DOI 10.1016/S0920-9964(98)00113-3; HIETALA J, 1995, LANCET, V346, P1130, DOI 10.1016/S0140-6736(95)91801-9; Jackson ME, 2001, J NEUROCHEM, V78, P920, DOI 10.1046/j.1471-4159.2001.00499.x; JASKIW GE, 1990, BRAIN RES, V534, P321, DOI 10.1016/0006-8993(90)90149-6; Kegeles LS, 2000, BIOL PSYCHIAT, V48, P627, DOI 10.1016/S0006-3223(00)00976-8; Kraepelin E., 1919, CUTTING SHEPHERD; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; LEWIS DA, 1995, PSYCHOL MED, V25, P887, DOI 10.1017/S0033291700037375; Lindstrom LH, 1999, BIOL PSYCHIAT, V46, P681, DOI 10.1016/S0006-3223(99)00109-2; MILETICH RS, 1993, BRAIN RES, V626, P1, DOI 10.1016/0006-8993(93)90556-3; Muller U, 1998, J NEUROSCI, V18, P2720; MURASE S, 1993, NEUROSCI LETT, V157, P53, DOI 10.1016/0304-3940(93)90641-W; NAPIER TC, 1992, NEUROREPORT, V3, P609, DOI 10.1097/00001756-199207000-00016; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; PYCOCK CJ, 1980, NATURE, V286, P74, DOI 10.1038/286074a0; REITH J, 1994, P NATL ACAD SCI USA, V91, P11651, DOI 10.1073/pnas.91.24.11651; Saunders RC, 1998, NATURE, V393, P169, DOI 10.1038/30245; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Talairach J., 1988, COPLANAR STEREOTAXIC; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	46	502	517	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					267	271		10.1038/nn804	http://dx.doi.org/10.1038/nn804			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865311				2022-12-28	WOS:000174146000018
J	Ahmadi, S; Lippross, S; Neuhuber, WL; Zeilhofer, HU				Ahmadi, S; Lippross, S; Neuhuber, WL; Zeilhofer, HU			PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLOOXYGENASE-2 MESSENGER-RNA; SPINAL-CORD; PROSTAGLANDIN E-2; AMINO-ACIDS; PERIPHERAL INFLAMMATION; SYNAPTIC TRANSMISSION; PROSTANOID RECEPTORS; PAIN ALLODYNIA; DEFICIENT MICE	Despite the crucial role that prostaglandins (PGs) have in the sensitization of the central nervous system to pain, their cellular and molecular targets leading to increased pain perception have remained elusive. Here we investigated the effects of PGE(2) on fast synaptic transmission onto neurons in the rat spinal cord dorsal horn, the first site of synaptic integration in the pain pathway. We identified the inhibitory (strychnine-sensitive) glycine receptor as a specific target of PGE(2). PGE(2), but not PGF(2 alpha), PGD(2) or PGI(2), reduced inhibitory glycinergic synaptic transmission in low nanomolar concentrations, whereas GABA(A), AMPA and NMDA receptor-mediated transmission remained unaffected. Inhibition of glycine receptors occurred via a postsynaptic mechanism involving the activation of EP2 receptors, cholera-toxin-sensitive G-proteins and cAMP-dependent protein kinase. Via this mechanism, PGE(2) may facilitate the transmission of nociceptive input through the spinal cord dorsal horn to higher brain areas where pain becomes conscious.	Emil Fischer Zentrum, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Anat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Zeilhofer, HU (corresponding author), Emil Fischer Zentrum, Inst Expt & Klin Pharmakol & Toxikol, Fahrstr 17, D-91054 Erlangen, Germany.		Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629				ARENA JM, 1979, POISONING TOXICITY S; Baba H, 2001, J NEUROSCI, V21, P1750, DOI 10.1523/JNEUROSCI.21-05-01750.2001; Becker C.-M., 1992, HDB EXPT PHARM, V102, P539; Beiche F, 1998, J NEUROIMMUNOL, V89, P26, DOI 10.1016/S0165-5728(98)00061-7; Beiche F, 1996, FEBS LETT, V390, P165, DOI 10.1016/0014-5793(96)00604-7; BEYER C, 1985, LIFE SCI, V37, P875, DOI 10.1016/0024-3205(85)90523-5; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Ceranik K, 1997, J NEUROSCI, V17, P5380; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; Doubell TP, 1999, TXB PAIN, V4, P165; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Fuxe K, 1991, VOLUME TRANSMISSION; Gosselin RE, 1976, CLIN TOXICOLOGY COMM; Guhring H, 2000, J NEUROSCI, V20, P6714, DOI 10.1523/JNEUROSCI.20-17-06714.2000; Ichitani Y, 1997, NEUROREPORT, V8, P2949, DOI 10.1097/00001756-199709080-00028; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kawamura T, 1997, LIFE SCI, V61, P2111, DOI 10.1016/S0024-3205(97)00884-9; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUMAZAWA T, 1993, BRAIN RES, V632, P321, DOI 10.1016/0006-8993(93)91169-S; Liebel JT, 1997, BRIT J PHARMACOL, V121, P425, DOI 10.1038/sj.bjp.0701149; MALMBERG AB, 1995, J NEUROSCI, V15, P2768; Malmberg AB, 1997, J NEUROSCI, V17, P7462; MATSUMURA K, 1992, BRAIN RES, V581, P292, DOI 10.1016/0006-8993(92)90720-T; MINAMI T, 1992, PAIN, V50, P223, DOI 10.1016/0304-3959(92)90166-9; Minami T, 1997, BRIT J PHARMACOL, V122, P605, DOI 10.1038/sj.bjp.0701421; Minami T, 1999, EUR J NEUROSCI, V11, P1849, DOI 10.1046/j.1460-9568.1999.00602.x; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NISHIHARA I, 1995, NEUROSCI LETT, V196, P57, DOI 10.1016/0304-3940(95)11839-O; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; PERPER JA, 1985, J FORENSIC SCI, V30, P1248; RIBEIRONETO FAP, 1985, METHOD ENZYMOL, V109, P566; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; YAKSH TL, 1994, TXB PAIN, P165; Yang LC, 1996, PAIN, V67, P345, DOI 10.1016/0304-3959(96)03106-5; Zeilhofer HU, 2000, J NEUROSCI, V20, P4922; ZIEGLGANSBERGER W, 1971, EXP BRAIN RES, V13, P111	47	242	254	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					34	40		10.1038/nn778	http://dx.doi.org/10.1038/nn778			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740501				2022-12-28	WOS:000173031800012
J	Zhang, KY; McQuibban, GA; Silva, C; Butler, GS; Johnston, JB; Holden, J; Clark-Lewis, I; Overall, CM; Power, C				Zhang, KY; McQuibban, GA; Silva, C; Butler, GS; Johnston, JB; Holden, J; Clark-Lewis, I; Overall, CM; Power, C			HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration	NATURE NEUROSCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-MEDIATED NEUROVIRULENCE; MATRIX-METALLOPROTEINASE; NERVOUS-SYSTEM; INTRACEREBRAL HEMORRHAGE; NEURONAL INJURY; GELATINASE-A; EXPRESSION; DEMENTIA; BRAIN	The mechanisms of neurodegeneration that result in human immunodeficiency virus (HIV) type 1 dementia have not yet been identified. Here, we report that HIV-infected macrophages secrete the zymogen matrix metalloproteinase-2 (MMP-2), which is activated by exposure to MT1-MMP on neurons. Stromal cell-derived factor 1 (SDF-1), a chemokine overexpressed by astrocytes during HIV infection, was converted to a highly neurotoxic protein after precise proteolytic processing by active MMP-2, which removed the N-terminal tetrapeptide. Implantation of cleaved SDF-1(5-67) into the basal ganglia of mice resulted in neuronal death and inflammation with ensuing neurobehavioral deficits that were abrogated by neutralizing antibodies to SDF-1 and an MMP inhibitor drug. Hence, this study identifies a new in vivo neurotoxic pathway in which cleavage of a chemokine by an induced metalloproteinase results in neuronal apoptosis that leads to neurodegeneration.	Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Calgary	Overall, CM (corresponding author), Univ Calgary, Dept Clin Neurosci, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Butler, Georgina/GQP-7553-2022; Power, Christopher/C-7181-2013	Butler, Georgina/0000-0003-1172-1578; Power, Christopher/0000-0002-5131-9711; Zhang, Kunyan/0000-0003-1078-6011				Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Berman NEJ, 1999, NEUROBIOL DIS, V6, P486, DOI 10.1006/nbdi.1999.0261; Bigg HF, 2001, CANCER RES, V61, P3610; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; CHESEBRO B, 1991, J VIROL, V65, P5782, DOI 10.1128/JVI.65.11.5782-5789.1991; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; HOIOK YH, 2000, MOL MECH NEURODEGENE, P111; Horuk R, 1998, NATURE, V393, P524, DOI 10.1038/31116; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Johnston JB, 2002, J VIROL, V76, P2622, DOI 10.1128/JVI.76.6.2622-2633.2002; Johnston JB, 2001, ANN NEUROL, V49, P230, DOI 10.1002/1531-8249(20010201)49:2<230::AID-ANA43>3.0.CO;2-O; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Langford D, 2002, J NEUROIMMUNOL, V127, P115, DOI 10.1016/S0165-5728(02)00068-1; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Miller RJ, 1999, TRENDS NEUROSCI, V22, P471, DOI 10.1016/S0166-2236(99)01408-3; Nagasawa T, 1999, Adv Immunol, V71, P211; Nath A, 1999, SEMIN NEUROL, V19, P113, DOI 10.1055/s-2008-1040830; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Ohtani Y, 1998, NEUROSCI LETT, V249, P163, DOI 10.1016/S0304-3940(98)00425-X; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Patrick MK, 2002, J VIROL, V76, P7923, DOI 10.1128/JVI.76.16.7923-7931.2002; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Shrikant P, 1996, J IMMUNOL, V156, P1307; Sisodia SS, 1999, J CLIN INVEST, V104, P1169, DOI 10.1172/JCI8508; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang KY, 2001, VIROLOGY, V283, P19, DOI 10.1006/viro.2001.0876	47	257	268	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1064	1071		10.1038/nn1127	http://dx.doi.org/10.1038/nn1127			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502291				2022-12-28	WOS:000185633600018
J	Goeke, S; Greene, EA; Grant, PK; Gates, MA; Crowner, D; Aigaki, T; Giniger, E				Goeke, S; Greene, EA; Grant, PK; Gates, MA; Crowner, D; Aigaki, T; Giniger, E			Alternative splicing of lola generates 19 transcription factors controlling axon guidance in Drosophila	NATURE NEUROSCIENCE			English	Article							ZINC FINGERS; DNA-BINDING; POZ DOMAIN; PROTEIN; EXPRESSION; ENCODES; FAMILY; GROWTH; RECEPTOR; GENOME	The Drosophila melanogaster transcription factor Lola (longitudinals lacking) is a pivotal regulator of neural wiring that sets the precise expression levels of proteins that execute specific axon guidance decisions. Lola has a zinc finger DNA binding domain and a BTB (for Broad-complex, Tramtrack and Bric a brac) dimerization motif. We now show that alternative splicing of the lola gene creates a family of 19 transcription factors. All lola isoforms share a common dimerization domain, but 17 have their own unique DNA-binding domains. Seven of these 17 isoforms are present in the distantly-related Dipteran Anopheles gambiae, suggesting that the properties of specific isoforms are likely to be critical to lola function. Analysis of the expression patterns of individual splice variants and of the phenotypes of mutants lacking single isoforms supports this idea and establishes that the alternative forms of lola are responsible for different functions of this gene. Thus, in this system, the alternative splicing of a key transcription factor helps to explain how a small genome encodes all the information that is necessary to specify the enormous diversity of axonal trajectories.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA; Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol, Osaka 5650082, Japan	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Tokyo Metropolitan University; Japan Science & Technology Agency (JST)	Giniger, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	eginiger@fhcrc.org	Giniger, Edward/C-1764-2015	Giniger, Edward/0000-0002-8340-6158; Grant, Paul/0000-0002-1099-0461				Appling DR, 1999, METHODS, V19, P338, DOI 10.1006/meth.1999.0861; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Cavarec L, 1997, MOL CELL BIOL, V17, P482, DOI 10.1128/MCB.17.1.482; CHENG NSN, 1994, GENETICS, V138, P1151; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Crowner D, 2002, DEVELOPMENT, V129, P1317; DIBELLO PR, 1991, GENETICS, V129, P385; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; GINIGER E, 1994, DEVELOPMENT, V120, P1385; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Liew CK, 2000, STRUCTURE, V8, P1157, DOI 10.1016/S0969-2126(00)00527-X; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Madden K, 1999, DEV BIOL, V213, P301, DOI 10.1006/dbio.1999.9399; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; OHSAKO T, IN PRESS GENE; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zheng W, 2003, J BIOL CHEM, V278, P48321, DOI 10.1074/jbc.M307930200	31	66	74	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					917	924		10.1038/nn1105	http://dx.doi.org/10.1038/nn1105			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897787				2022-12-28	WOS:000184970400009
J	Loewenstein, Y; Sompolinsky, H				Loewenstein, Y; Sompolinsky, H			Temporal integration by calcium dynamics in a model neuron	NATURE NEUROSCIENCE			English	Article							MEDIAL VESTIBULAR NUCLEUS; NETWORK MODEL; EYE-POSITION; INOSITOL 1,4,5-TRISPHOSPHATE; VESTIBULOOCULAR REFLEX; PERSISTENT ACTIVITY; PREFRONTAL CORTEX; OCULOMOTOR SYSTEM; WORKING-MEMORY; OSCILLATIONS	The calculation and memory of position variables by temporal integration of velocity signals is essential for posture, the vestibulo-ocular reflex (VOR) and navigation. Integrator neurons exhibit persistent firing at multiple rates, which represent the values of memorized position variables. A widespread hypothesis is that temporal integration is the outcome of reverberating feedback loops within recurrent networks, but this hypothesis has not been proven experimentally. Here we present a single-cell model of a neural integrator. The nonlinear dynamics of calcium gives rise to propagating calcium wave-fronts along dendritic processes. The wave-front velocity is modulated by synaptic inputs such that the front location covaries with the temporal sum of its previous inputs. Calcium-dependent currents convert this information into concomitant persistent firing. Calcium dynamics in single neurons could thus be the physiological basis of the graded persistent activity and temporal integration observed in neurons during analog memory tasks.	Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Loewenstein, Y (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.		Sompolinsky, Haim/ABB-8398-2021					Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; ARNOLD DB, 1992, PHILOS T ROY SOC B, V337, P327, DOI 10.1098/rstb.1992.0110; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; DULAC S, 1995, J COMP PHYSIOL A, V176, P641; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Fontanilla RA, 1998, BIOPHYS J, V75, P2079, DOI 10.1016/S0006-3495(98)77650-7; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210, DOI 10.1152/jn.1984.51.2.210; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Kandel E., 2000, PRINCIPLES NEURAL SC; Kato BM, 1999, J NEUROPHYSIOL, V81, P1587, DOI 10.1152/jn.1999.81.4.1587; Keener JP, 2000, PHYSICA D, V136, P1, DOI 10.1016/S0167-2789(99)00151-7; KOUTAKOV AA, 2002, NAT NEUROSCI, V5, P775; Kupferman R, 1997, BIOPHYS J, V72, P2430, DOI 10.1016/S0006-3495(97)78888-X; LAGNADO L, 1992, J PHYSIOL-LONDON, V455, P111, DOI 10.1113/jphysiol.1992.sp019293; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Mikhailov A. S, 1994, FDN SYNERGETICS DIST; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; Perrier JF, 1999, J NEUROPHYSIOL, V82, P730, DOI 10.1152/jn.1999.82.2.730; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; ROSAN MJ, 1972, IEEE T BIOMED ENG, V19, P362; SERAFIN M, 1991, EXP BRAIN RES, V84, P417, DOI 10.1007/BF00231464; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shriki O, 2003, NEURAL COMPUT, V15, P1809, DOI 10.1162/08997660360675053; Sneyd J, 1997, SIAM J APPL MATH, V57, P73, DOI 10.1137/S0036139995286035; SNEYD J, 1995, FASEB J, V9, P1463, DOI 10.1096/fasebj.9.14.7589988; Torres JJ, 2001, EUROPHYS LETT, V55, P746, DOI 10.1209/epl/i2001-00477-3; Wagner J, 1998, BIOPHYS J, V75, P2088, DOI 10.1016/S0006-3495(98)77651-9; WOLSZON LR, 1994, J NEUROSCI, V14, P3437; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xie XH, 2000, ADV NEUR IN, V12, P199	50	108	110	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					961	967		10.1038/nn1109	http://dx.doi.org/10.1038/nn1109			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12937421				2022-12-28	WOS:000184970400015
J	Yasuda, R; Sabatini, BL; Svoboda, K				Yasuda, R; Sabatini, BL; Svoboda, K			Plasticity of calcium channels in dendritic spines	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; HIPPOCAMPAL CA1 NEURONS; CA2+ CHANNELS; PYRAMIDAL NEURONS; SYNAPTIC TRANSMISSION; POSTSYNAPTIC DENSITY; RECEPTOR; INACTIVATION; INHIBITOR	Voltage-sensitive Ca2+ channels (VSCCs) constitute a major source of calcium ions in dendritic spines, but their function is unknown. Here we show that R-type VSCCs in spines of rat CA1 pyramidal neurons are depressed for at least 30 min after brief trains of back-propagating action potentials. Populations of channels in single spines are depressed stochastically and synchronously, independent of channels in the parent dendrite and other spines, implying that depression is the result of signaling restricted to individual spines. Induction of VSCC depression blocks theta-burst-induced long-term potentiation (LTP), indicating that postsynaptic action potentials can modulate synaptic plasticity by tuning VSCCs. Induction of depression requires [Ca2+] elevations and activation of L-type VSCCs, which activate Ca2+/calmodulin-dependent kinase II (CaMKII) and a cyclic adenosine monophosphate (cAMP)-dependent pathway. Given that L-type VSCCs do not contribute measurably to Ca2+ influx in spines, they must activate downstream effectors either directly through voltage-dependent conformational changes or via [Ca2+] microdomains.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BEAN BP, 1994, ION CHANNELS, P199; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; ITO K, 1995, NEUROSCI LETT, V183, P112, DOI 10.1016/0304-3940(94)11127-5; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Pologruto T. A., 2003, BIOMED ENG ONLINE, V2; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	49	198	201	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					948	955		10.1038/nn1112	http://dx.doi.org/10.1038/nn1112			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12937422				2022-12-28	WOS:000184970400013
J	Mayr, U; Awh, E; Laurey, P				Mayr, U; Awh, E; Laurey, P			Conflict adaptation effects in the absence of executive control	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL		Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Mayr, U (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.			Awh, Edward/0000-0002-5211-5278	NIA NIH HHS [R01 AG19296-01A1] Funding Source: Medline; NIMH NIH HHS [R01 MH64119] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cohen A, 1997, COGNITIVE PSYCHOL, V32, P128, DOI 10.1006/cogp.1997.0648; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; PASHLER H, 1991, J EXP PSYCHOL LEARN, V17, P33, DOI 10.1037/0278-7393.17.1.33; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7	12	607	619	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					450	452		10.1038/nn1051	http://dx.doi.org/10.1038/nn1051			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	672ZD	12704394				2022-12-28	WOS:000182553200010
J	Todorov, E; Jordan, MI				Todorov, E; Jordan, MI			Optimal feedback control as a theory of motor coordination	NATURE NEUROSCIENCE			English	Article							INERTIAL ANISOTROPY; ARM MOVEMENTS; MODEL; TASK; ACCURACY; SPEECH; GRASP	A central problem in motor control is understanding how the many biomechanical degrees of freedom are coordinated to achieve a common goal. An especially puzzling aspect of coordination is that behavioral goals are achieved reliably and repeatedly with movements rarely reproducible in their detail. Existing theoretical frameworks emphasize either goal achievement or the richness of motor variability, but fail to reconcile the two. Here we propose an alternative theory based on stochastic optimal feedback control. We show that the optimal strategy in the face of uncertainty is to allow variability in redundant (task-irrelevant) dimensions. This strategy does not enforce a desired trajectory, but uses feedback more intelligently, correcting only those deviations that interfere with task goals. From this framework, task-constrained variability, goal-directed corrections, motor synergies, controlled parameters, simplifying rules and discrete coordination modes emerge naturally. We present experimental results from a range of motor tasks to support this theory.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Todorov, E (corresponding author), Univ Calif San Diego, Dept Cognit Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Jordan, Michael I/C-5253-2013					Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bernstein N, 1967, COORDINATION REGULAT; BIZZI E, 1984, J NEUROSCI, V4, P2738; COLE KJ, 1987, J NEUROPHYSIOL, V57, P1498, DOI 10.1152/jn.1987.57.5.1498; COLE KJ, 1986, J NEUROPHYSIOL, V55, P1407, DOI 10.1152/jn.1986.55.6.1407; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; Davis M., 1985, STOCHASTIC MODELLING; Domkin D, 2002, EXP BRAIN RES, V143, P11, DOI 10.1007/s00221-001-0944-1; Flanagan JR, 2001, J NEUROSCI, V21, P1361; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gel'fand IM., 1971, MODELS STRUCTURAL FU; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Gottlieb GL, 1996, J NEUROPHYSIOL, V76, P3207, DOI 10.1152/jn.1996.76.5.3207; GRACCO VL, 1986, EXP BRAIN RES, V65, P156; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; Haggard P, 1995, EXP BRAIN RES, V107, P254; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HINTON G, 1984, J MOTOR BEHAV, V16, P171; Hoff B., 1992, THESIS U SO CALIFORN; JORDAN MI, 1990, ATTENTION PERFORM, V13, P796; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso S., 1995, DYNAMIC PATTERNS SEL; KOMILIS E, 1993, J MOTOR BEHAV, V25, P299, DOI 10.1080/00222895.1993.9941651; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; LOEB GE, 1990, COLD SH Q B, V55, P791; Marr D., 1982, VISION; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Robertson EM, 1997, EXP BRAIN RES, V117, P148, DOI 10.1007/s002210050208; Sabes PN, 1998, J NEUROSCI, V18, P5948; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; Todorov EV, 1998, THESIS MIT; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; VEREIJKEN B, 1992, J MOTOR BEHAV, V24, P133, DOI 10.1080/00222895.1992.9941608; WINTER DA, 1989, PERSPECTIVES COORDIN, P329; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460; WRIGHT CE, 1990, ATTENTION PERFORM, V13, P294	50	1844	1856	10	194	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1226	1235		10.1038/nn963	http://dx.doi.org/10.1038/nn963			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404008				2022-12-28	WOS:000178884600027
J	[Anonymous]				[Anonymous]			A new era in neuroscience	NATURE NEUROSCIENCE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1020	1021		10.1038/nn929	http://dx.doi.org/10.1038/nn929			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403974				2022-12-28	WOS:000179041300002
J	Carlson, G; Wang, Y; Alger, BE				Carlson, G; Wang, Y; Alger, BE			Endocannabinoids facilitate the induction of LTP in the hippocampus	NATURE NEUROSCIENCE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; PYRAMIDAL CELLS; CANNABINOIDS; INHIBITION; GABA; POTENTIATION; TERMINALS; NEURONS		Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Alger, BE (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036612, R01NS030219] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30219, NS36612] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Katona I, 1999, J NEUROSCI, V19, P4544; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659, DOI 10.1152/jn.1998.79.2.659; Lenz RA, 1999, J PHYSIOL-LONDON, V521, P147, DOI 10.1111/j.1469-7793.1999.00147.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; PITLER TA, 1992, J NEUROSCI, V12, P4122; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Wagner JJ, 1996, J PHYSIOL-LONDON, V495, P107, DOI 10.1113/jphysiol.1996.sp021577; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	15	240	247	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					723	724		10.1038/nn879	http://dx.doi.org/10.1038/nn879			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080342				2022-12-28	WOS:000177088900011
J	Fiala, JC; Allwardt, B; Harris, KM				Fiala, JC; Allwardt, B; Harris, KM			Dendritic spines do not split during hippocampal LTP or maturation	NATURE NEUROSCIENCE			English	Article							3-DIMENSIONAL STRUCTURE; SYNAPSES; FILOPODIA; CA1		Boston Univ, Dept Biol, Program Neurosci, Boston, MA 02215 USA	Boston University	Harris, KM (corresponding author), Boston Univ, Dept Biol, Program Neurosci, 5 Cummington St, Boston, MA 02215 USA.	harrisk@bu.edu		Harris, Kristen/0000-0002-1943-4744	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033574] Funding Source: NIH RePORTER; NIMH NIH HHS [MH/DA57351] Funding Source: Medline; NINDS NIH HHS [NS33574] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; JONES DG, 1995, REV NEUROSCIENCE, V6, P177; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Sorra KE, 1998, J COMP NEUROL, V398, P225; SORRA KE, 1993, J NEUROSCI, V13, P3736; Sorra KE, 1998, J NEUROSCI, V18, P658; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	15	97	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					297	298		10.1038/nn830	http://dx.doi.org/10.1038/nn830			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896399				2022-12-28	WOS:000174606900007
J	Newman, AJ; Bavelier, D; Corina, D; Jezzard, P; Neville, HJ				Newman, AJ; Bavelier, D; Corina, D; Jezzard, P; Neville, HJ			A critical period for right hemisphere recruitment in American Sign Language processing	NATURE NEUROSCIENCE			English	Article							2ND LANGUAGE; MATURATIONAL CONSTRAINTS; CEREBRAL ORGANIZATION; BILINGUAL BRAIN; ACQUISITION; ENGLISH; AGE; COMPREHENSION; VARIABILITY; EXPERIENCE	Signed languages such as American Sign Language (ASL) are natural languages that are formally similar to spoken languages, and thus present an opportunity to examine the effects of language structure and modality on the neural organization for language. Native learners of spoken languages show predominantly left-lateralized patterns of neural activation for language processing, whereas native learners of ASL show extensive right hemisphere (RH) and LH activation. We demonstrate that the RH angular gyrus is active during ASL processing only in native signers (hearing, ASL-English bilinguals) but not in those who acquired ASL after puberty (hearing, native English speakers). This is the first demonstration of a 'sensitive' or 'critical' period for language in an RH structure. This has implications for language acquisition and for understanding age-related changes in neuroplasticity more generally.	Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA; John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England	University of Oregon; University of Rochester; University of Washington; University of Washington Seattle; University of Oxford	Newman, AJ (corresponding author), Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA.		; Newman, Aaron/A-6835-2011	Bavelier, Daphne/0000-0002-5904-1240; Newman, Aaron/0000-0001-5290-8342; Jezzard, Peter/0000-0001-7912-2251	NIDCD NIH HHS [R29 DCO3099, DC00128] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003099] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Bavelier D, 1998, NEUROREPORT, V9, P1537, DOI 10.1097/00001756-199805110-00054; Chee MWL, 1999, J NEUROSCI, V19, P3050; Corina D, 1998, APHASIA IN ATYPICAL POPULATIONS, P261; CURTIS S, 1977, GENIE PSYCHOL STUDY; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Flege JE, 1999, J MEM LANG, V41, P78, DOI 10.1006/jmla.1999.2638; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Hickok G, 1999, BRAIN LANG, V66, P233, DOI 10.1006/brln.1998.1995; Hickok G, 1998, TRENDS COGN SCI, V2, P465, DOI 10.1016/S1364-6613(98)01263-7; Hickok G, 1996, NATURE, V381, P699, DOI 10.1038/381699a0; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Klein D, 1999, NEUROREPORT, V10, P2841, DOI 10.1097/00001756-199909090-00026; Klima E., 1979, SIGNS LANGUAGE; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Neville HJ, 1997, BRAIN LANG, V57, P285, DOI 10.1006/brln.1997.1739; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; OJEMANN GA, 1978, ARCH NEUROL-CHICAGO, V35, P409, DOI 10.1001/archneur.1978.00500310011002; OYAMA S, 1976, J PSYCHOLINGUIST RES, V5, P261, DOI 10.1007/BF01067377; Paradis M, 1998, APHASIA IN ATYPICAL POPULATIONS, P35; PENFIELD W, 1959, SPEECH MECHANISMS BR; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; SODERFELDT B, 1994, BRAIN LANG, V46, P59, DOI 10.1006/brln.1994.1004; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZOLAMORGAN S, 1988, SPATIAL COGNITION BR	35	138	146	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					76	80		10.1038/nn775	http://dx.doi.org/10.1038/nn775			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	507MG	11753419				2022-12-28	WOS:000173031800019
J	Romanski, LM; Goldman-Rakic, PS				Romanski, LM; Goldman-Rakic, PS			An auditory domain in primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							MONKEY FRONTAL-CORTEX; CONNECTIONS; NEURONS; SULCUS; UNIT		Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; Univ Rochester, Dept Neurobiol & Anat, Rochester, NY 14642 USA	Yale University; University of Rochester	Romanski, LM (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038546, R01MH038546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004845] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004845, R01 DC004845-01] Funding Source: Medline; NIMH NIH HHS [MH-38546, R01 MH038546, R37 MH038546] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AZUMA M, 1984, BRAIN RES, V298, P343, DOI 10.1016/0006-8993(84)91434-3; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; NEWMAN JD, 1976, EXP BRAIN RES, V25, P169; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; TANILA H, 1993, BEHAV BRAIN RES, V53, P63, DOI 10.1016/S0166-4328(05)80266-9; VAADIA E, 1986, J NEUROPHYSIOL, V56, P934, DOI 10.1152/jn.1986.56.4.934; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	15	257	264	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					15	16		10.1038/nn781	http://dx.doi.org/10.1038/nn781			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753413	Green Accepted			2022-12-28	WOS:000173031800008
J	Klausberger, T; Marton, LF; Baude, A; Roberts, JDB; Magill, PJ; Somogyi, P				Klausberger, T; Marton, LF; Baude, A; Roberts, JDB; Magill, PJ; Somogyi, P			Spike timing of dendrite-targeting bistratified cells during hippocampal network oscillations in vivo	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; GAP-JUNCTIONS; INTACT HIPPOCAMPUS; ACTION-POTENTIALS; PHASE-PRECESSION; NEUROPEPTIDE-Y; INTERNEURONS; INHIBITION; RECEPTOR	Behavior-contingent network oscillations bring about transient, functionally coherent neuronal assemblies in the cerebral cortex, including the hippocampus. Inhibitory input on and close to the soma is believed to phase intrinsic oscillations and output of pyramidal cells, but the function of GABA release to pyramidal cell dendrites remains unknown. We recorded the oscillation-locked spike timing of identified bistratified interneurons in rats. These cells mainly innervated small dendritic shafts of pyramidal cells co-aligned with the glutamatergic Schaffer collateral/commissural input. During theta oscillations, bistratified cells fired at a phase when, on average, pyramidal cell dendrites are most hyperpolarized. Interneurons targeting the perisomatic domain discharge at an earlier phase. During sharp wave-associated ripples, bistratified cells fired with high frequency and in-phase with basket cells, on average 1-2 ms after the discharges in pyramidal cell somata and dendrites. Our results indicate that bistratified cells rhythmically modulate glutamatergic input to the dendrites of pyramidal cells to actively promote the precise input/output transformation during network oscillations.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; IFR Jean Roche, Fac Med, CNRS, UMR 6150, F-13916 Marseille 20, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Klausberger, T (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.		Baude, Agnès/M-7356-2016	Baude, Agnès/0000-0002-7025-364X; Magill, Peter/0000-0001-7141-7071				ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; Bland BH, 2002, J NEUROPHYSIOL, V88, P3046, DOI 10.1152/jn.00315.2002; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colbert CM, 1997, J NEUROSCI, V17, P6512; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FERRAGUTI F, IN PRESS HIPPOCAMPUS; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frick A, 2003, J NEUROSCI, V23, P3243; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Halasy K, 1996, HIPPOCAMPUS, V6, P306, DOI 10.1002/(SICI)1098-1063(1996)6:3<306::AID-HIPO8>3.0.CO;2-K; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kamondi A, 1998, J NEUROSCI, V18, P3919; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; KOSAKA T, 1985, J COMP NEUROL, V231, P150, DOI 10.1002/cne.902310203; LEVEY AI, 1995, J COMP NEUROL, V351, P339, DOI 10.1002/cne.903510303; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Maccaferri G, 2002, J NEUROSCI, V22, P5462; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; ROY JP, 1984, J NEUROPHYSIOL, V51, P1220, DOI 10.1152/jn.1984.51.6.1220; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YLINEN A, 1995, J NEUROSCI, V15, P30; ZEZULA J, 1991, BRAIN RES, V563, P325, DOI 10.1016/0006-8993(91)91556-G	50	261	268	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					41	47		10.1038/nn1159	http://dx.doi.org/10.1038/nn1159			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14634650				2022-12-28	WOS:000187636000011
J	Bensafi, M; Porter, J; Pouliot, S; Mainland, J; Johnson, B; Zelano, C; Young, N; Bremner, E; Aframian, D; Khan, R; Sobel, N				Bensafi, M; Porter, J; Pouliot, S; Mainland, J; Johnson, B; Zelano, C; Young, N; Bremner, E; Aframian, D; Khan, R; Sobel, N			Olfactomotor activity during imagery mimics that during perception	NATURE NEUROSCIENCE			English	Article							MITRAL CELL-ACTIVITY; CORTEX	Neural representations created in the absence of external sensory stimuli are referred to as imagery(1), and such representations may be augmented by reenactment of sensorimotor processes(2). We measured nasal airflow in human subjects while they imagined sights, sounds and smells, and only during olfactory imagery did subjects spontaneously enact the motor component of olfaction-that is, they sniffed. Moreover, as in perception(3,4), imagery of pleasant odors involved larger sniffs than imagery of unpleasant odors, suggesting that the act of sniffing has a functional role in creating of olfactory percepts.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; McGill Univ, Montreal Neurol Inst, Dept Psychol, Montreal, PQ, Canada	University of California System; University of California Berkeley; University of California System; University of California Berkeley; McGill University	Bensafi, M (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 3210 Tolman Hall MC 1650, Berkeley, CA 94720 USA.		Mainland, Joel/C-5171-2009; Bensafi, Moustafa/H-6618-2017	Mainland, Joel/0000-0002-5056-4598; Bensafi, Moustafa/0000-0002-2991-3036; Sobel, Noam/0000-0002-3232-9391				Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Elmes DG, 1998, CHEM SENSES, V23, P443, DOI 10.1093/chemse/23.4.443; Fontanini A, 2003, J NEUROSCI, V23, P7993; FREEMAN WJ, 1983, BIOL PSYCHIAT, V18, P1107; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Herz RS, 2000, MEM COGNITION, V28, P957, DOI 10.3758/BF03209343; Johnson B. N., 2003, J NEUROPHYSIOL; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; TEGHTSOONIAN R, 1978, J EXP PSYCHOL HUMAN, V4, P144, DOI 10.1037/0096-1523.4.1.144	15	132	137	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1142	1144		10.1038/nn1145	http://dx.doi.org/10.1038/nn1145			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	737KH	14566343				2022-12-28	WOS:000186229200012
J	Schmitz, D; Mellor, J; Breustedt, J; Nicoll, RA				Schmitz, D; Mellor, J; Breustedt, J; Nicoll, RA			Presynaptic kainate receptors impart an associative property to hippocampal mossy fiber long-term potentiation	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; COMMISSURAL SYNAPSES; GLUTAMATE RECEPTORS; BINDING-SITES; 2 FORMS; CA3; LTP; TRANSMISSION; RESPONSES; CHANNELS	Hippocampal mossy fiber synapses show an unusual form of long-term potentiation (LTP) that is independent of NMDA receptor activation and is expressed presynaptically. Using receptor antagonists, as well as receptor knockout mice, we found that presynaptic kainate receptors facilitate the induction of mossy fiber long-term potentiation (LTP), although they are not required for this form of LTP. Most importantly, these receptors impart an associativity to mossy fiber LTP such that activity in neighboring mossy fiber synapses, or even associational/ commissural synapses, influences the threshold for inducing mossy fiber LTP. Such a mechanism greatly increases the computational power of this form of plasticity.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Humboldt Univ, Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; Univ Bristol, Sch Med Sci, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bristol; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Box 2140 Mission Bay Campus,600 16 St, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Schmitz, Dietmar/0000-0003-2741-5241				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 2000, NATURE, V406, P957, DOI 10.1038/35023077; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Bureau I, 1999, J NEUROSCI, V19, P653; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Dingledine R, 1999, PHARMACOL REV, V51, P7; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; Ji ZX, 2002, NEUROSCI LETT, V331, P71, DOI 10.1016/S0304-3940(02)00865-0; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamiya H, 2002, J NEUROSCI, V22, P9237; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; Nicoll RA, 2000, NATURE, V406, P957, DOI 10.1038/35023075; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, P NATL ACAD SCI USA, V98, P11003, DOI 10.1073/pnas.191351498; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; Wiebe SP, 1999, J NEUROSCI, V19, P10562; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	38	94	97	1	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1058	1063		10.1038/nn1116	http://dx.doi.org/10.1038/nn1116			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947409				2022-12-28	WOS:000185633600017
J	Brager, DH; Cai, X; Thompson, SM				Brager, DH; Cai, X; Thompson, SM			Activity-dependent activation of presynaptic protein kinase C mediates post-tetanic potentiation	NATURE NEUROSCIENCE			English	Article							SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; PHOSPHORYLATION; PLASTICITY; CALCIUM; RELEASE; ENHANCEMENT	Vesicle exocytosis is mediated by the complex interaction between synaptic vesicle and plasma membrane proteins, many of which are substrates for protein kinases(1-3). Exogenous protein kinase activators increase release probability at several mammalian CNS synapses(4-6), but the physiological conditions under which presynaptic protein kinases become activated are not known. We report here that calcium/phospholipid-dependent protein kinase C (PKC) is activated by high-frequency stimulation and mediates post-tetanic potentiation (PTP) in the rat hippocampus.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.		Cai, Xiang/AAD-8012-2021; Thompson, Scott M/K-8921-2015	Brager, Darrin/0000-0002-3736-0515	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040338] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH65488] Funding Source: Medline; NINDS NIH HHS [R01 NS40338] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKERS RF, 1987, J NEUROSCI, V7, P3976; Brager DH, 2002, J PHYSIOL-LONDON, V541, P545, DOI 10.1113/jphysiol.2001.015842; Capogna M, 1999, EUR J NEUROSCI, V11, P433, DOI 10.1046/j.1460-9568.1999.00450.x; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; DELANEY KR, 1989, J NEUROSCI, V9, P3558; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V245, P163, DOI 10.1113/jphysiol.1975.sp010839; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x	15	70	71	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					551	552		10.1038/nn1067	http://dx.doi.org/10.1038/nn1067			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754518				2022-12-28	WOS:000183140400008
J	Leopold, DA				Leopold, DA			Motion perception: read my LIP	NATURE NEUROSCIENCE			English	Editorial Material							LATERAL INTRAPARIETAL AREA; PARIETAL CORTEX; SELECTIVITY	Neural activity in the enigmatic lateral intraparietal area (LIP) of the monkey brain is now reported to reflect the perceived direction of ambiguous motion more faithfully than does activity in other areas apparently specialized for motion analysis.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Leopold, DA (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	david.leopold@tuebingen.mpg.de		Leopold, David/0000-0002-1345-6360				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Koffka K, 1935, PRINCIPLES GESTALT P; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; NEWSOME WT, 1986, J NEUROPHYSIOL, V55, P1340, DOI 10.1152/jn.1986.55.6.1340; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Wertheimer M, 1912, Z PSYCHOL Z ANGEW PS, V61, P265; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055	15	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					548	549		10.1038/nn0603-548	http://dx.doi.org/10.1038/nn0603-548			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12771959				2022-12-28	WOS:000183140400007
J	Krauzlis, RJ; Carello, CD				Krauzlis, RJ; Carello, CD			Going for the goal	NATURE NEUROSCIENCE			English	Editorial Material							SUPERIOR COLLICULUS; SACCADES; NEURONS; MONKEY; DISCHARGE; PURSUIT; CELLS	A new study shows that activity in the superior colliculus encodes the distance to the goal of the orienting movement, not the particular saccade or saccades used to get there.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rich@salk.edu		Richard, Krauzlis/0000-0002-1826-0447				Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Bergeron A, 2003, NAT NEUROSCI, V6, P404, DOI 10.1038/nn1027; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; Keller EL, 1996, J NEUROPHYSIOL, V76, P3573, DOI 10.1152/jn.1996.76.5.3573; KELLER EL, 1994, J NEUROPHYSIOL, V72, P2754, DOI 10.1152/jn.1994.72.6.2754; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; MUNOZ DP, 1991, SCIENCE, V251, P1358, DOI 10.1126/science.2003221; Munoz DP, 1996, J NEUROPHYSIOL, V75, P2562, DOI 10.1152/jn.1996.75.6.2562; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1642, DOI 10.1152/jn.1991.66.5.1642; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P2778, DOI 10.1152/jn.2002.87.6.2778; SPARKS DL, 1990, ANNU REV NEUROSCI, V13, P309, DOI 10.1146/annurev.ne.13.030190.001521; STANFORD TR, 1994, VISION RES, V34, P93, DOI 10.1016/0042-6989(94)90260-7	13	9	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					332	333		10.1038/nn0403-332	http://dx.doi.org/10.1038/nn0403-332			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12658279				2022-12-28	WOS:000181833100006
J	Park, D; Lee, S; Jun, K; Hong, YM; Kim, DY; Kim, YI; Shin, HS				Park, D; Lee, S; Jun, K; Hong, YM; Kim, DY; Kim, YI; Shin, HS			Translation of clock rhythmicity into neural firing in suprachiasmatic nucleus requires mGluR-PLC beta 4 signaling	NATURE NEUROSCIENCE			English	Article							CIRCADIAN RELEASE; AMINO-ACIDS; RECEPTORS		Korea Inst Sci & Technol, Natl CRI Ctr Calcium & Learning, Seoul 136791, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Pochon CHA Univ, Coll Med, CHA Gen Hosp, Seoul 135081, South Korea; Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; Korea Univ, Coll Med, Neurosci Res Inst, Seoul 136705, South Korea	Korea Institute of Science & Technology (KIST); Pohang University of Science & Technology (POSTECH); Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, YI (corresponding author), Korea Inst Sci & Technol, Natl CRI Ctr Calcium & Learning, Box 131, Seoul 136791, South Korea.			Kim, Yang/0000-0003-3420-7870				Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; GILLETTE MU, 1987, BRAIN RES BULL, V19, P135, DOI 10.1016/0361-9230(87)90176-6; Haak LL, 1999, J NEUROPHYSIOL, V81, P1308, DOI 10.1152/jn.1999.81.3.1308; Ikeda M, 2000, NEUROREPORT, V11, P907, DOI 10.1097/00001756-200004070-00002; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Shinohara K, 1998, NEUROREPORT, V9, P137, DOI 10.1097/00001756-199801050-00027; Shinohara K, 2000, NEUROSCI RES, V36, P245, DOI 10.1016/S0168-0102(99)00131-5	12	27	27	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					337	338		10.1038/nn1033	http://dx.doi.org/10.1038/nn1033			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640460				2022-12-28	WOS:000181833100007
J	Whited, JL; Garrity, PA				Whited, JL; Garrity, PA			Specifying axon identity with Syd-1	NATURE NEUROSCIENCE			English	Editorial Material							CULTURED HIPPOCAMPAL-NEURONS; POLARITY; ELEGANS	A molecule that may be important for sorting presynaptic components into the developing axon is now revealed by a study using the genetic tools available in C. elegans.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Whited, JL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave 68-230B, Cambridge, MA 02139 USA.			Garrity, Paul/0000-0002-8274-6564				Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Esch T, 1999, J NEUROSCI, V19, P6417; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X	9	1	2	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1107	1108		10.1038/nn1102-1107	http://dx.doi.org/10.1038/nn1102-1107			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404000				2022-12-28	WOS:000178884600006
J	Wang, YP; Dakubo, G; Howley, P; Campsall, KD; Mazarolle, CJ; Shiga, SA; Lewis, PM; McMahon, AP; Wallace, VA				Wang, YP; Dakubo, G; Howley, P; Campsall, KD; Mazarolle, CJ; Shiga, SA; Lewis, PM; McMahon, AP; Wallace, VA			Development of normal retinal organization depends on Sonic hedgehog signaling from ganglion cells	NATURE NEUROSCIENCE			English	Article							OPTIC-NERVE; DIFFERENTIATION; EXPRESSION; GENE		Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Inst Eye, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Inst Eye, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; Harvard Univ, Biolabs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Harvard University	Wallace, VA (corresponding author), Ottawa Hlth Res Inst, Program Mol Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.		McMahon, Andrew P/ABE-7520-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 33642] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown NL, 2001, DEVELOPMENT, V128, P2497; Campsall KD, 2002, DEV DYNAM, V224, P135, DOI 10.1002/dvdy.10092; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Jensen AM, 1997, DEVELOPMENT, V124, P363; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Willbold E, 1998, HISTOL HISTOPATHOL, V13, P531, DOI 10.14670/HH-13.531; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	15	112	116	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					831	832		10.1038/nn911	http://dx.doi.org/10.1038/nn911			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195432				2022-12-28	WOS:000177656300007
J	Sundstrom-Poromaa, I; Smith, DH; Gong, QH; Sabado, TN; Li, XS; Light, A; Wiedmann, M; Williams, K; Smith, SS				Sundstrom-Poromaa, I; Smith, DH; Gong, QH; Sabado, TN; Li, XS; Light, A; Wiedmann, M; Williams, K; Smith, SS			Hormonally regulated alpha(4)beta(2)delta GABA(A) receptors are a target for alcohol	NATURE NEUROSCIENCE			English	Article							PREMENSTRUAL-SYNDROME; ETHANOL		SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; MCP Hahnemann Univ, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Memorial Sloan Kettering Cancer Center; Drexel University; University of Chicago	Smith, SS (corresponding author), SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.			Sundstrom Poromaa, Inger/0000-0002-2491-2042; Smith, Sheryl/0000-0003-4308-3267	NIAAA NIH HHS [R01 AA012958-02, R01 AA012958, R01 AA012958-01, AA12958] Funding Source: Medline; NIDA NIH HHS [R01 DA009618-04, DA09618, R01 DA009618, R01 DA009618-05A2] Funding Source: Medline; NINDS NIH HHS [R01 NS035047, NS35047] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; COHEN HL, 1993, ELECTROEN CLIN NEURO, V86, P368, DOI 10.1016/0013-4694(93)90132-F; HOLFORD NHG, 1987, CLIN PHARMACOKINET, V13, P273, DOI 10.2165/00003088-198713050-00001; KALANT H, 1975, CAN MED ASSOC J, V112, P953; KOOB GF, 1988, ALCOHOL, V5, P437, DOI 10.1016/0741-8329(88)90079-1; Mahmoudi M, 1997, J NEUROCHEM, V68, P2485; MCLEOD DR, 1994, ALCOHOL CLIN EXP RES, V18, P664, DOI 10.1111/j.1530-0277.1994.tb00928.x; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Nusser Z, 1998, J NEUROSCI, V18, P1693; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Ueno S, 2001, ALCOHOL CLIN EXP RES, V25, p76S, DOI 10.1097/00000374-200105051-00014; Wan FJ, 1996, P NATL ACAD SCI USA, V93, P5049, DOI 10.1073/pnas.93.10.5049	15	267	272	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					721	722		10.1038/nn888	http://dx.doi.org/10.1038/nn888			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118257	Green Accepted			2022-12-28	WOS:000177088900010
J	Bai, JL; Ramos, RL; Ackman, JB; Thomas, AM; Lee, RV; LoTurco, JJ				Bai, JL; Ramos, RL; Ackman, JB; Thomas, AM; Lee, RV; LoTurco, JJ			RNAi reveals doublecortin is required for radial migration in rat neocortex	NATURE NEUROSCIENCE			English	Article							DOUBLE CORTEX SYNDROME; MICROTUBULE-ASSOCIATED PROTEIN; NEURONAL MIGRATION; CEREBRAL-CORTEX; GENE; MUTATIONS; BRAIN; PRECURSORS; CELLS	Mutations in the doublecortin gene (DCX) in humans cause malformation of the cerebral neocortex. Paradoxically, genetic deletion of Dcx in mice does not cause neocortical malformation. We used electroporation of plasmids encoding short hairpin RNA to create interference (RNAi) of DCX protein in utero, and we show that DCX is required for radial migration in developing rat neocortex. RNAi of DCX causes both cell-autonomous and non-cell autonomous disruptions in radial migration, and creates two disruptions in neocortical development. First, many neurons prematurely stop migrating to form subcortical band heterotopias within the intermediate zone and then white matter. Second, many neurons migrate into inappropriate neocortical lamina within normotopic cortex. In utero RNAi can therefore be effectively used to study the specific cellular roles of DCX in neocortical development and to produce an animal model of double cortex syndrome.	Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut	LoTurco, JJ (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, 3107 Horsebarn Hill Rd,U-4156, Storrs, CT 06269 USA.			Ackman, James/0000-0003-0802-6080; Lee, Richard/0000-0003-3386-8212	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH056524, R01MH056524] Funding Source: NIH RePORTER; NICHD NIH HHS [HD208066] Funding Source: Medline; NIMH NIH HHS [MH056524] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, CELL, V92, P51; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gabel LA, 2001, J NEUROPHYSIOL, V85, P495, DOI 10.1152/jn.2001.85.2.495; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gleeson JG, 2000, ANN NEUROL, V47, P265, DOI 10.1002/1531-8249(200002)47:2<265::AID-ANA22>3.3.CO;2-E; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Marin-Padilla M, 1999, REV NEUROLOGIA, V29, P208, DOI 10.33588/rn.2903.99148; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	22	428	443	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1277	1283		10.1038/nn1153	http://dx.doi.org/10.1038/nn1153			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625554				2022-12-28	WOS:000186725600012
J	Segev, I				Segev, I			Synchrony is stubborn in feedforward cortical networks	NATURE NEUROSCIENCE			English	Editorial Material							PROPAGATION; INFORMATION; INPUTS; CODE	Action potential propagation has been studied extensively in model networks. Now a new paper describes an innovative method of combining neuronal recordings with real-time neuronal modeling to create multi-layer feedforward networks. Neurons in deep layers tend to fire in synchrony, suggesting such networks may code sensory information by groups of neurons that fire together.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Segev, I (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.	idan@lobster.ls.huji.ac.il		Segev, Idan/0000-0001-7279-9630				Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AGMONSNIR H, 1993, J NEUROPHYSIOL, V70, P2066, DOI 10.1152/jn.1993.70.5.2066; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Litvak V, 2003, J NEUROSCI, V23, P3006; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903	15	19	19	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					543	544		10.1038/nn0603-543	http://dx.doi.org/10.1038/nn0603-543			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12771956				2022-12-28	WOS:000183140400004
J	Yamashita, T; Tohyama, M				Yamashita, T; Tohyama, M			The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI	NATURE NEUROSCIENCE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; BINDING PROTEIN-RHO; DISSOCIATION INHIBITOR; NOGO RECEPTOR; DEATH DOMAIN; AXON GROWTH; NEUROTROPHIN; P75(NTR); MYELIN; IDENTIFICATION	The neurotrophin receptor p75(NTR) is involved in the regulation of axonal elongation by neurotrophins as well as several myelin components, including Nogo, myelin-associated glycoprotein (MAG) and myelin oligodendrocyte glycoprotein (OMgp). Neurotrophins stimulate neurite outgrowth by inhibiting Rho activity, whereas myelin-derived proteins activate RhoA and thereby inhibit growth. Here we show that direct interaction of the Rho GDP dissociation inhibitor (Rho-GDI) with p75(NTR) initiates the activation of RhoA, and this interaction between p75(NTR) and Rho-GDI is strengthened by MAG or Nogo. We also found that p75(NTR) facilitates the release of prenylated RhoA from Rho-GDI. The peptide ligand that is associated with the fifth alpha helix of p75(NTR) inhibits the interaction between Rho-GDI and p75(NTR), thus silencing the action mediated by p75(NTR). This peptide has potential as a therapeutic agent against the inhibitory cues that block regeneration in the central nervous system.	Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka 5650871, Japan; CREST, Kawaguchi 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, 2-2 Yamadaoka, Osaka 5650871, Japan.	tyama@anat2.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018				Bentley CA, 2000, J NEUROSCI, V20, P7706; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Davies AM, 2000, CURR BIOL, V10, pR198, DOI 10.1016/S0960-9822(00)00351-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Ilag LL, 1999, BIOCHEM BIOPH RES CO, V255, P104, DOI 10.1006/bbrc.1999.0101; KOCH G, 1991, FEBS LETT, V291, P336, DOI 10.1016/0014-5793(91)81315-Y; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; MASUDA T, 1994, J BIOL CHEM, V269, P19713; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	28	364	379	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					461	467		10.1038/nn1045	http://dx.doi.org/10.1038/nn1045			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692556				2022-12-28	WOS:000182553200012
J	Baranauskas, G; Tkatch, T; Nagata, K; Yeh, JZ; Surmeier, DJ				Baranauskas, G; Tkatch, T; Nagata, K; Yeh, JZ; Surmeier, DJ			Kv3.4 subunits enhance the repolarizing efficiency of Kv3.1 channels in fast-spiking neurons	NATURE NEUROSCIENCE			English	Article							GATED K+ CHANNELS; NEOSTRIATAL CHOLINERGIC INTERNEURONS; POTASSIUM-CHANNEL; SUBTHALAMIC NUCLEUS; RAT HIPPOCAMPUS; A-TYPE; CURRENTS; BRAIN; EXPRESSION; PARKINSONISM	Neurons with the capacity to discharge at high rates-'fast-spiking' (FS) neurons-are critical participants in central motor and sensory circuits. It is widely accepted that K+ channels with Kv3.1 or Kv3.2 subunits underlie fast, delayed-rectifier (DR) currents that endow neurons with this FS ability. Expression of these subunits in heterologous systems, however, yields channels that open at more depolarized potentials than do native Kv3 family channels, suggesting that they differ. One possibility is that native channels incorporate a subunit that modifies gating. Molecular, electrophysiological and pharmacological studies reported here suggest that a splice variant of the Kv3.4 subunit coassembles with Kv3.1 subunits in rat brain FS neurons. Coassembly enhances the spike repolarizing efficiency of the channels, thereby reducing spike duration and enabling higher repetitive spike rates. These results suggest that manipulation of K3.4 subunit expression could be a useful means of controlling the dynamic range of FS neurons.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.			Tkatch, Tatiana/0000-0001-6626-7435	NINDS NIH HHS [NS26473, NS34696] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Baranauskas G, 1999, J NEUROSCI, V19, P6394; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Brew HM, 1995, J NEUROSCI, V15, P8011; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; DeLong MR, 2001, ANN NEUROL, V49, P142, DOI 10.1002/1531-8249(20010201)49:2<142::AID-ANA32>3.0.CO;2-O; DEMIERA EV, 1994, HDB MEMBRANE CHANNEL, P41; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Du J, 1996, J NEUROSCI, V16, P506; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; LENZ S, 1994, SYNAPSE, V18, P55, DOI 10.1002/syn.890180108; Macica CM, 2001, J NEUROSCI, V21, P1160; Martina M, 1998, J NEUROSCI, V18, P8111; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Song WJ, 1998, J NEUROSCI, V18, P3124; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; THOMPSON S, 1982, J GEN PHYSIOL, V80, P1, DOI 10.1085/jgp.80.1.1; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WEISER M, 1995, J NEUROSCI, V15, P4298; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Wigmore MA, 2000, J PHYSIOL-LONDON, V527, P493, DOI 10.1111/j.1469-7793.2000.t01-1-00493.x; Yan Z, 1996, J NEUROSCI, V16, P2592	34	114	122	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					258	266		10.1038/nn1019	http://dx.doi.org/10.1038/nn1019			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592408				2022-12-28	WOS:000181178300014
J	Hamann, S				Hamann, S			Nosing in on the emotional brain	NATURE NEUROSCIENCE			English	Editorial Material							HUMAN AMYGDALA; MOTIVATION; RESPONSES		Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	Emory University	Hamann, S (corresponding author), Emory Univ, Dept Psychol, 532 N Kilgo Circle, Atlanta, GA 30322 USA.	shamann@emory.edu	anand, amit/A-7222-2009					Adolphs R., 2000, NEUROPSYCHOLOGY EMOT, P194; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Canli T, 2000, J NEUROSCI, V20; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; DOLAN RJ, 2000, AMYGDALA FUNCTIONAL, P631; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Oya H, 2002, J NEUROSCI, V22, P9502; PRICE JL, 1991, HUMAN NERVOUS SYSTEM, P979; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5	14	38	38	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					106	108		10.1038/nn0203-106	http://dx.doi.org/10.1038/nn0203-106			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12555101				2022-12-28	WOS:000180669100005
J	Sankaranarayanan, S; Atluri, PP; Ryan, TA				Sankaranarayanan, S; Atluri, PP; Ryan, TA			Actin has a molecular scaffolding, not propulsive, role in presynaptic function	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN MYOSIN-V; SYNAPTIC VESICLES; NEUROTRANSMITTER RELEASE; CELLS; SYNAPSES; PROTEIN; POLYMERIZATION; ARCHITECTURE; CYTOSKELETON	We used actin tagged with enhanced green fluorescent protein (EGFP-actin) to characterize the distribution and dynamics of actin in living presynaptic terminals in rat CNS neurons. Actin was preferentially concentrated around-and appeared to surround-the presynaptic vesicle cluster. In resting terminals, similar to30% of actin was found to be in a polymerized but dynamic state, with a remodeling time scale of similar to20 s. During electrical activity, actin was further polymerized and recruited from nearby axonal regions to the regions surrounding vesicles. Treatment of terminals with the actin monomer-sequestering agent latrunculin-A completely dispersed the actin network and abolished activity-dependent actin dynamics. We used a variety of methods to examine the role of actin in the presynaptic vesicle cycle. These data rule out a propulsive role for actin, either in maintaining the vesicle cluster or in guiding vesicle recycling. Instead, we propose that actin acts as a scaffolding system for regulatory molecules in the nerve terminal.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548; Atluri, Pradeep/0000-0002-0871-8311	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61925] Funding Source: Medline; NINDS NIH HHS [NS24692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Ballestrem C, 1998, J CELL SCI, V111, P1649; Benfenati F, 1999, PHILOS T R SOC B, V354, P243, DOI 10.1098/rstb.1999.0376; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; CANO M, 1995, J CELL BIOL, V115, P677; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Evans LL, 1998, J CELL SCI, V111, P2055; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Holzinger A, 2001, METH MOL B, V161, P109; Job C, 1998, J CELL BIOL, V143, P1661, DOI 10.1083/jcb.143.6.1661; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; May RC, 2001, J CELL SCI, V114, P1061; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mounier N, 1997, J CELL SCI, V110, P839; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	40	245	250	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					127	135		10.1038/nn1002	http://dx.doi.org/10.1038/nn1002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536209				2022-12-28	WOS:000180669100012
J	Zwiers, MP; Van Opstal, AJ; Paige, GD				Zwiers, MP; Van Opstal, AJ; Paige, GD			Plasticity in human sound localization induced by compressed spatial vision	NATURE NEUROSCIENCE			English	Article							AUDITORY LOCALIZATION; SUPERIOR COLLICULUS; SPACE; REPRESENTATION; ORGANIZATION; ADAPTATION; ADJUSTMENT; NUCLEUS; GUIDES; CUES	Auditory and visual target locations are encoded differently in the brain, but must be co-calibrated to maintain cross-sensory concordance. Mechanisms that adjust spatial calibration across modalities have been described (for example, prism adaptation in owls), though rudimentarily in humans. We quantified the adaptation of human sound localization in response to spatially compressed vision (0.5x lenses for 2-3 days). This induced a corresponding compression of auditory localization that was most pronounced for azimuth (minimal for elevation) and was restricted to the visual field of the lenses. Sound localization was also affected outside the field of visual-auditory interaction (shifted centrally, not compressed). These results suggest that spatially modified vision induces adaptive changes in adult human sound localization, including novel mechanisms that account for spatial compression. Findings are consistent with a model in which the central processing of sound location is encoded by recruitment rather than by a place code.	Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands	University of Rochester; Radboud University Nijmegen	Paige, GD (corresponding author), Univ Rochester, Med Ctr, Dept Neurobiol & Anat, 601 Elmwood Ave,Box 603, Rochester, NY 14642 USA.	gary_paige@urmc.rochester.edu	Zwiers, Marcel P/D-2968-2009; van Opstal, John/D-1907-2010	Zwiers, Marcel P/0000-0001-5483-2935; van Opstal, John/0000-0001-5957-5712	NATIONAL INSTITUTE ON AGING [R01AG016319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001935] Funding Source: NIH RePORTER; NCRR NIH HHS [RR09283] Funding Source: Medline; NIA NIH HHS [AG16319] Funding Source: Medline; NIDCD NIH HHS [DC01935] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERTHOZ A, 1985, REV OCULOMOTOR RES, V1; Blauert J., 1997, SPATIAL HEARING PSYC; BRAINARD MS, 1995, J NEUROPHYSIOL, V73, P595, DOI 10.1152/jn.1995.73.2.595; CARR CE, 1993, J COMP NEUROL, V334, P337, DOI 10.1002/cne.903340302; FRENS MA, 1994, EXP BRAIN RES, V100, P293, DOI 10.1007/BF00227199; Good MD, 1996, J ACOUST SOC AM, V99, P1108, DOI 10.1121/1.415233; Goossens HHLM, 1999, J NEUROPHYSIOL, V81, P2720, DOI 10.1152/jn.1999.81.6.2720; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Hyde PS, 2001, J NEUROSCI, V21, P8586, DOI 10.1523/JNEUROSCI.21-21-08586.2001; Irvine DRF, 1986, PROGR SENSORY PHYSL; KING AJ, 1991, TRENDS NEUROSCI, V14, P31, DOI 10.1016/0166-2236(91)90181-S; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; KNUDSEN EI, 1986, J NEUROSCI, V6, P1918; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; Lackner J R, 1976, Environ Biol Med, V2, P137; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; MIDDLEBROOKS JC, 1992, J ACOUST SOC AM, V92, P2607, DOI 10.1121/1.404400; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; OLDFIELD SR, 1986, PERCEPTION, V15, P67, DOI 10.1068/p150067; Paige GD, 1998, J NEUROPHYSIOL, V80, P2391, DOI 10.1152/jn.1998.80.5.2391; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Shinn-Cunningham B, 2000, PERCEPT PSYCHOPHYS, V62, P33, DOI 10.3758/BF03212059; Shinn-Cunningham BG, 1998, J ACOUST SOC AM, V103, P3667, DOI 10.1121/1.423107; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Wightman FL, 1997, J ACOUST SOC AM, V101, P1050, DOI 10.1121/1.418029; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; WISE LZ, 1985, J NEUROPHYSIOL, V54, P185, DOI 10.1152/jn.1985.54.2.185; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001; Zwiers MP, 2001, EXP BRAIN RES, V140, P206, DOI 10.1007/s002210100800	34	106	106	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					175	181		10.1038/nn999	http://dx.doi.org/10.1038/nn999			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524547				2022-12-28	WOS:000180669100018
J	Hernandez, PJ; Sadeghian, K; Kelley, AE				Hernandez, PJ; Sadeghian, K; Kelley, AE			Early consolidation of instrumental learning requires protein synthesis in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MEMORY; DOPAMINE; ACQUISITION; EXTINCTION; RECEPTORS; NMDA; RAT; NEUROSCIENCE; ACTIVATION	It is widely held that long-term memories are established by consolidation of newly acquired information into stable neural representations, a process that requires protein synthesis and synaptic plasticity. Plasticity within the nucleus accumbens (NAc), a major component of the ventral striatum, is thought to mediate instrumental learning processes and many aspects of drug addiction. Here we show that the inhibition of protein synthesis within the NAc disrupts consolidation of an appetitive instrumental learning task (lever-pressing for food) in rats. Post-trial infusions of anisomycin immediately after the first several training sessions prevented consolidation, whereas infusions delayed by 2 or 4 hours had no effect. However, if the rats were allowed to learn the task, the behavior was not sensitive to disruption by intra-accumbens anisomycin. Control infusions into the medial NAc shell or the dorsolateral striatum did not impair learning; in fact, an enhancement was observed in the latter case. These results show that de novo protein synthesis within the NAc is necessary for the consolidation, but not reconsolidation, of appetitive instrumental memories.	Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, PJ (corresponding author), Univ Wisconsin, Neurosci Training Program, 7226 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	phernand@wisc.edu			NIDA NIH HHS [DA04788] Funding Source: Medline; NIGMS NIH HHS [GM07507] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004788, R01DA004788, R29DA004788] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; AGRANOFF BW, 1967, SCI AM, V216, P115, DOI 10.1038/scientificamerican0667-115; Baldwin AE, 2000, BEHAV NEUROSCI, V114, P84, DOI 10.1037/0735-7044.114.1.84; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bracha V, 1998, BRAIN RES, V788, P169, DOI 10.1016/S0006-8993(97)01535-7; CARLI M, 1985, NATURE, V313, P679, DOI 10.1038/313679a0; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; FAIRLEY P, 1986, BEHAV NEUROSCI, V100, P652, DOI 10.1037/0735-7044.100.5.652; FLEXNER LB, 1965, EXP NEUROL, V13, P264, DOI 10.1016/0014-4886(65)90114-7; FLOOD JF, 1973, PHYSIOL BEHAV, V10, P555, DOI 10.1016/0031-9384(73)90221-7; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Haber SN, 2000, J NEUROSCI, V20, P2369; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; RESCORLA RA, 1991, Q J EXP PSYCHOL-B, V43, P1; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Skinner BF., 1953, SCI HUMAN BEHAV; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; SPRINGER AD, 1976, BEHAV BIOL, V17, P547, DOI 10.1016/S0091-6773(76)90973-1; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	40	135	138	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1327	1331		10.1038/nn973	http://dx.doi.org/10.1038/nn973			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426572				2022-12-28	WOS:000179447500016
J	Wong, ST; Henley, JR; Kanning, KC; Huang, KH; Bothwell, M; Poo, M				Wong, ST; Henley, JR; Kanning, KC; Huang, KH; Bothwell, M; Poo, M			A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; NERVE GROWTH; AXONAL REGENERATION; DIFFUSIBLE FACTORS; NEURITE OUTGROWTH; RHO GTPASES; INHIBITOR; COLLAPSE; IDENTIFICATION; NEUROTROPHINS	Myelin-associated glycoprotein (MAG), an inhibitor of axon regeneration, binds with high affinity to the Nogo-66 receptor (NgR). Here we report that the p75 neurotrophin receptor (p75(NTR)) is a co-receptor of NgR for MAG signaling. In cultured human embryonic kidney (HEK) cells expressing NgR, p75(NTR) was required for MAG-induced intracellular Ca2+ elevation. Co-immunoprecipitation showed an association of NgR with p75NTR that can be disrupted by an antibody against p75(NTR) (NGFR5), and extensive coexpression was observed in the developing rat nervous system. Furthermore, NGFR5 abolished MAG-induced repulsive turning of Xenopus axonal growth cones and Ca2+ elevation, both in neurons and in NgR/p75(NTR)-expressing HEK cells. Thus we conclude that p75(NTR) is a co-receptor of NgR for MAG signaling and a potential therapeutic target for promoting nerve regeneration.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of California System; University of California Berkeley; University of Washington; University of Washington Seattle	Poo, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Huang, Kuo-Hua/AAA-4107-2021; Henley, John/D-7171-2011	Huang, Kuo-Hua/0000-0001-6232-296X; Henley, John/0000-0003-1846-5941; Bothwell, Mark/0000-0001-5423-2702				BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hutson LD, 2001, J NEUROBIOL, V49, P79, DOI 10.1002/neu.1067; Jiang H, 1997, J BIOL CHEM, V272, P6835, DOI 10.1074/jbc.272.11.6835; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MARANO N, 1987, J NEUROCHEM, V48, P225, DOI 10.1111/j.1471-4159.1987.tb13151.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; PHAMDINH D, 1994, J NEUROCHEM, V63, P2353; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Tabti N, 1998, CULTURING NERVE CELL, P237; Turnley AM, 1998, NEUROREPORT, V9, P1987, DOI 10.1097/00001756-199806220-00013; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Walsh GS, 1999, J NEUROSCI, V19, P258, DOI 10.1523/JNEUROSCI.19-01-00258.1999; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang Q, 1998, J NEUROSCI, V18, P4973; Wang XX, 2002, J NEUROSCI, V22, P5505; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN Q, 1988, J NEUROSCI, V8, P3481; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	50	359	387	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1302	1308		10.1038/nn975	http://dx.doi.org/10.1038/nn975			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426574				2022-12-28	WOS:000179447500013
J	Neri, P; Heeger, DJ				Neri, P; Heeger, DJ			Spatiotemporal mechanisms for detecting and identifying image features in human vision	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ATTENTION; COMPONENTS; SALIENCE; NEURONS; OVERT; MAP	Our visual system constantly selects salient features in the environment, so that only those features are attended and targeted by further processing efforts to identify them. Models of feature detection hypothesize that salient features are localized based on contrast energy (local variance in intensity) in the visual stimulus. This hypothesis, however, has not been tested directly. We used psychophysical reverse correlation to study how humans detect and identify basic image features (bars and short line segments). Subjects detected a briefly flashed 'target bar' that was embedded in 'noise bars' that randomly changed in intensity over space and time. By studying how the intensity of the noise bars affected performance, we were able to dissociate two processing stages: an early 'detection' stage, whereby only locations of high-contrast energy in the image are selected, followed (after similar to100 ms) by an 'identification' stage, whereby image intensity at selected locations is used to determine the identity (whether bright or dark) of the target.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Neri, P (corresponding author), Stanford Univ, Dept Psychol, Serra Mall 450, Stanford, CA 94305 USA.	pn@white.stanford.edu	Neri, Peter/G-1066-2012	Neri, Peter/0000-0003-1981-5309				Abbey CK, 2002, J VISION, V2, P66, DOI 10.1167/2.1.5; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Ahumada AJ, 1996, PERCEPTION, V25, P18; AHUMADA AJ, 1967, 29 UCLA; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Efron B., 1994, MONOGRAPHS STAT APPL; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Green R.H., 1966, RES POPUL ECOL, V8, P1, DOI [10.1007/BF02524740, DOI 10.1007/BF02524740]; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KNSTOV AA, 1996, NATURE, V384, P74; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Marr D., 1982, VISION; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; NOTHDURFT HC, IN PRESS VISION RES; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; PIOTROWSKI LN, 1982, PERCEPTION, V11, P337, DOI 10.1068/p110337; POLLEN DA, 1983, IEEE T SYST MAN CYB, V13, P907, DOI 10.1109/TSMC.1983.6313086; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Ringach DL, 1998, VISION RES, V38, P963, DOI 10.1016/S0042-6989(97)00322-2; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SAGI D, 1985, SCIENCE, V228, P1217, DOI 10.1126/science.4001937; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; THOMAS JP, 1983, J OPT SOC AM, V73, P751, DOI 10.1364/JOSA.73.000751; TOLHURST DJ, 1975, VISION RES, V15, P1367, DOI 10.1016/0042-6989(75)90192-3; Ziebell O, 1999, VISION RES, V39, P2113, DOI 10.1016/S0042-6989(98)00254-5	34	95	102	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					812	816		10.1038/nn886	http://dx.doi.org/10.1038/nn886			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12101403				2022-12-28	WOS:000177088900026
J	Zhu, Y; Yu, T; Zhang, XC; Nagasawa, T; Wu, JY; Rao, Y				Zhu, Y; Yu, T; Zhang, XC; Nagasawa, T; Wu, JY; Rao, Y			Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons	NATURE NEUROSCIENCE			English	Article							RECEPTOR CXCR4; LYMPHOPOIESIS; MYELOPOIESIS; MIGRATION; PROTEIN; MICE; SLIT; CNS		Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Mol & Cellular Immunol, Osaka 5901101, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wu, JY (corresponding author), Washington Univ, Sch Med, Dept Pediat, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.			Nagasawa, Takashi/0000-0002-1085-0960	NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2, R01 CA114197] Funding Source: Medline; NEI NIH HHS [R01 EY014576, R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02, R01 GM070967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Jazin EE, 1997, J NEUROIMMUNOL, V79, P148, DOI 10.1016/S0165-5728(97)00117-3; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	13	193	201	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					719	720		10.1038/nn881	http://dx.doi.org/10.1038/nn881			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080344	Green Accepted			2022-12-28	WOS:000177088900009
J	Knecht, S; Floel, A; Drager, B; Breitenstein, C; Sommer, J; Henningsen, H; Ringelstein, EB; Pascual-Leone, A				Knecht, S; Floel, A; Drager, B; Breitenstein, C; Sommer, J; Henningsen, H; Ringelstein, EB; Pascual-Leone, A			Degree of language lateralization determines susceptibility to unilateral brain lesions	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; RIGHT-HEMISPHERE; DOPPLER SONOGRAPHY; FUNCTIONAL MRI; WADA TEST; SPEECH; EXCITABILITY; ACTIVATION; HANDEDNESS; DOMINANCE	Language is considered a function of either the left or, in exceptional cases, the right side of the brain. Functional imaging studies show, however, that in the general population a graded continuum from left hemispheric to right hemispheric language lateralization exists. To determine the functional relevance of lateralization differences, we suppressed language regions using transcranial magnetic stimulation (TMS) in healthy human subjects who differed in lateralization of language-related brain activation. Language disruption correlated with both the degree and side of lateralization. Subjects with weak lateralization (more bilaterality) were less affected by either left- or right-side TMS than were subjects with strong lateralization to one hemisphere. Thus in some people, language processing seems to be distributed evenly between the hemispheres, allowing for ready compensation after a unilateral lesion.	Univ Munster, Dept Neurol, D-48129 Munster, Germany; Harvard Univ, Sch Med, Lab Magnet Brain Stimulat, Boston, MA 02215 USA	University of Munster; Harvard University; Harvard Medical School	Knecht, S (corresponding author), Univ Munster, Dept Neurol, Albert Schweitzer Str 33, D-48129 Munster, Germany.		Pascual-Leone, Alvaro/G-6566-2011; Floel, Agnes/A-9426-2017; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Knecht, Stefan/0000-0003-1056-9228				Bakar M, 1996, ARCH NEUROL-CHICAGO, V53, P1026, DOI 10.1001/archneur.1996.00550100112020; Baynes K, 1998, SCIENCE, V280, P902, DOI 10.1126/science.280.5365.902; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; BOTTINI G, 1994, BRAIN, V117, P1241, DOI 10.1093/brain/117.6.1241; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Deppe M, 2000, J CEREBR BLOOD F MET, V20, P263, DOI 10.1097/00004647-200002000-00006; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Epstein CM, 1998, J CLIN NEUROPHYSIOL, V15, P325, DOI 10.1097/00004691-199807000-00004; Flitman SS, 1998, NEUROLOGY, V50, P175, DOI 10.1212/WNL.50.1.175; Gazzaniga MS, 1996, BRAIN, V119, P1255, DOI 10.1093/brain/119.4.1255; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; JENNUM P, 1994, NEUROLOGY, V44, P269, DOI 10.1212/WNL.44.2.269; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Knecht S, 1998, STROKE, V29, P82, DOI 10.1161/01.STR.29.1.82; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Knecht S, 1998, STROKE, V29, P1155, DOI 10.1161/01.STR.29.6.1155; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KURTHEN M, 1992, BRAIN LANG, V43, P694, DOI 10.1016/0093-934X(92)90091-R; LICHTHEIM L, 1884, BRAIN, V7, P443; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Rafal R, 2001, NAT NEUROSCI, V4, P862, DOI 10.1038/nn0901-862; Risse GL, 1997, BRAIN COGNITION, V33, P118, DOI 10.1006/brcg.1997.0887; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1999, NEUROPSYCHOLOGIA, V37, P537, DOI 10.1016/S0028-3932(98)00102-X; WILLMES K, 1993, BRAIN, V116, P1527, DOI 10.1093/brain/116.6.1527	30	146	151	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					695	699		10.1038/nn868	http://dx.doi.org/10.1038/nn868			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055632				2022-12-28	WOS:000176414300021
J	Shin, OH; Rizo, J; Sudhof, TC				Shin, OH; Rizo, J; Sudhof, TC			Synaptotagmin function in dense core vesicle exocytosis studied in cracked PC12 cells	NATURE NEUROSCIENCE			English	Article							INTRACELLULAR CALCIUM-DEPENDENCE; REGULATED EXOCYTOSIS; C2 DOMAIN; TRANSMITTER RELEASE; PHOSPHOLIPASE A(2); SYNAPTIC VESICLES; BINDING DOMAIN; CA2+ SENSOR; PROTEIN; MEMBRANES	Ca2+-triggered dense-core vesicle exocytosis in PC12 cells does not require vesicular synaptotagmins 1 and 2, but may use plasma membrane synaptotagmins 3 and 7 as Ca2+ sensors. In support of this hypothesis, C-2 domains from the plasma membrane but not vesicular synaptotagmins inhibit PC12 cell exocytosis. Ca2+ induces binding of both plasma membrane and vesicular synaptotagmins to phospholipids and SNAREs (soluble N-ethylmaleimide-sensitive attachment protein receptors), although with distinct apparent Ca2+ affinities. Here we used gain-of-function C-2-domain mutants of synaptotagmin 1 and loss-of-function C-2-domain mutants of synaptotagmin 7 to examine how synaptotagmins function in dense-core vesicle exocytosis. Our data indicate that phospholipid- but not SNARE-binding by plasma membrane synaptotagmins is the primary determinant of Ca2+ triggered dense-core vesicle exocytosis. These results support a general lipid-based mechanism of action of synaptotagmins in exocytosis, with the specificity of various synaptotagmins for different types of fusion governed by their differential localizations and Ca2+ affinities.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu			NINDS NIH HHS [NS37200, NS40944] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200, R01NS040944] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHNERTHILGER G, 1987, BIOCHEMISTRY-US, V26, P7842, DOI 10.1021/bi00398a046; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2002, DIABETES, V51, pS12, DOI 10.2337/diabetes.51.2007.S12; Gerber SH, 2001, J BIOL CHEM, V276, P32288, DOI 10.1074/jbc.C100108200; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Kee Y, 1996, J NEUROSCI, V16, P1975; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; PERIN MS, 1991, J BIOL CHEM, V266, P623; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SHAO X, 2001, SCIENCE, V273, P248; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512; Zhong PY, 1997, BIOCHEMISTRY-US, V36, P4317, DOI 10.1021/bi9625408	46	71	73	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					649	656		10.1038/nn869	http://dx.doi.org/10.1038/nn869			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055633				2022-12-28	WOS:000176414300014
J	London, M; Schreibman, A; Hausser, M; Larkum, ME; Segev, I				London, M; Schreibman, A; Hausser, M; Larkum, ME; Segev, I			The information efficacy of a synapse	NATURE NEUROSCIENCE			English	Article							INPUTS; CONDUCTANCES; COINCIDENCE; VARIABILITY; INHIBITION; DENDRITES; TRANSIENT; RESPONSES; AMPLITUDE; LOCATION	We provide a functional measure, the synaptic information efficacy (SIE), to assess the impact of synaptic input on spike output. SIE is the mutual information shared by the presynaptic input and postsynaptic output spike trains. To estimate SIE we used a method based on compression algorithms. This method detects the effect of a single synaptic input on the postsynaptic spike output in the presence of massive background synaptic activity in neuron models of progressively increasing realism. SIE increased with increases either in time locking between the input synapse activity and the output spike or in the average number of output spikes. SIE depended on the context in which the synapse operates. We also measured SIE experimentally. Systematic exploration of the effect of synaptic and dendritic parameters on the SIE offers a fresh look at the synapse as a communication device and a quantitative measure of how much the dendritic synapse informs the axon.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Comp Sci, IL-91904 Jerusalem, Israel; UCL, Dept Physiol, London WC1E 6BT, England; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of London; University College London; Max Planck Society	Segev, I (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	idan@lobster.ls.huji.ac.il	London, Michael/B-4175-2010; Hausser, Michael/AAW-6827-2020	London, Michael/0000-0001-5137-1707; Hausser, Michael/0000-0002-2673-8957; Larkum, Matthew/0000-0001-9799-2656; Segev, Idan/0000-0001-7279-9630				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abeles M., 1991, CORTICONICS; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BERNANDER O, 1994, NEURAL COMPUT, V6, P622, DOI 10.1162/neco.1994.6.4.622; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; CARNEVALE NT, 1982, J NEUROPHYSIOL, V47, P606, DOI 10.1152/jn.1982.47.4.606; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; De Schutter E, 1998, J NEUROPHYSIOL, V80, P504; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; FETZ EE, 1983, J PHYSIOL-LONDON, P387; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hebb Donald O., 1949, ORG BEHAV; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; IANSEK R, 1973, J PHYSIOL-LONDON, V234, P665, DOI 10.1113/jphysiol.1973.sp010366; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Manwani A, 2001, NEURAL COMPUT, V13, P1, DOI 10.1162/089976601300014619; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MURTHY VN, 1994, NEURAL COMPUT, V6, P1111, DOI 10.1162/neco.1994.6.6.1111; NICOLL A, 1993, J PHYSIOL-LONDON, V468, P693, DOI 10.1113/jphysiol.1993.sp019795; OERTEL D, 1983, J NEUROSCI, V3, P2043; PINSKY PF, 1995, J COMPUT NEUROSCI, V2, P275, DOI 10.1007/BF00961439; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rall W, 1964, NEURAL THEORY MODELI, P73; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Rieke F., 1997, SPIKES EXPLORING NEU; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Schultz SR, 2001, PHYS REV LETT, V86, P5823, DOI 10.1103/PhysRevLett.86.5823; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHRRINGTON CS, 1897, TXB PHYSL, V3; STRATFORD RD, 1989, COMPUTING NEURON; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WILLEMS FMJ, 1995, IEEE T INFORM THEORY, V41, P653, DOI 10.1109/18.382012; YAMADA S, 1993, BIOL CYBERN, V68, P215, DOI 10.1007/BF00224854	50	105	108	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					332	340		10.1038/nn826	http://dx.doi.org/10.1038/nn826			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896396				2022-12-28	WOS:000174606900013
J	Kros, CJ; Marcotti, W; van Netten, SM; Self, TJ; Libby, RT; Brown, SDM; Richardson, GP; Steel, KP				Kros, CJ; Marcotti, W; van Netten, SM; Self, TJ; Libby, RT; Brown, SDM; Richardson, GP; Steel, KP			Reduced climbing and increased slipping adaptation in cochlear hair cells of mice with Myo7a mutations	NATURE NEUROSCIENCE			English	Article							MYOSIN-VIIA; MECHANOELECTRICAL TRANSDUCTION; AMINOGLYCOSIDE ACCUMULATION; MEMBRANE; DEAFNESS; CADHERIN; CURRENTS; MODEL; CHANNELS; PROTEIN	Mutations in Myo7a cause hereditary deafness in mice and humans. We describe the effects of two mutations, Myo7a(6J) and Myo7a(4626SB). on mechano-electrical transduction in cochlear hair cells. Both mutations result in two major functional abnormalities that would interfere with sound transduction. The hair bundles need to be displaced beyond their physiological operating range for mechanotransducer channels to open. Transducer currents also adapt more strongly than normal to excitatory stimuli. We conclude that myosin VIIA participates in anchoring and holding membrane-bound elements to the actin core of the stereocilium. Myosin VIIA is therefore required for the normal gating of transducer channels.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Groningen, Dept Neurobiophys, NL-9747 AG Groningen, Netherlands; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England	University of Sussex; University of Bristol; University of Groningen; University of Nottingham; MRC Harwell	Kros, CJ (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.	c.j.kros@sussex.ac.uk	Libby, Richard/Q-6720-2019	Libby, Richard/0000-0003-2844-7632				ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BARR E, 1994, GENE THER, V1, P51; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DENK W, 1992, J NEUROPHYSIOL, V68, P927, DOI 10.1152/jn.1992.68.3.927; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Garcia JA, 1998, J NEUROSCI, V18, P8637; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Kros C. J., 1995, ACTIVE HEARING, P113; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Lord EM, 1929, AM NAT, V63, P435, DOI 10.1086/280276; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Mburu Philomena, 1997, Genes and Function, V1, P191; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; RHODE WS, 1967, J ACOUST SOC AM, V42, P185, DOI 10.1121/1.1910547; Richardson GP, 1997, J NEUROSCI, V17, P9506; Richardson GP, 1999, ANN NY ACAD SCI, V884, P110; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; RUSSELL IJ, 1987, HEARING RES, V31, P9, DOI 10.1016/0378-5955(87)90210-3; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yamoah EN, 1996, NEURON, V17, P523, DOI 10.1016/S0896-6273(00)80184-1	47	193	200	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					41	47		10.1038/nn784	http://dx.doi.org/10.1038/nn784			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753415				2022-12-28	WOS:000173031800013
J	Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP				Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP			Expert face processing requires visual input to the right hemisphere during infancy	NATURE NEUROSCIENCE			English	Article							HUMAN FUSIFORM GYRUS; SPATIAL ATTENTION; DEPRIVATION; RECOGNITION; EXPERIENCE; PROSOPAGNOSIA; INFORMATION; INTEGRATION; ASYMMETRIES; PERCEPTION	Adult expertise in face processing is mediated largely by neural networks in the right hemisphere. Here we evaluate the contribution of early visual input in establishing this neural substrate. We compared visually normal individuals to patients for whom visual input had been restricted mainly to one hemisphere during infancy. We show that early deprivation of visual input to the right hemisphere severely impairs the development of expert face processing, whereas deprivation restricted mainly to the left hemisphere does not. Our results indicate that the neural circuitry responsible for adults' face expertise is not pre-specified, but requires early visual experience. However, the two hemispheres are not equipotent: only the right hemisphere is capable of using the early input to develop expertise at face processing.	McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Maurer, D (corresponding author), McMaster Univ, Dept Psychol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.							Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Bruce V., 1994, VIS COGN, V1, P141, DOI [DOI 10.1080/13506289408402299, 10.1080/13506289408402299]; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; de Schonen S., 1989, EUROPEAN B COGNITIVE, V9, P3; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Deruelle C, 1998, DEV NEUROPSYCHOL, V14, P535, DOI 10.1080/87565649809540727; DERUELLE C, 1991, BRAIN COGNITION, V16, P151, DOI 10.1016/0278-2626(91)90004-R; DERUELLE C, 1995, INFANT BEHAV DEV, V18, P123, DOI 10.1016/0163-6383(95)90042-X; DESCHONEN S, 1990, CHILD DEV, V61, P1192, DOI 10.2307/1130887; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Ellemberg D, 2000, VISION RES, V40, P3283, DOI 10.1016/S0042-6989(00)00165-6; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Geldart S, 2002, DEVELOPMENTAL SCI, V5, P490, DOI 10.1111/1467-7687.00242; GELDART S, 2000, THESIS MCMASTER U; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; GOLDBERG M, 1998, THESIS MCMASTER U; Goldberg MC, 2001, DEV NEUROPSYCHOL, V19, P53, DOI 10.1207/S15326942DN1901_5; Goldberg MC, 2001, DEVELOPMENTAL SCI, V4, P209, DOI 10.1111/1467-7687.00166; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; LeGrand R, 2001, NATURE, V412, P786; Lewis TL, 2002, VISION RES, V42, P939, DOI 10.1016/S0042-6989(02)00041-X; LEWIS TL, 1992, VISION RES, V32, P903, DOI 10.1016/0042-6989(92)90033-F; Liegeois F, 1997, NEUROPSYCHOLOGIA, V35, P381, DOI 10.1016/S0028-3932(96)00078-4; Liegeois F, 2000, NEUROPSYCHOLOGIA, V38, P1382, DOI 10.1016/S0028-3932(00)00041-5; MAUER D, 1989, APPL DEV PSYCHOL, V3, P108; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; MONDLOCH CJ, IN PRESS DEV FACE PR; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Sergent J., 1988, THOUGHT LANGUAGE, V108-131; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599	38	201	202	1	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1108	1112		10.1038/nn1121	http://dx.doi.org/10.1038/nn1121			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	727AK	12958600				2022-12-28	WOS:000185633600024
J	Zucker, RS				Zucker, RS			NCS-1 stirs somnolent synapses	NATURE NEUROSCIENCE			English	Editorial Material							SYNAPTIC FACILITATION; TRANSMITTER RELEASE; BUFFER SATURATION; CALCIUM; FREQUENIN; DROSOPHILA; TERMINALS; PROTEIN; CA2+		Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zucker, RS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, 111 Life Sci Addit, Berkeley, CA 94720 USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343				Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Jackson MB, 2003, J NEUROSCI, V23, P1612; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Matveev V, 2002, BIOPHYS J, V83, P1368, DOI 10.1016/S0006-3495(02)73907-6; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; POULAIN C, 1994, PFLUG ARCH EUR J PHY, V427, P71, DOI 10.1007/BF00585944; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	15	13	13	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1006	1008		10.1038/nn1003-1006	http://dx.doi.org/10.1038/nn1003-1006			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14513033				2022-12-28	WOS:000185633600006
J	Floresco, SB; West, AR; Ash, B; Moore, H; Grace, AA				Floresco, SB; West, AR; Ash, B; Moore, H; Grace, AA			Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS NEURONS; EXTRACELLULAR DOPAMINE; IN-VIVO; RECEPTORS; ACTIVATION; EFFLUX; SIGNAL; HIPPOCAMPAL; TRANSPORTER; RESPONSES	The mesolimbic dopamine system is centrally involved in reward and goal-directed behavior, and it has been implicated in multiple psychiatric disorders. Understanding the mechanism by which dopamine participates in these activities requires comprehension of the dynamics of dopamine release. Here we report dissociable regulation of dopamine neuron discharge by two separate afferent systems in rats; inhibition of pallidal afferents selectively increased the population activity of dopamine neurons, whereas activation of pedunculopontine inputs increased burst firing. Only the increase in population activity increased ventral striatal dopamine efflux. After blockade of dopamine reuptake, however, enhanced bursting increased dopamine efflux three times more than did enhanced population activity. These results provide insight into multiple regulatory systems that modulate dopamine system function: burst firing induces massive synaptic dopamine release, which is rapidly removed by reuptake before escaping the synaptic cleft, whereas increased population activity modulates tonic extrasynaptic dopamine levels that are less influenced by reuptake.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Floresco, SB (corresponding author), Univ Pittsburgh, Dept Neurosci, 446 Crawford Hall, Pittsburgh, PA 15260 USA.	floresco@psych.ubc.ca; grace@bns.pitt.edu	Floresco, Stan B/F-8160-2012	Floresco, Stan B/0000-0002-5633-243X; Grace, Anthony/0000-0003-1864-5504	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH011305] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH011305] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CLEMENTS JR, 1990, NEUROSCI LETT, V120, P70, DOI 10.1016/0304-3940(90)90170-E; Datla KP, 2002, EUR J NEUROSCI, V16, P1987, DOI 10.1046/j.1460-9568.2002.02249.x; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Floresco SB, 2001, J NEUROSCI, V21, P2851, DOI 10.1523/JNEUROSCI.21-08-02851.2001; GARRIS PA, 1994, J NEUROSCI, V14, P6084; GONO FG, 1993, NEUROSCIENCE, V24, P19; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Gronier B, 1998, BRIT J PHARMACOL, V124, P455, DOI 10.1038/sj.bjp.0701850; Howland JG, 2002, J NEUROSCI, V22, P1137, DOI 10.1523/JNEUROSCI.22-03-01137.2002; Karreman M, 1996, J NEUROCHEM, V67, P601; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; Kitamura M, 2001, NEUROSCIENCE, V104, P117, DOI 10.1016/S0306-4522(01)00053-7; LAURELLE M, 2000, BRAIN RES REV, V1, P371; MASLOWSKICOBUZZI RJ, 1994, NEUROSCIENCE, V62, P1103, DOI 10.1016/0306-4522(94)90347-6; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; MILNER KL, 1988, BRAIN RES, V452, P273, DOI 10.1016/0006-8993(88)90031-5; Moore H, 1998, J NEUROSCI, V18, P5068; Nirenberg MJ, 1997, J NEUROSCI, V17, P6899; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; ODONNELL P, 1994, BRAIN RES, V634, P105, DOI 10.1016/0006-8993(94)90263-1; PHILLIPS AG, 1993, CAN J PHYSIOL PHARM, V71, P387, DOI 10.1139/y93-059; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Samson HH, 2001, ALCOHOL, V23, P41, DOI 10.1016/S0741-8329(00)00122-1; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sesack SR, 2002, HANDB EXP PHARM 1, P63; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shim SS, 1996, NEUROPSYCHOPHARMACOL, V15, P437; TSAI CT, 1985, BRAIN RES, V49, P422; West AR, 2000, J NEUROPHYSIOL, V83, P1796, DOI 10.1152/jn.2000.83.4.1796; West AR, 1997, NEUROPHARMACOLOGY, V36, P1571, DOI 10.1016/S0028-3908(97)00148-2; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Wu M, 1996, BRAIN RES, V740, P151, DOI 10.1016/S0006-8993(96)00859-1; YANG CR, 1987, NEUROSCIENCE, V23, P1041, DOI 10.1016/0306-4522(87)90179-5; ZAHM DS, 1990, J COMP NEUROL, V302, P437, DOI 10.1002/cne.903020302	39	788	792	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					968	973		10.1038/nn1103	http://dx.doi.org/10.1038/nn1103			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897785				2022-12-28	WOS:000184970400016
J	Fukuchi-Shimogori, T; Grove, EA				Fukuchi-Shimogori, T; Grove, EA			Emx2 patterns the neocortex by regulating FGF positional signaling	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; MOLECULAR REGIONALIZATION; AREA IDENTITY; MOUSE-BRAIN; EXPRESSION; SPECIFICATION; GENES; TELENCEPHALON; MECHANISMS; FAMILY	Molecular genetic studies implicate fibroblast growth factor 8 (FGF8), and the transcription factor Emx2, in development of the neocortical area map. Both are proposed to specify area position along the anterior-to-posterior axis of the cortical primordium. Whether FGF8 and Emx2 act independently or coordinately, or whether one controls the other, has not been determined. Here we report that Emx2, by regulating FGF8, has an indirect but vital role in area-map development. Using electroporation- mediated gene transfer in living mouse embryos, we found that overexpressing Emx2 altered the area map, but only when ectopic Emx2 overlapped the FGF8 source. Furthermore, we found that FGF8 levels were decreased by excess Emx2, and increased in mice lacking Emx2. Finally, cortical domain shifts that characterize Emx2 mutants were rescued by sequestering excess FGF8 with a truncated FGF receptor construct. These findings begin to clarify the signaling network that patterns the neocortical area map.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Grove, EA (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, 947 E 58th St,MC0926, Chicago, IL 60637 USA.	egrove@drugs.bsd.uchicago.edu	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Arimatsu Y, 1999, DEVELOPMENT, V126, P629; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; BARBE MF, 1991, J NEUROSCI, V11, P519; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Eagleson KL, 1999, CEREB CORTEX, V9, P562, DOI 10.1093/cercor/9.6.562; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; Grove EA, 1998, DEVELOPMENT, V125, P2315; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; Nauta W., 1986, FUNDAMENTAL NEUROANA; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ornitz DM, 2001, GENOME BIOL, V2; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Shamim H, 1999, DEVELOPMENT, V126, P945; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Theil T, 1999, DEVELOPMENT, V126, P3561; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xu JS, 2000, DEVELOPMENT, V127, P1833; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	49	146	151	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					825	831		10.1038/nn1093	http://dx.doi.org/10.1038/nn1093			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872126				2022-12-28	WOS:000184413700011
J	Yevenes, GE; Peoples, RW; Tapia, JC; Parodi, J; Soto, X; Olate, J; Aguayo, LG				Yevenes, GE; Peoples, RW; Tapia, JC; Parodi, J; Soto, X; Olate, J; Aguayo, LG			Modulation of glycine-activated ion channel function by G-protein beta gamma subunits	NATURE NEUROSCIENCE			English	Article							VOLTAGE-DEPENDENT MODULATION; RAT SYMPATHETIC NEURONS; MOUSE SPINAL NEURONS; DORSAL HORN NEURONS; CALCIUM-CHANNELS; CA2+ CHANNELS; GABA(B) RECEPTOR; K+ CHANNELS; INHIBITION; EXPRESSION	Glycine receptors (GlyRs), together with GABA(A) and nicotinic acetylcholine (ACh) receptors, form part of the ligand-activated ion channel superfamily and regulate the excitability of the mammalian brain stem and spinal cord. Here we report that the ability of the neurotransmitter glycine to gate recombinant and native ionotropic GlyRs is modulated by the G protein betagamma dimer (Gbetagamma). We found that the amplitude of the glycine-activated Cl(-) current was enhanced after application of purified Gbetagamma or after activation of a G protein-coupled receptor. Overexpression of three distinct G protein alpha subunits (Galpha), as well as the Gbetagamma scavenger peptide ct-GRK2, significantly blunted the effect of G protein activation. Single-channel recordings from isolated membrane patches showed that Gbetagamma increased the GlyR open probability (nP(o)). Our results indicate that this interaction of Gbetagamma with GlyRs regulates both motor and sensory functions in the central nervous system.	Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile; NIAAA, Unit Cellular Neuropharmacol, Mol & Cellular Neurobiol Lab, NIH, Bethesda, MD 20892 USA; Univ Concepcion, Dept Mol Biol, Mol Genet Lab, Concepcion, Chile	Universidad de Concepcion; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Universidad de Concepcion	Aguayo, LG (corresponding author), Univ Concepcion, Dept Physiol, Neurophysiol Lab, Box 160-C, Concepcion, Chile.	laguayo@udec.cl	Soto, Ximena/HHN-6524-2022	Yevenes, Gonzalo/0000-0003-0294-4075; Soto Rodriguez, Ximena/0000-0003-2680-1837; Parodi, Jorge/0000-0002-9117-5433	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000448] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Asano T, 1999, J BIOL CHEM, V274, P21425, DOI 10.1074/jbc.274.30.21425; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Diverse-Pierluissi M, 2000, J BIOL CHEM, V275, P28380, DOI 10.1074/jbc.M003571200; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Geiman EJ, 2002, J COMP NEUROL, V444, P275, DOI 10.1002/cne.10148; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HWANG AS, 1989, J PHARMACOL EXP THER, V248, P1026; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Jeong SW, 1999, J NEUROSCI, V19, P4755; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; KANGRGA I, 1991, BRAIN RES, V562, P265, DOI 10.1016/0006-8993(91)90630-E; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Ruiz-Velasco V, 2000, J NEUROSCI, V20, P2183; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; SAWYNOK J, 1984, PROG NEURO-PSYCHOPH, V8, P581, DOI 10.1016/0278-5846(84)90018-6; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; SCHMID K, 1991, RESP PHYSIOL, V84, P351, DOI 10.1016/0034-5687(91)90129-7; SONG Y, 1990, NATURE, V348, P242, DOI 10.1038/348242a0; Tapia JC, 2001, NEUROSCIENCE, V108, P493, DOI 10.1016/S0306-4522(01)00348-7; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; van Zundert B, 2002, J NEUROPHYSIOL, V87, P640, DOI 10.1152/jn.00455.2001; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	46	74	77	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					819	824		10.1038/nn1095	http://dx.doi.org/10.1038/nn1095			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12858180				2022-12-28	WOS:000184413700010
J	Rosenzweig, ES; Redish, AD; McNaughton, BL; Barnes, CA				Rosenzweig, ES; Redish, AD; McNaughton, BL; Barnes, CA			Hippocampal map realignment and spatial learning	NATURE NEUROSCIENCE			English	Article							RABBIT FOLLOWING STIMULATION; LONG-LASTING POTENTIATION; SINGLE-UNIT-ACTIVITY; FREELY-MOVING RAT; PLACE CELLS; PATH INTEGRATION; SYNAPTIC TRANSMISSION; ENVIRONMENTAL CUES; ENSEMBLE ACTIVITY; PERFORANT PATH	The spatial selectivity of hippocampal neurons suggests that they contribute to an internal representation of current location. The activity of hippocampal pyramidal cells was recorded while adult (10-13 months old) and aged (24-28 months old) rats performed a task in which two spatial reference frames were put in conflict. Rats attempted to find an unmarked goal whose position was fixed relative to only one of the two reference frames. The ability of a rat's hippocampus to adjust to the conflicting information and use the 'correct' position estimate (hippocampal map 'realignment') was correlated with the rat's ability to find the hidden goal. In addition, aged rats were impaired relative to adult rats in both goal-finding accuracy and map realignment. Thus, changes in the effectiveness with which the hippocampal spatial representation is updated on the basis of external cues may contribute to both within-age-group spatial learning variability and age-related spatial learning deficits.	Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA; Univ Arizona, Dept Psychol, Tucson, AZ 85724 USA; Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Barnes, CA (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, 384 Life Sci N, Tucson, AZ 85724 USA.	carol@nsma.arizona.edu	Rosenzweig, Ephron/AAI-7541-2020	Rosenzweig, Ephron/0000-0002-0370-9643	NATIONAL INSTITUTE ON AGING [R37AG012609, F32AG005805, R01AG012609] Funding Source: NIH RePORTER; NIA NIH HHS [AG05805, AG12609] Funding Source: Medline; NIMH NIH HHS [MH01565] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barnes CA, 1990, HDB NEUROPSYCHOLOGY, P169; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bures J, 1997, P NATL ACAD SCI USA, V94, P343, DOI 10.1073/pnas.94.1.343; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; GALLAGHER M, 1988, NEUROBIOL AGING, V9, P363, DOI 10.1016/S0197-4580(88)80082-4; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Gothard KM, 1996, J NEUROSCI, V16, P823; Jeffery KJ, 1999, EXP BRAIN RES, V127, P151, DOI 10.1007/s002210050785; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Kubie J. L., 1983, NEUROBIOLOGY HIPPOCA, P433; Lenck-Santini PP, 2002, J NEUROSCI, V22, P9035; Lenck-Santini PP, 2001, HIPPOCAMPUS, V11, P377, DOI 10.1002/hipo.1052; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; McNaughton BL, 1996, J EXP BIOL, V199, P173; MIZUMORI SJY, 1989, J NEUROPHYSIOL, V61, P15, DOI 10.1152/jn.1989.61.1.15; MIZUMORI SJY, 1994, BRAIN RES, V644, P168, DOI 10.1016/0006-8993(94)90361-1; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PICO RM, 1985, BRAIN RES, V330, P369, DOI 10.1016/0006-8993(85)90700-0; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Redish AD, 2000, J NEUROSCI, V20, P9298; ROSENZWEIG ES, 2003, IN PRESS PROG NEUROB; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SHAPIRO ML, 1989, NEUROSCIENCE, V32, P1, DOI 10.1016/0306-4522(89)90103-6; SHARP PE, 1995, J NEUROSCI, V15, P173; Tanila H, 1997, J NEUROSCI, V17, P5167; Tanila H, 1997, J NEUROSCI, V17, P5155; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wilson IA, 2003, NEUROBIOL AGING, V24, P297, DOI 10.1016/S0197-4580(02)00080-5; Wilson MA, 1997, TRENDS NEUROSCI, V20, P102, DOI 10.1016/S0166-2236(96)01023-5; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	58	63	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					609	615		10.1038/nn1053	http://dx.doi.org/10.1038/nn1053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12717437				2022-12-28	WOS:000183140400018
J	Akten, B; Jauch, E; Genova, GK; Kim, EY; Edery, I; Raabe, T; Jackson, FR				Akten, B; Jauch, E; Genova, GK; Kim, EY; Edery, I; Raabe, T; Jackson, FR			A role for CK2 in the Drosophila circadian oscillator	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CK2; GENE-EXPRESSION; PERIOD PROTEIN; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; CLOCK PROTEINS; DOUBLE-TIME; RHYTHMS; MELANOGASTER; LIGHT	The posttranslational modification of clock proteins is critical for the function of circadian oscillators. By genetic analysis of a Drosophila melanogaster circadian clock mutant known as Andante, which has abnormally long circadian periods, we show that casein kinase 2 (CK2) has a role in determining period length. Andante is a mutation of the gene encoding the beta subunit of CK2 and is predicted to perturb CK2beta subunit dimerization. It is associated with reduced beta subunit levels, indicative of a defect in alpha:beta association and production of the tetrameric alpha2:beta2 holoenzyme. Consistent with a direct action on the clock mechanism, we show that CK2beta is localized within clock neurons and that the clock proteins Period (Per) and Timeless (Tim) accumulate to abnormally high levels in the Andante mutant. Furthermore, the nuclear translocation of Per and Tim is delayed in Andante, and this defect accounts for the long-period phenotype of the mutant. These results suggest a function for CK2-dependent phosphorylation in the molecular oscillator.	Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 01211 USA; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Tufts University; University of Wurzburg; Rutgers State University New Brunswick	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 01211 USA.			Jauch, Edward/0000-0002-3533-4364				Bidwai A P, 1999, Mol Cell Biol Res Commun, V1, P21, DOI 10.1006/mcbr.1999.0103; BIDWAI AP, 1993, ARCH BIOCHEM BIOPHYS, V300, P265, DOI 10.1006/abbi.1993.1037; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DiBartolomeis SM, 2002, MOL GENET GENOMICS, V267, P564, DOI 10.1007/s00438-002-0700-7; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Jauch E, 2002, GENE, V298, P29, DOI 10.1016/S0378-1119(02)00921-6; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; KONOPKA RJ, 1991, J NEUROGENET, V7, P103, DOI 10.3109/01677069109066214; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; NEWBY LM, 1995, DEV GENET, V16, P85, DOI 10.1002/dvg.1020160112; NEWBY LM, 1991, GENETICS, V128, P571; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; ORR D, 1982, THESIS CALTECH; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Shafer OT, 2002, J NEUROSCI, V22, P5946; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	35	228	232	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					251	257		10.1038/nn1007	http://dx.doi.org/10.1038/nn1007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563262				2022-12-28	WOS:000181178300013
J	Lee, HS; Nelms, JL; Nguyen, M; Silver, R; Lehman, MN				Lee, HS; Nelms, JL; Nguyen, M; Silver, R; Lehman, MN			The eye is necessary for a circadian rhythm in the suprachiasmatic nucleus	NATURE NEUROSCIENCE			English	Article							CALBINDIN-D-28K CELLS; PROTEIN-KINASE; MAP KINASE; HAMSTER; ACTIVATION; LIGHT		Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Program Neurosci, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Phys Sci Training Program, Cincinnati, OH 45267 USA; Columbia Univ, New York, NY 10027 USA; Barnard Coll, Dept Psychol, New York, NY 10027 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Columbia University	Lehman, MN (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.	michael.lehman@uc.edu	Jansen, Heiko T./A-5770-2008; Lehman, Michael/ABC-9076-2020	Jansen, Heiko T./0000-0003-0178-396X; Silver, Rae/0000-0001-8633-739X; Lehman, Michael/0000-0002-9076-5108				Bryant DN, 2000, J BIOL RHYTHM, V15, P103, DOI 10.1177/074873040001500204; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; Matsumoto S, 1996, J BIOL RHYTHM, V11, P145, DOI 10.1177/074873049601100207; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405	14	119	120	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					111	112		10.1038/nn1006	http://dx.doi.org/10.1038/nn1006			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536213				2022-12-28	WOS:000180669100007
J	Cayouette, M; Raff, M				Cayouette, M; Raff, M			Asymmetric segregation of Numb: a mechanism for neural specification from Drosophila to mammals	NATURE NEUROSCIENCE			English	Review							CELL-DIVISION; NEUROEPITHELIAL CELLS; CORTICAL NEUROGENESIS; ENDOCYTIC PROTEIN; NERVOUS-SYSTEM; MOUSE NUMB; STEM-CELLS; NOTCH; FATE; LOCALIZATION	It is a major challenge to understand how the neuroepithelial cells of the developing CNS choose between alternative cell fates to generate cell diversity. In invertebrates such as Drosophila melanogaster and Caenorhabditis elegans, asymmetric segregation of cell-fate determining proteins or mRNAs to the two daughter cells during precursor cell division plays a crucial part in cell diversification. There is increasing evidence that this mechanism also operates in vertebrate neural development and that Numb proteins, which function as cell-fate determinants during Drosophila development, may also function in this way in vertebrates. Recent studies on mouse cortical progenitor cells have provided the strongest evidence yet that this is the case. Here, we review these and other findings that suggest an important role for the asymmetric segregation of Numb proteins in vertebrate neural development.	UCL, Cell Biol Unit, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Cayouette, M (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Bldg,299 Campus Dr,D231, Stanford, CA 94305 USA.	m.cayouette@stanford.edu		Cayouette, Michel/0000-0003-4655-9048				Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schaefer M, 2001, EXP CELL RES, V271, P66, DOI 10.1006/excr.2001.5371; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; SHEN Q, IN PRESS DEVELOPMENT; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wan S, 2000, DEV BIOL, V217, P153, DOI 10.1006/dbio.1999.9499; Xie Y, 2001, BIOCHEM GENET, V39, P117, DOI 10.1023/A:1010269908398; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	41	148	154	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1265	1269		10.1038/nn1202-1265	http://dx.doi.org/10.1038/nn1202-1265			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12447381				2022-12-28	WOS:000179447500008
J	Sanders, LD; Newport, EL; Neville, HJ				Sanders, LD; Newport, EL; Neville, HJ			Segmenting nonsense: an event-related potential index of perceived onsets in continuous speech	NATURE NEUROSCIENCE			English	Article							BRAIN POTENTIALS; CUES; SEGMENTATION; INFANTS; WORDS	Speech segmentation, determining where one word ends and the next begins in continuous speech, is necessary for auditory language processing. However, because there are few direct indices of this fast, automatic process, it has been difficult to study. We recorded event-related brain potentials (ERPs) while adult humans listened to six pronounceable nonwords presented as continuous speech and compared the responses to nonword onsets before and after participants learned the nonsense words. In subjects showing the greatest behavioral evidence of word learning, word onsets elicited a larger N100 after than before training. Thus N100 amplitude indexes speech segmentation even for recently learned words without any acoustic segmentation cues. The timing and distribution of these results suggest specific processes that may be central to speech segmentation.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Rochester; University of Oregon	Sanders, LD (corresponding author), Univ Maryland, Dept Linguist, 3416 Marie Mt Hall, College Pk, MD 20742 USA.			Sanders, Lisa/0000-0001-6763-1462	NIDCD NIH HHS [R01 DC000167-21, R01 DC000167, R01 DC000167-26, R01 DC000481-12, R01 DC000128, R01 DC000481, R01 DC000128-24, DC00481, F32 DC000128, DC00128, DC00167] Funding Source: Medline; NIGMS NIH HHS [T32 GM007257, 5-T32-GM07257] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000167, F32DC000128, R01DC000481, R01DC000128] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; CUTLER A, 1992, J MEM LANG, V31, P218, DOI 10.1016/0749-596X(92)90012-M; CUTLER A, 1989, NATURE, V340, P229, DOI 10.1038/340229a0; HANSON JS, 1990, ECOL MODEL, V49, P277, DOI 10.1016/0304-3800(90)90031-B; HINK RF, 1978, BIOL PSYCHOL, V6, P1, DOI 10.1016/0301-0511(78)90002-9; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; McCandliss BD, 1997, COGNITIVE PSYCHOL, V33, P88, DOI 10.1006/cogp.1997.0661; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sanders LD, 2000, J SPEECH LANG HEAR R, V43, P1301, DOI 10.1044/jslhr.4306.1301; SANDERS LD, IN PRESS COGN BRAIN; SANDERS LD, IN PRESS J SPEECH LA	13	146	148	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					700	703		10.1038/nn873	http://dx.doi.org/10.1038/nn873			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	566EP	12068301	Green Accepted			2022-12-28	WOS:000176414300022
J	Zhang, XM; Firestein, S				Zhang, XM; Firestein, S			The olfactory receptor gene superfamily of the mouse	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; ODORANT RECEPTOR; SEQUENCE; CLUSTER; FAMILY; IDENTIFICATION; VERTEBRATES; EXPRESSION; NEURONS; ANOSMIA	Olfactory receptor (OR) genes are the largest gene superfamily in vertebrates. We have identified the mouse OR genes from the nearly complete Celera mouse genome by a comprehensive data mining strategy. We found 1,296 mouse OR genes (including similar to20% pseudogenes), which can be classified into 228 families. OR genes are distributed in 27 clusters on all mouse chromosomes except 12 and Y. One OR gene cluster matches a known locus mediating a specific anosmia, indicating the anosmia may be due directly to the loss of receptors. A large number of apparently functional 'fish-like' Class I OR genes in the mouse genome may have important roles in mammalian olfaction. Human ORs cover a similar 'receptor space' as the mouse ORs, suggesting that the human olfactory system has retained the ability to recognize a broad spectrum of chemicals even though humans have lost nearly two-thirds of the OR genes as compared to mice.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	sjf24@columbia.edu						Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Bulger M, 1999, P NATL ACAD SCI USA, V96, P5129, DOI 10.1073/pnas.96.9.5129; Carver EA, 1998, MAMM GENOME, V9, P349, DOI 10.1007/s003359900768; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; Ehlers A, 2000, GENOME RES, V10, P1968, DOI 10.1101/gr.10.12.1968; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Gibson AD, 2000, ANNU REV NEUROSCI, V23, P417, DOI 10.1146/annurev.neuro.23.1.417; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; GRIFF IC, 1995, CELL, V83, P407, DOI 10.1016/0092-8674(95)90118-3; Hoppe R, 2000, GENOMICS, V66, P284, DOI 10.1006/geno.2000.6205; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Lapidot M, 2001, GENOMICS, V71, P296, DOI 10.1006/geno.2000.6431; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mezler M, 2001, J EXP BIOL, V204, P2987; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Pilpel Y, 1999, PROTEIN SCI, V8, P969, DOI 10.1110/ps.8.5.969; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; Skoufos E, 1999, NUCLEIC ACIDS RES, V27, P343, DOI 10.1093/nar/27.1.343; Strotmann J, 1999, GENE, V236, P281, DOI 10.1016/S0378-1119(99)00275-9; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; WYSOCKI CJ, 1977, BEHAV GENET, V7, P171, DOI 10.1007/BF01066005; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zozulya S, 2001, GENOME BIOL, V2	40	627	736	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					124	133		10.1038/nn800	http://dx.doi.org/10.1038/nn800			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802173				2022-12-28	WOS:000173558400014
J	Andersen, SL; Arvanitogiannis, A; Pliakas, AM; LeBlanc, C; Carlezon, WA				Andersen, SL; Arvanitogiannis, A; Pliakas, AM; LeBlanc, C; Carlezon, WA			Altered responsiveness to cocaine in rats exposed to methylphenidate during development	NATURE NEUROSCIENCE			English	Article							EXPRESSION; DOPAMINE		Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; McLean Hosp, Belmont, MA 02478 USA	Harvard University; Harvard University; McLean Hospital	Andersen, SL (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	andersen@mclean.org			NIDA NIH HHS [DA12736] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012736] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDERSEN SL, IN PRESS BEHAV BRAIN; BALSKUBIK R, 1989, PSYCHOPHARMACOLOGY, V98, P203, DOI 10.1007/BF00444692; Biederman J, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.2.e20; Brandon CL, 2001, NEUROPSYCHOPHARMACOL, V25, P651, DOI 10.1016/S0893-133X(01)00281-0; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Robinson TE, 2000, ADDICTION, V95, pS91; ROSENGARTEN H, 1979, SCIENCE, V203, P1133, DOI 10.1126/science.570724; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; WARGIN W, 1983, J PHARMACOL EXP THER, V226, P382; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	15	231	233	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					13	14		10.1038/nn777	http://dx.doi.org/10.1038/nn777			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11731802				2022-12-28	WOS:000173031800007
J	Lin, SC; Bergles, DE				Lin, SC; Bergles, DE			Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus	NATURE NEUROSCIENCE			English	Article							IDENTIFIED GLIAL-CELLS; GABA(A) RECEPTORS; PROGENITOR-CELL; GLUTAMATE-RECEPTOR; ALPHA-5 SUBUNIT; WHITE-MATTER; MICE LACKING; A RECEPTOR; CURRENTS; NEURONS	Oligodendrocyte precursor cells (OPCs) express receptors for many neurotransmitters, but the mechanisms responsible for their activation are poorly understood. We have found that quantal release of GABA from interneurons elicits GABA(A) receptor currents with rapid rise times in hippocampal OPCs. These currents did not exhibit properties of spillover transmission or release by transporters, and immunofluorescence and electron microscopy suggest that interneuronal terminals are in direct contact with OPCs, indicating that these GABA currents are generated at direct interneuron-OPC synapses. The reversal potential of OPC GABA(A) currents was -43 mV, and interneuronal firing was correlated with transient depolarizations induced by GABA(A) receptors; however, GABA application induced a transient inhibition of currents mediated by AMPA receptors in OPCs. These results indicate that OPCs are a direct target of interneuronal collaterals and that the GABA-induced Cl- flux generated by these events may influence oligodendrocyte development by regulating the efficacy of glutamatergic signaling in OPCs.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,WBSB 813, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Messier, Claude/A-2322-2008; Bergles, Dwight/U-8343-2019	Messier, Claude/0000-0002-4791-1763; Bergles, Dwight/0000-0002-7133-7378				BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Burgard EC, 1996, MOL PHARMACOL, V50, P119; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Cohen AS, 2000, J NEUROPHYSIOL, V84, P2465, DOI 10.1152/jn.2000.84.5.2465; Collinson N, 2002, J NEUROSCI, V22, P5572; Dzubay JA, 1999, J NEUROSCI, V19, P5265; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Follett PL, 2000, J NEUROSCI, V20, P9235; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GILBERT P, 1984, J NEUROSCI, V4, P561; Goldstein PA, 2002, J NEUROPHYSIOL, V88, P3208, DOI 10.1152/jn.00885.2001; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Lavoie AM, 1996, NEUROPHARMACOLOGY, V35, P1383, DOI 10.1016/S0028-3908(96)00077-9; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; MUDRICKDONNON LA, 1993, J NEUROSCI, V13, P4660; Overstreet LS, 2000, J NEUROSCI, V20, P7914; Owens DF, 1996, J NEUROSCI, V16, P6414; PASTOR A, 1995, EUR J NEUROSCI, V7, P1188, DOI 10.1111/j.1460-9568.1995.tb01109.x; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Perrais D, 1999, J NEUROSCI, V19, P578; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; Porter JT, 1996, J NEUROSCI, V16, P5073; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Sciancalepore M, 1998, J NEUROPHYSIOL, V80, P2316, DOI 10.1152/jn.1998.80.5.2316; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STEINHAUSER C, 1992, EUR J NEUROSCI, V4, P472, DOI 10.1111/j.1460-9568.1992.tb00897.x; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Theodosis DT, 1996, TRENDS NEUROSCI, V19, P363, DOI 10.1016/0166-2236(96)10055-2; Tillet E, 1997, J BIOL CHEM, V272, P10769; Van Damme P, 2003, J NEUROSCI, V23, P4942; VONBLANKENFELD G, 1991, EUR J NEUROSCI, V3, P310; Williamson AV, 1998, NEUROPHARMACOLOGY, V37, P859, DOI 10.1016/S0028-3908(98)00016-1; Yuan XQ, 1998, DEVELOPMENT, V125, P2901	47	287	294	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					24	32		10.1038/nn1162	http://dx.doi.org/10.1038/nn1162			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14661022				2022-12-28	WOS:000187636000009
J	Ackermann, M; Matus, A				Ackermann, M; Matus, A			Activity-induced targeting of profilin and stabilization of dendritic spine morphology	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; EXCITATORY SYNAPTIC TRANSMISSION; DYNAMIC ACTIN-FILAMENTS; SILENT SYNAPSES; AREA CA1; IN-VIVO; VISUAL-CORTEX; ADULT CORTEX; PLASTICITY; LTP	Morphological changes in dendritic spines have been implicated in connective plasticity in brain circuitry, but the underlying pathway leading from synaptic transmission to structural change is unknown. Using primary neurons expressing GFP-tagged proteins, we found that profilin, a regulator of actin polymerization, is targeted to spine heads when postsynaptic NMDA receptors are activated and that actin-based changes in spine shape are concomitantly blocked. Profilin targeting was triggered by electrical stimulation patterns known to induce the long-term changes in synaptic responsiveness associated with memory formation. These results suggest that, in addition to electrophysiological changes, NMDA receptor activation initiates changes in the actin cytoskeleton of dendritic spines that stabilize synaptic structure.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Ackermann, M (corresponding author), Friedrich Miescher Inst, Box 2543, CH-4002 Basel, Switzerland.							ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Artola A, 1996, J NEUROPHYSIOL, V76, P984, DOI 10.1152/jn.1996.76.2.984; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHRISTOFI G, 1993, J NEUROPHYSIOL, V69, P219, DOI 10.1152/jn.1993.69.1.219; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; FINKEL T, 1994, P NATL ACAD SCI USA, V91, P1510, DOI 10.1073/pnas.91.4.1510; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hajkova L, 2000, EXP CELL RES, V256, P112, DOI 10.1006/excr.1999.4786; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; Isaac J, 2001, NEURON, V32, P963, DOI 10.1016/S0896-6273(01)00545-1; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Kim CH, 1999, J NEUROSCI, V19, P4314; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ottersen OP, 2002, NATURE, V420, P751, DOI 10.1038/420751a; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; ROELANDSE M, IN PRESS NEUROSCIENC; Rothkegel M, 1996, J CELL SCI, V109, P83; Rumpel S, 1998, J NEUROSCI, V18, P8863; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	50	208	212	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1194	1200		10.1038/nn1135	http://dx.doi.org/10.1038/nn1135			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555951				2022-12-28	WOS:000186229200019
J	Wang, J; Liu, SH; Fu, YP; Wang, JH; Lu, YM				Wang, J; Liu, SH; Fu, YP; Wang, JH; Lu, YM			Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors	NATURE NEUROSCIENCE			English	Article							EXCITATORY AMINO-ACIDS; DELAYED NEURONAL DEATH; NITRIC-OXIDE SYNTHASE; MOLECULAR-MECHANISMS; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; AMPA RECEPTORS; GLUTAMATE; NEUROTOXICITY; CALCIUM	CA1 pyramidal neurons degenerate after transient forebrain ischemia, whereas neurons in other regions of the hippocampus remain intact. Here we show that in rat hippocampal CA1 neurons, forebrain ischemia induces the phosphorylation of the N-methyl-D-aspartate (NMDA) receptor 2A subunit at Ser1232 (phospho-Ser1232). Ser1232 phosphorylation is catalyzed by cyclin-dependent kinase 5 (Cdk5). Inhibiting endogenous Cdk5, or perturbing interactions between Cdk5 and NR2A subunits, abolished NR2A phosphorylation at Ser1232 and protected CA1 pyramidal neurons from ischemic insult. Thus, we conclude that modulation of NMDA receptors by Cdk5 is the primary intracellular event underlying the ischemic injury of CA1 pyramidal neurons.	Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Neurosci Res Grp, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Lu, YM (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	luy@ucalgary.ca						Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; ANDINE P, 1988, J CEREBR BLOOD F MET, V8, P799, DOI 10.1038/jcbfm.1988.135; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1992, J BIOL CHEM, V267, P13383; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Liu HN, 2002, J NEUROCHEM, V82, P398, DOI 10.1046/j.1471-4159.2002.00981.x; Liu SH, 2003, J NEUROSCI, V23, P732; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mitani A, 1998, J CEREBR BLOOD F MET, V18, P1088, DOI 10.1097/00004647-199810000-00005; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Wang Fuhu, 2001, Expert Opin Ther Targets, V5, P557; Wang J, 2003, J NEUROSCI, V23, P826; Zhu DY, 2003, J NEUROSCI, V23, P223	50	203	237	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1039	1047		10.1038/nn1119	http://dx.doi.org/10.1038/nn1119			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502288				2022-12-28	WOS:000185633600015
J	Bota, M; Dong, HW; Swanson, LW				Bota, M; Dong, HW; Swanson, LW			From gene networks to brain networks	NATURE NEUROSCIENCE			English	Editorial Material							CONNECTIONS; NEURONS	The brain's structural organization is so complex that 2,500 years of analysis leaves pervasive uncertainty about (i) the identity of its basic parts (regions with their neuronal cell types and pathways interconnecting them), (ii) nomenclature, (iii) systematic classification of the parts with respect to topographic relationships and functional systems and (iv) the reliability of the connectional data itself. Here we present a prototype knowledge management system (http:// brancusi.usc.edu/bkms/) for analyzing the architecture of brain networks in a systematic, interactive and extendable way. It supports alternative interpretations and models, is based on fully referenced and annotated data and can interact with genomic and functional knowledge management systems through web services protocols.	Univ So Calif, NIBS Neurosci Program, Los Angeles, CA 90089 USA	University of Southern California	Swanson, LW (corresponding author), Univ So Calif, NIBS Neurosci Program, 3641 Watt Way, Los Angeles, CA 90089 USA.	lswanson@usc.edu	Wang, Charles/B-5565-2011	Wang, Charles/0000-0001-9331-8437				[Anonymous], [No title captured]; [Anonymous], 1996, HUMAN BRAIN SPINAL C; ARMSTRONG DM, 1983, J COMP NEUROL, V216, P53, DOI 10.1002/cne.902160106; Burns GAPC, 2000, PHILOS T R SOC B, V355, P55, DOI 10.1098/rstb.2000.0549; Burns GAPC, 2001, PHILOS T R SOC B, V356, P1187, DOI 10.1098/rstb.2001.0909; COWAN WM, 1965, J NEUROL NEUROSUR PS, V28, P137, DOI 10.1136/jnnp.28.2.137; Dashti AE, 1997, NEUROIMAGE, V5, P97, DOI 10.1006/nimg.1996.0253; Davidson E. H., 2001, DEV EVOLUTION; EGENHOFER MJ, 1991, INT J GEOGR INF SYST, V5, P161, DOI 10.1080/02693799108927841; Finger S., 1994, ORIGINS NEUROSCIENCE; Golgi C, 1873, GAZZ MED ITAL LOMBAR, V33, P244; Grey L.J., 1994, BRODMANNS LOCALIZATI; GRITTI I, 1993, J COMP NEUROL, V329, P438, DOI 10.1002/cne.903290403; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Kandel E., 2000, PRINCIPLES NEURAL SC; Meyer A., 1971, HIST ASPECTS CEREBRA; NAUTA W J H, 1969, P136; NAUTA WJH, 1952, STAIN TECHNOL, V27, P175, DOI 10.3109/10520295209105080; RAISMAN G, 1965, BRAIN, V88, P963, DOI 10.1093/brain/88.5.963; RAISMAN G, 1966, BRIT MED BULL, V22, P197, DOI 10.1093/oxfordjournals.bmb.a070473; RAISMAN G, 1966, BRAIN, V89, P83, DOI 10.1093/brain/89.1.83; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Steno N., 1965, LECT ANATOMY BRAIN; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Swanson L.W., 2000, BRAIN MAPPING SYSTEM, P77, DOI DOI 10.1016/B978-012692545-6/50005-2; Swanson L. W., 2003, BRAIN ARCHITECTURE U; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; SWANSON LW, 1995, TRENDS NEUROSCI, V18, P471, DOI 10.1016/0166-2236(95)92766-J; Swanson LW, 2000, TRENDS NEUROSCI, V23, P519, DOI 10.1016/S0166-2236(00)01639-8; Swanson LW, 1999, BRAIN RES BULL, V50, P397, DOI 10.1016/S0361-9230(99)00163-X; Swanson LW, 1999, BRAIN MAPS STRUCTURE; Vesalius Andreas, 1543, DE HUMANI CORPORIS F, p4r; Watson J.D., 1968, DOUBLE HELIX PERSONA; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wilder BG, 1896, J COMP NEUROL, V6, P216, DOI DOI 10.1002/CNE.910060306; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	84	86	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					795	799		10.1038/nn1096	http://dx.doi.org/10.1038/nn1096			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12886225				2022-12-28	WOS:000184413700006
J	Hoshi, N; Zhang, JS; Omaki, M; Takeuchi, T; Yokoyama, S; Wanaverbecq, N; Langeberg, LK; Yoneda, Y; Scott, JD; Brown, DA; Higashida, H				Hoshi, N; Zhang, JS; Omaki, M; Takeuchi, T; Yokoyama, S; Wanaverbecq, N; Langeberg, LK; Yoneda, Y; Scott, JD; Brown, DA; Higashida, H			AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; PROTEIN-KINASE-C; POTASSIUM CHANNEL SUBUNITS; M-CURRENT INHIBITION; ANCHORING PROTEIN; K+ CHANNELS; LINOPIRDINE DUP-996; CA2+ CHANNELS; MODULATION; RECEPTORS	M-type (KCNQ2/3) potassium channels are suppressed by activation of G(q/11)-coupled receptors, thereby increasing neuronal excitability. We show here that rat KCNQ2 can bind directly to the multivalent A-kinase-anchoring protein AKAP150. Peptides that block AKAP150 binding to the KCNQ2 channel complex antagonize the muscarinic inhibition of the currents. A mutant form of AKAP150, AKAP(DeltaA), which is unable to bind protein kinase C (PKC), also attenuates the agonist-induced current suppression. Analysis of recombinant KCNQ2 channels suggests that targeting of PKC through association with AKAP150 is important for the inhibition. Phosphorylation of KCNQ2 channels was increased by muscarinic stimulation; this was prevented either by coexpression with AKAP(DeltaA) or pretreatment with PKC inhibitors that compete with diacylglycerol. These inhibitors also reduced muscarinic inhibition of M-current. Our data indicate that AKAP150-bound PKC participates in receptor-induced inhibition of the M-current.	Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Kanazawa Univ, Fac Pharmaceut Sci, Dept Mol Pharmacol, Kanazawa, Ishikawa 9200934, Japan; UCL, Dept Pharmacol, London WC1E 6BT, England	Kanazawa University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Kanazawa University; University of London; University College London	Hoshi, N (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	hoshin@ohsu.edu	Yoneda, Yukio/ABI-1864-2020; Brown, David A/J-9019-2012; higashida, haruhiro/L-3773-2015	Yoneda, Yukio/0000-0002-4624-177X; higashida, haruhiro/0000-0002-1779-0606; Wanaverbecq, Nicolas/0000-0001-5486-2771	NIGMS NIH HHS [R37 GM048231, GM48231, R01 GM048231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brown D A, 1988, Ion Channels, V1, P55; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Delmas P, 1998, J PHYSIOL-LONDON, V506, P319, DOI 10.1111/j.1469-7793.1998.319bw.x; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Haley JE, 1998, J NEUROSCI, V18, P4521; Haley JE, 2000, J NEUROSCI, V20; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; Hoshi N, 1998, J BIOL CHEM, V273, P23080, DOI 10.1074/jbc.273.36.23080; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Lamas JA, 1997, EUR J NEUROSCI, V9, P605, DOI 10.1111/j.1460-9568.1997.tb01637.x; Marrion NV, 1996, NEURON, V16, P163, DOI 10.1016/S0896-6273(00)80033-1; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; SACHS CW, 1995, J BIOL CHEM, V270, P26639, DOI 10.1074/jbc.270.44.26639; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Sik A, 2000, EUR J NEUROSCI, V12, P1155, DOI 10.1046/j.1460-9568.2000.00002.x; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Takahashi Y, 1999, J PHYSIOL-LONDON, V521, P567, DOI 10.1111/j.1469-7793.1999.00567.x; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93	50	191	195	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					564	571		10.1038/nn1062	http://dx.doi.org/10.1038/nn1062			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754513	Green Accepted			2022-12-28	WOS:000183140400012
J	Roska, B; Werblin, F				Roska, B; Werblin, F			Rapid global shifts in natural scenes block spiking in specific ganglion cell types	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; POLYAXONAL AMACRINE CELLS; MACAQUE MONKEY RETINA; INNER PLEXIFORM LAYER; CONE BIPOLAR CELLS; MAMMALIAN RETINA; RABBIT RETINA; MORPHOLOGICAL CLASSIFICATION; LATERAL INTERACTIONS; PRIMATE RETINA	The mammalian retina contains more than a dozen different ganglion cell types, each with dendrites ramifying at different strata within the inner plexiform layer (IPL) and each carrying a unique representation of the visual world. We studied the inhibitory and excitatory inputs, as well as the spiking output, of each of the rabbit retinal ganglion cell type during rapid global shifts in 'natural' videos designed to mimic saccadic eye movements. These shifts generated stratum-specific transient inhibitory activity, affecting only those ganglion cells whose dendrites ramify within the central strata of the IPL. The inhibition was GABA-mediated, acted both pre- and postsynaptically and was fast enough to either prevent or delay spiking. These findings indicate that the fast, transient elevation of visual threshold during rapid shifts in scene has a significant retinal component.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Semmelweis Univ, Dept Biochem Med, H-1088 Budapest, Hungary	University of California System; University of California Berkeley; Semmelweis University	Roska, B (corresponding author), Harvard Univ, Harvard Soc Fellows, 78 Mt Auburn St, Cambridge, MA 02138 USA.		Roska, Botond/AAD-7268-2021					ARKIN MS, 1988, J COMP NEUROL, V270, P185, DOI 10.1002/cne.902700204; BARLOW HB, 1977, J PHYSIOL-LONDON, V269, P177, DOI 10.1113/jphysiol.1977.sp011898; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Cohen ED, 1998, J NEUROPHYSIOL, V80, P2975, DOI 10.1152/jn.1998.80.6.2975; COLLEWIJN H, 1977, J PHYSIOL-LONDON, V266, P471, DOI 10.1113/jphysiol.1977.sp011778; Cook PB, 1998, J NEUROSCI, V18, P2301; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V302, P49; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P391, DOI 10.1002/cne.903160402; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; FISCHER B, 1975, BRAIN RES, V83, P391, DOI 10.1016/0006-8993(75)90832-X; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; HUGHES A, 1971, DOC OPHTHALMOL, V30, P33, DOI 10.1007/BF00142518; Huxlin KR, 1997, J COMP NEUROL, V385, P309; KOCK JH, 1989, VISION RES, V29, P1, DOI 10.1016/0042-6989(89)90169-7; KOLB H, 1992, J COMP NEUROL, V318, P147, DOI 10.1002/cne.903180204; MACKAY DM, 1970, NATURE, V225, P90, DOI 10.1038/225872a0; Macneil MA, 1999, J COMP NEUROL, V413, P305; Mangrum WI, 2002, VISUAL NEUROSCI, V19, P767, DOI 10.1017/S0952523802196076; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; McGillem GS, 2001, VISUAL NEUROSCI, V18, P675, DOI 10.1017/S0952523801185019; MCILWAIN JT, 1966, EXP BRAIN RES, V1, P265; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; NODA H, 1975, J PHYSIOL-LONDON, V249, P87, DOI 10.1113/jphysiol.1975.sp011004; NODA H, 1974, BRAIN RES, V70, P340, DOI 10.1016/0006-8993(74)90323-0; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; POURCHO RG, 1983, J COMP NEUROL, V219, P25, DOI 10.1002/cne.902190104; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; RIGGS LA, 1974, VISION RES, V14, P997, DOI 10.1016/0042-6989(74)90169-2; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P101, DOI 10.1113/jphysiol.1978.sp012295; VANEY DI, 1988, PROC R SOC SER B-BIO, V235, P203, DOI 10.1098/rspb.1988.0072; Volgyi B, 2001, J COMP NEUROL, V440, P109, DOI 10.1002/cne.1373; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P88, DOI 10.1085/jgp.63.1.88; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P987, DOI 10.1152/jn.1969.32.6.987	50	94	95	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					600	608		10.1038/nn1061	http://dx.doi.org/10.1038/nn1061			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12740583				2022-12-28	WOS:000183140400017
J	Foxton, JM; Talcott, JB; Witton, C; Brace, H; McIntyre, F; Griffiths, TD				Foxton, JM; Talcott, JB; Witton, C; Brace, H; McIntyre, F; Griffiths, TD			Reading skills are related to global, but not local, acoustic pattern perception	NATURE NEUROSCIENCE			English	Article							INFANTS PERCEPTION; MELODIES; CONTOUR		Univ Newcastle Upon Tyne, Auditory Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Aston Univ, Behav & Cognit Sci Res Grp, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	Newcastle University - UK; Aston University	Foxton, JM (corresponding author), Univ Newcastle Upon Tyne, Auditory Grp, Sch Neurol Neurobiol & Psychiat, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			Griffiths, Timothy/0000-0001-8066-4381; Witton, Caroline/0000-0002-5610-4234				Bolinger D., 1958, WORD, V14, P109; DOWLING WJ, 1971, J ACOUST SOC AM, V49, P524, DOI 10.1121/1.1912382; France SJ, 2002, PERCEPT PSYCHOPHYS, V64, P169, DOI 10.3758/BF03195783; GIMSON AC, 1956, Z PHON, V9, P143; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; MORTON J, 1965, LANG SPEECH, V8, P159, DOI 10.1177/002383096500800303; Nelson H., 1991, NATL ADULT READING T; Olson R., 1994, FRAMES REFERENCE ASS, P243; Raven J.C., 1988, RAVENS PROGR MATRICE; SNOWLING MJ, 1981, PSYCHOL RES-PSYCH FO, V43, P219, DOI 10.1007/BF00309831; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TREHUB SE, 1984, CHILD DEV, V55, P821, DOI 10.2307/1130133; TREHUB SE, 1987, CHILD DEV, V58, P741, DOI 10.1111/j.1467-8624.1987.tb01414.x; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3	14	66	68	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					343	344		10.1038/nn1035	http://dx.doi.org/10.1038/nn1035			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12652304				2022-12-28	WOS:000181833100010
J	Sesti, F; Rajan, S; Gonzalez-Colaso, R; Nikolaeva, N; Goldstein, SAN				Sesti, F; Rajan, S; Gonzalez-Colaso, R; Nikolaeva, N; Goldstein, SAN			Hyperpolarization moves S4 sensors inward to open MVP, a methanococcal voltage-gated potassium channel	NATURE NEUROSCIENCE			English	Article							SHAKER K+ CHANNEL; 2 PORE DOMAINS; ION CHANNELS; SACCHAROMYCES-CEREVISIAE; CYCLIC-NUCLEOTIDE; PACEMAKER CHANNELS; SELECTIVITY FILTER; PLASMA-MEMBRANE; SODIUM-CHANNELS; KILLER TOXIN	MVP, a Methanococcus jannaschii voltage-gated potassium channel, was cloned and shown to operate in eukaryotic and prokaryotic cells. Like Pacemaker channels, MVP opens on hyperpolarization using S4 voltage sensors like those in classical channels activated by depolarization. The MVP S4 span resembles classical sensors in sequence, charge, topology and movement, traveling inward on hyperpolarization and outward on depolarization (via canaliculi in the protein that bring the extracellular and internal solutions into proximity across a short barrier). Thus, MVP opens with sensors inward indicating a reversal of S4 position and pore state compared to classical channels. Homologous channels in mammals and plants are expected to function similarly.	Yale Univ, Sch Med, Dept Pediat, Boyer Ctr Mol Med, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, Boyer Ctr Mol Med, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Dept Pediat, Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.		Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Hoth S, 1999, J BIOL CHEM, V274, P11599, DOI 10.1074/jbc.274.17.11599; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Saimi Y, 1999, Methods Enzymol, V294, P507; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sesti F, 2001, CELL, V105, P637, DOI 10.1016/S0092-8674(01)00376-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zei PC, 1998, J GEN PHYSIOL, V112, P679, DOI 10.1085/jgp.112.6.679; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	50	37	40	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					353	361		10.1038/nn1028	http://dx.doi.org/10.1038/nn1028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640457	Green Submitted			2022-12-28	WOS:000181833100012
J	Thompson, SM				Thompson, SM			Ephrins keep dendritic spines in shape	NATURE NEUROSCIENCE			English	Editorial Material							NEURAL DEVELOPMENT; EPH RECEPTORS; ESTROUS-CYCLE; HIPPOCAMPAL		Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Thompson, Scott M/K-8921-2015					Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; KLINTSOVA A, 1995, BRAIN RES, V690, P269, DOI 10.1016/0006-8993(95)00642-4; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; SCHEIBEL ME, 1974, EPILEPSIA, V9, P89; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549	15	16	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					103	104		10.1038/nn0203-103	http://dx.doi.org/10.1038/nn0203-103			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12555099				2022-12-28	WOS:000180669100003
J	Levkowitz, G; Zeller, J; Sirotkin, HI; French, D; Schilbach, S; Hashimoto, H; Hibi, M; Talbot, WS; Rosenthal, A				Levkowitz, G; Zeller, J; Sirotkin, HI; French, D; Schilbach, S; Hashimoto, H; Hibi, M; Talbot, WS; Rosenthal, A			Zinc finger protein too few controls the development of monoaminergic neurons	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; ZEBRAFISH FOREBRAIN; GENE; EXPRESSION; DROSOPHILA; DIFFERENTIATION; SPECIFICATION; INDUCTION; SIGNALS; EMBRYOS	The mechanism controlling the development of dopaminergic (DA) and serotonergic (5HT) neurons in vertebrates is not well understood. Here we characterized a zebrafish mutant-too few (too-that develops hindbrain 5HT and noradrenergic neurons, but does not develop hypothalamic DA and 5HT neurons. tof encodes a forebrain-specific zinc finger transcription repressor that is homologous to the mammalian Fezl (forebrain embryonic zinc finger-like protein). Mosaic and co-staining analyses showed that fezi was not expressed in DA or 5HT neurons and instead controlled development of these neurons non-cell-autonomously. Both the eh1-related repressor motif and the second zinc finger domain were necessary for tof function. Our results indicate that tof/fezi is a key component in regulating the development of monoaminergic neurons in the vertebrate brain.	Rinat Neurosci Corp, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Osaka Univ, Biomed Res Ctr, Div Mol Oncol, Suita, Osaka 5650871, Japan; RIKEN, Ctr Dev Biol, Lab Vertebrate Axis Format, Chuoh Ku, Kobe, Hyogo 6500047, Japan	Stanford University; Roche Holding; Genentech; Osaka University; RIKEN	Levkowitz, G (corresponding author), Rinat Neurosci Corp, 3155 Porter Dr, Palo Alto, CA 94304 USA.		Levkowitz, Gil/AAB-9441-2019; Hibi, Masahiko/I-6215-2014	Levkowitz, Gil/0000-0002-3896-1881; Hibi, Masahiko/0000-0002-9142-4444	NCRR NIH HHS [RR12349] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012349] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Chen WB, 2001, DEVELOPMENT, V128, P2385; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kandel ER, 1991, PRINCIPLES NEURAL SC, P1135; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lundell MJ, 1998, DEVELOPMENT, V125, P463; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Quint E, 2000, J EXP ZOOL, V288, P235, DOI 10.1002/1097-010X(20001015)288:3&lt;235::AID-JEZ4&gt;3.0.CO;2-J; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Wullimann MF, 2001, DEV BRAIN RES, V131, P173, DOI 10.1016/S0165-3806(01)00270-X; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	30	79	81	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					28	33		10.1038/nn979	http://dx.doi.org/10.1038/nn979			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469125				2022-12-28	WOS:000180089300012
J	Dawson, TM; Dawson, VL				Dawson, TM; Dawson, VL			Neuroprotective and neurorestorative strategies for Parkinson's disease	NATURE NEUROSCIENCE			English	Review							ALPHA-SYNUCLEIN; 2 PARTS; GDNF; AGGREGATION; GENETICS; THERAPY; MODELS; STRESS	Advances in understanding the molecular mechanisms of cell death and the pathogenesis of sporadic and familial Parkinson's disease are creating new opportunities for the development of neuroprotective and/or neurorestorative therapies. Here we review many of these advances, highlighting areas and strategies that might be particularly suited to the development of innovative approaches that prevent degeneration and/or restore function in Parkinson's disease.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A, 2000, NAT MED, V6, P1207, DOI 10.1038/81291; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Date I, 2001, CELL TRANSPLANT, V10, P397; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Dunnett SB, 2001, NAT REV NEUROSCI, V2, P365, DOI 10.1038/35072572; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Lavedan C, 2002, NEUROSCI LETT, V322, P57, DOI 10.1016/S0304-3940(01)02513-7; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Mayor S, 2002, BRIT MED J, V324, P997; McKay R, 2002, ANN NY ACAD SCI, V961, P44, DOI 10.1111/j.1749-6632.2002.tb03045.x; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Polymeropoulos MH, 2000, ANN NY ACAD SCI, V920, P28; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Wolfe Michael S., 2002, Current Topics in Medicinal Chemistry, V2, P371, DOI 10.2174/1568026024607535; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319	35	138	160	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1058	1061		10.1038/nn941	http://dx.doi.org/10.1038/nn941			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403986				2022-12-28	WOS:000179041300014
J	Scott, SH				Scott, SH			Optimal strategies for movement: success with variability	NATURE NEUROSCIENCE			English	Editorial Material							COORDINATION; PATTERNS	A new theory suggests the motor system acts as an optimal feedback controller and predicts such coordination features as task-constrained variability and goal-directed corrections.	Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada.	steve@biomed.queensu.ca						CLAMANN HP, 1969, BIOPHYS J, V9, P1233, DOI 10.1016/S0006-3495(69)86448-9; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Haggard P, 1995, EXP BRAIN RES, V107, P254; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; SCOTT SH, 1994, J NEUROSCI, V14, P7529; SHERWOOD DE, 1988, J MOTOR BEHAV, V20, P106; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	12	19	19	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1110	1111		10.1038/nn1102-1110	http://dx.doi.org/10.1038/nn1102-1110			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404002				2022-12-28	WOS:000178884600008
J	Carruth, LL; Reisert, I; Arnold, AP				Carruth, LL; Reisert, I; Arnold, AP			Sex chromosome genes directly affect brain sexual differentiation	NATURE NEUROSCIENCE			English	Article							DOPAMINERGIC-NEURONS; MOUSE-BRAIN; TESTOSTERONE; INVITRO		Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Neuroendocrinol Lab, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Ulm, Anat & Zellbiol Abt, D-89081 Ulm, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University	Arnold, AP (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA.			Arnold, Arthur/0000-0002-9908-9767	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059268] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59268] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnold AP., 2002, HORMONES BRAIN BEHAV, P105, DOI 10.1016/B978-012532104-4/50065-2; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BEYER C, 1992, CELL TISSUE RES, V270, P547, DOI 10.1007/BF00645057; DEVRIES GJ, IN PRESS J NEUROSCI; Dluzen D E, 2000, J Gend Specif Med, V3, P36; Lahr Georgia, 1995, Molecular Brain Research, V33, P179, DOI 10.1016/0169-328X(95)00136-G; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; PICON R, 1976, J ENDOCRINOL, V71, P231, DOI 10.1677/joe.0.0710231; PILGRIM C, 1992, HORM METAB RES, V24, P353, DOI 10.1055/s-2007-1003334; REISERT I, 1991, TRENDS NEUROSCI, V14, P467; Sibug R, 1996, DEV BRAIN RES, V93, P136, DOI 10.1016/0165-3806(96)00024-7; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	14	221	225	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					933	934		10.1038/nn922	http://dx.doi.org/10.1038/nn922			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244322				2022-12-28	WOS:000178242200009
J	Yantis, S; Schwarzbach, J; Serences, JT; Carlson, RL; Steinmetz, MA; Pekar, JJ; Courtney, SM				Yantis, S; Schwarzbach, J; Serences, JT; Carlson, RL; Steinmetz, MA; Pekar, JJ; Courtney, SM			Transient neural activity in human parietal cortex during spatial attention shifts	NATURE NEUROSCIENCE			English	Article							MULTIPLE-STIMULUS DISPLAYS; VISUAL-ATTENTION; BRAIN ACTIVITY; AREA 7A; SELECTIVE ATTENTION; NEURONAL RESPONSES; DIRECTED ATTENTION; MECHANISMS; MODULATION; SYSTEMS	Observers viewing a complex visual scene selectively attend to relevant locations or objects and ignore irrelevant ones. Selective attention to an object enhances its neural representation in extrastriate cortex, compared with those of unattended objects, via top-down attentional control signals. The posterior parietal cortex is centrally involved in this control of spatial attention. We examined brain activity during attention shifts using rapid, event-related fMRI of human observers as they covertly shifted attention between two peripheral spatial locations. Activation in extrastriate cortex increased after a shift of attention to the contralateral visual field and remained high during sustained contralateral attention. The time course of activity was substantially different in posterior parietal cortex, where transient increases in activation accompanied shifts of attention in either direction. This result suggests that activation of the parietal cortex is associated with a discrete signal to shift spatial attention, and is not the source of a signal to continuously maintain the current attentive state.	Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Yantis, S (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	yantis@jhu.edu	Yantis, Steven/A-7488-2009; Schwarzbach, Jens/D-1776-2010	Pekar, James/0000-0002-9830-0655	NCRR NIH HHS [P41-RR15241] Funding Source: Medline; NIDA NIH HHS [R01-DA13165] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013165] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Constantinidis C, 2001, CEREB CORTEX, V11, P592, DOI 10.1093/cercor/11.7.592; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Goebel R, 1993, ADV NEURAL INFORMATI, V5, P903; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LABERGE D, 1990, J NEUROSCI, V10, P613; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; POSNER MI, 1984, J NEUROSCI, V4, P1863; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sperling G., 1980, ATTENTION PERFORM, P347; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812	46	539	548	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					995	1002		10.1038/nn921	http://dx.doi.org/10.1038/nn921			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219097				2022-12-28	WOS:000178242200019
J	Birder, LA; Nakamura, Y; Kiss, S; Nealen, ML; Barrick, S; Kanai, AJ; Wang, E; Ruiz, G; de Groat, WC; Apodaca, G; Watkins, S; Caterina, MJ				Birder, LA; Nakamura, Y; Kiss, S; Nealen, ML; Barrick, S; Kanai, AJ; Wang, E; Ruiz, G; de Groat, WC; Apodaca, G; Watkins, S; Caterina, MJ			Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1	NATURE NEUROSCIENCE			English	Article							INTRAVESICAL CAPSAICIN; PAIN; RESINIFERATOXIN; RELEASE; CHANNEL; REFLEX; CELLS; ATP	In the urinary bladder, the capsaicin-gated ion channel TRPV1 is expressed both within afferent nerve terminals and within the epithelial cells that line the bladder lumen. To determine the significance of this expression pattern, we analyzed bladder function in mice lacking TRPV1. Compared with wild-type littermates, trpv1(-/-) mice had a higher frequency of low-amplitude, nonvoiding bladder contractions. This alteration was accompanied by reductions in both spinal cord signaling and reflex voiding during bladder filling (under anesthesia). In vitro, stretch-evoked ATP release and membrane capacitance changes were diminished in bladders excised from trpv1(-/-) mice, as was hypoosmolality-evoked ATP release from cultured trpv1(-/-) urothelial cells. These findings indicate that TRPV1 participates in normal bladder function and is essential for normal mechanically evoked purinergic signaling by the urothelium.	Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div,Lab Epithelial Cell Biol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA; Kanazawa Univ, Sch Med, Dept Urol, Kanazawa, Ishikawa 9208641, Japan; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kanazawa University; Johns Hopkins University; Johns Hopkins University	Birder, LA (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div,Lab Epithelial Cell Biol, Pittsburgh, PA 15213 USA.	lbirder@pitt.edu	Barrick, Stacey/J-1595-2015; Watkins, Simon/ABG-2590-2021; Apodaca, Gerard/HCJ-0048-2022; Barrick, Stacey/E-7130-2010	Watkins, Simon/0000-0003-4092-1552; Barrick, Stacey/0000-0002-4837-3741	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054824, R01DK057284, R01DK054425] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL57985] Funding Source: Medline; NIDDK NIH HHS [R01 DK54824, R01 DK57284, R01 DK54425] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Avelino A, 2002, NEUROSCIENCE, V109, P787, DOI 10.1016/S0306-4522(01)00496-1; Birder LA, 1998, AM J PHYSIOL-RENAL, V275, pF226, DOI 10.1152/ajprenal.1998.275.2.F226; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chancellor MB, 2000, UROLOGY, V55, P65, DOI 10.1016/S0090-4295(99)00499-9; Cheng CL, 1999, AM J PHYSIOL-REG I, V277, pR786, DOI 10.1152/ajpregu.1999.277.3.R786; Chuang YC, 2001, AM J PHYSIOL-REG I, V281, pR1302, DOI 10.1152/ajpregu.2001.281.4.R1302; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; de Groat WC, 2001, ANNU REV PHARMACOL, V41, P691, DOI 10.1146/annurev.pharmtox.41.1.691; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fovaeus M, 1998, ACTA PHYSIOL SCAND, V162, P115; Fowler CJ, 2000, UROLOGY, V55, P60, DOI 10.1016/S0090-4295(99)00498-7; Lazzeri M, 1996, J UROLOGY, V156, P947, DOI 10.1016/S0022-5347(01)65669-6; Lecci A, 2001, AUTON NEUROSCI-BASIC, V91, P37, DOI 10.1016/S1566-0702(01)00303-4; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MAGGI CA, 1984, EUR J PHARMACOL, V103, P41, DOI 10.1016/0014-2999(84)90187-0; MAGGI CA, 1986, J UROLOGY, V136, P696, DOI 10.1016/S0022-5347(17)45030-0; Namasivayam S, 1999, BJU INT, V84, P854; SANTICIOLI P, 1985, J UROLOGY, V133, P700, DOI 10.1016/S0022-5347(17)49164-6; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001	26	512	553	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					856	860		10.1038/nn902	http://dx.doi.org/10.1038/nn902			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161756				2022-12-28	WOS:000177656300015
J	Bosking, WH; Crowley, JC; Fitzpatrick, D				Bosking, WH; Crowley, JC; Fitzpatrick, D			Spatial coding of position and orientation in primary visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; OCULAR DOMINANCE; MACAQUE MONKEY; SUPERIOR COLLICULUS; CAT AREA-17; MAPS; ORGANIZATION; FIELD; SELECTIVITY; REPRESENTATION	We examined the spatial distribution of population activity in primary visual cortex (V1) of tree shrews with optical imaging and electrophysiology. A line stimulus, thinner than the average V1 receptive field, evoked a broad strip of neural activity of nearly constant size for all stimulus locations tested within the central 10degrees of visual space. Stimuli in adjacent positions activated highly overlapping populations of neurons; nevertheless, small changes in stimulus position produced orderly changes in the location of the peak of the population response. Statistically significant shifts in the population response were found for stimulus displacements an order of magnitude smaller than receptive field width, down to the limit of optical imaging resolution. Based on the pattern of population activity, we conclude that the map of visual space in V1 is orderly at a fine scale and has uniform coverage of position and orientation without local relationships in the mapping of these features.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.				NEI NIH HHS [EY06821] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; [Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; BALDI P, 1988, BIOL CYBERN, V59, P313, DOI 10.1007/BF00332921; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; CREUTZFELDT OD, 1974, EXP BRAIN RES, V21, P251; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; Groh JM, 1997, J NEUROSCI, V17, P4312; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; Hinton G. E., 1986, FOUNDATIONS, V1, P77; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; Jancke D, 1999, J NEUROSCI, V19, P9016, DOI 10.1523/JNEUROSCI.19-20-09016.1999; KAAS JH, 1972, BRAIN RES, V42, P491, DOI 10.1016/0006-8993(72)90548-3; Kim DS, 1999, NEUROREPORT, V10, P2515, DOI 10.1097/00001756-199908200-00015; McIlwain J T, 2001, Prog Brain Res, V130, P3; MCILWAIN JT, 1991, VISUAL NEUROSCI, V6, P3, DOI 10.1017/S0952523800000857; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Shmuel A, 1996, J NEUROSCI, V16, P6945; SPARKS DL, 1976, BRAIN RES, V113, P21, DOI 10.1016/0006-8993(76)90003-2; SWINDALE NV, 1991, BIOL CYBERN, V65, P415, DOI 10.1007/BF00204654; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0	46	98	101	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					874	882		10.1038/nn908	http://dx.doi.org/10.1038/nn908			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195429				2022-12-28	WOS:000177656300018
J	Washbourne, P; Bennett, JE; McAllister, AK				Washbourne, P; Bennett, JE; McAllister, AK			Rapid recruitment of NMDA receptor transport packets to nascent synapses	NATURE NEUROSCIENCE			English	Article							INDIVIDUAL EXCITATORY SYNAPSES; CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; AMPA RECEPTORS; GLUTAMATE RECEPTORS; SILENT SYNAPSES; SPINE FORMATION; SYNAPTOGENESIS; DYNAMICS; VESICLE	Although many of the molecules involved in synaptogenesis have been identified, the sequence and kinetics of synapse assembly in the central nervous system (CNS) remain largely unknown. We used simultaneous time-lapse imaging of fluorescent glutamate receptor subunits and presynaptic proteins in rat cortical neurons in vitro to determine the dynamics and time course of N-methyl-D-aspartate receptor (NMDAR) recruitment to nascent synapses. We found that both NMDA and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunits are present in mobile transport packets in neurons before and during synaptogenesis. NMDAR transport packets are more mobile than AMPAR subunits, moving along microtubules at about 4 mum/min, and are recruited to sites of axodendritic contact within minutes. Whereas NMDAR recruitment to new synapses can be either concurrent with or independent of the protein PSD-95, AMPARs are recruited with a slower time course. Thus, glutamatergic synapses can form rapidly by the sequential delivery of modular transport packets containing glutamate receptors.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Ct, Davis, CA 95616 USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [R01 EY13584] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013584] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aarts LHJ, 1998, MOL BIOL CELL, V9, P1279, DOI 10.1091/mbc.9.6.1279; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 1996, J NEUROSCI, V16, P6424; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Niethammer M, 1996, J NEUROSCI, V16, P2157; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Rumpel S, 1998, J NEUROSCI, V18, P8863; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	50	192	204	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					751	759		10.1038/nn883	http://dx.doi.org/10.1038/nn883			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089529				2022-12-28	WOS:000177088900018
J	Nordstrom, U; Jessell, TM; Edlund, T				Nordstrom, U; Jessell, TM; Edlund, T			Progressive induction of caudal neural character by graded Wnt signaling	NATURE NEUROSCIENCE			English	Article							POSTERIOR NONAXIAL MESODERM; CENTRAL-NERVOUS-SYSTEM; CHICK-EMBRYO; ANTERIOR NEUROECTODERM; DYNAMIC EXPRESSION; PARAXIAL MESODERM; MOUSE EMBRYO; SPINAL-CORD; ZEBRAFISH; XENOPUS	Early in differentiation, all neural cells have a rostral character. Only later do posteriorly positioned neural cells acquire characteristics of caudal forebrain, midbrain and hindbrain cells. Caudalization of neural tissue in the chick embryo apparently involves the convergent actions of (i) fibroblast growth factor (FGF) signaling and (ii) signaling from the caudal paraxial mesoderm, or 'PMC activity', which has not yet been defined molecularly. Here we report evidence that Wnt signaling underlies PMC activity, and show that Wnt signals act directly and in a graded manner on anterior neural cells to induce their progressive differentiation into caudal forebrain, midbrain and hindbrain cells.	Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	Thomas.Edlund@molbiol.umu.se						Bang AG, 1997, DEVELOPMENT, V124, P2075; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Baranski M, 2000, DEV BIOL, V217, P25, DOI 10.1006/dbio.1999.9516; Bell E, 2001, DEV BIOL, V236, P76, DOI 10.1006/dbio.2001.0301; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Foley AC, 2000, DEVELOPMENT, V127, P3839; Foley AC, 1997, DEVELOPMENT, V124, P2983; Fredieu JR, 1997, DEV BIOL, V186, P100, DOI 10.1006/dbio.1997.8566; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; HUME CR, 1993, DEVELOPMENT, V119, P1147; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maden M, 1999, BIOESSAYS, V21, P809, DOI 10.1002/(SICI)1521-1878(199910)21:10<809::AID-BIES2>3.0.CO;2-0; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; NIETO MA, 1991, DEVELOPMENT, P59; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; Popperl H, 1997, DEVELOPMENT, V124, P2997; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shamim H, 1998, MECH DEVELOP, V76, P157, DOI 10.1016/S0925-4773(98)00102-6; Shibamoto S, 1998, GENES CELLS, V3, P659; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Storey KG, 1998, DEVELOPMENT, V125, P473; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	50	205	208	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					525	532		10.1038/nn854	http://dx.doi.org/10.1038/nn854			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006981				2022-12-28	WOS:000175874600011
J	Kennerley, SW; Diedrichsen, J; Hazeltine, E; Semjen, A; Ivry, RB				Kennerley, SW; Diedrichsen, J; Hazeltine, E; Semjen, A; Ivry, RB			Callosotomy patients exhibit temporal uncoupling during continuous bimanual movements	NATURE NEUROSCIENCE			English	Article							COORDINATION; DIRECTION; DYNAMICS	Rhythmic bimanual movements are highly constrained in the temporal domain, with the gestures of the two hands tightly synchronized. Previous studies have implicated a subcortical locus for temporal coupling based on the observation that these constraints persist in callosotomy patients. We now report that such coupling is restricted to movements entailing a discrete event (such as a movement onset). Three callosotomy patients exhibited a striking lack of temporal coupling during continuous movements, with the two hands oscillating at non-identical frequencies. We propose a subcortical locus of temporal coupling for movements involving discrete events. In contrast, synchronization between the hands during continuous movements depends on interhemispheric transmission across the corpus callosum.	Univ Calif Berkeley, Berkeley, CA 94720 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CNRS, Ctr Rech Neurosci Cognit, F-13402 Marseille, France	University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Centre National de la Recherche Scientifique (CNRS)	Ivry, RB (corresponding author), Univ Calif Berkeley, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.		Diedrichsen, Jörn/AAQ-2242-2020; Kennerley, Steven W/E-3330-2018; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Kennerley, Steven W/0000-0002-5696-7507; Diedrichsen, Jörn/0000-0003-0264-8532; Hazeltine, Richard/0000-0002-0893-5789	NINDS NIH HHS [R01 NS30256, P50 NS17778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778, R01NS030256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Carson RG, 1997, Q J EXP PSYCHOL-A, V50, P664, DOI 10.1080/027249897392062; Cattaert D, 1999, BIOL CYBERN, V81, P343, DOI 10.1007/s004220050567; Corballis PM, 2001, NEUROLOGY, V57, P1345, DOI 10.1212/WNL.57.7.1345; Eliassen JC, 1999, EXP BRAIN RES, V128, P573, DOI 10.1007/s002210050884; Eliassen JC, 2000, BRAIN, V123, P2501, DOI 10.1093/brain/123.12.2501; Fisher NI, 1995, STAT ANAL CIRCULAR D; Franz EA, 1996, PSYCHOL SCI, V7, P306, DOI 10.1111/j.1467-9280.1996.tb00379.x; Franz EA, 1997, Q J EXP PSYCHOL-A, V50, P684, DOI 10.1080/027249897392071; FRANZ EA, 1991, ACTA PSYCHOL, V77, P137, DOI 10.1016/0001-6918(91)90028-X; GAZZANIGA MS, 1985, NEUROLOGY, V35, P1763, DOI 10.1212/WNL.35.12.1763; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Ivry RB, 1999, HUM MOVEMENT SCI, V18, P345, DOI 10.1016/S0167-9457(99)00014-7; Ivry RB, 1998, J EXP PSYCHOL HUMAN, V24, P463, DOI 10.1037/0096-1523.24.2.463; IVRY RB, IN PRESS BRAIN COGN; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; KELSO JAS, 1983, Q J EXP PSYCHOL-A, V35, P347; Kelso S., 1995, DYNAMIC PATTERNS SEL; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Porter R, 1993, CORTICOSPINAL FUNCTI; PREILOWSKI BF, 1972, NEUROPSYCHOLOGIA, V10, P267, DOI 10.1016/0028-3932(72)90018-8; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; SEMJEN A, 1995, J EXP PSYCHOL HUMAN, V21, P1139, DOI 10.1037/0096-1523.21.5.1139; Serrien DJ, 2001, NEUROREPORT, V12, P2721, DOI 10.1097/00001756-200108280-00026; SIDTIS JJ, 1981, J NEUROSCI, V1, P323; TULLER B, 1989, EXP BRAIN RES, V75, P306; Verschueren SMP, 1999, EXP BRAIN RES, V127, P182, DOI 10.1007/s002210050788; ZAIDEL D, 1977, NEUROPSYCHOLOGIA, V15, P193, DOI 10.1016/0028-3932(77)90028-8; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370	32	151	153	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					376	381		10.1038/nn822	http://dx.doi.org/10.1038/nn822			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	534UQ	11914724				2022-12-28	WOS:000174606900019
J	Nadarajah, B; Alifragis, P; Wong, ROL; Parnavelas, JG				Nadarajah, B; Alifragis, P; Wong, ROL; Parnavelas, JG			Ventricle-directed migration in the developing cerebral cortex	NATURE NEUROSCIENCE			English	Article							TANGENTIAL CELL DISPERSION; CENTRAL-NERVOUS-SYSTEM; LOCAL CIRCUIT NEURONS; GANGLIONIC EMINENCE; BASAL FOREBRAIN; DLX GENES; NEOCORTEX; ZONE; SPECIFICATION; DEPENDENCE	It is believed that postmitotic neurons migrate away from their sites of origin in the germinal zones to populate distant targets. Contrary to this notion, we found, using time-lapse imaging of brain slices, populations of neurons positioned at various levels of the developing neocortex that migrate towards the cortical ventricular zone. After a pause in this proliferative zone, they migrate radially in the direction of the pial surface to take up positions in the cortical plate. Immunohistochemical analysis together with tracer labeling in brain slices showed that cells showing ventricle-directed migration in the developing cortex are GABAergic interneurons originating in the ganglionic eminence in the ventral telencephalon. We speculate that combinations of chemoattractant and chemorepellent molecules are involved in this ventricle-directed migration and that interneurons may seek the cortical ventricular zone to receive layer information.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of London; University College London; Washington University (WUSTL)	Parnavelas, JG (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	j.parnavelas@ucl.ac.uk		Alifragis, Pavlos/0000-0003-0844-2316				Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BERRY M, 1965, J ANAT, V99, P691; CAVANAGH ME, 1988, J COMP NEUROL, V268, P1, DOI 10.1002/cne.902680102; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Denaxa M, 2001, DEVELOPMENT, V128, P4635; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; KOMURO H, 1995, J NEUROSCI, V15, P1110; Lavdas AA, 1999, J NEUROSCI, V19, P7881; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Mione MC, 1997, J NEUROSCI, V17, P2018; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Neyt C, 1997, J NEUROSCI, V17, P9194; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; ORourke NA, 1997, DEVELOPMENT, V124, P997; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Wichterle H, 2001, DEVELOPMENT, V128, P3759	32	174	180	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					218	224		10.1038/nn813	http://dx.doi.org/10.1038/nn813			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850632				2022-12-28	WOS:000174146000011
J	Rico, B; Xu, BJ; Reichardt, LF				Rico, B; Xu, BJ; Reichardt, LF			TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; TARGETED DISRUPTION; INHIBITORY SYNAPSES; GRANULE NEURONS; NERVOUS-SYSTEM; IN-VIVO; BRAIN; BDNF; RAT; EXPRESSION	Neurotrophins are essential to the normal development and maintenance of the nervous system. Neurotrophin signaling is mediated by Trk family tyrosine kinases such as TrkA, TrkB and TrkC, as well as by the pan-neurotrophin receptor p75NTR. Here we have deleted the trkB gene in cerebellar precursors by Wnt1-driven Cre-mediated recombination to study the function of the TrkB in the cerebellum. Despite the absence of TrkB, the mature cerebellum of mutant mice appears similar to that of wild type, with all types of cell present in normal numbers and positions. Granule and Purkinje cell dendrites appear normal and the former have typical numbers of excitatory synapses. By contrast, inhibitory interneurons are strongly affected: although present in normal numbers, they express reduced amounts of GABAergic markers and develop reduced numbers of GABAergic boutons and synaptic specializations. Thus, TrkB is essential to the development of GABAergic neurons and regulates synapse formation in addition to its role in the development of axon terminals.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Rico, Beatriz/0000-0002-0581-851X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033, P01 NS016033-23] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ALTMAN J, 1976, J COMP NEUROL, V165, P65, DOI 10.1002/cne.901650106; ALTMAN J, 1976, J COMP NEUROL, V165, P49, DOI 10.1002/cne.901650105; Balkowiec A, 1998, J PHYSIOL-LONDON, V510, P527, DOI 10.1111/j.1469-7793.1998.527bk.x; Bao SW, 1999, LEARN MEMORY, V6, P276; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chai Y, 2000, DEVELOPMENT, V127, P1671; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fukuda T, 1998, J COMP NEUROL, V399, P424, DOI 10.1002/(SICI)1096-9861(19980928)399:3<424::AID-CNE10>3.0.CO;2-8; GAO WQ, 1995, J NEUROSCI, V15, P2656; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ito M, 1984, CEREBELLUM NEURAL CO; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Lindholm D, 1997, PERSPECT DEV NEUROBI, V5, P83; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Martinez A, 1998, J NEUROSCI, V18, P7336; Marty S, 2000, J NEUROSCI, V20, P8087; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; Morara S, 1996, NEUROREPORT, V7, P2993, DOI 10.1097/00001756-199611250-00039; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Palay S. L., 1974, CEREBELLAR CORTEX CY; Rabacchi SA, 1999, J NEUROBIOL, V40, P254, DOI 10.1002/(SICI)1097-4695(199908)40:2<254::AID-NEU11>3.0.CO;2-4; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shimada A, 1998, J NEUROSCI, V18, P8559; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TOJO H, 1995, NEUROSCI LETT, V192, P169, DOI 10.1016/0304-3940(95)11637-C; VALVERDE F, 1993, NEUROSCI PROTOCOLS, V1, P1; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; WIDMER HR, 1994, DEV BRAIN RES, V80, P279, DOI 10.1016/0165-3806(94)90114-7; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yan Q, 1997, J COMP NEUROL, V378, P135	46	166	168	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					225	233		10.1038/nn808	http://dx.doi.org/10.1038/nn808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836532	Green Accepted			2022-12-28	WOS:000174146000012
J	Grosshans, DR; Clayton, DA; Coultrap, SJ; Browning, MD				Grosshans, DR; Clayton, DA; Coultrap, SJ; Browning, MD			LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; GLUTAMATE RECEPTORS; DIFFERENTIAL DISTRIBUTION; SYNAPTIC-TRANSMISSION; SUBUNIT; NR1; TRAFFICKING; ACTIVATION	In the CA1 region of the rat hippocampus, long-term potentiation (LTP) requires the activation of NMDA receptors (NMDARs) and leads to an enhancement of AMPA receptor (AMPAR) function. In neonatal hippocampus, this increase in synaptic strength seems to be mediated by delivery of AMPARs to the synapse. Here we studied changes in surface expression of native AMPA and NMDA receptors following induction of LTP in the adult rat brain. In contrast to early postnatal rats, we find that LTP in the adult rat does not alter membrane association of AMPARs. Instead, LTP leads to rapid surface expression of NM DARs in a PKC- and Src-family-dependent manner. The present study suggests a developmental shift in the LTP-dependent trafficking of AMPA receptors. Moreover, our results indicate that insertion of NMDA receptors may be a key step in regulating synaptic plasticity.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Med Sci Training Program, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Browning, MD (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave Box C236, Denver, CO 80262 USA.	michael.browning@uchsc.edu			NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009675] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA09675] Funding Source: Medline; NIA NIH HHS [AG04418-17] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Chazot PL, 1997, J NEUROCHEM, V68, P507; DAVID V, 1993, J BIOL CHEM, V268, P9585; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Grosshans DR, 2001, J NEUROCHEM, V76, P737, DOI 10.1046/j.1471-4159.2001.00034.x; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Mammen AL, 1997, J NEUROSCI, V17, P7351; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Okabe S, 1999, J NEUROSCI, V19, P7781; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pickard L, 2000, J NEUROSCI, V20, P7922; PORTER RM, 1993, J PATHOL, V170, P435, DOI 10.1002/path.1711700406; Racca C, 2000, J NEUROSCI, V20, P2512; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Salter MW, 1998, BIOCHEM PHARMACOL, V56, P789, DOI 10.1016/S0006-2952(98)00124-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Snell LD, 1996, MOL BRAIN RES, V40, P71; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; STONE LM, 1994, J NEUROSCI, V14, P301; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Waters J, 2000, J NEUROSCI, V20, P7863; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	47	281	293	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					27	33		10.1038/nn779	http://dx.doi.org/10.1038/nn779			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740502				2022-12-28	WOS:000173031800011
